variant_id,relationship_type,assay_type,chembl_id,src_id,confidence_score,assay_tissue,bao_format,description,assay_organism,assay_category,cell_id,assay_cell_type,curated_by,src_assay_id,assay_strain,assay_test_type,assay_id,tissue_id,assay_tax_id,tid,doc_id,assay_subcellular_fraction
,N,A,CHEMBL618647,1,1,Kidney,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7524,2113.0,10116.0,50597,9866,
,N,A,CHEMBL618648,1,1,Kidney,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7525,2113.0,10116.0,50597,9866,
,N,A,CHEMBL618649,1,1,Kidney,BAO_0000218,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7526,2113.0,10116.0,50597,9866,
,N,A,CHEMBL618650,1,1,Liver,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7527,2107.0,10116.0,50597,9866,
,N,A,CHEMBL618651,1,1,Liver,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7528,2107.0,10116.0,50597,9866,
,N,A,CHEMBL876497,1,1,Liver,BAO_0000218,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7529,2107.0,10116.0,50597,9866,
,N,A,CHEMBL618652,1,1,Lung,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7530,2048.0,10116.0,50597,9866,
,N,A,CHEMBL618653,1,1,Lung,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7531,2048.0,10116.0,50597,9866,
,N,A,CHEMBL618654,1,1,Lung,BAO_0000218,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7532,2048.0,10116.0,50597,9866,
,N,A,CHEMBL618655,1,1,,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Rattus norvegicus,,,,Intermediate,,,,7533,,10116.0,50597,6351,
,N,A,CHEMBL618656,1,1,,BAO_0000218,Compound was tested for solubility in water,Rattus norvegicus,,,,Intermediate,,,,7534,,10116.0,50597,1465,
,U,P,CHEMBL618657,1,0,,BAO_0000100,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,,,Intermediate,,,,7535,,,22229,5182,
,N,A,CHEMBL618658,1,1,,BAO_0000218,Solubility was determined,Rattus norvegicus,,,,Intermediate,,,,7536,,10116.0,50597,17847,
,N,A,CHEMBL618659,1,1,,BAO_0000218,solubility in water (ug/mL) at 37 degree C.,Rattus norvegicus,,,,Intermediate,,,,7537,,10116.0,50597,15339,
,N,A,CHEMBL618660,1,1,,BAO_0000218,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Rattus norvegicus,,,,Intermediate,,,,7538,,10116.0,50597,5202,
,N,A,CHEMBL618661,1,1,,BAO_0000218,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Rattus norvegicus,,,,Intermediate,,,,7539,,10116.0,50597,1088,
,N,A,CHEMBL873807,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,7540,,10116.0,50597,3169,
,N,A,CHEMBL618662,1,1,,BAO_0000218,Half life in Dawley rat,Rattus norvegicus,,,,Intermediate,,,,7541,,10116.0,50597,5353,
,N,A,CHEMBL618663,1,1,,BAO_0000218,Half life period after 3 mg/kg iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7542,,10116.0,50597,2864,
,N,A,CHEMBL618664,1,1,,BAO_0000218,Half life period after 3 mg/kg iv administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7543,,10116.0,50597,2864,
,N,A,CHEMBL618665,1,1,,BAO_0000218,Half life period after 3 mg/kg iv administration in the rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7544,,10116.0,50597,2864,
,N,A,CHEMBL876498,1,1,,BAO_0000218,Half life period in female Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,,7545,,10116.0,50597,6362,
,N,A,CHEMBL618666,1,1,,BAO_0000218,Half life period in rat,Rattus norvegicus,,,,Intermediate,,,,7546,,10116.0,50597,6249,
,N,A,CHEMBL620440,1,1,,BAO_0000218,Half-life in rats was determined,Rattus norvegicus,,,,Intermediate,,,,7547,,10116.0,50597,3169,
,N,A,CHEMBL620441,1,1,,BAO_0000218,Half-life in rats with metabolic oxidation,Rattus norvegicus,,,,Intermediate,,,,7548,,10116.0,50597,3169,
,N,A,CHEMBL620442,1,1,,BAO_0000218,Half-life in rats,Rattus norvegicus,,,,Intermediate,,,,7549,,10116.0,50597,3169,
,N,A,CHEMBL620443,1,1,,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7550,,10116.0,50597,17260,
,N,A,CHEMBL620444,1,1,,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7551,,10116.0,50597,17260,
,N,A,CHEMBL620445,1,1,,BAO_0000218,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7552,,10116.0,50597,17260,
,N,A,CHEMBL620446,1,1,,BAO_0000218,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7553,,10116.0,50597,17260,
,N,A,CHEMBL620447,1,1,Plasma,BAO_0000218,Biological half-life measured in plasma of rat,Rattus norvegicus,,,,Intermediate,,,,7554,1969.0,10116.0,50597,2879,
,N,A,CHEMBL621129,1,1,Plasma,BAO_0000218,Biological half-life measured in plasma of rat; 22-25,Rattus norvegicus,,,,Intermediate,,,,7555,1969.0,10116.0,50597,2879,
,N,A,CHEMBL621130,1,1,Plasma,BAO_0000218,Biological half-life measured in plasma of rat; 9-16,Rattus norvegicus,,,,Intermediate,,,,7556,1969.0,10116.0,50597,2879,
,N,A,CHEMBL873808,1,1,,BAO_0000218,Compound was evaluated for its half life when administered intravenously in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7557,,10116.0,50597,3184,
,N,A,CHEMBL876598,1,1,,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Rattus norvegicus,,,,Intermediate,,,In vivo,7558,,10116.0,50597,4891,
,N,A,CHEMBL621131,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7559,,10116.0,50597,429,
,N,A,CHEMBL621132,1,1,,BAO_0000218,Half life (T1/2) after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7560,,10116.0,50597,5656,
,N,A,CHEMBL621133,1,1,,BAO_0000218,Half life of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7561,,10116.0,50597,4413,
,N,A,CHEMBL621312,1,1,,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,7562,,10116.0,50597,3598,
,N,A,CHEMBL621313,1,1,,BAO_0000218,Half life of compound was determined in rat,Rattus norvegicus,,,,Intermediate,,,,7563,,10116.0,50597,17267,
,N,A,CHEMBL621314,1,1,Blood,BAO_0000218,Half life of compound was determined in rat blood,Rattus norvegicus,,,,Intermediate,,,,7564,178.0,10116.0,50597,4727,
,N,A,CHEMBL621315,1,1,,BAO_0000218,Half life at 1 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7565,,10116.0,50597,17651,
,N,A,CHEMBL621316,1,1,,BAO_0000218,Half life at 10 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7566,,10116.0,50597,17651,
,N,A,CHEMBL621317,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,7567,,10116.0,50597,401,
,N,A,CHEMBL621318,1,1,,BAO_0000218,Half life in rats in hours,Rattus norvegicus,,,,Intermediate,,,,7568,,10116.0,50597,4942,
,N,A,CHEMBL621319,1,1,,BAO_0000218,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7569,,10116.0,50597,17735,
,N,A,CHEMBL621377,1,1,,BAO_0000218,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7570,,10116.0,50597,6056,
,N,A,CHEMBL621378,1,1,,BAO_0000218,Half life was determined,Rattus norvegicus,,,,Intermediate,,,,7571,,10116.0,50597,5213,
,N,A,CHEMBL876599,1,1,,BAO_0000218,Half life after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7572,,10116.0,50597,6616,
,N,A,CHEMBL621379,1,1,,BAO_0000218,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7573,,10116.0,50597,5937,
,N,A,CHEMBL621380,1,1,Plasma,BAO_0000218,Half life in rat plasma,Rattus norvegicus,,,,Intermediate,,,,7574,1969.0,10116.0,50597,5819,
,N,A,CHEMBL621381,1,1,Plasma,BAO_0000218,Half life in rat plasma; Not detected,Rattus norvegicus,,,,Intermediate,,,,7575,1969.0,10116.0,50597,5819,
,N,A,CHEMBL618515,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,7576,,10116.0,50597,6803,
,N,A,CHEMBL618516,1,1,,BAO_0000218,Half life period of compound was determined after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7577,,10116.0,50597,17804,
,N,A,CHEMBL618517,1,1,,BAO_0000218,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7578,,10116.0,50597,17804,
,N,A,CHEMBL618518,1,1,,BAO_0000218,Half life period in rat,Rattus norvegicus,,,,Intermediate,,,,7579,,10116.0,50597,5948,
,N,A,CHEMBL618519,1,1,,BAO_0000218,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7580,,10116.0,50597,1916,
,N,A,CHEMBL618698,1,1,,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7581,,10116.0,50597,1916,
,N,A,CHEMBL618862,1,1,,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Rattus norvegicus,,,,Intermediate,,,In vivo,7582,,10116.0,50597,1916,
,N,A,CHEMBL618863,1,1,,BAO_0000218,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7583,,10116.0,50597,4890,
,N,A,CHEMBL618864,1,1,,BAO_0000218,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7584,,10116.0,50597,17764,
,N,A,CHEMBL618865,1,1,,BAO_0000218,Half life time in rat the dose of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7585,,10116.0,50597,4727,
,N,A,CHEMBL618866,1,1,,BAO_0000218,Half-life 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7586,,10116.0,50597,17509,
,N,A,CHEMBL618867,1,1,,BAO_0000218,Half-life 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7587,,10116.0,50597,17509,
,N,A,CHEMBL875828,1,1,,BAO_0000218,Half-life consistent with the observed metabolic steady state in rats,Rattus norvegicus,,,,Intermediate,,,,7588,,10116.0,50597,6597,
,N,A,CHEMBL618868,1,1,,BAO_0000218,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7589,,10116.0,50597,17735,
,N,A,CHEMBL618869,1,1,,BAO_0000218,Half-life for oxidative metabolic stability was determined using male human,Rattus norvegicus,,,,Intermediate,,,,7590,,10116.0,50597,6597,
,N,A,CHEMBL618870,1,1,,BAO_0000218,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,7591,,10116.0,50597,17670,
,N,A,CHEMBL618871,1,1,Plasma,BAO_0000218,Half-life in rat plasma,Rattus norvegicus,,,,Intermediate,,,,7592,1969.0,10116.0,50597,1696,
,N,A,CHEMBL618872,1,1,Plasma,BAO_0000218,Half-life in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,,7593,1969.0,10116.0,50597,1742,
,N,A,CHEMBL873816,1,1,,BAO_0000218,Half-life in rats was determined,Rattus norvegicus,,,,Intermediate,,,,7594,,10116.0,50597,17800,
,U,A,CHEMBL618873,1,0,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,,,Autocuration,,,,7595,,,22224,12923,
,U,A,CHEMBL621602,1,0,,BAO_0000019,Area under curve after oral dose of 0.1 mg//kg,,,,,Autocuration,,,,7596,,,22224,11954,
,U,A,CHEMBL621603,1,0,,BAO_0000218,Area under curve after oral dose of 0.3 mg/kg,,,,,Autocuration,,,,7597,,,22224,11954,
,U,A,CHEMBL621604,1,0,,BAO_0000218,Area under curve after oral dose of 1 mg/kg,,,,,Autocuration,,,,7598,,,22224,11954,
,U,A,CHEMBL621605,1,0,,BAO_0000218,Area under curve after oral dose of 10 mg/kg,,,,,Autocuration,,,,7599,,,22224,11954,
,U,A,CHEMBL621606,1,0,,BAO_0000218,Area under curve after oral dose of 23.4 mg/kg,,,,,Autocuration,,,,7600,,,22224,11954,
,U,A,CHEMBL621607,1,0,,BAO_0000218,Area under curve after oral dose of 3 mg/kg,,,,,Autocuration,,,,7601,,,22224,11954,
,U,A,CHEMBL621608,1,0,,BAO_0000218,Area under curve after oral dose of 3.87 mg/kg,,,,,Autocuration,,,,7602,,,22224,11954,
,U,A,CHEMBL621609,1,0,,BAO_0000019,Area under curve was determined,,,,,Autocuration,,,,7603,,,22224,5237,
,U,A,CHEMBL621610,1,0,,BAO_0000218,Area under curve at a dose of 10 mg/kg,,,,,Autocuration,,,,7604,,,22224,4026,
,N,A,CHEMBL621611,1,1,,BAO_0000218,Area under curve was determined; ND=No data,Rattus norvegicus,,,,Intermediate,,,,7605,,10116.0,50597,5237,
,N,A,CHEMBL621612,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7606,,10116.0,50597,14793,
,N,A,CHEMBL622308,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7607,,10116.0,50597,14793,
,N,A,CHEMBL622309,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7608,,10116.0,50597,14793,
,N,A,CHEMBL622310,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7609,,10116.0,50597,14793,
,N,A,CHEMBL622311,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7610,,10116.0,50597,14793,
,N,A,CHEMBL622312,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Rattus norvegicus,,,,Intermediate,,,,7611,,10116.0,50597,14793,
,N,A,CHEMBL622931,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7612,,10116.0,50597,14793,
,N,A,CHEMBL622932,1,1,,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Rattus norvegicus,,,,Intermediate,,,,7613,,10116.0,50597,14793,
,N,A,CHEMBL622736,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7614,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622737,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7615,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622738,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7616,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622739,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7617,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622740,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7618,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622741,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7619,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622742,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,,Intermediate,,,,7620,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622743,1,1,Plasma,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,,Intermediate,,,,7621,1969.0,10116.0,50597,14793,
,N,A,CHEMBL622744,1,1,Plasma,BAO_0000218,AUC in mice,Mus musculus,,,,Intermediate,,,,7622,1969.0,10090.0,50594,11637,
,U,A,CHEMBL624134,1,0,,BAO_0000019,Area under curve was measured from the graph obtained from concentration Vs time,,,,,Autocuration,,,,7623,,,22224,11149,
,U,A,CHEMBL624135,1,0,,BAO_0000019,Area under curve value of compound per hour after oral administration,,,,,Autocuration,,,,7624,,,22224,10016,
,N,A,CHEMBL624136,1,1,,BAO_0000218,Area under curve was determined after oral administration in rats,Rattus norvegicus,,,,Intermediate,,,,7625,,10116.0,50597,17796,
,N,A,CHEMBL624137,1,1,,BAO_0000218,Area under curve was determined after oral administration in rats; No data,Rattus norvegicus,,,,Intermediate,,,,7626,,10116.0,50597,17796,
,N,A,CHEMBL624320,1,1,,BAO_0000218,Area under curve was determined after oral administration in rats;No data,Rattus norvegicus,,,,Intermediate,,,,7627,,10116.0,50597,17796,
,N,A,CHEMBL624321,1,1,,BAO_0000218,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,,,,Intermediate,,,,7628,,9615.0,50588,12923,
,N,A,CHEMBL624322,1,1,,BAO_0000218,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7629,,10116.0,50597,15372,
,N,A,CHEMBL624323,1,1,,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.06 in rats,Rattus norvegicus,,,,Intermediate,,,,7630,,10116.0,50597,15372,
,N,A,CHEMBL624324,1,1,,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7631,,10116.0,50597,15372,
,N,A,CHEMBL624325,1,1,,BAO_0000218,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7632,,10116.0,50597,15372,
,N,A,CHEMBL624326,1,1,,BAO_0000218,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7633,,10116.0,50597,15372,
,N,A,CHEMBL624327,1,1,,BAO_0000218,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7634,,10116.0,50597,15372,
,N,A,CHEMBL624328,1,1,,BAO_0000218,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,7635,,10116.0,50597,15372,
,N,A,CHEMBL627848,1,1,,BAO_0000218,Area under curve was determined in Dogs after peroral administration,Canis lupus familiaris,,,,Intermediate,,,,7636,,9615.0,50588,14169,
,N,A,CHEMBL627849,1,1,,BAO_0000218,Area under curve was determined in Rats after peroral administration,Rattus norvegicus,,,,Intermediate,,,,7637,,10116.0,50597,14169,
,N,A,CHEMBL627850,1,1,,BAO_0000218,Area under curve was determined in carotid blood of rat when administered intradermally,Rattus norvegicus,,,,Intermediate,,,,7638,,10116.0,50597,14258,
,N,A,CHEMBL627851,1,1,,BAO_0000218,Area under curve was determined in portal blood of rat when administered intradermally,Rattus norvegicus,,,,Intermediate,,,,7639,,10116.0,50597,14258,
,N,A,CHEMBL627852,1,1,,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,,7640,,10090.0,50594,15011,
,N,A,CHEMBL627853,1,1,,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,,7641,,10090.0,50594,15011,
,N,A,CHEMBL627854,1,1,,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,,Intermediate,,,,7642,,10090.0,50594,15011,
,N,A,CHEMBL627855,1,1,,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,,7643,,10090.0,50594,15011,
,N,A,CHEMBL627856,1,1,,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,,,,Intermediate,,,,7644,,10090.0,50594,15011,
,N,A,CHEMBL875339,1,1,,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,,7645,,10090.0,50594,15011,
,N,A,CHEMBL627857,1,1,,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Mus musculus,,,,Intermediate,,,,7646,,10090.0,50594,15011,
,N,A,CHEMBL627858,1,1,Spleen,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7647,2106.0,10116.0,50597,11195,
,N,A,CHEMBL627859,1,1,Blood,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7648,178.0,10116.0,50597,10130,
,N,A,CHEMBL627860,1,1,Brain,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7649,955.0,10116.0,50597,10130,
,N,A,CHEMBL627019,1,1,Heart,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7650,948.0,10116.0,50597,10130,
,N,A,CHEMBL627020,1,1,Liver,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7651,2107.0,10116.0,50597,10130,
,N,A,CHEMBL627021,1,1,Lung,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7652,2048.0,10116.0,50597,10130,
,N,A,CHEMBL627022,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7653,2385.0,10116.0,50597,10130,
,N,A,CHEMBL627023,1,1,,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7654,,10116.0,50597,10130,
,N,A,CHEMBL627024,1,1,Spleen,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7655,2106.0,10116.0,50597,10130,
,N,A,CHEMBL627025,1,1,Thyroid gland,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7656,2046.0,10116.0,50597,10130,
,N,A,CHEMBL627026,1,1,Kidney,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7657,2113.0,10116.0,50597,10130,
,N,A,CHEMBL627027,1,1,Blood,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7658,178.0,10116.0,50597,10130,
,N,A,CHEMBL627028,1,1,Brain,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7659,955.0,10116.0,50597,10130,
,N,A,CHEMBL627029,1,1,Heart,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7660,948.0,10116.0,50597,10130,
,N,A,CHEMBL627030,1,1,Kidney,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7661,2113.0,10116.0,50597,10130,
,N,A,CHEMBL627031,1,1,Liver,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7662,2107.0,10116.0,50597,10130,
,N,A,CHEMBL627032,1,1,Lung,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7663,2048.0,10116.0,50597,10130,
,N,A,CHEMBL627033,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7664,2385.0,10116.0,50597,10130,
,N,A,CHEMBL627034,1,1,,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7665,,10116.0,50597,10130,
,N,A,CHEMBL627035,1,1,Spleen,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7666,2106.0,10116.0,50597,10130,
,N,A,CHEMBL627036,1,1,Thyroid gland,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7667,2046.0,10116.0,50597,10130,
,N,A,CHEMBL875340,1,1,Blood,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7668,178.0,10116.0,50597,10130,
,N,A,CHEMBL627037,1,1,Heart,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7669,948.0,10116.0,50597,10130,
,N,A,CHEMBL627038,1,1,Kidney,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7670,2113.0,10116.0,50597,10130,
,N,A,CHEMBL627039,1,1,Liver,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7671,2107.0,10116.0,50597,10130,
,N,A,CHEMBL627040,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7672,2385.0,10116.0,50597,10130,
,N,A,CHEMBL624663,1,1,Spleen,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7673,2106.0,10116.0,50597,10130,
,N,A,CHEMBL625963,1,1,Thyroid gland,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7674,2046.0,10116.0,50597,10130,
,N,A,CHEMBL876799,1,1,Brain,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7675,955.0,10116.0,50597,10130,
,N,A,CHEMBL626133,1,1,Lung,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7676,2048.0,10116.0,50597,10130,
,N,A,CHEMBL626134,1,1,,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,,Intermediate,,,,7677,,10116.0,50597,10130,
,N,A,CHEMBL626135,1,1,,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,7678,,10116.0,50597,6295,
,N,A,CHEMBL626136,1,1,,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,7679,,10116.0,50597,6296,
,N,A,CHEMBL626137,1,1,,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Rattus norvegicus,,,,Intermediate,,,,7680,,10116.0,50597,6296,
,N,A,CHEMBL626138,1,1,,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,7681,,10116.0,50597,6295,
,N,A,CHEMBL626139,1,1,,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,7682,,10116.0,50597,6296,
,N,A,CHEMBL626140,1,1,,BAO_0000218,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7683,,10116.0,50597,17260,
,N,A,CHEMBL626141,1,1,,BAO_0000218,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7684,,10116.0,50597,17260,
,N,A,CHEMBL626142,1,1,,BAO_0000218,C24h in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,7685,,10116.0,50597,17686,
,N,A,CHEMBL627930,1,1,Muscle tissue,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7686,2385.0,10116.0,50597,9866,
,N,A,CHEMBL627931,1,1,Muscle tissue,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7687,2385.0,10116.0,50597,9866,
,N,A,CHEMBL627932,1,1,Muscle tissue,BAO_0000218,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7688,2385.0,10116.0,50597,9866,
,N,A,CHEMBL627933,1,1,Spleen,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7689,2106.0,10116.0,50597,9866,
,N,A,CHEMBL627934,1,1,Spleen,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7690,2106.0,10116.0,50597,9866,
,N,A,CHEMBL627935,1,1,Spleen,BAO_0000218,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7691,2106.0,10116.0,50597,9866,
,N,A,CHEMBL627936,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7692,178.0,10116.0,50597,9866,
,N,A,CHEMBL627937,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7693,178.0,10116.0,50597,9866,
,N,A,CHEMBL627938,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7694,178.0,10116.0,50597,9866,
,N,A,CHEMBL627939,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7695,178.0,10116.0,50597,9866,
,N,A,CHEMBL627940,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7696,178.0,10116.0,50597,9866,
,N,A,CHEMBL627941,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7697,178.0,10116.0,50597,9866,
,N,A,CHEMBL876800,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7698,178.0,10116.0,50597,9866,
,N,A,CHEMBL627942,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7699,178.0,10116.0,50597,9866,
,N,A,CHEMBL627943,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7700,178.0,10116.0,50597,9866,
,N,A,CHEMBL627944,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7701,178.0,10116.0,50597,9866,
,N,A,CHEMBL627945,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7702,178.0,10116.0,50597,9866,
,N,A,CHEMBL628584,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7703,178.0,10116.0,50597,9866,
,N,A,CHEMBL628585,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7704,178.0,10116.0,50597,9866,
,N,A,CHEMBL628586,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7705,178.0,10116.0,50597,9866,
,N,A,CHEMBL628587,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7706,178.0,10116.0,50597,9866,
,N,A,CHEMBL628588,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7707,178.0,10116.0,50597,9866,
,N,A,CHEMBL628589,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7708,178.0,10116.0,50597,9866,
,N,A,CHEMBL625304,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7709,178.0,10116.0,50597,9866,
,N,A,CHEMBL625305,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7710,178.0,10116.0,50597,9866,
,N,A,CHEMBL625306,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7711,178.0,10116.0,50597,9866,
,N,A,CHEMBL625307,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7712,178.0,10116.0,50597,9866,
,N,A,CHEMBL625308,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7713,178.0,10116.0,50597,9866,
,N,A,CHEMBL627740,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7714,178.0,10116.0,50597,9866,
,N,A,CHEMBL627741,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7715,178.0,10116.0,50597,9866,
,N,A,CHEMBL627742,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7716,178.0,10116.0,50597,9866,
,N,A,CHEMBL627743,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,7717,178.0,10116.0,50597,9866,
,N,A,CHEMBL627744,1,1,Blood,BAO_0000218,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7718,178.0,10116.0,50597,9866,
,N,A,CHEMBL627745,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7719,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL627746,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7720,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL627747,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7721,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL876810,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7722,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL627748,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7723,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL627749,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7724,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL627750,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7725,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618728,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7726,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618729,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7727,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618730,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7728,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618731,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7729,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618732,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7730,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618733,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7731,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618734,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7732,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618735,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7733,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL876602,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7734,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618736,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7735,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618737,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7736,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618738,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7737,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618739,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7738,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618740,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7739,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618741,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7740,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618742,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,7741,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618743,1,1,Bone,BAO_0000218,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7742,10000001.0,10116.0,50597,9866,
,N,A,CHEMBL618744,1,1,Plasma,BAO_0000218,Half-life from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7743,1969.0,10116.0,50597,17752,
,N,A,CHEMBL618745,1,1,,BAO_0000218,Half-life in male rat,Rattus norvegicus,,,,Intermediate,,,,7744,,10116.0,50597,5610,
,N,A,CHEMBL620479,1,1,,BAO_0000218,Half-life in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,7745,,10116.0,50597,5939,
,N,A,CHEMBL620480,1,1,,BAO_0000218,Half-life in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,7746,,10116.0,50597,5939,
,N,A,CHEMBL620481,1,1,,BAO_0000218,Half-life in rat at a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7747,,10116.0,50597,17771,
,N,A,CHEMBL620482,1,1,,BAO_0000218,Half-life was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,,7748,,10116.0,50597,1974,
,N,A,CHEMBL876603,1,1,,BAO_0000218,Half-life was measured in rat,Rattus norvegicus,,,,Intermediate,,,,7749,,10116.0,50597,4239,
,N,A,CHEMBL620483,1,1,,BAO_0000218,Half-life period for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,7750,,10116.0,50597,6681,
,N,A,CHEMBL620484,1,1,,BAO_0000218,Half-life period in rats after intravenous administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7751,,10116.0,50597,17752,
,N,A,CHEMBL620485,1,1,,BAO_0000218,Half-life period in rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7752,,10116.0,50597,6046,
,N,A,CHEMBL620486,1,1,,BAO_0000218,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,7753,,10116.0,50597,6685,
,N,A,CHEMBL620487,1,1,,BAO_0000218,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,7754,,10116.0,50597,6685,
,N,A,CHEMBL620488,1,1,,BAO_0000218,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,7755,,10116.0,50597,6685,
,N,A,CHEMBL620489,1,1,,BAO_0000218,Half-life time in rat the dose of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7756,,10116.0,50597,4727,
,N,A,CHEMBL620490,1,1,,BAO_0000218,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7757,,10116.0,50597,1088,
,N,A,CHEMBL620491,1,1,,BAO_0000218,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7758,,10116.0,50597,5610,
,N,A,CHEMBL876604,1,1,Plasma,BAO_0000218,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,,,Intermediate,,,In vivo,7759,1969.0,10116.0,50597,3032,
,N,A,CHEMBL620492,1,1,,BAO_0000218,Oral half life was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7760,,10116.0,50597,5199,
,N,A,CHEMBL620493,1,1,,BAO_0000218,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,In vivo,7761,,10116.0,50597,14941,
,N,A,CHEMBL620494,1,1,,BAO_0000218,Pharmacokinetic property (t1/2) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7762,,10116.0,50597,4408,
,N,A,CHEMBL620495,1,1,Plasma,BAO_0000218,Plasma elimination half-life was determined,Rattus norvegicus,,,,Intermediate,,,,7763,1969.0,10116.0,50597,2552,
,N,A,CHEMBL620496,1,1,Plasma,BAO_0000218,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,,,Intermediate,,,In vivo,7764,1969.0,10116.0,50597,5199,
,N,A,CHEMBL620497,1,1,Plasma,BAO_0000218,Plasma half life was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7765,1969.0,10116.0,50597,15662,
,N,A,CHEMBL620498,1,1,Plasma,BAO_0000218,Plasma half-life was determined,Rattus norvegicus,,,,Intermediate,,,,7766,1969.0,10116.0,50597,1465,
,N,A,CHEMBL620499,1,1,Plasma,BAO_0000218,Plasma half-life following oral administration in Fisher rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7767,1969.0,10116.0,50597,1446,
,N,A,CHEMBL620500,1,1,Plasma,BAO_0000218,Plasma half-life in rat,Rattus norvegicus,,,,Intermediate,,,,7768,1969.0,10116.0,50597,6824,
,N,A,CHEMBL873809,1,1,Plasma,BAO_0000218,Plasmatic Half-life after intravenous administration to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7769,1969.0,10116.0,50597,17533,
,N,A,CHEMBL620501,1,1,,BAO_0000218,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7770,,10116.0,50597,5979,
,N,A,CHEMBL620502,1,1,,BAO_0000218,Terminal half life after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7771,,10116.0,50597,4689,
,N,A,CHEMBL620503,1,1,,BAO_0000218,Terminal half life in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7772,,10116.0,50597,4689,
,N,A,CHEMBL620504,1,1,,BAO_0000218,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7773,,10116.0,50597,2463,
,N,A,CHEMBL876605,1,1,,BAO_0000218,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7774,,10116.0,50597,4883,
,N,A,CHEMBL620505,1,1,,BAO_0000218,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7775,,10116.0,50597,4883,
,N,A,CHEMBL873811,1,1,Plasma,BAO_0000218,plasma half life was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7776,1969.0,10116.0,50597,15662,
,N,A,CHEMBL624016,1,1,,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,7777,,10116.0,50597,3598,
,N,A,CHEMBL624017,1,1,,BAO_0000218,Half life of compound determined in rat,Rattus norvegicus,,,,Intermediate,,,,7778,,10116.0,50597,4576,
,N,A,CHEMBL624018,1,1,,BAO_0000218,Mean residence time determined in rat,Rattus norvegicus,,,,Intermediate,,,,7779,,10116.0,50597,4576,
,N,A,CHEMBL624019,1,1,,BAO_0000218,Plasma half life determined in rat,Rattus norvegicus,,,,Intermediate,,,,7780,,10116.0,50597,4576,
,N,A,CHEMBL624020,1,1,Brain,BAO_0000218,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7781,955.0,10116.0,50597,4910,
,N,A,CHEMBL624201,1,1,,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum time period,Rattus norvegicus,,,,Intermediate,,,In vivo,7782,,10116.0,50597,4891,
,N,A,CHEMBL872528,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7783,,10116.0,50597,429,
,N,A,CHEMBL624202,1,1,,BAO_0000218,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7784,,10116.0,50597,5974,
,N,A,CHEMBL624203,1,1,,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7785,,10116.0,50597,5974,
,N,A,CHEMBL624350,1,1,,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7786,,10116.0,50597,5974,
,N,A,CHEMBL621320,1,1,,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7787,,10116.0,50597,5974,
,N,A,CHEMBL621321,1,1,,BAO_0000218,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7788,,10116.0,50597,17582,
,N,A,CHEMBL621322,1,1,,BAO_0000218,Maximum time (Tmax) required to reach Cmax in rats,Rattus norvegicus,,,,Intermediate,,,,7789,,10116.0,50597,4026,
,N,A,CHEMBL621323,1,1,,BAO_0000218,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7790,,10116.0,50597,4890,
,N,A,CHEMBL621324,1,1,,BAO_0000218,Maximum time of clearance of compound in rats after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7791,,10116.0,50597,6571,
,N,A,CHEMBL621325,1,1,,BAO_0000218,Maximum time at the dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,7792,,10116.0,50597,4727,
,N,A,CHEMBL875837,1,1,Plasma,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7793,1969.0,10116.0,50597,17651,
,N,A,CHEMBL621326,1,1,Plasma,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7794,1969.0,10116.0,50597,17651,
,N,A,CHEMBL621327,1,1,,BAO_0000218,Tmax in Guinea pig (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,7795,,10116.0,50597,14465,
,N,A,CHEMBL621328,1,1,,BAO_0000218,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,In vivo,7796,,10116.0,50597,14941,
,N,A,CHEMBL621329,1,1,,BAO_0000218,Pharmacokinetic parameter (Tmax) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7797,,10116.0,50597,5960,
,N,A,CHEMBL621330,1,1,,BAO_0000218,Pharmacokinetic parameter (Tmax) was estimated,Rattus norvegicus,,,,Intermediate,,,In vivo,7798,,10116.0,50597,5022,
,N,A,CHEMBL621331,1,1,,BAO_0000218,Pharmacokinetic property (Tmax) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7799,,10116.0,50597,4408,
,N,A,CHEMBL621332,1,1,,BAO_0000218,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,,Intermediate,,,In vivo,7800,,10116.0,50597,5983,
,N,A,CHEMBL621333,1,1,,BAO_0000218,T max in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7801,,10116.0,50597,4689,
,N,A,CHEMBL621334,1,1,,BAO_0000218,T max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7802,,10116.0,50597,2792,
,N,A,CHEMBL621335,1,1,,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,,,,Intermediate,,,,7803,,10090.0,50594,15011,
,N,A,CHEMBL621336,1,1,,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Canis lupus familiaris,,,,Intermediate,,,,7804,,9615.0,50588,14180,
,N,A,CHEMBL621337,1,1,,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Rattus norvegicus,,,,Intermediate,,,,7805,,10116.0,50597,14180,
,N,A,CHEMBL621338,1,1,,BAO_0000218,Area under curve was measured after i.v. administration into Beagle dog.,Canis lupus familiaris,,,,Intermediate,,,,7806,,9615.0,50588,14599,
,N,A,CHEMBL875838,1,1,,BAO_0000218,Area under curve was measured after iv administration into Beagle dog,Canis lupus familiaris,,,,Intermediate,,,,7807,,9615.0,50588,14599,
,N,A,CHEMBL621339,1,1,,BAO_0000218,Area under curve was measured after po administration into Beagle dog,Canis lupus familiaris,,,,Intermediate,,,,7808,,9615.0,50588,14599,
,N,A,CHEMBL621340,1,1,,BAO_0000218,Area under curve was measured after po administration into Beagle dog.,Canis lupus familiaris,,,,Intermediate,,,,7809,,9615.0,50588,14599,
,U,A,CHEMBL621341,1,0,,BAO_0000218,Area under curve was measured at peroral dose of 3 mg/kg,,,,,Autocuration,,,,7810,,,22224,15675,
,U,A,CHEMBL621342,1,0,,BAO_0000019,Area under curve was measured by using concentration Vs time,,,,,Autocuration,,,,7811,,,22224,12706,
,U,A,CHEMBL621343,1,0,,BAO_0000019,Area under curve was measured by using concentration Vs time; not tested,,,,,Autocuration,,,,7812,,,22224,12706,
,N,A,CHEMBL621344,1,1,,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Mus musculus,,,,Intermediate,,,,7813,,10090.0,50594,9750,
,N,A,CHEMBL621345,1,1,,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration.,Mus musculus,,,,Intermediate,,,,7814,,10090.0,50594,9750,
,U,A,CHEMBL621346,1,0,,BAO_0000019,Area under curve(AUC) value of the compound,,,,,Autocuration,,,,7815,,,22224,14691,
,U,A,CHEMBL621347,1,0,,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,,,Autocuration,,,,7816,,,22224,14691,
,N,A,CHEMBL621348,1,1,,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,,,,Intermediate,,,,7817,,9615.0,50588,14691,
,U,A,CHEMBL621349,1,0,Blood,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood,,,,,Autocuration,,,,7818,178.0,,22224,2939,
,U,A,CHEMBL621350,1,0,Blood,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,,,Autocuration,,,,7819,178.0,,22224,2939,
,U,A,CHEMBL875839,1,0,Blood,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; No data,,,,,Autocuration,,,,7820,178.0,,22224,2939,
,U,A,CHEMBL620211,1,0,Blood,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood,,,,,Autocuration,,,,7821,178.0,,22224,2939,
,U,A,CHEMBL620212,1,0,Blood,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,,,Autocuration,,,,7822,178.0,,22224,2939,
,U,A,CHEMBL620213,1,0,Blood,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; No data,,,,,Autocuration,,,,7823,178.0,,22224,2939,
,N,A,CHEMBL620214,1,1,Plasma,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,,,,Intermediate,,,,7824,1969.0,9544.0,50797,9552,
,N,A,CHEMBL620215,1,1,Plasma,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,,,,Intermediate,,,,7825,1969.0,9544.0,50797,9552,
,N,A,CHEMBL620216,1,1,Plasma,BAO_0000218,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Macaca mulatta,,,,Intermediate,,,,7826,1969.0,9544.0,50797,9552,
,N,A,CHEMBL620888,1,1,Plasma,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Canis lupus familiaris,,,,Intermediate,,,,7827,1969.0,9615.0,50588,9552,
,N,A,CHEMBL620889,1,1,Plasma,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Canis lupus familiaris,,,,Intermediate,,,,7828,1969.0,9615.0,50588,9552,
,U,A,CHEMBL620890,1,0,Plasma,BAO_0000019,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,,,Autocuration,,,,7829,1969.0,,22224,9552,
,N,A,CHEMBL620891,1,1,Plasma,BAO_0000218,Area under plasma time curve determined in male rat,Rattus norvegicus,,,,Intermediate,,,,7830,1969.0,10116.0,50597,11911,
,U,A,CHEMBL620892,1,0,,BAO_0000019,Area under the MAP curve measured over 5 min.,,,,,Autocuration,,,,7831,,,22224,16618,
,N,A,CHEMBL621079,1,1,,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Mus musculus,,,,Intermediate,,,,7832,,10090.0,50594,14387,
,N,A,CHEMBL621080,1,1,,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Mus musculus,,,,Intermediate,,,,7833,,10090.0,50594,14387,
,N,A,CHEMBL621081,1,1,,BAO_0000218,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,,7834,,9615.0,50588,12836,
,N,A,CHEMBL621082,1,1,,BAO_0000218,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Cricetinae,,,,Intermediate,,,,7835,,10026.0,100712,12836,
,N,A,CHEMBL621083,1,1,,BAO_0000218,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,,7836,,10116.0,50597,12836,
,N,A,CHEMBL621084,1,1,,BAO_0000218,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Canis lupus familiaris,,,,Intermediate,,,,7837,,9615.0,50588,14339,
,N,A,CHEMBL621085,1,1,,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,,,,Intermediate,,,,7838,,9615.0,50588,14339,
,N,A,CHEMBL621086,1,1,,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Canis lupus familiaris,,,,Intermediate,,,,7839,,9615.0,50588,14339,
,N,A,CHEMBL621087,1,1,,BAO_0000218,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Canis lupus familiaris,,,,Intermediate,,,,7840,,9615.0,50588,10524,
,N,A,CHEMBL622607,1,1,,BAO_0000218,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,,,,Intermediate,,,,7841,,9615.0,50588,9994,
,N,A,CHEMBL622608,1,1,,BAO_0000218,Serum AUC in marmosets (IV dose),Canis lupus familiaris,,,,Intermediate,,,,7842,,9615.0,50588,11325,
,U,A,CHEMBL624481,1,0,,BAO_0000019,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,,,Autocuration,,,,7843,,,22224,12536,
,U,A,CHEMBL624482,1,0,,BAO_0000019,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,,,Autocuration,,,,7844,,,22224,12536,
,U,A,CHEMBL624483,1,0,,BAO_0000019,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,,,Autocuration,,,,7845,,,22224,12536,
,U,A,CHEMBL624484,1,0,,BAO_0000019,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,,,Autocuration,,,,7846,,,22224,12536,
,U,A,CHEMBL624485,1,0,,BAO_0000019,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,,,Autocuration,,,,7847,,,22224,12536,
,N,A,CHEMBL624486,1,1,,BAO_0000218,Area under the curve for fumarate salt was evaluated in F344 Rats.,Rattus norvegicus,,,,Intermediate,,,,7848,,10116.0,50597,15556,
,U,A,CHEMBL624487,1,0,,BAO_0000019,Area under the curve for the compound was calculated.,,,,,Autocuration,,,,7849,,,22224,2809,
,U,A,CHEMBL624488,1,0,,BAO_0000019,Area under the curve in concentration/ time,,,,,Autocuration,,,,7850,,,22224,9511,
,N,A,CHEMBL624489,1,1,,BAO_0000218,Area under the curve administered intraintestinal in rats.,Rattus norvegicus,,,,Intermediate,,,,7851,,10116.0,50597,12818,
,N,A,CHEMBL625184,1,1,,BAO_0000218,Area under the curve administered intravenously in rats.,Rattus norvegicus,,,,Intermediate,,,,7852,,10116.0,50597,12818,
,U,A,CHEMBL625185,1,0,,BAO_0000019,Area under the curve during intravenous administration,,,,,Autocuration,,,,7853,,,22224,15118,
,U,A,CHEMBL875954,1,0,,BAO_0000019,Area under the curve during intravenous administration; Not determined,,,,,Autocuration,,,,7854,,,22224,15118,
,U,A,CHEMBL625186,1,0,,BAO_0000019,Area under the curve during systemic administration,,,,,Autocuration,,,,7855,,,22224,15118,
,U,A,CHEMBL625187,1,0,,BAO_0000019,Area under the curve during systemic administration; Not determined,,,,,Autocuration,,,,7856,,,22224,15118,
,U,A,CHEMBL625188,1,0,,BAO_0000019,Area under the curve was calculated for the compound.,,,,,Autocuration,,,,7857,,,22224,2632,
,N,A,CHEMBL625189,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,,7858,,9615.0,50588,14346,
,N,A,CHEMBL625190,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,,7859,,9615.0,50588,14346,
,N,A,CHEMBL621733,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,7860,,10116.0,50597,14346,
,N,A,CHEMBL621734,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,7861,,10116.0,50597,14346,
,N,A,CHEMBL621735,1,1,,BAO_0000218,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,,7862,,10116.0,50597,11149,
,N,A,CHEMBL621736,1,1,Plasma,BAO_0000218,Clearance of the drug was measured in the plasma of rat; No data,Rattus norvegicus,,,,Intermediate,,,,7863,1969.0,10116.0,50597,17796,
,N,A,CHEMBL621737,1,1,Plasma,BAO_0000218,The pharmacokinetic parameter plasma clearance in vivo in rats,Rattus norvegicus,,,,Intermediate,,,,7864,1969.0,10116.0,50597,5247,
,N,A,CHEMBL621738,1,1,,BAO_0000218,Plasma clearance at the dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,7865,,10116.0,50597,4727,
,N,A,CHEMBL622806,1,1,,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7866,,10116.0,50597,5654,
,N,A,CHEMBL623519,1,1,,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7867,,10116.0,50597,5654,
,N,A,CHEMBL623520,1,1,,BAO_0000218,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7868,,10116.0,50597,17260,
,N,A,CHEMBL623521,1,1,,BAO_0000218,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7869,,10116.0,50597,17065,
,N,A,CHEMBL623522,1,1,,BAO_0000218,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7870,,10116.0,50597,17671,
,N,A,CHEMBL623523,1,1,,BAO_0000218,Clearance rate in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7871,,10116.0,50597,6672,
,N,A,CHEMBL623690,1,1,,BAO_0000218,Clearance rate in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7872,,10116.0,50597,6673,
,N,A,CHEMBL623691,1,1,,BAO_0000218,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7873,,10116.0,50597,5978,
,N,A,CHEMBL623692,1,1,,BAO_0000218,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7874,,10116.0,50597,5978,
,N,A,CHEMBL623693,1,1,,BAO_0000218,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7875,,10116.0,50597,5978,
,N,A,CHEMBL623694,1,1,,BAO_0000218,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7876,,10116.0,50597,5978,
,N,A,CHEMBL623695,1,1,,BAO_0000218,Clearance of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7877,,10116.0,50597,4413,
,N,A,CHEMBL623696,1,1,,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7878,,10116.0,50597,2661,
,N,A,CHEMBL623697,1,1,,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7879,,10116.0,50597,2661,
,U,A,CHEMBL623698,1,0,Plasma,BAO_0000218,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,,,,Intermediate,,,In vivo,7880,1969.0,9544.0,22224,5005,
,U,A,CHEMBL623699,1,0,Plasma,BAO_0000218,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7881,1969.0,10116.0,22224,5005,
,N,A,CHEMBL623700,1,1,,BAO_0000218,Mean (%CV) PK parameters for CL(mL/min/kg).,Rattus norvegicus,,,,Intermediate,,,In vivo,7882,,10116.0,50597,15765,
,N,A,CHEMBL623701,1,1,,BAO_0000218,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7883,,10116.0,50597,3747,
,N,A,CHEMBL623702,1,1,Plasma,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Rattus norvegicus,,,,Intermediate,,,In vivo,7884,1969.0,10116.0,50597,16366,
,N,A,CHEMBL623703,1,1,,BAO_0000218,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7885,,10116.0,50597,4199,
,N,A,CHEMBL623704,1,1,,BAO_0000218,Plasma clearance in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7886,,10116.0,50597,17267,
,N,A,CHEMBL623705,1,1,,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,7887,,10116.0,50597,6535,
,N,A,CHEMBL623706,1,1,,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,7888,,10116.0,50597,6535,
,N,A,CHEMBL623707,1,1,,BAO_0000218,Plasma clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7889,,10116.0,50597,5041,
,N,A,CHEMBL623708,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7890,,10116.0,50597,5960,
,N,A,CHEMBL623709,1,1,,BAO_0000218,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7891,,10116.0,50597,5937,
,N,A,CHEMBL623710,1,1,,BAO_0000218,Plasma clearance in rat by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7892,,10116.0,50597,5871,
,N,A,CHEMBL623711,1,1,,BAO_0000218,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7893,,10116.0,50597,5874,
,N,A,CHEMBL623712,1,1,,BAO_0000218,Plasma clearance in rat p.o.,Rattus norvegicus,,,,Intermediate,,,In vivo,7894,,10116.0,50597,6504,
,N,A,CHEMBL623713,1,1,,BAO_0000218,Plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7895,,10116.0,50597,6803,
,N,A,CHEMBL623714,1,1,,BAO_0000218,Plasma clearance was determined; ND denotes no data,Rattus norvegicus,,,,Intermediate,,,In vivo,7896,,10116.0,50597,5041,
,N,A,CHEMBL623715,1,1,,BAO_0000218,Plasma clearance was determined; ND denotes not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7897,,10116.0,50597,5041,
,N,A,CHEMBL623716,1,1,,BAO_0000218,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,7898,,10116.0,50597,1916,
,N,A,CHEMBL622980,1,1,,BAO_0000218,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,,,Intermediate,,,In vivo,7899,,10116.0,50597,5199,
,N,A,CHEMBL622981,1,1,,BAO_0000218,Plasma administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7900,,10116.0,50597,16367,
,N,A,CHEMBL622982,1,1,,BAO_0000218,Plasma clearance of the compound in female Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7901,,10116.0,50597,6362,
,N,A,CHEMBL622983,1,1,,BAO_0000218,Plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7902,,10116.0,50597,15662,
,N,A,CHEMBL622984,1,1,,BAO_0000218,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7903,,10116.0,50597,6215,
,N,A,CHEMBL622985,1,1,,BAO_0000218,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7904,,10116.0,50597,1466,
,N,A,CHEMBL623631,1,1,Plasma,BAO_0000218,plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7905,1969.0,10116.0,50597,15662,
,N,A,CHEMBL623632,1,1,,BAO_0000218,In vivo CL/F determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7906,,10116.0,50597,4723,
,N,A,CHEMBL623633,1,1,Plasma,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7907,1969.0,10116.0,50597,2792,
,N,A,CHEMBL623634,1,1,Plasma,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7908,1969.0,10116.0,50597,2792,
,N,A,CHEMBL623635,1,1,,BAO_0000218,Compound was tested for the lower blood clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7909,,10116.0,50597,5213,
,N,A,CHEMBL621195,1,1,,BAO_0000218,Evaluated for the low clearance in rat (in vivo),Rattus norvegicus,,,,Intermediate,,,In vivo,7910,,10116.0,50597,4687,
,N,A,CHEMBL621196,1,1,,BAO_0000218,Pharmacokinetic property (CLb)of the compound was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7911,,10116.0,50597,3371,
,N,A,CHEMBL875287,1,1,,BAO_0000218,Rapid clearance after intravenous administration in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7912,,10116.0,50597,4690,
,N,A,CHEMBL621197,1,1,,BAO_0000218,Clearance measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7913,,10116.0,50597,5702,
,N,A,CHEMBL621198,1,1,Plasma,BAO_0000218,Compound was evaluated for plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7914,1969.0,10116.0,50597,740,
,N,A,CHEMBL621199,1,1,Plasma,BAO_0000218,Low plasma clearance was calculated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7915,1969.0,10116.0,50597,4853,
,N,A,CHEMBL621200,1,1,,BAO_0000218,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7916,,10116.0,50597,5789,
,N,A,CHEMBL621201,1,1,,BAO_0000218,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7917,,10116.0,50597,4527,
,N,A,CHEMBL621202,1,1,,BAO_0000218,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,7918,,10116.0,50597,4527,
,N,A,CHEMBL621203,1,1,,BAO_0000218,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7919,,10116.0,50597,6518,
,N,A,CHEMBL621204,1,1,,BAO_0000218,Plasma clearance after IV dosing at 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7920,,10116.0,50597,6518,
,N,A,CHEMBL621205,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7921,948.0,10116.0,50597,9866,
,N,A,CHEMBL621206,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7922,948.0,10116.0,50597,9866,
,N,A,CHEMBL621207,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7923,948.0,10116.0,50597,9866,
,N,A,CHEMBL621208,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7924,948.0,10116.0,50597,9866,
,N,A,CHEMBL621209,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7925,948.0,10116.0,50597,9866,
,N,A,CHEMBL876484,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7926,948.0,10116.0,50597,9866,
,N,A,CHEMBL621210,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7927,948.0,10116.0,50597,9866,
,N,A,CHEMBL621211,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7928,948.0,10116.0,50597,9866,
,N,A,CHEMBL621212,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7929,948.0,10116.0,50597,9866,
,N,A,CHEMBL621213,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7930,948.0,10116.0,50597,9866,
,N,A,CHEMBL621214,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7931,948.0,10116.0,50597,9866,
,N,A,CHEMBL621215,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7932,948.0,10116.0,50597,9866,
,N,A,CHEMBL621216,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7933,948.0,10116.0,50597,9866,
,N,A,CHEMBL621217,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7934,948.0,10116.0,50597,9866,
,N,A,CHEMBL621218,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7935,948.0,10116.0,50597,9866,
,N,A,CHEMBL621219,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7936,948.0,10116.0,50597,9866,
,N,A,CHEMBL621220,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7937,948.0,10116.0,50597,9866,
,N,A,CHEMBL621221,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7938,948.0,10116.0,50597,9866,
,N,A,CHEMBL621222,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7939,948.0,10116.0,50597,9866,
,N,A,CHEMBL621223,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7940,948.0,10116.0,50597,9866,
,N,A,CHEMBL876485,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7941,948.0,10116.0,50597,9866,
,N,A,CHEMBL621224,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7942,948.0,10116.0,50597,9866,
,N,A,CHEMBL621225,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,7943,948.0,10116.0,50597,9866,
,N,A,CHEMBL621226,1,1,Heart,BAO_0000218,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7944,948.0,10116.0,50597,9866,
,N,A,CHEMBL621227,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7945,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621228,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7946,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621229,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7947,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621230,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7948,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621231,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,7949,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621232,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7950,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621233,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7951,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621234,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7952,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621235,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,7953,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621236,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7954,2113.0,10116.0,50597,9866,
,N,A,CHEMBL621237,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,7955,2113.0,10116.0,50597,9866,
,N,A,CHEMBL876486,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7956,2113.0,10116.0,50597,9866,
,N,A,CHEMBL622436,1,1,Intestine,BAO_0000218,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7957,160.0,10116.0,50597,9866,
,N,A,CHEMBL622437,1,1,Intestine,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7958,160.0,10116.0,50597,9866,
,N,A,CHEMBL622438,1,1,Intestine,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7959,160.0,10116.0,50597,9866,
,N,A,CHEMBL622439,1,1,Liver,BAO_0000218,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7960,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622440,1,1,Liver,BAO_0000218,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7961,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622441,1,1,Liver,BAO_0000218,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,7962,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622442,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7963,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622443,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7964,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622444,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7965,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622445,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7966,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622446,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,,,Intermediate,,,In vivo,7967,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622447,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7968,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622448,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,7969,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622449,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,7970,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622450,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7971,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622451,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7972,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622452,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7973,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622453,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7974,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622454,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7975,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622455,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,7976,2107.0,10116.0,50597,9866,
,N,A,CHEMBL876024,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,7977,2107.0,10116.0,50597,9866,
,N,A,CHEMBL622456,1,1,,BAO_0000218,T max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7978,,10116.0,50597,2792,
,N,A,CHEMBL622457,1,1,,BAO_0000218,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,7979,,10116.0,50597,15078,
,N,A,CHEMBL622458,1,1,,BAO_0000218,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,7980,,10116.0,50597,15078,
,N,A,CHEMBL622459,1,1,,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,,Intermediate,,,,7981,,10116.0,50597,15022,
,N,A,CHEMBL873343,1,1,,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,,Intermediate,,,,7982,,10116.0,50597,15022,
,N,A,CHEMBL622460,1,1,,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,,Intermediate,,,,7983,,10116.0,50597,15022,
,N,A,CHEMBL622461,1,1,Plasma,BAO_0000218,Time for maximum plasma concentration determined in rat,Rattus norvegicus,,,,Intermediate,,,,7984,1969.0,10116.0,50597,4576,
,N,A,CHEMBL622462,1,1,Plasma,BAO_0000218,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,7985,1969.0,10116.0,50597,6681,
,N,A,CHEMBL622463,1,1,,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7986,,10116.0,50597,16365,
,N,A,CHEMBL622464,1,1,,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7987,,10116.0,50597,16365,
,N,A,CHEMBL622465,1,1,,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7988,,10116.0,50597,16365,
,N,A,CHEMBL622466,1,1,,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7989,,10116.0,50597,16365,
,N,A,CHEMBL622467,1,1,,BAO_0000218,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7990,,10116.0,50597,16365,
,N,A,CHEMBL622468,1,1,Plasma,BAO_0000218,Time of maximum plasma concentration in rat,Rattus norvegicus,,,,Intermediate,,,,7991,1969.0,10116.0,50597,6824,
,N,A,CHEMBL876025,1,1,Plasma,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,7992,1969.0,10116.0,50597,6685,
,N,A,CHEMBL622469,1,1,Plasma,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,,,Intermediate,,,,7993,1969.0,10116.0,50597,6685,
,N,A,CHEMBL622470,1,1,Plasma,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,,7994,1969.0,10116.0,50597,6685,
,N,A,CHEMBL622471,1,1,,BAO_0000218,Time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,7995,,10116.0,50597,15662,
,N,A,CHEMBL622472,1,1,Plasma,BAO_0000218,Time required to reach maximum concentration in rat plasma,Rattus norvegicus,,,,Intermediate,,,,7996,1969.0,10116.0,50597,1742,
,N,A,CHEMBL622473,1,1,Plasma,BAO_0000218,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,7997,1969.0,10116.0,50597,2774,
,N,A,CHEMBL624282,1,1,Plasma,BAO_0000218,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,7998,1969.0,10116.0,50597,5199,
,N,A,CHEMBL624283,1,1,Plasma,BAO_0000218,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,7999,1969.0,10116.0,50597,12873,
,N,A,CHEMBL624284,1,1,Plasma,BAO_0000218,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8000,1969.0,10116.0,50597,12873,
,N,A,CHEMBL624285,1,1,Plasma,BAO_0000218,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8001,1969.0,10116.0,50597,1916,
,N,A,CHEMBL624286,1,1,,BAO_0000218,Time to reach Cmax after oral administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8002,,10116.0,50597,16367,
,N,A,CHEMBL624287,1,1,,BAO_0000218,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Rattus norvegicus,,,,Intermediate,,,In vivo,8003,,10116.0,50597,16366,
,N,A,CHEMBL624288,1,1,,BAO_0000218,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Rattus norvegicus,,,,Intermediate,,,,8004,,10116.0,50597,216,
,N,A,CHEMBL624289,1,1,Plasma,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,,,Intermediate,,,In vivo,8005,1969.0,10116.0,50597,6410,
,N,A,CHEMBL873344,1,1,Plasma,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8006,1969.0,10116.0,50597,6410,
,N,A,CHEMBL619623,1,1,,BAO_0000218,Tmax after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8007,,10116.0,50597,6215,
,N,A,CHEMBL621399,1,1,,BAO_0000218,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,8008,,10116.0,50597,3598,
,N,A,CHEMBL621400,1,1,,BAO_0000218,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8009,,10116.0,50597,4527,
,N,A,CHEMBL621401,1,1,,BAO_0000218,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,8010,,10116.0,50597,17670,
,N,A,CHEMBL621402,1,1,,BAO_0000218,Tmax was determined,Rattus norvegicus,,,,Intermediate,,,,8011,,10116.0,50597,1465,
,N,A,CHEMBL621403,1,1,,BAO_0000218,Tmax was determined,Rattus norvegicus,,,,Intermediate,,,,8012,,10116.0,50597,2552,
,N,A,CHEMBL621121,1,1,,BAO_0000218,Tmax after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8013,,10116.0,50597,5656,
,N,A,CHEMBL872525,1,1,,BAO_0000218,Tmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8014,,10116.0,50597,17764,
,N,A,CHEMBL621122,1,1,,BAO_0000218,Tmax in male rat,Rattus norvegicus,,,,Intermediate,,,,8015,,10116.0,50597,5610,
,N,A,CHEMBL621123,1,1,,BAO_0000218,Tmax in rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8016,,10116.0,50597,6046,
,N,A,CHEMBL621124,1,1,,BAO_0000218,Tmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8017,,10116.0,50597,5874,
,N,A,CHEMBL621125,1,1,,BAO_0000218,Tmax in rats,Rattus norvegicus,,,,Intermediate,,,,8018,,10116.0,50597,17596,
,N,A,CHEMBL621126,1,1,,BAO_0000218,Tmax was measured in rats after peroral administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8019,,10116.0,50597,17804,
,N,A,CHEMBL621127,1,1,,BAO_0000218,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,8020,,10116.0,50597,1908,
,N,A,CHEMBL621128,1,1,,BAO_0000218,Tmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8021,,10116.0,50597,2959,
,N,A,CHEMBL618263,1,1,,BAO_0000218,Tmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8022,,10116.0,50597,6757,
,N,A,CHEMBL618264,1,1,,BAO_0000218,Tmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8023,,10116.0,50597,6757,
,N,A,CHEMBL618265,1,1,,BAO_0000218,Tmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8024,,10116.0,50597,6757,
,N,A,CHEMBL618266,1,1,Plasma,BAO_0000218,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,,,Intermediate,,,In vivo,8025,1969.0,10116.0,50597,4186,
,N,A,CHEMBL618267,1,1,,BAO_0000218,time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8026,,10116.0,50597,15662,
,N,A,CHEMBL618450,1,1,Urine,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Rattus norvegicus,,,,Intermediate,,,,8027,1088.0,10116.0,50597,429,
,N,A,CHEMBL618451,1,1,Urine,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Rattus norvegicus,,,,Intermediate,,,,8028,1088.0,10116.0,50597,429,
,N,A,CHEMBL618452,1,1,,BAO_0000218,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,,Intermediate,,,,8029,,10116.0,50597,5546,
,N,A,CHEMBL618453,1,1,Urine,BAO_0000218,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Rattus norvegicus,,,,Intermediate,,,,8030,1088.0,10116.0,50597,3173,
,N,A,CHEMBL618454,1,1,Urine,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Rattus norvegicus,,,,Intermediate,,,,8031,1088.0,10116.0,50597,3173,
,N,A,CHEMBL618455,1,1,Urine,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Rattus norvegicus,,,,Intermediate,,,,8032,1088.0,10116.0,50597,3173,
,N,A,CHEMBL618456,1,1,,BAO_0000218,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8033,,10116.0,50597,4257,
,N,A,CHEMBL618457,1,1,,BAO_0000218,Compound distribution in rat tissues was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8034,,10116.0,50597,6011,
,N,A,CHEMBL618458,1,1,,BAO_0000218,Volume of distribution was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8035,,10116.0,50597,5472,
,N,A,CHEMBL618459,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8036,,10116.0,50597,14346,
,N,A,CHEMBL876733,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8037,,10116.0,50597,14346,
,N,A,CHEMBL618460,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,,8038,,9615.0,50588,14346,
,N,A,CHEMBL618461,1,1,,BAO_0000218,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8039,,10116.0,50597,14346,
,U,A,CHEMBL618462,1,0,,BAO_0000019,Area under the curve was determined after oral administration (300 uM/Kg),,,,,Autocuration,,,,8040,,,22224,15469,
,N,A,CHEMBL618463,1,1,,BAO_0000218,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8041,,10116.0,50597,14346,
,N,A,CHEMBL618464,1,1,,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8042,,10116.0,50597,14346,
,N,A,CHEMBL618465,1,1,,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8043,,10116.0,50597,14346,
,N,A,CHEMBL618466,1,1,,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8044,,10116.0,50597,14346,
,N,A,CHEMBL618467,1,1,,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,,8045,,10116.0,50597,14346,
,N,A,CHEMBL618468,1,1,,BAO_0000218,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,8046,,10116.0,50597,15372,
,N,A,CHEMBL618469,1,1,Plasma,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Canis lupus familiaris,,,,Intermediate,,,,8047,1969.0,9615.0,50588,12935,
,N,A,CHEMBL618470,1,1,Plasma,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Canis lupus familiaris,,,,Intermediate,,,,8048,1969.0,9615.0,50588,12935,
,U,A,CHEMBL618471,1,0,,BAO_0000218,Plasma drug AUC in rat (PO dose),,,,,Autocuration,,,,8049,,,22224,14813,
,N,A,CHEMBL618472,1,1,,BAO_0000218,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Mus musculus,,,,Intermediate,,,,8050,,10090.0,50594,15792,
,U,A,CHEMBL618473,1,0,,BAO_0000218,Area under was determined at a dose of 30 mg/kg,,,,,Autocuration,,,,8051,,,22224,3579,
,N,A,CHEMBL621699,1,1,,BAO_0000218,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Mustela putorius furo,,,,Intermediate,,,,8052,,9669.0,50506,12487,
,N,A,CHEMBL621700,1,1,,BAO_0000218,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Rattus norvegicus,,,,Intermediate,,,,8053,,10116.0,50597,12487,
,N,A,CHEMBL621701,1,1,,BAO_0000218,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Rattus norvegicus,,,,Intermediate,,,,8054,,10116.0,50597,12487,
,N,A,CHEMBL621702,1,1,,BAO_0000218,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Mustela putorius furo,,,,Intermediate,,,,8055,,9669.0,50506,12487,
,N,A,CHEMBL621703,1,1,,BAO_0000218,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,,,,Intermediate,,,,8056,,9615.0,50588,12487,
,N,A,CHEMBL621704,1,1,,BAO_0000218,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,,,,Intermediate,,,,8057,,9615.0,50588,12487,
,N,A,CHEMBL624259,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8058,,10116.0,50597,12902,
,N,A,CHEMBL624260,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8059,,10116.0,50597,12902,
,N,A,CHEMBL624430,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8060,,10116.0,50597,12902,
,N,A,CHEMBL624431,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8061,,10116.0,50597,12902,
,N,A,CHEMBL624432,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8062,,10116.0,50597,12902,
,N,A,CHEMBL624433,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8063,,10116.0,50597,12902,
,N,A,CHEMBL624434,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8064,,10116.0,50597,12902,
,N,A,CHEMBL624435,1,1,,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Rattus norvegicus,,,,Intermediate,,,,8065,,10116.0,50597,12902,
,N,A,CHEMBL618570,1,1,,BAO_0000218,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,,Intermediate,,,,8066,,10090.0,50594,12745,
,N,A,CHEMBL618571,1,1,,BAO_0000218,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,,Intermediate,,,,8067,,10090.0,50594,12745,
,N,A,CHEMBL618572,1,1,,BAO_0000218,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Mus musculus,,,,Intermediate,,,,8068,,10090.0,50594,12745,
,N,A,CHEMBL618573,1,1,,BAO_0000218,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,,Intermediate,,,,8069,,10090.0,50594,12745,
,N,A,CHEMBL619267,1,1,,BAO_0000218,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,,Intermediate,,,,8070,,10090.0,50594,12745,
,N,A,CHEMBL619431,1,1,,BAO_0000218,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,,Intermediate,,,,8071,,10090.0,50594,12745,
,N,A,CHEMBL619432,1,1,,BAO_0000218,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Mus musculus,,,,Intermediate,,,,8072,,10090.0,50594,12745,
,N,A,CHEMBL619433,1,1,,BAO_0000218,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,,Intermediate,,,,8073,,10090.0,50594,12745,
,U,A,CHEMBL619434,1,0,Plasma,BAO_0000218,AUC in mice after oral dose (50 mg/kg),,,,,Autocuration,,,,8074,1969.0,,22224,13298,
,N,A,CHEMBL619435,1,1,Serum,BAO_0000218,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Mus musculus,,,,Intermediate,,,,8075,1977.0,10090.0,50594,12226,
,U,A,CHEMBL619436,1,0,Plasma,BAO_0000019,AUC (0-4 hr) ug/ml/h,,,,,Autocuration,,,,8076,1969.0,,22224,12634,
,N,A,CHEMBL619437,1,1,,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Rattus norvegicus,,,,Intermediate,,,,8077,,10116.0,50597,14810,
,U,A,CHEMBL619438,1,0,,BAO_0000218,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,,,Autocuration,,,,8078,,,22224,13889,
,N,A,CHEMBL619439,1,1,,BAO_0000218,Compound was evaluated for Area under curve in mice,Mus musculus,,,,Intermediate,,,,8079,,10090.0,50594,10018,
,N,A,CHEMBL619440,1,1,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,,,,Intermediate,,,,8080,,10116.0,50597,8758,
,U,F,CHEMBL619441,1,0,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,,Autocuration,,,,8081,,,22224,8758,
,N,A,CHEMBL619442,1,1,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,,,,Intermediate,,,,8082,,10116.0,50597,8758,
,U,A,CHEMBL875156,1,0,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,,,Autocuration,,,,8083,,,22224,2249,
,U,A,CHEMBL619443,1,0,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,,,Autocuration,,,,8084,,,22224,2249,
,U,A,CHEMBL619444,1,0,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,,,Autocuration,,,,8085,,,22224,2249,
,U,A,CHEMBL623464,1,0,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,,,Autocuration,,,,8086,,,22224,2249,
,N,A,CHEMBL623465,1,1,,BAO_0000218,Compound was evaluated for area under curve when administered through oral route in mouse,Mus musculus,,,,Intermediate,,,,8087,,10090.0,50594,15115,
,N,A,CHEMBL623466,1,1,,BAO_0000218,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,8088,,10116.0,50597,6518,
,N,A,CHEMBL623467,1,1,,BAO_0000218,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,8089,,10116.0,50597,6518,
,N,A,CHEMBL623468,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8090,,10116.0,50597,6249,
,N,A,CHEMBL622660,1,1,,BAO_0000218,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8091,,10116.0,50597,2463,
,N,A,CHEMBL622661,1,1,,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8092,,10116.0,50597,4969,
,N,F,CHEMBL622662,1,1,,BAO_0000218,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8093,,10116.0,50597,17720,
,N,A,CHEMBL622663,1,1,,BAO_0000218,Pharmacokinetic property (total body clearance) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8094,,10116.0,50597,3457,
,N,A,CHEMBL622664,1,1,,BAO_0000218,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8095,,10116.0,50597,5983,
,N,A,CHEMBL622665,1,1,,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,8096,,10116.0,50597,6295,
,N,A,CHEMBL622666,1,1,,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,8097,,10116.0,50597,6296,
,N,A,CHEMBL621615,1,1,,BAO_0000218,Cl in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8098,,10116.0,50597,17686,
,N,A,CHEMBL621616,1,1,,BAO_0000218,Clearance of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8099,,10116.0,50597,17764,
,N,A,CHEMBL621617,1,1,,BAO_0000218,Clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8100,,10116.0,50597,5503,
,N,A,CHEMBL621618,1,1,,BAO_0000218,Clearance by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8101,,10116.0,50597,4368,
,N,A,CHEMBL621619,1,1,,BAO_0000218,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8102,,10116.0,50597,6005,
,N,A,CHEMBL621620,1,1,,BAO_0000218,Clearance rate after i.v. administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8103,,10116.0,50597,5031,
,N,A,CHEMBL621786,1,1,,BAO_0000218,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8104,,10116.0,50597,4890,
,N,A,CHEMBL621787,1,1,,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8105,,10116.0,50597,5182,
,N,A,CHEMBL621788,1,1,,BAO_0000218,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8106,,10116.0,50597,5979,
,N,A,CHEMBL621789,1,1,,BAO_0000218,Clearance (Cl) after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8107,,10116.0,50597,5656,
,N,A,CHEMBL621790,1,1,,BAO_0000218,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8108,,10116.0,50597,17804,
,N,A,CHEMBL621791,1,1,Plasma,BAO_0000218,Compound was tested for plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8109,1969.0,10116.0,50597,4839,
,N,A,CHEMBL621792,1,1,,BAO_0000218,In vitro microsome metabolism clearance in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vitro,8110,,10116.0,50597,5041,Microsomes
,N,A,CHEMBL621793,1,1,,BAO_0000218,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Rattus norvegicus,,,,Intermediate,,,In vitro,8111,,10116.0,50597,5041,Microsomes
,N,A,CHEMBL621794,1,1,,BAO_0000218,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8112,,10116.0,50597,5974,
,N,A,CHEMBL621795,1,1,Plasma,BAO_0000218,In vivo plasma clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8113,1969.0,10116.0,50597,5496,
,N,A,CHEMBL621796,1,1,,BAO_0000218,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8114,,10116.0,50597,5739,
,N,A,CHEMBL621797,1,1,Liver,BAO_0000218,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Rattus norvegicus,,401.0,Hepatocyte,Intermediate,,,In vivo,8115,2107.0,10116.0,50597,5676,
,N,A,CHEMBL621798,1,1,,BAO_0000218,Pharmacokinetic property (Plasma clearance) was measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8116,,10116.0,50597,4239,
,N,A,CHEMBL621799,1,1,,BAO_0000218,Pharmacokinetic property (clearance) in rat i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8117,,10116.0,50597,5676,
,N,A,CHEMBL621800,1,1,,BAO_0000218,"Plasma Clearance was evaluated in rats, iv",Rattus norvegicus,,,,Intermediate,,,In vivo,8118,,10116.0,50597,1918,
,N,A,CHEMBL621801,1,1,,BAO_0000218,Plasma clearance (in vivo) in rats was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8119,,10116.0,50597,17800,
,N,A,CHEMBL621802,1,1,,BAO_0000218,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8120,,10116.0,50597,6056,
,N,A,CHEMBL618596,1,1,,BAO_0000218,Plasma clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8121,,10116.0,50597,5496,
,N,A,CHEMBL618597,1,1,,BAO_0000218,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8122,,10116.0,50597,5939,
,N,A,CHEMBL618598,1,1,,BAO_0000218,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8123,,10116.0,50597,5939,
,N,A,CHEMBL618599,1,1,,BAO_0000218,Plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8124,,10116.0,50597,17752,
,N,A,CHEMBL618600,1,1,,BAO_0000218,Plasma clearance rate determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8125,,10116.0,50597,4576,
,N,A,CHEMBL618601,1,1,,BAO_0000218,Plasma clearance was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8126,,10116.0,50597,6011,
,N,A,CHEMBL618602,1,1,,BAO_0000218,Plasma clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8127,,10116.0,50597,5510,
,N,A,CHEMBL618603,1,1,,BAO_0000218,Plasma clearance value in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8128,,10116.0,50597,5948,
,N,A,CHEMBL618604,1,1,Liver,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,,,,Intermediate,,,Ex vivo,8129,2107.0,10116.0,50597,6125,
,N,A,CHEMBL618605,1,1,,BAO_0000218,Clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8130,,10116.0,50597,4839,
,N,A,CHEMBL618606,1,1,,BAO_0000218,Total body clearance in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8131,,10116.0,50597,17686,
,N,A,CHEMBL618607,1,1,,BAO_0000218,Clearance of compound in rats after intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8132,,10116.0,50597,6571,
,N,A,CHEMBL618608,1,1,,BAO_0000218,Clearance after iv administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8133,,10116.0,50597,3364,
,N,A,CHEMBL618609,1,1,,BAO_0000218,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8134,,10116.0,50597,13569,
,N,A,CHEMBL618610,1,1,,BAO_0000218,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8135,,10116.0,50597,13569,
,N,A,CHEMBL618611,1,1,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8136,,10116.0,50597,13569,
,N,A,CHEMBL618612,1,1,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8137,,10116.0,50597,13569,
,N,A,CHEMBL618613,1,1,,BAO_0000218,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8138,,10116.0,50597,13569,
,N,A,CHEMBL621076,1,1,,BAO_0000218,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8139,,10116.0,50597,13569,
,N,A,CHEMBL621077,1,1,,BAO_0000218,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8140,,10116.0,50597,13569,
,N,A,CHEMBL621078,1,1,,BAO_0000218,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,8141,,10116.0,50597,17670,
,N,A,CHEMBL621251,1,1,,BAO_0000218,Clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8142,,10116.0,50597,5970,
,N,A,CHEMBL621252,1,1,,BAO_0000218,Clearance in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8143,,10116.0,50597,6495,
,N,A,CHEMBL621253,1,1,,BAO_0000218,Clearance in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,8144,,10116.0,50597,4590,
,N,A,CHEMBL621254,1,1,,BAO_0000218,Clearance rate following an oral dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8145,,10116.0,50597,6193,
,N,A,CHEMBL621255,1,1,,BAO_0000218,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,8146,,10116.0,50597,2832,
,N,A,CHEMBL621256,1,1,Plasma,BAO_0000218,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Rattus norvegicus,,,,Intermediate,,,In vivo,8147,1969.0,10116.0,50597,1052,
,N,A,CHEMBL621257,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8148,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621258,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8149,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621259,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8150,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621260,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8151,2107.0,10116.0,50597,9866,
,N,A,CHEMBL876494,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8152,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621261,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8153,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621262,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8154,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621263,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8155,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621264,1,1,Liver,BAO_0000218,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,8156,2107.0,10116.0,50597,9866,
,N,A,CHEMBL621265,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8157,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621266,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,8158,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621267,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8159,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621268,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8160,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621269,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8161,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621270,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8162,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621271,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8163,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621272,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8164,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621273,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8165,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621274,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8166,2385.0,10116.0,50597,9866,
,N,A,CHEMBL876495,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8167,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621275,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8168,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621276,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,8169,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621277,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,8170,2385.0,10116.0,50597,9866,
,N,A,CHEMBL621278,1,1,Intestine,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8171,160.0,10116.0,50597,9866,
,N,A,CHEMBL621279,1,1,Intestine,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8172,160.0,10116.0,50597,9866,
,N,A,CHEMBL621280,1,1,Intestine,BAO_0000218,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Rattus norvegicus,,,,Intermediate,,,In vivo,8173,160.0,10116.0,50597,9866,
,N,A,CHEMBL621281,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8174,2106.0,10116.0,50597,9866,
,N,A,CHEMBL621282,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,8175,2106.0,10116.0,50597,9866,
,N,A,CHEMBL621283,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,8176,2106.0,10116.0,50597,9866,
,N,A,CHEMBL621284,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,,,Intermediate,,,In vivo,8177,2106.0,10116.0,50597,9866,
,N,A,CHEMBL621285,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8178,2106.0,10116.0,50597,9866,
,N,A,CHEMBL621286,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8179,2106.0,10116.0,50597,9866,
,N,A,CHEMBL623220,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8180,2106.0,10116.0,50597,9866,
,N,A,CHEMBL623221,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,,,Intermediate,,,In vivo,8181,2106.0,10116.0,50597,9866,
,N,A,CHEMBL876029,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,,,Intermediate,,,In vivo,8182,2106.0,10116.0,50597,9866,
,N,A,CHEMBL623222,1,1,Stomach,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8183,945.0,10116.0,50597,9866,
,N,A,CHEMBL623223,1,1,Stomach,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8184,945.0,10116.0,50597,9866,
,N,A,CHEMBL621445,1,1,Stomach,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Rattus norvegicus,,,,Intermediate,,,In vivo,8185,945.0,10116.0,50597,9866,
,N,A,CHEMBL621446,1,1,Blood,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8186,178.0,10116.0,50597,13950,
,N,A,CHEMBL621447,1,1,Blood,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8187,178.0,10116.0,50597,13950,
,N,A,CHEMBL619681,1,1,Blood,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8188,178.0,10116.0,50597,13950,
,N,A,CHEMBL619682,1,1,Blood,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8189,178.0,10116.0,50597,13950,
,N,A,CHEMBL619683,1,1,Blood,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8190,178.0,10116.0,50597,13950,
,N,A,CHEMBL619684,1,1,Brain,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8191,955.0,10116.0,50597,13950,
,N,A,CHEMBL619685,1,1,Brain,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8192,955.0,10116.0,50597,13950,
,N,A,CHEMBL619686,1,1,Brain,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8193,955.0,10116.0,50597,13950,
,N,A,CHEMBL619687,1,1,Brain,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8194,955.0,10116.0,50597,13950,
,N,A,CHEMBL619688,1,1,Brain,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8195,955.0,10116.0,50597,13950,
,N,A,CHEMBL619689,1,1,Heart,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8196,948.0,10116.0,50597,13950,
,N,A,CHEMBL619690,1,1,Heart,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8197,948.0,10116.0,50597,13950,
,N,A,CHEMBL619691,1,1,Heart,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8198,948.0,10116.0,50597,13950,
,N,A,CHEMBL619692,1,1,,BAO_0000218,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8199,,10116.0,50597,6062,
,N,A,CHEMBL619693,1,1,,BAO_0000218,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,,8200,,10116.0,50597,3598,
,N,A,CHEMBL619694,1,1,,BAO_0000218,Vc value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,8201,,10116.0,50597,1908,
,N,A,CHEMBL619695,1,1,,BAO_0000218,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8202,,10116.0,50597,17596,
,N,A,CHEMBL619696,1,1,,BAO_0000218,Compound was evaluated for pharmacokinetic parameter volume of distribution,Rattus norvegicus,,,,Intermediate,,,In vivo,8203,,10116.0,50597,4891,
,N,A,CHEMBL619697,1,1,,BAO_0000218,Compound was evaluated for volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8204,,10116.0,50597,740,
,N,A,CHEMBL619698,1,1,,BAO_0000218,Steady state volume distribution was determined; steady state(ss),Rattus norvegicus,,,,Intermediate,,,In vivo,8205,,10116.0,50597,16366,
,N,A,CHEMBL619699,1,1,,BAO_0000218,Steady state volume of distribution after iv administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8206,,10116.0,50597,3364,
,N,A,CHEMBL619700,1,1,,BAO_0000218,Steady state volume of distribution dosing at 3 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,8207,,10116.0,50597,2552,
,N,A,CHEMBL619701,1,1,,BAO_0000218,The compound was evaluated for volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8208,,10116.0,50597,406,
,N,A,CHEMBL619702,1,1,,BAO_0000218,The compound was tested for volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8209,,10116.0,50597,12500,
,N,A,CHEMBL620335,1,1,,BAO_0000218,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Rattus norvegicus,,,,Intermediate,,,In vivo,8210,,10116.0,50597,12500,
,N,A,CHEMBL620336,1,1,,BAO_0000218,Volume distribution (VD) after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8211,,10116.0,50597,5656,
,N,A,CHEMBL620337,1,1,,BAO_0000218,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8212,,10116.0,50597,17671,
,N,A,CHEMBL620520,1,1,,BAO_0000218,Volume distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8213,,10116.0,50597,1094,
,N,A,CHEMBL620521,1,1,,BAO_0000218,Volume distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8214,,10116.0,50597,5833,
,N,A,CHEMBL875825,1,1,,BAO_0000218,Volume distribution in rat after peroral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8215,,10116.0,50597,5939,
,N,A,CHEMBL620522,1,1,,BAO_0000218,Volume distribution in rat after peroral administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8216,,10116.0,50597,5939,
,N,A,CHEMBL620523,1,1,,BAO_0000218,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8217,,10116.0,50597,6005,
,N,A,CHEMBL620524,1,1,,BAO_0000218,Volume of distribution in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,8218,,10116.0,50597,1696,
,N,A,CHEMBL620525,1,1,,BAO_0000218,Volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8219,,10116.0,50597,6672,
,N,A,CHEMBL620526,1,1,,BAO_0000218,Volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8220,,10116.0,50597,6673,
,N,A,CHEMBL620527,1,1,,BAO_0000218,Volume of distribution in rat by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8221,,10116.0,50597,5871,
,N,A,CHEMBL620528,1,1,,BAO_0000218,Volume of distribution in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8222,,10116.0,50597,6803,
,N,A,CHEMBL620529,1,1,,BAO_0000218,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,,,Intermediate,,,In vivo,8223,,10116.0,50597,5199,
,N,A,CHEMBL620530,1,1,,BAO_0000218,Volume distribution at the dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,8224,,10116.0,50597,4727,
,N,A,CHEMBL620531,1,1,,BAO_0000218,Steady state volume of distribution was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8225,,10116.0,50597,16367,
,U,A,CHEMBL620532,1,0,,BAO_0000218,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,,,,Intermediate,,,In vivo,8226,,9544.0,22224,5005,
,U,A,CHEMBL620533,1,0,,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8227,,10116.0,22224,5005,
,U,A,CHEMBL620534,1,0,,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8228,,10116.0,22224,5005,
,N,A,CHEMBL620535,1,1,,BAO_0000218,Mean (%CV) PK parameters for Vdss(mL/kg).,Rattus norvegicus,,,,Intermediate,,,In vivo,8229,,10116.0,50597,15765,
,N,A,CHEMBL875826,1,1,,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8230,,10116.0,50597,2792,
,N,A,CHEMBL620536,1,1,,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8231,,10116.0,50597,2792,
,N,A,CHEMBL620537,1,1,,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8232,,10116.0,50597,5334,
,N,A,CHEMBL618526,1,1,,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8233,,10116.0,50597,5334,
,N,A,CHEMBL618527,1,1,,BAO_0000218,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8234,,10116.0,50597,5739,
,N,A,CHEMBL618528,1,1,,BAO_0000218,Pharmacokinetic property (Vdss) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8235,,10116.0,50597,5789,
,N,A,CHEMBL618529,1,1,,BAO_0000218,Pharmacokinetic property (vdss) was measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8236,,10116.0,50597,4239,
,N,A,CHEMBL618530,1,1,,BAO_0000218,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8237,,10116.0,50597,4709,
,N,A,CHEMBL618531,1,1,,BAO_0000218,Volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8238,,10116.0,50597,6642,
,N,A,CHEMBL618532,1,1,,BAO_0000218,The pharmacokinetic parameter volume of distribution in vivo in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8239,,10116.0,50597,5247,
,N,F,CHEMBL618533,1,1,,BAO_0000218,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8240,,10116.0,50597,17720,
,N,A,CHEMBL618534,1,1,,BAO_0000218,Vdss in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8241,,10116.0,50597,17686,
,N,A,CHEMBL618535,1,1,,BAO_0000218,Volume distribution after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8242,,10116.0,50597,4689,
,N,A,CHEMBL618536,1,1,,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8243,,10116.0,50597,5654,
,N,A,CHEMBL618537,1,1,,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8244,,10116.0,50597,5654,
,N,A,CHEMBL618538,1,1,,BAO_0000218,Volume distribution at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8245,,10116.0,50597,4527,
,N,A,CHEMBL618539,1,1,,BAO_0000218,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8246,,10116.0,50597,4521,
,N,A,CHEMBL618540,1,1,,BAO_0000218,Volume distribution was calculated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8247,,10116.0,50597,6057,
,N,A,CHEMBL618541,1,1,,BAO_0000218,Volume distribution was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8248,,10116.0,50597,5510,
,N,A,CHEMBL618542,1,1,,BAO_0000218,Volume of distribution after intravenous administration was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8249,,10116.0,50597,2938,
,N,A,CHEMBL622544,1,1,,BAO_0000218,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8250,,10116.0,50597,6679,
,N,A,CHEMBL622545,1,1,,BAO_0000218,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,8251,,10116.0,50597,6685,
,N,A,CHEMBL622546,1,1,,BAO_0000218,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,8252,,10116.0,50597,6685,
,N,A,CHEMBL622547,1,1,,BAO_0000218,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,8253,,10116.0,50597,6685,
,N,A,CHEMBL622548,1,1,,BAO_0000218,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8254,,10116.0,50597,5145,
,N,A,CHEMBL622549,1,1,,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8255,,10116.0,50597,6467,
,N,A,CHEMBL622550,1,1,,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8256,,10116.0,50597,6467,
,N,A,CHEMBL622551,1,1,,BAO_0000218,Compound was evaluated for area under curve when administered through oral route to mouse,Mus musculus,,,,Intermediate,,,,8257,,10090.0,50594,15115,
,N,A,CHEMBL622552,1,1,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,,,,Intermediate,,,,8258,,10116.0,50597,8758,
,N,A,CHEMBL622553,1,1,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,,,,Intermediate,,,,8259,,10116.0,50597,8758,
,U,F,CHEMBL622554,1,0,,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,,,Autocuration,,,In vivo,8260,,,22224,8267,
,N,A,CHEMBL622555,1,1,,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,,8261,,9615.0,50588,8267,
,N,A,CHEMBL622556,1,1,,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Mus musculus,,,,Intermediate,,,,8262,,10090.0,50594,14239,
,N,A,CHEMBL622557,1,1,,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Mus musculus,,,,Intermediate,,,,8263,,10090.0,50594,14239,
,N,A,CHEMBL622558,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Mus musculus,,,,Intermediate,,,,8264,178.0,10090.0,50594,10754,
,N,A,CHEMBL622559,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Mus musculus,,,,Intermediate,,,,8265,178.0,10090.0,50594,10754,
,N,A,CHEMBL622560,1,1,,BAO_0000218,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Canis lupus familiaris,,,,Intermediate,,,,8266,,9615.0,50588,10754,
,N,A,CHEMBL622561,1,1,,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,,Intermediate,,,,8267,,10116.0,50597,14681,
,N,A,CHEMBL622562,1,1,,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Rattus norvegicus,,,,Intermediate,,,,8268,,10116.0,50597,14681,
,N,A,CHEMBL622563,1,1,,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,,Intermediate,,,,8269,,10116.0,50597,14681,
,U,A,CHEMBL622564,1,0,,BAO_0000019,Concentration of compound in Central nervous system,,,,,Autocuration,,,,8270,,,22224,13118,
,U,A,CHEMBL622565,1,0,,BAO_0000019,Concentration of compound in Central nervous system; Not detectable,,,,,Autocuration,,,,8271,,,22224,13118,
,N,A,CHEMBL622566,1,1,,BAO_0000218,"Concentration of diester in the blood, following oral administration in mice",Mus musculus,,,,Intermediate,,,,8272,,10090.0,50594,13318,
,N,A,CHEMBL624515,1,1,,BAO_0000218,"Concentration of monoester in the blood, following oral administration in mice",Mus musculus,,,,Intermediate,,,,8273,,10090.0,50594,13318,
,N,A,CHEMBL624516,1,1,,BAO_0000218,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Mus musculus,,,,Intermediate,,,,8274,,10090.0,50594,13318,
,U,A,CHEMBL624517,1,0,,BAO_0000019,Evaluated for Pharmacokinetic property: Area under the curve,,,,,Autocuration,,,,8275,,,22224,15692,
,N,A,CHEMBL624518,1,1,,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Mus musculus,,,,Intermediate,,,,8276,,10090.0,50594,14839,
,N,A,CHEMBL624519,1,1,,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Macaca fascicularis,,,,Intermediate,,,,8277,,9541.0,100710,14839,
,N,A,CHEMBL624520,1,1,,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,,,,Intermediate,,,,8278,,9541.0,100710,14839,
,N,A,CHEMBL624521,1,1,,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Macaca fascicularis,,,,Intermediate,,,,8279,,9541.0,100710,14839,
,N,A,CHEMBL624522,1,1,,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,,,,Intermediate,,,,8280,,9541.0,100710,14839,
,N,A,CHEMBL624523,1,1,,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Macaca fascicularis,,,,Intermediate,,,,8281,,9541.0,100710,14839,
,N,A,CHEMBL624409,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8282,,9541.0,100710,14839,
,N,A,CHEMBL624410,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8283,,9541.0,100710,14839,
,N,A,CHEMBL624411,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8284,,9541.0,100710,14839,
,N,A,CHEMBL623531,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8285,,9541.0,100710,14839,
,N,A,CHEMBL623532,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8286,,9541.0,100710,14839,
,N,A,CHEMBL623533,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8287,,9541.0,100710,14839,
,N,A,CHEMBL623534,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,,Intermediate,,,,8288,,9541.0,100710,14839,
,N,A,CHEMBL623535,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8289,,10090.0,50594,14839,
,N,A,CHEMBL623536,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8290,,10090.0,50594,14839,
,N,A,CHEMBL623537,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8291,,10090.0,50594,14839,
,N,A,CHEMBL623538,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8292,,10090.0,50594,14839,
,N,A,CHEMBL623539,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8293,,10090.0,50594,14839,
,N,A,CHEMBL623540,1,1,,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,,Intermediate,,,,8294,,10090.0,50594,14839,
,N,A,CHEMBL623541,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Mus musculus,,,,Intermediate,,,,8295,,10090.0,50594,14839,
,N,A,CHEMBL623542,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,,Intermediate,,,,8296,,10090.0,50594,14839,
,N,A,CHEMBL623543,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Mus musculus,,,,Intermediate,,,,8297,,10090.0,50594,14839,
,N,A,CHEMBL623544,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Mus musculus,,,,Intermediate,,,,8298,,10090.0,50594,14839,
,N,A,CHEMBL623545,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,,Intermediate,,,,8299,,10090.0,50594,14839,
,N,A,CHEMBL623546,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Mus musculus,,,,Intermediate,,,,8300,,10090.0,50594,14839,
,N,A,CHEMBL623547,1,1,Plasma,BAO_0000218,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8301,1969.0,10116.0,50597,5408,
,N,A,CHEMBL623548,1,1,,BAO_0000218,High i.v. clearance in Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8302,,10116.0,50597,6827,
,N,A,CHEMBL623549,1,1,Liver,BAO_0000218,In vitro clearance in rat liver microsomes,Rattus norvegicus,,,,Intermediate,,,In vitro,8303,2107.0,10116.0,50597,17538,Microsomes
,N,A,CHEMBL623550,1,1,Liver,BAO_0000218,Intrinsic clearance in rat liver microsomes was determined,Rattus norvegicus,,,,Intermediate,,,In vitro,8304,2107.0,10116.0,50597,6331,Microsomes
,N,A,CHEMBL875276,1,1,Liver,BAO_0000218,Intrinsic clearance in rat hepatocytes was determined,Rattus norvegicus,,401.0,Hepatocyte,Intermediate,,,In vitro,8305,2107.0,10116.0,50597,5948,
,N,A,CHEMBL621872,1,1,,BAO_0000218,Plasma Clearance was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8306,,10116.0,50597,4026,
,N,A,CHEMBL621873,1,1,,BAO_0000218,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8307,,10116.0,50597,6647,
,N,A,CHEMBL621874,1,1,,BAO_0000218,Plasma clearance in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,8308,,10116.0,50597,1696,
,N,A,CHEMBL621875,1,1,,BAO_0000218,Plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8309,,10116.0,50597,6597,
,N,A,CHEMBL621876,1,1,,BAO_0000218,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8310,,10116.0,50597,347,
,N,A,CHEMBL621877,1,1,,BAO_0000218,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8311,,10116.0,50597,16423,
,N,A,CHEMBL621878,1,1,,BAO_0000218,Plasma clearance was measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8312,,10116.0,50597,2879,
,N,A,CHEMBL621879,1,1,,BAO_0000218,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8313,,10116.0,50597,4883,
,N,A,CHEMBL621880,1,1,Plasma,BAO_0000218,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Rattus norvegicus,,,,Intermediate,,,In vivo,8314,1969.0,10116.0,50597,5328,
,N,A,CHEMBL621881,1,1,,BAO_0000218,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8315,,10116.0,50597,5160,
,N,A,CHEMBL621882,1,1,,BAO_0000218,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8316,,10116.0,50597,17582,
,N,A,CHEMBL875283,1,1,,BAO_0000218,Total clearance at 1 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8317,,10116.0,50597,17651,
,N,A,CHEMBL621883,1,1,,BAO_0000218,Total clearance at 10 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8318,,10116.0,50597,17651,
,N,A,CHEMBL621884,1,1,,BAO_0000218,Clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8319,,10116.0,50597,6596,
,N,A,CHEMBL621885,1,1,,BAO_0000218,Plasma clearance rate determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8320,,10116.0,50597,4796,
,N,A,CHEMBL621886,1,1,,BAO_0000218,Clearance of compound in rat was evaluated,Rattus norvegicus,,,,Intermediate,,,In vivo,8321,,10116.0,50597,6850,
,N,A,CHEMBL621887,1,1,Plasma,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8322,1969.0,10116.0,50597,5932,
,N,A,CHEMBL621888,1,1,,BAO_0000218,Pharmacokinetic property (blood clearance) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8323,,10116.0,50597,3371,
,N,A,CHEMBL621889,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8324,,10116.0,50597,2083,
,N,A,CHEMBL621890,1,1,,BAO_0000218,Plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8325,,10116.0,50597,4942,
,N,A,CHEMBL621891,1,1,Liver,BAO_0000218,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Rattus norvegicus,,,,Intermediate,,,In vitro,8326,2107.0,10116.0,50597,6838,Microsomes
,N,A,CHEMBL621892,1,1,,BAO_0000218,Clearance in Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8327,,10116.0,50597,5353,
,N,A,CHEMBL621893,1,1,,BAO_0000218,Clearance rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8328,,10116.0,50597,6641,
,N,A,CHEMBL621894,1,1,,BAO_0000218,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Rattus norvegicus,,,,Intermediate,,,In vivo,8329,,10116.0,50597,6641,
,N,A,CHEMBL621895,1,1,,BAO_0000218,Clearance rat; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8330,,10116.0,50597,6641,
,N,A,CHEMBL875284,1,1,,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8331,,10116.0,50597,6444,
,N,A,CHEMBL618699,1,1,,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8332,,10116.0,50597,6444,
,N,A,CHEMBL618700,1,1,,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8333,,10116.0,50597,6444,
,N,A,CHEMBL618701,1,1,,BAO_0000218,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8334,,10116.0,50597,6211,
,N,A,CHEMBL876600,1,1,Plasma,BAO_0000218,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,,,,Intermediate,,,In vivo,8335,1969.0,10116.0,50597,12873,
,N,A,CHEMBL618702,1,1,,BAO_0000218,Clearance of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8336,,10116.0,50597,6570,
,N,A,CHEMBL618703,1,1,,BAO_0000218,Compound was evaluated for Hepatic clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8337,,10116.0,50597,3341,
,N,A,CHEMBL618704,1,1,,BAO_0000218,In vivo clearance after 5 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8338,,10116.0,50597,4891,
,N,A,CHEMBL618705,1,1,Plasma,BAO_0000218,Compound was tested for plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8339,1969.0,10116.0,50597,1094,
,N,A,CHEMBL618706,1,1,,BAO_0000218,Hepatic clearance after intravenous administration was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8340,,10116.0,50597,2938,
,N,A,CHEMBL618707,1,1,,BAO_0000218,Lower clearance in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,8341,,10116.0,50597,17853,
,N,A,CHEMBL618708,1,1,Plasma,BAO_0000218,Pharmacokinetic parameter expressed as plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8342,1969.0,10116.0,50597,6049,
,N,A,CHEMBL618709,1,1,,BAO_0000218,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8343,,10116.0,50597,5789,
,N,A,CHEMBL618710,1,1,,BAO_0000218,Plasma clearance in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8344,,10116.0,50597,4514,
,N,A,CHEMBL618711,1,1,,BAO_0000218,Plasma clearance (Clp) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8345,,10116.0,50597,6448,
,N,A,CHEMBL618712,1,1,,BAO_0000218,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8346,,10116.0,50597,6062,
,N,A,CHEMBL618713,1,1,,BAO_0000218,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Rattus norvegicus,,,,Intermediate,,,In vivo,8347,,10116.0,50597,5710,
,N,A,CHEMBL618714,1,1,,BAO_0000218,Plasma clearance after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8348,,10116.0,50597,4709,
,N,A,CHEMBL618715,1,1,,BAO_0000218,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8349,,10116.0,50597,4521,
,N,A,CHEMBL618716,1,1,,BAO_0000218,Plasma clearance in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8350,,10116.0,50597,1742,
,N,A,CHEMBL876601,1,1,,BAO_0000218,Plasma clearance measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8351,,10116.0,50597,6057,
,N,A,CHEMBL618717,1,1,,BAO_0000218,Plasma clearance was calculated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8352,,10116.0,50597,6057,
,N,A,CHEMBL618718,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8353,,10116.0,50597,5145,
,N,A,CHEMBL618719,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8354,,10116.0,50597,5833,
,N,A,CHEMBL618720,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8355,,10116.0,50597,6453,
,N,A,CHEMBL618721,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8356,,10116.0,50597,6640,
,N,A,CHEMBL621477,1,1,,BAO_0000218,Plasma clearance in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8357,,10116.0,50597,6305,
,N,A,CHEMBL621478,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8358,,10116.0,50597,6642,
,N,A,CHEMBL621479,1,1,,BAO_0000218,Plasma clearance was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8359,,10116.0,50597,5472,
,N,A,CHEMBL621480,1,1,,BAO_0000218,Plasma clearance was evaluated in rat; Not tested,Rattus norvegicus,,,,Intermediate,,,In vivo,8360,,10116.0,50597,5472,
,N,A,CHEMBL621481,1,1,,BAO_0000218,Plasma clearance rate was determined for the compound in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8361,,10116.0,50597,5144,
,N,A,CHEMBL621482,1,1,,BAO_0000218,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,8362,,10116.0,50597,6685,
,N,A,CHEMBL621483,1,1,,BAO_0000218,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,8363,,10116.0,50597,6685,
,N,A,CHEMBL621484,1,1,,BAO_0000218,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,8364,,10116.0,50597,6685,
,N,A,CHEMBL621485,1,1,Heart,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8365,948.0,10116.0,50597,13950,
,N,A,CHEMBL621486,1,1,Heart,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8366,948.0,10116.0,50597,13950,
,N,A,CHEMBL621487,1,1,Intestine,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8367,160.0,10116.0,50597,13950,
,N,A,CHEMBL621488,1,1,Intestine,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8368,160.0,10116.0,50597,13950,
,N,A,CHEMBL621489,1,1,Intestine,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8369,160.0,10116.0,50597,13950,
,N,A,CHEMBL621490,1,1,Intestine,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8370,160.0,10116.0,50597,13950,
,N,A,CHEMBL621491,1,1,Intestine,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8371,160.0,10116.0,50597,13950,
,N,A,CHEMBL621492,1,1,Kidney,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8372,2113.0,10116.0,50597,13950,
,N,A,CHEMBL621493,1,1,Kidney,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8373,2113.0,10116.0,50597,13950,
,N,A,CHEMBL621494,1,1,Kidney,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8374,2113.0,10116.0,50597,13950,
,N,A,CHEMBL621495,1,1,Kidney,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8375,2113.0,10116.0,50597,13950,
,N,A,CHEMBL621496,1,1,Kidney,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8376,2113.0,10116.0,50597,13950,
,N,A,CHEMBL621497,1,1,Liver,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8377,2107.0,10116.0,50597,13950,
,N,A,CHEMBL621498,1,1,Liver,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8378,2107.0,10116.0,50597,13950,
,N,A,CHEMBL621499,1,1,Liver,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8379,2107.0,10116.0,50597,13950,
,N,A,CHEMBL618634,1,1,Liver,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8380,2107.0,10116.0,50597,13950,
,N,A,CHEMBL618635,1,1,Liver,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8381,2107.0,10116.0,50597,13950,
,N,A,CHEMBL618636,1,1,Lung,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8382,2048.0,10116.0,50597,13950,
,N,A,CHEMBL619737,1,1,Lung,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8383,2048.0,10116.0,50597,13950,
,N,A,CHEMBL619738,1,1,Lung,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8384,2048.0,10116.0,50597,13950,
,N,A,CHEMBL624329,1,1,Lung,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8385,2048.0,10116.0,50597,13950,
,N,A,CHEMBL624330,1,1,Lung,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8386,2048.0,10116.0,50597,13950,
,N,A,CHEMBL624331,1,1,Muscle tissue,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8387,2385.0,10116.0,50597,13950,
,N,A,CHEMBL624332,1,1,Muscle tissue,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8388,2385.0,10116.0,50597,13950,
,N,A,CHEMBL624333,1,1,Muscle tissue,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8389,2385.0,10116.0,50597,13950,
,N,A,CHEMBL624334,1,1,Muscle tissue,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8390,2385.0,10116.0,50597,13950,
,N,A,CHEMBL624335,1,1,Muscle tissue,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8391,2385.0,10116.0,50597,13950,
,N,A,CHEMBL620016,1,1,Spleen,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8392,2106.0,10116.0,50597,13950,
,N,A,CHEMBL620169,1,1,Spleen,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8393,2106.0,10116.0,50597,13950,
,N,A,CHEMBL620170,1,1,Spleen,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8394,2106.0,10116.0,50597,13950,
,N,A,CHEMBL620171,1,1,Spleen,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8395,2106.0,10116.0,50597,13950,
,N,A,CHEMBL620172,1,1,Spleen,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8396,2106.0,10116.0,50597,13950,
,N,A,CHEMBL620173,1,1,Stomach,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8397,945.0,10116.0,50597,13950,
,N,A,CHEMBL620174,1,1,Stomach,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8398,945.0,10116.0,50597,13950,
,N,A,CHEMBL620175,1,1,Stomach,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8399,945.0,10116.0,50597,13950,
,N,A,CHEMBL620176,1,1,Stomach,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8400,945.0,10116.0,50597,13950,
,N,A,CHEMBL620177,1,1,Stomach,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,8401,945.0,10116.0,50597,13950,
,N,A,CHEMBL620178,1,1,Cerebellum,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8402,2037.0,10116.0,50597,13950,
,N,A,CHEMBL620179,1,1,Cerebellum,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8403,2037.0,10116.0,50597,13950,
,N,A,CHEMBL620180,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8404,,10116.0,50597,13950,
,N,A,CHEMBL620181,1,1,,BAO_0000218,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8405,,10116.0,50597,6570,
,N,A,CHEMBL620182,1,1,,BAO_0000218,Volume of distribution of compound in rats after intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8406,,10116.0,50597,6571,
,N,A,CHEMBL620183,1,1,,BAO_0000218,Volume of distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8407,,10116.0,50597,6453,
,N,A,CHEMBL620184,1,1,,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8408,,10116.0,50597,6444,
,N,A,CHEMBL620185,1,1,,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8409,,10116.0,50597,6444,
,N,A,CHEMBL620186,1,1,,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8410,,10116.0,50597,6444,
,N,A,CHEMBL620187,1,1,,BAO_0000218,Volume of distribution was determined in Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8411,,10116.0,50597,5353,
,N,A,CHEMBL620188,1,1,,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8412,,10116.0,50597,5334,
,N,A,CHEMBL620189,1,1,,BAO_0000218,Volume of distribution was reported in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8413,,10116.0,50597,5334,
,N,A,CHEMBL620190,1,1,,BAO_0000218,Volumes of distribution in rat after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8414,,10116.0,50597,6641,
,N,A,CHEMBL620191,1,1,,BAO_0000218,Volumes of distribution in rat after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8415,,10116.0,50597,6641,
,N,A,CHEMBL620192,1,1,,BAO_0000218,Volumes of distribution in rat after po administration; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8416,,10116.0,50597,6641,
,N,A,CHEMBL620193,1,1,,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8417,,10116.0,50597,5676,
,N,A,CHEMBL620194,1,1,,BAO_0000218,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Rattus norvegicus,,,,Intermediate,,,In vivo,8418,,10116.0,50597,6410,
,N,A,CHEMBL876730,1,1,,BAO_0000218,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,8419,,10116.0,50597,17670,
,N,A,CHEMBL620195,1,1,,BAO_0000218,Volume distribution in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8420,,10116.0,50597,6495,
,N,A,CHEMBL620196,1,1,,BAO_0000218,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8421,,10116.0,50597,5408,
,N,A,CHEMBL620197,1,1,,BAO_0000218,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8422,,10116.0,50597,4883,
,N,A,CHEMBL620198,1,1,,BAO_0000218,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8423,,10116.0,50597,6647,
,N,A,CHEMBL620199,1,1,,BAO_0000218,Volume of distribution in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8424,,10116.0,50597,6495,
,N,A,CHEMBL620200,1,1,,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8425,,10116.0,50597,2661,
,N,A,CHEMBL620201,1,1,,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8426,,10116.0,50597,2661,
,N,A,CHEMBL620202,1,1,,BAO_0000218,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8427,,10116.0,50597,5974,
,N,A,CHEMBL620203,1,1,,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8428,,10116.0,50597,5974,
,N,A,CHEMBL620204,1,1,,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Rattus norvegicus,,,,Intermediate,,,In vivo,8429,,10116.0,50597,5974,
,N,A,CHEMBL620205,1,1,,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8430,,10116.0,50597,5974,
,N,A,CHEMBL624664,1,1,,BAO_0000218,Pharmacokinetic parameter (Vss) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8431,,10116.0,50597,5960,
,N,A,CHEMBL624665,1,1,,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8432,,10116.0,50597,5676,
,N,A,CHEMBL624666,1,1,,BAO_0000218,Pharmacokinetic property (Vss) in rat,Rattus norvegicus,,,,Intermediate,,,,8433,,10116.0,50597,5948,
,N,A,CHEMBL624667,1,1,,BAO_0000218,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8434,,10116.0,50597,5979,
,N,A,CHEMBL624668,1,1,,BAO_0000218,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8435,,10116.0,50597,5978,
,N,A,CHEMBL624669,1,1,,BAO_0000218,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8436,,10116.0,50597,5978,
,N,A,CHEMBL624670,1,1,,BAO_0000218,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8437,,10116.0,50597,5978,
,N,A,CHEMBL624671,1,1,,BAO_0000218,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8438,,10116.0,50597,5978,
,N,A,CHEMBL624672,1,1,,BAO_0000218,Steady state volume distribution in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8439,,10116.0,50597,6448,
,N,A,CHEMBL624673,1,1,Plasma,BAO_0000218,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Rattus norvegicus,,,,Intermediate,,,In vivo,8440,1969.0,10116.0,50597,12873,
,N,A,CHEMBL624674,1,1,,BAO_0000218,Steady state volume of distribution determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8441,,10116.0,50597,4576,
,N,A,CHEMBL624675,1,1,,BAO_0000218,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8442,,10116.0,50597,17582,
,N,A,CHEMBL621728,1,1,,BAO_0000218,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8443,,10116.0,50597,1466,
,N,A,CHEMBL621729,1,1,,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Rattus norvegicus,,,,Intermediate,,,,8444,,10116.0,50597,5182,
,N,A,CHEMBL621730,1,1,,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Rattus norvegicus,,,,Intermediate,,,,8445,,10116.0,50597,5182,
,N,A,CHEMBL621731,1,1,,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,8446,,10116.0,50597,6535,
,N,A,CHEMBL621732,1,1,,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,8447,,10116.0,50597,6535,
,N,A,CHEMBL621908,1,1,,BAO_0000218,Volume in steady state distribution value was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8448,,10116.0,50597,5041,
,N,A,CHEMBL875347,1,1,,BAO_0000218,Volume in steady state distribution value was determined; ND denotes no data,Rattus norvegicus,,,,Intermediate,,,In vivo,8449,,10116.0,50597,5041,
,N,A,CHEMBL621909,1,1,,BAO_0000218,Volume in steady state distribution value was determined; ND denotes not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8450,,10116.0,50597,5041,
,N,A,CHEMBL621910,1,1,,BAO_0000218,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8451,,10116.0,50597,17065,
,N,A,CHEMBL621911,1,1,,BAO_0000218,Volume of distribution at steady state was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8452,,10116.0,50597,6597,
,N,A,CHEMBL621912,1,1,,BAO_0000218,Volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8453,,10116.0,50597,15662,
,N,A,CHEMBL621913,1,1,,BAO_0000218,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8454,,10116.0,50597,6485,
,N,A,CHEMBL621914,1,1,,BAO_0000218,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8455,,10116.0,50597,17655,
,N,A,CHEMBL621915,1,1,,BAO_0000218,Volume of distribution after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8456,,10116.0,50597,6616,
,N,A,CHEMBL621916,1,1,,BAO_0000218,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8457,,10116.0,50597,1916,
,N,A,CHEMBL621917,1,1,Liver,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,,,,Intermediate,,,In vivo,8458,2107.0,10090.0,50594,16438,
,N,A,CHEMBL621918,1,1,Liver,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,,,,Intermediate,,,In vivo,8459,2107.0,10090.0,50594,16438,
,N,A,CHEMBL621919,1,1,Spleen,BAO_0000218,Biodistribution of compound (oxidized form) in spleen tissue,Mus musculus,,,,Intermediate,,,In vivo,8460,2106.0,10090.0,50594,16438,
,N,A,CHEMBL621920,1,1,Spleen,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Mus musculus,,,,Intermediate,,,In vivo,8461,2106.0,10090.0,50594,16438,
,N,A,CHEMBL621921,1,1,Spleen,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Mus musculus,,,,Intermediate,,,In vivo,8462,2106.0,10090.0,50594,16438,
,N,A,CHEMBL622401,1,1,Spleen,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8463,2106.0,10090.0,50594,16438,
,N,A,CHEMBL875348,1,1,Spleen,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,,,,Intermediate,,,In vivo,8464,2106.0,10090.0,50594,16438,
,N,A,CHEMBL622402,1,1,Spleen,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,,,,Intermediate,,,In vivo,8465,2106.0,10090.0,50594,16438,
,N,A,CHEMBL622403,1,1,Blood,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Mus musculus,,,,Intermediate,,,In vivo,8466,178.0,10090.0,50594,16438,
,N,A,CHEMBL622404,1,1,Blood,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8467,178.0,10090.0,50594,16438,
,N,A,CHEMBL622405,1,1,Brain,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Mus musculus,,,,Intermediate,,,In vivo,8468,955.0,10090.0,50594,16438,
,N,A,CHEMBL622406,1,1,Brain,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8469,955.0,10090.0,50594,16438,
,N,A,CHEMBL622407,1,1,Brain,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8470,955.0,10090.0,50594,16438,
,N,A,CHEMBL622408,1,1,Heart,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Mus musculus,,,,Intermediate,,,In vivo,8471,948.0,10090.0,50594,16438,
,N,A,CHEMBL622409,1,1,Heart,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8472,948.0,10090.0,50594,16438,
,N,A,CHEMBL622410,1,1,Heart,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8473,948.0,10090.0,50594,16438,
,N,A,CHEMBL622411,1,1,Kidney,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Mus musculus,,,,Intermediate,,,In vivo,8474,2113.0,10090.0,50594,16438,
,N,A,CHEMBL627864,1,1,Kidney,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8475,2113.0,10090.0,50594,16438,
,N,A,CHEMBL627865,1,1,Kidney,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8476,2113.0,10090.0,50594,16438,
,N,A,CHEMBL627866,1,1,Liver,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Mus musculus,,,,Intermediate,,,In vivo,8477,2107.0,10090.0,50594,16438,
,N,A,CHEMBL627751,1,1,Liver,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8478,2107.0,10090.0,50594,16438,
,N,A,CHEMBL627752,1,1,Spleen,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Mus musculus,,,,Intermediate,,,In vivo,8479,2106.0,10090.0,50594,16438,
,N,A,CHEMBL627753,1,1,Spleen,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8480,2106.0,10090.0,50594,16438,
,N,A,CHEMBL627754,1,1,Spleen,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,,,Intermediate,,,In vivo,8481,2106.0,10090.0,50594,16438,
,N,A,CHEMBL627755,1,1,,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Mus musculus,,,,Intermediate,,,,8482,,10090.0,50594,12467,
,N,A,CHEMBL627756,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8483,955.0,10090.0,50594,17208,
,N,A,CHEMBL627757,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8484,955.0,10090.0,50594,17208,
,N,A,CHEMBL627758,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8485,955.0,10090.0,50594,17208,
,N,A,CHEMBL627759,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8486,955.0,10090.0,50594,17208,
,N,A,CHEMBL627760,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8487,955.0,10090.0,50594,17208,
,N,A,CHEMBL627761,1,1,Brain,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8488,955.0,10090.0,50594,17208,
,N,A,CHEMBL876811,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8489,948.0,10090.0,50594,17208,
,N,A,CHEMBL627762,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8490,948.0,10090.0,50594,17208,
,N,A,CHEMBL627763,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8491,948.0,10090.0,50594,17208,
,N,A,CHEMBL627764,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8492,948.0,10090.0,50594,17208,
,N,A,CHEMBL627765,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8493,948.0,10090.0,50594,17208,
,N,A,CHEMBL627766,1,1,Heart,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8494,948.0,10090.0,50594,17208,
,N,A,CHEMBL627767,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8495,2113.0,10090.0,50594,17208,
,N,A,CHEMBL627768,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8496,2113.0,10090.0,50594,17208,
,N,A,CHEMBL628422,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8497,2113.0,10090.0,50594,17208,
,N,A,CHEMBL628423,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8498,2113.0,10090.0,50594,17208,
,N,A,CHEMBL628424,1,1,,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8499,,10116.0,50597,5089,
,N,A,CHEMBL628425,1,1,,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8500,,10116.0,50597,5089,
,N,A,CHEMBL628426,1,1,,BAO_0000218,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8501,,10116.0,50597,4257,
,N,A,CHEMBL628427,1,1,,BAO_0000218,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8502,,10116.0,50597,6679,
,N,A,CHEMBL626938,1,1,,BAO_0000218,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8503,,10116.0,50597,5546,
,N,A,CHEMBL626939,1,1,,BAO_0000218,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8504,,10116.0,50597,6141,
,N,A,CHEMBL626940,1,1,,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8505,,10116.0,50597,5334,
,N,A,CHEMBL626941,1,1,,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8506,,10116.0,50597,5334,
,N,A,CHEMBL626942,1,1,,BAO_0000218,Plasma clearance was reported in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8507,,10116.0,50597,5334,
,N,A,CHEMBL876812,1,1,,BAO_0000218,Plasma clearance after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8508,,10116.0,50597,4689,
,N,A,CHEMBL626943,1,1,,BAO_0000218,Plasma clearance of compound in rats was evaluated,Rattus norvegicus,,,,Intermediate,,,In vivo,8509,,10116.0,50597,6848,
,N,A,CHEMBL626944,1,1,,BAO_0000218,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8510,,10116.0,50597,6848,
,N,A,CHEMBL626945,1,1,,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8511,,10116.0,50597,6467,
,N,A,CHEMBL626946,1,1,,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8512,,10116.0,50597,6467,
,N,A,CHEMBL626856,1,1,,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8513,,10116.0,50597,4956,
,N,A,CHEMBL626857,1,1,,BAO_0000218,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,8514,,10116.0,50597,5529,
,N,A,CHEMBL626858,1,1,Plasma,BAO_0000218,The compound was evaluated for plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8515,1969.0,10116.0,50597,406,
,N,A,CHEMBL627018,1,1,Plasma,BAO_0000218,Total plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8516,1969.0,10116.0,50597,17655,
,N,A,CHEMBL625331,1,1,Blood,BAO_0000218,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,8517,178.0,10116.0,50597,3293,
,N,A,CHEMBL625332,1,1,Blood,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8518,178.0,10116.0,50597,4075,
,N,A,CHEMBL877590,1,1,,BAO_0000218,C max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8519,,10116.0,50597,2792,
,N,A,CHEMBL625333,1,1,,BAO_0000218,C max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8520,,10116.0,50597,2792,
,N,A,CHEMBL625334,1,1,,BAO_0000218,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8521,,10116.0,50597,17594,
,N,A,CHEMBL625335,1,1,,BAO_0000218,Cmax after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8522,,10116.0,50597,17594,
,N,A,CHEMBL625336,1,1,,BAO_0000218,Cmax of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8523,,10116.0,50597,4762,
,N,A,CHEMBL625337,1,1,,BAO_0000218,Cmax 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8524,,10116.0,50597,17509,
,N,A,CHEMBL625338,1,1,,BAO_0000218,Cmax 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8525,,10116.0,50597,17509,
,N,A,CHEMBL625339,1,1,Plasma,BAO_0000218,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8526,1969.0,10116.0,50597,1466,
,N,A,CHEMBL625340,1,1,,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,8527,,10116.0,50597,6535,
,N,A,CHEMBL625341,1,1,,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,8528,,10116.0,50597,6535,
,N,A,CHEMBL622687,1,1,,BAO_0000218,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8529,,10116.0,50597,3169,
,N,A,CHEMBL622688,1,1,Plasma,BAO_0000218,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8530,1969.0,10116.0,50597,6515,
,N,A,CHEMBL622689,1,1,Blood,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8531,178.0,10116.0,50597,11149,
,N,A,CHEMBL620295,1,1,Blood,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8532,178.0,10116.0,50597,11149,
,N,A,CHEMBL620296,1,1,,BAO_0000218,Cmax after 10 mg/kg oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8533,,10116.0,50597,17858,
,N,A,CHEMBL620297,1,1,,BAO_0000218,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,8534,,10116.0,50597,6518,
,N,A,CHEMBL620298,1,1,,BAO_0000218,Cmax after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,8535,,10116.0,50597,6518,
,N,A,CHEMBL620299,1,1,,BAO_0000218,Cmax after oral administration at 20 mpk in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8536,,10116.0,50597,4426,
,N,A,CHEMBL620300,1,1,,BAO_0000218,Cmax after oral administration at 20 mpk in rats; Not performed.,Rattus norvegicus,,,,Intermediate,,,In vivo,8537,,10116.0,50597,4426,
,N,A,CHEMBL620301,1,1,,BAO_0000218,Cmax after oral administration at 20 mpk in rats d; Not performed.,Rattus norvegicus,,,,Intermediate,,,In vivo,8538,,10116.0,50597,4426,
,N,A,CHEMBL620302,1,1,,BAO_0000218,Cmax after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8539,,10116.0,50597,5656,
,N,A,CHEMBL620303,1,1,,BAO_0000218,Cmax after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8540,,10116.0,50597,6518,
,N,A,CHEMBL620304,1,1,,BAO_0000218,Cmax after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8541,,10116.0,50597,6518,
,N,A,CHEMBL620305,1,1,,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8542,,10116.0,50597,6113,
,N,A,CHEMBL620306,1,1,,BAO_0000218,Cmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8543,,10116.0,50597,17764,
,N,A,CHEMBL620307,1,1,,BAO_0000218,Cmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8544,,10116.0,50597,4756,
,N,A,CHEMBL620308,1,1,,BAO_0000218,Cmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8545,,10116.0,50597,4756,
,N,A,CHEMBL620309,1,1,,BAO_0000218,Cmax by administering at 20 mg/kg p.o. in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8546,,10116.0,50597,6402,
,N,A,CHEMBL620310,1,1,,BAO_0000218,Cmax in male rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8547,,10116.0,50597,5610,
,N,A,CHEMBL620311,1,1,,BAO_0000218,Cmax in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8548,,10116.0,50597,5207,
,N,A,CHEMBL620312,1,1,,BAO_0000218,Cmax in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8549,,10116.0,50597,6011,
,N,A,CHEMBL620313,1,1,,BAO_0000218,Cmax in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8550,,10116.0,50597,6504,
,N,A,CHEMBL620314,1,1,,BAO_0000218,Cmax in rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8551,,10116.0,50597,6046,
,N,A,CHEMBL620315,1,1,,BAO_0000218,Cmax in rat at the dose of 1 mg/kg i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,8552,,10116.0,50597,6504,
,N,A,CHEMBL620316,1,1,,BAO_0000218,Cmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8553,,10116.0,50597,5874,
,N,A,CHEMBL620317,1,1,,BAO_0000218,Cmax in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8554,,10116.0,50597,17686,
,N,A,CHEMBL620318,1,1,,BAO_0000218,Cmax in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8555,,10116.0,50597,5836,
,N,A,CHEMBL620319,1,1,,BAO_0000218,Cmax in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8556,,10116.0,50597,17596,
,N,A,CHEMBL620320,1,1,,BAO_0000218,Cmax was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8557,,10116.0,50597,16423,
,N,A,CHEMBL620321,1,1,,BAO_0000218,Cmax was measured in rats after peroral administration at 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8558,,10116.0,50597,17804,
,N,A,CHEMBL620322,1,1,,BAO_0000218,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,8559,,10116.0,50597,1908,
,N,A,CHEMBL620323,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8560,,10116.0,50597,13950,
,N,A,CHEMBL620324,1,1,Frontal cortex,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8561,1870.0,10116.0,50597,13950,
,N,A,CHEMBL620325,1,1,Frontal cortex,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8562,1870.0,10116.0,50597,13950,
,N,A,CHEMBL620326,1,1,Hippocampus,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8563,10000000.0,10116.0,50597,13950,
,N,A,CHEMBL620327,1,1,Hippocampus,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8564,10000000.0,10116.0,50597,13950,
,N,A,CHEMBL620328,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8565,,10116.0,50597,13950,
,N,A,CHEMBL620329,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8566,,10116.0,50597,13950,
,N,A,CHEMBL620330,1,1,Midbrain,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8567,1891.0,10116.0,50597,13950,
,N,A,CHEMBL875286,1,1,Midbrain,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8568,1891.0,10116.0,50597,13950,
,N,A,CHEMBL620331,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8569,,10116.0,50597,13950,
,N,A,CHEMBL620332,1,1,,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8570,,10116.0,50597,13950,
,N,A,CHEMBL620333,1,1,Striatum,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8571,2435.0,10116.0,50597,13950,
,N,A,CHEMBL620334,1,1,Striatum,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,,Intermediate,,,,8572,2435.0,10116.0,50597,13950,
,N,A,CHEMBL621015,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8573,178.0,10116.0,50597,16434,
,N,A,CHEMBL621016,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8574,178.0,10116.0,50597,16434,
,N,A,CHEMBL621191,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8575,178.0,10116.0,50597,16434,
,N,A,CHEMBL621192,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8576,178.0,10116.0,50597,16434,
,N,A,CHEMBL621193,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8577,178.0,10116.0,50597,16434,
,N,A,CHEMBL621194,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8578,178.0,10116.0,50597,16434,
,N,A,CHEMBL624204,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8579,178.0,10116.0,50597,16434,
,N,A,CHEMBL624205,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8580,178.0,10116.0,50597,16434,
,N,A,CHEMBL624206,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8581,178.0,10116.0,50597,16435,
,N,A,CHEMBL624207,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8582,178.0,10116.0,50597,16435,
,N,A,CHEMBL624208,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8583,178.0,10116.0,50597,16435,
,N,A,CHEMBL624209,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8584,178.0,10116.0,50597,16435,
,N,A,CHEMBL624210,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8585,178.0,10116.0,50597,16435,
,N,A,CHEMBL624211,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8586,178.0,10116.0,50597,16435,
,N,A,CHEMBL624212,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8587,178.0,10116.0,50597,16435,
,N,A,CHEMBL624213,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8588,178.0,10116.0,50597,16435,
,N,A,CHEMBL876611,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,8589,178.0,10116.0,50597,16434,
,N,A,CHEMBL624214,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,8590,178.0,10116.0,50597,16434,
,N,A,CHEMBL624215,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,8591,178.0,10116.0,50597,16434,
,N,A,CHEMBL624216,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8592,178.0,10116.0,50597,16435,
,N,A,CHEMBL624217,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8593,178.0,10116.0,50597,16435,
,N,A,CHEMBL624218,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8594,178.0,10116.0,50597,16435,
,N,A,CHEMBL624219,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8595,178.0,10116.0,50597,16435,
,N,A,CHEMBL624220,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8596,178.0,10116.0,50597,16435,
,N,A,CHEMBL624221,1,1,Blood,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8597,178.0,10116.0,50597,16435,
,N,A,CHEMBL624222,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8598,,10116.0,50597,16434,
,N,A,CHEMBL624223,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8599,,10116.0,50597,16434,
,N,A,CHEMBL624224,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8600,,10116.0,50597,16434,
,N,A,CHEMBL624225,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8601,,10116.0,50597,16434,
,N,A,CHEMBL622420,1,1,,BAO_0000218,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8602,,10116.0,50597,17764,
,N,A,CHEMBL622421,1,1,,BAO_0000218,Volume of steady state distribution after i.v. administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8603,,10116.0,50597,5031,
,N,A,CHEMBL622422,1,1,,BAO_0000218,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8604,,10116.0,50597,6215,
,N,A,CHEMBL622423,1,1,,BAO_0000218,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8605,,10116.0,50597,17671,
,N,A,CHEMBL622424,1,1,,BAO_0000218,Vss was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8606,,10116.0,50597,17752,
,N,A,CHEMBL622425,1,1,,BAO_0000218,Vss in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8607,,10116.0,50597,6596,
,N,A,CHEMBL876612,1,1,,BAO_0000218,Vss was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8608,,10116.0,50597,16423,
,N,A,CHEMBL622426,1,1,,BAO_0000218,volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8609,,10116.0,50597,15662,
,N,A,CHEMBL622427,1,1,,BAO_0000218,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8610,,10116.0,50597,6062,
,N,A,CHEMBL622428,1,1,,BAO_0000218,Pharmacokinetic (PK) parameter Vz in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8611,,10116.0,50597,5874,
,N,A,CHEMBL622429,1,1,,BAO_0000218,Volume distribution in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8612,,10116.0,50597,4942,
,N,A,CHEMBL622430,1,1,,BAO_0000218,Volume of distribution in rat; No data,Rattus norvegicus,,,,Intermediate,,,In vivo,8613,,10116.0,50597,17796,
,N,A,CHEMBL622431,1,1,,BAO_0000218,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8614,,10116.0,50597,4890,
,N,A,CHEMBL622432,1,1,Ileum,BAO_0000218,% absorption predicted from in vitro rat ileum transport studies,Rattus norvegicus,,,,Intermediate,,,,8615,2116.0,10116.0,50597,15765,
,N,A,CHEMBL622433,1,1,,BAO_0000218,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8616,,10116.0,50597,13569,
,N,A,CHEMBL622434,1,1,,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8617,,10116.0,50597,13569,
,N,A,CHEMBL622435,1,1,,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8618,,10116.0,50597,13569,
,N,A,CHEMBL618748,1,1,,BAO_0000218,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,8619,,10116.0,50597,13569,
,N,A,CHEMBL618749,1,1,,BAO_0000218,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8620,,10116.0,50597,13569,
,N,A,CHEMBL618750,1,1,,BAO_0000218,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8621,,10116.0,50597,13569,
,N,A,CHEMBL618751,1,1,,BAO_0000218,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8622,,10116.0,50597,13569,
,N,A,CHEMBL618752,1,1,,BAO_0000218,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8623,,10116.0,50597,13569,
,N,A,CHEMBL618753,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8624,,10116.0,50597,4576,
,N,A,CHEMBL618754,1,1,Plasma,BAO_0000218,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Rattus norvegicus,,,,Intermediate,,,In vivo,8625,1969.0,10116.0,50597,750,
,N,A,CHEMBL618755,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8626,,10116.0,50597,750,
,N,A,CHEMBL618756,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8627,,10116.0,50597,4590,
,N,A,CHEMBL618757,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8628,,10116.0,50597,1716,
,N,A,CHEMBL618758,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8629,,10116.0,50597,1974,
,N,A,CHEMBL621088,1,1,,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,8630,,10116.0,50597,4502,
,N,A,CHEMBL621089,1,1,,BAO_0000218,Pharmacokinetic property (cLogP) in rat,Rattus norvegicus,,,,Intermediate,,,,8631,,10116.0,50597,3371,
,N,F,CHEMBL621090,1,1,Blood,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,,,,Intermediate,,,,8632,178.0,10116.0,50597,9099,
,N,F,CHEMBL621091,1,1,Blood,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,,,,Intermediate,,,,8633,178.0,10116.0,50597,9099,
,N,A,CHEMBL876731,1,1,,BAO_0000218,Clearance in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,8634,,10116.0,50597,4590,
,N,A,CHEMBL621092,1,1,,BAO_0000218,Compound was evaluated for its clearance when administered intravenously in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8635,,10116.0,50597,3184,
,N,A,CHEMBL621093,1,1,,BAO_0000218,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8636,,10116.0,50597,16456,
,N,A,CHEMBL621094,1,1,,BAO_0000218,Blood: Brain distribution ratio is determined in rat,Rattus norvegicus,,,,Intermediate,,,,8637,,10116.0,50597,4199,
,N,A,CHEMBL621095,1,1,,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Rattus norvegicus,,,,Intermediate,,,,8638,,10116.0,50597,4199,
,N,A,CHEMBL621096,1,1,,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Rattus norvegicus,,,,Intermediate,,,,8639,,10116.0,50597,4199,
,N,A,CHEMBL621097,1,1,Kidney,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,8640,2113.0,10116.0,50597,8677,
,N,F,CHEMBL621098,1,1,,BAO_0000218,Percent dose excreted in 0-48 hours administered ip to male rat,Rattus norvegicus,,,,Intermediate,,,,8641,,10116.0,50597,7449,
,N,A,CHEMBL621099,1,1,Cerebellum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8642,2037.0,10116.0,50597,11977,
,N,A,CHEMBL621100,1,1,Cerebellum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8643,2037.0,10116.0,50597,11977,
,N,A,CHEMBL621101,1,1,Cerebellum,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,,8644,2037.0,10116.0,50597,11977,
,N,A,CHEMBL621102,1,1,Cerebellum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8645,2037.0,10116.0,50597,11977,
,N,A,CHEMBL876732,1,1,Cerebellum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8646,2037.0,10116.0,50597,11977,
,N,A,CHEMBL621103,1,1,,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8647,,10116.0,50597,11977,
,N,A,CHEMBL621104,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8648,,10116.0,50597,11977,
,N,A,CHEMBL621105,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,,8649,,10116.0,50597,11977,
,N,A,CHEMBL621106,1,1,,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8650,,10116.0,50597,11977,
,N,A,CHEMBL621107,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8651,,10116.0,50597,11977,
,N,A,CHEMBL621108,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8652,,10116.0,50597,11977,
,N,A,CHEMBL621109,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8653,,10116.0,50597,11977,
,N,A,CHEMBL621110,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8654,2113.0,10090.0,50594,17208,
,N,A,CHEMBL621111,1,1,Kidney,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8655,2113.0,10090.0,50594,17208,
,N,A,CHEMBL622541,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8656,2107.0,10090.0,50594,17208,
,N,A,CHEMBL622542,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8657,2107.0,10090.0,50594,17208,
,N,A,CHEMBL622543,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8658,2107.0,10090.0,50594,17208,
,N,A,CHEMBL624412,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8659,2107.0,10090.0,50594,17208,
,N,A,CHEMBL624413,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8660,2107.0,10090.0,50594,17208,
,N,A,CHEMBL624414,1,1,Liver,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8661,2107.0,10090.0,50594,17208,
,N,A,CHEMBL624415,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8662,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624416,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8663,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624417,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8664,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624418,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8665,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624419,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8666,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624420,1,1,Lung,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8667,2048.0,10090.0,50594,17208,
,N,A,CHEMBL624421,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8668,2385.0,10090.0,50594,17208,
,N,A,CHEMBL624422,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8669,2385.0,10090.0,50594,17208,
,N,A,CHEMBL624423,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8670,2385.0,10090.0,50594,17208,
,N,A,CHEMBL625123,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8671,2385.0,10090.0,50594,17208,
,N,A,CHEMBL625124,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8672,2385.0,10090.0,50594,17208,
,N,A,CHEMBL625125,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8673,2385.0,10090.0,50594,17208,
,N,A,CHEMBL625126,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8674,14.0,10090.0,50594,17208,
,N,A,CHEMBL626947,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8675,14.0,10090.0,50594,17208,
,N,A,CHEMBL626948,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8676,14.0,10090.0,50594,17208,
,N,A,CHEMBL626949,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8677,14.0,10090.0,50594,17208,
,N,A,CHEMBL626950,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8678,14.0,10090.0,50594,17208,
,N,A,CHEMBL626951,1,1,Zone of skin,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8679,14.0,10090.0,50594,17208,
,N,A,CHEMBL626952,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8680,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626953,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8681,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626954,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8682,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626955,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8683,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626956,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8684,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626957,1,1,Spleen,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8685,2106.0,10090.0,50594,17208,
,N,A,CHEMBL626958,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8686,178.0,10090.0,50594,17208,
,N,A,CHEMBL626959,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8687,178.0,10090.0,50594,17208,
,N,A,CHEMBL626960,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8688,178.0,10090.0,50594,17208,
,N,A,CHEMBL626961,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8689,178.0,10090.0,50594,17208,
,N,A,CHEMBL627589,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8690,178.0,10090.0,50594,17208,
,N,A,CHEMBL627590,1,1,Blood,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,,,Intermediate,,,In vivo,8691,178.0,10090.0,50594,17208,
,N,A,CHEMBL627591,1,1,,BAO_0000218,Time taken for EC90 was determined when tested in mouse,Mus musculus,,,,Intermediate,,,,8692,,10090.0,50594,3132,
,N,A,CHEMBL627592,1,1,,BAO_0000218,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Mus musculus,,,,Intermediate,,,,8693,,10090.0,50594,3132,
,N,A,CHEMBL627593,1,1,,BAO_0000218,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Mus musculus,,,,Intermediate,,,In vivo,8694,,10090.0,50594,16597,
,N,A,CHEMBL627594,1,1,,BAO_0000218,Half life in mice,Mus musculus,,,,Intermediate,,,,8695,,10090.0,50594,5727,
,N,A,CHEMBL876813,1,1,,BAO_0000218,Half life period in mouse after 10 mg/Kg dose,Mus musculus,,,,Intermediate,,,In vivo,8696,,10090.0,50594,5302,
,N,A,CHEMBL627595,1,1,,BAO_0000218,Half life period in mouse after 10 mg/kg dose,Mus musculus,,,,Intermediate,,,In vivo,8697,,10090.0,50594,5302,
,N,A,CHEMBL627596,1,1,,BAO_0000218,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Mus musculus,,,,Intermediate,,,In vivo,8698,,10090.0,50594,6348,
,N,A,CHEMBL627597,1,1,,BAO_0000218,Cmax value at 5 mg/kg po was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8699,,10116.0,50597,5964,
,N,A,CHEMBL627598,1,1,,BAO_0000218,Cmax value evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8700,,10116.0,50597,6078,
,N,A,CHEMBL627599,1,1,Brain,BAO_0000218,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Rattus norvegicus,,,,Intermediate,,,In vivo,8701,955.0,10116.0,50597,5206,
,N,A,CHEMBL627600,1,1,,BAO_0000218,Cmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8702,,10116.0,50597,2959,
,N,A,CHEMBL627601,1,1,,BAO_0000218,Cmax value at 1 mg/kg po in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8703,,10116.0,50597,5964,
,N,A,CHEMBL627776,1,1,,BAO_0000218,Cmax value at 5 mg/kg po in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8704,,10116.0,50597,5964,
,N,A,CHEMBL627777,1,1,,BAO_0000218,Cmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8705,,10116.0,50597,6757,
,N,A,CHEMBL627778,1,1,,BAO_0000218,Cmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8706,,10116.0,50597,6757,
,N,A,CHEMBL627779,1,1,,BAO_0000218,Cmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8707,,10116.0,50597,6757,
,N,A,CHEMBL876814,1,1,,BAO_0000218,Cmax value in rats at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8708,,10116.0,50597,17617,
,N,A,CHEMBL627780,1,1,,BAO_0000218,Cmax value was evaluated in rats at a dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8709,,10116.0,50597,1445,
,N,A,CHEMBL627781,1,1,,BAO_0000218,Cmax value was determined after peroral administration of 20 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8710,,10116.0,50597,6082,
,N,A,CHEMBL627782,1,1,,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,,,,Intermediate,,,In vivo,8711,,10116.0,50597,1446,
,N,A,CHEMBL627783,1,1,Plasma,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8712,1969.0,10116.0,50597,5407,
,N,A,CHEMBL627784,1,1,Plasma,BAO_0000218,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8713,1969.0,10116.0,50597,2690,
,N,A,CHEMBL627785,1,1,,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8714,,10116.0,50597,2661,
,N,A,CHEMBL627786,1,1,,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8715,,10116.0,50597,2661,
,N,A,CHEMBL627787,1,1,Plasma,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,8716,1969.0,10116.0,50597,4891,
,N,A,CHEMBL627788,1,1,Plasma,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8717,1969.0,10116.0,50597,2807,
,N,A,CHEMBL626579,1,1,Plasma,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8718,1969.0,10116.0,50597,2807,
,N,A,CHEMBL626580,1,1,Plasma,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8719,1969.0,10116.0,50597,2807,
,N,A,CHEMBL876815,1,1,,BAO_0000218,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8720,,10116.0,50597,3634,
,N,A,CHEMBL626581,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8721,1969.0,10116.0,50597,1881,
,N,A,CHEMBL626582,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,8722,1969.0,10116.0,50597,1881,
,N,A,CHEMBL626583,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8723,,10116.0,50597,429,
,N,A,CHEMBL626205,1,1,,BAO_0000218,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8724,,10116.0,50597,5974,
,N,A,CHEMBL626206,1,1,,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8725,,10116.0,50597,5974,
,N,A,CHEMBL626207,1,1,,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8726,,10116.0,50597,5974,
,N,A,CHEMBL623882,1,1,,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8727,,10116.0,50597,5974,
,N,A,CHEMBL623883,1,1,,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8728,,10116.0,50597,17582,
,N,A,CHEMBL623884,1,1,,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,8729,,10116.0,50597,17582,
,N,A,CHEMBL623885,1,1,Plasma,BAO_0000218,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,,,Intermediate,,,In vivo,8730,1969.0,10116.0,50597,3032,
,N,A,CHEMBL623886,1,1,Plasma,BAO_0000218,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8731,1969.0,10116.0,50597,6295,
,N,A,CHEMBL623887,1,1,,BAO_0000218,Maximal concentration in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8732,,10116.0,50597,6619,
,N,A,CHEMBL623888,1,1,,BAO_0000218,Maximal concentration after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8733,,10116.0,50597,6616,
,N,A,CHEMBL623889,1,1,Plasma,BAO_0000218,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8734,1969.0,10116.0,50597,3249,
,N,A,CHEMBL623890,1,1,Plasma,BAO_0000218,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8735,1969.0,10116.0,50597,17791,
,N,A,CHEMBL623891,1,1,Plasma,BAO_0000218,Cmax in rat plasma after oral dose (50 mg/Kg),Rattus norvegicus,,,,Intermediate,,,In vivo,8736,1969.0,10116.0,50597,17791,
,N,A,CHEMBL623892,1,1,Plasma,BAO_0000218,Maximal plasma concentration was determined.,Rattus norvegicus,,,,Intermediate,,,In vivo,8737,1969.0,10116.0,50597,1360,
,N,A,CHEMBL623893,1,1,Plasma,BAO_0000218,Maximal plasma drug concentration was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8738,1969.0,10116.0,50597,2552,
,N,A,CHEMBL877616,1,1,,BAO_0000218,Maximal concentration in rats after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8739,,10116.0,50597,6571,
,N,A,CHEMBL623894,1,1,,BAO_0000218,Maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8740,,10116.0,50597,6570,
,N,A,CHEMBL623895,1,1,Plasma,BAO_0000218,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Rattus norvegicus,,,,Intermediate,,,In vivo,8741,1969.0,10116.0,50597,6567,
,N,A,CHEMBL623896,1,1,,BAO_0000218,Maximum concentration of compound in rat was evaluated.,Rattus norvegicus,,,,Intermediate,,,In vivo,8742,,10116.0,50597,3031,
,N,A,CHEMBL623897,1,1,,BAO_0000218,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8743,,10116.0,50597,3436,
,N,A,CHEMBL623898,1,1,,BAO_0000218,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8744,,10116.0,50597,3436,
,N,A,CHEMBL623899,1,1,,BAO_0000218,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8745,,10116.0,50597,2083,
,N,A,CHEMBL623900,1,1,,BAO_0000218,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8746,,10116.0,50597,3436,
,N,A,CHEMBL623901,1,1,,BAO_0000218,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8747,,10116.0,50597,4527,
,N,A,CHEMBL623902,1,1,,BAO_0000218,Maximum concentration was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8748,,10116.0,50597,1974,
,N,A,CHEMBL623903,1,1,Cerebrospinal fluid,BAO_0000218,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8749,1359.0,10116.0,50597,3307,
,N,A,CHEMBL623904,1,1,Plasma,BAO_0000218,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8750,1969.0,10116.0,50597,3307,
,N,A,CHEMBL877617,1,1,Plasma,BAO_0000218,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8751,1969.0,10116.0,50597,1916,
,N,A,CHEMBL623905,1,1,,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8752,,10116.0,50597,1500,
,N,A,CHEMBL623906,1,1,,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8753,,10116.0,50597,1500,
,N,A,CHEMBL623907,1,1,Plasma,BAO_0000218,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,,,Intermediate,,,In vivo,8754,1969.0,10116.0,50597,4186,
,N,A,CHEMBL623908,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8755,,10116.0,50597,16434,
,N,A,CHEMBL623909,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8756,,10116.0,50597,16434,
,N,A,CHEMBL623910,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8757,,10116.0,50597,16434,
,N,A,CHEMBL623911,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8758,,10116.0,50597,16434,
,N,A,CHEMBL623912,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8759,,10116.0,50597,16435,
,N,A,CHEMBL624616,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8760,,10116.0,50597,16435,
,N,A,CHEMBL624617,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8761,,10116.0,50597,16435,
,N,A,CHEMBL624618,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8762,,10116.0,50597,16435,
,N,A,CHEMBL624619,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8763,,10116.0,50597,16435,
,N,A,CHEMBL624794,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8764,,10116.0,50597,16435,
,N,A,CHEMBL624795,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8765,,10116.0,50597,16435,
,N,A,CHEMBL623921,1,1,,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8766,,10116.0,50597,16435,
,N,A,CHEMBL623922,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,8767,,10116.0,50597,16434,
,N,A,CHEMBL623923,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,8768,,10116.0,50597,16434,
,N,A,CHEMBL623924,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,8769,,10116.0,50597,16434,
,N,A,CHEMBL623925,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8770,,10116.0,50597,16435,
,N,A,CHEMBL623926,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8771,,10116.0,50597,16435,
,N,A,CHEMBL623927,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8772,,10116.0,50597,16435,
,N,A,CHEMBL623928,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8773,,10116.0,50597,16435,
,N,A,CHEMBL623929,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8774,,10116.0,50597,16435,
,N,A,CHEMBL623930,1,1,,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8775,,10116.0,50597,16435,
,N,A,CHEMBL623931,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8776,955.0,10116.0,50597,16434,
,N,A,CHEMBL622165,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8777,955.0,10116.0,50597,16434,
,N,A,CHEMBL621249,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8778,955.0,10116.0,50597,16434,
,N,A,CHEMBL621250,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8779,955.0,10116.0,50597,16434,
,N,A,CHEMBL621448,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8780,955.0,10116.0,50597,16434,
,N,A,CHEMBL621449,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8781,955.0,10116.0,50597,16434,
,N,A,CHEMBL621450,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8782,955.0,10116.0,50597,16434,
,N,A,CHEMBL621451,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8783,955.0,10116.0,50597,16434,
,N,A,CHEMBL621452,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8784,955.0,10116.0,50597,16435,
,N,A,CHEMBL621453,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8785,955.0,10116.0,50597,16435,
,N,A,CHEMBL621454,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8786,955.0,10116.0,50597,16435,
,N,A,CHEMBL621455,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8787,955.0,10116.0,50597,16435,
,N,A,CHEMBL621456,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8788,955.0,10116.0,50597,16435,
,N,A,CHEMBL625145,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8789,955.0,10116.0,50597,16435,
,N,A,CHEMBL875847,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8790,955.0,10116.0,50597,16435,
,N,A,CHEMBL625146,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8791,955.0,10116.0,50597,16435,
,N,A,CHEMBL625147,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,8792,955.0,10116.0,50597,16434,
,N,A,CHEMBL625148,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,8793,955.0,10116.0,50597,16434,
,N,A,CHEMBL625149,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,8794,955.0,10116.0,50597,16434,
,N,A,CHEMBL625150,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8795,955.0,10116.0,50597,16435,
,N,A,CHEMBL625151,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8796,955.0,10116.0,50597,16435,
,N,A,CHEMBL625152,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8797,955.0,10116.0,50597,16435,
,N,A,CHEMBL625153,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8798,955.0,10116.0,50597,16435,
,N,A,CHEMBL625154,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8799,955.0,10116.0,50597,16435,
,N,A,CHEMBL625155,1,1,Brain,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8800,955.0,10116.0,50597,16435,
,N,A,CHEMBL625156,1,1,,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,,8801,,10116.0,50597,11977,
,N,A,CHEMBL624354,1,1,,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8802,,10116.0,50597,11977,
,N,A,CHEMBL624355,1,1,Hippocampus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8803,10000000.0,10116.0,50597,11977,
,N,A,CHEMBL624356,1,1,Hippocampus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8804,10000000.0,10116.0,50597,11977,
,N,A,CHEMBL624357,1,1,Hippocampus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8805,10000000.0,10116.0,50597,11977,
,N,A,CHEMBL624358,1,1,Hippocampus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8806,10000000.0,10116.0,50597,11977,
,N,A,CHEMBL624359,1,1,Striatum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8807,2435.0,10116.0,50597,11977,
,N,A,CHEMBL624360,1,1,Striatum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8808,2435.0,10116.0,50597,11977,
,N,A,CHEMBL624361,1,1,Striatum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,,8809,2435.0,10116.0,50597,11977,
,N,A,CHEMBL624362,1,1,Striatum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8810,2435.0,10116.0,50597,11977,
,N,A,CHEMBL624363,1,1,Striatum,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,,8811,2435.0,10116.0,50597,11977,
,N,A,CHEMBL624364,1,1,Blood,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8812,178.0,10116.0,50597,11977,
,N,A,CHEMBL624365,1,1,Blood,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8813,178.0,10116.0,50597,11977,
,N,A,CHEMBL624366,1,1,Blood,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8814,178.0,10116.0,50597,11977,
,N,A,CHEMBL624367,1,1,Blood,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8815,178.0,10116.0,50597,11977,
,N,A,CHEMBL624368,1,1,Brain,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8816,955.0,10116.0,50597,11977,
,N,A,CHEMBL624369,1,1,Brain,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8817,955.0,10116.0,50597,11977,
,N,A,CHEMBL624370,1,1,Brain,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8818,955.0,10116.0,50597,11977,
,N,A,CHEMBL625069,1,1,Brain,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8819,955.0,10116.0,50597,11977,
,N,A,CHEMBL625070,1,1,Brain,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8820,955.0,10116.0,50597,11977,
,N,A,CHEMBL626051,1,1,Heart,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8821,948.0,10116.0,50597,11977,
,N,A,CHEMBL626052,1,1,Heart,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8822,948.0,10116.0,50597,11977,
,N,A,CHEMBL626053,1,1,Heart,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8823,948.0,10116.0,50597,11977,
,N,A,CHEMBL626054,1,1,Heart,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8824,948.0,10116.0,50597,11977,
,N,A,CHEMBL626055,1,1,Heart,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8825,948.0,10116.0,50597,11977,
,N,A,CHEMBL626056,1,1,Kidney,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8826,2113.0,10116.0,50597,11977,
,N,A,CHEMBL626057,1,1,Kidney,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8827,2113.0,10116.0,50597,11977,
,N,A,CHEMBL625193,1,1,Kidney,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8828,2113.0,10116.0,50597,11977,
,N,A,CHEMBL625194,1,1,Kidney,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8829,2113.0,10116.0,50597,11977,
,N,A,CHEMBL625195,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8830,2107.0,10116.0,50597,11977,
,N,A,CHEMBL625196,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8831,2107.0,10116.0,50597,11977,
,N,A,CHEMBL625197,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8832,2107.0,10116.0,50597,11977,
,N,A,CHEMBL625198,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8833,2107.0,10116.0,50597,11977,
,N,A,CHEMBL627929,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8834,2107.0,10116.0,50597,11977,
,N,A,CHEMBL627074,1,1,Lung,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8835,2048.0,10116.0,50597,11977,
,N,A,CHEMBL627075,1,1,Lung,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8836,2048.0,10116.0,50597,11977,
,N,A,CHEMBL627076,1,1,Lung,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8837,2048.0,10116.0,50597,11977,
,N,A,CHEMBL627077,1,1,Lung,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8838,2048.0,10116.0,50597,11977,
,N,A,CHEMBL627078,1,1,Lung,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8839,2048.0,10116.0,50597,11977,
,N,A,CHEMBL627079,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8840,2385.0,10116.0,50597,11977,
,N,A,CHEMBL873824,1,1,,BAO_0000218,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Mus musculus,,,,Intermediate,,,In vivo,8841,,10090.0,50594,4573,
,N,A,CHEMBL627080,1,1,Plasma,BAO_0000218,Half life in mouse plasma was determined at dose 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,8842,1969.0,10090.0,50594,3132,
,N,A,CHEMBL627081,1,1,,BAO_0000218,Half life was determined,Mus musculus,,,,Intermediate,,,,8843,,10090.0,50594,17718,
,N,A,CHEMBL627082,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,,,,Intermediate,,,In vivo,8844,,10090.0,50594,17728,
,N,A,CHEMBL627083,1,1,,BAO_0000218,Half-life in male mice after 1 mg/kg intravenous dose,Mus musculus,,,,Intermediate,,,In vivo,8845,,10090.0,50594,5961,
,N,A,CHEMBL627085,1,1,Plasma,BAO_0000218,Half life in mice plasma,Mus musculus,,,,Intermediate,,,,8847,1969.0,10090.0,50594,17731,
,N,A,CHEMBL627086,1,1,,BAO_0000218,Half life in mouse,Mus musculus,,,,Intermediate,,,,8848,,10090.0,50594,17592,
,N,A,CHEMBL627087,1,1,Plasma,BAO_0000218,Half life in mouse plasma at dose 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,8849,1969.0,10090.0,50594,3132,
,N,A,CHEMBL627088,1,1,,BAO_0000218,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Mus musculus,,,,Intermediate,,,In vivo,8850,,10090.0,50594,17729,
,N,A,CHEMBL627089,1,1,,BAO_0000218,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Mus musculus,,,,Intermediate,,,In vivo,8851,,10090.0,50594,17729,
,N,A,CHEMBL627090,1,1,,BAO_0000218,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Mus musculus,,,,Intermediate,,,In vivo,8852,,10090.0,50594,17729,
,N,A,CHEMBL627091,1,1,,BAO_0000218,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Mus musculus,,,,Intermediate,,,In vivo,8853,,10090.0,50594,3277,
,N,A,CHEMBL627092,1,1,,BAO_0000218,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Mus musculus,,,,Intermediate,,,In vivo,8854,,10090.0,50594,3760,
,N,A,CHEMBL876785,1,1,,BAO_0000218,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Mus musculus,,,,Intermediate,,,In vivo,8855,,10090.0,50594,3760,
,N,A,CHEMBL627093,1,1,,BAO_0000218,Half-life by iv administration in mouse,Mus musculus,,,,Intermediate,,,In vivo,8856,,10090.0,50594,2862,
,N,A,CHEMBL627094,1,1,,BAO_0000218,Half-life by oral administration in mouse,Mus musculus,,,,Intermediate,,,In vivo,8857,,10090.0,50594,2862,
,N,A,CHEMBL627095,1,1,,BAO_0000218,Half-life in mice,Mus musculus,,,,Intermediate,,,,8858,,10090.0,50594,5980,
,N,A,CHEMBL627096,1,1,Brain,BAO_0000218,Half-life using mouse brain homogenate,Mus musculus,,,,Intermediate,,,,8859,955.0,10090.0,50594,6159,
,N,A,CHEMBL627097,1,1,,BAO_0000218,Half-life was measured in mice,Mus musculus,,,,Intermediate,,,,8860,,10090.0,50594,6254,
,N,A,CHEMBL627098,1,1,,BAO_0000218,Half-life was measured in mouse after an iv dose of 1 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,8861,,10090.0,50594,6062,
,N,A,CHEMBL627099,1,1,Blood,BAO_0000218,Half-life period was determined in mouse blood,Mus musculus,,,,Intermediate,,,,8862,178.0,10090.0,50594,1574,
,N,A,CHEMBL627100,1,1,Brain,BAO_0000218,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Mus musculus,,,,Intermediate,,,,8863,955.0,10090.0,50594,56,
,N,A,CHEMBL627101,1,1,Plasma,BAO_0000218,Plasma half life in mouse,Mus musculus,,,,Intermediate,,,,8864,1969.0,10090.0,50594,993,
,N,A,CHEMBL627102,1,1,,BAO_0000218,Stability of the peptide in the presence of mouse serum,Mus musculus,,,,Intermediate,,,,8865,,10090.0,50594,6652,
,N,A,CHEMBL627103,1,1,,BAO_0000218,Terminal half life of compound was determined in mouse,Mus musculus,,,,Intermediate,,,,8866,,10090.0,50594,17852,
,N,A,CHEMBL627104,1,1,,BAO_0000218,Terminal half life was evaluated in mice after intravenous administration,Mus musculus,,,,Intermediate,,,In vivo,8867,,10090.0,50594,2675,
,N,A,CHEMBL627105,1,1,,BAO_0000218,Terminal half life was evaluated in mice after oral administration,Mus musculus,,,,Intermediate,,,In vivo,8868,,10090.0,50594,2675,
,N,A,CHEMBL876786,1,1,,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Mus musculus,,,,Intermediate,,,,8869,,10090.0,50594,499,
,N,A,CHEMBL873825,1,1,,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Mus musculus,,,,Intermediate,,,,8870,,10090.0,50594,499,
,N,A,CHEMBL627106,1,1,,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Mus musculus,,,,Intermediate,,,,8871,,10090.0,50594,499,
,N,A,CHEMBL626336,1,1,,BAO_0000218,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,8872,,10090.0,50594,14239,
,N,A,CHEMBL877462,1,1,,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Mus musculus,,,,Intermediate,,,In vivo,8873,,10090.0,50594,5506,
,N,A,CHEMBL626337,1,1,,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Mus musculus,,,,Intermediate,,,In vivo,8874,,10090.0,50594,5506,
,N,A,CHEMBL626338,1,1,,BAO_0000218,Half life after intraperitoneal administration of 100 mg/kg in mice,Mus musculus,,,,Intermediate,,,,8875,,10090.0,50594,17734,
,N,A,CHEMBL626339,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Mus musculus,,,,Intermediate,,,In vivo,8876,,10090.0,50594,17728,
,N,A,CHEMBL626340,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,,,,Intermediate,,,In vivo,8877,,10090.0,50594,17728,
,N,A,CHEMBL625377,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Mus musculus,,,,Intermediate,,,In vivo,8878,,10090.0,50594,17728,
,N,A,CHEMBL625378,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Mus musculus,,,,Intermediate,,,In vivo,8879,,10090.0,50594,17728,
,N,A,CHEMBL625379,1,1,,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Mus musculus,,,,Intermediate,,,In vivo,8880,,10090.0,50594,17728,
,U,A,CHEMBL625380,1,0,,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Sus scrofa,,,,Autocuration,,,,8881,,9823.0,22224,14294,Microsomes
,U,A,CHEMBL625381,1,0,,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Sus scrofa,,,,Autocuration,,,,8882,,9823.0,22224,14294,Microsomes
,U,A,CHEMBL625382,1,0,,BAO_0000019,Stability to porcine renal DHP-I,Sus scrofa,,,,Autocuration,,,,8883,,9823.0,22224,6056,
,U,A,CHEMBL873828,1,0,,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Sus scrofa,,,,Autocuration,,,In vivo,8884,,9823.0,22224,1317,
,U,A,CHEMBL625383,1,0,,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Sus scrofa,,,,Autocuration,,,In vivo,8885,,9823.0,22224,1317,
,U,A,CHEMBL625384,1,0,,BAO_0000019,Half-life of the parent prodrug in porcine esterase solution,Sus scrofa,,,,Autocuration,,,,8886,,9823.0,22224,5229,
,U,A,CHEMBL625385,1,0,,BAO_0000019,"First order rate constant, k was determined in in pig liver Esterase",Sus scrofa,,,,Autocuration,,,,8887,,9823.0,22224,4231,
,U,A,CHEMBL625386,1,0,Liver,BAO_0000221,Half life of the in pig liver Esterase,Sus scrofa,,,,Autocuration,,,,8888,2107.0,9823.0,22224,4231,
,U,A,CHEMBL623571,1,0,Liver,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Sus scrofa,,,,Autocuration,,,,8889,2107.0,9823.0,22224,5318,
,U,A,CHEMBL623572,1,0,Liver,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Sus scrofa,,,,Autocuration,,,,8890,2107.0,9823.0,22224,5318,
,U,A,CHEMBL623573,1,0,Liver,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Sus scrofa,,,,Autocuration,,,,8891,2107.0,9823.0,22224,5318,
,U,A,CHEMBL623574,1,0,Liver,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Sus scrofa,,,,Autocuration,,,,8892,2107.0,9823.0,22224,3305,
,U,A,CHEMBL623575,1,0,Liver,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Sus scrofa,,,,Autocuration,,,,8893,2107.0,9823.0,22224,3305,
,U,A,CHEMBL623749,1,0,Liver,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Sus scrofa,,,,Autocuration,,,,8894,2107.0,9823.0,22224,2842,
,U,A,CHEMBL623750,1,0,Liver,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Sus scrofa,,,,Autocuration,,,,8895,2107.0,9823.0,22224,2842,
,U,A,CHEMBL623751,1,0,Liver,BAO_0000221,Half-life in vitro in pig liver,Sus scrofa,,,,Autocuration,,,In vitro,8896,2107.0,9823.0,22224,889,
,U,A,CHEMBL623752,1,0,Liver,BAO_0000221,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Sus scrofa,,,,Autocuration,,,,8897,2107.0,9823.0,22224,1904,
,N,A,CHEMBL623753,1,1,Plasma,BAO_0000218,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Rattus norvegicus,,,,Intermediate,,,In vivo,8898,1969.0,10116.0,50597,4186,
,N,A,CHEMBL623754,1,1,Plasma,BAO_0000218,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,8899,1969.0,10116.0,50597,2774,
,N,A,CHEMBL623755,1,1,Plasma,BAO_0000218,Maximum concentration in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,8900,1969.0,10116.0,50597,1742,
,N,A,CHEMBL623756,1,1,,BAO_0000218,Maximum concentration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8901,,10116.0,50597,3169,
,N,A,CHEMBL623757,1,1,,BAO_0000218,Maximum concentration in rats at 1-2 hours,Rattus norvegicus,,,,Intermediate,,,In vivo,8902,,10116.0,50597,3169,
,N,A,CHEMBL623758,1,1,,BAO_0000218,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Rattus norvegicus,,,,Intermediate,,,In vivo,8903,,10116.0,50597,2081,
,N,A,CHEMBL623759,1,1,Brain,BAO_0000218,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8904,955.0,10116.0,50597,3307,
,N,A,CHEMBL623760,1,1,,BAO_0000218,Maximum concentration at the dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8905,,10116.0,50597,4727,
,N,A,CHEMBL623761,1,1,,BAO_0000218,Maximum concentration was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8906,,10116.0,50597,6597,
,N,A,CHEMBL623762,1,1,Plasma,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8907,1969.0,10116.0,50597,16365,
,N,A,CHEMBL877594,1,1,Plasma,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8908,1969.0,10116.0,50597,16365,
,N,A,CHEMBL623763,1,1,Plasma,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8909,1969.0,10116.0,50597,16365,
,N,A,CHEMBL623764,1,1,Plasma,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8910,1969.0,10116.0,50597,16365,
,N,A,CHEMBL623765,1,1,Plasma,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8911,1969.0,10116.0,50597,16365,
,N,A,CHEMBL623766,1,1,Blood,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8912,178.0,10116.0,50597,2591,
,N,A,CHEMBL623767,1,1,Blood,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8913,178.0,10116.0,50597,2591,
,N,A,CHEMBL623768,1,1,Blood,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8914,178.0,10116.0,50597,2591,
,N,A,CHEMBL623769,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8915,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623770,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8916,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623771,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8917,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623772,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8918,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623773,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8919,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623774,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8920,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623775,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8921,1969.0,10116.0,50597,5978,
,N,A,CHEMBL623776,1,1,,BAO_0000218,Cmax in rat (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,8922,,10116.0,50597,14465,
,N,A,CHEMBL622191,1,1,Plasma,BAO_0000218,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8923,1969.0,10116.0,50597,4723,
,N,A,CHEMBL622192,1,1,Plasma,BAO_0000218,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8924,1969.0,10116.0,50597,4723,
,N,A,CHEMBL622193,1,1,Plasma,BAO_0000218,Maximum plasma concentration determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8925,1969.0,10116.0,50597,4576,
,N,A,CHEMBL622194,1,1,Plasma,BAO_0000218,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8926,1969.0,10116.0,50597,12873,
,N,A,CHEMBL622195,1,1,Plasma,BAO_0000218,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,8927,1969.0,10116.0,50597,12873,
,N,A,CHEMBL622196,1,1,Plasma,BAO_0000218,Maximum plasma concentration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8928,1969.0,10116.0,50597,6824,
,N,A,CHEMBL622197,1,1,Plasma,BAO_0000218,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8929,1969.0,10116.0,50597,17065,
,N,A,CHEMBL622198,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8930,1969.0,10116.0,50597,2932,
,N,A,CHEMBL622199,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Rattus norvegicus,,,,Intermediate,,,In vivo,8931,1969.0,10116.0,50597,2932,
,N,A,CHEMBL622200,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound was measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8932,1969.0,10116.0,50597,2879,
,N,A,CHEMBL622201,1,1,Plasma,BAO_0000218,Maximum plasma concentration after 20 mg/kg oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,8933,1969.0,10116.0,50597,2864,
,N,A,CHEMBL623990,1,1,Plasma,BAO_0000218,Maximum plasma concentration after oral administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8934,1969.0,10116.0,50597,16367,
,N,A,CHEMBL623991,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,In vivo,8935,1969.0,10116.0,50597,17717,
,N,A,CHEMBL623992,1,1,Plasma,BAO_0000218,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,8936,1969.0,10116.0,50597,17717,
,N,A,CHEMBL623993,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,In vivo,8937,1969.0,10116.0,50597,17717,
,N,A,CHEMBL623994,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,,,Intermediate,,,In vivo,8938,1969.0,10116.0,50597,17717,
,N,F,CHEMBL623995,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8939,1969.0,10116.0,50597,17720,
,N,F,CHEMBL623996,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8940,1969.0,10116.0,50597,17720,
,N,F,CHEMBL623997,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8941,1969.0,10116.0,50597,17720,
,N,A,CHEMBL623998,1,1,Plasma,BAO_0000218,Maximum plasma concentration dosed orally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8942,1969.0,10116.0,50597,4516,
,N,A,CHEMBL623999,1,1,Plasma,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours,Rattus norvegicus,,,,Intermediate,,,In vivo,8943,1969.0,10116.0,50597,4516,
,N,A,CHEMBL624000,1,1,Plasma,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Rattus norvegicus,,,,Intermediate,,,In vivo,8944,1969.0,10116.0,50597,4516,
,N,A,CHEMBL624001,1,1,Plasma,BAO_0000218,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,8945,1969.0,10116.0,50597,5199,
,N,A,CHEMBL624002,1,1,Plasma,BAO_0000218,Maximum plasma concentration in rat after po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,8946,1969.0,10116.0,50597,17538,
,N,A,CHEMBL624003,1,1,Plasma,BAO_0000218,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,8947,1969.0,10116.0,50597,6685,
,N,A,CHEMBL624004,1,1,Plasma,BAO_0000218,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,8948,1969.0,10116.0,50597,6685,
,N,A,CHEMBL624005,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8949,948.0,10116.0,50597,16434,
,N,A,CHEMBL624006,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8950,948.0,10116.0,50597,16434,
,N,A,CHEMBL624007,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8951,948.0,10116.0,50597,16434,
,N,A,CHEMBL624008,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8952,948.0,10116.0,50597,16434,
,N,A,CHEMBL624009,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8953,948.0,10116.0,50597,16434,
,N,A,CHEMBL874387,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8954,948.0,10116.0,50597,16434,
,N,A,CHEMBL624010,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8955,948.0,10116.0,50597,16434,
,N,A,CHEMBL624011,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8956,948.0,10116.0,50597,16434,
,N,A,CHEMBL624012,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8957,948.0,10116.0,50597,16435,
,N,A,CHEMBL624013,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8958,948.0,10116.0,50597,16435,
,N,A,CHEMBL624736,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8959,948.0,10116.0,50597,16435,
,N,A,CHEMBL624737,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8960,948.0,10116.0,50597,16435,
,N,A,CHEMBL624738,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,8961,948.0,10116.0,50597,16434,
,N,A,CHEMBL624739,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,8962,948.0,10116.0,50597,16434,
,N,A,CHEMBL624740,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,8963,948.0,10116.0,50597,16434,
,N,A,CHEMBL624896,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8964,948.0,10116.0,50597,16435,
,N,A,CHEMBL624897,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8965,948.0,10116.0,50597,16435,
,N,A,CHEMBL624108,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8966,948.0,10116.0,50597,16435,
,N,A,CHEMBL624109,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8967,948.0,10116.0,50597,16435,
,N,A,CHEMBL624110,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,8968,948.0,10116.0,50597,16435,
,N,A,CHEMBL624111,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,8969,948.0,10116.0,50597,16435,
,N,A,CHEMBL624112,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8970,948.0,10116.0,50597,16435,
,N,A,CHEMBL624113,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8971,948.0,10116.0,50597,16435,
,N,A,CHEMBL619709,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8972,948.0,10116.0,50597,16435,
,N,A,CHEMBL619710,1,1,Heart,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8973,948.0,10116.0,50597,16435,
,N,A,CHEMBL619711,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8974,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619712,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8975,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619713,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8976,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619714,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8977,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619715,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8978,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619716,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8979,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619717,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8980,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619718,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8981,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619719,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8982,2113.0,10116.0,50597,16435,
,N,A,CHEMBL875329,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8983,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619720,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8984,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619721,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8985,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619722,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,8986,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619723,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,8987,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619724,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,8988,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619725,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,8989,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619726,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,8990,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619727,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,8991,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619728,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,8992,2113.0,10116.0,50597,16434,
,N,A,CHEMBL619729,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,8993,2113.0,10116.0,50597,16435,
,N,A,CHEMBL619730,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8994,2385.0,10116.0,50597,11977,
,N,A,CHEMBL619731,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8995,2385.0,10116.0,50597,11977,
,N,A,CHEMBL619732,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8996,2385.0,10116.0,50597,11977,
,N,A,CHEMBL619733,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8997,2385.0,10116.0,50597,11977,
,N,A,CHEMBL619734,1,1,Muscle tissue,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8998,2385.0,10116.0,50597,11977,
,N,A,CHEMBL619735,1,1,Zone of skin,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,8999,14.0,10116.0,50597,11977,
,N,A,CHEMBL875330,1,1,Zone of skin,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9000,14.0,10116.0,50597,11977,
,N,A,CHEMBL628465,1,1,Zone of skin,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9001,14.0,10116.0,50597,11977,
,N,A,CHEMBL628466,1,1,Zone of skin,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9002,14.0,10116.0,50597,11977,
,N,A,CHEMBL628467,1,1,Zone of skin,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9003,14.0,10116.0,50597,11977,
,N,A,CHEMBL628468,1,1,Spleen,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9004,2106.0,10116.0,50597,11977,
,N,A,CHEMBL628469,1,1,Spleen,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9005,2106.0,10116.0,50597,11977,
,N,A,CHEMBL628470,1,1,Spleen,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9006,2106.0,10116.0,50597,11977,
,N,A,CHEMBL628471,1,1,Spleen,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9007,2106.0,10116.0,50597,11977,
,N,A,CHEMBL628472,1,1,Spleen,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9008,2106.0,10116.0,50597,11977,
,N,A,CHEMBL625191,1,1,Thyroid gland,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9009,2046.0,10116.0,50597,11977,
,N,A,CHEMBL625192,1,1,Thyroid gland,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9010,2046.0,10116.0,50597,11977,
,N,A,CHEMBL875337,1,1,Thyroid gland,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9011,2046.0,10116.0,50597,11977,
,N,A,CHEMBL626341,1,1,Thyroid gland,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9012,2046.0,10116.0,50597,11977,
,N,A,CHEMBL626342,1,1,Thyroid gland,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9013,2046.0,10116.0,50597,11977,
,N,A,CHEMBL621943,1,1,Liver,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,,Intermediate,,,In vivo,9014,2107.0,10116.0,50597,11977,
,N,A,CHEMBL621944,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,9015,,10116.0,50597,3748,
,N,A,CHEMBL621945,1,1,,BAO_0000218,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Rattus norvegicus,,,,Intermediate,,,,9016,,10116.0,50597,15765,
,N,A,CHEMBL621946,1,1,,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,,,,Intermediate,,,,9017,,10116.0,50597,4871,
,N,A,CHEMBL621947,1,1,,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,,,,Intermediate,,,,9018,,10116.0,50597,4871,
,N,A,CHEMBL621948,1,1,,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,,,,Intermediate,,,,9019,,10116.0,50597,4872,
,N,A,CHEMBL621949,1,1,,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,,,,Intermediate,,,,9020,,10116.0,50597,4872,
,N,A,CHEMBL621950,1,1,,BAO_0000218,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Rattus norvegicus,,,,Intermediate,,,,9021,,10116.0,50597,5413,
,N,A,CHEMBL621951,1,1,,BAO_0000218,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Rattus norvegicus,,,,Intermediate,,,,9022,,10116.0,50597,5413,
,N,A,CHEMBL621952,1,1,Blood,BAO_0000218,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Rattus norvegicus,,,,Intermediate,,,In vivo,9023,178.0,10116.0,50597,15272,
,N,A,CHEMBL621953,1,1,Liver,BAO_0000218,Stability (%) in rat liver microsomes,Rattus norvegicus,,,,Intermediate,,,,9024,2107.0,10116.0,50597,4689,
,N,A,CHEMBL621954,1,1,,BAO_0000218,Area under curve was calculated after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,9025,,10116.0,50597,6057,
,N,A,CHEMBL621955,1,1,,BAO_0000218,Area under the curve was calculated after iv administration in rat,Rattus norvegicus,,,,Intermediate,,,,9026,,10116.0,50597,6057,
,N,A,CHEMBL621956,1,1,,BAO_0000218,Area under the curve was calculated in rat after peroral administration,Rattus norvegicus,,,,Intermediate,,,,9027,,10116.0,50597,6057,
,N,A,CHEMBL621957,1,1,,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,,9028,,10116.0,50597,6211,
,N,A,CHEMBL621958,1,1,,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,9029,,10116.0,50597,5710,
,N,A,CHEMBL621959,1,1,,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,9030,,10116.0,50597,5710,
,N,A,CHEMBL621960,1,1,,BAO_0000218,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,,Intermediate,,,,9031,,10116.0,50597,17853,
,N,A,CHEMBL621961,1,1,,BAO_0000218,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Rattus norvegicus,,,,Intermediate,,,,9032,,10116.0,50597,17853,
,N,A,CHEMBL621962,1,1,,BAO_0000218,p value of the compound,Rattus norvegicus,,,,Intermediate,,,,9033,,10116.0,50597,15765,
,N,F,CHEMBL876787,1,1,,BAO_0000218,p value of the compound,Rattus norvegicus,,,,Intermediate,,,,9034,,10116.0,50597,15765,
,N,A,CHEMBL621963,1,1,,BAO_0000218,p value of the compound,Rattus norvegicus,,,,Intermediate,,,,9035,,10116.0,50597,15765,
,N,A,CHEMBL622637,1,1,Stomach,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9036,945.0,10116.0,50597,6175,
,N,A,CHEMBL622638,1,1,Stomach,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9037,945.0,10116.0,50597,6175,
,N,A,CHEMBL626561,1,1,Stomach,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9038,945.0,10116.0,50597,6175,
,U,F,CHEMBL626562,1,0,,BAO_0000019,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Oryctolagus cuniculus,,,,Autocuration,,,,9039,,9986.0,22224,7991,
,U,A,CHEMBL626563,1,0,,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Oryctolagus cuniculus,,,,Autocuration,,,,9040,,9986.0,22224,429,
,U,A,CHEMBL626564,1,0,,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Oryctolagus cuniculus,,,,Autocuration,,,,9041,,9986.0,22224,429,
,U,A,CHEMBL626565,1,0,,BAO_0000218,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9042,,9986.0,22224,6253,
,U,A,CHEMBL626566,1,0,,BAO_0000218,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9043,,9986.0,22224,6253,
,U,A,CHEMBL626567,1,0,,BAO_0000218,Clearance rate in rabbits,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9044,,9986.0,22224,3615,
,U,A,CHEMBL626568,1,0,,BAO_0000218,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9045,,9986.0,22224,4059,
,U,A,CHEMBL626569,1,0,,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9046,,9986.0,22224,5124,
,U,A,CHEMBL626570,1,0,,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9047,,9986.0,22224,5124,
,U,A,CHEMBL626571,1,0,,BAO_0000218,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9048,,9986.0,22224,5124,
,U,A,CHEMBL626572,1,0,,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9049,,9986.0,22224,429,
,U,A,CHEMBL626573,1,0,Plasma,BAO_0000218,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9050,1969.0,9986.0,22224,4059,
,U,A,CHEMBL626574,1,0,Liver,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Oryctolagus cuniculus,,,,Autocuration,,,,9051,2107.0,9986.0,22224,9659,Microsomes
,U,A,CHEMBL626575,1,0,Liver,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Oryctolagus cuniculus,,,,Autocuration,,,,9052,2107.0,9986.0,22224,9659,Microsomes
,U,A,CHEMBL626576,1,0,,BAO_0000218,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Oryctolagus cuniculus,,,,Autocuration,,,,9053,,9986.0,22224,3639,
,U,A,CHEMBL626577,1,0,,BAO_0000218,Dose at which bioavailability of perorally administered compound was tested in rabbit,Oryctolagus cuniculus,,,,Autocuration,,,,9054,,9986.0,22224,3639,
,U,A,CHEMBL626578,1,0,,BAO_0000218,The compound was tested for its bioavailability in rabbit (by oral dosage).,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9055,,9986.0,22224,3639,
,U,A,CHEMBL625263,1,0,,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9056,,9986.0,22224,5124,
,U,A,CHEMBL625264,1,0,,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9057,,9986.0,22224,5124,
,U,A,CHEMBL625265,1,0,,BAO_0000218,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9058,,9986.0,22224,5124,
,U,A,CHEMBL625266,1,0,,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Oryctolagus cuniculus,,,,Autocuration,,,,9059,,9986.0,22224,14294,Microsomes
,U,A,CHEMBL876796,1,0,,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Oryctolagus cuniculus,,,,Autocuration,,,,9060,,9986.0,22224,14294,Microsomes
,U,A,CHEMBL625267,1,0,,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9061,,9986.0,22224,429,
,U,A,CHEMBL625268,1,0,Plasma,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9062,1969.0,9986.0,22224,5124,
,U,A,CHEMBL625269,1,0,Plasma,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9063,1969.0,9986.0,22224,5124,
,U,A,CHEMBL624689,1,0,Plasma,BAO_0000218,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9064,1969.0,9986.0,22224,5124,
,U,A,CHEMBL624690,1,0,,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9065,,9986.0,22224,429,
,U,A,CHEMBL624691,1,0,Urine,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Oryctolagus cuniculus,,,,Autocuration,,,,9066,1088.0,9986.0,22224,429,
,U,A,CHEMBL624692,1,0,Urine,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Oryctolagus cuniculus,,,,Autocuration,,,,9067,1088.0,9986.0,22224,429,
,U,A,CHEMBL624693,1,0,,BAO_0000218,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9068,,9986.0,22224,4059,
,U,A,CHEMBL624694,1,0,,BAO_0000218,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9069,,9986.0,22224,4137,
,U,A,CHEMBL877596,1,0,,BAO_0000221,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Oryctolagus cuniculus,,,,Autocuration,,,In vitro,9070,,9986.0,22224,11672,
,U,A,CHEMBL624695,1,0,,BAO_0000019,Time within which only 10% of the drug was degraded,Oryctolagus cuniculus,,,,Autocuration,,,,9071,,9986.0,22224,12886,
,U,A,CHEMBL624696,1,0,Liver,BAO_0000221,Half life period in rabbit liver homogenate,Oryctolagus cuniculus,,,,Autocuration,,,,9072,2107.0,9986.0,22224,3853,
,U,A,CHEMBL624697,1,0,,BAO_0000019,Half life value in rabbits,Oryctolagus cuniculus,,,,Autocuration,,,,9073,,9986.0,22224,3615,
,U,A,CHEMBL624698,1,0,Blood,BAO_0000218,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9074,178.0,9986.0,22224,6253,
,U,A,CHEMBL624699,1,0,Blood,BAO_0000218,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9075,178.0,9986.0,22224,6253,
,U,A,CHEMBL624700,1,0,,BAO_0000218,Half-life period in rabbits following intravenous administration at 2 mg/kg,Oryctolagus cuniculus,,,,Autocuration,,,In vivo,9076,,9986.0,22224,6077,
,N,A,CHEMBL622903,1,1,Plasma,BAO_0000218,AUC 0-8 hr value in rats at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9077,1969.0,10116.0,50597,17617,
,N,A,CHEMBL622904,1,1,Plasma,BAO_0000218,AUC after administration at 2000 mg/kg/day in rats,Rattus norvegicus,,,,Intermediate,,,,9078,1969.0,10116.0,50597,17594,
,N,A,CHEMBL622905,1,1,Plasma,BAO_0000218,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Rattus norvegicus,,,,Intermediate,,,,9079,1969.0,10116.0,50597,6149,
,N,A,CHEMBL622906,1,1,Plasma,BAO_0000218,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,,9080,1969.0,10116.0,50597,17260,
,N,A,CHEMBL622907,1,1,Plasma,BAO_0000218,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,,9081,1969.0,10116.0,50597,17260,
,N,A,CHEMBL622908,1,1,Plasma,BAO_0000218,AUC in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,9082,1969.0,10116.0,50597,6644,
,N,A,CHEMBL622909,1,1,Plasma,BAO_0000218,AUC in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,9083,1969.0,10116.0,50597,6644,
,N,A,CHEMBL622910,1,1,Plasma,BAO_0000218,AUC in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,9084,1969.0,10116.0,50597,6644,
,N,A,CHEMBL622911,1,1,Brain,BAO_0000218,AUC in rat brain after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9085,955.0,10116.0,50597,6495,
,N,A,CHEMBL622912,1,1,Plasma,BAO_0000218,AUC in rat p.o.,Rattus norvegicus,,,,Intermediate,,,,9086,1969.0,10116.0,50597,6504,
,N,A,CHEMBL622913,1,1,Plasma,BAO_0000218,AUC in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,9087,1969.0,10116.0,50597,17686,
,N,A,CHEMBL622914,1,1,Plasma,BAO_0000218,AUC in rat plasma after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9088,1969.0,10116.0,50597,6495,
,N,A,CHEMBL622915,1,1,Plasma,BAO_0000218,AUC in rats,Rattus norvegicus,,,,Intermediate,,,,9089,1969.0,10116.0,50597,216,
,N,A,CHEMBL622916,1,1,Plasma,BAO_0000218,AUC value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,,9090,1969.0,10116.0,50597,1908,
,N,A,CHEMBL622917,1,1,Plasma,BAO_0000218,AUC value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,,9091,1969.0,10116.0,50597,1908,
,N,A,CHEMBL622918,1,1,Plasma,BAO_0000218,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,9092,1969.0,10116.0,50597,6685,
,N,A,CHEMBL622919,1,1,Plasma,BAO_0000218,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Rattus norvegicus,,,,Intermediate,,,In vivo,9093,1969.0,10116.0,50597,216,
,N,A,CHEMBL622920,1,1,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9094,1969.0,10116.0,50597,6049,
,N,A,CHEMBL622921,1,1,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9095,1969.0,10116.0,50597,2463,
,N,A,CHEMBL622922,1,1,Plasma,BAO_0000218,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9096,1969.0,10116.0,50597,6679,
,N,A,CHEMBL622923,1,1,Plasma,BAO_0000218,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9097,1969.0,10116.0,50597,6681,
,N,A,CHEMBL877604,1,1,Plasma,BAO_0000218,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9098,1969.0,10116.0,50597,4890,
,N,A,CHEMBL622924,1,1,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9099,1969.0,10116.0,50597,6410,
,N,A,CHEMBL622925,1,1,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9100,1969.0,10116.0,50597,6410,
,N,A,CHEMBL622926,1,1,Plasma,BAO_0000218,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Rattus norvegicus,,,,Intermediate,,,In vivo,9101,1969.0,10116.0,50597,16366,
,N,A,CHEMBL623625,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9102,1969.0,10116.0,50597,6227,
,N,A,CHEMBL623626,1,1,Plasma,BAO_0000218,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,9103,1969.0,10116.0,50597,3598,
,N,A,CHEMBL623627,1,1,Plasma,BAO_0000218,Maximum plasma drug concentration was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9104,1969.0,10116.0,50597,1465,
,N,A,CHEMBL623628,1,1,,BAO_0000218,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9105,,10116.0,50597,4368,
,N,A,CHEMBL623629,1,1,Plasma,BAO_0000218,Mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9106,1969.0,10116.0,50597,15662,
,N,A,CHEMBL623630,1,1,Plasma,BAO_0000218,Mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9107,1969.0,10116.0,50597,15662,
,N,A,CHEMBL623804,1,1,,BAO_0000218,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9108,,10116.0,50597,5355,
,N,A,CHEMBL623805,1,1,,BAO_0000218,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9109,,10116.0,50597,5355,
,N,A,CHEMBL623806,1,1,Plasma,BAO_0000218,Peak oral plasma concentration was determined in rats by oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9110,1969.0,10116.0,50597,1567,
,N,A,CHEMBL623807,1,1,Plasma,BAO_0000218,Peak plasma concentration (Cmax) was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9111,1969.0,10116.0,50597,4026,
,N,A,CHEMBL623808,1,1,Plasma,BAO_0000218,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9112,1969.0,10116.0,50597,6193,
,N,A,CHEMBL623809,1,1,Plasma,BAO_0000218,Peak plasma concentration (Cmax) in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9113,1969.0,10116.0,50597,4026,
,N,A,CHEMBL623810,1,1,Plasma,BAO_0000218,Peak plasma concentration at 1 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9114,1969.0,10116.0,50597,6485,
,N,A,CHEMBL623811,1,1,Plasma,BAO_0000218,Peak plasma concentration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9115,1969.0,10116.0,50597,17655,
,N,A,CHEMBL623812,1,1,Plasma,BAO_0000218,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,In vivo,9116,1969.0,10116.0,50597,14941,
,N,A,CHEMBL877605,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9117,,10116.0,50597,5394,
,N,A,CHEMBL623813,1,1,,BAO_0000218,Pharmacokinetic property (Cmax) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9118,,10116.0,50597,4408,
,N,A,CHEMBL623814,1,1,,BAO_0000218,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,,Intermediate,,,In vivo,9119,,10116.0,50597,5983,
,N,A,CHEMBL623815,1,1,,BAO_0000218,Cmax in rat after 3mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9120,,10116.0,50597,4878,
,N,A,CHEMBL623816,1,1,,BAO_0000218,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,Sprague-Dawley,In vivo,9121,,10116.0,50597,5862,
,N,A,CHEMBL623145,1,1,,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9122,,10116.0,50597,4517,
,N,A,CHEMBL623146,1,1,Plasma,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9123,1969.0,10116.0,50597,5932,
,N,A,CHEMBL623147,1,1,Plasma,BAO_0000218,Plasma concentration after oral administration of 100 mg/kg to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9124,1969.0,10116.0,50597,5436,
,N,A,CHEMBL623042,1,1,Brain,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9125,955.0,10116.0,50597,4910,
,N,A,CHEMBL623043,1,1,,BAO_0000218,Tested for the Cmax in rat at 10 mg/kg per orally,Rattus norvegicus,,,,Intermediate,,,In vivo,9126,,10116.0,50597,4950,
,N,A,CHEMBL623044,1,1,,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,9127,,10116.0,50597,15078,
,N,A,CHEMBL623045,1,1,,BAO_0000218,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,9128,,10116.0,50597,15078,
,N,A,CHEMBL623046,1,1,,BAO_0000218,Bioavailability as oral Cmax in rats at 30 mins,Rattus norvegicus,,,,Intermediate,,,In vivo,9129,,10116.0,50597,3360,
,N,A,CHEMBL623226,1,1,,BAO_0000218,Bioavailability as oral Cmax in rats at 6hr,Rattus norvegicus,,,,Intermediate,,,In vivo,9130,,10116.0,50597,3360,
,N,A,CHEMBL623227,1,1,,BAO_0000218,The maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9131,,10116.0,50597,15022,
,N,A,CHEMBL623228,1,1,,BAO_0000218,The maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9132,,10116.0,50597,15022,
,N,A,CHEMBL623229,1,1,,BAO_0000218,The maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9133,,10116.0,50597,15022,
,N,A,CHEMBL623230,1,1,Plasma,BAO_0000218,The maximum plasma levels for the compounds were determined by LC-MS.,Rattus norvegicus,,,,Intermediate,,,In vivo,9134,1969.0,10116.0,50597,5160,
,N,A,CHEMBL623231,1,1,Plasma,BAO_0000218,mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9135,1969.0,10116.0,50597,15662,
,N,A,CHEMBL623232,1,1,Plasma,BAO_0000218,mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9136,1969.0,10116.0,50597,15662,
,N,A,CHEMBL623233,1,1,,BAO_0000218,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9137,,10116.0,50597,4709,
,N,A,CHEMBL623234,1,1,,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Rattus norvegicus,,,,Intermediate,,,,9138,,10116.0,50597,3535,
,N,A,CHEMBL623235,1,1,,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 1 hr,Rattus norvegicus,,,,Intermediate,,,,9139,,10116.0,50597,3535,
,N,A,CHEMBL623236,1,1,,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 2 hr,Rattus norvegicus,,,,Intermediate,,,,9140,,10116.0,50597,3535,
,N,A,CHEMBL623237,1,1,,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Rattus norvegicus,,,,Intermediate,,,,9141,,10116.0,50597,3535,
,N,A,CHEMBL623238,1,1,,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Rattus norvegicus,,,,Intermediate,,,,9142,,10116.0,50597,3535,
,N,A,CHEMBL623239,1,1,,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Rattus norvegicus,,,,Intermediate,,,,9143,,10116.0,50597,3535,
,U,A,CHEMBL623240,1,0,Plasma,BAO_0000218,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Rattus norvegicus,,,,Intermediate,,,In vivo,9144,1969.0,10116.0,22224,5005,
,N,A,CHEMBL623241,1,1,Hypothalamus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Rattus norvegicus,,,,Intermediate,,,,9145,1898.0,10116.0,50597,6326,
,N,A,CHEMBL623242,1,1,Hypothalamus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Rattus norvegicus,,,,Intermediate,,,,9146,1898.0,10116.0,50597,6326,
,N,A,CHEMBL874394,1,1,,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Rattus norvegicus,,,,Intermediate,,,,9147,,10116.0,50597,6326,
,N,A,CHEMBL623243,1,1,,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Rattus norvegicus,,,,Intermediate,,,,9148,,10116.0,50597,6326,
,N,A,CHEMBL623244,1,1,,BAO_0000218,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9149,,10116.0,50597,17411,
,N,A,CHEMBL623245,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9150,2113.0,10116.0,50597,16435,
,N,A,CHEMBL623246,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9151,2113.0,10116.0,50597,16435,
,N,A,CHEMBL623247,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9152,2113.0,10116.0,50597,16435,
,N,A,CHEMBL623248,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9153,2113.0,10116.0,50597,16435,
,N,A,CHEMBL623249,1,1,Kidney,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9154,2113.0,10116.0,50597,16435,
,N,A,CHEMBL625072,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9155,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625073,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9156,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625074,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9157,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625075,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9158,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625076,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9159,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625077,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9160,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625078,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9161,2107.0,10116.0,50597,16434,
,N,A,CHEMBL874395,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9162,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625079,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9163,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625080,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9164,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625081,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9165,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625082,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9166,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625083,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9167,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625084,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9168,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625085,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9169,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625086,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9170,2107.0,10116.0,50597,16435,
,N,A,CHEMBL625087,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9171,2107.0,10116.0,50597,16434,
,N,A,CHEMBL625088,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9172,2107.0,10116.0,50597,16434,
,N,A,CHEMBL622205,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9173,2107.0,10116.0,50597,16434,
,N,A,CHEMBL622206,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9174,2107.0,10116.0,50597,16435,
,N,A,CHEMBL622207,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9175,2107.0,10116.0,50597,16435,
,N,A,CHEMBL622366,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9176,2107.0,10116.0,50597,16435,
,N,A,CHEMBL622367,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9177,2107.0,10116.0,50597,16435,
,N,A,CHEMBL875331,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9178,2107.0,10116.0,50597,16435,
,N,A,CHEMBL622368,1,1,Liver,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9179,2107.0,10116.0,50597,16435,
,N,A,CHEMBL622369,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9180,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622370,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9181,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622371,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9182,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622372,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9183,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622373,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9184,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622374,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9185,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622375,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9186,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622376,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9187,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622377,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9188,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622378,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9189,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622379,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9190,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622380,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9191,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622381,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9192,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622382,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9193,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622383,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9194,2048.0,10116.0,50597,16434,
,N,A,CHEMBL875332,1,1,Stomach,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9195,945.0,10116.0,50597,6175,
,N,A,CHEMBL622384,1,1,Stomach,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9196,945.0,10116.0,50597,6175,
,N,A,CHEMBL622385,1,1,Stomach,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9197,945.0,10116.0,50597,6175,
,N,A,CHEMBL622386,1,1,Stomach,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,,,Intermediate,,,,9198,945.0,10116.0,50597,6175,
,N,A,CHEMBL622387,1,1,,BAO_0000218,The compound was tested for the plasma binding in rat,Rattus norvegicus,,,,Intermediate,,,,9199,,10116.0,50597,10839,
,N,A,CHEMBL622388,1,1,,BAO_0000218,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Rattus norvegicus,,,,Intermediate,,,,9200,,10116.0,50597,16459,
,N,A,CHEMBL622389,1,1,,BAO_0000218,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Rattus norvegicus,,,,Intermediate,,,,9201,,10116.0,50597,16459,
,N,A,CHEMBL622390,1,1,,BAO_0000218,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Rattus norvegicus,,,,Intermediate,,,,9202,,10116.0,50597,16459,
,N,A,CHEMBL622391,1,1,,BAO_0000218,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Rattus norvegicus,,,,Intermediate,,,,9203,,10116.0,50597,16459,
,N,A,CHEMBL622392,1,1,,BAO_0000218,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Rattus norvegicus,,,,Intermediate,,,,9204,,10116.0,50597,16459,
,N,A,CHEMBL622393,1,1,,BAO_0000218,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Rattus norvegicus,,,,Intermediate,,,,9205,,10116.0,50597,16459,
,N,A,CHEMBL622394,1,1,,BAO_0000218,Plasma level at 2 hr after administration of the compound,Rattus norvegicus,,,,Intermediate,,,,9206,,10116.0,50597,3278,
,N,A,CHEMBL622395,1,1,,BAO_0000218,plasma level at 2 hr after administration of the compound,Rattus norvegicus,,,,Intermediate,,,,9207,,10116.0,50597,3278,
,N,A,CHEMBL622396,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 1 min,Rattus norvegicus,,,,Intermediate,,,,9208,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624894,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 10 min,Rattus norvegicus,,,,Intermediate,,,,9209,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624895,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 10 mins,Rattus norvegicus,,,,Intermediate,,,,9210,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624058,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 2 hr,Rattus norvegicus,,,,Intermediate,,,,9211,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624059,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 3 min,Rattus norvegicus,,,,Intermediate,,,,9212,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624060,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 3 mins,Rattus norvegicus,,,,Intermediate,,,,9213,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624061,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 5 min,Rattus norvegicus,,,,Intermediate,,,,9214,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624062,1,1,Serum,BAO_0000218,Stability in rat serum measured as % recovery at 5 mins,Rattus norvegicus,,,,Intermediate,,,,9215,1977.0,10116.0,50597,4684,
,N,A,CHEMBL624063,1,1,,BAO_0000218,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9216,,10116.0,50597,16456,
,N,A,CHEMBL624064,1,1,,BAO_0000218,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9217,,10116.0,50597,16456,
,N,A,CHEMBL624065,1,1,Plasma,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Rattus norvegicus,,,,Intermediate,,,,9218,1969.0,10116.0,50597,723,
,N,A,CHEMBL624066,1,1,Plasma,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Rattus norvegicus,,,,Intermediate,,,,9219,1969.0,10116.0,50597,723,
,N,A,CHEMBL877490,1,1,,BAO_0000218,Half life tested in mature male rat at a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9220,,10116.0,50597,5160,
,N,A,CHEMBL874442,1,1,,BAO_0000218,Half life after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9221,,10116.0,50597,4709,
,N,A,CHEMBL626890,1,1,,BAO_0000218,Half life period after administration (30 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9222,,10116.0,50597,5633,
,N,A,CHEMBL626891,1,1,,BAO_0000218,Half life period in rat after 5 mg/Kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9223,,10116.0,50597,5302,
,N,A,CHEMBL626892,1,1,,BAO_0000218,Half life period in rat after 5 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9224,,10116.0,50597,5302,
,N,A,CHEMBL626893,1,1,,BAO_0000218,Half life period was determined,Rattus norvegicus,,,,Intermediate,,,,9225,,10116.0,50597,17791,
,N,A,CHEMBL626894,1,1,,BAO_0000218,Half life period was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,,9226,,10116.0,50597,17791,
,N,A,CHEMBL626895,1,1,,BAO_0000218,Half life period was evaluated in rat; 0.5-1.0,Rattus norvegicus,,,,Intermediate,,,,9227,,10116.0,50597,17791,
,N,A,CHEMBL626896,1,1,,BAO_0000218,Half life period was evaluated in rat; 5.9-7.5,Rattus norvegicus,,,,Intermediate,,,,9228,,10116.0,50597,17791,
,N,A,CHEMBL626897,1,1,Plasma,BAO_0000218,Half-life in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9229,1969.0,10116.0,50597,14512,
,N,A,CHEMBL626898,1,1,,BAO_0000218,Half-life time in rat was determined,Rattus norvegicus,,,,Intermediate,,,,9230,,10116.0,50597,6230,
,N,A,CHEMBL626899,1,1,,BAO_0000218,Terminal half-life after iv administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9231,,10116.0,50597,3364,
,N,A,CHEMBL626900,1,1,,BAO_0000218,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9232,,10116.0,50597,6874,
,N,A,CHEMBL626901,1,1,,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Rattus norvegicus,,,,Intermediate,,,,9233,,10116.0,50597,857,
,N,A,CHEMBL626902,1,1,,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Rattus norvegicus,,,,Intermediate,,,In vivo,9234,,10116.0,50597,858,
,N,A,CHEMBL626903,1,1,,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Rattus norvegicus,,,,Intermediate,,,In vivo,9235,,10116.0,50597,858,
,N,A,CHEMBL874443,1,1,,BAO_0000218,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9236,,10116.0,50597,5355,
,N,A,CHEMBL626904,1,1,,BAO_0000218,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9237,,10116.0,50597,5355,
,N,A,CHEMBL626905,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,9238,,10116.0,50597,6305,
,N,A,CHEMBL873830,1,1,Plasma,BAO_0000218,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9239,1969.0,10116.0,50597,13501,
,N,A,CHEMBL626906,1,1,,BAO_0000218,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9240,,10116.0,50597,17594,
,N,A,CHEMBL631076,1,1,Plasma,BAO_0000218,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,,,Intermediate,,,In vivo,9241,1969.0,10116.0,50597,4186,
,N,A,CHEMBL631077,1,1,Plasma,BAO_0000218,Biological half-life was measured in plasma of rats,Rattus norvegicus,,,,Intermediate,,,,9242,1969.0,10116.0,50597,2932,
,N,A,CHEMBL631078,1,1,,BAO_0000218,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9243,,10116.0,50597,17065,
,N,A,CHEMBL631079,1,1,,BAO_0000218,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,9244,,10116.0,50597,15765,
,N,A,CHEMBL631080,1,1,,BAO_0000218,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9245,,10116.0,50597,2713,
,N,A,CHEMBL631081,1,1,,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9246,,10116.0,50597,2661,
,N,A,CHEMBL631239,1,1,,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9247,,10116.0,50597,2661,
,N,A,CHEMBL631240,1,1,Plasma,BAO_0000218,Compound was evaluated for plasma half life in rat,Rattus norvegicus,,,,Intermediate,,,,9248,1969.0,10116.0,50597,740,
,N,A,CHEMBL631241,1,1,Plasma,BAO_0000218,AUC value at a dose of 5 mg/kg (p.o.) in rats,Rattus norvegicus,,,,Intermediate,,,,9249,1969.0,10116.0,50597,6597,
,N,A,CHEMBL631242,1,1,Plasma,BAO_0000218,AUC value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,,Intermediate,,,,9250,1969.0,10116.0,50597,2959,
,N,A,CHEMBL631243,1,1,Plasma,BAO_0000218,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9251,1969.0,10116.0,50597,17594,
,N,A,CHEMBL874444,1,1,Plasma,BAO_0000218,AUC0-96 after administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9252,1969.0,10116.0,50597,17596,
,N,A,CHEMBL631244,1,1,Plasma,BAO_0000218,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9253,1969.0,10116.0,50597,17594,
,N,A,CHEMBL631245,1,1,,BAO_0000218,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Rattus norvegicus,,,,Intermediate,,,,9254,,10116.0,50597,3293,
,N,A,CHEMBL627162,1,1,,BAO_0000218,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,,9255,,10116.0,50597,6757,
,N,A,CHEMBL627163,1,1,,BAO_0000218,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,,9256,,10116.0,50597,6757,
,N,A,CHEMBL627164,1,1,,BAO_0000218,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,,Intermediate,,,,9257,,10116.0,50597,6757,
,N,A,CHEMBL627165,1,1,Kidney,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Rattus norvegicus,,,,Intermediate,,,,9258,2113.0,10116.0,50597,5979,
,N,A,CHEMBL627166,1,1,,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Rattus norvegicus,,,,Intermediate,,,,9259,,10116.0,50597,5979,
,N,A,CHEMBL627167,1,1,,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Rattus norvegicus,,,,Intermediate,,,,9260,,10116.0,50597,5979,
,N,A,CHEMBL627822,1,1,,BAO_0000218,Area under curve (AUC) at a dose of 30 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9261,,10116.0,50597,4026,
,N,A,CHEMBL627823,1,1,,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9262,,10116.0,50597,5355,
,N,A,CHEMBL627824,1,1,,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9263,,10116.0,50597,5355,
,N,A,CHEMBL627825,1,1,,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9264,,10116.0,50597,5355,
,N,A,CHEMBL627826,1,1,,BAO_0000218,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,,9265,,10116.0,50597,5633,
,N,A,CHEMBL627827,1,1,,BAO_0000218,Area under curve (Pharmacokinetic property) was determined,Rattus norvegicus,,,,Intermediate,,,,9266,,10116.0,50597,1716,
,N,A,CHEMBL627828,1,1,,BAO_0000218,Area under curve (Pharmacokinetic property) of the compound; Not determined,Rattus norvegicus,,,,Intermediate,,,,9267,,10116.0,50597,1716,
,N,A,CHEMBL627829,1,1,,BAO_0000218,Area under curve after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,,9268,,10116.0,50597,4689,
,N,A,CHEMBL627830,1,1,,BAO_0000218,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,,9269,,10116.0,50597,4527,
,N,A,CHEMBL627831,1,1,,BAO_0000218,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,,9270,,10116.0,50597,4527,
,N,A,CHEMBL627832,1,1,,BAO_0000218,Area under curve in male SD rats was observed after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,,9271,,10116.0,50597,15662,
,N,A,CHEMBL627833,1,1,,BAO_0000218,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,,Intermediate,,,,9272,,10116.0,50597,4413,
,N,A,CHEMBL627834,1,1,,BAO_0000218,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,,9273,,10116.0,50597,3598,
,N,A,CHEMBL628004,1,1,,BAO_0000218,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,,9274,,10116.0,50597,3598,
,N,A,CHEMBL628005,1,1,,BAO_0000218,Area under curve at 5 mg/kg po was determined in rat,Rattus norvegicus,,,,Intermediate,,,,9275,,10116.0,50597,5964,
,N,A,CHEMBL628006,1,1,,BAO_0000218,Area under curve in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9276,,10116.0,50597,4689,
,N,A,CHEMBL628007,1,1,,BAO_0000218,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,,,Intermediate,,,,9277,,10116.0,50597,4186,
,N,A,CHEMBL625676,1,1,,BAO_0000218,Area under curve was determined,Rattus norvegicus,,,,Intermediate,,,,9278,,10116.0,50597,5510,
,N,A,CHEMBL631309,1,1,,BAO_0000218,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Rattus norvegicus,,,,Intermediate,,,,9279,,10116.0,50597,17858,
,N,A,CHEMBL631310,1,1,,BAO_0000218,Area under curve after intravenous administration at 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9280,,10116.0,50597,17804,
,N,A,CHEMBL631311,1,1,,BAO_0000218,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Rattus norvegicus,,,,Intermediate,,,,9281,,10116.0,50597,6106,
,N,A,CHEMBL631312,1,1,,BAO_0000218,Area under curve at 4 hr in rat,Rattus norvegicus,,,,Intermediate,,,,9282,,10116.0,50597,5964,
,N,A,CHEMBL631313,1,1,,BAO_0000218,Area under curve at a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9283,,10116.0,50597,4026,
,N,A,CHEMBL631314,1,1,,BAO_0000218,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,,9284,,10116.0,50597,4756,
,N,A,CHEMBL631315,1,1,,BAO_0000218,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,,9285,,10116.0,50597,4756,
,N,A,CHEMBL631316,1,1,,BAO_0000218,Area under curve for a 2-mpk po dose in SD rats,Rattus norvegicus,,,,Intermediate,,,,9286,,10116.0,50597,5862,
,N,A,CHEMBL631317,1,1,,BAO_0000218,Area under curve in SD rats,Rattus norvegicus,,,,Intermediate,,,,9287,,10116.0,50597,5862,
,N,A,CHEMBL874471,1,1,,BAO_0000218,Area under curve in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,9288,,10116.0,50597,6644,
,N,A,CHEMBL631318,1,1,,BAO_0000218,Area under curve in rat by po administration at 0-24 hr,Rattus norvegicus,,,,Intermediate,,,,9289,,10116.0,50597,5871,
,N,A,CHEMBL631319,1,1,Plasma,BAO_0000218,Area under curve in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9290,1969.0,10116.0,50597,5919,
,N,A,CHEMBL631320,1,1,,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9291,,10116.0,50597,5939,
,N,A,CHEMBL631321,1,1,,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9292,,10116.0,50597,5939,
,N,A,CHEMBL631322,1,1,,BAO_0000218,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,,,,Intermediate,,,,9293,,10116.0,50597,10,
,N,A,CHEMBL631323,1,1,,BAO_0000218,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,,9294,,10116.0,50597,11149,
,N,A,CHEMBL631324,1,1,,BAO_0000218,Area under curve value in rat at a dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9295,,10116.0,50597,5302,
,N,A,CHEMBL631325,1,1,,BAO_0000218,Area under curve was determined after oral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9296,,10116.0,50597,17796,
,N,A,CHEMBL631326,1,1,,BAO_0000218,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,,9297,,10116.0,50597,4890,
,N,A,CHEMBL631327,1,1,,BAO_0000218,Area under curve was determined after peroral administration in rat,Rattus norvegicus,,,,Intermediate,,,,9298,,10116.0,50597,6011,
,N,A,CHEMBL631328,1,1,,BAO_0000218,Area under curve was determined at a dose 30 mpk administered orally.,Rattus norvegicus,,,,Intermediate,,,,9299,,10116.0,50597,5375,
,N,A,CHEMBL631329,1,1,,BAO_0000218,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,,9300,,10116.0,50597,17764,
,N,A,CHEMBL627217,1,1,,BAO_0000218,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9301,,10116.0,50597,4368,
,N,A,CHEMBL626352,1,1,,BAO_0000218,Area under curve was determined in male rat,Rattus norvegicus,,,,Intermediate,,,,9302,,10116.0,50597,5610,
,N,A,CHEMBL626353,1,1,,BAO_0000218,Area under curve was determined in rat after PO administration,Rattus norvegicus,,,,Intermediate,,,,9303,,10116.0,50597,5833,
,N,A,CHEMBL626354,1,1,,BAO_0000218,Area under curve was determined in rat after a 3 mg/kg of oral dose,Rattus norvegicus,,,,Intermediate,,,,9304,,10116.0,50597,4257,
,N,A,CHEMBL626355,1,1,,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9305,,10116.0,50597,5937,
,N,A,CHEMBL626356,1,1,,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9306,,10116.0,50597,5932,
,N,A,CHEMBL626357,1,1,,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Rattus norvegicus,,,,Intermediate,,,,9307,,10116.0,50597,5932,
,N,A,CHEMBL626358,1,1,,BAO_0000218,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9308,,10116.0,50597,17411,
,N,A,CHEMBL626359,1,1,,BAO_0000218,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9309,,10116.0,50597,17411,
,N,A,CHEMBL626360,1,1,Plasma,BAO_0000218,Peak plasma concentration in rat at a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9310,1969.0,10116.0,50597,17771,
,N,A,CHEMBL626361,1,1,,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated.,Rattus norvegicus,,,,Intermediate,,,,9311,,10116.0,50597,1628,
,N,A,CHEMBL626362,1,1,,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated; Not available,Rattus norvegicus,,,,Intermediate,,,,9312,,10116.0,50597,1628,
,N,A,CHEMBL626363,1,1,,BAO_0000218,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9313,,10116.0,50597,17411,
,N,A,CHEMBL626970,1,1,,BAO_0000218,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9314,,10116.0,50597,4910,
,N,A,CHEMBL626971,1,1,,BAO_0000218,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9315,,10116.0,50597,4910,
,N,A,CHEMBL626972,1,1,Plasma,BAO_0000218,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9316,1969.0,10116.0,50597,4910,
,N,A,CHEMBL626973,1,1,Plasma,BAO_0000218,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9317,1969.0,10116.0,50597,4910,
,N,A,CHEMBL626974,1,1,Plasma,BAO_0000218,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9318,1969.0,10116.0,50597,4910,
,N,A,CHEMBL874592,1,1,Plasma,BAO_0000218,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9319,1969.0,10116.0,50597,4910,
,N,A,CHEMBL626975,1,1,,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Rattus norvegicus,,,,Intermediate,,,,9320,,10116.0,50597,5510,
,N,A,CHEMBL626976,1,1,,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Rattus norvegicus,,,,Intermediate,,,,9321,,10116.0,50597,5510,
,N,A,CHEMBL626977,1,1,,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Rattus norvegicus,,,,Intermediate,,,,9322,,10116.0,50597,5510,
,N,A,CHEMBL626978,1,1,,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Rattus norvegicus,,,,Intermediate,,,,9323,,10116.0,50597,5510,
,N,A,CHEMBL626979,1,1,,BAO_0000218,PK study was carried to determine the relative absorption ranking in rat.,Rattus norvegicus,,,,Intermediate,,,,9324,,10116.0,50597,16427,
,N,A,CHEMBL626980,1,1,Plasma,BAO_0000218,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9325,1969.0,10116.0,50597,4689,
,N,A,CHEMBL626981,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9326,178.0,10116.0,50597,11450,
,N,A,CHEMBL626982,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9327,178.0,10116.0,50597,11450,
,N,A,CHEMBL626983,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9328,178.0,10116.0,50597,11450,
,N,A,CHEMBL622522,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Rattus norvegicus,,,,Intermediate,,,,9329,178.0,10116.0,50597,11450,
,N,A,CHEMBL622523,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9330,178.0,10116.0,50597,11450,
,N,A,CHEMBL622524,1,1,Blood,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Rattus norvegicus,,,,Intermediate,,,,9331,178.0,10116.0,50597,11450,
,N,A,CHEMBL622525,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9332,955.0,10116.0,50597,11450,
,N,A,CHEMBL622526,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9333,955.0,10116.0,50597,11450,
,N,A,CHEMBL619849,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9334,955.0,10116.0,50597,11450,
,N,A,CHEMBL619850,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9335,955.0,10116.0,50597,11450,
,N,A,CHEMBL623864,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9336,955.0,10116.0,50597,11450,
,N,A,CHEMBL623865,1,1,Brain,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9337,955.0,10116.0,50597,11450,
,N,A,CHEMBL623866,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9338,948.0,10116.0,50597,11450,
,N,A,CHEMBL623867,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9339,948.0,10116.0,50597,11450,
,N,A,CHEMBL877615,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9340,948.0,10116.0,50597,11450,
,N,A,CHEMBL623868,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9341,948.0,10116.0,50597,11450,
,N,A,CHEMBL623869,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9342,948.0,10116.0,50597,11450,
,N,A,CHEMBL623870,1,1,Heart,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9343,948.0,10116.0,50597,11450,
,N,A,CHEMBL623871,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9344,2048.0,10116.0,50597,16434,
,N,A,CHEMBL623872,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9345,2048.0,10116.0,50597,16434,
,N,A,CHEMBL622129,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9346,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622130,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9347,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622131,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9348,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622132,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9349,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622133,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9350,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622134,1,1,Lung,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9351,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622135,1,1,Lung,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9352,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622136,1,1,Lung,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9353,2048.0,10116.0,50597,16435,
,N,A,CHEMBL622137,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9354,2385.0,10116.0,50597,16434,
,N,A,CHEMBL622138,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9355,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623017,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9356,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623018,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9357,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623019,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9358,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623020,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9359,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623021,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9360,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623022,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9361,2385.0,10116.0,50597,16434,
,N,A,CHEMBL623023,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9362,2385.0,10116.0,50597,16435,
,N,A,CHEMBL623024,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9363,2385.0,10116.0,50597,16435,
,N,A,CHEMBL623025,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9364,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620545,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9365,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620546,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9366,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620547,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9367,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620548,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9368,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620549,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9369,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620550,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9370,2385.0,10116.0,50597,16434,
,N,A,CHEMBL620551,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9371,2385.0,10116.0,50597,16434,
,N,A,CHEMBL620552,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9372,2385.0,10116.0,50597,16434,
,N,A,CHEMBL620553,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9373,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620554,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9374,2385.0,10116.0,50597,16435,
,N,A,CHEMBL875845,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9375,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620555,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9376,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620556,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9377,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620557,1,1,Muscle tissue,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9378,2385.0,10116.0,50597,16435,
,N,A,CHEMBL620558,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9379,,10116.0,50597,16434,
,N,A,CHEMBL620559,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9380,,10116.0,50597,16434,
,N,A,CHEMBL622939,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9381,,10116.0,50597,16434,
,N,A,CHEMBL622940,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9382,,10116.0,50597,16434,
,N,A,CHEMBL622941,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9383,,10116.0,50597,16434,
,N,A,CHEMBL622942,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9384,,10116.0,50597,16434,
,N,A,CHEMBL622943,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9385,,10116.0,50597,16434,
,N,A,CHEMBL622944,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9386,,10116.0,50597,16434,
,N,A,CHEMBL622945,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9387,,10116.0,50597,16435,
,N,A,CHEMBL622946,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9388,,10116.0,50597,16435,
,N,A,CHEMBL622947,1,1,,BAO_0000218,Compound was evaluated for terminal half life in rat,Rattus norvegicus,,,,Intermediate,,,,9389,,10116.0,50597,3341,
,N,A,CHEMBL622948,1,1,Plasma,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Rattus norvegicus,,,,Intermediate,,,In vivo,9390,1969.0,10116.0,50597,3634,
,N,A,CHEMBL622949,1,1,Plasma,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Rattus norvegicus,,,,Intermediate,,,In vivo,9391,1969.0,10116.0,50597,3634,
,N,A,CHEMBL622950,1,1,,BAO_0000218,Compound was tested for its half life in rat,Rattus norvegicus,,,,Intermediate,,,,9392,,10116.0,50597,4839,
,U,A,CHEMBL622951,1,0,Plasma,BAO_0000218,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Macaca mulatta,,,,Intermediate,,,In vivo,9393,1969.0,9544.0,22224,5005,
,U,A,CHEMBL622952,1,0,Plasma,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,9394,1969.0,10116.0,22224,5005,
,U,A,CHEMBL622953,1,0,Plasma,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Rattus norvegicus,,,,Intermediate,,,,9395,1969.0,10116.0,22224,5005,
,N,A,CHEMBL873818,1,1,Plasma,BAO_0000218,Compound was tested for plasma half-life period in rat,Rattus norvegicus,,,,Intermediate,,,,9396,1969.0,10116.0,50597,1094,
,N,A,CHEMBL622954,1,1,,BAO_0000218,Elimination half life after i.v. administration of compound in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9397,,10116.0,50597,5031,
,N,A,CHEMBL622955,1,1,,BAO_0000218,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9398,,10116.0,50597,6518,
,N,A,CHEMBL875229,1,1,,BAO_0000218,Elimination half-life after IV dosing at 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9399,,10116.0,50597,6518,
,N,A,CHEMBL622956,1,1,,BAO_0000218,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9400,,10116.0,50597,6518,
,N,A,CHEMBL622957,1,1,,BAO_0000218,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9401,,10116.0,50597,6518,
,N,A,CHEMBL622958,1,1,Brain,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9402,955.0,10116.0,50597,5408,
,N,A,CHEMBL622959,1,1,Plasma,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,,Intermediate,,,In vivo,9403,1969.0,10116.0,50597,5408,
,N,A,CHEMBL622960,1,1,Brain,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,,,,Intermediate,,,In vivo,9404,955.0,10116.0,50597,5408,
,N,A,CHEMBL622961,1,1,Plasma,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,,Intermediate,,,In vivo,9405,1969.0,10116.0,50597,5408,
,N,A,CHEMBL622962,1,1,,BAO_0000218,Evaluated for the half life in rat (in vivo),Rattus norvegicus,,,,Intermediate,,,In vivo,9406,,10116.0,50597,4687,
,N,A,CHEMBL622963,1,1,,BAO_0000218,Hafl life in rat,Rattus norvegicus,,,,Intermediate,,,,9407,,10116.0,50597,6640,
,N,A,CHEMBL622964,1,1,,BAO_0000218,Hafl life rat,Rattus norvegicus,,,,Intermediate,,,,9408,,10116.0,50597,6640,
,N,A,CHEMBL622965,1,1,,BAO_0000218,Hafl life rat,Rattus norvegicus,,,,Intermediate,,,,9409,,10116.0,50597,6641,
,N,A,CHEMBL622966,1,1,,BAO_0000218,Hafl life rat; Not determined,Rattus norvegicus,,,,Intermediate,,,,9410,,10116.0,50597,6640,
,N,A,CHEMBL622967,1,1,,BAO_0000218,Hafl life rat; Not determined,Rattus norvegicus,,,,Intermediate,,,,9411,,10116.0,50597,6641,
,N,A,CHEMBL622968,1,1,Kidney,BAO_0000218,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9412,2113.0,10116.0,50597,17411,
,N,A,CHEMBL622969,1,1,Liver,BAO_0000218,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9413,2107.0,10116.0,50597,17411,
,N,A,CHEMBL875327,1,1,Lung,BAO_0000218,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9414,2048.0,10116.0,50597,17411,
,N,A,CHEMBL628638,1,1,,BAO_0000218,Half life in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9415,,10116.0,50597,6570,
,N,A,CHEMBL628639,1,1,,BAO_0000218,Half life in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9416,,10116.0,50597,6570,
,N,A,CHEMBL625840,1,1,,BAO_0000218,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9417,,10116.0,50597,17411,
,N,A,CHEMBL625841,1,1,,BAO_0000218,Half life of 10 mg/kg oral dose determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9418,,10116.0,50597,4722,
,N,A,CHEMBL625842,1,1,,BAO_0000218,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9419,,10116.0,50597,5978,
,N,A,CHEMBL625843,1,1,,BAO_0000218,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9420,,10116.0,50597,5978,
,N,A,CHEMBL625844,1,1,,BAO_0000218,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9421,,10116.0,50597,5978,
,N,A,CHEMBL873822,1,1,,BAO_0000218,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9422,,10116.0,50597,5978,
,N,A,CHEMBL625845,1,1,,BAO_0000218,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9423,,10116.0,50597,5978,
,N,A,CHEMBL627059,1,1,,BAO_0000218,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9424,,10116.0,50597,5978,
,N,A,CHEMBL627060,1,1,,BAO_0000218,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9425,,10116.0,50597,5978,
,N,A,CHEMBL627061,1,1,,BAO_0000218,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9426,,10116.0,50597,5978,
,N,A,CHEMBL627709,1,1,,BAO_0000218,Half life of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9427,,10116.0,50597,4762,
,N,A,CHEMBL627710,1,1,,BAO_0000218,Half life of compound determined after intravenous administration to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9428,,10116.0,50597,5327,
,N,A,CHEMBL627711,1,1,,BAO_0000218,Half life of compound was determined in rat,Rattus norvegicus,,,,Intermediate,,,,9429,,10116.0,50597,4847,
,N,A,CHEMBL627712,1,1,Plasma,BAO_0000218,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9430,1969.0,10116.0,50597,17720,
,N,A,CHEMBL627713,1,1,,BAO_0000218,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9431,,10116.0,50597,4723,
,N,A,CHEMBL627714,1,1,,BAO_0000218,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9432,,10116.0,50597,4723,
,U,A,CHEMBL627889,1,0,,BAO_0000218,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Macaca fascicularis,,,,Intermediate,,,In vivo,9433,,9541.0,22224,4256,
,U,A,CHEMBL627890,1,0,,BAO_0000218,Half life determined in rat by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9434,,10116.0,22224,4256,
,N,A,CHEMBL627891,1,1,,BAO_0000218,Half life determined in rats after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9435,,10116.0,50597,4722,
,N,A,CHEMBL627892,1,1,Plasma,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,9436,1969.0,10116.0,50597,6535,
,N,A,CHEMBL627893,1,1,Plasma,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,,,,Intermediate,,,In vivo,9437,1969.0,10116.0,50597,6535,
,N,A,CHEMBL627894,1,1,Plasma,BAO_0000218,Half life in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,,9438,1969.0,10116.0,50597,1435,
,N,A,CHEMBL627895,1,1,Plasma,BAO_0000218,Half life in rat plasma was determined; NA means not applicable,Rattus norvegicus,,,,Intermediate,,,,9439,1969.0,10116.0,50597,1435,
,N,A,CHEMBL627896,1,1,,BAO_0000218,Half life in rat was tested,Rattus norvegicus,,,,Intermediate,,,,9440,,10116.0,50597,5206,
,N,A,CHEMBL627897,1,1,Plasma,BAO_0000218,Half life measured in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9441,1969.0,10116.0,50597,6080,
,N,A,CHEMBL627898,1,1,,BAO_0000218,Half life recorded in rats,Rattus norvegicus,,,,Intermediate,,,,9442,,10116.0,50597,4449,
,N,A,CHEMBL627899,1,1,,BAO_0000218,Half life was calculated,Rattus norvegicus,,,,Intermediate,,,,9443,,10116.0,50597,6057,
,N,A,CHEMBL873823,1,1,,BAO_0000218,Half life was calculated in rat,Rattus norvegicus,,,,Intermediate,,,,9444,,10116.0,50597,6057,
,N,A,CHEMBL627900,1,1,,BAO_0000218,Half life was determined,Rattus norvegicus,,,,Intermediate,,,,9445,,10116.0,50597,3747,
,N,A,CHEMBL627901,1,1,,BAO_0000218,Half life after 10 mg/kg oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9446,,10116.0,50597,17858,
,N,A,CHEMBL627902,1,1,,BAO_0000218,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9447,,10116.0,50597,16365,
,N,A,CHEMBL627903,1,1,,BAO_0000218,Half life after administering orally a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9448,,10116.0,50597,16365,
,N,A,CHEMBL627904,1,1,,BAO_0000218,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Rattus norvegicus,,,,Intermediate,,,,9449,,10116.0,50597,5031,
,N,A,CHEMBL627905,1,1,,BAO_0000218,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Rattus norvegicus,,,,Intermediate,,,,9450,,10116.0,50597,4722,
,N,A,CHEMBL627906,1,1,,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9451,,10116.0,50597,6078,
,N,A,CHEMBL627907,1,1,,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9452,,10116.0,50597,6078,
,N,A,CHEMBL876783,1,1,,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9453,,10116.0,50597,6078,
,N,A,CHEMBL627908,1,1,,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Rattus norvegicus,,,,Intermediate,,,,9454,,10116.0,50597,6078,
,N,A,CHEMBL627909,1,1,,BAO_0000218,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,,Intermediate,,,,9455,,10116.0,50597,17065,
,N,A,CHEMBL627910,1,1,,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Rattus norvegicus,,,,Intermediate,,,,9456,,10116.0,50597,1353,
,N,A,CHEMBL627911,1,1,,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Rattus norvegicus,,,,Intermediate,,,,9457,,10116.0,50597,1353,
,N,A,CHEMBL627912,1,1,,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Rattus norvegicus,,,,Intermediate,,,,9458,,10116.0,50597,1353,
,N,A,CHEMBL627913,1,1,,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Rattus norvegicus,,,,Intermediate,,,,9459,,10116.0,50597,1353,
,N,A,CHEMBL627914,1,1,,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Rattus norvegicus,,,,Intermediate,,,,9460,,10116.0,50597,1353,
,N,A,CHEMBL627915,1,1,,BAO_0000218,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,,Intermediate,,,,9461,,10116.0,50597,16423,
,N,A,CHEMBL627916,1,1,,BAO_0000218,Area under the curve was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,,Intermediate,,,,9462,,10116.0,50597,16423,
,N,A,CHEMBL627917,1,1,,BAO_0000218,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9463,,10116.0,50597,6062,
,N,A,CHEMBL627918,1,1,,BAO_0000218,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9464,,10116.0,50597,6056,
,N,A,CHEMBL627919,1,1,,BAO_0000218,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Rattus norvegicus,,,,Intermediate,,,,9465,,10116.0,50597,5182,
,N,A,CHEMBL627920,1,1,,BAO_0000218,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9466,,10116.0,50597,6410,
,N,A,CHEMBL627921,1,1,,BAO_0000218,Area under the curve was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9467,,10116.0,50597,6410,
,N,A,CHEMBL627922,1,1,,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9468,,10116.0,50597,4723,
,N,A,CHEMBL876784,1,1,,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9469,,10116.0,50597,4723,
,N,A,CHEMBL627923,1,1,,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9470,,10116.0,50597,4723,
,N,A,CHEMBL626208,1,1,,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9471,,10116.0,50597,4723,
,N,A,CHEMBL626209,1,1,,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9472,,10116.0,50597,4723,
,N,A,CHEMBL626210,1,1,,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,,9473,,10116.0,50597,4723,
,N,A,CHEMBL627994,1,1,Plasma,BAO_0000218,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,,,,Intermediate,,,,9474,1969.0,10116.0,50597,2463,
,N,A,CHEMBL627995,1,1,,BAO_0000218,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9475,,10116.0,50597,4709,
,N,A,CHEMBL627996,1,1,,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Rattus norvegicus,,,,Intermediate,,,,9476,,10116.0,50597,4075,
,N,A,CHEMBL627997,1,1,,BAO_0000218,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Rattus norvegicus,,,,Intermediate,,,,9477,,10116.0,50597,5394,
,N,A,CHEMBL627998,1,1,,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,,9478,,10116.0,50597,2661,
,N,A,CHEMBL628640,1,1,,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,,9479,,10116.0,50597,2661,
,N,A,CHEMBL628641,1,1,,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,,9480,,10116.0,50597,2661,
,N,A,CHEMBL628642,1,1,,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,,9481,,10116.0,50597,2661,
,N,A,CHEMBL628643,1,1,,BAO_0000218,Compound was evaluated for area under the curve expressed as (h*ug/ml),Rattus norvegicus,,,,Intermediate,,,,9482,,10116.0,50597,17791,
,N,A,CHEMBL628644,1,1,,BAO_0000218,Compound was tested for area under curve in rat,Rattus norvegicus,,,,Intermediate,,,,9483,,10116.0,50597,2591,
,N,A,CHEMBL628645,1,1,,BAO_0000218,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Rattus norvegicus,,,,Intermediate,,,,9484,,10116.0,50597,6567,
,N,A,CHEMBL628646,1,1,,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,,9485,,10116.0,50597,6211,
,N,A,CHEMBL628647,1,1,,BAO_0000218,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Rattus norvegicus,,,,Intermediate,,,,9486,,10116.0,50597,5529,
,N,A,CHEMBL628648,1,1,,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,,,,Intermediate,,,,9487,,10116.0,50597,5408,
,N,A,CHEMBL625358,1,1,,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,,Intermediate,,,,9488,,10116.0,50597,5408,
,N,A,CHEMBL625359,1,1,,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,,,,Intermediate,,,,9489,,10116.0,50597,5408,
,N,A,CHEMBL625360,1,1,,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,,Intermediate,,,,9490,,10116.0,50597,5408,
,N,A,CHEMBL625361,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Rattus norvegicus,,,,Intermediate,,,,9491,,10116.0,50597,429,
,N,A,CHEMBL625362,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Rattus norvegicus,,,,Intermediate,,,,9492,,10116.0,50597,429,
,N,A,CHEMBL625363,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Rattus norvegicus,,,,Intermediate,,,,9493,,10116.0,50597,429,
,N,A,CHEMBL625364,1,1,,BAO_0000218,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,,,,Intermediate,,,,9494,,10116.0,50597,4796,
,N,A,CHEMBL625365,1,1,,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,,9495,,10116.0,50597,5974,
,N,A,CHEMBL625366,1,1,,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,,9496,,10116.0,50597,5974,
,N,A,CHEMBL625367,1,1,,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,,9497,,10116.0,50597,5974,
,N,A,CHEMBL625368,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9498,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625369,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9499,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625370,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9500,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625371,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9501,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625372,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9502,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625373,1,1,Kidney,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9503,2113.0,10116.0,50597,11450,
,N,A,CHEMBL625374,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9504,2107.0,10116.0,50597,11450,
,N,A,CHEMBL877593,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9505,2107.0,10116.0,50597,11450,
,N,A,CHEMBL625375,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9506,2107.0,10116.0,50597,11450,
,N,A,CHEMBL625376,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9507,2107.0,10116.0,50597,11450,
,N,A,CHEMBL621973,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9508,2107.0,10116.0,50597,11450,
,N,A,CHEMBL621974,1,1,Liver,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9509,2107.0,10116.0,50597,11450,
,N,A,CHEMBL621975,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9510,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622166,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9511,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622167,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9512,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622168,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Rattus norvegicus,,,,Intermediate,,,,9513,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622169,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9514,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622170,1,1,Lung,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9515,2048.0,10116.0,50597,11450,
,N,A,CHEMBL622171,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9516,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622172,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9517,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622173,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9518,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622174,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9519,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622175,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9520,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622176,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9521,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622177,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9522,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622178,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9523,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622179,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9524,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622180,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9525,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622181,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9526,,10116.0,50597,16435,
,N,A,CHEMBL622182,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9527,,10116.0,50597,16435,
,N,A,CHEMBL622183,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9528,,10116.0,50597,16435,
,N,A,CHEMBL622184,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9529,,10116.0,50597,16435,
,N,A,CHEMBL622185,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9530,,10116.0,50597,16435,
,N,A,CHEMBL622186,1,1,,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9531,,10116.0,50597,16435,
,N,A,CHEMBL622187,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9532,,10116.0,50597,16434,
,N,A,CHEMBL625002,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9533,,10116.0,50597,16434,
,N,A,CHEMBL622090,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9534,,10116.0,50597,16434,
,N,A,CHEMBL622091,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9535,,10116.0,50597,16435,
,N,A,CHEMBL622092,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9536,,10116.0,50597,16435,
,N,A,CHEMBL622093,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9537,,10116.0,50597,16435,
,N,A,CHEMBL622094,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9538,,10116.0,50597,16435,
,N,A,CHEMBL622095,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9539,,10116.0,50597,16435,
,N,A,CHEMBL622264,1,1,,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9540,,10116.0,50597,16435,
,N,A,CHEMBL622265,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9541,2106.0,10116.0,50597,16434,
,N,A,CHEMBL622266,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9542,2106.0,10116.0,50597,16434,
,N,A,CHEMBL622267,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9543,2106.0,10116.0,50597,16434,
,N,A,CHEMBL622268,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9544,2106.0,10116.0,50597,16434,
,N,A,CHEMBL622269,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9545,2106.0,10116.0,50597,16434,
,N,A,CHEMBL625071,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9546,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621621,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9547,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621622,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9548,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621623,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9549,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621624,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9550,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621625,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9551,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621626,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9552,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621627,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9553,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621628,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9554,2106.0,10116.0,50597,16435,
,N,A,CHEMBL875328,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9555,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621629,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9556,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621630,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9557,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621631,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9558,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621632,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9559,2106.0,10116.0,50597,16434,
,N,A,CHEMBL621633,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9560,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621634,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9561,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621635,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9562,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621636,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9563,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621637,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9564,2106.0,10116.0,50597,16435,
,N,A,CHEMBL621638,1,1,Spleen,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9565,2106.0,10116.0,50597,16435,
,N,A,CHEMBL618883,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9566,,10116.0,50597,16434,
,N,A,CHEMBL618884,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9567,,10116.0,50597,16434,
,N,A,CHEMBL628627,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9568,,10116.0,50597,16434,
,N,A,CHEMBL628628,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9569,,10116.0,50597,16434,
,N,A,CHEMBL628629,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9570,,10116.0,50597,16434,
,N,A,CHEMBL628630,1,1,,BAO_0000218,Half life after administering orally a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9571,,10116.0,50597,16365,
,N,A,CHEMBL628631,1,1,,BAO_0000218,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9572,,10116.0,50597,16365,
,N,A,CHEMBL628632,1,1,,BAO_0000218,Half life after administering intravenously a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9573,,10116.0,50597,16365,
,N,A,CHEMBL628633,1,1,,BAO_0000218,Half life after oral dosing in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9574,,10116.0,50597,526,
,N,A,CHEMBL628634,1,1,,BAO_0000218,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9575,,10116.0,50597,16365,
,N,A,CHEMBL627789,1,1,,BAO_0000218,Half life by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9576,,10116.0,50597,4368,
,N,A,CHEMBL627790,1,1,,BAO_0000218,Half life in rat,Rattus norvegicus,,,,Intermediate,,,,9577,,10116.0,50597,3371,
,N,A,CHEMBL627791,1,1,,BAO_0000218,Half life in rat,Rattus norvegicus,,,,Intermediate,,,,9578,,10116.0,50597,6448,
,N,A,CHEMBL627792,1,1,,BAO_0000218,Half life in rat,Rattus norvegicus,,,,Intermediate,,,,9579,,10116.0,50597,6453,
,N,A,CHEMBL627793,1,1,,BAO_0000218,Half life in rat after intravenous administration of the compound,Rattus norvegicus,,,,Intermediate,,,In vivo,9580,,10116.0,50597,4353,
,N,A,CHEMBL627794,1,1,Plasma,BAO_0000218,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,,,,Intermediate,,,In vivo,9581,1969.0,10116.0,50597,4353,
,N,A,CHEMBL627795,1,1,,BAO_0000218,Half life in rat after po administration of the compound,Rattus norvegicus,,,,Intermediate,,,In vivo,9582,,10116.0,50597,4353,
,N,A,CHEMBL627796,1,1,,BAO_0000218,Half life in rat after po administration of the compound; ND means Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9583,,10116.0,50597,4353,
,N,A,CHEMBL875335,1,1,Plasma,BAO_0000218,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Rattus norvegicus,,,,Intermediate,,,In vivo,9584,1969.0,10116.0,50597,4353,
,N,A,CHEMBL627797,1,1,Plasma,BAO_0000218,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,,,,Intermediate,,,In vivo,9585,1969.0,10116.0,50597,4353,
,N,A,CHEMBL627798,1,1,,BAO_0000218,Half life in rat i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,9586,,10116.0,50597,5789,
,N,A,CHEMBL627799,1,1,,BAO_0000218,Half life in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,9587,,10116.0,50597,17686,
,N,A,CHEMBL627800,1,1,,BAO_0000218,Half life in rats,Rattus norvegicus,,,,Intermediate,,,,9588,,10116.0,50597,6495,
,N,A,CHEMBL627801,1,1,,BAO_0000218,Half life in rats after intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9589,,10116.0,50597,484,
,N,A,CHEMBL627802,1,1,,BAO_0000218,Half life in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9590,,10116.0,50597,6467,
,N,A,CHEMBL627803,1,1,,BAO_0000218,Half life in rat,Rattus norvegicus,,,,Expert,,,,9591,,10116.0,50597,6642,
,N,A,CHEMBL873820,1,1,,BAO_0000218,Half life was evaluated after intravenous administration to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9592,,10116.0,50597,16367,
,N,A,CHEMBL627804,1,1,,BAO_0000218,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Rattus norvegicus,,,,Intermediate,,,,9593,,10116.0,50597,1369,
,N,A,CHEMBL627805,1,1,,BAO_0000218,Half life was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,,9594,,10116.0,50597,5472,
,N,A,CHEMBL627806,1,1,,BAO_0000218,Half life was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,,9595,,10116.0,50597,6049,
,N,A,CHEMBL627107,1,1,,BAO_0000218,Half life was evaluated in rat; Not tested,Rattus norvegicus,,,,Intermediate,,,,9596,,10116.0,50597,5472,
,N,A,CHEMBL627108,1,1,,BAO_0000218,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9597,,10116.0,50597,16366,
,N,A,CHEMBL627109,1,1,,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9598,,10116.0,50597,11149,
,N,A,CHEMBL627110,1,1,Blood,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9599,178.0,10116.0,50597,11149,
,U,A,CHEMBL627111,1,0,,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,,,,Intermediate,,,In vivo,9600,,9443.0,22224,2891,
,U,A,CHEMBL627112,1,0,,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,,,,Intermediate,,,In vivo,9601,,9443.0,22224,2891,
,U,A,CHEMBL627113,1,0,,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9602,,10116.0,22224,2891,
,U,A,CHEMBL627114,1,0,,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9603,,10116.0,22224,2891,
,N,A,CHEMBL627115,1,1,,BAO_0000218,Half life (t1/2) was determined,Rattus norvegicus,,,,Intermediate,,,,9604,,10116.0,50597,4026,
,N,A,CHEMBL627116,1,1,,BAO_0000218,Half life period at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,,9605,,10116.0,50597,4527,
,N,A,CHEMBL627117,1,1,,BAO_0000218,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9606,,10116.0,50597,4527,
,N,A,CHEMBL627118,1,1,,BAO_0000218,Half life period was determined,Rattus norvegicus,,,,Intermediate,,,,9607,,10116.0,50597,5503,
,N,A,CHEMBL627119,1,1,,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9608,,10116.0,50597,4426,
,N,A,CHEMBL627120,1,1,,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Rattus norvegicus,,,,Intermediate,,,In vivo,9609,,10116.0,50597,4426,
,N,A,CHEMBL626922,1,1,,BAO_0000218,Half life period after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9610,,10116.0,50597,6109,
,N,A,CHEMBL626923,1,1,,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9611,,10116.0,50597,5654,
,N,A,CHEMBL626924,1,1,,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9612,,10116.0,50597,5654,
,N,A,CHEMBL626925,1,1,Plasma,BAO_0000218,Half life period in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,,,,Intermediate,,,,9613,1969.0,10116.0,50597,4755,
,N,A,CHEMBL626926,1,1,,BAO_0000218,Half life period in SD rats,Rattus norvegicus,,,,Intermediate,,,,9614,,10116.0,50597,5862,
,N,A,CHEMBL626927,1,1,Plasma,BAO_0000218,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Rattus norvegicus,,,,Intermediate,,,,9615,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626928,1,1,Plasma,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,,,,Intermediate,,,,9616,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626929,1,1,Plasma,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,,,Intermediate,,,,9617,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626930,1,1,Plasma,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,,,Intermediate,,,,9618,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626931,1,1,,BAO_0000218,Half life period in rat,Rattus norvegicus,,,,Intermediate,,,,9619,,10116.0,50597,5960,
,N,A,CHEMBL626932,1,1,,BAO_0000218,Half life period in rat,Rattus norvegicus,,,,Intermediate,,,,9620,,10116.0,50597,6103,
,N,A,CHEMBL626933,1,1,,BAO_0000218,Half life period in rat,Rattus norvegicus,,,,Intermediate,,,,9621,,10116.0,50597,6317,
,N,A,CHEMBL873826,1,1,,BAO_0000218,Half life period in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9622,,10116.0,50597,6644,
,N,A,CHEMBL626934,1,1,,BAO_0000218,Half life period in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9623,,10116.0,50597,6644,
,N,A,CHEMBL626935,1,1,,BAO_0000218,Half life period in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9624,,10116.0,50597,6644,
,N,A,CHEMBL626936,1,1,,BAO_0000218,Half life period in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,9625,,10116.0,50597,6644,
,N,A,CHEMBL626937,1,1,,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,,9626,,10116.0,50597,5974,
,N,A,CHEMBL625906,1,1,,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9627,,10116.0,50597,6295,
,N,A,CHEMBL625907,1,1,,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9628,,10116.0,50597,6296,
,N,A,CHEMBL625908,1,1,,BAO_0000218,PK study was carried to determine AUC (area under curve) value in rat,Rattus norvegicus,,,,Intermediate,,,,9629,,10116.0,50597,16427,
,N,A,CHEMBL625909,1,1,,BAO_0000218,Pharmacokinetic parameter AUC after intravenous administration to rats,Rattus norvegicus,,,,Intermediate,,,,9630,,10116.0,50597,16367,
,N,A,CHEMBL625910,1,1,,BAO_0000218,Pharmacokinetic parameter AUC after oral administration to rats,Rattus norvegicus,,,,Intermediate,,,,9631,,10116.0,50597,16367,
,N,A,CHEMBL625911,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9632,,10116.0,50597,16365,
,N,A,CHEMBL625912,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,,Intermediate,,,,9633,,10116.0,50597,16365,
,N,A,CHEMBL626538,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,,Intermediate,,,,9634,,10116.0,50597,16365,
,N,A,CHEMBL876794,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Rattus norvegicus,,,,Intermediate,,,,9635,,10116.0,50597,16365,
,N,A,CHEMBL626539,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Rattus norvegicus,,,,Intermediate,,,,9636,,10116.0,50597,16365,
,N,A,CHEMBL626540,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,,Intermediate,,,,9637,,10116.0,50597,16365,
,N,A,CHEMBL626541,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9638,,10116.0,50597,5394,
,N,A,CHEMBL626542,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9639,,10116.0,50597,5394,
,N,A,CHEMBL626543,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,,9640,,10116.0,50597,2792,
,N,A,CHEMBL626544,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,,9641,,10116.0,50597,2792,
,N,A,CHEMBL626545,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,,9642,,10116.0,50597,2792,
,N,A,CHEMBL626546,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,,9643,,10116.0,50597,2792,
,N,A,CHEMBL626547,1,1,,BAO_0000218,Pharmacokinetic parameter area under curve was reported,Rattus norvegicus,,,,Intermediate,,,,9644,,10116.0,50597,5334,
,N,A,CHEMBL626548,1,1,,BAO_0000218,Pharmacokinetic property (AUC) in rat,Rattus norvegicus,,,,Intermediate,,,,9645,,10116.0,50597,4408,
,N,A,CHEMBL626549,1,1,,BAO_0000218,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,,Intermediate,,,,9646,,10116.0,50597,5983,
,N,A,CHEMBL626550,1,1,,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Rattus norvegicus,,,,Intermediate,,,,9647,,10116.0,50597,4397,
,N,A,CHEMBL626551,1,1,,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Rattus norvegicus,,,,Intermediate,,,,9648,,10116.0,50597,4397,
,N,A,CHEMBL623777,1,1,,BAO_0000218,Pharmacokinetic property was determined,Rattus norvegicus,,,,Intermediate,,,,9649,,10116.0,50597,5491,
,N,A,CHEMBL623778,1,1,,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9650,,10116.0,50597,5491,
,N,A,CHEMBL623779,1,1,,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Rattus norvegicus,,,,Intermediate,,,,9651,,10116.0,50597,5491,
,N,A,CHEMBL623780,1,1,Plasma,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9652,1969.0,10116.0,50597,4199,
,N,A,CHEMBL622015,1,1,Plasma,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9653,1969.0,10116.0,50597,4199,
,N,A,CHEMBL622016,1,1,Plasma,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9654,1969.0,10116.0,50597,4199,
,N,A,CHEMBL622017,1,1,,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Rattus norvegicus,,,,Intermediate,,,,9655,,10116.0,50597,5173,
,N,A,CHEMBL622018,1,1,,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Rattus norvegicus,,,,Intermediate,,,,9656,,10116.0,50597,5173,
,N,A,CHEMBL622019,1,1,,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Rattus norvegicus,,,,Intermediate,,,,9657,,10116.0,50597,5173,
,N,A,CHEMBL622020,1,1,,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Rattus norvegicus,,,,Intermediate,,,,9658,,10116.0,50597,5173,
,N,A,CHEMBL622021,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Rattus norvegicus,,,,Intermediate,,,,9659,,10116.0,50597,16366,
,N,A,CHEMBL622022,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Rattus norvegicus,,,,Intermediate,,,,9660,,10116.0,50597,16366,
,N,A,CHEMBL622023,1,1,,BAO_0000218,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Rattus norvegicus,,,,Intermediate,,,,9661,,10116.0,50597,5327,
,N,A,CHEMBL622024,1,1,,BAO_0000218,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,9662,,10116.0,50597,6681,
,N,A,CHEMBL622693,1,1,,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Rattus norvegicus,,,,Intermediate,,,,9663,,10116.0,50597,12873,
,N,A,CHEMBL622694,1,1,,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Rattus norvegicus,,,,Intermediate,,,,9664,,10116.0,50597,12873,
,N,A,CHEMBL622695,1,1,,BAO_0000218,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9665,,10116.0,50597,6685,
,N,A,CHEMBL622696,1,1,,BAO_0000218,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,,,Intermediate,,,,9666,,10116.0,50597,6685,
,N,A,CHEMBL622697,1,1,,BAO_0000218,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,,Intermediate,,,,9667,,10116.0,50597,6685,
,N,A,CHEMBL622874,1,1,,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Rattus norvegicus,,,,Intermediate,,,,9668,,10116.0,50597,6619,
,N,A,CHEMBL622875,1,1,,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Rattus norvegicus,,,,Intermediate,,,,9669,,10116.0,50597,6619,
,N,A,CHEMBL622876,1,1,,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,,,,Intermediate,,,,9670,,10116.0,50597,10363,
,N,A,CHEMBL622877,1,1,,BAO_0000218,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,,,,Intermediate,,,,9671,,10116.0,50597,4796,
,N,A,CHEMBL622878,1,1,,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9672,,10116.0,50597,4910,
,N,A,CHEMBL622879,1,1,Plasma,BAO_0000218,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,9673,1969.0,10116.0,50597,4910,
,N,A,CHEMBL877602,1,1,,BAO_0000218,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Rattus norvegicus,,,,Intermediate,,,,9674,,10116.0,50597,4839,
,N,A,CHEMBL622880,1,1,,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9675,,10116.0,50597,15078,
,N,A,CHEMBL622881,1,1,,BAO_0000218,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9676,,10116.0,50597,15078,
,N,A,CHEMBL622882,1,1,,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9677,,10116.0,50597,15078,
,N,A,CHEMBL622883,1,1,,BAO_0000218,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9678,,10116.0,50597,15078,
,N,A,CHEMBL622884,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Rattus norvegicus,,,,Intermediate,,,,9679,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622885,1,1,Thyroid gland,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Rattus norvegicus,,,,Intermediate,,,,9680,2046.0,10116.0,50597,11450,
,N,A,CHEMBL622886,1,1,,BAO_0000218,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,,Intermediate,,,,9681,,10116.0,50597,8151,
,N,A,CHEMBL622887,1,1,,BAO_0000218,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,9682,,10116.0,50597,8151,
,N,A,CHEMBL622888,1,1,Urine,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,9683,1088.0,10116.0,50597,8151,
,N,A,CHEMBL622889,1,1,Blood,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9684,178.0,10116.0,50597,8677,
,N,A,CHEMBL622890,1,1,Blood,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9685,178.0,10116.0,50597,8677,
,N,A,CHEMBL622891,1,1,Blood,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9686,178.0,10116.0,50597,8677,
,N,A,CHEMBL877603,1,1,Blood,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9687,178.0,10116.0,50597,8677,
,N,A,CHEMBL622892,1,1,Brain,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9688,955.0,10116.0,50597,8677,
,N,A,CHEMBL622893,1,1,Brain,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9689,955.0,10116.0,50597,8677,
,N,A,CHEMBL622894,1,1,Brain,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9690,955.0,10116.0,50597,8677,
,N,A,CHEMBL622895,1,1,Brain,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9691,955.0,10116.0,50597,8677,
,N,A,CHEMBL622896,1,1,Brain,BAO_0000218,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9692,955.0,10116.0,50597,8677,
,N,A,CHEMBL622897,1,1,Heart,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9693,948.0,10116.0,50597,8677,
,N,A,CHEMBL622898,1,1,Heart,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9694,948.0,10116.0,50597,8677,
,N,A,CHEMBL622899,1,1,Heart,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9695,948.0,10116.0,50597,8677,
,N,A,CHEMBL622900,1,1,Kidney,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9696,2113.0,10116.0,50597,8677,
,N,A,CHEMBL624114,1,1,Kidney,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9697,2113.0,10116.0,50597,8677,
,N,A,CHEMBL624115,1,1,Kidney,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9698,2113.0,10116.0,50597,8677,
,N,A,CHEMBL624116,1,1,Kidney,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9699,2113.0,10116.0,50597,8677,
,N,A,CHEMBL624117,1,1,Liver,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9700,2107.0,10116.0,50597,8677,
,N,A,CHEMBL624118,1,1,Liver,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9701,2107.0,10116.0,50597,8677,
,N,A,CHEMBL624119,1,1,Liver,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9702,2107.0,10116.0,50597,8677,
,N,A,CHEMBL624120,1,1,Liver,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9703,2107.0,10116.0,50597,8677,
,N,A,CHEMBL624121,1,1,Lung,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9704,2048.0,10116.0,50597,8677,
,N,A,CHEMBL624122,1,1,Lung,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9705,2048.0,10116.0,50597,8677,
,N,A,CHEMBL624123,1,1,Lung,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9706,2048.0,10116.0,50597,8677,
,N,A,CHEMBL624124,1,1,Lung,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9707,2048.0,10116.0,50597,8677,
,N,A,CHEMBL624125,1,1,Muscle tissue,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9708,2385.0,10116.0,50597,8677,
,N,A,CHEMBL624126,1,1,Muscle tissue,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9709,2385.0,10116.0,50597,8677,
,N,A,CHEMBL624127,1,1,Muscle tissue,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9710,2385.0,10116.0,50597,8677,
,N,A,CHEMBL624128,1,1,Muscle tissue,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9711,2385.0,10116.0,50597,8677,
,N,A,CHEMBL624129,1,1,Zone of skin,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9712,14.0,10116.0,50597,8677,
,N,A,CHEMBL624130,1,1,Zone of skin,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9713,14.0,10116.0,50597,8677,
,N,A,CHEMBL622340,1,1,Zone of skin,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9714,14.0,10116.0,50597,8677,
,N,A,CHEMBL622341,1,1,Zone of skin,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9715,14.0,10116.0,50597,8677,
,N,A,CHEMBL622342,1,1,Intestine,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9716,160.0,10116.0,50597,8677,
,N,A,CHEMBL622343,1,1,Intestine,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9717,160.0,10116.0,50597,8677,
,N,A,CHEMBL622344,1,1,Intestine,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9718,160.0,10116.0,50597,8677,
,N,A,CHEMBL622345,1,1,Intestine,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9719,160.0,10116.0,50597,8677,
,N,A,CHEMBL622346,1,1,Spleen,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9720,2106.0,10116.0,50597,8677,
,N,A,CHEMBL622347,1,1,Spleen,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9721,2106.0,10116.0,50597,8677,
,N,A,CHEMBL622348,1,1,Spleen,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9722,2106.0,10116.0,50597,8677,
,N,A,CHEMBL622349,1,1,Spleen,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9723,2106.0,10116.0,50597,8677,
,N,A,CHEMBL622350,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9724,,10116.0,50597,16434,
,N,A,CHEMBL622351,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9725,,10116.0,50597,16434,
,N,A,CHEMBL622352,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9726,,10116.0,50597,16434,
,N,A,CHEMBL622353,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9727,,10116.0,50597,16435,
,N,A,CHEMBL622354,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9728,,10116.0,50597,16435,
,N,A,CHEMBL622355,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9729,,10116.0,50597,16435,
,N,A,CHEMBL622356,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9730,,10116.0,50597,16435,
,N,A,CHEMBL622357,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9731,,10116.0,50597,16435,
,N,A,CHEMBL622358,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,,Intermediate,,,,9732,,10116.0,50597,16435,
,N,A,CHEMBL622359,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9733,,10116.0,50597,16435,
,N,A,CHEMBL874393,1,1,,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9734,,10116.0,50597,16435,
,N,A,CHEMBL622872,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9735,,10116.0,50597,16434,
,N,A,CHEMBL622873,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9736,,10116.0,50597,16434,
,N,A,CHEMBL623047,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9737,,10116.0,50597,16434,
,N,A,CHEMBL623048,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9738,,10116.0,50597,16435,
,N,A,CHEMBL623049,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9739,,10116.0,50597,16435,
,N,A,CHEMBL623050,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9740,,10116.0,50597,16435,
,N,A,CHEMBL623051,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9741,,10116.0,50597,16435,
,N,A,CHEMBL623052,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9742,,10116.0,50597,16435,
,N,A,CHEMBL626343,1,1,,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9743,,10116.0,50597,16435,
,N,A,CHEMBL626344,1,1,,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,,Intermediate,,,,9744,,10116.0,50597,16434,
,N,A,CHEMBL626345,1,1,,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,,Intermediate,,,,9745,,10116.0,50597,16434,
,N,A,CHEMBL626346,1,1,,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,,Intermediate,,,,9746,,10116.0,50597,16434,
,N,A,CHEMBL626347,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,,Intermediate,,,,9747,,10116.0,50597,16434,
,N,A,CHEMBL626348,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,,Intermediate,,,,9748,,10116.0,50597,16434,
,N,A,CHEMBL626349,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,,Intermediate,,,,9749,,10116.0,50597,16434,
,N,F,CHEMBL626350,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9750,,10116.0,50597,16435,
,N,A,CHEMBL626351,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9751,,10116.0,50597,16435,
,N,A,CHEMBL627650,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9752,,10116.0,50597,16435,
,N,F,CHEMBL627651,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,,Intermediate,,,,9753,,10116.0,50597,16435,
,N,A,CHEMBL627652,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,,Intermediate,,,,9754,,10116.0,50597,16435,
,N,A,CHEMBL627653,1,1,,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,,Intermediate,,,,9755,,10116.0,50597,16435,
,N,A,CHEMBL627654,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9756,,10116.0,50597,13091,
,N,A,CHEMBL627835,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9757,,10116.0,50597,13091,
,N,A,CHEMBL627836,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9758,,10116.0,50597,13091,
,N,A,CHEMBL627837,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9759,,10116.0,50597,13091,
,N,A,CHEMBL627838,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9760,,10116.0,50597,13091,
,N,A,CHEMBL875338,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9761,,10116.0,50597,13091,
,N,A,CHEMBL627839,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9762,,10116.0,50597,13091,
,N,A,CHEMBL627840,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9763,,10116.0,50597,13091,
,N,A,CHEMBL627841,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9764,,10116.0,50597,13091,
,N,A,CHEMBL627842,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9765,,10116.0,50597,13091,
,N,A,CHEMBL627843,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9766,,10116.0,50597,13091,
,N,A,CHEMBL627844,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9767,,10116.0,50597,13091,
,N,A,CHEMBL627845,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9768,,10116.0,50597,13091,
,N,A,CHEMBL627846,1,1,,BAO_0000218,Half life period in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9769,,10116.0,50597,5874,
,N,A,CHEMBL627847,1,1,Plasma,BAO_0000218,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Rattus norvegicus,,,,Intermediate,,,,9770,1969.0,10116.0,50597,1515,
,N,A,CHEMBL873821,1,1,Plasma,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,,,,Intermediate,,,,9771,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626079,1,1,Plasma,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,,,Intermediate,,,,9772,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626080,1,1,Plasma,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,,,Intermediate,,,,9773,1969.0,10116.0,50597,1515,
,N,A,CHEMBL626081,1,1,Plasma,BAO_0000218,Half life period was evaluated in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9774,1969.0,10116.0,50597,5491,
,N,A,CHEMBL875344,1,1,Plasma,BAO_0000218,Half life period was evaluated in rat plasma; Not tested,Rattus norvegicus,,,,Intermediate,,,,9775,1969.0,10116.0,50597,5491,
,N,A,CHEMBL626082,1,1,,BAO_0000218,Half life period was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,,9776,,10116.0,50597,1918,
,N,A,CHEMBL626250,1,1,,BAO_0000218,"Half life period was evaluated in rats, iv",Rattus norvegicus,,,,Intermediate,,,In vivo,9777,,10116.0,50597,1918,
,N,A,CHEMBL626251,1,1,,BAO_0000218,Half life period after intravenous administration at 5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9778,,10116.0,50597,6113,
,N,A,CHEMBL626252,1,1,,BAO_0000218,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9779,,10116.0,50597,5546,
,N,A,CHEMBL626253,1,1,,BAO_0000218,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9780,,10116.0,50597,5553,
,N,A,CHEMBL626254,1,1,Plasma,BAO_0000218,Half life stability of compound was evaluated in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9781,1969.0,10116.0,50597,4188,
,N,A,CHEMBL626255,1,1,,BAO_0000218,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9782,,10116.0,50597,6215,
,N,A,CHEMBL626256,1,1,,BAO_0000218,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9783,,10116.0,50597,6141,
,N,A,CHEMBL626257,1,1,,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9784,,10116.0,50597,5182,
,N,A,CHEMBL626258,1,1,,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Rattus norvegicus,,,,Intermediate,,,In vivo,9785,,10116.0,50597,5182,
,N,A,CHEMBL626259,1,1,,BAO_0000218,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,9786,,10116.0,50597,5710,
,N,A,CHEMBL626260,1,1,,BAO_0000218,Half in rat i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,9787,,10116.0,50597,5789,
,N,A,CHEMBL875345,1,1,,BAO_0000218,Half period in rat after intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9788,,10116.0,50597,6011,
,N,A,CHEMBL626261,1,1,,BAO_0000218,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9789,,10116.0,50597,17594,
,N,A,CHEMBL626262,1,1,Liver,BAO_0000218,Half-life measured in in vitro Cathepsin B assay in rat liver,Rattus norvegicus,,,,Intermediate,,,In vitro,9790,2107.0,10116.0,50597,12357,
,N,A,CHEMBL626263,1,1,,BAO_0000218,Half-life of compound was determined in rats,Rattus norvegicus,,,,Intermediate,,,,9791,,10116.0,50597,5210,
,N,A,CHEMBL625270,1,1,,BAO_0000218,Half-life at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9792,,10116.0,50597,17596,
,N,A,CHEMBL625271,1,1,,BAO_0000218,Half-life determined in rat,Rattus norvegicus,,,,Intermediate,,,,9793,,10116.0,50597,6672,
,N,A,CHEMBL625272,1,1,,BAO_0000218,Half-life determined in rat,Rattus norvegicus,,,,Intermediate,,,,9794,,10116.0,50597,6673,
,N,A,CHEMBL625273,1,1,Brain,BAO_0000218,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9795,955.0,10116.0,50597,4910,
,N,A,CHEMBL625274,1,1,Plasma,BAO_0000218,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Rattus norvegicus,,,,Intermediate,,,,9796,1969.0,10116.0,50597,3741,
,N,A,CHEMBL625275,1,1,,BAO_0000218,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9797,,10116.0,50597,17671,
,N,A,CHEMBL625276,1,1,Plasma,BAO_0000218,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9798,1969.0,10116.0,50597,4910,
,N,A,CHEMBL625277,1,1,Plasma,BAO_0000218,Half-life in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9799,1969.0,10116.0,50597,17537,
,N,A,CHEMBL625278,1,1,Plasma,BAO_0000218,Half-life in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,,9800,1969.0,10116.0,50597,4965,
,N,A,CHEMBL625279,1,1,Plasma,BAO_0000218,Half-life in rat plasma; Not tested,Rattus norvegicus,,,,Intermediate,,,,9801,1969.0,10116.0,50597,17537,
,N,A,CHEMBL625280,1,1,Serum,BAO_0000218,Half-life in rat serum,Rattus norvegicus,,,,Intermediate,,,,9802,1977.0,10116.0,50597,6124,
,N,A,CHEMBL876797,1,1,Serum,BAO_0000218,Half-life in rat serum; na is not available,Rattus norvegicus,,,,Intermediate,,,,9803,1977.0,10116.0,50597,6124,
,N,A,CHEMBL625281,1,1,,BAO_0000218,Half-life was calculated in rat,Rattus norvegicus,,,,Intermediate,,,,9804,,10116.0,50597,6078,
,N,A,CHEMBL873827,1,1,Plasma,BAO_0000218,Half-life was calculated in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9805,1969.0,10116.0,50597,17668,
,N,A,CHEMBL625282,1,1,,BAO_0000218,Half-life was determined,Rattus norvegicus,,,,Intermediate,,,,9806,,10116.0,50597,3185,
,N,A,CHEMBL625283,1,1,,BAO_0000218,Half-life was determined,Rattus norvegicus,,,,Intermediate,,,,9807,,10116.0,50597,4883,
,N,A,CHEMBL625284,1,1,,BAO_0000218,Half-life after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9808,,10116.0,50597,2959,
,N,A,CHEMBL625285,1,1,,BAO_0000218,Half-life after administration of 3.2 mg/kg intravenously in male rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9809,,10116.0,50597,4029,
,N,A,CHEMBL625286,1,1,,BAO_0000218,Half-life after intravenous administration in female rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9810,,10116.0,50597,4029,
,N,A,CHEMBL625287,1,1,,BAO_0000218,Half-life after intravenous administration in male rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9811,,10116.0,50597,4029,
,N,A,CHEMBL625288,1,1,,BAO_0000218,Half-life after intravenous dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9812,,10116.0,50597,6180,
,N,A,CHEMBL625289,1,1,Liver,BAO_0000218,Half-life in a rat liver homogenate preparation,Rattus norvegicus,,,,Intermediate,,,,9813,2107.0,10116.0,50597,1557,
,N,A,CHEMBL625290,1,1,Plasma,BAO_0000218,Half-life in plasma of rat,Rattus norvegicus,,,,Intermediate,,,,9814,1969.0,10116.0,50597,12500,
,N,A,CHEMBL876798,1,1,Plasma,BAO_0000218,Half-life in plasma of rat at dose of 3-10 mgkg,Rattus norvegicus,,,,Intermediate,,,,9815,1969.0,10116.0,50597,12500,
,N,A,CHEMBL625291,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9816,,10116.0,50597,5064,
,N,A,CHEMBL625292,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9817,,10116.0,50597,5145,
,N,A,CHEMBL625293,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9818,,10116.0,50597,5147,
,N,A,CHEMBL622832,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9819,,10116.0,50597,5833,
,N,A,CHEMBL622833,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9820,,10116.0,50597,6596,
,N,A,CHEMBL622834,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,9821,,10116.0,50597,17655,
,N,A,CHEMBL622835,1,1,,BAO_0000218,Half-life in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9822,,10116.0,50597,6495,
,N,A,CHEMBL622836,1,1,,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9823,,10116.0,50597,17538,
,N,A,CHEMBL622837,1,1,,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,9824,,10116.0,50597,17538,
,N,A,CHEMBL622838,1,1,,BAO_0000218,Half-life in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,,,,Intermediate,,,In vivo,9825,,10116.0,50597,10,
,N,A,CHEMBL622839,1,1,Brain,BAO_0000218,Half-life in rat brain homogenate,Rattus norvegicus,,,,Intermediate,,,,9826,955.0,10116.0,50597,17669,
,N,A,CHEMBL622840,1,1,Plasma,BAO_0000218,Half-life in rat plasma,Rattus norvegicus,,,,Intermediate,,,,9827,1969.0,10116.0,50597,17065,
,N,A,CHEMBL622841,1,1,,BAO_0000218,Half-life in rats,Rattus norvegicus,,,,Intermediate,,,,9828,,10116.0,50597,4333,
,N,A,CHEMBL622842,1,1,,BAO_0000218,Half-life in Dawley rats,Rattus norvegicus,,,,Intermediate,,,,9829,,10116.0,50597,6827,
,N,A,CHEMBL622843,1,1,Plasma,BAO_0000218,Half-life in vitro in rat plasma,Rattus norvegicus,,,,Intermediate,,,In vitro,9830,1969.0,10116.0,50597,889,
,N,A,CHEMBL622844,1,1,Plasma,BAO_0000218,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Rattus norvegicus,,,,Intermediate,,,In vitro,9831,1969.0,10116.0,50597,889,
,N,A,CHEMBL622845,1,1,,BAO_0000218,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Rattus norvegicus,,,,Intermediate,,,,9832,,10116.0,50597,3747,
,N,A,CHEMBL622846,1,1,,BAO_0000218,The area under the curve of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,,Intermediate,,,,9833,,10116.0,50597,15022,
,N,A,CHEMBL622847,1,1,,BAO_0000218,The area under the curve of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,,Intermediate,,,,9834,,10116.0,50597,15022,
,N,A,CHEMBL622848,1,1,,BAO_0000218,The area under the curve of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,,Intermediate,,,,9835,,10116.0,50597,15022,
,N,A,CHEMBL622849,1,1,,BAO_0000218,Bioavailability as oral AUC in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9836,,10116.0,50597,3360,
,N,A,CHEMBL622850,1,1,Plasma,BAO_0000218,The plasma concentration versus time curve (AUC) was determined,Rattus norvegicus,,,,Intermediate,,,,9837,1969.0,10116.0,50597,5334,
,N,A,CHEMBL876807,1,1,,BAO_0000218,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9838,,10116.0,50597,17411,
,N,A,CHEMBL622851,1,1,,BAO_0000218,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9839,,10116.0,50597,17411,
,N,A,CHEMBL622852,1,1,,BAO_0000218,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9840,,10116.0,50597,17411,
,N,A,CHEMBL622853,1,1,,BAO_0000218,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Rattus norvegicus,,,,Intermediate,,,,9841,,10116.0,50597,6570,
,N,A,CHEMBL622854,1,1,,BAO_0000218,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Rattus norvegicus,,,,Intermediate,,,,9842,,10116.0,50597,6570,
,N,A,CHEMBL622855,1,1,,BAO_0000218,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9843,,10116.0,50597,17411,
,N,A,CHEMBL622856,1,1,Plasma,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,,9844,1969.0,10116.0,50597,14941,
,N,A,CHEMBL622857,1,1,Plasma,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,,9845,1969.0,10116.0,50597,14941,
,N,A,CHEMBL622858,1,1,Plasma,BAO_0000218,AUC in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9846,1969.0,10116.0,50597,17538,
,N,A,CHEMBL622859,1,1,Plasma,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9847,1969.0,10116.0,50597,17752,
,N,A,CHEMBL622860,1,1,,BAO_0000218,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,,,,Intermediate,,,,9848,,10116.0,50597,17509,
,N,A,CHEMBL622861,1,1,,BAO_0000218,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9849,,10116.0,50597,17509,
,N,A,CHEMBL622862,1,1,,BAO_0000218,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,,,,Intermediate,,,,9850,,10116.0,50597,17509,
,N,A,CHEMBL622863,1,1,,BAO_0000218,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,,,,Intermediate,,,,9851,,10116.0,50597,17509,
,N,A,CHEMBL623817,1,1,,BAO_0000218,Area under curve value 6 hr after po administration in rat,Rattus norvegicus,,,,Intermediate,,,,9852,,10116.0,50597,17509,
,N,A,CHEMBL623818,1,1,,BAO_0000218,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,,9853,,10116.0,50597,17717,
,N,A,CHEMBL623819,1,1,,BAO_0000218,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,,,,Intermediate,,,,9854,,10116.0,50597,17717,
,N,A,CHEMBL623820,1,1,,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,,9855,,10116.0,50597,17717,
,N,A,CHEMBL623821,1,1,,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,,,Intermediate,,,,9856,,10116.0,50597,17717,
,N,A,CHEMBL623822,1,1,Plasma,BAO_0000218,AUC normalized for dose (AUCN) in rat,Rattus norvegicus,,,,Intermediate,,,,9857,1969.0,10116.0,50597,6642,
,N,A,CHEMBL623823,1,1,,BAO_0000218,Area under curve in rat after p.o. administration,Rattus norvegicus,,,,Intermediate,,,,9858,,10116.0,50597,6640,
,N,A,CHEMBL623824,1,1,,BAO_0000218,Area under curve in rat after p.o. administration,Rattus norvegicus,,,,Intermediate,,,,9859,,10116.0,50597,6641,
,N,A,CHEMBL623825,1,1,,BAO_0000218,Area under curve in rat after p.o. administration; Not determined,Rattus norvegicus,,,,Intermediate,,,,9860,,10116.0,50597,6641,
,N,A,CHEMBL622070,1,1,,BAO_0000218,Area under curve in rat after peroral administration,Rattus norvegicus,,,,Intermediate,,,,9861,,10116.0,50597,6641,
,N,A,CHEMBL622071,1,1,,BAO_0000218,Area under curve (carotid artery) value of the compound,Rattus norvegicus,,,,Intermediate,,,,9862,,10116.0,50597,3603,
,N,A,CHEMBL622072,1,1,,BAO_0000218,Bioavailability expressed as the area under curve of rat carotid artery,Rattus norvegicus,,,,Intermediate,,,,9863,,10116.0,50597,3550,
,N,A,CHEMBL622073,1,1,,BAO_0000218,Area under curve in male SD rats was observed after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,,9864,,10116.0,50597,15662,
,N,A,CHEMBL622074,1,1,,BAO_0000218,Area under curve of the compound was determined,Rattus norvegicus,,,,Intermediate,,,,9865,,10116.0,50597,17720,
,N,A,CHEMBL622075,1,1,,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Rattus norvegicus,,,,Intermediate,,,,9866,,10116.0,50597,5407,
,N,A,CHEMBL622076,1,1,Plasma,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9867,1969.0,10116.0,50597,17752,
,N,A,CHEMBL622077,1,1,Plasma,BAO_0000218,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,9868,1969.0,10116.0,50597,17752,
,N,A,CHEMBL622078,1,1,,BAO_0000218,Area under curve (portal vein) value of the compound,Rattus norvegicus,,,,Intermediate,,,,9869,,10116.0,50597,3603,
,N,A,CHEMBL622079,1,1,,BAO_0000218,Bioavailability expressed as the area under curve of rat portal vein,Rattus norvegicus,,,,Intermediate,,,,9870,,10116.0,50597,3550,
,N,A,CHEMBL622080,1,1,Plasma,BAO_0000218,Area Under plasma concentration time curve in rat upon peroral administration,Rattus norvegicus,,,,Intermediate,,,,9871,1969.0,10116.0,50597,17655,
,N,A,CHEMBL877612,1,1,,BAO_0000218,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9872,,10116.0,50597,17582,
,N,A,CHEMBL622081,1,1,,BAO_0000218,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,9873,,10116.0,50597,17582,
,N,A,CHEMBL622082,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats,Rattus norvegicus,,,,Intermediate,,,,9874,,10116.0,50597,17791,
,N,A,CHEMBL622083,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats after iv administration,Rattus norvegicus,,,,Intermediate,,,,9875,,10116.0,50597,17791,
,N,A,CHEMBL622084,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 30-80,Rattus norvegicus,,,,Intermediate,,,,9876,,10116.0,50597,17791,
,N,A,CHEMBL622085,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 50-60,Rattus norvegicus,,,,Intermediate,,,,9877,,10116.0,50597,17791,
,N,A,CHEMBL622086,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats; no data,Rattus norvegicus,,,,Intermediate,,,,9878,,10116.0,50597,17791,
,N,A,CHEMBL622087,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats; peptide,Rattus norvegicus,,,,Intermediate,,,,9879,,10116.0,50597,17791,
,N,A,CHEMBL622088,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Rattus norvegicus,,,,Intermediate,,,,9880,178.0,10116.0,50597,7768,
,N,A,CHEMBL622089,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Rattus norvegicus,,,,Intermediate,,,,9881,178.0,10116.0,50597,7768,
,N,A,CHEMBL623685,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Rattus norvegicus,,,,Intermediate,,,,9882,178.0,10116.0,50597,7768,
,N,A,CHEMBL623686,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Rattus norvegicus,,,,Intermediate,,,,9883,178.0,10116.0,50597,7768,
,N,A,CHEMBL623687,1,1,Stomach,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9884,945.0,10116.0,50597,8677,
,N,A,CHEMBL623688,1,1,Stomach,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9885,945.0,10116.0,50597,8677,
,N,A,CHEMBL623689,1,1,Stomach,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9886,945.0,10116.0,50597,8677,
,N,A,CHEMBL622485,1,1,Stomach,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9887,945.0,10116.0,50597,8677,
,N,A,CHEMBL622486,1,1,Thyroid gland,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9888,2046.0,10116.0,50597,8677,
,N,A,CHEMBL877613,1,1,Thyroid gland,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9889,2046.0,10116.0,50597,8677,
,N,A,CHEMBL622487,1,1,Thyroid gland,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9890,2046.0,10116.0,50597,8677,
,N,A,CHEMBL622488,1,1,Thyroid gland,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9891,2046.0,10116.0,50597,8677,
,N,A,CHEMBL622489,1,1,Heart,BAO_0000218,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,,,Intermediate,,,In vivo,9892,948.0,10116.0,50597,8677,
,N,A,CHEMBL622490,1,1,Urine,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,,,Intermediate,,,,9893,1088.0,10116.0,50597,6899,
,N,A,CHEMBL622491,1,1,Urine,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,,,,Intermediate,,,,9894,1088.0,10116.0,50597,6899,
,N,A,CHEMBL622492,1,1,Liver,BAO_0000218,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Rattus norvegicus,,,,Intermediate,,,,9895,2107.0,10116.0,50597,6899,
,N,A,CHEMBL622493,1,1,Urine,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,,,Intermediate,,,,9896,1088.0,10116.0,50597,6899,
,N,A,CHEMBL622494,1,1,Urine,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,,,,Intermediate,,,,9897,1088.0,10116.0,50597,6899,
,N,A,CHEMBL622495,1,1,Muscle tissue,BAO_0000218,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,,,Intermediate,,,,9898,2385.0,10116.0,50597,8677,
,N,A,CHEMBL622496,1,1,,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Rattus norvegicus,,,,Intermediate,,,,9899,,10116.0,50597,6899,
,N,A,CHEMBL622497,1,1,Urine,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,,,Intermediate,,,,9900,1088.0,10116.0,50597,6899,
,N,A,CHEMBL622498,1,1,,BAO_0000218,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Rattus norvegicus,,,,Intermediate,,,,9901,,10116.0,50597,2189,
,N,A,CHEMBL624918,1,1,Urine,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Rattus norvegicus,,,,Intermediate,,,,9902,1088.0,10116.0,50597,2189,
,N,A,CHEMBL624919,1,1,Urine,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Rattus norvegicus,,,,Intermediate,,,,9903,1088.0,10116.0,50597,2189,
,N,A,CHEMBL624920,1,1,Blood,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9904,178.0,10116.0,50597,10839,
,N,A,CHEMBL624921,1,1,Blood,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9905,178.0,10116.0,50597,10839,
,N,A,CHEMBL624922,1,1,Brain,BAO_0000218,Biodistribution of compound in rat brain after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9906,955.0,10116.0,50597,10839,
,N,A,CHEMBL624923,1,1,Heart,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9907,948.0,10116.0,50597,10839,
,N,A,CHEMBL624924,1,1,Heart,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9908,948.0,10116.0,50597,10839,
,N,A,CHEMBL624925,1,1,Kidney,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9909,2113.0,10116.0,50597,10839,
,N,A,CHEMBL624926,1,1,Kidney,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9910,2113.0,10116.0,50597,10839,
,N,A,CHEMBL624927,1,1,Liver,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9911,2107.0,10116.0,50597,10839,
,N,A,CHEMBL874402,1,1,Liver,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9912,2107.0,10116.0,50597,10839,
,N,A,CHEMBL624928,1,1,Lung,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9913,2048.0,10116.0,50597,10839,
,N,A,CHEMBL624929,1,1,Lung,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9914,2048.0,10116.0,50597,10839,
,N,A,CHEMBL624930,1,1,Muscle tissue,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9915,2385.0,10116.0,50597,10839,
,N,A,CHEMBL624931,1,1,Muscle tissue,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,9916,2385.0,10116.0,50597,10839,
,N,A,CHEMBL624932,1,1,Heart,BAO_0000218,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9917,948.0,10116.0,50597,4043,
,N,A,CHEMBL624933,1,1,Heart,BAO_0000218,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9918,948.0,10116.0,50597,4043,
,N,A,CHEMBL624934,1,1,Liver,BAO_0000218,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9919,2107.0,10116.0,50597,4043,
,N,A,CHEMBL624935,1,1,Liver,BAO_0000218,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9920,2107.0,10116.0,50597,4043,
,N,A,CHEMBL624936,1,1,,BAO_0000218,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9921,,10116.0,50597,4043,
,N,A,CHEMBL624937,1,1,,BAO_0000218,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9922,,10116.0,50597,4043,
,N,A,CHEMBL624938,1,1,Spleen,BAO_0000218,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9923,2106.0,10116.0,50597,4043,
,N,A,CHEMBL624939,1,1,Spleen,BAO_0000218,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9924,2106.0,10116.0,50597,4043,
,N,A,CHEMBL624940,1,1,,BAO_0000218,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9925,,10116.0,50597,4043,
,N,A,CHEMBL874403,1,1,,BAO_0000218,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,,Intermediate,,,,9926,,10116.0,50597,4043,
,N,A,CHEMBL624941,1,1,,BAO_0000218,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Rattus norvegicus,,,,Intermediate,,,,9927,,10116.0,50597,1446,
,N,A,CHEMBL624942,1,1,Urine,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Rattus norvegicus,,,,Intermediate,,,,9928,1088.0,10116.0,50597,9971,
,N,A,CHEMBL624943,1,1,Urine,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Rattus norvegicus,,,,Intermediate,,,,9929,1088.0,10116.0,50597,9971,
,N,A,CHEMBL624944,1,1,,BAO_0000218,% Bioavailability after 1 day of the drug administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9930,,10116.0,50597,5765,
,N,A,CHEMBL624945,1,1,,BAO_0000218,% Bioavailability after 4 day of the drug administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9931,,10116.0,50597,5765,
,N,A,CHEMBL624946,1,1,,BAO_0000218,Absolute bioavailability was evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,9932,,10116.0,50597,4257,
,N,A,CHEMBL624947,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9933,,10116.0,50597,13091,
,N,A,CHEMBL624948,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9934,,10116.0,50597,13091,
,N,A,CHEMBL624949,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9935,,10116.0,50597,13091,
,N,A,CHEMBL622025,1,1,Kidney,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9936,2113.0,10116.0,50597,13091,
,N,A,CHEMBL622026,1,1,Kidney,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9937,2113.0,10116.0,50597,13091,
,N,A,CHEMBL622027,1,1,Kidney,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9938,2113.0,10116.0,50597,13091,
,N,A,CHEMBL622028,1,1,Kidney,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9939,2113.0,10116.0,50597,13091,
,N,A,CHEMBL622029,1,1,Liver,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9940,2107.0,10116.0,50597,13091,
,N,A,CHEMBL622208,1,1,Liver,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9941,2107.0,10116.0,50597,13091,
,N,A,CHEMBL622209,1,1,Liver,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9942,2107.0,10116.0,50597,13091,
,N,A,CHEMBL622210,1,1,Liver,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9943,2107.0,10116.0,50597,13091,
,N,A,CHEMBL622211,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9944,,10116.0,50597,13091,
,N,A,CHEMBL622212,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9945,,10116.0,50597,13091,
,N,A,CHEMBL622213,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9946,,10116.0,50597,13091,
,N,A,CHEMBL874404,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9947,,10116.0,50597,13091,
,N,A,CHEMBL620452,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9948,2385.0,10116.0,50597,13091,
,N,A,CHEMBL620453,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9949,2385.0,10116.0,50597,13091,
,N,A,CHEMBL620454,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9950,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624067,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9951,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624068,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9952,,10116.0,50597,13091,
,N,A,CHEMBL624069,1,1,Female gonad,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9953,992.0,10116.0,50597,13091,
,N,A,CHEMBL624070,1,1,Female gonad,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9954,992.0,10116.0,50597,13091,
,N,A,CHEMBL624071,1,1,Female gonad,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9955,992.0,10116.0,50597,13091,
,N,A,CHEMBL624072,1,1,Uterus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9956,995.0,10116.0,50597,13091,
,N,A,CHEMBL624073,1,1,Uterus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9957,995.0,10116.0,50597,13091,
,N,A,CHEMBL624788,1,1,Uterus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9958,995.0,10116.0,50597,13091,
,N,A,CHEMBL624789,1,1,Uterus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9959,995.0,10116.0,50597,13091,
,N,A,CHEMBL624790,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9960,,10116.0,50597,13091,
,N,A,CHEMBL624791,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9961,,10116.0,50597,13091,
,N,A,CHEMBL624792,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9962,,10116.0,50597,13091,
,N,A,CHEMBL624793,1,1,,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9963,,10116.0,50597,13091,
,N,A,CHEMBL877491,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Rattus norvegicus,,,,Intermediate,,,,9964,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624957,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Rattus norvegicus,,,,Intermediate,,,,9965,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624958,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9966,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624959,1,1,Muscle tissue,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Rattus norvegicus,,,,Intermediate,,,,9967,2385.0,10116.0,50597,13091,
,N,A,CHEMBL624960,1,1,,BAO_0000218,Dissociation constant was determined,Rattus norvegicus,,,,Intermediate,,,,9968,,10116.0,50597,11977,
,N,A,CHEMBL624961,1,1,,BAO_0000218,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,,Intermediate,,,,9969,,10116.0,50597,14941,
,N,A,CHEMBL624962,1,1,,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9970,,10116.0,50597,15078,
,N,A,CHEMBL624963,1,1,,BAO_0000218,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,9971,,10116.0,50597,15078,
,N,A,CHEMBL624964,1,1,,BAO_0000218,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,,,,Intermediate,,,,9972,,10116.0,50597,4755,
,N,A,CHEMBL624965,1,1,,BAO_0000218,LogP value was evaluated in the in situ rat gut perfusion assay,Rattus norvegicus,,,,Intermediate,,,,9973,,10116.0,50597,589,
,N,A,CHEMBL624966,1,1,,BAO_0000218,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9974,,10116.0,50597,17582,
,N,A,CHEMBL624967,1,1,,BAO_0000218,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9975,,10116.0,50597,5031,
,N,A,CHEMBL624968,1,1,,BAO_0000218,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9976,,10116.0,50597,17764,
,N,A,CHEMBL624969,1,1,,BAO_0000218,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,,9977,,10116.0,50597,17720,
,N,F,CHEMBL624970,1,1,,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Rattus norvegicus,,,,Expert,,,,9978,,10116.0,50597,2862,
,N,A,CHEMBL624971,1,1,,BAO_0000218,Half-life was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,,Intermediate,,,,9979,,10116.0,50597,16423,
,N,A,CHEMBL624972,1,1,,BAO_0000218,Half-life was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9980,,10116.0,50597,16423,
,N,A,CHEMBL624973,1,1,,BAO_0000218,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9981,,10116.0,50597,6005,
,N,A,CHEMBL624974,1,1,Plasma,BAO_0000218,Half-life was evaluated in plasma of rat,Rattus norvegicus,,,,Intermediate,,,,9982,1969.0,10116.0,50597,2938,
,N,A,CHEMBL624975,1,1,,BAO_0000218,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9983,,10116.0,50597,6410,
,N,A,CHEMBL877492,1,1,,BAO_0000218,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9984,,10116.0,50597,6410,
,N,A,CHEMBL624976,1,1,,BAO_0000218,Half-life was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9985,,10116.0,50597,6062,
,N,A,CHEMBL624977,1,1,,BAO_0000218,Half-life period of compound in rats after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9986,,10116.0,50597,6571,
,N,A,CHEMBL626848,1,1,Plasma,BAO_0000218,Half-life period of compound was measured in rat plasma.,Rattus norvegicus,,,,Intermediate,,,,9987,1969.0,10116.0,50597,3136,
,N,A,CHEMBL626849,1,1,Plasma,BAO_0000218,Half-life period of compound was measured in rat plasma; ND is not determined,Rattus norvegicus,,,,Intermediate,,,,9988,1969.0,10116.0,50597,3136,
,N,A,CHEMBL626850,1,1,Plasma,BAO_0000218,Half-life period of compound was measured in rat plasma; not determined,Rattus norvegicus,,,,Intermediate,,,,9989,1969.0,10116.0,50597,3136,
,N,A,CHEMBL626851,1,1,,BAO_0000218,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9990,,10116.0,50597,4521,
,N,A,CHEMBL626852,1,1,,BAO_0000218,Half-life period in rat by iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9991,,10116.0,50597,5871,
,N,A,CHEMBL626853,1,1,,BAO_0000218,Half-life period in rats following intravenous administration at 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,9992,,10116.0,50597,6077,
,N,A,CHEMBL626854,1,1,,BAO_0000218,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,,Intermediate,,,In vivo,9993,,10116.0,50597,6679,
,N,A,CHEMBL627486,1,1,,BAO_0000218,Half-life period was determined for the compound in rat,Rattus norvegicus,,,,Intermediate,,,,9994,,10116.0,50597,5144,
,N,A,CHEMBL627487,1,1,,BAO_0000218,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,9995,,10116.0,50597,4498,
,N,A,CHEMBL627488,1,1,,BAO_0000218,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,,,,Intermediate,,,In vivo,9996,,10116.0,50597,4498,
,N,A,CHEMBL627489,1,1,,BAO_0000218,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,9997,,10116.0,50597,1908,
,N,A,CHEMBL627490,1,1,,BAO_0000218,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,9998,,10116.0,50597,6211,
,N,A,CHEMBL873829,1,1,,BAO_0000218,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,9999,,10116.0,50597,5529,
,N,A,CHEMBL627655,1,1,,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,10000,,10116.0,50597,6444,
,N,A,CHEMBL625994,1,1,,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10001,,10116.0,50597,6444,
,N,A,CHEMBL625995,1,1,,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10002,,10116.0,50597,6444,
,N,A,CHEMBL625996,1,1,,BAO_0000218,Half-life in rat,Rattus norvegicus,,,,Intermediate,,,,10003,,10116.0,50597,5207,
,N,A,CHEMBL625850,1,1,Plasma,BAO_0000218,In vitro half life in rat plasma,Rattus norvegicus,,,,Intermediate,,,In vitro,10004,1969.0,10116.0,50597,530,
,N,A,CHEMBL625851,1,1,Plasma,BAO_0000218,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Rattus norvegicus,,,,Intermediate,,,In vitro,10005,1969.0,10116.0,50597,1116,
,N,A,CHEMBL625852,1,1,,BAO_0000218,In vitro half life in rat,Rattus norvegicus,,,,Intermediate,,,In vitro,10006,,10116.0,50597,3219,
,N,A,CHEMBL625853,1,1,,BAO_0000218,In vivo half life period after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10007,,10116.0,50597,6109,
,N,A,CHEMBL625854,1,1,,BAO_0000218,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10008,,10116.0,50597,17582,
,N,A,CHEMBL874450,1,1,,BAO_0000218,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10009,,10116.0,50597,17582,
,N,A,CHEMBL625855,1,1,,BAO_0000218,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10010,,10116.0,50597,5974,
,N,A,CHEMBL625856,1,1,,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10011,,10116.0,50597,5974,
,N,A,CHEMBL625857,1,1,,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10012,,10116.0,50597,5974,
,N,A,CHEMBL873831,1,1,,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10013,,10116.0,50597,5974,
,N,A,CHEMBL625858,1,1,,BAO_0000218,Longer half-life in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10014,,10116.0,50597,17853,
,N,A,CHEMBL625859,1,1,,BAO_0000218,Longer half-life in rat (p.o.) at 2.0 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10015,,10116.0,50597,17853,
,N,A,CHEMBL625860,1,1,,BAO_0000218,Pharmacokinetic property (half life) in rat,Rattus norvegicus,,,,Intermediate,,,,10016,,10116.0,50597,3457,
,N,A,CHEMBL625861,1,1,,BAO_0000218,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10017,,10116.0,50597,2792,
,N,A,CHEMBL625862,1,1,,BAO_0000218,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10018,,10116.0,50597,2792,
,N,A,CHEMBL625863,1,1,,BAO_0000218,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10019,,10116.0,50597,2792,
,N,A,CHEMBL625864,1,1,,BAO_0000218,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10020,,10116.0,50597,2792,
,N,A,CHEMBL625865,1,1,,BAO_0000218,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10021,,10116.0,50597,5739,
,N,A,CHEMBL625866,1,1,,BAO_0000218,Pharmacokinetic half time was determined intravenously in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,10022,,10116.0,50597,15765,
,N,A,CHEMBL625867,1,1,Plasma,BAO_0000218,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Rattus norvegicus,,,,Intermediate,,,In vivo,10023,1969.0,10116.0,50597,6567,
,N,A,CHEMBL625868,1,1,Plasma,BAO_0000218,Plasma half life of hydrolysis of the compound,Rattus norvegicus,,,,Intermediate,,,,10024,1969.0,10116.0,50597,2448,
,N,A,CHEMBL625869,1,1,Plasma,BAO_0000218,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10025,1969.0,10116.0,50597,5423,
,N,A,CHEMBL874451,1,1,Plasma,BAO_0000218,Plasma half life period was calculated in rat,Rattus norvegicus,,,,Intermediate,,,,10026,1969.0,10116.0,50597,4853,
,N,A,CHEMBL625870,1,1,Plasma,BAO_0000218,Plasma half-life in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,,10027,1969.0,10116.0,50597,4514,
,N,A,CHEMBL625871,1,1,Plasma,BAO_0000218,Plasma half-life in Sprague-Dawley rats; Not determined,Rattus norvegicus,,,,Intermediate,,,,10028,1969.0,10116.0,50597,4514,
,N,A,CHEMBL625872,1,1,Plasma,BAO_0000218,Plasma half-life in rats,Rattus norvegicus,,,,Intermediate,,,,10029,1969.0,10116.0,50597,1500,
,N,A,CHEMBL625873,1,1,Plasma,BAO_0000218,Plasma half-life in rats; <MQL,Rattus norvegicus,,,,Intermediate,,,,10030,1969.0,10116.0,50597,1500,
,N,A,CHEMBL625874,1,1,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was determined,Rattus norvegicus,,,,Intermediate,,,,10031,1969.0,10116.0,50597,5334,
,N,A,CHEMBL625875,1,1,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,,10032,1969.0,10116.0,50597,5334,
,N,A,CHEMBL625876,1,1,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10033,1969.0,10116.0,50597,5334,
,N,A,CHEMBL631258,1,1,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10034,1969.0,10116.0,50597,5334,
,N,A,CHEMBL631259,1,1,Plasma,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Rattus norvegicus,,,,Intermediate,,,,10035,1969.0,10116.0,50597,4956,
,N,A,CHEMBL631260,1,1,Plasma,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Rattus norvegicus,,,,Intermediate,,,,10036,1969.0,10116.0,50597,4956,
,N,A,CHEMBL631261,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Rattus norvegicus,,,,Intermediate,,,,10037,178.0,10116.0,50597,7768,
,N,A,CHEMBL631262,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Rattus norvegicus,,,,Intermediate,,,,10038,178.0,10116.0,50597,7768,
,N,A,CHEMBL631263,1,1,Blood,BAO_0000218,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Rattus norvegicus,,,,Intermediate,,,,10039,178.0,10116.0,50597,7768,
,N,A,CHEMBL631264,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Rattus norvegicus,,,,Intermediate,,,,10040,,10116.0,50597,7768,
,N,A,CHEMBL631265,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Rattus norvegicus,,,,Intermediate,,,,10041,,10116.0,50597,7768,
,N,A,CHEMBL631266,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Rattus norvegicus,,,,Intermediate,,,,10042,,10116.0,50597,7768,
,N,A,CHEMBL631267,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Rattus norvegicus,,,,Intermediate,,,,10043,,10116.0,50597,7768,
,N,A,CHEMBL631268,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Rattus norvegicus,,,,Intermediate,,,,10044,,10116.0,50597,7768,
,N,A,CHEMBL631269,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Rattus norvegicus,,,,Intermediate,,,,10045,,10116.0,50597,7768,
,N,A,CHEMBL631270,1,1,,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Rattus norvegicus,,,,Intermediate,,,,10046,,10116.0,50597,7768,
,N,A,CHEMBL631271,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,,,,Intermediate,,,,10047,948.0,10116.0,50597,7768,
,N,A,CHEMBL631272,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Rattus norvegicus,,,,Intermediate,,,,10048,948.0,10116.0,50597,7768,
,N,A,CHEMBL631273,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Rattus norvegicus,,,,Intermediate,,,,10049,948.0,10116.0,50597,7768,
,N,A,CHEMBL631274,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Rattus norvegicus,,,,Intermediate,,,,10050,948.0,10116.0,50597,7768,
,N,A,CHEMBL631275,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Rattus norvegicus,,,,Intermediate,,,,10051,948.0,10116.0,50597,7768,
,N,A,CHEMBL626984,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Rattus norvegicus,,,,Intermediate,,,,10052,948.0,10116.0,50597,7768,
,N,A,CHEMBL626985,1,1,Heart,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Rattus norvegicus,,,,Intermediate,,,,10053,948.0,10116.0,50597,7768,
,N,A,CHEMBL626986,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,,,,Intermediate,,,,10054,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626987,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Rattus norvegicus,,,,Intermediate,,,,10055,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626988,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Rattus norvegicus,,,,Intermediate,,,,10056,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626989,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Rattus norvegicus,,,,Intermediate,,,,10057,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626990,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Rattus norvegicus,,,,Intermediate,,,,10058,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626991,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Rattus norvegicus,,,,Intermediate,,,,10059,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626992,1,1,Liver,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Rattus norvegicus,,,,Intermediate,,,,10060,2107.0,10116.0,50597,7768,
,N,A,CHEMBL626993,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Rattus norvegicus,,,,Intermediate,,,,10061,2048.0,10116.0,50597,7768,
,N,A,CHEMBL874593,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Rattus norvegicus,,,,Intermediate,,,,10062,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626994,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Rattus norvegicus,,,,Intermediate,,,,10063,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626995,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Rattus norvegicus,,,,Intermediate,,,,10064,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626190,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Rattus norvegicus,,,,Intermediate,,,,10065,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626191,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Rattus norvegicus,,,,Intermediate,,,,10066,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626364,1,1,Lung,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Rattus norvegicus,,,,Intermediate,,,,10067,2048.0,10116.0,50597,7768,
,N,A,CHEMBL626365,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Rattus norvegicus,,,,Intermediate,,,,10068,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626366,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Rattus norvegicus,,,,Intermediate,,,,10069,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626367,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Rattus norvegicus,,,,Intermediate,,,,10070,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626368,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Rattus norvegicus,,,,Intermediate,,,,10071,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626369,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Rattus norvegicus,,,,Intermediate,,,,10072,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626370,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Rattus norvegicus,,,,Intermediate,,,,10073,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626371,1,1,,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,,,,Intermediate,,,In vivo,10074,,10116.0,50597,4498,
,N,A,CHEMBL626372,1,1,,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,,,,Intermediate,,,In vivo,10075,,10116.0,50597,4498,
,N,A,CHEMBL626373,1,1,,BAO_0000218,Bioavailability after a dose of 10 mg/kg p.o.,Rattus norvegicus,,,,Intermediate,,,In vivo,10076,,10116.0,50597,3603,
,N,A,CHEMBL626374,1,1,,BAO_0000218,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10077,,10116.0,50597,6215,
,N,A,CHEMBL626375,1,1,,BAO_0000218,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Rattus norvegicus,,,,Intermediate,,,In vivo,10078,,10116.0,50597,5710,
,N,A,CHEMBL626376,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10079,,10116.0,50597,5710,
,N,A,CHEMBL626377,1,1,,BAO_0000218,Bioavailability in rat po was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10080,,10116.0,50597,5676,
,N,A,CHEMBL626378,1,1,,BAO_0000218,Bioavailability of compound at 10 mg/kg in rat after oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10081,,10116.0,50597,17667,
,N,A,CHEMBL626379,1,1,,BAO_0000218,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10082,,10116.0,50597,17667,
,N,A,CHEMBL626380,1,1,,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10083,,10116.0,50597,6848,
,N,A,CHEMBL626381,1,1,,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10084,,10116.0,50597,6848,
,N,A,CHEMBL626382,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10085,,10116.0,50597,17267,
,N,A,CHEMBL626383,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (female),Rattus norvegicus,,,,Intermediate,,,In vivo,10086,,10116.0,50597,6362,
,N,A,CHEMBL874652,1,1,,BAO_0000218,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10087,,10116.0,50597,17671,
,N,A,CHEMBL626384,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10088,,10116.0,50597,17671,
,N,A,CHEMBL626385,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,10089,,10116.0,50597,4333,
,N,A,CHEMBL626386,1,1,,BAO_0000218,Bioavailability in rat at an oral dose of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10090,,10116.0,50597,6077,
,N,A,CHEMBL626387,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10091,,10116.0,50597,3278,
,N,A,CHEMBL626388,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10092,,10116.0,50597,5964,
,N,A,CHEMBL626389,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10093,,10116.0,50597,4884,
,N,A,CHEMBL626390,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10094,,10116.0,50597,4905,
,N,A,CHEMBL626391,1,1,,BAO_0000218,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Rattus norvegicus,,,,Intermediate,,,In vivo,10095,,10116.0,50597,4884,
,N,A,CHEMBL626392,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10096,,10116.0,50597,6850,
,N,A,CHEMBL626393,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10097,,10116.0,50597,2864,
,N,A,CHEMBL623026,1,1,,BAO_0000218,Bioavailability was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10098,,10116.0,50597,5780,
,N,A,CHEMBL623027,1,1,,BAO_0000218,Bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10099,,10116.0,50597,1465,
,N,A,CHEMBL623028,1,1,,BAO_0000218,Bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10100,,10116.0,50597,5199,
,N,A,CHEMBL623029,1,1,,BAO_0000218,Bioavailability in rat after 1 day dosing,Rattus norvegicus,,,,Intermediate,,,In vivo,10101,,10116.0,50597,5765,
,N,A,CHEMBL623030,1,1,,BAO_0000218,Bioavailability in rat after 4 day dosing,Rattus norvegicus,,,,Intermediate,,,In vivo,10102,,10116.0,50597,5765,
,N,A,CHEMBL623031,1,1,,BAO_0000218,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,10103,,10116.0,50597,6518,
,N,A,CHEMBL623032,1,1,,BAO_0000218,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,,,,Intermediate,,,In vivo,10104,,10116.0,50597,6518,
,N,A,CHEMBL623033,1,1,,BAO_0000218,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10105,,10116.0,50597,6518,
,N,A,CHEMBL623034,1,1,,BAO_0000218,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10106,,10116.0,50597,6518,
,N,A,CHEMBL623035,1,1,,BAO_0000218,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10107,,10116.0,50597,2083,
,N,A,CHEMBL623036,1,1,,BAO_0000218,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10108,,10116.0,50597,17260,
,N,A,CHEMBL623037,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10109,,10116.0,50597,4956,
,N,A,CHEMBL623038,1,1,,BAO_0000218,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10110,,10116.0,50597,4368,
,N,A,CHEMBL874385,1,1,Plasma,BAO_0000218,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10111,1969.0,10116.0,50597,17752,
,N,A,CHEMBL623039,1,1,,BAO_0000218,Bioavailability in rat (Fisher) (fasted),Rattus norvegicus,,,,Intermediate,,,In vivo,10112,,10116.0,50597,1446,
,U,A,CHEMBL623040,1,0,,BAO_0000218,Bioavailability in monkey after po administration of 10 mg/kg dose,Primates,,,,Intermediate,,,In vivo,10113,,9443.0,22224,2891,
,U,A,CHEMBL623041,1,0,,BAO_0000218,Oral bioavailability in monkey (dose 10 mg/kg),Primates,,,,Intermediate,,,In vivo,10114,,9443.0,22224,2891,
,N,A,CHEMBL623741,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10115,,10116.0,50597,6672,
,N,A,CHEMBL623742,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10116,,10116.0,50597,6673,
,N,A,CHEMBL623743,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10117,,10116.0,50597,17655,
,N,A,CHEMBL623744,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10118,,10116.0,50597,17796,
,N,A,CHEMBL623745,1,1,,BAO_0000218,Bioavailability in rat (dose 2.0 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10119,,10116.0,50597,17853,
,N,A,CHEMBL623746,1,1,,BAO_0000218,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10120,,10116.0,50597,4521,
,N,A,CHEMBL623747,1,1,,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10121,,10116.0,50597,4940,
,U,A,CHEMBL623748,1,0,,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10122,,10116.0,22224,2891,
,U,A,CHEMBL623916,1,0,,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10123,,10116.0,22224,2891,
,N,A,CHEMBL623917,1,1,,BAO_0000218,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10124,,10116.0,50597,4521,
,N,A,CHEMBL623918,1,1,,BAO_0000218,Bioavailability in rat (dose 2 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10125,,10116.0,50597,17686,
,N,A,CHEMBL874386,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10126,,10116.0,50597,17796,
,N,A,CHEMBL623919,1,1,Plasma,BAO_0000218,Bioavailability in rat; Only traces detected in rat plasma,Rattus norvegicus,,,,Intermediate,,,In vivo,10127,1969.0,10116.0,50597,17796,
,N,A,CHEMBL623920,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10128,,10116.0,50597,5064,
,N,A,CHEMBL623148,1,1,,BAO_0000218,Bioavailability upon oral administration of compound,Rattus norvegicus,,,,Intermediate,,,In vivo,10129,,10116.0,50597,5147,
,N,A,CHEMBL623149,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10130,,10116.0,50597,1916,
,N,A,CHEMBL623150,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10131,,10116.0,50597,6049,
,N,A,CHEMBL623151,1,1,,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Rattus norvegicus,,,,Intermediate,,,In vivo,10132,,10116.0,50597,1445,
,N,A,CHEMBL623152,1,1,,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Rattus norvegicus,,,,Intermediate,,,In vivo,10133,,10116.0,50597,1445,
,N,F,CHEMBL623153,1,1,,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Rattus norvegicus,,,,Expert,,,,10134,,10116.0,50597,2862,
,N,F,CHEMBL623154,1,1,,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Rattus norvegicus,,,,Expert,,,,10135,,10116.0,50597,2862,
,N,A,CHEMBL623155,1,1,,BAO_0000218,In vitro and metabolic stability was determined,Rattus norvegicus,,,,Intermediate,,,,10136,,10116.0,50597,4194,
,N,A,CHEMBL623156,1,1,,BAO_0000218,In vitro metabolic stability in rat hepatocytes,Rattus norvegicus,,,,Intermediate,,,,10137,,10116.0,50597,4194,
,N,A,CHEMBL623157,1,1,,BAO_0000218,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Rattus norvegicus,,,,Intermediate,,,,10138,,10116.0,50597,5486,
,N,A,CHEMBL623158,1,1,Liver,BAO_0000218,Metabolic rate for compound was observed in rat hepatocytes,Rattus norvegicus,,401.0,Hepatocyte,Intermediate,,,In vitro,10139,2107.0,10116.0,50597,17582,
,N,A,CHEMBL623159,1,1,,BAO_0000218,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Rattus norvegicus,,,,Intermediate,,,,10140,,10116.0,50597,5600,
,N,A,CHEMBL874390,1,1,,BAO_0000218,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Rattus norvegicus,,,,Intermediate,,,,10141,,10116.0,50597,14294,
,N,A,CHEMBL623160,1,1,,BAO_0000218,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Rattus norvegicus,,,,Intermediate,,,,10142,,10116.0,50597,14294,
,N,A,CHEMBL623161,1,1,,BAO_0000218,Metabolism of compound in rat S9 microsomes; Trace,Rattus norvegicus,,,,Intermediate,,,,10143,,10116.0,50597,14294,
,N,A,CHEMBL623162,1,1,,BAO_0000218,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Rattus norvegicus,,,,Intermediate,,,,10144,,10116.0,50597,17847,
,N,A,CHEMBL623163,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10145,,10116.0,50597,11020,
,N,A,CHEMBL623164,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,,Intermediate,,,,10146,,10116.0,50597,11020,
,N,A,CHEMBL623165,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Rattus norvegicus,,,,Intermediate,,,,10147,,10116.0,50597,11020,
,N,A,CHEMBL623166,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,,Intermediate,,,,10148,,10116.0,50597,11020,
,N,A,CHEMBL624983,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Rattus norvegicus,,,,Intermediate,,,,10149,,10116.0,50597,11020,
,N,A,CHEMBL624984,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Rattus norvegicus,,,,Intermediate,,,,10150,,10116.0,50597,11020,
,N,A,CHEMBL624985,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10151,,10116.0,50597,11020,
,N,A,CHEMBL622970,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Rattus norvegicus,,,,Intermediate,,,,10152,,10116.0,50597,11020,
,N,A,CHEMBL622971,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10153,,10116.0,50597,11020,
,N,A,CHEMBL622972,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10154,,10116.0,50597,11020,
,N,A,CHEMBL622973,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10155,,10116.0,50597,11020,
,N,A,CHEMBL622974,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10156,,10116.0,50597,11020,
,N,A,CHEMBL622975,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10157,,10116.0,50597,11020,
,N,A,CHEMBL622976,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10158,,10116.0,50597,11020,
,N,A,CHEMBL622977,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Rattus norvegicus,,,,Intermediate,,,,10159,,10116.0,50597,11020,
,N,A,CHEMBL624351,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10160,,10116.0,50597,11020,
,N,A,CHEMBL624352,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,,Intermediate,,,,10161,,10116.0,50597,11020,
,N,A,CHEMBL624353,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,,Intermediate,,,,10162,,10116.0,50597,11020,
,N,A,CHEMBL622397,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,,Intermediate,,,,10163,,10116.0,50597,11020,
,N,A,CHEMBL622398,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,,,,Intermediate,,,,10164,,10116.0,50597,11020,
,N,A,CHEMBL622399,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,,,,Intermediate,,,,10165,,10116.0,50597,11020,
,N,A,CHEMBL622400,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,,Intermediate,,,,10166,,10116.0,50597,11020,
,N,A,CHEMBL628428,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10167,,10116.0,50597,11020,
,N,A,CHEMBL628590,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Rattus norvegicus,,,,Intermediate,,,,10168,,10116.0,50597,11020,
,N,A,CHEMBL628591,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10169,,10116.0,50597,11020,
,N,A,CHEMBL628592,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10170,,10116.0,50597,11020,
,N,A,CHEMBL628593,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10171,,10116.0,50597,11020,
,N,A,CHEMBL875333,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10172,,10116.0,50597,11020,
,N,A,CHEMBL628594,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10173,,10116.0,50597,11020,
,N,A,CHEMBL628595,1,1,Plasma,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Rattus norvegicus,,,,Intermediate,,,,10174,1969.0,10116.0,50597,4969,
,N,A,CHEMBL628596,1,1,Plasma,BAO_0000218,Stability in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,,10175,1969.0,10116.0,50597,6737,
,N,A,CHEMBL628597,1,1,Plasma,BAO_0000218,Stability in rat plasma was determined; ND= no data,Rattus norvegicus,,,,Intermediate,,,,10176,1969.0,10116.0,50597,6737,
,N,A,CHEMBL628598,1,1,Plasma,BAO_0000218,Tested for plasma half life period in rat (0-8 hr),Rattus norvegicus,,,,Intermediate,,,,10177,1969.0,10116.0,50597,5089,
,N,A,CHEMBL628599,1,1,Plasma,BAO_0000218,Tested for plasma half life period in rat (0-8 hr); Not determined,Rattus norvegicus,,,,Intermediate,,,,10178,1969.0,10116.0,50597,5089,
,N,A,CHEMBL628600,1,1,,BAO_0000218,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10179,,10116.0,50597,1466,
,N,A,CHEMBL628601,1,1,,BAO_0000218,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10180,,10116.0,50597,1466,
,N,A,CHEMBL628602,1,1,,BAO_0000218,Tested for the half life in rat,Rattus norvegicus,,,,Intermediate,,,,10181,,10116.0,50597,4950,
,N,A,CHEMBL628603,1,1,,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Rattus norvegicus,,,,Intermediate,,,In vitro,10182,,10116.0,50597,2412,
,N,A,CHEMBL628604,1,1,,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Rattus norvegicus,,,,Intermediate,,,In vitro,10183,,10116.0,50597,2412,
,N,A,CHEMBL628605,1,1,,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Rattus norvegicus,,,,Intermediate,,,In vitro,10184,,10116.0,50597,2412,
,N,A,CHEMBL628606,1,1,,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Rattus norvegicus,,,,Intermediate,,,In vitro,10185,,10116.0,50597,2412,
,N,A,CHEMBL628607,1,1,,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Rattus norvegicus,,,,Intermediate,,,In vitro,10186,,10116.0,50597,2412,
,N,A,CHEMBL628608,1,1,,BAO_0000218,The biological half life the compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,,Intermediate,,,,10187,,10116.0,50597,15022,
,N,A,CHEMBL628609,1,1,,BAO_0000218,The biological half life the compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,,Intermediate,,,,10188,,10116.0,50597,15022,
,N,A,CHEMBL628610,1,1,Plasma,BAO_0000218,The compound was evaluated for plasma half life period in rat,Rattus norvegicus,,,,Intermediate,,,,10189,1969.0,10116.0,50597,406,
,N,A,CHEMBL873819,1,1,,BAO_0000218,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,10190,,10116.0,50597,15078,
,N,A,CHEMBL628611,1,1,,BAO_0000218,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,10191,,10116.0,50597,15078,
,N,A,CHEMBL628612,1,1,,BAO_0000218,The pharmacokinetic parameter half-life period in vivo in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10192,,10116.0,50597,5247,
,N,A,CHEMBL628613,1,1,,BAO_0000218,"The pharmacokinetic property, Half-life was determined",Rattus norvegicus,,,,Intermediate,,,In vivo,10193,,10116.0,50597,5041,
,N,A,CHEMBL628614,1,1,,BAO_0000218,"The pharmacokinetic property, Half-life in rat in vivo",Rattus norvegicus,,,,Intermediate,,,In vivo,10194,,10116.0,50597,5041,
,N,A,CHEMBL628615,1,1,,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Rattus norvegicus,,,,Intermediate,,,In vivo,10195,,10116.0,50597,5041,
,N,A,CHEMBL628616,1,1,,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Rattus norvegicus,,,,Intermediate,,,In vivo,10196,,10116.0,50597,5041,
,N,A,CHEMBL627924,1,1,Plasma,BAO_0000218,The plasma half life period in rats,Rattus norvegicus,,,,Intermediate,,,,10197,1969.0,10116.0,50597,3918,
,N,A,CHEMBL627925,1,1,Liver,BAO_0000218,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Rattus norvegicus,,,,Intermediate,,,,10198,2107.0,10116.0,50597,2906,
,N,A,CHEMBL627926,1,1,,BAO_0000218,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10199,,10116.0,50597,6467,
,N,A,CHEMBL627927,1,1,,BAO_0000218,t1/2 (apparent elimination)of the compound was determined,Rattus norvegicus,,,,Intermediate,,,,10200,,10116.0,50597,5510,
,N,A,CHEMBL627928,1,1,,BAO_0000218,t1/2 value in rat,Rattus norvegicus,,,,Intermediate,,,,10201,,10116.0,50597,3788,
,N,A,CHEMBL627539,1,1,,BAO_0000218,Half life in rat,Rattus norvegicus,,,,Intermediate,,,,10202,,10116.0,50597,17796,
,N,A,CHEMBL876790,1,1,Plasma,BAO_0000218,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,,,,Intermediate,,,In vivo,10203,1969.0,10116.0,50597,12873,
,N,A,CHEMBL858186,1,1,,BAO_0000218,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,,,,Intermediate,,,In vivo,10204,,10116.0,50597,5983,
,N,A,CHEMBL627540,1,1,,BAO_0000218,Half-life period in fasted rats,Rattus norvegicus,,,,Intermediate,,,,10205,,10116.0,50597,15765,
,N,A,CHEMBL627541,1,1,,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10206,,10116.0,50597,2661,
,N,A,CHEMBL627715,1,1,,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10207,,10116.0,50597,2661,
,N,A,CHEMBL627716,1,1,,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10208,,10116.0,50597,429,
,N,A,CHEMBL627717,1,1,,BAO_0000218,Maximum time required to achieve Cmax was determined in rat,Rattus norvegicus,,,,Intermediate,,,,10209,,10116.0,50597,17655,
,N,A,CHEMBL627718,1,1,,BAO_0000218,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10210,,10116.0,50597,17717,
,N,A,CHEMBL627719,1,1,,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10211,,10116.0,50597,17717,
,N,A,CHEMBL627720,1,1,,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,,,Intermediate,,,In vivo,10212,,10116.0,50597,17717,
,N,A,CHEMBL627721,1,1,,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10213,,10116.0,50597,6570,
,N,A,CHEMBL627722,1,1,,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Rattus norvegicus,,,,Intermediate,,,In vivo,10214,,10116.0,50597,6570,
,N,A,CHEMBL627723,1,1,,BAO_0000218,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10215,,10116.0,50597,5978,
,N,A,CHEMBL626058,1,1,,BAO_0000218,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10216,,10116.0,50597,5978,
,N,A,CHEMBL626059,1,1,,BAO_0000218,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10217,,10116.0,50597,5978,
,N,A,CHEMBL626060,1,1,,BAO_0000218,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10218,,10116.0,50597,5978,
,N,A,CHEMBL626061,1,1,Plasma,BAO_0000218,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10219,1969.0,10116.0,50597,17720,
,N,A,CHEMBL876791,1,1,,BAO_0000218,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10220,,10116.0,50597,4723,
,N,A,CHEMBL626062,1,1,,BAO_0000218,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10221,,10116.0,50597,4723,
,N,A,CHEMBL626063,1,1,,BAO_0000218,Tmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10222,,10116.0,50597,4756,
,N,A,CHEMBL626064,1,1,,BAO_0000218,Tmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10223,,10116.0,50597,4756,
,N,A,CHEMBL626065,1,1,Plasma,BAO_0000218,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10224,1969.0,10116.0,50597,17720,
,N,A,CHEMBL626066,1,1,Plasma,BAO_0000218,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10225,1969.0,10116.0,50597,17720,
,N,A,CHEMBL626067,1,1,,BAO_0000218,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10226,,10116.0,50597,1466,
,N,F,CHEMBL626068,1,1,,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Rattus norvegicus,,,,Intermediate,,,,10227,,10116.0,50597,7449,
,N,F,CHEMBL626069,1,1,,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Rattus norvegicus,,,,Intermediate,,,,10228,,10116.0,50597,7449,
,N,F,CHEMBL626070,1,1,,BAO_0000218,Percent total excretion of 3-methoxyacetaminophen glucuronide,Rattus norvegicus,,,,Intermediate,,,,10229,,10116.0,50597,7449,
,N,F,CHEMBL626071,1,1,,BAO_0000218,Percent total excretion of N-methoxyacetaminophen glucuronide,Rattus norvegicus,,,,Intermediate,,,,10230,,10116.0,50597,7449,
,N,F,CHEMBL626072,1,1,,BAO_0000218,Percent total excretion of N-methoxyacetaminophen sulfate,Rattus norvegicus,,,,Intermediate,,,,10231,,10116.0,50597,7449,
,N,F,CHEMBL626073,1,1,,BAO_0000218,Percent total excretion of acetaminophen,Rattus norvegicus,,,,Intermediate,,,,10232,,10116.0,50597,7449,
,N,A,CHEMBL626741,1,1,Thyroid gland,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Rattus norvegicus,,,,Intermediate,,,,10233,2046.0,10116.0,50597,7768,
,N,A,CHEMBL626742,1,1,,BAO_0000218,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Rattus norvegicus,,,,Intermediate,,,,10234,,10116.0,50597,17655,
,N,A,CHEMBL626743,1,1,,BAO_0000218,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Rattus norvegicus,,,,Intermediate,,,,10235,,10116.0,50597,17735,
,N,A,CHEMBL876792,1,1,,BAO_0000218,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Rattus norvegicus,,,,Intermediate,,,,10236,,10116.0,50597,5960,
,N,A,CHEMBL626744,1,1,,BAO_0000218,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,,Intermediate,,,,10237,,10116.0,50597,17735,
,N,A,CHEMBL626745,1,1,,BAO_0000218,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,,,,Intermediate,,,,10238,,10116.0,50597,7116,
,N,A,CHEMBL626746,1,1,Plasma,BAO_0000218,AUC in rat after 3mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10239,1969.0,10116.0,50597,4878,
,N,A,CHEMBL626747,1,1,,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,10240,,10116.0,50597,5939,
,N,A,CHEMBL626748,1,1,,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,10241,,10116.0,50597,5939,
,N,A,CHEMBL626749,1,1,,BAO_0000218,Bioavailability administered orally at a dose of 10 mg/kg to rats,Rattus norvegicus,,,,Intermediate,,,,10242,,10116.0,50597,16367,
,N,A,CHEMBL626750,1,1,,BAO_0000218,Oral Bioavailability was determined,Rattus norvegicus,,,,Intermediate,,,,10243,,10116.0,50597,16366,
,N,A,CHEMBL626751,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,,10244,,10116.0,50597,4426,
,N,A,CHEMBL626913,1,1,,BAO_0000218,Oral bioavailability in rat; Not performed.,Rattus norvegicus,,,,Intermediate,,,,10245,,10116.0,50597,4426,
,N,A,CHEMBL626914,1,1,,BAO_0000218,Bioavailability,Rattus norvegicus,,,,Intermediate,,,,10246,,10116.0,50597,5041,
,N,A,CHEMBL626915,1,1,,BAO_0000218,Bioavailability was determined; ND denotes no data,Rattus norvegicus,,,,Intermediate,,,,10247,,10116.0,50597,5041,
,N,A,CHEMBL626916,1,1,,BAO_0000218,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,10248,,10116.0,50597,1500,
,N,A,CHEMBL626917,1,1,,BAO_0000218,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,10249,,10116.0,50597,1500,
,N,A,CHEMBL626918,1,1,,BAO_0000218,Binding towards rat plasma protein at 10 uM,Rattus norvegicus,,,,Intermediate,,,,10250,,10116.0,50597,17409,
,N,A,CHEMBL626919,1,1,,BAO_0000218,Binding towards rat plasma protein at 100 uM,Rattus norvegicus,,,,Intermediate,,,,10251,,10116.0,50597,17409,
,N,A,CHEMBL626920,1,1,,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10252,,10116.0,50597,2959,
,N,A,CHEMBL621976,1,1,,BAO_0000218,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10253,,10116.0,50597,13501,
,N,A,CHEMBL877599,1,1,,BAO_0000218,Bioavailability in rat after 5 mg/kg oral gavage,Rattus norvegicus,,,,Intermediate,,,In vivo,10254,,10116.0,50597,6567,
,N,A,CHEMBL621977,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10255,,10116.0,50597,6571,
,N,A,CHEMBL621978,1,1,,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10256,,10116.0,50597,6715,
,N,A,CHEMBL621979,1,1,,BAO_0000218,Bioavailability in rat (dose 3 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10257,,10116.0,50597,6715,
,N,A,CHEMBL621980,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10258,,10116.0,50597,2932,
,N,A,CHEMBL621981,1,1,,BAO_0000218,Bioavailability of the compound in rats after administration of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10259,,10116.0,50597,4171,
,N,A,CHEMBL621982,1,1,,BAO_0000218,Bioavailability after administration of 10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10260,,10116.0,50597,17509,
,N,A,CHEMBL882953,1,1,,BAO_0000218,Bioavailability after administration of 2 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10261,,10116.0,50597,17509,
,N,A,CHEMBL621983,1,1,,BAO_0000218,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10262,,10116.0,50597,4527,
,N,A,CHEMBL621984,1,1,,BAO_0000218,Bioavailability in dogs was determined; high,Rattus norvegicus,,,,Intermediate,,,In vivo,10263,,10116.0,50597,4026,
,N,A,CHEMBL621985,1,1,,BAO_0000218,Bioavailability in monkey after intravenous administration at 1 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10264,,10116.0,50597,6659,
,N,A,CHEMBL621986,1,1,,BAO_0000218,Bioavailability in monkey after peroral administration at 10 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10265,,10116.0,50597,6659,
,N,A,CHEMBL621987,1,1,,BAO_0000218,Bioavailability in rat after intravenous administration at 1 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10266,,10116.0,50597,6659,
,N,F,CHEMBL877600,1,1,,BAO_0000218,Bioavailability in rat after intravenous administration at 2 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10267,,10116.0,50597,6659,
,N,A,CHEMBL621988,1,1,,BAO_0000218,Bioavailability in rat after peroral administration at 30 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10268,,10116.0,50597,6659,
,N,F,CHEMBL621989,1,1,,BAO_0000218,Bioavailability in rat after peroral administration at at 100 mpk,Rattus norvegicus,,,,Intermediate,,,In vivo,10269,,10116.0,50597,6659,
,N,A,CHEMBL621990,1,1,,BAO_0000218,Bioavailability in rats was evaluated,Rattus norvegicus,,,,Intermediate,,,In vivo,10270,,10116.0,50597,6597,
,N,A,CHEMBL621991,1,1,,BAO_0000218,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,10271,,10116.0,50597,1202,
,N,A,CHEMBL621992,1,1,,BAO_0000218,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,10272,,10116.0,50597,1202,
,N,A,CHEMBL621993,1,1,,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,10273,,10116.0,50597,1202,
,N,A,CHEMBL621994,1,1,,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Rattus norvegicus,,,,Intermediate,,,In vivo,10274,,10116.0,50597,1202,
,N,A,CHEMBL621995,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10275,,10116.0,50597,5207,
,N,A,CHEMBL621996,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10276,,10116.0,50597,5970,
,N,A,CHEMBL621997,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10277,,10116.0,50597,17538,
,N,A,CHEMBL621998,1,1,,BAO_0000218,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10278,,10116.0,50597,17538,
,N,A,CHEMBL621999,1,1,,BAO_0000218,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10279,,10116.0,50597,1466,
,N,A,CHEMBL622000,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10280,,10116.0,50597,2879,
,N,A,CHEMBL622001,1,1,,BAO_0000218,Bioavailability was measured in rat after oral administration; 2-4,Rattus norvegicus,,,,Intermediate,,,In vivo,10281,,10116.0,50597,2879,
,N,A,CHEMBL622002,1,1,,BAO_0000218,Bioavailability was measured in rat after oral administration; 3-7,Rattus norvegicus,,,,Intermediate,,,In vivo,10282,,10116.0,50597,2879,
,N,A,CHEMBL622003,1,1,,BAO_0000218,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,,,,Intermediate,,,In vivo,10283,,10116.0,50597,3777,
,N,A,CHEMBL877601,1,1,,BAO_0000218,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,,,,Intermediate,,,In vivo,10284,,10116.0,50597,3777,
,N,A,CHEMBL624871,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10285,,10116.0,50597,3777,
,N,A,CHEMBL622004,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10286,,10116.0,50597,3777,
,N,A,CHEMBL882954,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10287,,10116.0,50597,5423,
,N,A,CHEMBL622005,1,1,,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Rattus norvegicus,,,,Intermediate,,,In vivo,10288,,10116.0,50597,16365,
,N,A,CHEMBL622006,1,1,,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10289,,10116.0,50597,16365,
,N,A,CHEMBL622007,1,1,,BAO_0000218,Bioavailability was measured in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10290,,10116.0,50597,4239,
,N,A,CHEMBL622008,1,1,,BAO_0000218,Bioavailability was reported,Rattus norvegicus,,,,Intermediate,,,In vivo,10291,,10116.0,50597,5438,
,N,A,CHEMBL622009,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10292,,10116.0,50597,5334,
,N,A,CHEMBL622010,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10293,,10116.0,50597,5334,
,N,A,CHEMBL622011,1,1,,BAO_0000218,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10294,,10116.0,50597,4199,
,N,A,CHEMBL622012,1,1,,BAO_0000218,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10295,,10116.0,50597,4199,
,N,A,CHEMBL622013,1,1,,BAO_0000218,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Rattus norvegicus,,,,Intermediate,,,In vivo,10296,,10116.0,50597,4199,
,N,A,CHEMBL622014,1,1,,BAO_0000218,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10297,,10116.0,50597,4890,
,N,A,CHEMBL624749,1,1,,BAO_0000218,Bioavailability was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10298,,10116.0,50597,2792,
,N,A,CHEMBL624750,1,1,,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10299,,10116.0,50597,5529,
,N,A,CHEMBL624751,1,1,,BAO_0000218,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,10300,,10116.0,50597,6685,
,N,A,CHEMBL624752,1,1,,BAO_0000218,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,10301,,10116.0,50597,6685,
,N,A,CHEMBL624753,1,1,,BAO_0000218,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,,,Intermediate,,,In vivo,10302,,10116.0,50597,6685,
,N,A,CHEMBL624754,1,1,,BAO_0000218,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10303,,10116.0,50597,6005,
,N,A,CHEMBL624755,1,1,,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,,,Intermediate,,,In vivo,10304,,10116.0,50597,6410,
,N,A,CHEMBL624756,1,1,,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10305,,10116.0,50597,6410,
,N,A,CHEMBL624757,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10306,,10116.0,50597,6103,
,N,A,CHEMBL624758,1,1,,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,,,Intermediate,,,In vivo,10307,,10116.0,50597,6410,
,N,A,CHEMBL622270,1,1,,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10308,,10116.0,50597,6410,
,N,A,CHEMBL622271,1,1,,BAO_0000218,Bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,,Intermediate,,,In vivo,10309,,10116.0,50597,5353,
,N,A,CHEMBL622272,1,1,,BAO_0000218,Bioavailability in rat at the dose of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10310,,10116.0,50597,4727,
,N,A,CHEMBL622273,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10311,,10116.0,50597,17804,
,N,A,CHEMBL622274,1,1,,BAO_0000218,Bioavailability in rat (cannulated) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10312,,10116.0,50597,5809,
,N,A,CHEMBL622275,1,1,,BAO_0000218,Bioavailability value of compound in rats was determined after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10313,,10116.0,50597,17804,
,N,A,CHEMBL622276,1,1,,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10314,,10116.0,50597,3634,
,N,A,CHEMBL622277,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10315,,10116.0,50597,3341,
,N,A,CHEMBL622278,1,1,,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10316,,10116.0,50597,2690,
,N,A,CHEMBL622279,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10317,,10116.0,50597,3184,
,N,A,CHEMBL622280,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10318,,10116.0,50597,740,
,N,A,CHEMBL624083,1,1,,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 15-27 %,Rattus norvegicus,,,,Intermediate,,,In vivo,10319,,10116.0,50597,1806,
,N,A,CHEMBL624084,1,1,,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Rattus norvegicus,,,,Intermediate,,,In vivo,10320,,10116.0,50597,4891,
,N,A,CHEMBL624085,1,1,,BAO_0000218,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Rattus norvegicus,,,,Intermediate,,,In vivo,10321,,10116.0,50597,3634,
,N,A,CHEMBL624086,1,1,,BAO_0000218,Compound was tested for bioavailability in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10322,,10116.0,50597,64,
,N,A,CHEMBL624087,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10323,,10116.0,50597,4839,
,N,A,CHEMBL624088,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10324,,10116.0,50597,1094,
,U,A,CHEMBL624089,1,0,,BAO_0000218,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Macaca mulatta,,,,Intermediate,,,In vivo,10325,,9544.0,22224,5005,
,U,A,CHEMBL624090,1,0,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10326,,10116.0,22224,5005,
,N,A,CHEMBL624091,1,1,,BAO_0000218,Evaluated for the bioavailability in rat (in vivo),Rattus norvegicus,,,,Intermediate,,,In vivo,10327,,10116.0,50597,4687,
,N,A,CHEMBL624092,1,1,,BAO_0000218,F value of compound in rats was determined after peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10328,,10116.0,50597,17804,
,N,A,CHEMBL624093,1,1,,BAO_0000218,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10329,,10116.0,50597,5974,
,N,A,CHEMBL624094,1,1,,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10330,,10116.0,50597,5974,
,N,A,CHEMBL624095,1,1,,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10331,,10116.0,50597,5974,
,N,A,CHEMBL624096,1,1,,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10332,,10116.0,50597,5974,
,N,A,CHEMBL624097,1,1,,BAO_0000218,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Rattus norvegicus,,,,Intermediate,,,In vivo,10333,,10116.0,50597,1088,
,N,A,CHEMBL624098,1,1,,BAO_0000218,Maximum fall in carotid flow in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10334,,10116.0,50597,1742,
,N,A,CHEMBL874392,1,1,,BAO_0000218,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10335,,10116.0,50597,4689,
,N,A,CHEMBL624099,1,1,,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10336,,10116.0,50597,2463,
,N,A,CHEMBL624100,1,1,,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10337,,10116.0,50597,5654,
,N,A,CHEMBL624101,1,1,,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10338,,10116.0,50597,5654,
,N,A,CHEMBL624102,1,1,,BAO_0000218,Oral bioavailability in rat (male Wistar),Rattus norvegicus,,,,Intermediate,,,In vivo,10339,,10116.0,50597,6874,
,N,A,CHEMBL624103,1,1,,BAO_0000218,Oral bioavailability after administration (30 mg/kg) in rat; good,Rattus norvegicus,,,,Intermediate,,,In vivo,10340,,10116.0,50597,5633,
,N,A,CHEMBL624104,1,1,,BAO_0000218,Oral bioavailability at the dose of 2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10341,,10116.0,50597,5496,
,N,A,CHEMBL624105,1,1,,BAO_0000218,Oral bioavailability determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10342,,10116.0,50597,2358,
,N,A,CHEMBL624106,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10343,,10116.0,50597,16456,
,N,A,CHEMBL624107,1,1,,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10344,,10116.0,50597,5302,
,N,A,CHEMBL623943,1,1,,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10345,,10116.0,50597,5302,
,N,A,CHEMBL623944,1,1,,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10346,,10116.0,50597,5302,
,N,A,CHEMBL623945,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10347,,10116.0,50597,11020,
,N,A,CHEMBL623946,1,1,,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,,,,Intermediate,,,,10348,,10116.0,50597,11020,
,N,A,CHEMBL623947,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10349,,10116.0,50597,11020,
,N,A,CHEMBL623948,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Rattus norvegicus,,,,Intermediate,,,,10350,,10116.0,50597,11020,
,N,A,CHEMBL623949,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Rattus norvegicus,,,,Intermediate,,,,10351,,10116.0,50597,11020,
,N,A,CHEMBL623950,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Rattus norvegicus,,,,Intermediate,,,,10352,,10116.0,50597,11020,
,N,A,CHEMBL874398,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Rattus norvegicus,,,,Intermediate,,,,10353,,10116.0,50597,11020,
,N,A,CHEMBL623951,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Rattus norvegicus,,,,Intermediate,,,,10354,,10116.0,50597,11020,
,N,A,CHEMBL623952,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10355,,10116.0,50597,11020,
,N,A,CHEMBL623953,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Rattus norvegicus,,,,Intermediate,,,,10356,,10116.0,50597,11020,
,N,A,CHEMBL623954,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10357,,10116.0,50597,11020,
,N,A,CHEMBL623955,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10358,,10116.0,50597,11020,
,N,A,CHEMBL623956,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10359,,10116.0,50597,11020,
,N,A,CHEMBL627807,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10360,,10116.0,50597,11020,
,N,A,CHEMBL627808,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10361,,10116.0,50597,11020,
,N,A,CHEMBL627809,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,,Intermediate,,,,10362,,10116.0,50597,11020,
,N,A,CHEMBL627810,1,1,,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Rattus norvegicus,,,,Intermediate,,,,10363,,10116.0,50597,11020,
,N,A,CHEMBL627811,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Rattus norvegicus,,,,Intermediate,,,,10364,,10116.0,50597,11020,
,N,A,CHEMBL627812,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Rattus norvegicus,,,,Intermediate,,,,10365,,10116.0,50597,11020,
,N,A,CHEMBL627813,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Rattus norvegicus,,,,Intermediate,,,,10366,,10116.0,50597,11020,
,N,A,CHEMBL627814,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Rattus norvegicus,,,,Intermediate,,,,10367,,10116.0,50597,11020,
,N,A,CHEMBL875336,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Rattus norvegicus,,,,Intermediate,,,,10368,,10116.0,50597,11020,
,N,A,CHEMBL627815,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Rattus norvegicus,,,,Intermediate,,,,10369,,10116.0,50597,11020,
,N,A,CHEMBL627816,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Rattus norvegicus,,,,Intermediate,,,,10370,,10116.0,50597,11020,
,N,A,CHEMBL627817,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Rattus norvegicus,,,,Intermediate,,,,10371,,10116.0,50597,11020,
,N,A,CHEMBL627818,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Rattus norvegicus,,,,Intermediate,,,,10372,,10116.0,50597,11020,
,N,A,CHEMBL627819,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Rattus norvegicus,,,,Intermediate,,,,10373,,10116.0,50597,11020,
,N,A,CHEMBL627820,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Rattus norvegicus,,,,Intermediate,,,,10374,,10116.0,50597,11020,
,N,A,CHEMBL627821,1,1,,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Rattus norvegicus,,,,Intermediate,,,,10375,,10116.0,50597,11020,
,N,A,CHEMBL628464,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10376,,10116.0,50597,11020,
,N,A,CHEMBL626239,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,,Intermediate,,,,10377,,10116.0,50597,11020,
,N,A,CHEMBL626240,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,,Intermediate,,,,10378,,10116.0,50597,11020,
,N,A,CHEMBL626241,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,,Intermediate,,,,10379,,10116.0,50597,11020,
,N,A,CHEMBL626242,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,,,,Intermediate,,,,10380,,10116.0,50597,11020,
,N,A,CHEMBL626243,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,,,,Intermediate,,,,10381,,10116.0,50597,11020,
,N,A,CHEMBL626244,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,,Intermediate,,,,10382,,10116.0,50597,11020,
,N,A,CHEMBL626907,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10383,,10116.0,50597,11020,
,N,A,CHEMBL626908,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10384,,10116.0,50597,11020,
,N,A,CHEMBL626909,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10385,,10116.0,50597,11020,
,N,A,CHEMBL626910,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,,Intermediate,,,,10386,,10116.0,50597,11020,
,N,F,CHEMBL875342,1,1,,BAO_0000218,Percent total excretion of acetaminophen cysteine conjugate,Rattus norvegicus,,,,Intermediate,,,,10387,,10116.0,50597,7449,
,N,F,CHEMBL626911,1,1,,BAO_0000218,Percent total excretion of acetaminophen glucuronide,Rattus norvegicus,,,,Intermediate,,,,10388,,10116.0,50597,7449,
,N,F,CHEMBL626912,1,1,,BAO_0000218,Percent total excretion of acetaminophen sulfate,Rattus norvegicus,,,,Intermediate,,,,10389,,10116.0,50597,7449,
,N,F,CHEMBL627065,1,1,,BAO_0000218,Percent total excretion of acetaminophen-mercapturic acid,Rattus norvegicus,,,,Intermediate,,,,10390,,10116.0,50597,7449,
,N,A,CHEMBL627066,1,1,Urine,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Rattus norvegicus,,,,Intermediate,,,,10391,1088.0,10116.0,50597,3172,
,N,A,CHEMBL627067,1,1,,BAO_0000218,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10392,,10116.0,50597,16456,
,U,A,CHEMBL627068,1,0,Muscle tissue,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,ratrat,,,,Autocuration,,,In vivo,10393,2385.0,8656.0,22224,10839,
,U,A,CHEMBL627069,1,0,Muscle tissue,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,ratrat,,,,Autocuration,,,In vivo,10394,2385.0,8656.0,22224,10839,
,U,A,CHEMBL627070,1,0,,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10395,,9940.0,22224,5334,
,U,A,CHEMBL627071,1,0,,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10396,,9940.0,22224,5334,
,U,A,CHEMBL627072,1,0,,BAO_0000218,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10397,,9940.0,22224,5334,
,U,A,CHEMBL627073,1,0,,BAO_0000218,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10398,,9940.0,22224,5334,
,U,A,CHEMBL625387,1,0,,BAO_0000218,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10399,,9940.0,22224,5334,
,U,A,CHEMBL625388,1,0,,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10400,,9940.0,22224,5334,
,U,A,CHEMBL625389,1,0,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10401,1969.0,9940.0,22224,5334,
,U,A,CHEMBL875343,1,0,Plasma,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,,Autocuration,,,In vivo,10402,1969.0,9940.0,22224,5334,
,N,A,CHEMBL876795,1,1,,BAO_0000218,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Serpentes,,,,Intermediate,,,,10403,,8570.0,50497,1735,
,N,A,CHEMBL626552,1,1,,BAO_0000218,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Serpentes,,,,Intermediate,,,,10404,,8570.0,50497,1469,
,N,A,CHEMBL626553,1,1,,BAO_0000218,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Serpentes,,,,Intermediate,,,,10405,,8570.0,50497,1336,
,U,A,CHEMBL626554,1,0,Plasma,BAO_0000366,The human biological plasma half life of the compound,Homo sapiens,,,,Autocuration,,,,10406,1969.0,9606.0,22224,12403,
,N,A,CHEMBL626555,1,1,Urine,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,10407,1088.0,10116.0,50597,8151,
,N,A,CHEMBL626556,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,,,,Intermediate,,,,10408,,10116.0,50597,8004,
,N,A,CHEMBL626557,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10409,,10116.0,50597,8004,
,N,A,CHEMBL626558,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,,,,Intermediate,,,,10410,,10116.0,50597,8004,
,N,A,CHEMBL626559,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10411,,10116.0,50597,8004,
,N,A,CHEMBL626560,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10412,,10116.0,50597,8004,
,N,A,CHEMBL876803,1,1,,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10413,,10116.0,50597,8004,
,N,A,CHEMBL627964,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,,,,Intermediate,,,,10414,,10116.0,50597,8004,
,N,A,CHEMBL627965,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10415,,10116.0,50597,8004,
,N,A,CHEMBL627966,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,,,,Intermediate,,,,10416,,10116.0,50597,8004,
,N,A,CHEMBL627967,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10417,,10116.0,50597,8004,
,N,A,CHEMBL627968,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10418,,10116.0,50597,8004,
,N,A,CHEMBL627969,1,1,,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10419,,10116.0,50597,8004,
,N,A,CHEMBL627970,1,1,,BAO_0000218,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10420,,10116.0,50597,8004,
,N,A,CHEMBL627971,1,1,Blood,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10421,178.0,10116.0,50597,8004,
,N,A,CHEMBL627972,1,1,Blood,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Rattus norvegicus,,,,Intermediate,,,,10422,178.0,10116.0,50597,8004,
,D,B,CHEMBL856029,1,9,,BAO_0000357,Dissociation constant against binding to human cyclophilin A,Homo sapiens,,,,Expert,,,,10423,,9606.0,180,15917,
,H,B,CHEMBL627973,1,8,,BAO_0000019,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Bos taurus,,,,Expert,,,,10424,,9913.0,11591,12396,
,U,A,CHEMBL627974,1,0,,BAO_0000019,-Log C was determined by performing the electroshock minimum test,,,,,Autocuration,,,,10425,,,22224,7065,
,U,A,CHEMBL627975,1,0,,BAO_0000019,-Log C was determined by performing the foot shock test,,,,,Autocuration,,,,10426,,,22224,7065,
,U,A,CHEMBL627976,1,0,,BAO_0000019,-Log C was determined by performing the incl screen test,,,,,Autocuration,,,,10427,,,22224,7065,
,U,A,CHEMBL627977,1,0,,BAO_0000019,-Log C was determined by performing the maximum electroshock test,,,,,Autocuration,,,,10428,,,22224,7065,
,U,A,CHEMBL627978,1,0,,BAO_0000019,-Log C was determined by performing the pentylenetetrazole test,,,,,Autocuration,,,,10429,,,22224,7065,
,U,A,CHEMBL627979,1,0,,BAO_0000019,Tested for experimental arotinoid inhibitory dose,,,,,Autocuration,,,,10430,,,22224,12415,
,U,A,CHEMBL876804,1,0,,BAO_0000019,Negative log transformed activity,,,,,Autocuration,,,,10431,,,22224,10256,
,U,A,CHEMBL627980,1,0,,BAO_0000019,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,,,Autocuration,,,,10432,,,22224,7991,
,N,A,CHEMBL627981,1,1,,BAO_0000218,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Cavia porcellus,,,,Intermediate,,,,10433,,10141.0,50512,14342,
,N,A,CHEMBL627982,1,1,,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Cavia porcellus,,,,Intermediate,,,,10434,,10141.0,50512,14342,
,N,A,CHEMBL627983,1,1,,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Cavia porcellus,,,,Intermediate,,,,10435,,10141.0,50512,14342,
,N,A,CHEMBL627984,1,1,Ileum,BAO_0000218,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Cavia porcellus,,,,Intermediate,,,,10436,2116.0,10141.0,50512,14342,
,U,P,CHEMBL627985,1,0,,BAO_0000100,Solubility in water was determined; values expressed as -log,,,,,Autocuration,,,,10437,,,22229,6047,
,U,A,CHEMBL627986,1,0,,BAO_0000019,Ratio of Kcat to that of Km was determined,,,,,Autocuration,,,,10438,,,22224,17269,
,U,A,CHEMBL627987,1,0,,BAO_0000019,Observed first order rate constant,,,,,Autocuration,,,,10439,,,22224,10026,
,U,A,CHEMBL627988,1,0,,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,,,Autocuration,,,,10440,,,22224,14583,
,N,A,CHEMBL627989,1,1,,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10441,,10116.0,50597,2661,
,N,A,CHEMBL627990,1,1,,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10442,,10116.0,50597,2661,
,N,A,CHEMBL876805,1,1,,BAO_0000218,Oral Bioavailability after administration of 10 mg/kg in male rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10443,,10116.0,50597,4029,
,N,A,CHEMBL627991,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10444,,10116.0,50597,17735,
,N,A,CHEMBL627992,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10445,,10116.0,50597,4576,
,N,A,CHEMBL627993,1,1,,BAO_0000218,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10446,,10116.0,50597,17582,
,N,A,CHEMBL622817,1,1,,BAO_0000218,Oral bioavailability at 1 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10447,,10116.0,50597,17651,
,N,A,CHEMBL622818,1,1,,BAO_0000218,Oral bioavailability at 10 mg/kg was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10448,,10116.0,50597,17651,
,N,A,CHEMBL622819,1,1,,BAO_0000218,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Rattus norvegicus,,,,Intermediate,,,In vivo,10449,,10116.0,50597,17670,
,N,A,CHEMBL872267,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10450,,10116.0,50597,5045,
,N,A,CHEMBL622820,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10451,,10116.0,50597,1696,
,N,A,CHEMBL622821,1,1,,BAO_0000218,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10452,,10116.0,50597,17764,
,N,A,CHEMBL622822,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10453,,10116.0,50597,6448,
,N,A,CHEMBL622823,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10454,,10116.0,50597,6596,
,N,A,CHEMBL622824,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10455,,10116.0,50597,17547,
,N,A,CHEMBL622825,1,1,,BAO_0000218,Oral bioavailability in rat at a dose of 3 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10456,,10116.0,50597,17771,
,N,A,CHEMBL622901,1,1,,BAO_0000218,Oral bioavailability in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10457,,10116.0,50597,6495,
,N,A,CHEMBL622902,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10458,,10116.0,50597,4558,
,N,A,CHEMBL621844,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10459,,10116.0,50597,17596,
,N,A,CHEMBL621845,1,1,,BAO_0000218,Oral bioavailability in Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10460,,10116.0,50597,6827,
,N,A,CHEMBL621846,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10461,,10116.0,50597,4026,
,N,A,CHEMBL621847,1,1,,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10462,,10116.0,50597,10,
,N,A,CHEMBL877609,1,1,,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10463,,10116.0,50597,17717,
,N,A,CHEMBL621848,1,1,,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10464,,10116.0,50597,17717,
,N,A,CHEMBL621849,1,1,,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10465,,10116.0,50597,17717,
,N,A,CHEMBL622030,1,1,,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10466,,10116.0,50597,17717,
,N,A,CHEMBL622031,1,1,,BAO_0000218,Percent oral bioavailability determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10467,,10116.0,50597,4796,
,N,A,CHEMBL622032,1,1,,BAO_0000218,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10468,,10116.0,50597,4883,
,N,A,CHEMBL622033,1,1,,BAO_0000218,The compound was evaluated for bioavailability in rats; 32-51,Rattus norvegicus,,,,Intermediate,,,In vivo,10469,,10116.0,50597,2137,
,N,A,CHEMBL622034,1,1,,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10470,,10116.0,50597,2959,
,N,A,CHEMBL622035,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10471,,10116.0,50597,1361,
,N,A,CHEMBL882966,1,1,,BAO_0000218,Bioavailability percent in rat at the dose of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10472,,10116.0,50597,4727,
,N,A,CHEMBL622036,1,1,,BAO_0000218,Bioavailability was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10473,,10116.0,50597,16423,
,N,A,CHEMBL622037,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10474,,10116.0,50597,5206,
,N,A,CHEMBL622038,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10475,,10116.0,50597,6448,
,N,A,CHEMBL622039,1,1,,BAO_0000218,Bioavailability in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10476,,10116.0,50597,17723,
,N,A,CHEMBL622040,1,1,Blood,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10477,178.0,10116.0,50597,17738,
,N,A,CHEMBL622041,1,1,Blood,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10478,178.0,10116.0,50597,17738,
,N,A,CHEMBL622042,1,1,Blood,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10479,178.0,10116.0,50597,17738,
,N,A,CHEMBL622043,1,1,Blood,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10480,178.0,10116.0,50597,17738,
,N,A,CHEMBL622044,1,1,Blood,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10481,178.0,10116.0,50597,17738,
,N,A,CHEMBL622045,1,1,Bone,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10482,10000001.0,10116.0,50597,17738,
,N,A,CHEMBL622046,1,1,Bone,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10483,10000001.0,10116.0,50597,17738,
,N,A,CHEMBL622047,1,1,Bone,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10484,10000001.0,10116.0,50597,17738,
,N,A,CHEMBL877610,1,1,Bone,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10485,10000001.0,10116.0,50597,17738,
,N,A,CHEMBL622048,1,1,Brain,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10486,955.0,10116.0,50597,17738,
,N,A,CHEMBL622049,1,1,Brain,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10487,955.0,10116.0,50597,17738,
,N,A,CHEMBL622050,1,1,Brain,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10488,955.0,10116.0,50597,17738,
,N,A,CHEMBL622051,1,1,Brain,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10489,955.0,10116.0,50597,17738,
,N,A,CHEMBL622052,1,1,,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10490,,10116.0,50597,17738,
,N,A,CHEMBL622053,1,1,,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10491,,10116.0,50597,17738,
,N,A,CHEMBL622054,1,1,,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10492,,10116.0,50597,17738,
,N,A,CHEMBL622055,1,1,,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10493,,10116.0,50597,17738,
,N,A,CHEMBL622056,1,1,,BAO_0000218,Oral bioavailability in rats was determined; High,Rattus norvegicus,,,,Intermediate,,,In vivo,10494,,10116.0,50597,5237,
,N,A,CHEMBL622057,1,1,,BAO_0000218,Oral bioavailability in the rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10495,,10116.0,50597,5503,
,N,A,CHEMBL628008,1,1,,BAO_0000218,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Rattus norvegicus,,,,Intermediate,,,In vivo,10496,,10116.0,50597,15765,
,N,A,CHEMBL622058,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10497,,10116.0,50597,15660,
,N,A,CHEMBL622059,1,1,,BAO_0000218,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10498,,10116.0,50597,5978,
,N,A,CHEMBL622060,1,1,,BAO_0000218,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10499,,10116.0,50597,5978,
,N,A,CHEMBL622061,1,1,,BAO_0000218,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10500,,10116.0,50597,5978,
,N,A,CHEMBL622062,1,1,,BAO_0000218,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10501,,10116.0,50597,5978,
,N,A,CHEMBL622063,1,1,,BAO_0000218,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10502,,10116.0,50597,5656,
,N,A,CHEMBL877611,1,1,,BAO_0000218,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,10503,,10116.0,50597,3598,
,N,A,CHEMBL622064,1,1,,BAO_0000218,Oral bioavailability of compound in Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10504,,10116.0,50597,4216,
,N,A,CHEMBL622065,1,1,,BAO_0000218,Oral bioavailability of compound in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10505,,10116.0,50597,17839,
,N,A,CHEMBL622066,1,1,,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10506,,10116.0,50597,6570,
,N,A,CHEMBL622067,1,1,,BAO_0000218,Oral bioavailability of compound in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10507,,10116.0,50597,5334,
,N,A,CHEMBL622068,1,1,,BAO_0000218,Oral bioavailability of compound in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10508,,10116.0,50597,6886,
,N,A,CHEMBL622069,1,1,,BAO_0000218,Oral bioavailability of compound was determined in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10509,,10116.0,50597,5210,
,N,A,CHEMBL624796,1,1,,BAO_0000218,Oral bioavailability at a dose of 30 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10510,,10116.0,50597,4170,
,N,A,CHEMBL624797,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10511,,10116.0,50597,6028,
,N,A,CHEMBL623053,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10512,,10116.0,50597,6028,
,N,A,CHEMBL623054,1,1,,BAO_0000218,Oral bioavailability evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10513,,10116.0,50597,6078,
,N,A,CHEMBL623055,1,1,,BAO_0000218,Oral bioavailability in fasted rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10514,,10116.0,50597,6168,
,N,A,CHEMBL623056,1,1,,BAO_0000218,Oral bioavailability in fed rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10515,,10116.0,50597,6168,
,N,A,CHEMBL623057,1,1,,BAO_0000218,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10516,,10116.0,50597,5160,
,N,A,CHEMBL623058,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10517,,10116.0,50597,6057,
,N,A,CHEMBL623059,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10518,,10116.0,50597,6535,
,N,A,CHEMBL623060,1,1,,BAO_0000218,Oral bioavailability in rat after administration of 10 mg/kg po,Rattus norvegicus,,,,Intermediate,,,In vivo,10519,,10116.0,50597,6535,
,N,A,CHEMBL623061,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10520,,10116.0,50597,4194,
,N,A,CHEMBL623062,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10521,,10116.0,50597,6230,
,N,A,CHEMBL623063,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10522,,10116.0,50597,6619,
,N,A,CHEMBL623064,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10523,,10116.0,50597,17607,
,N,A,CHEMBL623065,1,1,,BAO_0000218,Oral bioavailability in ratrs,Rattus norvegicus,,,,Intermediate,,,In vivo,10524,,10116.0,50597,4942,
,N,A,CHEMBL623066,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10525,,10116.0,50597,4942,
,N,A,CHEMBL623067,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10526,,10116.0,50597,6646,
,N,A,CHEMBL623068,1,1,,BAO_0000218,Oral bioavailability in rats was determined; High,Rattus norvegicus,,,,Intermediate,,,In vivo,10527,,10116.0,50597,5237,
,N,A,CHEMBL623069,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10528,,10116.0,50597,6646,
,N,A,CHEMBL623070,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10529,,10116.0,50597,4449,
,N,A,CHEMBL623071,1,1,,BAO_0000218,Oral bioavailability was calculated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10530,,10116.0,50597,6057,
,N,A,CHEMBL623072,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10531,,10116.0,50597,2552,
,N,A,CHEMBL623073,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10532,,10116.0,50597,5496,
,N,A,CHEMBL623074,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10533,,10116.0,50597,6484,
,N,A,CHEMBL623075,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10534,,10116.0,50597,6485,
,N,A,CHEMBL623076,1,1,,BAO_0000218,Oral bioavailability after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10535,,10116.0,50597,6616,
,N,A,CHEMBL623077,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10536,,10116.0,50597,4969,
,N,A,CHEMBL623078,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,,Intermediate,,,In vivo,10537,,10116.0,50597,5862,
,N,A,CHEMBL623079,1,1,,BAO_0000218,Oral bioavailability in Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10538,,10116.0,50597,4514,
,N,A,CHEMBL623080,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10539,,10116.0,50597,4514,
,N,A,CHEMBL623081,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10540,,10116.0,50597,4514,
,N,A,CHEMBL623082,1,1,,BAO_0000218,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10541,,10116.0,50597,5546,
,N,A,CHEMBL874400,1,1,,BAO_0000218,Oral bioavailability in fasted rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10542,,10116.0,50597,6168,
,N,A,CHEMBL623083,1,1,,BAO_0000218,Oral bioavailability in fed rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10543,,10116.0,50597,6168,
,N,A,CHEMBL623084,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10544,,10116.0,50597,3624,
,N,A,CHEMBL623085,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10545,,10116.0,50597,5213,
,N,A,CHEMBL623086,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10546,,10116.0,50597,5496,
,N,A,CHEMBL623087,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10547,,10116.0,50597,5553,
,N,A,CHEMBL623088,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10548,,10116.0,50597,5833,
,N,A,CHEMBL623089,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10549,,10116.0,50597,5836,
,N,A,CHEMBL623090,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10550,,10116.0,50597,5865,
,N,A,CHEMBL623091,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10551,,10116.0,50597,5960,
,N,A,CHEMBL623092,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10552,,10116.0,50597,6249,
,N,A,CHEMBL623093,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10553,,10116.0,50597,6448,
,N,A,CHEMBL874401,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10554,,10116.0,50597,6453,
,N,A,CHEMBL623094,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10555,,10116.0,50597,6640,
,N,A,CHEMBL623095,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10556,,10116.0,50597,17607,
,N,A,CHEMBL623096,1,1,,BAO_0000218,Oral bioavailability in rat after peroral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10557,,10116.0,50597,5939,
,N,A,CHEMBL624913,1,1,,BAO_0000218,Oral bioavailability in rat after peroral administration at 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10558,,10116.0,50597,5939,
,N,A,CHEMBL624914,1,1,,BAO_0000218,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10559,,10116.0,50597,6281,
,N,A,CHEMBL624915,1,1,,BAO_0000218,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10560,,10116.0,50597,5874,
,N,A,CHEMBL624916,1,1,,BAO_0000218,Oral bioavailability in rat; Not measured,Rattus norvegicus,,,,Intermediate,,,In vivo,10561,,10116.0,50597,5213,
,N,A,CHEMBL624917,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10562,,10116.0,50597,4964,
,N,A,CHEMBL625157,1,1,,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,,,,Intermediate,,,,10563,,10116.0,50597,11020,
,N,A,CHEMBL625158,1,1,Liver,BAO_0000218,In vitro metabolic potential in rat liver microsomes,Rattus norvegicus,,,,Intermediate,,,,10564,2107.0,10116.0,50597,6251,
,N,A,CHEMBL625159,1,1,,BAO_0000218,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Rattus norvegicus,,,,Intermediate,,,In vivo,10565,,10116.0,50597,1568,
,N,A,CHEMBL625160,1,1,,BAO_0000218,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,,,Intermediate,,,In vivo,10566,,10116.0,50597,3032,
,N,A,CHEMBL625161,1,1,,BAO_0000218,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10567,,10116.0,50597,3748,
,N,A,CHEMBL625162,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10568,,10116.0,50597,401,
,N,A,CHEMBL625163,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10569,,10116.0,50597,6512,
,N,A,CHEMBL625164,1,1,,BAO_0000218,Oral bioavailability in rats at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10570,,10116.0,50597,17617,
,N,A,CHEMBL625165,1,1,,BAO_0000218,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10571,,10116.0,50597,6679,
,N,A,CHEMBL625166,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10572,,10116.0,50597,6742,
,N,A,CHEMBL625167,1,1,,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Rattus norvegicus,,,,Intermediate,,,,10573,,10116.0,50597,589,
,N,A,CHEMBL625168,1,1,,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Rattus norvegicus,,,,Intermediate,,,,10574,,10116.0,50597,589,
,N,A,CHEMBL625169,1,1,,BAO_0000218,Plasma clearance of the compound,Rattus norvegicus,,,,Intermediate,,,In vivo,10575,,10116.0,50597,3185,
,N,A,CHEMBL626264,1,1,,BAO_0000218,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10576,,10116.0,50597,17596,
,N,A,CHEMBL626265,1,1,,BAO_0000218,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10577,,10116.0,50597,2713,
,N,A,CHEMBL626266,1,1,Plasma,BAO_0000218,The compound was tested for plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10578,1969.0,10116.0,50597,12500,
,N,A,CHEMBL626267,1,1,Plasma,BAO_0000218,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Rattus norvegicus,,,,Intermediate,,,In vivo,10579,1969.0,10116.0,50597,12500,
,N,A,CHEMBL626268,1,1,,BAO_0000218,Plasma concentration upon oral administration of 1 mg/Kg in rats,Rattus norvegicus,,,,Intermediate,,,,10580,,10116.0,50597,2713,
,N,A,CHEMBL626269,1,1,,BAO_0000218,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Rattus norvegicus,,,,Intermediate,,,,10581,,10116.0,50597,1446,
,N,A,CHEMBL626270,1,1,,BAO_0000218,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Rattus norvegicus,,,,Intermediate,,,,10582,,10116.0,50597,6227,
,N,A,CHEMBL626271,1,1,,BAO_0000218,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,10583,,10116.0,50597,4709,
,N,A,CHEMBL626272,1,1,,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Rattus norvegicus,,,,Intermediate,,,,10584,,10116.0,50597,5510,
,N,A,CHEMBL626273,1,1,,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,,,,Intermediate,,,,10585,,10116.0,50597,5510,
,N,A,CHEMBL875346,1,1,,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,,,,Intermediate,,,,10586,,10116.0,50597,5510,
,N,A,CHEMBL626274,1,1,,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Rattus norvegicus,,,,Intermediate,,,,10587,,10116.0,50597,5510,
,N,A,CHEMBL626275,1,1,,BAO_0000218,Compound was tested for protein binding in rat plasma,Rattus norvegicus,,,,Intermediate,,,,10588,,10116.0,50597,4514,
,N,A,CHEMBL624646,1,1,,BAO_0000218,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Rattus norvegicus,,,,Intermediate,,,,10589,,10116.0,50597,2713,
,N,A,CHEMBL624647,1,1,,BAO_0000218,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Rattus norvegicus,,,,Intermediate,,,,10590,,10116.0,50597,2713,
,N,A,CHEMBL624648,1,1,Liver,BAO_0000218,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Rattus norvegicus,,,,Intermediate,,,,10591,2107.0,10116.0,50597,5340,
,N,A,CHEMBL624649,1,1,,BAO_0000218,Area under curve ratio was determined (po/iv) in rat,Rattus norvegicus,,,,Intermediate,,,,10592,,10116.0,50597,12058,
,N,A,CHEMBL624650,1,1,,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,,10593,,10116.0,50597,11195,
,N,A,CHEMBL624651,1,1,,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,,10594,,10116.0,50597,11195,
,N,A,CHEMBL624652,1,1,,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,,10595,,10116.0,50597,11195,
,N,A,CHEMBL624653,1,1,,BAO_0000218,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,10596,,10116.0,50597,6495,
,N,A,CHEMBL624654,1,1,,BAO_0000218,Ratio of AUCbrain to AUCplasma,Rattus norvegicus,,,,Intermediate,,,,10597,,10116.0,50597,6078,
,N,A,CHEMBL624655,1,1,,BAO_0000218,Ratio of brain to plasma,Rattus norvegicus,,,,Intermediate,,,,10598,,10116.0,50597,5656,
,N,A,CHEMBL624656,1,1,,BAO_0000218,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Rattus norvegicus,,,,Intermediate,,,,10599,,10116.0,50597,4910,
,N,A,CHEMBL624657,1,1,,BAO_0000218,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,,,,Intermediate,,,,10600,,10116.0,50597,4910,
,N,A,CHEMBL624658,1,1,,BAO_0000218,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,,,,Intermediate,,,,10601,,10116.0,50597,4910,
,N,A,CHEMBL624659,1,1,,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,,Intermediate,,,,10602,,10116.0,50597,10130,
,N,A,CHEMBL624660,1,1,,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,,Intermediate,,,,10603,,10116.0,50597,10130,
,N,A,CHEMBL624661,1,1,,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,,Intermediate,,,,10604,,10116.0,50597,10130,
,N,A,CHEMBL624662,1,1,,BAO_0000218,Steady state brain :blood ratio was determined,Rattus norvegicus,,,,Intermediate,,,,10605,,10116.0,50597,5213,
,N,A,CHEMBL625199,1,1,,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,10606,,10116.0,50597,4910,
,N,A,CHEMBL625200,1,1,,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,,,,Intermediate,,,,10607,,10116.0,50597,4910,
,N,A,CHEMBL625201,1,1,,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,,Intermediate,,,,10608,,10116.0,50597,4910,
,N,A,CHEMBL625202,1,1,,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,,,,Intermediate,,,,10609,,10116.0,50597,4910,
,N,A,CHEMBL625203,1,1,,BAO_0000218,Percentage recovery after 3h incubation with rat hapatocytes was determined,Rattus norvegicus,,,,Intermediate,,,,10610,,10116.0,50597,2083,
,N,A,CHEMBL625204,1,1,,BAO_0000218,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,,,,Intermediate,,,,10611,,10116.0,50597,2082,
,N,A,CHEMBL625205,1,1,,BAO_0000218,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,,,,Intermediate,,,,10612,,10116.0,50597,2082,
,N,A,CHEMBL625206,1,1,,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,,10613,,10116.0,50597,6351,
,U,A,CHEMBL625207,1,0,,BAO_0000019,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,,,Autocuration,,,,10614,,,22224,14583,
,U,A,CHEMBL625208,1,0,,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,,,Autocuration,,,,10615,,,22224,14583,
,N,A,CHEMBL625209,1,1,,BAO_0000218,In vivo absorption in Caco-2 cell line monolayers was determined,Homo sapiens,,495.0,Caco-2,Intermediate,,,,10616,,9606.0,50587,4608,
,U,P,CHEMBL625210,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,10617,,,22229,13668,
,N,A,CHEMBL625211,1,1,,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,,10618,,10116.0,50597,5669,
,N,A,CHEMBL625212,1,1,,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,,Intermediate,,,,10619,,9544.0,50797,5669,
,N,A,CHEMBL625213,1,1,,BAO_0000218,Area under curve was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,,10620,,10116.0,50597,5669,
,N,A,CHEMBL625214,1,1,,BAO_0000218,Area under curve was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,,10621,,10116.0,50597,5669,
,N,A,CHEMBL874542,1,1,,BAO_0000218,Area under curve was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,,10622,,10116.0,50597,5669,
,U,P,CHEMBL625215,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (AlogP),,,,,Autocuration,,,,10623,,,22229,6472,
,U,A,CHEMBL625216,1,0,,BAO_0000019,Activated partial thromboplastin time measured,,,,,Autocuration,,,,10624,,,22224,15106,
,U,P,CHEMBL625217,1,0,,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,,,Autocuration,,,,10625,,,22224,15207,
,U,P,CHEMBL625218,1,0,,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,,,Autocuration,,,,10626,,,22224,15207,
,N,A,CHEMBL622864,1,1,Plasma,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Canis lupus familiaris,,,,Intermediate,,,,10627,1969.0,9615.0,50588,13941,
,N,A,CHEMBL622865,1,1,Plasma,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Rattus norvegicus,,,,Intermediate,,,,10628,1969.0,10116.0,50597,13941,
,N,A,CHEMBL622866,1,1,Plasma,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Rattus norvegicus,,,,Intermediate,,,,10629,1969.0,10116.0,50597,13941,
,N,A,CHEMBL622867,1,1,Plasma,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Canis lupus familiaris,,,,Intermediate,,,,10630,1969.0,9615.0,50588,13941,
,N,A,CHEMBL876808,1,1,Plasma,BAO_0000218,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,,Intermediate,,,,10631,1969.0,10141.0,50512,15240,
,U,A,CHEMBL627725,1,0,Brain,BAO_0000019,AUC in brain,,,,,Autocuration,,,,10632,955.0,,22224,10655,
,U,A,CHEMBL627726,1,0,Serum,BAO_0000019,AUC in serum,,,,,Autocuration,,,,10633,1977.0,,22224,10655,
,U,A,CHEMBL627727,1,0,Plasma,BAO_0000019,AUC was determined,,,,,Autocuration,,,,10634,1969.0,,22224,6504,
,U,A,CHEMBL627728,1,0,Plasma,BAO_0000019,AUC of the compound.,,,,,Autocuration,,,,10635,1969.0,,22224,10615,
,U,A,CHEMBL627729,1,0,Plasma,BAO_0000019,AUC value (0-4 hr),,,,,Autocuration,,,,10636,1969.0,,22224,10353,
,U,A,CHEMBL627730,1,0,Plasma,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,,,Autocuration,,,,10637,1969.0,,22224,14907,
,U,A,CHEMBL627731,1,0,Plasma,BAO_0000019,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,,,Autocuration,,,,10638,1969.0,,22224,14907,
,U,A,CHEMBL627732,1,0,Plasma,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,,,Autocuration,,,,10639,1969.0,,22224,14907,
,U,A,CHEMBL627733,1,0,Plasma,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,,,Autocuration,,,,10640,1969.0,,22224,14907,
,N,A,CHEMBL627734,1,1,Plasma,BAO_0000218,AUC(area under curve) was determined after intravenous administration in rats,Rattus norvegicus,,,,Intermediate,,,,10641,1969.0,10116.0,50597,16359,
,N,A,CHEMBL627735,1,1,Plasma,BAO_0000218,AUC(area under curve) was determined after oral administration in rats,Rattus norvegicus,,,,Intermediate,,,,10642,1969.0,10116.0,50597,16359,
,N,A,CHEMBL627736,1,1,Plasma,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,,Intermediate,,,,10643,1969.0,10141.0,50512,15240,
,N,A,CHEMBL876809,1,1,Plasma,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,,,,Intermediate,,,,10644,1969.0,10116.0,50597,15240,
,U,A,CHEMBL627737,1,0,,BAO_0000019,Area Under Curve after oral dosing of 100 uM/Kg,,,,,Autocuration,,,,10645,,,22224,15469,
,U,A,CHEMBL627738,1,0,,BAO_0000019,Area Under Curve after oral dosing of 30 uM/Kg,,,,,Autocuration,,,,10646,,,22224,15469,
,U,A,CHEMBL627739,1,0,,BAO_0000019,Area Under Curve was measured by ploting the graph between concentration verses time,,,,,Autocuration,,,,10647,,,22224,13520,
,N,A,CHEMBL626143,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,,,,Intermediate,,,,10648,,9615.0,50588,17025,
,U,A,CHEMBL626144,1,0,,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Simiiformes,,,,Autocuration,,,,10649,,314293.0,22224,17025,
,N,A,CHEMBL626145,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,,,,Intermediate,,,,10650,,9986.0,50592,17025,
,N,A,CHEMBL626146,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,,,,Intermediate,,,,10651,,10116.0,50597,17025,
,N,A,CHEMBL626147,1,1,Blood,BAO_0000218,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Rattus norvegicus,,,,Intermediate,,,,10652,178.0,10116.0,50597,12032,
,U,A,CHEMBL626148,1,0,,BAO_0000019,Area under curve (AUC) was determined,,,,,Autocuration,,,,10653,,,22224,10291,
,U,A,CHEMBL626149,1,0,,BAO_0000218,Area under curve (AUC) following ip administration at 1 mg/kg,,,,,Autocuration,,,,10654,,,22224,5767,
,U,A,CHEMBL626150,1,0,,BAO_0000019,Area under curve (AUC) was determined; ND is Not determined,,,,,Autocuration,,,,10655,,,22224,1434,
,N,A,CHEMBL626151,1,1,,BAO_0000218,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Canis lupus familiaris,,,,Intermediate,,,,10656,,9615.0,50588,14925,
,N,A,CHEMBL626152,1,1,,BAO_0000218,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,,,,Intermediate,,,,10657,,9615.0,50588,14925,
,N,A,CHEMBL626153,1,1,,BAO_0000218,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,,,,Intermediate,,,,10658,,9615.0,50588,14925,
,U,A,CHEMBL626154,1,0,,BAO_0000019,Area under curve (AUR) was determined,,,,,Autocuration,,,,10659,,,22224,1434,
,U,A,CHEMBL626155,1,0,,BAO_0000019,Area under curve at 1 uM/dg administered intravenously,,,,,Autocuration,,,,10660,,,22224,11883,
,U,A,CHEMBL626156,1,0,,BAO_0000019,Area under curve at 10 uM/dg administered perorally,,,,,Autocuration,,,,10661,,,22224,11883,
,U,A,CHEMBL626157,1,0,,BAO_0000019,Area under curve at 2 uM/dg administered intravenously,,,,,Autocuration,,,,10662,,,22224,11883,
,U,A,CHEMBL626158,1,0,,BAO_0000019,Area under curve at 20 uM/dg administered perorally,,,,,Autocuration,,,,10663,,,22224,11883,
,N,A,CHEMBL626159,1,1,,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in dog,Canis lupus familiaris,,,,Intermediate,,,,10664,,9615.0,50588,15233,
,N,A,CHEMBL626160,1,1,,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,10665,,10116.0,50597,15233,
,N,A,CHEMBL626161,1,1,,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in dog,Canis lupus familiaris,,,,Intermediate,,,,10666,,9615.0,50588,15233,
,N,A,CHEMBL626162,1,1,,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,10667,,10116.0,50597,15233,
,U,A,CHEMBL626163,1,0,,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,,,Autocuration,,,,10668,,,22224,12978,
,U,A,CHEMBL626164,1,0,,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,,,Autocuration,,,,10669,,,22224,12978,
,N,A,CHEMBL626165,1,1,,BAO_0000218,Area under curve measured as conc vs time after intravenous administration to mice.,Mus musculus,,,,Intermediate,,,,10670,,10090.0,50594,11355,
,N,A,CHEMBL626166,1,1,,BAO_0000218,Area under curve measured as conc vs time after peroral administration to mice.,Mus musculus,,,,Intermediate,,,,10671,,10090.0,50594,11355,
,N,A,CHEMBL626167,1,1,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,,,,Intermediate,,,,10672,,9615.0,50588,12923,
,N,A,CHEMBL626168,1,1,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,,,,Intermediate,,,,10673,,9615.0,50588,12923,
,N,A,CHEMBL877463,1,1,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Canis lupus familiaris,,,,Intermediate,,,,10674,,9615.0,50588,12923,
,N,A,CHEMBL626169,1,1,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,,,,Intermediate,,,,10675,,9615.0,50588,12923,
,N,A,CHEMBL626170,1,1,Heart,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10676,948.0,10116.0,50597,17738,
,N,A,CHEMBL626171,1,1,Heart,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10677,948.0,10116.0,50597,17738,
,N,A,CHEMBL626172,1,1,Heart,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10678,948.0,10116.0,50597,17738,
,N,A,CHEMBL626173,1,1,Heart,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10679,948.0,10116.0,50597,17738,
,N,A,CHEMBL626174,1,1,Kidney,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10680,2113.0,10116.0,50597,17738,
,N,A,CHEMBL626175,1,1,Kidney,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10681,2113.0,10116.0,50597,17738,
,N,A,CHEMBL626176,1,1,Kidney,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10682,2113.0,10116.0,50597,17738,
,N,A,CHEMBL626177,1,1,Kidney,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10683,2113.0,10116.0,50597,17738,
,N,A,CHEMBL622499,1,1,Kidney,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10684,2113.0,10116.0,50597,17738,
,N,A,CHEMBL622500,1,1,Liver,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10685,2107.0,10116.0,50597,17738,
,N,A,CHEMBL622501,1,1,Liver,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10686,2107.0,10116.0,50597,17738,
,N,A,CHEMBL622502,1,1,Liver,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10687,2107.0,10116.0,50597,17738,
,N,A,CHEMBL622503,1,1,Liver,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10688,2107.0,10116.0,50597,17738,
,N,A,CHEMBL877614,1,1,Liver,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10689,2107.0,10116.0,50597,17738,
,N,A,CHEMBL624839,1,1,Lung,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10690,2048.0,10116.0,50597,17738,
,N,A,CHEMBL624840,1,1,Lung,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10691,2048.0,10116.0,50597,17738,
,N,A,CHEMBL624841,1,1,Lung,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10692,2048.0,10116.0,50597,17738,
,N,A,CHEMBL624842,1,1,Lung,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10693,2048.0,10116.0,50597,17738,
,N,A,CHEMBL624843,1,1,Muscle tissue,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10694,2385.0,10116.0,50597,17738,
,N,A,CHEMBL624844,1,1,Muscle tissue,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10695,2385.0,10116.0,50597,17738,
,N,A,CHEMBL624845,1,1,Muscle tissue,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10696,2385.0,10116.0,50597,17738,
,N,A,CHEMBL621904,1,1,Muscle tissue,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,,Intermediate,,,In vivo,10697,2385.0,10116.0,50597,17738,
,N,A,CHEMBL621905,1,1,Blood,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10698,178.0,10116.0,50597,11195,
,N,A,CHEMBL874382,1,1,Blood,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10699,178.0,10116.0,50597,11195,
,N,A,CHEMBL621906,1,1,Blood,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10700,178.0,10116.0,50597,11195,
,N,A,CHEMBL621907,1,1,Brain,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10701,955.0,10116.0,50597,11195,
,N,A,CHEMBL622096,1,1,Brain,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10702,955.0,10116.0,50597,11195,
,N,A,CHEMBL622097,1,1,Brain,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10703,955.0,10116.0,50597,11195,
,N,A,CHEMBL622098,1,1,Heart,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10704,948.0,10116.0,50597,11195,
,N,A,CHEMBL622099,1,1,Heart,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10705,948.0,10116.0,50597,11195,
,N,A,CHEMBL622100,1,1,Heart,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10706,948.0,10116.0,50597,11195,
,N,A,CHEMBL622101,1,1,Kidney,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10707,2113.0,10116.0,50597,11195,
,N,A,CHEMBL622102,1,1,Kidney,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10708,2113.0,10116.0,50597,11195,
,N,A,CHEMBL622103,1,1,Kidney,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10709,2113.0,10116.0,50597,11195,
,N,A,CHEMBL622104,1,1,Liver,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10710,2107.0,10116.0,50597,11195,
,N,A,CHEMBL622105,1,1,Liver,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10711,2107.0,10116.0,50597,11195,
,N,A,CHEMBL622106,1,1,Liver,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10712,2107.0,10116.0,50597,11195,
,N,A,CHEMBL622107,1,1,Lung,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10713,2048.0,10116.0,50597,11195,
,N,A,CHEMBL622108,1,1,Lung,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10714,2048.0,10116.0,50597,11195,
,N,A,CHEMBL622109,1,1,Lung,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10715,2048.0,10116.0,50597,11195,
,N,A,CHEMBL622110,1,1,Muscle tissue,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10716,2385.0,10116.0,50597,11195,
,N,A,CHEMBL622111,1,1,Muscle tissue,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10717,2385.0,10116.0,50597,11195,
,N,A,CHEMBL874383,1,1,Muscle tissue,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10718,2385.0,10116.0,50597,11195,
,N,A,CHEMBL622112,1,1,Zone of skin,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10719,14.0,10116.0,50597,11195,
,N,A,CHEMBL622113,1,1,Zone of skin,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10720,14.0,10116.0,50597,11195,
,N,A,CHEMBL622114,1,1,Zone of skin,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10721,14.0,10116.0,50597,11195,
,N,A,CHEMBL622115,1,1,Spleen,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10722,2106.0,10116.0,50597,11195,
,N,A,CHEMBL622116,1,1,Spleen,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10723,2106.0,10116.0,50597,11195,
,N,A,CHEMBL622117,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10724,,10116.0,50597,6193,
,N,A,CHEMBL622118,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10725,,10116.0,50597,6803,
,N,A,CHEMBL622119,1,1,,BAO_0000218,Oral bioavailability in rats at 6 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10726,,10116.0,50597,6647,
,N,A,CHEMBL622120,1,1,,BAO_0000218,Oral bioavailability in rat (dose 6 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10727,,10116.0,50597,6647,
,N,A,CHEMBL622121,1,1,,BAO_0000218,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Rattus norvegicus,,,,Intermediate,,,In vivo,10728,,10116.0,50597,6647,
,N,A,CHEMBL622122,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10729,,10116.0,50597,6640,
,N,A,CHEMBL622123,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10730,,10116.0,50597,6641,
,N,A,CHEMBL622124,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10731,,10116.0,50597,6641,
,N,A,CHEMBL622125,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10732,,10116.0,50597,6642,
,N,A,CHEMBL622126,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10733,,10116.0,50597,5472,
,N,A,CHEMBL620455,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10734,,10116.0,50597,6141,
,N,A,CHEMBL620456,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10735,,10116.0,50597,4390,
,N,A,CHEMBL620457,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10736,,10116.0,50597,5472,
,N,A,CHEMBL620458,1,1,,BAO_0000218,Oral bioavailability was evaluated; Not tested,Rattus norvegicus,,,,Intermediate,,,In vivo,10737,,10116.0,50597,5472,
,N,A,CHEMBL620459,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10738,,10116.0,50597,5438,
,N,A,CHEMBL620460,1,1,,BAO_0000218,Oral bioavailability in rat by oral dosing,Rattus norvegicus,,,,Intermediate,,,In vivo,10739,,10116.0,50597,4883,
,N,A,CHEMBL620461,1,1,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10740,,10116.0,50597,1908,
,N,A,CHEMBL620462,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,,Intermediate,,,In vivo,10741,,10116.0,50597,4853,
,N,A,CHEMBL620463,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10742,,10116.0,50597,4853,
,N,A,CHEMBL620464,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10743,,10116.0,50597,4853,
,N,A,CHEMBL620465,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10744,,10116.0,50597,4853,
,N,A,CHEMBL620466,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10745,,10116.0,50597,4853,
,N,A,CHEMBL620467,1,1,,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10746,,10116.0,50597,4853,
,N,A,CHEMBL620468,1,1,,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10747,,10116.0,50597,4853,
,N,A,CHEMBL620469,1,1,,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Rattus norvegicus,,,,Intermediate,,,In vivo,10748,,10116.0,50597,12873,
,N,A,CHEMBL620470,1,1,,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Rattus norvegicus,,,,Intermediate,,,In vivo,10749,,10116.0,50597,12873,
,N,A,CHEMBL620471,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10750,,10116.0,50597,3169,
,N,A,CHEMBL620472,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10751,,10116.0,50597,6305,
,N,A,CHEMBL620473,1,1,,BAO_0000218,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10752,,10116.0,50597,4762,
,N,A,CHEMBL620474,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10753,,10116.0,50597,17847,
,N,A,CHEMBL620475,1,1,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10754,,10116.0,50597,6211,
,N,A,CHEMBL620476,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10755,,10116.0,50597,6011,
,N,A,CHEMBL620477,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10756,,10116.0,50597,6317,
,N,A,CHEMBL620478,1,1,,BAO_0000218,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10757,,10116.0,50597,6644,
,N,A,CHEMBL618768,1,1,,BAO_0000218,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10758,,10116.0,50597,6644,
,N,A,CHEMBL618769,1,1,,BAO_0000218,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10759,,10116.0,50597,6644,
,N,A,CHEMBL618770,1,1,,BAO_0000218,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10760,,10116.0,50597,6644,
,N,A,CHEMBL618771,1,1,,BAO_0000218,Oral bioavailability (dose 20 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10761,,10116.0,50597,6113,
,N,A,CHEMBL618772,1,1,,BAO_0000218,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10762,,10116.0,50597,5937,
,N,A,CHEMBL618773,1,1,,BAO_0000218,Oral bioavailability in rat at 10 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,In vivo,10763,,10116.0,50597,5711,
,N,A,CHEMBL875842,1,1,,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10764,,10116.0,50597,17717,
,N,A,CHEMBL618774,1,1,,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,,,,Intermediate,,,In vivo,10765,,10116.0,50597,17717,
,N,A,CHEMBL618775,1,1,,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,,Intermediate,,,In vivo,10766,,10116.0,50597,17717,
,N,A,CHEMBL618776,1,1,,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10767,,10116.0,50597,17717,
,N,A,CHEMBL618777,1,1,,BAO_0000218,Percent bioavailability (F) in rats after iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,10768,,10116.0,50597,4722,
,N,A,CHEMBL618778,1,1,,BAO_0000218,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10769,,10116.0,50597,4722,
,N,A,CHEMBL618779,1,1,,BAO_0000218,Bioavailability in rat (dose 5 uM/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10770,,10116.0,50597,4353,
,N,A,CHEMBL618780,1,1,,BAO_0000218,Oral bioavailability,Rattus norvegicus,,,,Intermediate,,,In vivo,10771,,10116.0,50597,15662,
,N,A,CHEMBL618781,1,1,,BAO_0000218,Bioavailability in rat (dose 2 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10772,,10116.0,50597,4756,
,N,A,CHEMBL618782,1,1,,BAO_0000218,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10773,,10116.0,50597,4756,
,N,A,CHEMBL618783,1,1,,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,10774,,10116.0,50597,3436,
,N,A,CHEMBL618784,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10775,,10116.0,50597,17800,
,N,A,CHEMBL618785,1,1,,BAO_0000218,Percent oral bioavailability evaluated in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10776,,10116.0,50597,15762,
,N,A,CHEMBL618786,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10777,,10116.0,50597,5089,
,N,A,CHEMBL618787,1,1,,BAO_0000218,Percent oral bioavailability in rat; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10778,,10116.0,50597,5089,
,N,A,CHEMBL618788,1,1,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10779,,10116.0,50597,3185,
,N,A,CHEMBL618789,1,1,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10780,,10116.0,50597,5145,
,N,A,CHEMBL618790,1,1,,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Rattus norvegicus,,,,Intermediate,,,In vivo,10781,,10116.0,50597,3457,
,N,A,CHEMBL618791,1,1,,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Rattus norvegicus,,,,Intermediate,,,In vivo,10782,,10116.0,50597,3457,
,N,A,CHEMBL875843,1,1,,BAO_0000218,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10783,,10116.0,50597,5983,
,N,A,CHEMBL618792,1,1,,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,,Intermediate,,,In vivo,10784,,10116.0,50597,5739,
,N,A,CHEMBL623395,1,1,,BAO_0000218,Cmax at a dose of 30 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10785,,10116.0,50597,3579,
,U,A,CHEMBL623396,1,0,,BAO_0000218,Cmax in monkeys at a dose of 1 mg/kg,Simiiformes,,,,Autocuration,,,In vivo,10786,,314293.0,22224,17788,
,N,A,CHEMBL623397,1,1,,BAO_0000218,Cmax in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10787,,10116.0,50597,14956,
,N,A,CHEMBL623398,1,1,,BAO_0000218,Cmax in rats at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,10788,,10116.0,50597,17788,
,N,A,CHEMBL623399,1,1,,BAO_0000218,Cmax was measured in mice after an oral dose of 50 mg/kg.,Mus musculus,,,,Intermediate,,,In vivo,10789,,10090.0,50594,9750,
,U,A,CHEMBL623400,1,0,,BAO_0000218,"Cmax value at a dose of 12.7 uM/kg, po",,,,,Autocuration,,,In vivo,10790,,,22224,12767,
,U,A,CHEMBL623401,1,0,,BAO_0000218,"Cmax value at a dose of 6.3 uM/kg, iv",,,,,Autocuration,,,In vivo,10791,,,22224,12767,
,U,A,CHEMBL623402,1,0,,BAO_0000218,"Cmax value at a dose of 7.1 uM/kg, iv",,,,,Autocuration,,,In vivo,10792,,,22224,12767,
,U,A,CHEMBL623403,1,0,,BAO_0000218,Cmax value of compound was determined after 1 hr,,,,,Autocuration,,,In vivo,10793,,,22224,12703,
,U,A,CHEMBL623404,1,0,,BAO_0000218,Cmax value of the compound,,,,,Autocuration,,,In vivo,10794,,,22224,15778,
,N,A,CHEMBL625997,1,1,,BAO_0000218,Cmax value administered intraintestinal in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,10795,,10116.0,50597,12818,
,N,A,CHEMBL625998,1,1,,BAO_0000218,Cmax value administered perorally was determined in rat; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,10796,,10116.0,50597,14964,
,U,A,CHEMBL625999,1,0,,BAO_0000218,Cmax value at the dose of 2.3 mg/kg,,,,,Autocuration,,,In vivo,10797,,,22224,15808,
,U,A,CHEMBL626000,1,0,,BAO_0000218,Cmax value at the dose of 5 mg/kg,,,,,Autocuration,,,In vivo,10798,,,22224,15808,
,U,A,CHEMBL626001,1,0,,BAO_0000218,Cmax value in the period of 8 hr after dosing. ,,,,,Autocuration,,,In vivo,10799,,,22224,15778,
,U,A,CHEMBL626002,1,0,,BAO_0000218,Cmax value at a oral dose of 20 mg/kg; Not tested,,,,,Autocuration,,,In vivo,10800,,,22224,3715,
,U,A,CHEMBL626003,1,0,,BAO_0000218,Cmax value at a oral dose of 20 mg/kg,,,,,Autocuration,,,In vivo,10801,,,22224,3715,
,N,A,CHEMBL626004,1,1,,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,,,,Intermediate,,,In vivo,10802,,10116.0,50597,1446,
,N,A,CHEMBL626005,1,1,,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,,Intermediate,,,In vivo,10803,,10141.0,50512,15240,
,N,A,CHEMBL626006,1,1,,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,10804,,10116.0,50597,15240,
,N,A,CHEMBL626007,1,1,Plasma,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Rattus norvegicus,,,,Intermediate,,,In vivo,10805,1969.0,10116.0,50597,14810,
,N,A,CHEMBL626008,1,1,Plasma,BAO_0000218,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,10806,1969.0,10090.0,50594,14239,
,N,A,CHEMBL626009,1,1,Liver,BAO_0000218,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Canis lupus familiaris,,,,Intermediate,,,In vivo,10807,2107.0,9615.0,50588,12555,
,N,A,CHEMBL626010,1,1,,BAO_0000218,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Canis lupus familiaris,,,,Intermediate,,,In vivo,10808,,9615.0,50588,10754,
,N,A,CHEMBL626011,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,10809,178.0,10090.0,50594,10754,
,N,A,CHEMBL626012,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,10810,178.0,10090.0,50594,10754,
,N,A,CHEMBL626013,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,10811,178.0,10090.0,50594,10754,
,N,A,CHEMBL626014,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,10812,178.0,10090.0,50594,10754,
,N,A,CHEMBL877496,1,1,Blood,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Mus musculus,,,,Intermediate,,,In vivo,10813,178.0,10090.0,50594,10754,
,N,F,CHEMBL626015,1,1,,BAO_0000218,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10814,,9615.0,50588,14600,
,N,F,CHEMBL626016,1,1,,BAO_0000218,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10815,,9615.0,50588,14600,
,N,F,CHEMBL626017,1,1,,BAO_0000218,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10816,,9615.0,50588,14600,
,N,A,CHEMBL626018,1,1,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10817,1969.0,9615.0,50588,13543,
,N,A,CHEMBL626692,1,1,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10818,1969.0,9615.0,50588,13543,
,N,A,CHEMBL626693,1,1,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10819,1969.0,10116.0,50597,13543,
,U,A,CHEMBL626694,1,0,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,,,,Autocuration,,,In vivo,10820,1969.0,10116.0,22224,13543,
,N,A,CHEMBL626695,1,1,Blood,BAO_0000218,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,10821,178.0,9615.0,50588,14600,
,N,A,CHEMBL626696,1,1,Blood,BAO_0000218,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,10822,178.0,9615.0,50588,14600,
,N,A,CHEMBL626697,1,1,Blood,BAO_0000218,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,10823,178.0,9615.0,50588,14600,
,N,A,CHEMBL626859,1,1,Blood,BAO_0000218,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Canis lupus familiaris,,,,Intermediate,,,In vivo,10824,178.0,9615.0,50588,14600,
,N,A,CHEMBL626860,1,1,Blood,BAO_0000218,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,10825,178.0,9615.0,50588,14600,
,N,A,CHEMBL626861,1,1,Blood,BAO_0000218,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,10826,178.0,9615.0,50588,14600,
,N,A,CHEMBL626296,1,1,,BAO_0000218,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,,Intermediate,,,In vivo,10827,,10116.0,50597,14681,
,U,A,CHEMBL626297,1,0,,BAO_0000218,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,,,Autocuration,,,In vivo,10828,,,22224,15905,
,U,A,CHEMBL626298,1,0,Plasma,BAO_0000218,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,,,Autocuration,,,In vivo,10829,1969.0,,22224,15905,
,N,A,CHEMBL626299,1,1,Plasma,BAO_0000218,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Rattus norvegicus,,,,Intermediate,,,In vivo,10830,1969.0,10116.0,50597,13304,
,N,A,CHEMBL626300,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Rattus norvegicus,,,,Intermediate,,,In vivo,10831,1969.0,10116.0,50597,15137,
,N,A,CHEMBL626301,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Rattus norvegicus,,,,Intermediate,,,In vivo,10832,1969.0,10116.0,50597,15137,
,N,A,CHEMBL626962,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Rattus norvegicus,,,,Intermediate,,,In vivo,10833,1969.0,10116.0,50597,15137,
,N,A,CHEMBL626963,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Rattus norvegicus,,,,Intermediate,,,In vivo,10834,1969.0,10116.0,50597,15137,
,N,A,CHEMBL626964,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Rattus norvegicus,,,,Intermediate,,,In vivo,10835,1969.0,10116.0,50597,15137,
,N,A,CHEMBL626965,1,1,Plasma,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Macaca fascicularis,,,,Intermediate,,,In vivo,10836,1969.0,9541.0,100710,14839,
,N,A,CHEMBL626966,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10837,1969.0,10090.0,50594,14839,
,N,A,CHEMBL626967,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10838,1969.0,10090.0,50594,14839,
,N,A,CHEMBL626968,1,1,Plasma,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Macaca fascicularis,,,,Intermediate,,,In vivo,10839,1969.0,9541.0,100710,14839,
,N,A,CHEMBL626969,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Rattus norvegicus,,,,Intermediate,,,,10840,948.0,10116.0,50597,8418,
,N,A,CHEMBL627126,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Rattus norvegicus,,,,Intermediate,,,,10841,948.0,10116.0,50597,8418,
,N,A,CHEMBL631276,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Rattus norvegicus,,,,Intermediate,,,,10842,948.0,10116.0,50597,8418,
,N,A,CHEMBL631277,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Rattus norvegicus,,,,Intermediate,,,,10843,948.0,10116.0,50597,8418,
,N,A,CHEMBL631278,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Rattus norvegicus,,,,Intermediate,,,,10844,948.0,10116.0,50597,8418,
,N,A,CHEMBL874457,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Rattus norvegicus,,,,Intermediate,,,,10845,948.0,10116.0,50597,8418,
,N,A,CHEMBL631279,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Rattus norvegicus,,,,Intermediate,,,,10846,948.0,10116.0,50597,8418,
,N,A,CHEMBL631280,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Rattus norvegicus,,,,Intermediate,,,,10847,948.0,10116.0,50597,8418,
,N,A,CHEMBL631281,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Rattus norvegicus,,,,Intermediate,,,,10848,948.0,10116.0,50597,8418,
,N,A,CHEMBL631968,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Rattus norvegicus,,,,Intermediate,,,,10849,948.0,10116.0,50597,8418,
,N,A,CHEMBL631969,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Rattus norvegicus,,,,Intermediate,,,,10850,948.0,10116.0,50597,8418,
,N,A,CHEMBL631970,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Rattus norvegicus,,,,Intermediate,,,,10851,948.0,10116.0,50597,8418,
,N,A,CHEMBL631971,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Rattus norvegicus,,,,Intermediate,,,,10852,948.0,10116.0,50597,8418,
,N,A,CHEMBL631972,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Rattus norvegicus,,,,Intermediate,,,,10853,948.0,10116.0,50597,8418,
,N,A,CHEMBL630435,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Rattus norvegicus,,,,Intermediate,,,,10854,948.0,10116.0,50597,8418,
,N,A,CHEMBL630436,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Rattus norvegicus,,,,Intermediate,,,,10855,948.0,10116.0,50597,8418,
,N,A,CHEMBL630437,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Rattus norvegicus,,,,Intermediate,,,,10856,948.0,10116.0,50597,8418,
,N,A,CHEMBL630438,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Rattus norvegicus,,,,Intermediate,,,,10857,948.0,10116.0,50597,8418,
,N,A,CHEMBL630439,1,1,Heart,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Rattus norvegicus,,,,Intermediate,,,,10858,948.0,10116.0,50597,8418,
,N,A,CHEMBL630440,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Rattus norvegicus,,,,Intermediate,,,,10859,2113.0,10116.0,50597,8418,
,N,A,CHEMBL630441,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Rattus norvegicus,,,,Intermediate,,,,10860,2113.0,10116.0,50597,8418,
,N,A,CHEMBL630442,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Rattus norvegicus,,,,Intermediate,,,,10861,2113.0,10116.0,50597,8418,
,N,A,CHEMBL625234,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Rattus norvegicus,,,,Intermediate,,,,10862,2113.0,10116.0,50597,8418,
,N,A,CHEMBL625235,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Rattus norvegicus,,,,Intermediate,,,,10863,2113.0,10116.0,50597,8418,
,N,A,CHEMBL625236,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Rattus norvegicus,,,,Intermediate,,,,10864,2113.0,10116.0,50597,8418,
,N,A,CHEMBL625237,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Rattus norvegicus,,,,Intermediate,,,,10865,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626125,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Rattus norvegicus,,,,Intermediate,,,,10866,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626126,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Rattus norvegicus,,,,Intermediate,,,,10867,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626127,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Rattus norvegicus,,,,Intermediate,,,,10868,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626128,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Rattus norvegicus,,,,Intermediate,,,,10869,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626129,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Rattus norvegicus,,,,Intermediate,,,,10870,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626130,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Rattus norvegicus,,,,Intermediate,,,,10871,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626131,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Rattus norvegicus,,,,Intermediate,,,,10872,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626132,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Rattus norvegicus,,,,Intermediate,,,,10873,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626752,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Rattus norvegicus,,,,Intermediate,,,,10874,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626753,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Rattus norvegicus,,,,Intermediate,,,,10875,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626754,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Rattus norvegicus,,,,Intermediate,,,,10876,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626755,1,1,Kidney,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Rattus norvegicus,,,,Intermediate,,,,10877,2113.0,10116.0,50597,8418,
,N,A,CHEMBL626756,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Rattus norvegicus,,,,Intermediate,,,,10878,2107.0,10116.0,50597,8418,
,N,A,CHEMBL626757,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Rattus norvegicus,,,,Intermediate,,,,10879,2107.0,10116.0,50597,8418,
,N,A,CHEMBL626758,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Rattus norvegicus,,,,Intermediate,,,,10880,2107.0,10116.0,50597,8418,
,N,A,CHEMBL626759,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Rattus norvegicus,,,,Intermediate,,,,10881,2107.0,10116.0,50597,8418,
,N,A,CHEMBL626760,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Rattus norvegicus,,,,Intermediate,,,,10882,2107.0,10116.0,50597,8418,
,N,A,CHEMBL626394,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10883,,9615.0,50588,6996,
,N,A,CHEMBL626395,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,10884,,9615.0,50588,6996,
,N,A,CHEMBL626396,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10885,,9615.0,50588,6996,
,N,A,CHEMBL626397,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,10886,,9615.0,50588,6996,
,N,A,CHEMBL626398,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,10887,,9615.0,50588,6996,
,N,A,CHEMBL626399,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10888,,9615.0,50588,6996,
,N,A,CHEMBL874653,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,10889,,10116.0,50597,6996,
,N,A,CHEMBL626400,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10890,,10116.0,50597,6996,
,N,A,CHEMBL626401,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10891,,10116.0,50597,6996,
,N,A,CHEMBL626402,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,10892,,10116.0,50597,6996,
,N,A,CHEMBL626403,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,10893,,10116.0,50597,6996,
,N,A,CHEMBL626404,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10894,,10116.0,50597,6996,
,N,A,CHEMBL626405,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,10895,,10116.0,50597,6996,
,N,A,CHEMBL625529,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10896,,10116.0,50597,6996,
,N,A,CHEMBL625530,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10897,,10116.0,50597,6996,
,N,A,CHEMBL625531,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,10898,,10116.0,50597,6996,
,N,A,CHEMBL625532,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,10899,,10116.0,50597,6996,
,N,A,CHEMBL625533,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10900,,10116.0,50597,6996,
,N,A,CHEMBL875474,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,10901,,10116.0,50597,6996,
,N,A,CHEMBL625534,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10902,,10116.0,50597,6996,
,N,A,CHEMBL625535,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10903,,10116.0,50597,6996,
,N,A,CHEMBL625536,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,10904,,10116.0,50597,6996,
,N,A,CHEMBL625537,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,10905,,10116.0,50597,6996,
,N,A,CHEMBL625538,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10906,,10116.0,50597,6996,
,N,A,CHEMBL625539,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,10907,,10116.0,50597,6996,
,N,A,CHEMBL625540,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10908,,10116.0,50597,6996,
,N,A,CHEMBL625541,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10909,,10116.0,50597,6996,
,N,A,CHEMBL625542,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,10910,,10116.0,50597,6996,
,N,A,CHEMBL625543,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,10911,,10116.0,50597,6996,
,N,A,CHEMBL625544,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,10912,,10116.0,50597,6996,
,N,A,CHEMBL625545,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,10913,,9615.0,50588,6996,
,N,A,CHEMBL625546,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10914,,9615.0,50588,6996,
,N,A,CHEMBL625547,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,10915,,9615.0,50588,6996,
,N,A,CHEMBL625548,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10916,,9615.0,50588,6996,
,N,A,CHEMBL625549,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10917,,9615.0,50588,6996,
,N,A,CHEMBL625550,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10918,,9615.0,50588,6996,
,N,A,CHEMBL625551,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10919,,9615.0,50588,6996,
,N,A,CHEMBL875475,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10920,,9615.0,50588,6996,
,N,A,CHEMBL625552,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10921,,9615.0,50588,6996,
,N,A,CHEMBL625553,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10922,,9615.0,50588,6996,
,N,A,CHEMBL625554,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,10923,,9615.0,50588,6996,
,N,A,CHEMBL625555,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,10924,,9615.0,50588,6996,
,N,A,CHEMBL625556,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10925,,9615.0,50588,6996,
,N,A,CHEMBL624986,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,10926,,9615.0,50588,6996,
,N,A,CHEMBL624987,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,10927,,9615.0,50588,6996,
,N,A,CHEMBL624988,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,10928,,9615.0,50588,6996,
,N,A,CHEMBL624989,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Canis lupus familiaris,,,,Intermediate,,,In vivo,10929,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624990,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Canis lupus familiaris,,,,Intermediate,,,In vivo,10930,1637.0,9615.0,50588,9025,
,N,A,CHEMBL874391,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Canis lupus familiaris,,,,Intermediate,,,In vivo,10931,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624991,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Canis lupus familiaris,,,,Intermediate,,,In vivo,10932,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624992,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Canis lupus familiaris,,,,Intermediate,,,In vivo,10933,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624993,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Canis lupus familiaris,,,,Intermediate,,,In vivo,10934,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624994,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Canis lupus familiaris,,,,Intermediate,,,In vivo,10935,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624995,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Canis lupus familiaris,,,,Intermediate,,,In vivo,10936,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624996,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Canis lupus familiaris,,,,Intermediate,,,In vivo,10937,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624997,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Canis lupus familiaris,,,,Intermediate,,,In vivo,10938,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624998,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Canis lupus familiaris,,,,Intermediate,,,In vivo,10939,1637.0,9615.0,50588,9025,
,N,A,CHEMBL624999,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Canis lupus familiaris,,,,Intermediate,,,In vivo,10940,1637.0,9615.0,50588,9025,
,N,A,CHEMBL882955,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Canis lupus familiaris,,,,Intermediate,,,In vivo,10941,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625000,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Canis lupus familiaris,,,,Intermediate,,,In vivo,10942,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625001,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Canis lupus familiaris,,,,Intermediate,,,In vivo,10943,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625089,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Canis lupus familiaris,,,,Intermediate,,,In vivo,10944,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625090,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Canis lupus familiaris,,,,Intermediate,,,In vivo,10945,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625091,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Canis lupus familiaris,,,,Intermediate,,,In vivo,10946,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625092,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Canis lupus familiaris,,,,Intermediate,,,In vivo,10947,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625093,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Canis lupus familiaris,,,,Intermediate,,,In vivo,10948,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625094,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Canis lupus familiaris,,,,Intermediate,,,In vivo,10949,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625095,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Canis lupus familiaris,,,,Intermediate,,,In vivo,10950,1637.0,9615.0,50588,9025,
,N,A,CHEMBL625096,1,1,,BAO_0000218,Compound was evaluated for its bioavailability in the dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,10951,,9615.0,50588,2249,
,N,A,CHEMBL625097,1,1,,BAO_0000218,Compound was evaluated for its bioavailability in the rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10952,,10116.0,50597,2249,
,U,A,CHEMBL882956,1,0,,BAO_0000218,Compound was evaluated for oral bioavailability,,,,,Autocuration,,,In vivo,10953,,,22224,17515,
,N,A,CHEMBL625098,1,1,,BAO_0000218,Compound was evaluated for percentage of Oral bioavailability in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,10954,,10116.0,50597,14541,
,U,A,CHEMBL625099,1,0,,BAO_0000218,Bioavailability in guinea pig,Cavia porcellus,,,,Autocuration,,,In vivo,10955,,10141.0,22224,12797,
,N,A,CHEMBL625100,1,1,,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10956,,10116.0,50597,12797,
,N,A,CHEMBL625101,1,1,,BAO_0000218,Compound was evaluated for the oral bioavailability in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,10957,,9615.0,50588,12797,
,N,A,CHEMBL874396,1,1,,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10958,,10116.0,50597,12797,
,U,F,CHEMBL625102,1,0,,BAO_0000218,Bioavailability in dog (dosed i.v.),Canis lupus familiaris,,,,Autocuration,,,In vivo,10959,,9615.0,22224,11727,
,N,A,CHEMBL625103,1,1,,BAO_0000218,Compound was tested for in vivo bioavailability in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,10960,,9615.0,50588,13249,
,N,A,CHEMBL625104,1,1,,BAO_0000218,Compound was tested for in vivo bioavailability in hamsters,Cricetinae,,,,Intermediate,,,In vivo,10961,,10026.0,100712,13249,
,U,A,CHEMBL625105,1,0,,BAO_0000218,Compound was tested for in vivo bioavailability in monkey,Simiiformes,,,,Autocuration,,,In vivo,10962,,314293.0,22224,13249,
,N,A,CHEMBL625106,1,1,,BAO_0000218,Compound was tested for in vivo bioavailability in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10963,,10116.0,50597,13249,
,U,A,CHEMBL625107,1,0,,BAO_0000218,Oral bioavailability in mouse,Mus musculus,,,,Autocuration,,,In vivo,10964,,10090.0,22224,9552,
,N,A,CHEMBL625108,1,1,,BAO_0000218,Compound was tested for percent of oral bioavailability in mice; 56-74,Mus musculus,,,,Intermediate,,,In vivo,10965,,10090.0,50594,9552,
,U,A,CHEMBL625109,1,0,,BAO_0000218,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Mus musculus,,,,Autocuration,,,In vivo,10966,,10090.0,22224,14839,
,U,A,CHEMBL625110,1,0,,BAO_0000218,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Macaca fascicularis,,,,Autocuration,,,In vivo,10967,,9541.0,22224,14839,
,U,A,CHEMBL625111,1,0,,BAO_0000218,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Macaca fascicularis,,,,Autocuration,,,In vivo,10968,,9541.0,22224,14839,
,N,A,CHEMBL625112,1,1,,BAO_0000218,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Mus musculus,,,,Intermediate,,,In vivo,10969,,10090.0,50594,14839,
,N,A,CHEMBL875334,1,1,,BAO_0000218,Oral bioavailability in nude mice,Mus musculus,,,,Intermediate,,,In vivo,10970,,10090.0,50594,14839,
,U,A,CHEMBL628617,1,0,,BAO_0000218,Bioavailability in monkey (i.d. dosing),Primates,,,,Autocuration,,,In vivo,10971,,9443.0,22224,11219,
,U,A,CHEMBL628618,1,0,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,10972,,10116.0,22224,9552,
,U,A,CHEMBL628619,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,,,Autocuration,,,In vivo,10973,,,22224,11732,
,U,A,CHEMBL628620,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,,,Autocuration,,,In vivo,10974,,,22224,11732,
,N,A,CHEMBL628621,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,,Intermediate,,,In vivo,10975,,9541.0,100710,14839,
,N,A,CHEMBL628622,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,,Intermediate,,,In vivo,10976,,9541.0,100710,14839,
,N,A,CHEMBL628623,1,1,,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,,Intermediate,,,In vivo,10977,,9541.0,100710,14839,
,N,A,CHEMBL628624,1,1,Plasma,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Macaca fascicularis,,,,Intermediate,,,In vivo,10978,1969.0,9541.0,100710,14839,
,N,A,CHEMBL628625,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10979,1969.0,10090.0,50594,14839,
,N,A,CHEMBL628626,1,1,Plasma,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Macaca fascicularis,,,,Intermediate,,,In vivo,10980,1969.0,9541.0,100710,14839,
,N,A,CHEMBL627041,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10981,1969.0,10090.0,50594,14839,
,N,A,CHEMBL627042,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10982,1969.0,10090.0,50594,14839,
,N,A,CHEMBL627043,1,1,Plasma,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,,,Intermediate,,,In vivo,10983,1969.0,10090.0,50594,14839,
,U,A,CHEMBL627044,1,0,Plasma,BAO_0000218,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,,,Autocuration,,,In vivo,10984,1969.0,,22224,13932,
,N,A,CHEMBL627045,1,1,Plasma,BAO_0000218,Cmax in mouse plasma,Mus musculus,,,,Intermediate,,,In vivo,10985,1969.0,10090.0,50594,11637,
,U,A,CHEMBL627046,1,0,Plasma,BAO_0000218,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,,,Autocuration,,,In vivo,10986,1969.0,,22224,11637,
,N,A,CHEMBL627047,1,1,Plasma,BAO_0000218,Maximal plasma concentration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10987,1969.0,10116.0,50597,13960,
,N,A,CHEMBL627048,1,1,Plasma,BAO_0000218,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10988,1969.0,10116.0,50597,15905,
,N,A,CHEMBL627049,1,1,,BAO_0000218,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10989,,10116.0,50597,14062,
,N,A,CHEMBL627050,1,1,,BAO_0000218,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10990,,10116.0,50597,14062,
,N,A,CHEMBL627051,1,1,,BAO_0000218,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10991,,10116.0,50597,14062,
,N,A,CHEMBL627052,1,1,,BAO_0000218,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10992,,10116.0,50597,14062,
,N,A,CHEMBL627053,1,1,,BAO_0000218,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10993,,10116.0,50597,14062,
,N,A,CHEMBL627054,1,1,,BAO_0000218,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,10994,,10116.0,50597,14062,
,N,A,CHEMBL627055,1,1,,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,10995,,10090.0,50594,15011,
,N,A,CHEMBL627056,1,1,,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,10996,,10090.0,50594,15011,
,N,A,CHEMBL627057,1,1,,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,,Intermediate,,,In vivo,10997,,10090.0,50594,15011,
,N,A,CHEMBL627058,1,1,,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,10998,,10090.0,50594,15011,
,N,A,CHEMBL626211,1,1,,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,10999,,10090.0,50594,15011,
,U,A,CHEMBL626212,1,0,,BAO_0000218,Maximum Concentration of the compound.,,,,,Autocuration,,,In vivo,11000,,,22224,10291,
,N,A,CHEMBL626213,1,1,,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11001,,9615.0,50588,14599,
,N,A,CHEMBL626214,1,1,,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11002,,9615.0,50588,14599,
,N,A,CHEMBL626215,1,1,,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11003,,9615.0,50588,14599,
,N,A,CHEMBL626216,1,1,,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11004,,9615.0,50588,14599,
,U,A,CHEMBL626217,1,0,Blood,BAO_0000218,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,,,Autocuration,,,In vivo,11005,178.0,,22224,12767,
,U,A,CHEMBL626218,1,0,Blood,BAO_0000218,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,,,Autocuration,,,In vivo,11006,178.0,,22224,12767,
,U,A,CHEMBL626219,1,0,Blood,BAO_0000218,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,,,Autocuration,,,In vivo,11007,178.0,,22224,12767,
,U,A,CHEMBL626220,1,0,Blood,BAO_0000218,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,,,Autocuration,,,In vivo,11008,178.0,,22224,12767,
,U,A,CHEMBL626221,1,0,Blood,BAO_0000218,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,,,Autocuration,,,In vivo,11009,178.0,,22224,12767,
,U,A,CHEMBL626222,1,0,Blood,BAO_0000218,Maximum blood level reached at dose of 10.6 uM/kg orally,,,,,Autocuration,,,In vivo,11010,178.0,,22224,12767,
,N,A,CHEMBL626223,1,1,,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Cavia porcellus,,,,Intermediate,,,In vivo,11011,,10141.0,50512,14706,
,N,A,CHEMBL626224,1,1,,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Cavia porcellus,,,,Intermediate,,,In vivo,11012,,10141.0,50512,14706,
,N,A,CHEMBL626225,1,1,Brain,BAO_0000218,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11013,955.0,10116.0,50597,14793,
,N,A,CHEMBL626226,1,1,Brain,BAO_0000218,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11014,955.0,10116.0,50597,14793,
,N,A,CHEMBL626227,1,1,Brain,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11015,955.0,10116.0,50597,14793,
,N,A,CHEMBL626228,1,1,Brain,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11016,955.0,10116.0,50597,14793,
,N,A,CHEMBL626229,1,1,,BAO_0000218,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11017,,10116.0,50597,14793,
,N,A,CHEMBL626921,1,1,,BAO_0000218,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11018,,10116.0,50597,14793,
,N,A,CHEMBL876793,1,1,,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11019,,10116.0,50597,14793,
,N,A,CHEMBL625309,1,1,,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11020,,10116.0,50597,14793,
,N,A,CHEMBL625310,1,1,,BAO_0000218,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Bacillus subtilis,,,,Intermediate,,,In vivo,11021,,1423.0,50278,10524,
,U,A,CHEMBL625311,1,0,,BAO_0000218,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Simiiformes,,,,Autocuration,,,In vivo,11022,,314293.0,22224,11871,
,N,A,CHEMBL625312,1,1,,BAO_0000218,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11023,,10116.0,50597,11871,
,U,A,CHEMBL625313,1,0,,BAO_0000218,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,,,Autocuration,,,In vivo,11024,,,22224,3437,
,N,A,CHEMBL625314,1,1,,BAO_0000218,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Mus musculus,,,,Intermediate,,,In vivo,11025,,10090.0,50594,12038,
,N,A,CHEMBL625315,1,1,,BAO_0000218,Maximum concentration in male rats after iv administration of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11026,,10116.0,50597,12038,
,N,A,CHEMBL625316,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Rattus norvegicus,,,,Intermediate,,,,11027,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625317,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Rattus norvegicus,,,,Intermediate,,,,11028,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625318,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Rattus norvegicus,,,,Intermediate,,,,11029,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625319,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Rattus norvegicus,,,,Intermediate,,,,11030,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625320,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Rattus norvegicus,,,,Intermediate,,,,11031,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625321,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Rattus norvegicus,,,,Intermediate,,,,11032,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625322,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Rattus norvegicus,,,,Intermediate,,,,11033,2107.0,10116.0,50597,8418,
,N,A,CHEMBL876801,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Rattus norvegicus,,,,Intermediate,,,,11034,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625323,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Rattus norvegicus,,,,Intermediate,,,,11035,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625324,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Rattus norvegicus,,,,Intermediate,,,,11036,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625325,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Rattus norvegicus,,,,Intermediate,,,,11037,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625326,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Rattus norvegicus,,,,Intermediate,,,,11038,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625327,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Rattus norvegicus,,,,Intermediate,,,,11039,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625328,1,1,Liver,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Rattus norvegicus,,,,Intermediate,,,,11040,2107.0,10116.0,50597,8418,
,N,A,CHEMBL625329,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Rattus norvegicus,,,,Intermediate,,,,11041,2048.0,10116.0,50597,8418,
,N,A,CHEMBL625330,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Rattus norvegicus,,,,Intermediate,,,,11042,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627774,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Rattus norvegicus,,,,Intermediate,,,,11043,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627775,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Rattus norvegicus,,,,Intermediate,,,,11044,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627949,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Rattus norvegicus,,,,Intermediate,,,,11045,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627950,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Rattus norvegicus,,,,Intermediate,,,,11046,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627951,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Rattus norvegicus,,,,Intermediate,,,,11047,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627952,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Rattus norvegicus,,,,Intermediate,,,,11048,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627953,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Rattus norvegicus,,,,Intermediate,,,,11049,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627954,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Rattus norvegicus,,,,Intermediate,,,,11050,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627955,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Rattus norvegicus,,,,Intermediate,,,,11051,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627956,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Rattus norvegicus,,,,Intermediate,,,,11052,2048.0,10116.0,50597,8418,
,N,A,CHEMBL876802,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Rattus norvegicus,,,,Intermediate,,,,11053,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627957,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Rattus norvegicus,,,,Intermediate,,,,11054,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627958,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Rattus norvegicus,,,,Intermediate,,,,11055,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627959,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Rattus norvegicus,,,,Intermediate,,,,11056,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627960,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Rattus norvegicus,,,,Intermediate,,,,11057,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627961,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Rattus norvegicus,,,,Intermediate,,,,11058,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627962,1,1,Lung,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Rattus norvegicus,,,,Intermediate,,,,11059,2048.0,10116.0,50597,8418,
,N,A,CHEMBL627963,1,1,,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11060,,10116.0,50597,9796,
,N,A,CHEMBL624759,1,1,,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11061,,10116.0,50597,9796,
,N,A,CHEMBL624760,1,1,,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11062,,10116.0,50597,9796,
,N,A,CHEMBL624761,1,1,,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11063,,10116.0,50597,9796,
,N,A,CHEMBL877607,1,1,,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11064,,10116.0,50597,9796,
,N,A,CHEMBL624762,1,1,Liver,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11065,2107.0,10116.0,50597,9796,
,N,A,CHEMBL624763,1,1,Liver,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11066,2107.0,10116.0,50597,9796,
,N,A,CHEMBL624764,1,1,Liver,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11067,2107.0,10116.0,50597,9796,
,N,A,CHEMBL624765,1,1,Liver,BAO_0000218,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11068,2107.0,10116.0,50597,9796,
,N,A,CHEMBL624766,1,1,Liver,BAO_0000218,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11069,2107.0,10116.0,50597,9796,
,N,A,CHEMBL624767,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11070,,9615.0,50588,6996,
,N,A,CHEMBL624768,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,11071,,9615.0,50588,6996,
,N,A,CHEMBL624769,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11072,,9615.0,50588,6996,
,N,A,CHEMBL624770,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,11073,,9615.0,50588,6996,
,N,A,CHEMBL624771,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,11074,,9615.0,50588,6996,
,N,A,CHEMBL624772,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11075,,9615.0,50588,6996,
,N,A,CHEMBL624773,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,11076,,10116.0,50597,6996,
,N,A,CHEMBL624774,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11077,,10116.0,50597,6996,
,N,A,CHEMBL624775,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11078,,10116.0,50597,6996,
,N,A,CHEMBL624776,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,11079,,10116.0,50597,6996,
,N,A,CHEMBL624777,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,11080,,10116.0,50597,6996,
,N,A,CHEMBL624778,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11081,,10116.0,50597,6996,
,N,A,CHEMBL624779,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,11082,,10116.0,50597,6996,
,N,A,CHEMBL624780,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,11083,,10116.0,50597,6996,
,N,A,CHEMBL624781,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,11084,,10116.0,50597,6996,
,N,A,CHEMBL877608,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11085,,10116.0,50597,6996,
,N,A,CHEMBL624782,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11086,,10116.0,50597,6996,
,N,A,CHEMBL624783,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11087,,10116.0,50597,6996,
,N,A,CHEMBL624784,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,11088,,10116.0,50597,6996,
,N,A,CHEMBL624785,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11089,,10116.0,50597,6996,
,N,A,CHEMBL624786,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11090,,10116.0,50597,6996,
,N,A,CHEMBL624787,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,11091,,10116.0,50597,6996,
,N,A,CHEMBL628676,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11092,,10116.0,50597,6996,
,N,A,CHEMBL621842,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,11093,,10116.0,50597,6996,
,N,A,CHEMBL621843,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11094,,10116.0,50597,6996,
,N,A,CHEMBL623873,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11095,,10116.0,50597,6996,
,N,A,CHEMBL623874,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,11096,,10116.0,50597,6996,
,N,A,CHEMBL623875,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,11097,,10116.0,50597,6996,
,N,A,CHEMBL623876,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,11098,,10116.0,50597,6996,
,N,A,CHEMBL623877,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,11099,,9615.0,50588,6996,
,N,A,CHEMBL623878,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11100,,9615.0,50588,6996,
,N,A,CHEMBL623879,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,11101,,9615.0,50588,6996,
,N,A,CHEMBL623880,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11102,,9615.0,50588,6996,
,N,A,CHEMBL623881,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11103,,9615.0,50588,6996,
,N,A,CHEMBL623957,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11104,,9615.0,50588,6996,
,N,A,CHEMBL623958,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11105,,9615.0,50588,6996,
,N,A,CHEMBL623959,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11106,,9615.0,50588,6996,
,N,A,CHEMBL623960,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11107,,9615.0,50588,6996,
,N,A,CHEMBL623961,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11108,,9615.0,50588,6996,
,N,A,CHEMBL623962,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,11109,,9615.0,50588,6996,
,N,A,CHEMBL624676,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,11110,,9615.0,50588,6996,
,N,A,CHEMBL624677,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11111,,9615.0,50588,6996,
,N,A,CHEMBL624678,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,11112,,9615.0,50588,6996,
,N,A,CHEMBL624679,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11113,,9615.0,50588,6996,
,N,A,CHEMBL624680,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,11114,,9615.0,50588,6996,
,U,A,CHEMBL624849,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,,,Autocuration,,,In vivo,11115,,,22224,11732,
,U,A,CHEMBL624850,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,,,Autocuration,,,In vivo,11116,,,22224,11732,
,U,A,CHEMBL874399,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,,,Autocuration,,,In vivo,11117,,,22224,11732,
,U,A,CHEMBL624851,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,,,Autocuration,,,In vivo,11118,,,22224,11732,
,U,A,CHEMBL624852,1,0,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,,,Autocuration,,,In vivo,11119,,,22224,11732,
,U,A,CHEMBL624853,1,0,,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,,Autocuration,,,In vivo,11120,,10116.0,22224,13359,
,U,A,CHEMBL624854,1,0,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,,Autocuration,,,In vivo,11121,,10116.0,22224,16618,
,U,A,CHEMBL624855,1,0,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,11122,,10116.0,22224,13960,
,U,A,CHEMBL624856,1,0,,BAO_0000218,Oral bioavailability in rats was determined in vivo,Rattus norvegicus,,,,Autocuration,,,In vivo,11123,,10116.0,22224,13917,
,U,A,CHEMBL882957,1,0,,BAO_0000218,Oral bioavailability in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,11124,,9615.0,22224,14266,
,U,A,CHEMBL624857,1,0,,BAO_0000218,Oral bioavailability of compound in monkey,Simiiformes,,,,Autocuration,,,In vivo,11125,,314293.0,22224,12359,
,N,A,CHEMBL622202,1,1,,BAO_0000218,Oral bioavailability of compound in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11126,,10116.0,50597,12359,
,U,A,CHEMBL622203,1,0,,BAO_0000218,Bioavailability in rat of PMEA prodrug,Rattus norvegicus,,,,Autocuration,,,In vivo,11127,,10116.0,22224,12359,
,N,A,CHEMBL625522,1,1,,BAO_0000218,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Rattus norvegicus,,,,Intermediate,,,In vivo,11128,,10116.0,50597,12359,
,U,A,CHEMBL622868,1,0,,BAO_0000218,Serum conc at 3 hours following 25 mg/kg dose,Macaca mulatta,,,,Autocuration,,,In vivo,11129,,9544.0,22224,10791,
,U,A,CHEMBL622869,1,0,Urine,BAO_0000218,Urine conc 0-5 hours following 25 mg/kg dose,Macaca mulatta,,,,Autocuration,,,In vivo,11130,1088.0,9544.0,22224,10791,
,U,A,CHEMBL622870,1,0,Urine,BAO_0000218,Urine conc 0-24 hours following 25 mg/kg dose,Macaca mulatta,,,,Autocuration,,,In vivo,11131,1088.0,9544.0,22224,10791,
,U,A,CHEMBL622871,1,0,,BAO_0000218,Oral bioavailability in African green monkeys; 20-25,Chlorocebus aethiops,,,,Autocuration,,,In vivo,11132,,9534.0,22224,138,
,N,A,CHEMBL620560,1,1,,BAO_0000218,Oral bioavailability in cynomolgus monkey.,Macaca fascicularis,,,,Intermediate,,,In vivo,11133,,9541.0,100710,14521,
,U,A,CHEMBL620561,1,0,,BAO_0000218,Oral bioavailability in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,11134,,9615.0,22224,13953,
,N,A,CHEMBL620562,1,1,,BAO_0000218,Oral bioavailability in dog at 10 mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11135,,9615.0,50588,12836,
,N,A,CHEMBL620563,1,1,,BAO_0000218,Oral bioavailability in hamster at 10 mg/kg oral dose,Cricetinae,,,,Intermediate,,,In vivo,11136,,10026.0,100712,12836,
,N,A,CHEMBL620564,1,1,,BAO_0000218,Oral bioavailability in rat at 10 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11137,,10116.0,50597,12836,
,U,A,CHEMBL872265,1,0,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,11138,,10116.0,22224,14521,
,U,A,CHEMBL620565,1,0,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,11139,,10116.0,22224,13953,
,U,A,CHEMBL620566,1,0,,BAO_0000218,Oral bioavailability,Eutheria,,,,Autocuration,,,In vivo,11140,,9347.0,22224,6799,
,U,A,CHEMBL620567,1,0,,BAO_0000218,Oral bioavailability was determined; range 49-102%,,,,,Autocuration,,,In vivo,11141,,,22224,11311,
,N,A,CHEMBL620568,1,1,,BAO_0000218,Oral bioavailability was determined in dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,11142,,9615.0,50588,4013,
,U,A,CHEMBL620569,1,0,,BAO_0000218,Oral bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,11143,,10116.0,22224,4013,
,U,A,CHEMBL620570,1,0,,BAO_0000218,Oral bioavailability,Eutheria,,,,Autocuration,,,In vivo,11144,,9347.0,22224,17591,
,U,A,CHEMBL620571,1,0,,BAO_0000218,Oral bioavailability was determined; Not orally available,,,,,Autocuration,,,In vivo,11145,,,22224,17591,
,N,A,CHEMBL620572,1,1,,BAO_0000218,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,,Intermediate,,,In vivo,11146,,10090.0,50594,15011,
,U,A,CHEMBL620573,1,0,,BAO_0000218,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Mus musculus,,,,Autocuration,,,In vivo,11147,,10090.0,22224,15011,
,U,A,CHEMBL620574,1,0,,BAO_0000218,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Mus musculus,,,,Autocuration,,,In vivo,11148,,10090.0,22224,15011,
,U,A,CHEMBL620575,1,0,,BAO_0000218,Oral bioavailability in Rhesus monkey,Macaca mulatta,,,,Autocuration,,,In vivo,11149,,9544.0,22224,9552,
,U,A,CHEMBL620576,1,0,,BAO_0000218,Oral bioavailability in dog (female mongrel),Canis lupus familiaris,,,,Autocuration,,,In vivo,11150,,9615.0,22224,9552,
,U,A,CHEMBL875846,1,0,,BAO_0000218,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,,,Autocuration,,,In vivo,11151,,,22224,3639,
,U,A,CHEMBL620577,1,0,,BAO_0000218,Oral bioavailability in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,11152,,9615.0,22224,13397,
,U,A,CHEMBL620578,1,0,,BAO_0000218,Percentage Bioavailability was evaluated.,,,,,Autocuration,,,In vivo,11153,,,22224,3031,
,U,A,CHEMBL620579,1,0,,BAO_0000218,Bioavailability in rat administered i.d.,Rattus norvegicus,,,,Autocuration,,,In vivo,11154,,10116.0,22224,12818,
,U,A,CHEMBL621248,1,0,,BAO_0000218,Bioavailability,Eutheria,,,,Autocuration,,,In vivo,11155,,9347.0,22224,4847,
,U,A,CHEMBL625390,1,0,,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,,,,Autocuration,,,In vivo,11156,,9615.0,22224,12421,
,U,A,CHEMBL625391,1,0,,BAO_0000218,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Rattus norvegicus,,,,Autocuration,,,In vivo,11157,,10116.0,22224,11966,
,U,A,CHEMBL872266,1,0,,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Primates,,,,Autocuration,,,In vivo,11158,,9443.0,22224,11218,
,U,A,CHEMBL625392,1,0,,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,,,,Autocuration,,,In vivo,11159,,10116.0,22224,13129,
,N,A,CHEMBL625393,1,1,,BAO_0000218,The oral bioavailability was measured on rats after oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11160,,10116.0,50597,12350,
,N,A,CHEMBL625394,1,1,,BAO_0000218,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11161,,10116.0,50597,2231,
,N,A,CHEMBL625395,1,1,,BAO_0000218,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,,,,Intermediate,,,In vivo,11162,,9544.0,50797,2231,
,U,A,CHEMBL625396,1,0,,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,,,,Autocuration,,,In vivo,11163,,10116.0,22224,12187,
,U,A,CHEMBL625397,1,0,,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,,,,Autocuration,,,In vivo,11164,,9615.0,22224,12421,
,N,A,CHEMBL625398,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11165,,10090.0,50594,13256,
,N,A,CHEMBL625399,1,1,Blood,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11166,178.0,10090.0,50594,13256,
,N,A,CHEMBL626074,1,1,Cerebellum,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11167,2037.0,10090.0,50594,13256,
,N,A,CHEMBL626075,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11168,,10090.0,50594,13256,
,N,A,CHEMBL626076,1,1,Plasma,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11169,1969.0,10116.0,50597,2231,
,N,A,CHEMBL626077,1,1,Plasma,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,,,,Intermediate,,,In vivo,11170,1969.0,9544.0,50797,2231,
,N,A,CHEMBL626078,1,1,Blood,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Rattus norvegicus,,,,Intermediate,,,In vivo,11171,178.0,10116.0,50597,12178,
,U,A,CHEMBL625846,1,0,Blood,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,,,Autocuration,,,In vivo,11172,178.0,,22224,12178,
,U,A,CHEMBL625847,1,0,Blood,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,,,Autocuration,,,In vivo,11173,178.0,,22224,12178,
,N,A,CHEMBL625848,1,1,,BAO_0000218,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Rattus norvegicus,,,,Expert,,,In vivo,11174,,10116.0,50597,15633,
,N,A,CHEMBL625849,1,1,Plasma,BAO_0000218,Maximum concentration of compound in plasma administered orally to rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11175,1969.0,10116.0,50597,14258,
,N,A,CHEMBL626023,1,1,Plasma,BAO_0000218,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Canis lupus familiaris,,,,Intermediate,,,In vivo,11176,1969.0,9615.0,50588,14224,
,N,A,CHEMBL626024,1,1,Plasma,BAO_0000218,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Canis lupus familiaris,,,,Intermediate,,,In vivo,11177,1969.0,9615.0,50588,14224,
,N,A,CHEMBL626025,1,1,Plasma,BAO_0000218,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Canis lupus familiaris,,,,Intermediate,,,In vivo,11178,1969.0,9615.0,50588,14224,
,U,A,CHEMBL626026,1,0,,BAO_0000218,Maximum concentration after 10 mg/kg by oral administration,,,,,Autocuration,,,In vivo,11179,,,22224,5566,
,U,A,CHEMBL626027,1,0,,BAO_0000218,Maximum concentration at a dose of 1.5 mg/kg,,,,,Autocuration,,,In vivo,11180,,,22224,16935,
,U,A,CHEMBL626028,1,0,,BAO_0000218,Maximum concentration at a dose of 2.0 mg/kg,,,,,Autocuration,,,In vivo,11181,,,22224,16935,
,N,A,CHEMBL626029,1,1,Plasma,BAO_0000218,Maximum concentration in dog plasma,Canis lupus familiaris,,,,Intermediate,,,In vivo,11182,1969.0,9615.0,50588,14224,
,U,A,CHEMBL626030,1,0,Plasma,BAO_0000218,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,,,Autocuration,,,In vivo,11183,1969.0,,22224,12536,
,U,A,CHEMBL626031,1,0,Plasma,BAO_0000218,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,,,Autocuration,,,In vivo,11184,1969.0,,22224,12536,
,U,A,CHEMBL626032,1,0,Plasma,BAO_0000218,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,,,Autocuration,,,In vivo,11185,1969.0,,22224,12536,
,U,A,CHEMBL626033,1,0,Plasma,BAO_0000218,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,,,Autocuration,,,In vivo,11186,1969.0,,22224,12536,
,U,A,CHEMBL626034,1,0,Plasma,BAO_0000218,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,,,Autocuration,,,In vivo,11187,1969.0,,22224,12536,
,N,A,CHEMBL626035,1,1,Plasma,BAO_0000218,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,,,,Intermediate,,,In vivo,11188,1969.0,9615.0,50588,9994,
,U,A,CHEMBL626036,1,0,Plasma,BAO_0000218,Maximum concentration in plasma at Tmax,,,,,Autocuration,,,In vivo,11189,1969.0,,22224,1434,
,N,A,CHEMBL626037,1,1,Plasma,BAO_0000218,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Canis lupus familiaris,,,,Expert,,,In vivo,11190,1969.0,9615.0,50588,12836,
,N,A,CHEMBL626038,1,1,Plasma,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Cricetinae,,,,Intermediate,,,In vivo,11191,1969.0,10026.0,100712,12836,
,N,A,CHEMBL626039,1,1,Plasma,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11192,1969.0,10116.0,50597,12836,
,N,A,CHEMBL626040,1,1,Plasma,BAO_0000218,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11193,1969.0,10116.0,50597,12545,
,N,A,CHEMBL626041,1,1,Plasma,BAO_0000218,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Oryctolagus cuniculus,,,,Intermediate,,,In vivo,11194,1969.0,9986.0,50592,13856,
,U,A,CHEMBL626042,1,0,,BAO_0000218,Maximum concentration was calculated,,,,,Autocuration,,,In vivo,11195,,,22224,3550,
,U,A,CHEMBL626043,1,0,,BAO_0000218,Maximum concentration was calculated.,,,,,Autocuration,,,In vivo,11196,,,22224,2632,
,U,A,CHEMBL626044,1,0,,BAO_0000218,Maximum concentration at a peroral dose of 10 mg/kg,,,,,Autocuration,,,In vivo,11197,,,22224,5566,
,U,A,CHEMBL626045,1,0,,BAO_0000218,Maximum concentration of the drug at 10 uM/dg administered perorally,,,,,Autocuration,,,In vivo,11198,,,22224,11883,
,U,A,CHEMBL626046,1,0,,BAO_0000218,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,,,Autocuration,,,In vivo,11199,,,22224,11883,
,N,A,CHEMBL626047,1,1,Plasma,BAO_0000218,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Canis lupus familiaris,,,,Intermediate,,,In vivo,11200,1969.0,9615.0,50588,14122,
,N,A,CHEMBL626048,1,1,Plasma,BAO_0000218,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Cricetinae,,,,Intermediate,,,In vivo,11201,1969.0,10026.0,100712,14122,
,N,A,CHEMBL626049,1,1,Plasma,BAO_0000218,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Rattus norvegicus,,,,Intermediate,,,In vivo,11202,1969.0,10116.0,50597,14122,
,N,A,CHEMBL626050,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11203,1969.0,10116.0,50597,12542,
,N,A,CHEMBL874541,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11204,1969.0,9615.0,50588,12542,
,N,A,CHEMBL622826,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Cricetinae,,,,Intermediate,,,In vivo,11205,1969.0,10026.0,100712,12542,
,N,A,CHEMBL622827,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Cricetinae,,,,Intermediate,,,In vivo,11206,1969.0,10026.0,100712,12542,
,N,A,CHEMBL622828,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11207,1969.0,10116.0,50597,12542,
,N,A,CHEMBL622829,1,1,Plasma,BAO_0000218,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Rattus norvegicus,,,,Intermediate,,,In vivo,11208,1969.0,10116.0,50597,14080,
,N,A,CHEMBL876806,1,1,,BAO_0000218,Maximum concentration reached following intravenous administration in male rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11209,,10116.0,50597,11911,
,N,A,CHEMBL622830,1,1,,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11210,,9615.0,50588,13204,
,N,A,CHEMBL622831,1,1,,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11211,,10116.0,50597,13204,
,N,A,CHEMBL626794,1,1,,BAO_0000218,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,11212,,9615.0,50588,14346,
,N,A,CHEMBL626795,1,1,,BAO_0000218,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11213,,10116.0,50597,14346,
,N,A,CHEMBL626796,1,1,,BAO_0000218,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11214,,10116.0,50597,14346,
,N,A,CHEMBL626797,1,1,,BAO_0000218,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11215,,10116.0,50597,14346,
,N,A,CHEMBL626798,1,1,,BAO_0000218,Maximum drug concentration is determined after oral dosing in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,11216,,10116.0,50597,14127,
,N,A,CHEMBL626799,1,1,,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,11217,,9615.0,50588,14339,
,N,A,CHEMBL626800,1,1,,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fed dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,11218,,9615.0,50588,14339,
,U,A,CHEMBL626801,1,0,Plasma,BAO_0000218,Maximum plasma concentration,,,,,Autocuration,,,In vivo,11219,1969.0,,22224,13494,
,N,A,CHEMBL876816,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Rattus norvegicus,,,,Intermediate,,,In vivo,11220,1969.0,10116.0,50597,14925,
,N,A,CHEMBL626802,1,1,Plasma,BAO_0000218,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11221,1969.0,10116.0,50597,14474,
,N,A,CHEMBL626803,1,1,Plasma,BAO_0000218,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11222,1969.0,9615.0,50588,14474,
,U,A,CHEMBL626804,1,0,Plasma,BAO_0000218,Maximum plasma concentration following oral administration of 30 umol/kg,,,,,Autocuration,,,In vivo,11223,1969.0,,22224,13917,
,N,A,CHEMBL626805,1,1,Plasma,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Rattus norvegicus,,,,Intermediate,,,,11224,1969.0,10116.0,50597,9796,
,N,A,CHEMBL626309,1,1,Plasma,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11225,1969.0,10116.0,50597,9796,
,N,A,CHEMBL626310,1,1,Plasma,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11226,1969.0,10116.0,50597,9796,
,N,A,CHEMBL626311,1,1,Plasma,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11227,1969.0,10116.0,50597,9796,
,N,A,CHEMBL626312,1,1,Plasma,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11228,1969.0,10116.0,50597,9796,
,N,A,CHEMBL626313,1,1,Uterus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11229,995.0,10116.0,50597,9796,
,N,A,CHEMBL626314,1,1,Uterus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11230,995.0,10116.0,50597,9796,
,N,A,CHEMBL626315,1,1,Uterus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11231,995.0,10116.0,50597,9796,
,N,A,CHEMBL626316,1,1,Uterus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11232,995.0,10116.0,50597,9796,
,N,A,CHEMBL626317,1,1,Uterus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,,Intermediate,,,,11233,995.0,10116.0,50597,9796,
,N,A,CHEMBL626318,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11234,,10116.0,50597,8363,
,N,A,CHEMBL626319,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11235,,10116.0,50597,8363,
,N,A,CHEMBL626320,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11236,,10116.0,50597,8363,
,N,A,CHEMBL875053,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11237,,10116.0,50597,8363,
,N,A,CHEMBL626321,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11238,,10116.0,50597,8363,
,N,A,CHEMBL626322,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11239,,10116.0,50597,8363,
,N,A,CHEMBL626323,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11240,,10116.0,50597,8363,
,N,A,CHEMBL626324,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11241,,10116.0,50597,8363,
,N,A,CHEMBL626325,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11242,,10116.0,50597,8363,
,N,A,CHEMBL626326,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11243,,10116.0,50597,8363,
,N,A,CHEMBL626327,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,,Intermediate,,,,11244,,10116.0,50597,8363,
,N,A,CHEMBL626328,1,1,,BAO_0000218,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,,Intermediate,,,,11245,,10116.0,50597,8363,
,N,A,CHEMBL626329,1,1,Blood,BAO_0000218,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11246,178.0,10116.0,50597,8684,
,N,A,CHEMBL626330,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11247,178.0,10116.0,50597,8684,
,N,A,CHEMBL626331,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11248,178.0,10116.0,50597,8684,
,N,A,CHEMBL626332,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11249,178.0,10116.0,50597,8684,
,N,A,CHEMBL626333,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11250,178.0,10116.0,50597,8684,
,N,A,CHEMBL626334,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11251,178.0,10116.0,50597,8684,
,N,A,CHEMBL626335,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11252,178.0,10116.0,50597,8684,
,N,A,CHEMBL624798,1,1,Blood,BAO_0000218,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11253,178.0,10116.0,50597,8684,
,N,A,CHEMBL624799,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11254,955.0,10116.0,50597,8684,
,N,A,CHEMBL624800,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11255,955.0,10116.0,50597,8684,
,N,A,CHEMBL624801,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11256,955.0,10116.0,50597,8684,
,N,A,CHEMBL624802,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11257,955.0,10116.0,50597,8684,
,N,A,CHEMBL624803,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11258,955.0,10116.0,50597,8684,
,N,A,CHEMBL624804,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11259,955.0,10116.0,50597,8684,
,N,A,CHEMBL624805,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11260,955.0,10116.0,50597,8684,
,N,A,CHEMBL624806,1,1,Brain,BAO_0000218,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11261,955.0,10116.0,50597,8684,
,N,A,CHEMBL624807,1,1,,BAO_0000218,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11262,,10116.0,50597,8684,
,N,A,CHEMBL624808,1,1,,BAO_0000218,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11263,,10116.0,50597,8684,
,N,A,CHEMBL624809,1,1,,BAO_0000218,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11264,,10116.0,50597,8684,
,N,A,CHEMBL624810,1,1,,BAO_0000218,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11265,,10116.0,50597,8684,
,N,A,CHEMBL877618,1,1,,BAO_0000218,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11266,,10116.0,50597,8684,
,N,A,CHEMBL624811,1,1,,BAO_0000218,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11267,,10116.0,50597,8684,
,N,A,CHEMBL624812,1,1,,BAO_0000218,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11268,,10116.0,50597,8684,
,N,A,CHEMBL624813,1,1,,BAO_0000218,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11269,,10116.0,50597,8684,
,N,A,CHEMBL624814,1,1,,BAO_0000218,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11270,,10116.0,50597,8684,
,N,A,CHEMBL624815,1,1,,BAO_0000218,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11271,,10116.0,50597,8684,
,N,A,CHEMBL624816,1,1,,BAO_0000218,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11272,,10116.0,50597,8684,
,N,A,CHEMBL624817,1,1,,BAO_0000218,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11273,,10116.0,50597,8684,
,N,A,CHEMBL624818,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11274,,9615.0,50588,6996,
,N,A,CHEMBL624819,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,11275,,9615.0,50588,6996,
,N,A,CHEMBL624820,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11276,,9615.0,50588,6996,
,N,A,CHEMBL624821,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,11277,,9615.0,50588,6996,
,N,A,CHEMBL624822,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,11278,,9615.0,50588,6996,
,N,A,CHEMBL624823,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,11279,,9615.0,50588,6996,
,N,A,CHEMBL624824,1,1,,BAO_0000218,Observed diffusion coefficient in organic solvent for Escherichia coli,Escherichia coli,,,,Intermediate,,,,11280,,562.0,50212,15599,
,N,A,CHEMBL624825,1,1,Blood,BAO_0000218,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11281,178.0,10116.0,50597,9614,
,N,A,CHEMBL624826,1,1,Blood,BAO_0000218,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11282,178.0,10116.0,50597,9614,
,N,A,CHEMBL876817,1,1,Cardiac atrium,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11283,2081.0,10116.0,50597,9614,
,N,A,CHEMBL624827,1,1,Cardiac atrium,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11284,2081.0,10116.0,50597,9614,
,N,A,CHEMBL624828,1,1,,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11285,,10116.0,50597,9614,
,N,A,CHEMBL624829,1,1,,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11286,,10116.0,50597,9614,
,N,A,CHEMBL624830,1,1,Liver,BAO_0000218,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11287,2107.0,10116.0,50597,9614,
,N,A,CHEMBL624831,1,1,Liver,BAO_0000218,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11288,2107.0,10116.0,50597,9614,
,N,A,CHEMBL624832,1,1,Cardiac atrium,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11289,2081.0,10116.0,50597,9614,
,N,A,CHEMBL624833,1,1,Cardiac atrium,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11290,2081.0,10116.0,50597,9614,
,N,A,CHEMBL624834,1,1,,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11291,,10116.0,50597,9614,
,N,A,CHEMBL624835,1,1,,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11292,,10116.0,50597,9614,
,N,A,CHEMBL624836,1,1,Spleen,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,,Intermediate,,,,11293,2106.0,10116.0,50597,9614,
,N,A,CHEMBL624837,1,1,Spleen,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,,Intermediate,,,,11294,2106.0,10116.0,50597,9614,
,N,A,CHEMBL624838,1,1,Blood,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11295,178.0,10116.0,50597,9071,
,N,A,CHEMBL622188,1,1,Blood,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11296,178.0,10116.0,50597,9071,
,N,A,CHEMBL622189,1,1,Heart,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11297,948.0,10116.0,50597,9071,
,N,A,CHEMBL622190,1,1,Heart,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Rattus norvegicus,,,,Intermediate,,,,11298,948.0,10116.0,50597,9071,
,N,A,CHEMBL625170,1,1,Heart,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11299,948.0,10116.0,50597,9071,
,N,A,CHEMBL625171,1,1,Kidney,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11300,2113.0,10116.0,50597,9071,
,N,A,CHEMBL625172,1,1,Kidney,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11301,2113.0,10116.0,50597,9071,
,N,A,CHEMBL625173,1,1,Kidney,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11302,2113.0,10116.0,50597,9071,
,N,A,CHEMBL625174,1,1,Liver,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11303,2107.0,10116.0,50597,9071,
,N,A,CHEMBL625175,1,1,Liver,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11304,2107.0,10116.0,50597,9071,
,N,A,CHEMBL625176,1,1,Liver,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Rattus norvegicus,,,,Intermediate,,,,11305,2107.0,10116.0,50597,9071,
,N,A,CHEMBL625177,1,1,Lung,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11306,2048.0,10116.0,50597,9071,
,N,A,CHEMBL625178,1,1,Lung,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11307,2048.0,10116.0,50597,9071,
,N,A,CHEMBL625179,1,1,Lung,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Rattus norvegicus,,,,Intermediate,,,,11308,2048.0,10116.0,50597,9071,
,N,A,CHEMBL625180,1,1,Lung,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,,,,Intermediate,,,,11309,2048.0,10116.0,50597,9071,
,U,A,CHEMBL625181,1,0,,BAO_0000218,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,,,Autocuration,,,,11310,,,22224,10677,
,N,A,CHEMBL625182,1,1,Urine,BAO_0000218,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Mus musculus,,,,Intermediate,,,,11311,1088.0,10090.0,50594,9750,
,N,A,CHEMBL625183,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11312,,10116.0,50597,8319,
,N,A,CHEMBL875848,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11313,,10116.0,50597,8319,
,N,A,CHEMBL622260,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11314,,10116.0,50597,8319,
,N,A,CHEMBL622261,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11315,,10116.0,50597,8319,
,N,A,CHEMBL622262,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11316,,10116.0,50597,8319,
,N,A,CHEMBL622263,1,1,Kidney,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11317,2113.0,10116.0,50597,8319,
,N,A,CHEMBL622418,1,1,Kidney,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11318,2113.0,10116.0,50597,8319,
,N,A,CHEMBL622419,1,1,Liver,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11319,2107.0,10116.0,50597,8319,
,N,A,CHEMBL623388,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11320,,10090.0,50594,13256,
,N,A,CHEMBL623389,1,1,Liver,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11321,2107.0,10090.0,50594,13256,
,N,A,CHEMBL623390,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11322,,10090.0,50594,13256,
,N,A,CHEMBL623391,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11323,,10090.0,50594,13256,
,N,A,CHEMBL623392,1,1,Blood,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11324,178.0,10090.0,50594,13256,
,N,A,CHEMBL623393,1,1,Cerebellum,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11325,2037.0,10090.0,50594,13256,
,N,A,CHEMBL623394,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11326,,10090.0,50594,13256,
,N,A,CHEMBL618885,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11327,,10090.0,50594,13256,
,N,A,CHEMBL618886,1,1,Liver,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11328,2107.0,10090.0,50594,13256,
,N,A,CHEMBL618887,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11329,,10090.0,50594,13256,
,N,A,CHEMBL619535,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11330,,10090.0,50594,13256,
,N,A,CHEMBL619536,1,1,Blood,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11331,178.0,10090.0,50594,13256,
,N,A,CHEMBL619537,1,1,Cerebellum,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11332,2037.0,10090.0,50594,13256,
,N,A,CHEMBL619705,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11333,,10090.0,50594,13256,
,N,A,CHEMBL619706,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11334,,10090.0,50594,13256,
,N,A,CHEMBL619707,1,1,Liver,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11335,2107.0,10090.0,50594,13256,
,N,A,CHEMBL619708,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11336,,10090.0,50594,13256,
,N,A,CHEMBL625219,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11337,,10090.0,50594,13256,
,N,A,CHEMBL625220,1,1,Blood,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11338,178.0,10090.0,50594,13256,
,N,A,CHEMBL625221,1,1,Cerebellum,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11339,2037.0,10090.0,50594,13256,
,N,A,CHEMBL625222,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11340,,10090.0,50594,13256,
,N,A,CHEMBL625223,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11341,,10090.0,50594,13256,
,N,A,CHEMBL625224,1,1,Liver,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11342,2107.0,10090.0,50594,13256,
,N,A,CHEMBL625225,1,1,,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,,Intermediate,,,In vivo,11343,,10090.0,50594,13256,
,N,A,CHEMBL625226,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11344,178.0,10116.0,50597,8829,
,N,A,CHEMBL625227,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11345,178.0,10116.0,50597,8829,
,N,A,CHEMBL625228,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11346,178.0,10116.0,50597,8829,
,N,A,CHEMBL875354,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11347,178.0,10116.0,50597,8829,
,N,A,CHEMBL625229,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11348,178.0,10116.0,50597,8829,
,N,A,CHEMBL625230,1,1,Blood,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11349,178.0,10116.0,50597,8829,
,N,A,CHEMBL625231,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11350,948.0,10116.0,50597,8829,
,N,A,CHEMBL625900,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11351,948.0,10116.0,50597,8829,
,N,A,CHEMBL625901,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11352,948.0,10116.0,50597,8829,
,N,A,CHEMBL625902,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11353,948.0,10116.0,50597,8829,
,N,A,CHEMBL625903,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11354,948.0,10116.0,50597,8829,
,N,A,CHEMBL625904,1,1,Heart,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11355,948.0,10116.0,50597,8829,
,N,A,CHEMBL625905,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11356,2107.0,10116.0,50597,8829,
,N,A,CHEMBL627861,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11357,2107.0,10116.0,50597,8829,
,N,A,CHEMBL627862,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11358,2107.0,10116.0,50597,8829,
,N,A,CHEMBL627863,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11359,2107.0,10116.0,50597,8829,
,N,A,CHEMBL627769,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11360,2107.0,10116.0,50597,8829,
,N,A,CHEMBL627770,1,1,Plasma,BAO_0000218,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,,,,Intermediate,,,In vivo,11361,1969.0,9615.0,50588,13249,
,N,A,CHEMBL627771,1,1,,BAO_0000218,Cmax in cynomolgus monkey (PO dose),Macaca fascicularis,,,,Intermediate,,,In vivo,11362,,9541.0,100710,13622,
,N,A,CHEMBL627772,1,1,,BAO_0000218,Cmax in rat (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,11363,,10116.0,50597,13622,
,N,A,CHEMBL627773,1,1,,BAO_0000218,Cmax in rat (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,11364,,10116.0,50597,13622,
,N,A,CHEMBL621922,1,1,Plasma,BAO_0000218,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11365,1969.0,10116.0,50597,13494,
,N,A,CHEMBL621923,1,1,Plasma,BAO_0000218,Cmax in rat plasma after oral dose (10 mg/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,11366,1969.0,10116.0,50597,12170,
,U,A,CHEMBL621924,1,0,Plasma,BAO_0000218,Cmax in plasma after oral dose (10 mg/kg),,,,,Autocuration,,,In vivo,11367,1969.0,,22224,12170,
,N,A,CHEMBL621925,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,,,,Intermediate,,,In vivo,11368,1969.0,9615.0,50588,17025,
,U,A,CHEMBL621926,1,0,Plasma,BAO_0000218,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Simiiformes,,,,Autocuration,,,In vivo,11369,1969.0,314293.0,22224,17025,
,N,A,CHEMBL621927,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,,,,Intermediate,,,In vivo,11370,1969.0,9986.0,50592,17025,
,N,A,CHEMBL621928,1,1,Plasma,BAO_0000218,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,,,,Intermediate,,,In vivo,11371,1969.0,10116.0,50597,17025,
,N,A,CHEMBL621929,1,1,Plasma,BAO_0000218,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,11372,1969.0,10116.0,50597,14187,
,N,A,CHEMBL621930,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Mus musculus,,,,Intermediate,,,In vivo,11373,1969.0,10090.0,50594,14816,
,N,A,CHEMBL621931,1,1,Plasma,BAO_0000218,Maximum plasma concentration after oral dosing in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11374,1969.0,10116.0,50597,17820,
,U,A,CHEMBL621932,1,0,Plasma,BAO_0000218,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11375,1969.0,,22224,14380,
,U,A,CHEMBL621933,1,0,Plasma,BAO_0000218,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11376,1969.0,,22224,14380,
,N,A,CHEMBL621934,1,1,Plasma,BAO_0000218,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Canis lupus familiaris,,,,Intermediate,,,In vivo,11377,1969.0,9615.0,50588,14691,
,N,A,CHEMBL621935,1,1,Plasma,BAO_0000218,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,,,,Intermediate,,,In vivo,11378,1969.0,9615.0,50588,14691,
,N,A,CHEMBL621936,1,1,Plasma,BAO_0000218,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11379,1969.0,10116.0,50597,13375,
,U,A,CHEMBL621937,1,0,Plasma,BAO_0000218,Maximum plasma concentration was determined,,,,,Autocuration,,,In vivo,11380,1969.0,,22224,6236,
,U,A,CHEMBL621938,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11381,1969.0,,22224,14380,
,U,A,CHEMBL621939,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11382,1969.0,,22224,14380,
,U,A,CHEMBL621940,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11383,1969.0,,22224,14380,
,U,A,CHEMBL621941,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11384,1969.0,,22224,14380,
,U,A,CHEMBL621942,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11385,1969.0,,22224,14380,
,U,A,CHEMBL626178,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11386,1969.0,,22224,14380,
,U,A,CHEMBL626179,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11387,1969.0,,22224,14380,
,U,A,CHEMBL626180,1,0,Plasma,BAO_0000218,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,In vivo,11388,1969.0,,22224,14380,
,N,A,CHEMBL626181,1,1,Plasma,BAO_0000218,Plasma Cmax in rat (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,11389,1969.0,10116.0,50597,13622,
,N,A,CHEMBL626182,1,1,,BAO_0000218,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11390,,10116.0,50597,15372,
,N,A,CHEMBL626183,1,1,,BAO_0000218,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11391,,10116.0,50597,15372,
,N,A,CHEMBL626184,1,1,,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11392,,10116.0,50597,15372,
,N,A,CHEMBL626185,1,1,,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11393,,10116.0,50597,15372,
,N,A,CHEMBL626186,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11394,1969.0,9615.0,50588,14925,
,N,A,CHEMBL877589,1,1,Plasma,BAO_0000218,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11395,1969.0,9615.0,50588,14925,
,U,A,CHEMBL626187,1,0,,BAO_0000218,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,,,Autocuration,,,In vivo,11396,,,22224,11883,
,U,A,CHEMBL626188,1,0,,BAO_0000218,Maximum concentration of the drug at 20 uM/dg administered perorally,,,,,Autocuration,,,In vivo,11397,,,22224,11883,
,U,A,CHEMBL626189,1,0,,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,,,Autocuration,,,In vivo,11398,,,22224,13391,
,U,A,CHEMBL626855,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,In vivo,11399,178.0,,22224,13391,
,U,A,CHEMBL623781,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,In vivo,11400,178.0,,22224,13391,
,U,A,CHEMBL623782,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,In vivo,11401,178.0,,22224,13391,
,N,A,CHEMBL623783,1,1,Plasma,BAO_0000218,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11402,1969.0,10116.0,50597,16360,
,N,A,CHEMBL623784,1,1,Plasma,BAO_0000218,Cmax in dog plasma after 1mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11403,1969.0,9615.0,50588,3673,
,N,A,CHEMBL623785,1,1,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11404,1969.0,9615.0,50588,14431,
,N,A,CHEMBL623786,1,1,Plasma,BAO_0000218,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11405,1969.0,10116.0,50597,14431,
,N,A,CHEMBL623787,1,1,,BAO_0000218,Oral maximum concentration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11406,,10116.0,50597,14964,
,N,A,CHEMBL623788,1,1,,BAO_0000218,Oral maximum concentration in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11407,,10116.0,50597,14964,
,N,A,CHEMBL623789,1,1,Plasma,BAO_0000218,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Mus musculus,,,,Intermediate,,,In vivo,11408,1969.0,10090.0,50594,14209,
,N,A,CHEMBL623790,1,1,Blood,BAO_0000218,Peak concentration in blood after intravenous administration to mice,Mus musculus,,,,Intermediate,,,In vivo,11409,178.0,10090.0,50594,11355,
,N,A,CHEMBL623791,1,1,Blood,BAO_0000218,Peak concentration in blood after peroral administration to mice,Mus musculus,,,,Intermediate,,,In vivo,11410,178.0,10090.0,50594,11355,
,N,A,CHEMBL623792,1,1,Plasma,BAO_0000218,Peak concentration in rat plasma was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,11411,1969.0,10116.0,50597,11966,
,U,A,CHEMBL623793,1,0,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,,,,Autocuration,,,In vivo,11412,1969.0,314293.0,22224,8918,
,N,A,CHEMBL623794,1,1,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,,,,Intermediate,,,In vivo,11413,1969.0,10090.0,50594,8918,
,N,A,CHEMBL623795,1,1,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11414,1969.0,10116.0,50597,8918,
,N,A,CHEMBL623796,1,1,,BAO_0000218,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11415,,10116.0,50597,8684,
,N,A,CHEMBL623797,1,1,,BAO_0000218,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11416,,10116.0,50597,8684,
,N,A,CHEMBL623798,1,1,,BAO_0000218,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11417,,10116.0,50597,8684,
,N,A,CHEMBL623799,1,1,,BAO_0000218,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11418,,10116.0,50597,8684,
,N,A,CHEMBL624490,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11419,160.0,10116.0,50597,8684,
,N,A,CHEMBL624491,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11420,160.0,10116.0,50597,8684,
,N,A,CHEMBL624492,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11421,160.0,10116.0,50597,8684,
,N,A,CHEMBL624493,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11422,160.0,10116.0,50597,8684,
,N,A,CHEMBL877595,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11423,160.0,10116.0,50597,8684,
,N,A,CHEMBL624494,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11424,160.0,10116.0,50597,8684,
,N,A,CHEMBL624495,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11425,160.0,10116.0,50597,8684,
,N,A,CHEMBL624681,1,1,Intestine,BAO_0000218,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11426,160.0,10116.0,50597,8684,
,N,A,CHEMBL624682,1,1,,BAO_0000218,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11427,,10116.0,50597,8684,
,N,A,CHEMBL624683,1,1,,BAO_0000218,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11428,,10116.0,50597,8684,
,N,A,CHEMBL624684,1,1,,BAO_0000218,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11429,,10116.0,50597,8684,
,N,A,CHEMBL624685,1,1,,BAO_0000218,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11430,,10116.0,50597,8684,
,N,A,CHEMBL624686,1,1,,BAO_0000218,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11431,,10116.0,50597,8684,
,N,A,CHEMBL624687,1,1,,BAO_0000218,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11432,,10116.0,50597,8684,
,N,A,CHEMBL624688,1,1,,BAO_0000218,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11433,,10116.0,50597,8684,
,N,A,CHEMBL627161,1,1,,BAO_0000218,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11434,,10116.0,50597,8684,
,N,A,CHEMBL622127,1,1,,BAO_0000218,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11435,,10116.0,50597,8684,
,N,A,CHEMBL622128,1,1,,BAO_0000218,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11436,,10116.0,50597,8684,
,N,A,CHEMBL874384,1,1,,BAO_0000218,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11437,,10116.0,50597,8684,
,N,A,CHEMBL624898,1,1,,BAO_0000218,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11438,,10116.0,50597,8684,
,N,A,CHEMBL624899,1,1,,BAO_0000218,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11439,,10116.0,50597,8684,
,N,A,CHEMBL624900,1,1,,BAO_0000218,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11440,,10116.0,50597,8684,
,N,A,CHEMBL624901,1,1,,BAO_0000218,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11441,,10116.0,50597,8684,
,N,A,CHEMBL624902,1,1,,BAO_0000218,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11442,,10116.0,50597,8684,
,N,A,CHEMBL624903,1,1,,BAO_0000218,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11443,,10116.0,50597,8684,
,N,A,CHEMBL624904,1,1,,BAO_0000218,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11444,,10116.0,50597,8684,
,N,A,CHEMBL624905,1,1,,BAO_0000218,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11445,,10116.0,50597,8684,
,N,A,CHEMBL624906,1,1,,BAO_0000218,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11446,,10116.0,50597,8684,
,N,A,CHEMBL624907,1,1,,BAO_0000218,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11447,,10116.0,50597,8684,
,N,A,CHEMBL624908,1,1,,BAO_0000218,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11448,,10116.0,50597,8684,
,N,A,CHEMBL624909,1,1,,BAO_0000218,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11449,,10116.0,50597,8684,
,N,A,CHEMBL624910,1,1,,BAO_0000218,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11450,,10116.0,50597,8684,
,N,A,CHEMBL624911,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11451,2385.0,10116.0,50597,8684,
,N,A,CHEMBL874388,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11452,2385.0,10116.0,50597,8684,
,N,A,CHEMBL624912,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11453,2385.0,10116.0,50597,8684,
,N,A,CHEMBL622930,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11454,2385.0,10116.0,50597,8684,
,N,A,CHEMBL623121,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11455,2385.0,10116.0,50597,8684,
,N,A,CHEMBL623122,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11456,2385.0,10116.0,50597,8684,
,N,A,CHEMBL623123,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11457,2385.0,10116.0,50597,8684,
,N,A,CHEMBL623124,1,1,Muscle tissue,BAO_0000218,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11458,2385.0,10116.0,50597,8684,
,N,A,CHEMBL623125,1,1,,BAO_0000218,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11459,,10116.0,50597,8684,
,N,A,CHEMBL623126,1,1,,BAO_0000218,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11460,,10116.0,50597,8684,
,N,A,CHEMBL623127,1,1,,BAO_0000218,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11461,,10116.0,50597,8684,
,N,A,CHEMBL623128,1,1,,BAO_0000218,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11462,,10116.0,50597,8684,
,N,A,CHEMBL623129,1,1,,BAO_0000218,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11463,,10116.0,50597,8684,
,N,A,CHEMBL623130,1,1,,BAO_0000218,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11464,,10116.0,50597,8684,
,N,A,CHEMBL623131,1,1,,BAO_0000218,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11465,,10116.0,50597,8684,
,N,A,CHEMBL623132,1,1,,BAO_0000218,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11466,,10116.0,50597,8684,
,N,A,CHEMBL623133,1,1,Liver,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11467,2107.0,10116.0,50597,8319,
,N,A,CHEMBL623134,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11468,,10116.0,50597,8319,
,N,A,CHEMBL874389,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11469,,10116.0,50597,8319,
,N,A,CHEMBL623135,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11470,,10116.0,50597,8319,
,N,A,CHEMBL623136,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11471,,10116.0,50597,8319,
,N,A,CHEMBL623137,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11472,,10116.0,50597,8319,
,N,A,CHEMBL623138,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11473,,10116.0,50597,8319,
,N,A,CHEMBL623139,1,1,Kidney,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11474,2113.0,10116.0,50597,8319,
,N,A,CHEMBL623140,1,1,Kidney,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11475,2113.0,10116.0,50597,8319,
,N,A,CHEMBL623141,1,1,Liver,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11476,2107.0,10116.0,50597,8319,
,N,A,CHEMBL623142,1,1,Liver,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11477,2107.0,10116.0,50597,8319,
,N,A,CHEMBL623143,1,1,,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11478,,10116.0,50597,8319,
,N,A,CHEMBL623144,1,1,Urine,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Mus musculus,,,,Intermediate,,,,11479,1088.0,10090.0,50594,14571,
,N,A,CHEMBL623405,1,1,Urine,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Rattus norvegicus,,,,Intermediate,,,,11480,1088.0,10116.0,50597,14571,
,N,A,CHEMBL624074,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11481,,10116.0,50597,8319,
,N,A,CHEMBL624075,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11482,,10116.0,50597,8319,
,N,A,CHEMBL624076,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11483,,10116.0,50597,8319,
,N,A,CHEMBL624077,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11484,,10116.0,50597,8319,
,N,A,CHEMBL624078,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11485,,10116.0,50597,8319,
,N,A,CHEMBL624079,1,1,Kidney,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11486,2113.0,10116.0,50597,8319,
,N,A,CHEMBL624261,1,1,Kidney,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11487,2113.0,10116.0,50597,8319,
,N,A,CHEMBL624262,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11488,,10116.0,50597,8319,
,N,A,CHEMBL624263,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11489,,10116.0,50597,8319,
,N,A,CHEMBL624264,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11490,,10116.0,50597,8319,
,N,A,CHEMBL624265,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11491,,10116.0,50597,8319,
,N,A,CHEMBL624266,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11492,,10116.0,50597,8319,
,N,A,CHEMBL624267,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11493,,10116.0,50597,8319,
,N,A,CHEMBL624268,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11494,,10116.0,50597,8319,
,N,A,CHEMBL875227,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11495,,10116.0,50597,8319,
,N,A,CHEMBL624269,1,1,Kidney,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11496,2113.0,10116.0,50597,8319,
,N,A,CHEMBL624270,1,1,Kidney,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11497,2113.0,10116.0,50597,8319,
,N,A,CHEMBL624271,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,,Intermediate,,,,11498,,10116.0,50597,8319,
,N,A,CHEMBL624272,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11499,,10116.0,50597,8319,
,N,A,CHEMBL624273,1,1,,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,,Intermediate,,,,11500,,10116.0,50597,8319,
,N,A,CHEMBL624274,1,1,Urine,BAO_0000218,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11501,1088.0,10116.0,50597,12064,
,N,A,CHEMBL624275,1,1,Urine,BAO_0000218,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11502,1088.0,10116.0,50597,12064,
,N,A,CHEMBL624276,1,1,Urine,BAO_0000218,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11503,1088.0,10116.0,50597,12064,
,N,A,CHEMBL624277,1,1,Urine,BAO_0000218,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11504,1088.0,10116.0,50597,12038,
,U,A,CHEMBL624278,1,0,,BAO_0000019,% dose converted to 2-amino-5-chlorophenyl sulfate,,,,,Autocuration,,,,11505,,,22224,14314,
,U,A,CHEMBL624279,1,0,,BAO_0000019,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,,,Autocuration,,,,11506,,,22224,14314,
,N,A,CHEMBL624280,1,1,Feces,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,,,Intermediate,,,,11507,1988.0,10116.0,50597,11488,
,N,A,CHEMBL624281,1,1,Feces,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,,,Intermediate,,,,11508,1988.0,10116.0,50597,11488,
,N,A,CHEMBL622933,1,1,Feces,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,,,Intermediate,,,,11509,1988.0,10116.0,50597,11488,
,N,A,CHEMBL622934,1,1,Feces,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,,,Intermediate,,,,11510,1988.0,10116.0,50597,11488,
,N,A,CHEMBL622935,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11511,2107.0,10116.0,50597,8829,
,N,A,CHEMBL622936,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11512,2107.0,10116.0,50597,8829,
,N,A,CHEMBL875228,1,1,Liver,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11513,2107.0,10116.0,50597,8829,
,N,A,CHEMBL622937,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11514,2048.0,10116.0,50597,8829,
,N,A,CHEMBL622938,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11515,2048.0,10116.0,50597,8829,
,N,A,CHEMBL619736,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11516,2048.0,10116.0,50597,8829,
,N,A,CHEMBL625117,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11517,2048.0,10116.0,50597,8829,
,N,A,CHEMBL625118,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11518,2048.0,10116.0,50597,8829,
,N,A,CHEMBL625119,1,1,Lung,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,,,Intermediate,,,In vivo,11519,2048.0,10116.0,50597,8829,
,N,A,CHEMBL625120,1,1,Cerebellum,BAO_0000218,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Rattus norvegicus,,,,Intermediate,,,In vivo,11520,2037.0,10116.0,50597,14972,
,N,A,CHEMBL625121,1,1,,BAO_0000218,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Rattus norvegicus,,,,Intermediate,,,In vivo,11521,,10116.0,50597,14972,
,N,A,CHEMBL625122,1,1,Thalamus,BAO_0000218,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Rattus norvegicus,,,,Intermediate,,,In vivo,11522,10000006.0,10116.0,50597,14972,
,N,A,CHEMBL622204,1,1,Blood,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11523,178.0,10116.0,50597,14608,
,N,A,CHEMBL877503,1,1,Blood,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11524,178.0,10116.0,50597,14608,
,N,A,CHEMBL627127,1,1,Blood,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11525,178.0,10116.0,50597,14608,
,U,A,CHEMBL627128,1,0,Hippocampus,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,,,Autocuration,,,In vivo,11526,10000000.0,,22224,14608,
,U,A,CHEMBL627129,1,0,Hippocampus,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,,,Autocuration,,,In vivo,11527,10000000.0,,22224,14608,
,U,A,CHEMBL627130,1,0,Hippocampus,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,,,Autocuration,,,In vivo,11528,10000000.0,,22224,14608,
,N,A,CHEMBL627131,1,1,Brain,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11529,955.0,10116.0,50597,14608,
,N,A,CHEMBL627132,1,1,Brain,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11530,955.0,10116.0,50597,14608,
,N,A,CHEMBL627133,1,1,Brain,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11531,955.0,10116.0,50597,14608,
,N,A,CHEMBL627134,1,1,Cerebellum,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11532,2037.0,10116.0,50597,14608,
,N,A,CHEMBL627135,1,1,Cerebellum,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11533,2037.0,10116.0,50597,14608,
,N,A,CHEMBL627136,1,1,Cerebellum,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11534,2037.0,10116.0,50597,14608,
,N,A,CHEMBL628435,1,1,,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11535,,10116.0,50597,14608,
,N,A,CHEMBL628436,1,1,,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11536,,10116.0,50597,14608,
,N,A,CHEMBL628437,1,1,,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11537,,10116.0,50597,14608,
,N,A,CHEMBL628438,1,1,Heart,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11538,948.0,10116.0,50597,14608,
,N,A,CHEMBL628439,1,1,Heart,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11539,948.0,10116.0,50597,14608,
,N,A,CHEMBL628440,1,1,Heart,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11540,948.0,10116.0,50597,14608,
,N,A,CHEMBL628441,1,1,Hippocampus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11541,10000000.0,10116.0,50597,14608,
,N,A,CHEMBL628442,1,1,Hippocampus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11542,10000000.0,10116.0,50597,14608,
,N,A,CHEMBL628443,1,1,Hippocampus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11543,10000000.0,10116.0,50597,14608,
,N,A,CHEMBL628444,1,1,Kidney,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11544,2113.0,10116.0,50597,14608,
,N,A,CHEMBL628445,1,1,Kidney,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11545,2113.0,10116.0,50597,14608,
,N,A,CHEMBL877504,1,1,Kidney,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11546,2113.0,10116.0,50597,14608,
,N,A,CHEMBL628446,1,1,Liver,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11547,2107.0,10116.0,50597,14608,
,N,A,CHEMBL626874,1,1,Liver,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11548,2107.0,10116.0,50597,14608,
,N,A,CHEMBL626875,1,1,Liver,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11549,2107.0,10116.0,50597,14608,
,N,A,CHEMBL626876,1,1,Lung,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11550,2048.0,10116.0,50597,14608,
,N,A,CHEMBL626877,1,1,Lung,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11551,2048.0,10116.0,50597,14608,
,N,A,CHEMBL626878,1,1,Lung,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11552,2048.0,10116.0,50597,14608,
,N,A,CHEMBL626879,1,1,Muscle tissue,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11553,2385.0,10116.0,50597,14608,
,U,A,CHEMBL626880,1,0,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,,,,Autocuration,,,In vivo,11554,1969.0,314293.0,22224,8918,
,N,A,CHEMBL626881,1,1,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,,,,Intermediate,,,In vivo,11555,1969.0,10090.0,50594,8918,
,N,A,CHEMBL626882,1,1,Plasma,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11556,1969.0,10116.0,50597,8918,
,N,A,CHEMBL626883,1,1,Plasma,BAO_0000218,Peak plasma concentration was measured in dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,11557,1969.0,9615.0,50588,14470,
,N,A,CHEMBL626884,1,1,,BAO_0000218,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11558,,10116.0,50597,14393,
,N,A,CHEMBL626885,1,1,,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11559,,10116.0,50597,14886,
,N,A,CHEMBL626886,1,1,,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11560,,10116.0,50597,14886,
,N,A,CHEMBL626887,1,1,,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11561,,10116.0,50597,14886,
,N,A,CHEMBL626888,1,1,,BAO_0000218,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11562,,10116.0,50597,14393,
,N,A,CHEMBL626889,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11563,,9615.0,50588,13465,
,U,A,CHEMBL626761,1,0,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Simiiformes,,,,Autocuration,,,In vivo,11564,,314293.0,22224,13465,
,N,A,CHEMBL626762,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11565,,9615.0,50588,13465,
,N,A,CHEMBL626763,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11566,,9615.0,50588,13465,
,N,A,CHEMBL626764,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11567,,10116.0,50597,13465,
,N,A,CHEMBL626765,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11568,,10116.0,50597,13465,
,N,A,CHEMBL626766,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11569,,9615.0,50588,13465,
,N,A,CHEMBL626767,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11570,,10116.0,50597,13465,
,N,A,CHEMBL626768,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Rattus norvegicus,,,,Intermediate,,,In vivo,11571,,10116.0,50597,13465,
,N,A,CHEMBL626769,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11572,,9615.0,50588,13465,
,N,A,CHEMBL874463,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11573,,9615.0,50588,13465,
,U,A,CHEMBL626770,1,0,,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Simiiformes,,,,Autocuration,,,In vivo,11574,,314293.0,22224,13465,
,U,A,CHEMBL626771,1,0,,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Simiiformes,,,,Autocuration,,,In vivo,11575,,314293.0,22224,13465,
,N,A,CHEMBL626772,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11576,,10116.0,50597,13465,
,N,A,CHEMBL626773,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,,,,Intermediate,,,In vivo,11577,,9541.0,100710,14731,
,N,A,CHEMBL626774,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Mus musculus,,,,Intermediate,,,In vivo,11578,,10090.0,50594,14731,
,N,A,CHEMBL626775,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,,,,Intermediate,,,In vivo,11579,,9615.0,50588,13376,
,N,A,CHEMBL626776,1,1,,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,,,,Intermediate,,,In vivo,11580,,9615.0,50588,13376,
,N,A,CHEMBL626777,1,1,,BAO_0000218,Maximum concentration (Cmax) in rat when administered orally,Rattus norvegicus,,,,Intermediate,,,In vivo,11581,,10116.0,50597,14443,
,U,A,CHEMBL626778,1,0,Plasma,BAO_0000218,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Simiiformes,,,,Autocuration,,,In vivo,11582,1969.0,314293.0,22224,13465,
,U,A,CHEMBL626779,1,0,,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Rattus norvegicus,,,,Autocuration,,,In vivo,11583,,10116.0,22224,16359,
,U,A,CHEMBL626780,1,0,,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Rattus norvegicus,,,,Autocuration,,,In vivo,11584,,10116.0,22224,16359,
,U,A,CHEMBL626781,1,0,Plasma,BAO_0000218,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,,,Autocuration,,,In vivo,11585,1969.0,,22224,15618,
,N,A,CHEMBL632164,1,1,,BAO_0000218,Pharmacokinetic profile Cmax was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11586,,10116.0,50597,14554,
,N,A,CHEMBL632165,1,1,,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Canis lupus familiaris,,,,Intermediate,,,In vivo,11587,,9615.0,50588,11537,
,N,A,CHEMBL632166,1,1,,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Mus musculus,,,,Intermediate,,,In vivo,11588,,10090.0,50594,11537,
,N,A,CHEMBL632167,1,1,,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Canis lupus familiaris,,,,Intermediate,,,In vivo,11589,,9615.0,50588,11537,
,N,A,CHEMBL632168,1,1,,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Mus musculus,,,,Intermediate,,,In vivo,11590,,10090.0,50594,11537,
,U,A,CHEMBL632169,1,0,Plasma,BAO_0000218,Cmax in rat plasma,Rattus norvegicus,,,,Autocuration,,,In vivo,11591,1969.0,10116.0,22224,2021,
,N,A,CHEMBL632170,1,1,Plasma,BAO_0000218,Cmax in dog plasma after 30mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11592,1969.0,9615.0,50588,5932,
,N,A,CHEMBL632171,1,1,Plasma,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11593,1969.0,10116.0,50597,5932,
,N,A,CHEMBL632172,1,1,Plasma,BAO_0000218,Plasma level in rats at 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,11594,1969.0,10116.0,50597,17320,
,N,A,CHEMBL632173,1,1,Plasma,BAO_0000218,Tested for maximum plasma concentration in mice,Mus musculus,,,,Intermediate,,,In vivo,11595,1969.0,10090.0,50594,15831,
,N,A,CHEMBL632174,1,1,,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,In vivo,11596,,10116.0,50597,15078,
,N,A,CHEMBL632175,1,1,,BAO_0000218,The Cmax values in female wistar rats.,Rattus norvegicus,,,,Intermediate,,,In vivo,11597,,10116.0,50597,14941,
,N,A,CHEMBL632176,1,1,Plasma,BAO_0000218,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,11598,1969.0,9615.0,50588,15343,
,N,A,CHEMBL632177,1,1,Plasma,BAO_0000218,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,In vivo,11599,1969.0,10116.0,50597,15343,
,N,A,CHEMBL632178,1,1,Plasma,BAO_0000218,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Rattus norvegicus,,,,Intermediate,,,In vivo,11600,1969.0,10116.0,50597,14856,
,N,A,CHEMBL632179,1,1,,BAO_0000218,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,11601,,10116.0,50597,13129,
,N,A,CHEMBL632180,1,1,Blood,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11602,178.0,10116.0,50597,13098,
,N,A,CHEMBL632181,1,1,Blood,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11603,178.0,10116.0,50597,13098,
,N,A,CHEMBL632182,1,1,Blood,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11604,178.0,10116.0,50597,13098,
,U,A,CHEMBL632183,1,0,Blood,BAO_0000218,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Mus musculus,,,,Autocuration,,,In vivo,11605,178.0,10090.0,22224,15478,
,N,A,CHEMBL632184,1,1,,BAO_0000218,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11606,,9615.0,50588,15341,
,N,A,CHEMBL874470,1,1,,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11607,,10116.0,50597,15341,
,N,A,CHEMBL631302,1,1,,BAO_0000218,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11608,,10116.0,50597,8684,
,N,A,CHEMBL631303,1,1,,BAO_0000218,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11609,,10116.0,50597,8684,
,N,A,CHEMBL631304,1,1,,BAO_0000218,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11610,,10116.0,50597,8684,
,N,A,CHEMBL631305,1,1,,BAO_0000218,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11611,,10116.0,50597,8684,
,N,A,CHEMBL631306,1,1,,BAO_0000218,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11612,,10116.0,50597,8684,
,N,A,CHEMBL631307,1,1,,BAO_0000218,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11613,,10116.0,50597,8684,
,N,A,CHEMBL631308,1,1,,BAO_0000218,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11614,,10116.0,50597,8684,
,N,A,CHEMBL625557,1,1,,BAO_0000218,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11615,,10116.0,50597,8684,
,N,A,CHEMBL625558,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11616,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625559,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11617,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625560,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11618,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625561,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11619,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625562,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11620,2106.0,10116.0,50597,8684,
,N,A,CHEMBL875320,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11621,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625563,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11622,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625564,1,1,Spleen,BAO_0000218,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11623,2106.0,10116.0,50597,8684,
,N,A,CHEMBL625565,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11624,995.0,10116.0,50597,8684,
,N,A,CHEMBL625566,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11625,995.0,10116.0,50597,8684,
,N,A,CHEMBL625567,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11626,995.0,10116.0,50597,8684,
,N,A,CHEMBL625568,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11627,995.0,10116.0,50597,8684,
,N,A,CHEMBL628217,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11628,995.0,10116.0,50597,8684,
,N,A,CHEMBL628218,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11629,995.0,10116.0,50597,8684,
,N,A,CHEMBL628219,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11630,995.0,10116.0,50597,8684,
,N,A,CHEMBL628220,1,1,Uterus,BAO_0000218,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,,Intermediate,,,,11631,995.0,10116.0,50597,8684,
,U,A,CHEMBL628221,1,0,,BAO_0000019,Distribution in the blood after 120 min of intravenous administration,,,,,Autocuration,,,,11632,,,22224,8926,
,U,A,CHEMBL628222,1,0,,BAO_0000019,Distribution in the blood after 15 min of intravenous administration,,,,,Autocuration,,,,11633,,,22224,8926,
,U,A,CHEMBL628223,1,0,,BAO_0000019,Distribution in the blood after 30 min of intravenous administration,,,,,Autocuration,,,,11634,,,22224,8926,
,U,A,CHEMBL628224,1,0,,BAO_0000019,Distribution in the blood after 5 min of intravenous administration,,,,,Autocuration,,,,11635,,,22224,8926,
,U,A,CHEMBL628225,1,0,,BAO_0000019,Distribution in the blood after 60 min of intravenous administration,,,,,Autocuration,,,,11636,,,22224,8926,
,U,A,CHEMBL628226,1,0,,BAO_0000019,Distribution in the blood after 90 min of intravenous administration,,,,,Autocuration,,,,11637,,,22224,8926,
,U,A,CHEMBL628227,1,0,,BAO_0000019,Distribution in the bone after 120 min of intravenous administration,,,,,Autocuration,,,,11638,,,22224,8926,
,U,A,CHEMBL875481,1,0,,BAO_0000019,Distribution in the bone after 15 min of intravenous administration,,,,,Autocuration,,,,11639,,,22224,8926,
,U,A,CHEMBL628228,1,0,,BAO_0000019,Distribution in the bone after 30 min of intravenous administration,,,,,Autocuration,,,,11640,,,22224,8926,
,U,A,CHEMBL628229,1,0,,BAO_0000019,Distribution in the bone after 5 min of intravenous administration,,,,,Autocuration,,,,11641,,,22224,8926,
,U,A,CHEMBL628230,1,0,,BAO_0000019,Distribution in the bone after 60 min of intravenous administration,,,,,Autocuration,,,,11642,,,22224,8926,
,U,A,CHEMBL628231,1,0,,BAO_0000019,Distribution in the bone after 90 min of intravenous administration,,,,,Autocuration,,,,11643,,,22224,8926,
,U,A,CHEMBL628232,1,0,,BAO_0000019,Distribution in the heart after 120 min of intravenous administration,,,,,Autocuration,,,,11644,,,22224,8926,
,U,A,CHEMBL628233,1,0,,BAO_0000019,Distribution in the heart after 15 min of intravenous administration,,,,,Autocuration,,,,11645,,,22224,8926,
,U,A,CHEMBL628234,1,0,,BAO_0000019,Distribution in the heart after 30 min of intravenous administration,,,,,Autocuration,,,,11646,,,22224,8926,
,U,A,CHEMBL628235,1,0,,BAO_0000019,Distribution in the heart after 5 min of intravenous administration,,,,,Autocuration,,,,11647,,,22224,8926,
,U,A,CHEMBL628236,1,0,,BAO_0000019,Distribution in the heart after 60 min of intravenous administration,,,,,Autocuration,,,,11648,,,22224,8926,
,U,A,CHEMBL628237,1,0,,BAO_0000019,Distribution in the heart after 90 min of intravenous administration,,,,,Autocuration,,,,11649,,,22224,8926,
,U,A,CHEMBL628238,1,0,,BAO_0000019,Distribution in the kidneys after 120 min of intravenous administration,,,,,Autocuration,,,,11650,,,22224,8926,
,U,A,CHEMBL628239,1,0,,BAO_0000019,Distribution in the kidneys after 15 min of intravenous administration,,,,,Autocuration,,,,11651,,,22224,8926,
,U,A,CHEMBL628240,1,0,,BAO_0000019,Distribution in the kidneys after 30 min of intravenous administration,,,,,Autocuration,,,,11652,,,22224,8926,
,U,A,CHEMBL628241,1,0,,BAO_0000019,Distribution in the kidneys after 5 min of intravenous administration,,,,,Autocuration,,,,11653,,,22224,8926,
,U,A,CHEMBL628242,1,0,,BAO_0000019,Distribution in the kidneys after 60 min of intravenous administration,,,,,Autocuration,,,,11654,,,22224,8926,
,U,A,CHEMBL875482,1,0,,BAO_0000019,Distribution in the kidneys after 90 min of intravenous administration,,,,,Autocuration,,,,11655,,,22224,8926,
,U,A,CHEMBL628243,1,0,,BAO_0000019,Distribution in the liver after 120 min of intravenous administration,,,,,Autocuration,,,,11656,,,22224,8926,
,U,A,CHEMBL628244,1,0,,BAO_0000019,Distribution in the liver after 15 min of intravenous administration,,,,,Autocuration,,,,11657,,,22224,8926,
,U,A,CHEMBL628245,1,0,,BAO_0000019,Distribution in the liver after 30 min of intravenous administration,,,,,Autocuration,,,,11658,,,22224,8926,
,U,A,CHEMBL628246,1,0,,BAO_0000019,Distribution in the liver after 5 min of intravenous administration,,,,,Autocuration,,,,11659,,,22224,8926,
,U,A,CHEMBL628247,1,0,,BAO_0000019,Distribution in the liver after 60 min of intravenous administration,,,,,Autocuration,,,,11660,,,22224,8926,
,U,A,CHEMBL628248,1,0,,BAO_0000019,Distribution in the liver after 90 min of intravenous administration,,,,,Autocuration,,,,11661,,,22224,8926,
,U,A,CHEMBL628249,1,0,,BAO_0000019,Distribution in the lung after 120 min of intravenous administration,,,,,Autocuration,,,,11662,,,22224,8926,
,N,A,CHEMBL625452,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,,Intermediate,,,,11663,,10090.0,50594,14839,
,N,A,CHEMBL625453,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,,Intermediate,,,,11664,,10090.0,50594,14839,
,N,A,CHEMBL625454,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,,Intermediate,,,,11665,,10090.0,50594,14839,
,N,A,CHEMBL623844,1,1,,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,,Intermediate,,,,11666,,10090.0,50594,14839,
,N,A,CHEMBL623845,1,1,,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,,,,Intermediate,,,,11667,,10116.0,50597,12178,
,N,A,CHEMBL623846,1,1,,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,,,,Intermediate,,,,11668,,10116.0,50597,12178,
,U,A,CHEMBL623847,1,0,,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,,,Autocuration,,,,11669,,,22224,12178,
,N,A,CHEMBL623848,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,,Intermediate,,,,11670,,9541.0,100710,12186,
,N,A,CHEMBL623849,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,,Intermediate,,,,11671,,9541.0,100710,12186,
,N,A,CHEMBL623850,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,,Intermediate,,,,11672,,9541.0,100710,12186,
,N,A,CHEMBL623851,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,,Intermediate,,,,11673,,9541.0,100710,12186,
,U,A,CHEMBL623852,1,0,,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,,Autocuration,,,,11674,,314293.0,22224,12187,
,N,A,CHEMBL624551,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,,,,Intermediate,,,,11675,,9669.0,50506,12187,
,N,A,CHEMBL624552,1,1,,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,,,,Intermediate,,,,11676,,9669.0,50506,12187,
,U,A,CHEMBL624553,1,0,,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,,Autocuration,,,,11677,,314293.0,22224,12187,
,U,A,CHEMBL624554,1,0,,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Simiiformes,,,,Autocuration,,,,11678,,314293.0,22224,12187,
,N,A,CHEMBL624555,1,1,,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,11679,,10116.0,50597,12187,
,N,A,CHEMBL624741,1,1,,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,,Intermediate,,,,11680,,10116.0,50597,12187,
,N,A,CHEMBL624742,1,1,,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,,Intermediate,,,,11681,,9615.0,50588,14122,
,N,A,CHEMBL624743,1,1,,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,,Intermediate,,,,11682,,10026.0,100712,14122,
,N,A,CHEMBL877606,1,1,,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,,,,Intermediate,,,,11683,,10116.0,50597,14122,
,U,A,CHEMBL624744,1,0,,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,,,Autocuration,,,,11684,,,22224,13391,
,U,A,CHEMBL624745,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,,11685,178.0,,22224,13391,
,U,A,CHEMBL624746,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,,11686,178.0,,22224,13391,
,U,A,CHEMBL624747,1,0,Blood,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,,,Autocuration,,,,11687,178.0,,22224,13391,
,U,A,CHEMBL624748,1,0,,BAO_0000019,Oral absorption expressed as Area under curve was determined,,,,,Autocuration,,,,11688,,,22224,16360,
,N,A,CHEMBL622504,1,1,,BAO_0000218,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Canis lupus familiaris,,,,Intermediate,,,,11689,,9615.0,50588,3673,
,N,A,CHEMBL622505,1,1,,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,,Intermediate,,,,11690,,9615.0,50588,14122,
,N,A,CHEMBL622506,1,1,,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,,Intermediate,,,,11691,,10026.0,100712,14122,
,N,A,CHEMBL622507,1,1,,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,,Intermediate,,,,11692,,10026.0,100712,14122,
,N,A,CHEMBL622508,1,1,,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,,,,Intermediate,,,,11693,,10116.0,50597,14122,
,U,A,CHEMBL622509,1,0,,BAO_0000019,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,,,Autocuration,,,,11694,,,22224,13889,
,N,A,CHEMBL622510,1,1,,BAO_0000218,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,,11695,,10116.0,50597,14393,
,N,A,CHEMBL622511,1,1,,BAO_0000218,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Rattus norvegicus,,,,Intermediate,,,,11696,,10116.0,50597,17279,
,N,A,CHEMBL622512,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,,,,Intermediate,,,,11697,,9541.0,100710,14548,
,N,A,CHEMBL622513,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,,,,Intermediate,,,,11698,,9541.0,100710,14548,
,N,A,CHEMBL622514,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Macaca fascicularis,,,,Intermediate,,,,11699,,9541.0,100710,14548,
,N,A,CHEMBL622515,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,,,,Intermediate,,,,11700,,9615.0,50588,14548,
,N,A,CHEMBL622516,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Canis lupus familiaris,,,,Intermediate,,,,11701,,9615.0,50588,14548,
,N,A,CHEMBL622517,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,11702,,10116.0,50597,14548,
,N,A,CHEMBL622518,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,11703,,10116.0,50597,14548,
,N,A,CHEMBL622519,1,1,,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,11704,,10116.0,50597,14548,
,N,A,CHEMBL622520,1,1,Muscle tissue,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11705,2385.0,10116.0,50597,14608,
,N,A,CHEMBL622521,1,1,Muscle tissue,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11706,2385.0,10116.0,50597,14608,
,N,A,CHEMBL625113,1,1,Zone of skin,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Mus musculus,,,,Intermediate,,,In vivo,11707,14.0,10090.0,50594,14608,
,N,A,CHEMBL625114,1,1,Zone of skin,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11708,14.0,10116.0,50597,14608,
,N,A,CHEMBL874397,1,1,Zone of skin,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11709,14.0,10116.0,50597,14608,
,N,A,CHEMBL625115,1,1,Spleen,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11710,2106.0,10116.0,50597,14608,
,N,A,CHEMBL625116,1,1,Spleen,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11711,2106.0,10116.0,50597,14608,
,N,A,CHEMBL623932,1,1,Spleen,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11712,2106.0,10116.0,50597,14608,
,N,A,CHEMBL623933,1,1,Striatum,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11713,2435.0,10116.0,50597,14608,
,N,A,CHEMBL623934,1,1,Striatum,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11714,2435.0,10116.0,50597,14608,
,N,A,CHEMBL623935,1,1,Striatum,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11715,2435.0,10116.0,50597,14608,
,N,A,CHEMBL623936,1,1,Thyroid gland,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11716,2046.0,10116.0,50597,14608,
,N,A,CHEMBL623937,1,1,Thyroid gland,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11717,2046.0,10116.0,50597,14608,
,N,A,CHEMBL623938,1,1,Thyroid gland,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,,Intermediate,,,In vivo,11718,2046.0,10116.0,50597,14608,
,N,A,CHEMBL623939,1,1,,BAO_0000218,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11719,,10090.0,50594,15383,
,N,A,CHEMBL623940,1,1,,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,,,Intermediate,,,,11720,,10090.0,50594,15383,
,N,A,CHEMBL623941,1,1,,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,,Intermediate,,,,11721,,10090.0,50594,15383,
,N,A,CHEMBL627216,1,1,,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11722,,10090.0,50594,15383,
,N,A,CHEMBL623942,1,1,,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11723,,10090.0,50594,15383,
,N,A,CHEMBL618793,1,1,Brain,BAO_0000218,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11724,955.0,10090.0,50594,15383,
,N,A,CHEMBL618794,1,1,Brain,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11725,955.0,10090.0,50594,15383,
,N,A,CHEMBL618795,1,1,Brain,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11726,955.0,10090.0,50594,15383,
,N,A,CHEMBL618796,1,1,,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11727,,10090.0,50594,15383,
,N,A,CHEMBL618797,1,1,,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11728,,10090.0,50594,15383,
,N,A,CHEMBL618798,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,,,,Intermediate,,,,11729,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618799,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11730,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618800,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,,,Intermediate,,,,11731,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618801,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,,Intermediate,,,,11732,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618802,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11733,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618803,1,1,Kidney,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11734,2113.0,10090.0,50594,15383,
,N,A,CHEMBL618804,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,,,,Intermediate,,,,11735,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618805,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11736,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618806,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,,,Intermediate,,,,11737,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618807,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,,Intermediate,,,,11738,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618808,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11739,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618809,1,1,Liver,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11740,2107.0,10090.0,50594,15383,
,N,A,CHEMBL618810,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11741,2385.0,10090.0,50594,15383,
,N,A,CHEMBL618811,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,,,Intermediate,,,,11742,2385.0,10090.0,50594,15383,
,N,A,CHEMBL875844,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,,Intermediate,,,,11743,2385.0,10090.0,50594,15383,
,N,A,CHEMBL618812,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11744,2385.0,10090.0,50594,15383,
,N,A,CHEMBL618813,1,1,Muscle tissue,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11745,2385.0,10090.0,50594,15383,
,N,A,CHEMBL618814,1,1,,BAO_0000218,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11746,,10090.0,50594,15383,
,N,A,CHEMBL618815,1,1,,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11747,,10090.0,50594,15383,
,N,A,CHEMBL618816,1,1,,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11748,,10090.0,50594,15383,
,N,A,CHEMBL618817,1,1,,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11749,,10090.0,50594,15383,
,N,A,CHEMBL620544,1,1,,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11750,,10090.0,50594,15383,
,N,A,CHEMBL626230,1,1,,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11751,,10116.0,50597,15341,
,N,A,CHEMBL626231,1,1,,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11752,,10116.0,50597,15341,
,N,A,CHEMBL626232,1,1,,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,11753,,10116.0,50597,15341,
,N,A,CHEMBL626233,1,1,Plasma,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,11754,1969.0,9615.0,50588,14906,
,N,A,CHEMBL626234,1,1,Plasma,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11755,1969.0,10116.0,50597,14906,
,N,A,CHEMBL875341,1,1,Plasma,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,11756,1969.0,10116.0,50597,14906,
,N,A,CHEMBL626235,1,1,Plasma,BAO_0000218,The maximum plasma concentration (100 mg/kg) administered orally in human,Homo sapiens,,,,Intermediate,,,In vivo,11757,1969.0,9606.0,50587,14215,
,U,A,CHEMBL626236,1,0,Plasma,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Callithrix,,,,Autocuration,,,In vivo,11758,1969.0,9481.0,22224,14215,
,U,A,CHEMBL626237,1,0,Plasma,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Simiiformes,,,,Autocuration,,,In vivo,11759,1969.0,314293.0,22224,14215,
,N,A,CHEMBL626238,1,1,Plasma,BAO_0000218,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11760,1969.0,9615.0,50588,14215,
,N,A,CHEMBL622412,1,1,Plasma,BAO_0000218,The maximum plasma concentration (200 mg/kg) administered orally in human,Homo sapiens,,,,Intermediate,,,In vivo,11761,1969.0,9606.0,50587,14215,
,N,A,CHEMBL623114,1,1,Plasma,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11762,1969.0,10116.0,50597,14215,
,U,A,CHEMBL623115,1,0,Plasma,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Callithrix,,,,Autocuration,,,In vivo,11763,1969.0,9481.0,22224,14215,
,U,A,CHEMBL623116,1,0,Plasma,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Simiiformes,,,,Autocuration,,,In vivo,11764,1969.0,314293.0,22224,14215,
,U,A,CHEMBL623117,1,0,Plasma,BAO_0000218,The maximum plasma concentration (30 mg/kg) administered orally in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,11765,1969.0,9615.0,22224,14215,
,N,A,CHEMBL623118,1,1,Plasma,BAO_0000218,The maximum plasma concentration (400 mg/kg) administered orally in human,Homo sapiens,,,,Intermediate,,,In vivo,11766,1969.0,9606.0,50587,14215,
,N,A,CHEMBL623119,1,1,Plasma,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11767,1969.0,10116.0,50597,14215,
,N,A,CHEMBL623120,1,1,Plasma,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11768,1969.0,10116.0,50597,14215,
,N,A,CHEMBL623286,1,1,Plasma,BAO_0000218,The maximum plasma concentration (800 mg/kg) administered orally in human,Homo sapiens,,,,Intermediate,,,In vivo,11769,1969.0,9606.0,50587,14215,
,N,A,CHEMBL623287,1,1,Plasma,BAO_0000218,The maximum plasma concentration was measured on rats,Rattus norvegicus,,,,Intermediate,,,In vivo,11770,1969.0,10116.0,50597,14067,
,N,A,CHEMBL623288,1,1,Plasma,BAO_0000218,The maximum plasma concentration was measured on rats after oral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11771,1969.0,10116.0,50597,12350,
,N,A,CHEMBL623289,1,1,Plasma,BAO_0000218,Plasma drug Cmax in rat (PO dose),Rattus norvegicus,,,,Intermediate,,,In vivo,11772,1969.0,10116.0,50597,14813,
,U,A,CHEMBL623290,1,0,,BAO_0000218,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,,,Autocuration,,,In vivo,11773,,,22224,12536,
,N,A,CHEMBL623291,1,1,Plasma,BAO_0000218,maximum Plasma concentration in Dog was determined after Peroral administration,Canis lupus familiaris,,,,Intermediate,,,In vivo,11774,1969.0,9615.0,50588,14169,
,N,A,CHEMBL623292,1,1,Plasma,BAO_0000218,maximum Plasma concentration in Rats was determined after Peroral administration,Rattus norvegicus,,,,Intermediate,,,In vivo,11775,1969.0,10116.0,50597,14169,
,N,A,CHEMBL623293,1,1,Plasma,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,11776,1969.0,9615.0,50588,15604,
,U,A,CHEMBL623294,1,0,Plasma,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,,,,Autocuration,,,In vivo,11777,1969.0,314293.0,22224,15604,
,N,A,CHEMBL623295,1,1,Plasma,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,11778,1969.0,10116.0,50597,15604,
,N,A,CHEMBL623296,1,1,,BAO_0000218,maximum concentration was measured when administered through oral route in mice,Mus musculus,,,,Intermediate,,,In vivo,11779,,10090.0,50594,14387,
,N,A,CHEMBL875349,1,1,,BAO_0000218,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Mus musculus,,,,Intermediate,,,,11780,,10090.0,50594,15115,
,U,A,CHEMBL623297,1,0,,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Simiiformes,,,,Autocuration,,,,11781,,314293.0,22224,15115,
,U,A,CHEMBL623298,1,0,,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Simiiformes,,,,Autocuration,,,,11782,,314293.0,22224,15115,
,U,A,CHEMBL623299,1,0,,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Simiiformes,,,,Autocuration,,,,11783,,314293.0,22224,15115,
,N,A,CHEMBL623300,1,1,,BAO_0000218,Pharmacokinetic parameter was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,,11784,,10116.0,50597,16359,
,N,A,CHEMBL623301,1,1,,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,,,,Intermediate,,,,11785,,10090.0,50594,12829,
,N,A,CHEMBL623302,1,1,,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Mus musculus,,,,Intermediate,,,,11786,,10090.0,50594,12829,
,N,A,CHEMBL623303,1,1,,BAO_0000218,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,,,,Intermediate,,,,11787,,10090.0,50594,12829,
,N,A,CHEMBL623304,1,1,,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Mus musculus,,,,Intermediate,,,,11788,,10090.0,50594,12829,
,N,A,CHEMBL623305,1,1,,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Mus musculus,,,,Intermediate,,,,11789,,10090.0,50594,12829,
,N,A,CHEMBL623306,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,,,Intermediate,,,,11790,1969.0,10116.0,50597,15137,
,N,A,CHEMBL623307,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,,,Intermediate,,,,11791,1969.0,10116.0,50597,15137,
,N,A,CHEMBL623308,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,,,Intermediate,,,,11792,1969.0,10116.0,50597,15137,
,N,A,CHEMBL623309,1,1,Plasma,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Mus musculus,,,,Intermediate,,,,11793,1969.0,10090.0,50594,15137,
,N,A,CHEMBL623310,1,1,,BAO_0000218,Plasma Concentration after 120 min of oral administration to mice,Mus musculus,,,,Intermediate,,,,11794,,10090.0,50594,13509,
,N,A,CHEMBL623311,1,1,,BAO_0000218,Plasma Concentration after 30 min of oral administration to mice,Mus musculus,,,,Intermediate,,,,11795,,10090.0,50594,13509,
,N,A,CHEMBL623312,1,1,,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice,Macaca fascicularis,,,,Intermediate,,,,11796,,9541.0,100710,13509,
,N,A,CHEMBL875350,1,1,,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice; Not determined,Mus musculus,,,,Intermediate,,,,11797,,10090.0,50594,13509,
,N,A,CHEMBL628635,1,1,,BAO_0000218,Plasma Concentration after 90 min of oral administration to mice,Mus musculus,,,,Intermediate,,,,11798,,10090.0,50594,13509,
,N,A,CHEMBL628636,1,1,,BAO_0000218,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11799,,10116.0,50597,12064,
,N,A,CHEMBL628637,1,1,,BAO_0000218,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11800,,10116.0,50597,12064,
,N,A,CHEMBL628058,1,1,,BAO_0000218,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,,Intermediate,,,,11801,,10116.0,50597,12064,
,N,A,CHEMBL628059,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Rattus norvegicus,,,,Intermediate,,,,11802,,10116.0,50597,10677,
,N,A,CHEMBL628060,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Rattus norvegicus,,,,Intermediate,,,,11803,,10116.0,50597,10677,
,U,A,CHEMBL628061,1,0,,BAO_0000019,Distribution in the lung after 15 min of intravenous administration,,,,,Autocuration,,,,11804,,,22224,8926,
,U,A,CHEMBL628062,1,0,,BAO_0000019,Distribution in the lung after 30 min of intravenous administration,,,,,Autocuration,,,,11805,,,22224,8926,
,U,A,CHEMBL628063,1,0,,BAO_0000019,Distribution in the lung after 5 min of intravenous administration,,,,,Autocuration,,,,11806,,,22224,8926,
,U,A,CHEMBL628064,1,0,,BAO_0000019,Distribution in the lung after 60 min of intravenous administration,,,,,Autocuration,,,,11807,,,22224,8926,
,U,A,CHEMBL628065,1,0,,BAO_0000019,Distribution in the lung after 90 min of intravenous administration,,,,,Autocuration,,,,11808,,,22224,8926,
,U,A,CHEMBL628066,1,0,Muscle tissue,BAO_0000019,Distribution in the muscle after 120 min of intravenous administration,,,,,Autocuration,,,,11809,2385.0,,22224,8926,
,U,A,CHEMBL628067,1,0,Muscle tissue,BAO_0000019,Distribution in the muscle after 15 min of intravenous administration,,,,,Autocuration,,,,11810,2385.0,,22224,8926,
,N,A,CHEMBL874646,1,1,Muscle tissue,BAO_0000218,Distribution in the muscle after 30 min of intravenous administration,Mus musculus,,,,Intermediate,,,,11811,2385.0,10090.0,50594,8926,
,U,A,CHEMBL628068,1,0,Muscle tissue,BAO_0000019,Distribution in the muscle after 5 min of intravenous administration,,,,,Autocuration,,,,11812,2385.0,,22224,8926,
,U,A,CHEMBL628069,1,0,Muscle tissue,BAO_0000019,Distribution in the muscle after 60 min of intravenous administration,,,,,Autocuration,,,,11813,2385.0,,22224,8926,
,U,A,CHEMBL628070,1,0,Muscle tissue,BAO_0000019,Distribution in the muscle after 90 min of intravenous administration,,,,,Autocuration,,,,11814,2385.0,,22224,8926,
,U,A,CHEMBL628071,1,0,Spleen,BAO_0000019,Distribution in the spleen after 120 min of intravenous administration,,,,,Autocuration,,,,11815,2106.0,,22224,8926,
,U,A,CHEMBL628072,1,0,Spleen,BAO_0000019,Distribution in the spleen after 15 min of intravenous administration,,,,,Autocuration,,,,11816,2106.0,,22224,8926,
,U,A,CHEMBL628073,1,0,Spleen,BAO_0000019,Distribution in the spleen after 30 min of intravenous administration,,,,,Autocuration,,,,11817,2106.0,,22224,8926,
,U,A,CHEMBL628074,1,0,Spleen,BAO_0000019,Distribution in the spleen after 5 min of intravenous administration,,,,,Autocuration,,,,11818,2106.0,,22224,8926,
,U,A,CHEMBL628075,1,0,Spleen,BAO_0000019,Distribution in the spleen after 60 min of intravenous administration,,,,,Autocuration,,,,11819,2106.0,,22224,8926,
,U,A,CHEMBL628076,1,0,Spleen,BAO_0000019,Distribution in the spleen after 90 min of intravenous administration,,,,,Autocuration,,,,11820,2106.0,,22224,8926,
,N,A,CHEMBL628077,1,1,Adrenal cortex,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11821,1235.0,10116.0,50597,7570,
,N,A,CHEMBL628078,1,1,Blood,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11822,178.0,10116.0,50597,7570,
,N,A,CHEMBL628079,1,1,Liver,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11823,2107.0,10116.0,50597,7570,
,N,A,CHEMBL628080,1,1,Female gonad,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11824,992.0,10116.0,50597,7570,
,N,A,CHEMBL628081,1,1,Thyroid gland,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11825,2046.0,10116.0,50597,7570,
,N,A,CHEMBL628082,1,1,Adrenal cortex,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11826,1235.0,10116.0,50597,7570,
,N,A,CHEMBL874647,1,1,Blood,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11827,178.0,10116.0,50597,7570,
,N,A,CHEMBL626406,1,1,Liver,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11828,2107.0,10116.0,50597,7570,
,N,A,CHEMBL626407,1,1,Female gonad,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11829,992.0,10116.0,50597,7570,
,N,A,CHEMBL626408,1,1,Thyroid gland,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,,,,Intermediate,,,,11830,2046.0,10116.0,50597,7570,
,N,A,CHEMBL626409,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Rattus norvegicus,,,,Intermediate,,,,11831,178.0,10116.0,50597,8608,
,N,A,CHEMBL626410,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Rattus norvegicus,,,,Intermediate,,,,11832,178.0,10116.0,50597,8608,
,N,A,CHEMBL626411,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Rattus norvegicus,,,,Intermediate,,,,11833,178.0,10116.0,50597,8608,
,N,A,CHEMBL626412,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Rattus norvegicus,,,,Intermediate,,,,11834,178.0,10116.0,50597,8608,
,N,A,CHEMBL626413,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Rattus norvegicus,,,,Intermediate,,,,11835,178.0,10116.0,50597,8608,
,N,A,CHEMBL626414,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Rattus norvegicus,,,,Intermediate,,,,11836,178.0,10116.0,50597,8608,
,N,A,CHEMBL626415,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Rattus norvegicus,,,,Intermediate,,,,11837,178.0,10116.0,50597,8608,
,N,A,CHEMBL626416,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Rattus norvegicus,,,,Intermediate,,,,11838,178.0,10116.0,50597,8608,
,N,A,CHEMBL627062,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Rattus norvegicus,,,,Intermediate,,,,11839,178.0,10116.0,50597,8608,
,N,A,CHEMBL627063,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Rattus norvegicus,,,,Intermediate,,,,11840,178.0,10116.0,50597,8608,
,N,A,CHEMBL627064,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Rattus norvegicus,,,,Intermediate,,,,11841,178.0,10116.0,50597,8608,
,N,A,CHEMBL627227,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Rattus norvegicus,,,,Intermediate,,,,11842,178.0,10116.0,50597,8608,
,N,A,CHEMBL627228,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Rattus norvegicus,,,,Intermediate,,,,11843,178.0,10116.0,50597,8608,
,N,A,CHEMBL627229,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Rattus norvegicus,,,,Intermediate,,,,11844,178.0,10116.0,50597,8608,
,N,A,CHEMBL625792,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Rattus norvegicus,,,,Intermediate,,,,11845,178.0,10116.0,50597,8608,
,N,A,CHEMBL625793,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Rattus norvegicus,,,,Intermediate,,,,11846,178.0,10116.0,50597,8608,
,N,A,CHEMBL625794,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Rattus norvegicus,,,,Intermediate,,,,11847,178.0,10116.0,50597,8608,
,N,A,CHEMBL625795,1,1,Blood,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Rattus norvegicus,,,,Intermediate,,,,11848,178.0,10116.0,50597,8608,
,N,A,CHEMBL625796,1,1,,BAO_0000218,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Mus musculus,,,,Intermediate,,,,11849,,10090.0,50594,13792,
,N,A,CHEMBL625797,1,1,,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,,,,Intermediate,,,,11850,,9615.0,50588,13376,
,N,A,CHEMBL625798,1,1,,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,,,,Intermediate,,,,11851,,9615.0,50588,13376,
,U,A,CHEMBL875613,1,0,,BAO_0000218,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11852,,,22224,14380,
,U,A,CHEMBL625799,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11853,,,22224,14380,
,U,A,CHEMBL625800,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11854,,,22224,14380,
,U,A,CHEMBL625801,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11855,,,22224,14380,
,U,A,CHEMBL625802,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11856,,,22224,14380,
,U,A,CHEMBL625803,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11857,,,22224,14380,
,U,A,CHEMBL625804,1,0,,BAO_0000019,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,,,Autocuration,,,,11858,,,22224,14380,
,U,A,CHEMBL622530,1,0,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,,,Autocuration,,,,11859,,,22224,14380,
,N,A,CHEMBL622531,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Mus musculus,,,,Intermediate,,,,11860,,10090.0,50594,13701,
,N,A,CHEMBL622532,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11861,,10090.0,50594,13701,
,N,A,CHEMBL623176,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11862,,10090.0,50594,13701,
,N,A,CHEMBL623177,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11863,,10090.0,50594,13701,
,N,A,CHEMBL623178,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11864,,10090.0,50594,13701,
,N,A,CHEMBL623179,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,,,,Intermediate,,,,11865,,10090.0,50594,13701,
,N,A,CHEMBL623180,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11866,,10090.0,50594,13701,
,N,A,CHEMBL623181,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11867,,10090.0,50594,13701,
,N,A,CHEMBL624131,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11868,,10090.0,50594,13701,
,N,A,CHEMBL624132,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11869,,10090.0,50594,13701,
,N,A,CHEMBL624133,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11870,,10090.0,50594,13701,
,N,A,CHEMBL624846,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Mus musculus,,,,Intermediate,,,,11871,,10090.0,50594,13701,
,N,A,CHEMBL624847,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11872,,10090.0,50594,13701,
,N,A,CHEMBL624848,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11873,,10090.0,50594,13701,
,N,A,CHEMBL625012,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11874,,10090.0,50594,13701,
,N,A,CHEMBL625013,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11875,,10090.0,50594,13701,
,N,A,CHEMBL625014,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,,,,Intermediate,,,,11876,,10090.0,50594,13701,
,N,A,CHEMBL625015,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Mus musculus,,,,Intermediate,,,,11877,,10090.0,50594,13701,
,N,A,CHEMBL625016,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11878,,10090.0,50594,13701,
,N,A,CHEMBL625017,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Mus musculus,,,,Intermediate,,,,11879,,10090.0,50594,13701,
,N,A,CHEMBL625018,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11880,,10090.0,50594,13701,
,N,A,CHEMBL625019,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11881,,10090.0,50594,13701,
,N,A,CHEMBL625020,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,11882,,10090.0,50594,13701,
,N,A,CHEMBL625021,1,1,,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Mus musculus,,,,Intermediate,,,,11883,,10090.0,50594,13701,
,N,A,CHEMBL625022,1,1,,BAO_0000218,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,,11884,,10116.0,50597,14393,
,N,A,CHEMBL625023,1,1,,BAO_0000218,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Mus musculus,,,,Intermediate,,,,11885,,10090.0,50594,14731,
,N,A,CHEMBL625024,1,1,,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Macaca fascicularis,,,,Intermediate,,,,11886,,9541.0,100710,14731,
,N,A,CHEMBL627626,1,1,,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,,,,Intermediate,,,,11887,,9541.0,100710,14731,
,U,A,CHEMBL627627,1,0,Brain,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,,,Autocuration,,,,11888,955.0,,22224,13758,
,U,A,CHEMBL627628,1,0,Serum,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,,,Autocuration,,,,11889,1977.0,,22224,13758,
,U,A,CHEMBL627629,1,0,Brain,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,,,Autocuration,,,,11890,955.0,,22224,13758,
,U,A,CHEMBL627630,1,0,Serum,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,,,Autocuration,,,,11891,1977.0,,22224,13758,
,U,A,CHEMBL627631,1,0,,BAO_0000019,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,,,Autocuration,,,,11892,,,22224,16359,
,U,A,CHEMBL629515,1,0,,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,,,Autocuration,,,,11893,,,22224,16359,
,N,A,CHEMBL629516,1,1,Spleen,BAO_0000218,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11894,2106.0,10090.0,50594,15383,
,N,A,CHEMBL629517,1,1,Spleen,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11895,2106.0,10090.0,50594,15383,
,N,A,CHEMBL629518,1,1,Spleen,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11896,2106.0,10090.0,50594,15383,
,N,A,CHEMBL877499,1,1,,BAO_0000218,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,,Intermediate,,,,11897,,10090.0,50594,15383,
,N,A,CHEMBL629519,1,1,,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,,Intermediate,,,,11898,,10090.0,50594,15383,
,N,A,CHEMBL629520,1,1,,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,,Intermediate,,,,11899,,10090.0,50594,15383,
,N,A,CHEMBL629521,1,1,,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,,Intermediate,,,,11900,,10090.0,50594,15383,
,N,A,CHEMBL629522,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Mus musculus,,,,Intermediate,,,,11901,,10090.0,50594,14439,
,N,A,CHEMBL629523,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Mus musculus,,,,Intermediate,,,,11902,,10090.0,50594,14439,
,N,A,CHEMBL629524,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,,Intermediate,,,,11903,,10090.0,50594,14439,
,N,A,CHEMBL629525,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Mus musculus,,,,Intermediate,,,,11904,,10090.0,50594,14439,
,N,A,CHEMBL629526,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Mus musculus,,,,Intermediate,,,,11905,,10090.0,50594,14439,
,N,A,CHEMBL629527,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Mus musculus,,,,Intermediate,,,,11906,,10090.0,50594,14439,
,N,A,CHEMBL629528,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,,Intermediate,,,,11907,,10090.0,50594,14439,
,N,A,CHEMBL629529,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Mus musculus,,,,Intermediate,,,,11908,,10090.0,50594,14439,
,N,A,CHEMBL629530,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Mus musculus,,,,Intermediate,,,,11909,,10090.0,50594,14439,
,N,A,CHEMBL629531,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Mus musculus,,,,Intermediate,,,,11910,,10090.0,50594,14439,
,N,A,CHEMBL628656,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,,Intermediate,,,,11911,,10090.0,50594,14439,
,N,A,CHEMBL628657,1,1,,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Mus musculus,,,,Intermediate,,,,11912,,10090.0,50594,14439,
,N,A,CHEMBL628658,1,1,,BAO_0000218,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11913,,10116.0,50597,13751,
,N,A,CHEMBL628659,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11914,,10116.0,50597,13751,
,N,A,CHEMBL877500,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11915,,10116.0,50597,13751,
,N,A,CHEMBL628660,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11916,,10116.0,50597,13751,
,N,A,CHEMBL628661,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11917,,10116.0,50597,13751,
,N,A,CHEMBL628662,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11918,,10116.0,50597,13751,
,N,A,CHEMBL628663,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11919,,10116.0,50597,13751,
,N,A,CHEMBL628664,1,1,,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11920,,10116.0,50597,13751,
,N,A,CHEMBL628665,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11921,178.0,10116.0,50597,13751,
,N,A,CHEMBL628666,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11922,178.0,10116.0,50597,13751,
,N,A,CHEMBL628667,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11923,178.0,10116.0,50597,13751,
,N,A,CHEMBL628668,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11924,178.0,10116.0,50597,13751,
,N,A,CHEMBL628669,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11925,178.0,10116.0,50597,13751,
,N,A,CHEMBL628670,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11926,178.0,10116.0,50597,13751,
,N,A,CHEMBL628671,1,1,Blood,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11927,178.0,10116.0,50597,13751,
,N,A,CHEMBL628672,1,1,Bone,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11928,10000001.0,10116.0,50597,13751,
,N,A,CHEMBL630300,1,1,Bone,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11929,10000001.0,10116.0,50597,13751,
,N,A,CHEMBL629787,1,1,Bone,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11930,10000001.0,10116.0,50597,13751,
,N,A,CHEMBL629788,1,1,Bone,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11931,10000001.0,10116.0,50597,13751,
,N,A,CHEMBL629789,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11932,955.0,10116.0,50597,13751,
,N,A,CHEMBL629790,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11933,955.0,10116.0,50597,13751,
,N,A,CHEMBL629791,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11934,955.0,10116.0,50597,13751,
,N,A,CHEMBL629792,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11935,955.0,10116.0,50597,13751,
,N,A,CHEMBL629793,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11936,955.0,10116.0,50597,13751,
,N,A,CHEMBL629794,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,11937,955.0,10116.0,50597,13751,
,N,A,CHEMBL874459,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Rattus norvegicus,,,,Intermediate,,,,11938,,10116.0,50597,10677,
,N,A,CHEMBL629795,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Rattus norvegicus,,,,Intermediate,,,,11939,,10116.0,50597,10677,
,N,A,CHEMBL629796,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Rattus norvegicus,,,,Intermediate,,,,11940,,10116.0,50597,10677,
,N,A,CHEMBL629797,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Rattus norvegicus,,,,Intermediate,,,,11941,,10116.0,50597,10677,
,N,A,CHEMBL629798,1,1,,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Rattus norvegicus,,,,Intermediate,,,,11942,,10116.0,50597,10677,
,N,A,CHEMBL629799,1,1,Adrenal gland,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11943,2369.0,10116.0,50597,10911,
,N,A,CHEMBL629800,1,1,Adrenal gland,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11944,2369.0,10116.0,50597,10911,
,N,A,CHEMBL629801,1,1,Adrenal gland,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11945,2369.0,10116.0,50597,10911,
,N,A,CHEMBL629802,1,1,Adrenal gland,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Rattus norvegicus,,,,Intermediate,,,In vivo,11946,2369.0,10116.0,50597,10911,
,N,A,CHEMBL629803,1,1,Adrenal gland,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11947,2369.0,10116.0,50597,10911,
,N,A,CHEMBL629804,1,1,Blood,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11948,178.0,10116.0,50597,10911,
,N,A,CHEMBL629805,1,1,Blood,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11949,178.0,10116.0,50597,10911,
,N,A,CHEMBL629806,1,1,Blood,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11950,178.0,10116.0,50597,10911,
,N,A,CHEMBL629807,1,1,Blood,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11951,178.0,10116.0,50597,10911,
,N,A,CHEMBL629808,1,1,Blood,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11952,178.0,10116.0,50597,10911,
,N,A,CHEMBL629809,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11953,955.0,10116.0,50597,10911,
,N,A,CHEMBL629810,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11954,955.0,10116.0,50597,10911,
,N,A,CHEMBL629811,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11955,955.0,10116.0,50597,10911,
,N,A,CHEMBL629812,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11956,955.0,10116.0,50597,10911,
,N,A,CHEMBL629813,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11957,955.0,10116.0,50597,10911,
,N,A,CHEMBL874460,1,1,Brain,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11958,955.0,10116.0,50597,10911,
,N,A,CHEMBL629814,1,1,,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11959,,10116.0,50597,10911,
,N,A,CHEMBL629815,1,1,,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11960,,10116.0,50597,10911,
,N,A,CHEMBL629816,1,1,,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11961,,10116.0,50597,10911,
,N,A,CHEMBL629817,1,1,,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11962,,10116.0,50597,10911,
,N,A,CHEMBL626643,1,1,Kidney,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11963,2113.0,10116.0,50597,10911,
,N,A,CHEMBL626644,1,1,Kidney,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11964,2113.0,10116.0,50597,10911,
,N,A,CHEMBL626806,1,1,Kidney,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11965,2113.0,10116.0,50597,10911,
,N,A,CHEMBL626807,1,1,Kidney,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11966,2113.0,10116.0,50597,10911,
,N,A,CHEMBL627261,1,1,Liver,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11967,2107.0,10116.0,50597,10911,
,N,A,CHEMBL627262,1,1,Liver,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11968,2107.0,10116.0,50597,10911,
,N,A,CHEMBL627263,1,1,Liver,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11969,2107.0,10116.0,50597,10911,
,N,A,CHEMBL627264,1,1,Liver,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11970,2107.0,10116.0,50597,10911,
,N,A,CHEMBL627265,1,1,Lung,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11971,2048.0,10116.0,50597,10911,
,N,A,CHEMBL627266,1,1,Lung,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11972,2048.0,10116.0,50597,10911,
,N,A,CHEMBL627267,1,1,Lung,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11973,2048.0,10116.0,50597,10911,
,N,A,CHEMBL627268,1,1,Lung,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11974,2048.0,10116.0,50597,10911,
,N,A,CHEMBL627269,1,1,Muscle tissue,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11975,2385.0,10116.0,50597,10911,
,N,A,CHEMBL627270,1,1,Muscle tissue,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,11976,2385.0,10116.0,50597,10911,
,N,A,CHEMBL627271,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Rattus norvegicus,,,,Intermediate,,,,11977,,10116.0,50597,8608,
,N,A,CHEMBL627946,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Rattus norvegicus,,,,Intermediate,,,,11978,,10116.0,50597,8608,
,N,A,CHEMBL875472,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Rattus norvegicus,,,,Intermediate,,,,11979,,10116.0,50597,8608,
,N,A,CHEMBL627947,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Rattus norvegicus,,,,Intermediate,,,,11980,,10116.0,50597,8608,
,N,A,CHEMBL627948,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Rattus norvegicus,,,,Intermediate,,,,11981,,10116.0,50597,8608,
,N,A,CHEMBL628113,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Rattus norvegicus,,,,Intermediate,,,,11982,,10116.0,50597,8608,
,N,A,CHEMBL628114,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Rattus norvegicus,,,,Intermediate,,,,11983,,10116.0,50597,8608,
,N,A,CHEMBL628115,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Rattus norvegicus,,,,Intermediate,,,,11984,,10116.0,50597,8608,
,N,A,CHEMBL628116,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Rattus norvegicus,,,,Intermediate,,,,11985,,10116.0,50597,8608,
,N,A,CHEMBL628117,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Rattus norvegicus,,,,Intermediate,,,,11986,,10116.0,50597,8608,
,N,A,CHEMBL628118,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Rattus norvegicus,,,,Intermediate,,,,11987,,10116.0,50597,8608,
,N,A,CHEMBL628119,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Rattus norvegicus,,,,Intermediate,,,,11988,,10116.0,50597,8608,
,N,A,CHEMBL628120,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Rattus norvegicus,,,,Intermediate,,,,11989,,10116.0,50597,8608,
,N,A,CHEMBL628121,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Rattus norvegicus,,,,Intermediate,,,,11990,,10116.0,50597,8608,
,N,A,CHEMBL628122,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Rattus norvegicus,,,,Intermediate,,,,11991,,10116.0,50597,8608,
,N,A,CHEMBL627297,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Rattus norvegicus,,,,Intermediate,,,,11992,,10116.0,50597,8608,
,N,A,CHEMBL627298,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Rattus norvegicus,,,,Intermediate,,,,11993,,10116.0,50597,8608,
,N,A,CHEMBL627299,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Rattus norvegicus,,,,Intermediate,,,,11994,,10116.0,50597,8608,
,N,A,CHEMBL627300,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Rattus norvegicus,,,,Intermediate,,,,11995,,10116.0,50597,8608,
,N,A,CHEMBL627301,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Rattus norvegicus,,,,Intermediate,,,,11996,,10116.0,50597,8608,
,N,A,CHEMBL627302,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Rattus norvegicus,,,,Intermediate,,,,11997,,10116.0,50597,8608,
,N,A,CHEMBL627303,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Rattus norvegicus,,,,Intermediate,,,,11998,,10116.0,50597,8608,
,N,A,CHEMBL627304,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Rattus norvegicus,,,,Intermediate,,,,11999,,10116.0,50597,8608,
,N,A,CHEMBL627305,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Rattus norvegicus,,,,Intermediate,,,,12000,,10116.0,50597,8608,
,N,A,CHEMBL627306,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,,,,Intermediate,,,,12001,,10116.0,50597,8608,
,N,A,CHEMBL623982,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Rattus norvegicus,,,,Intermediate,,,,12002,,10116.0,50597,8608,
,N,A,CHEMBL623983,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Rattus norvegicus,,,,Intermediate,,,,12003,,10116.0,50597,8608,
,N,A,CHEMBL623984,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Rattus norvegicus,,,,Intermediate,,,,12004,,10116.0,50597,8608,
,N,A,CHEMBL623985,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Rattus norvegicus,,,,Intermediate,,,,12005,,10116.0,50597,8608,
,N,A,CHEMBL623986,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Rattus norvegicus,,,,Intermediate,,,,12006,,10116.0,50597,8608,
,N,A,CHEMBL623987,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Rattus norvegicus,,,,Intermediate,,,,12007,,10116.0,50597,8608,
,N,A,CHEMBL623988,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Rattus norvegicus,,,,Intermediate,,,,12008,,10116.0,50597,8608,
,N,A,CHEMBL623989,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Rattus norvegicus,,,,Intermediate,,,,12009,,10116.0,50597,8608,
,N,A,CHEMBL622215,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Rattus norvegicus,,,,Intermediate,,,,12010,,10116.0,50597,8608,
,N,A,CHEMBL622216,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Rattus norvegicus,,,,Intermediate,,,,12011,,10116.0,50597,8608,
,N,A,CHEMBL877481,1,1,,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Rattus norvegicus,,,,Intermediate,,,,12012,,10116.0,50597,8608,
,U,A,CHEMBL622217,1,0,,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,,,Autocuration,,,,12013,,,22224,16359,
,N,A,CHEMBL622218,1,1,,BAO_0000218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,,,,Intermediate,,,,12014,,10090.0,50594,13701,
,N,A,CHEMBL622219,1,1,,BAO_0000218,Pharmacokinetic profile AUC was evaluated in rats,Rattus norvegicus,,,,Intermediate,,,,12015,,10116.0,50597,14554,
,U,A,CHEMBL622220,1,0,,BAO_0000019,Pharmacokinetic property (Area under curve),,,,,Autocuration,,,,12016,,,22224,6241,
,N,A,CHEMBL622221,1,1,,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Canis lupus familiaris,,,,Intermediate,,,,12017,,9615.0,50588,11537,
,N,A,CHEMBL622222,1,1,,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Mus musculus,,,,Intermediate,,,,12018,,10090.0,50594,11537,
,N,A,CHEMBL622223,1,1,,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Canis lupus familiaris,,,,Intermediate,,,,12019,,9615.0,50588,11537,
,N,A,CHEMBL622224,1,1,,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Mus musculus,,,,Intermediate,,,,12020,,10090.0,50594,11537,
,U,A,CHEMBL622225,1,0,,BAO_0000019,Plasma concentration (AUC) was determined,,,,,Autocuration,,,,12021,,,22224,13118,
,U,A,CHEMBL622226,1,0,,BAO_0000019,Plasma concentration (AUC) was determined; Not detectable,,,,,Autocuration,,,,12022,,,22224,13118,
,N,A,CHEMBL624154,1,1,,BAO_0000218,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Cavia porcellus,,,,Intermediate,,,,12023,,10141.0,50512,9562,
,N,A,CHEMBL624155,1,1,,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12024,,10116.0,50597,10363,
,N,A,CHEMBL624156,1,1,,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,,,,Intermediate,,,,12025,,10116.0,50597,10363,
,N,A,CHEMBL624157,1,1,,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12026,,10116.0,50597,10363,
,N,A,CHEMBL624158,1,1,,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12027,,10116.0,50597,10363,
,N,A,CHEMBL624159,1,1,,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,,,,Intermediate,,,,12028,,10116.0,50597,12504,
,N,A,CHEMBL624160,1,1,,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,,,,Intermediate,,,,12029,,10116.0,50597,12504,
,N,A,CHEMBL624161,1,1,,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,,,,Intermediate,,,,12030,,10116.0,50597,12504,
,N,A,CHEMBL624162,1,1,,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,,,,Intermediate,,,,12031,,10116.0,50597,12504,
,N,A,CHEMBL624163,1,1,,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Canis lupus familiaris,,,,Intermediate,,,,12032,,9615.0,50588,13317,
,N,A,CHEMBL624164,1,1,,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,12033,,10116.0,50597,15078,
,N,A,CHEMBL624165,1,1,,BAO_0000218,The AUC(0-infinity) values in female wistar rats.,Rattus norvegicus,,,,Intermediate,,,,12034,,10116.0,50597,14941,
,N,A,CHEMBL624166,1,1,,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,12035,,10116.0,50597,15078,
,N,A,CHEMBL624167,1,1,,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Rattus norvegicus,,,,Intermediate,,,,12036,,10116.0,50597,15078,
,N,A,CHEMBL624168,1,1,,BAO_0000218,The AUC(0-t)values in female wistar rats.,Rattus norvegicus,,,,Intermediate,,,,12037,,10116.0,50597,14941,
,N,A,CHEMBL624169,1,1,,BAO_0000218,The Area under the concentration time curve of compound was measured on rats,Rattus norvegicus,,,,Intermediate,,,,12038,,10116.0,50597,14067,
,N,A,CHEMBL624170,1,1,,BAO_0000218,The area under curve (100 mg/kg) administered orally in humans,Homo sapiens,,,,Intermediate,,,,12039,,9606.0,50587,14215,
,U,A,CHEMBL624171,1,0,,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Callithrix,,,,Autocuration,,,,12040,,9481.0,22224,14215,
,U,A,CHEMBL624172,1,0,,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in monkey,Simiiformes,,,,Autocuration,,,,12041,,314293.0,22224,14215,
,N,A,CHEMBL624173,1,1,,BAO_0000218,The area under curve (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,,,,Intermediate,,,,12042,,9615.0,50588,14215,
,N,A,CHEMBL877488,1,1,,BAO_0000218,The area under curve (200 mg/kg) administered orally in humans,Homo sapiens,,,,Intermediate,,,,12043,,9606.0,50587,14215,
,N,A,CHEMBL624174,1,1,,BAO_0000218,The area under curve (25 mg/kg) administered intravenously in rat,Rattus norvegicus,,,,Intermediate,,,,12044,,10116.0,50597,14215,
,U,A,CHEMBL624175,1,0,,BAO_0000218,The area under curve (25 mg/kg) administered orally in marmoset,Callithrix,,,,Autocuration,,,,12045,,9481.0,22224,14215,
,U,A,CHEMBL624176,1,0,,BAO_0000218,The area under curve (25 mg/kg) administered orally in monkey,Simiiformes,,,,Autocuration,,,,12046,,314293.0,22224,14215,
,N,A,CHEMBL624177,1,1,,BAO_0000218,The area under curve (30 mg/kg) administered orally in dog,Canis lupus familiaris,,,,Intermediate,,,,12047,,9615.0,50588,14215,
,N,A,CHEMBL624178,1,1,,BAO_0000218,The area under curve (400 mg/kg) administered orally in humans,Homo sapiens,,,,Intermediate,,,,12048,,9606.0,50587,14215,
,N,A,CHEMBL624179,1,1,,BAO_0000218,The area under curve (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,,,,Intermediate,,,,12049,,10116.0,50597,14215,
,N,A,CHEMBL627689,1,1,,BAO_0000218,The area under curve (50 mg/kg) administered orally in rat,Rattus norvegicus,,,,Intermediate,,,,12050,,10116.0,50597,14215,
,N,A,CHEMBL627690,1,1,,BAO_0000218,The area under curve (800 mg/kg) administered orally in humans,Homo sapiens,,,,Intermediate,,,,12051,,9606.0,50587,14215,
,U,A,CHEMBL627691,1,0,,BAO_0000019,The compound was evaluated for area under the curve,,,,,Autocuration,,,,12052,,,22224,11324,
,U,A,CHEMBL627692,1,0,,BAO_0000019,The compound was evaluated for area under the curve in marmosets,Callithrix,,,,Autocuration,,,,12053,,9481.0,22224,11324,
,U,A,CHEMBL627693,1,0,,BAO_0000019,The compound was evaluated for area under the curve in marmosets,Callithrix,,,,Autocuration,,,,12054,,9481.0,22224,11324,
,N,A,CHEMBL627694,1,1,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,,Intermediate,,,,12055,,10116.0,50597,13875,
,N,A,CHEMBL627695,1,1,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,,Intermediate,,,,12056,,10116.0,50597,13875,
,U,A,CHEMBL627696,1,0,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,,,Autocuration,,,,12057,,,22224,13875,
,N,A,CHEMBL627697,1,1,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,,Intermediate,,,,12058,,10116.0,50597,13875,
,N,A,CHEMBL627698,1,1,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,,Intermediate,,,,12059,,10116.0,50597,13875,
,N,A,CHEMBL627699,1,1,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,,Intermediate,,,,12060,,10116.0,50597,13875,
,N,A,CHEMBL627700,1,1,,BAO_0000218,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Rattus norvegicus,,,,Intermediate,,,,12061,,10116.0,50597,13807,
,N,A,CHEMBL627701,1,1,,BAO_0000218,Total drug exposure is determined after oral dosing in rats.,Rattus norvegicus,,,,Intermediate,,,,12062,,10116.0,50597,14127,
,U,A,CHEMBL627702,1,0,,BAO_0000218,Total drug exposure (5 mg/kg) when administered intravenously,,,,,Autocuration,,,,12063,,,22224,15116,
,U,A,CHEMBL627703,1,0,,BAO_0000218,Total drug exposure (5 mg/kg) when administered orally,,,,,Autocuration,,,,12064,,,22224,15116,
,U,A,CHEMBL626873,1,0,,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,,,,Autocuration,,,,12065,,314293.0,22224,15604,
,N,A,CHEMBL629583,1,1,,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,,12066,,10116.0,50597,15604,
,N,A,CHEMBL629584,1,1,,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,,,,Intermediate,,,,12067,,9615.0,50588,15604,
,N,A,CHEMBL629585,1,1,,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,,,,Intermediate,,,,12068,,9615.0,50588,15604,
,N,A,CHEMBL629586,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12069,955.0,10116.0,50597,13751,
,N,A,CHEMBL629587,1,1,Brain,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12070,955.0,10116.0,50597,13751,
,N,A,CHEMBL629588,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12071,,10116.0,50597,13751,
,N,A,CHEMBL629589,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12072,,10116.0,50597,13751,
,N,A,CHEMBL629590,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12073,,10116.0,50597,13751,
,N,A,CHEMBL629591,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12074,,10116.0,50597,13751,
,N,A,CHEMBL629592,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12075,,10116.0,50597,13751,
,N,A,CHEMBL629593,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12076,,10116.0,50597,13751,
,N,A,CHEMBL629594,1,1,,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12077,,10116.0,50597,13751,
,N,A,CHEMBL629595,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12078,948.0,10116.0,50597,13751,
,N,A,CHEMBL630290,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12079,948.0,10116.0,50597,13751,
,N,A,CHEMBL627137,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12080,948.0,10116.0,50597,13751,
,N,A,CHEMBL627138,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12081,948.0,10116.0,50597,13751,
,N,A,CHEMBL627139,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12082,948.0,10116.0,50597,13751,
,N,A,CHEMBL627140,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12083,948.0,10116.0,50597,13751,
,N,A,CHEMBL627141,1,1,Heart,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12084,948.0,10116.0,50597,13751,
,N,A,CHEMBL627142,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12085,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627143,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12086,2113.0,10116.0,50597,13751,
,N,A,CHEMBL874449,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12087,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627144,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12088,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627145,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12089,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627146,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12090,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627147,1,1,Kidney,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12091,2113.0,10116.0,50597,13751,
,N,A,CHEMBL627148,1,1,Liver,BAO_0000218,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12092,2107.0,10116.0,50597,13751,
,N,A,CHEMBL627149,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12093,2048.0,10116.0,50597,13751,
,N,A,CHEMBL632160,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12094,2048.0,10116.0,50597,13751,
,N,A,CHEMBL632161,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12095,2048.0,10116.0,50597,13751,
,N,A,CHEMBL632162,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12096,2048.0,10116.0,50597,13751,
,N,A,CHEMBL632163,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12097,2048.0,10116.0,50597,13751,
,N,A,CHEMBL874469,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12098,2048.0,10116.0,50597,13751,
,N,A,CHEMBL627182,1,1,Lung,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12099,2048.0,10116.0,50597,13751,
,N,A,CHEMBL627183,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12100,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627184,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12101,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627185,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12102,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627186,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12103,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627187,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12104,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627188,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12105,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627189,1,1,Muscle tissue,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12106,2385.0,10116.0,50597,13751,
,N,A,CHEMBL627190,1,1,,BAO_0000218,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12107,,10116.0,50597,13751,
,N,A,CHEMBL627191,1,1,Liver,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12108,2107.0,10116.0,50597,13751,
,N,A,CHEMBL627192,1,1,Liver,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12109,2107.0,10116.0,50597,13751,
,N,A,CHEMBL627193,1,1,Liver,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12110,2107.0,10116.0,50597,13751,
,N,A,CHEMBL874590,1,1,Muscle tissue,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12111,2385.0,10116.0,50597,10911,
,N,A,CHEMBL627194,1,1,Muscle tissue,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12112,2385.0,10116.0,50597,10911,
,N,A,CHEMBL627195,1,1,Muscle tissue,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12113,2385.0,10116.0,50597,10911,
,N,A,CHEMBL627196,1,1,Female gonad,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12114,992.0,10116.0,50597,10911,
,N,A,CHEMBL627197,1,1,Female gonad,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12115,992.0,10116.0,50597,10911,
,N,A,CHEMBL627198,1,1,Female gonad,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12116,992.0,10116.0,50597,10911,
,N,A,CHEMBL627199,1,1,Female gonad,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Rattus norvegicus,,,,Intermediate,,,In vivo,12117,992.0,10116.0,50597,10911,
,N,A,CHEMBL627200,1,1,Female gonad,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12118,992.0,10116.0,50597,10911,
,N,A,CHEMBL627201,1,1,Plasma,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12119,1969.0,10116.0,50597,10911,
,N,A,CHEMBL627202,1,1,Plasma,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12120,1969.0,10116.0,50597,10911,
,N,A,CHEMBL627203,1,1,Plasma,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12121,1969.0,10116.0,50597,10911,
,N,A,CHEMBL627204,1,1,Plasma,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12122,1969.0,10116.0,50597,10911,
,N,A,CHEMBL627205,1,1,Spleen,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12123,2106.0,10116.0,50597,10911,
,N,A,CHEMBL627206,1,1,Spleen,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12124,2106.0,10116.0,50597,10911,
,N,A,CHEMBL627207,1,1,Spleen,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12125,2106.0,10116.0,50597,10911,
,N,A,CHEMBL627208,1,1,Spleen,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12126,2106.0,10116.0,50597,10911,
,N,A,CHEMBL627209,1,1,Thyroid gland,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12127,2046.0,10116.0,50597,10911,
,N,A,CHEMBL627210,1,1,Thyroid gland,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12128,2046.0,10116.0,50597,10911,
,N,A,CHEMBL627211,1,1,Thyroid gland,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12129,2046.0,10116.0,50597,10911,
,N,A,CHEMBL627212,1,1,Thyroid gland,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12130,2046.0,10116.0,50597,10911,
,N,A,CHEMBL627213,1,1,Uterus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12131,995.0,10116.0,50597,10911,
,N,A,CHEMBL626599,1,1,Uterus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12132,995.0,10116.0,50597,10911,
,N,A,CHEMBL626600,1,1,Uterus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12133,995.0,10116.0,50597,10911,
,N,A,CHEMBL626601,1,1,Uterus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,,Intermediate,,,In vivo,12134,995.0,10116.0,50597,10911,
,U,A,CHEMBL627484,1,0,,BAO_0000019,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,,,Autocuration,,,,12135,,,22224,8081,
,N,A,CHEMBL627485,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Macaca fascicularis,,,,Intermediate,,,,12136,1969.0,9541.0,100710,17248,
,N,A,CHEMBL628147,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Macaca fascicularis,,,,Intermediate,,,,12137,1969.0,9541.0,100710,17248,
,N,A,CHEMBL628148,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Macaca fascicularis,,,,Intermediate,,,,12138,1969.0,9541.0,100710,17248,
,N,A,CHEMBL628149,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Canis lupus familiaris,,,,Intermediate,,,,12139,1969.0,9615.0,50588,17248,
,N,A,CHEMBL628150,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Canis lupus familiaris,,,,Intermediate,,,,12140,1969.0,9615.0,50588,17248,
,N,A,CHEMBL628318,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Canis lupus familiaris,,,,Intermediate,,,,12141,1969.0,9615.0,50588,17248,
,N,A,CHEMBL628319,1,1,Plasma,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Canis lupus familiaris,,,,Intermediate,,,,12142,1969.0,9615.0,50588,17248,
,N,A,CHEMBL875609,1,1,,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,,,,Intermediate,,,,12143,,9615.0,50588,15592,
,U,A,CHEMBL628320,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,,,Autocuration,,,,12144,,,22224,7040,
,U,A,CHEMBL628321,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,,,Autocuration,,,,12145,,,22224,7040,
,U,A,CHEMBL628322,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,,,Autocuration,,,,12146,,,22224,7040,
,U,A,CHEMBL628323,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,,,Autocuration,,,,12147,,,22224,7040,
,U,A,CHEMBL628324,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,,,Autocuration,,,,12148,,,22224,7040,
,U,A,CHEMBL628325,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,,,Autocuration,,,,12149,,,22224,7040,
,U,A,CHEMBL628326,1,0,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,,,Autocuration,,,,12150,,,22224,7040,
,N,A,CHEMBL628327,1,1,Adrenal medulla,BAO_0000218,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12151,1236.0,9615.0,50588,9614,
,N,A,CHEMBL628328,1,1,Adrenal medulla,BAO_0000218,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12152,1236.0,9615.0,50588,9614,
,N,A,CHEMBL628329,1,1,Blood,BAO_0000218,"Concentration of compound in blood of dog 1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12153,178.0,9615.0,50588,9614,
,N,A,CHEMBL628330,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Rattus norvegicus,,,,Intermediate,,,,12154,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628331,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Rattus norvegicus,,,,Intermediate,,,,12155,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628332,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Rattus norvegicus,,,,Intermediate,,,,12156,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628333,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Rattus norvegicus,,,,Intermediate,,,,12157,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628334,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Rattus norvegicus,,,,Intermediate,,,,12158,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628335,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Rattus norvegicus,,,,Intermediate,,,,12159,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628336,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Rattus norvegicus,,,,Intermediate,,,,12160,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628337,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,,,,Intermediate,,,,12161,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628338,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Rattus norvegicus,,,,Intermediate,,,,12162,2107.0,10116.0,50597,8608,
,N,A,CHEMBL875610,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Rattus norvegicus,,,,Intermediate,,,,12163,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628339,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Rattus norvegicus,,,,Intermediate,,,,12164,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628340,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Rattus norvegicus,,,,Intermediate,,,,12165,2107.0,10116.0,50597,8608,
,N,A,CHEMBL628341,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Rattus norvegicus,,,,Intermediate,,,,12166,2107.0,10116.0,50597,8608,
,N,A,CHEMBL622214,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Rattus norvegicus,,,,Intermediate,,,,12167,2107.0,10116.0,50597,8608,
,N,A,CHEMBL623167,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Rattus norvegicus,,,,Intermediate,,,,12168,2107.0,10116.0,50597,8608,
,N,A,CHEMBL623168,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Rattus norvegicus,,,,Intermediate,,,,12169,2107.0,10116.0,50597,8608,
,N,A,CHEMBL623169,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Rattus norvegicus,,,,Intermediate,,,,12170,2107.0,10116.0,50597,8608,
,N,A,CHEMBL623170,1,1,Liver,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Rattus norvegicus,,,,Intermediate,,,,12171,2107.0,10116.0,50597,8608,
,N,A,CHEMBL627224,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Rattus norvegicus,,,,Intermediate,,,,12172,2048.0,10116.0,50597,8608,
,N,A,CHEMBL875634,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Rattus norvegicus,,,,Intermediate,,,,12173,2048.0,10116.0,50597,8608,
,N,A,CHEMBL627225,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Rattus norvegicus,,,,Intermediate,,,,12174,2048.0,10116.0,50597,8608,
,N,A,CHEMBL627226,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Rattus norvegicus,,,,Intermediate,,,,12175,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626083,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Rattus norvegicus,,,,Intermediate,,,,12176,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626084,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Rattus norvegicus,,,,Intermediate,,,,12177,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626085,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Rattus norvegicus,,,,Intermediate,,,,12178,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626086,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Rattus norvegicus,,,,Intermediate,,,,12179,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626087,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Rattus norvegicus,,,,Intermediate,,,,12180,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626088,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Rattus norvegicus,,,,Intermediate,,,,12181,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626089,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Rattus norvegicus,,,,Intermediate,,,,12182,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626090,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Rattus norvegicus,,,,Intermediate,,,,12183,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626091,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Rattus norvegicus,,,,Intermediate,,,,12184,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626092,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Rattus norvegicus,,,,Intermediate,,,,12185,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626093,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Rattus norvegicus,,,,Intermediate,,,,12186,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626094,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Rattus norvegicus,,,,Intermediate,,,,12187,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626095,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Rattus norvegicus,,,,Intermediate,,,,12188,2048.0,10116.0,50597,8608,
,N,A,CHEMBL626096,1,1,Lung,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Rattus norvegicus,,,,Intermediate,,,,12189,2048.0,10116.0,50597,8608,
,U,A,CHEMBL626097,1,0,,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,,,,Autocuration,,,,12190,,314293.0,22224,15604,
,N,A,CHEMBL626098,1,1,,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,,12191,,10116.0,50597,15604,
,U,A,CHEMBL626099,1,0,Plasma,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,,,Autocuration,,,,12192,1969.0,,22224,1806,
,U,A,CHEMBL626100,1,0,Plasma,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,,,Autocuration,,,,12193,1969.0,,22224,1806,
,N,A,CHEMBL626101,1,1,Plasma,BAO_0000218,AUC 0-inf in dog,Canis lupus familiaris,,,,Intermediate,,,,12194,1969.0,9615.0,50588,17237,
,N,A,CHEMBL626102,1,1,Plasma,BAO_0000218,AUC 0-inf in guinea pig,Cavia porcellus,,,,Intermediate,,,,12195,1969.0,10141.0,50512,17237,
,N,A,CHEMBL626103,1,1,Plasma,BAO_0000218,AUC 0-t in dog,Canis lupus familiaris,,,,Intermediate,,,,12196,1969.0,9615.0,50588,17237,
,N,A,CHEMBL628391,1,1,Plasma,BAO_0000218,AUC 0-t in guinea pig,Cavia porcellus,,,,Intermediate,,,,12197,1969.0,10141.0,50512,17237,
,N,A,CHEMBL628392,1,1,,BAO_0000218,The compound was tested for brain to plasma partition in rat,Rattus norvegicus,,,,Intermediate,,,,12198,,10116.0,50597,15194,
,N,A,CHEMBL628393,1,1,,BAO_0000218,The compound was tested for brain to plasma partition in rat.,Rattus norvegicus,,,,Intermediate,,,,12199,,10116.0,50597,15194,
,U,A,CHEMBL628394,1,0,Blood,BAO_0000019,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,,,Autocuration,,,,12200,178.0,,22224,8787,
,N,A,CHEMBL628395,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,,Intermediate,,,,12201,,9615.0,50588,17025,
,U,A,CHEMBL628396,1,0,,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,,Autocuration,,,,12202,,314293.0,22224,17025,
,N,A,CHEMBL628397,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,,Intermediate,,,,12203,,9986.0,50592,17025,
,N,A,CHEMBL628398,1,1,,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,,Intermediate,,,,12204,,10116.0,50597,17025,
,N,A,CHEMBL628399,1,1,,BAO_0000218,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,,,,Intermediate,,,,12205,,9544.0,50797,4236,
,N,A,CHEMBL628400,1,1,,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,,,,Intermediate,,,,12206,,9615.0,50588,15343,
,N,A,CHEMBL874907,1,1,,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,12207,,10116.0,50597,15343,
,U,A,CHEMBL628401,1,0,,BAO_0000019,Area under curve of the compound was determined,,,,,Autocuration,,,,12208,,,22224,17720,
,U,A,CHEMBL628402,1,0,Plasma,BAO_0000218,AUC in monkeys at a dose of 1 mg/kg,Simiiformes,,,,Autocuration,,,,12209,1969.0,314293.0,22224,17788,
,N,A,CHEMBL628403,1,1,Plasma,BAO_0000218,AUC in rats at a dose of 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12210,1969.0,10116.0,50597,17788,
,U,A,CHEMBL628404,1,0,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 2,,,,,Autocuration,,,,12211,,,22224,8778,
,U,A,CHEMBL628405,1,0,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 4,,,,,Autocuration,,,,12212,,,22224,8778,
,U,A,CHEMBL628406,1,0,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 7,,,,,Autocuration,,,,12213,,,22224,8778,
,N,A,CHEMBL628407,1,1,,BAO_0000218,Compound was evaluated for its absorption in the rats,Rattus norvegicus,,,,Intermediate,,,,12214,,10116.0,50597,2249,
,N,A,CHEMBL628408,1,1,Urine,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,,,,Intermediate,,,,12215,1088.0,10116.0,50597,8881,
,N,A,CHEMBL629171,1,1,Urine,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Rattus norvegicus,,,,Intermediate,,,,12216,1088.0,10116.0,50597,8881,
,N,A,CHEMBL629172,1,1,Urine,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,,,,Intermediate,,,,12217,1088.0,10116.0,50597,8881,
,N,A,CHEMBL629173,1,1,Urine,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Rattus norvegicus,,,,Intermediate,,,,12218,1088.0,10116.0,50597,8881,
,N,A,CHEMBL629174,1,1,,BAO_0000218,In vitro percent permeability into rat ileum,Rattus norvegicus,,,,Intermediate,,,,12219,,10116.0,50597,15286,
,N,A,CHEMBL629175,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-17,Rattus norvegicus,,,,Intermediate,,,,12220,,10116.0,50597,15286,
,N,A,CHEMBL629176,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-18,Rattus norvegicus,,,,Intermediate,,,,12221,,10116.0,50597,15286,
,N,A,CHEMBL629177,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-19,Rattus norvegicus,,,,Intermediate,,,,12222,,10116.0,50597,15286,
,N,A,CHEMBL629178,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 12-15,Rattus norvegicus,,,,Intermediate,,,,12223,,10116.0,50597,15286,
,N,A,CHEMBL631869,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 13-19,Rattus norvegicus,,,,Intermediate,,,,12224,,10116.0,50597,15286,
,N,A,CHEMBL631870,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 14-17,Rattus norvegicus,,,,Intermediate,,,,12225,,10116.0,50597,15286,
,N,A,CHEMBL631871,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 15-18,Rattus norvegicus,,,,Intermediate,,,,12226,,10116.0,50597,15286,
,N,A,CHEMBL631872,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 2-5,Rattus norvegicus,,,,Intermediate,,,,12227,,10116.0,50597,15286,
,U,A,CHEMBL875775,1,0,Ileum,BAO_0000221,In vitro percent permeability into rat ileum; Range is 23-42,,,,,Autocuration,,,,12228,2116.0,,22224,15286,
,N,A,CHEMBL631873,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 28-36,Rattus norvegicus,,,,Intermediate,,,,12229,,10116.0,50597,15286,
,N,A,CHEMBL631874,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 29-35,Rattus norvegicus,,,,Intermediate,,,,12230,,10116.0,50597,15286,
,N,A,CHEMBL631875,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 46-66,Rattus norvegicus,,,,Intermediate,,,,12231,,10116.0,50597,15286,
,N,A,CHEMBL631876,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 50-68,Rattus norvegicus,,,,Intermediate,,,,12232,,10116.0,50597,15286,
,N,A,CHEMBL631877,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; Range is 78-81,Rattus norvegicus,,,,Intermediate,,,,12233,,10116.0,50597,15286,
,N,A,CHEMBL631878,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Rattus norvegicus,,,,Intermediate,,,,12234,,10116.0,50597,15286,
,N,A,CHEMBL631879,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; nd indicates not detected,Rattus norvegicus,,,,Intermediate,,,,12235,,10116.0,50597,15286,
,N,A,CHEMBL631880,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not detected,Rattus norvegicus,,,,Intermediate,,,,12236,,10116.0,50597,15286,
,N,A,CHEMBL631881,1,1,,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not tested,Rattus norvegicus,,,,Intermediate,,,,12237,,10116.0,50597,15286,
,N,A,CHEMBL631882,1,1,,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats,Rattus norvegicus,,,,Intermediate,,,,12238,,10116.0,50597,13770,
,N,A,CHEMBL630749,1,1,,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats.,Rattus norvegicus,,,,Intermediate,,,,12239,,10116.0,50597,13770,
,N,A,CHEMBL630750,1,1,,BAO_0000218,Oral absorption using Caco-2 cell monolayers.,Homo sapiens,,,,Intermediate,,,,12240,,9606.0,50587,5202,
,N,A,CHEMBL630253,1,1,,BAO_0000218,Percent of the drug absorbed after administration to humans was determined,Homo sapiens,,,,Intermediate,,,,12241,,9606.0,50587,14920,
,N,A,CHEMBL630254,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,,,,Intermediate,,,,12242,1969.0,10116.0,50597,14103,
,N,A,CHEMBL630255,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,,,,Intermediate,,,,12243,1969.0,10116.0,50597,14103,
,N,A,CHEMBL630256,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,,,,Intermediate,,,,12244,1969.0,10116.0,50597,14103,
,N,A,CHEMBL875781,1,1,Liver,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12245,2107.0,10116.0,50597,13751,
,N,A,CHEMBL630257,1,1,Liver,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12246,2107.0,10116.0,50597,13751,
,N,A,CHEMBL630258,1,1,Liver,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,,Intermediate,,,In vivo,12247,2107.0,10116.0,50597,13751,
,N,A,CHEMBL630259,1,1,,BAO_0000218,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,,,Intermediate,,,,12248,,10116.0,50597,15807,
,N,A,CHEMBL630260,1,1,Striatum,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,,,Intermediate,,,,12249,2435.0,10116.0,50597,15807,
,N,A,CHEMBL630261,1,1,Striatum,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,,,Intermediate,,,,12250,2435.0,10116.0,50597,15807,
,N,A,CHEMBL630262,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Rattus norvegicus,,,,Intermediate,,,,12251,,10116.0,50597,14950,
,N,A,CHEMBL630263,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12252,,10116.0,50597,14950,
,N,A,CHEMBL630264,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Rattus norvegicus,,,,Intermediate,,,,12253,,10116.0,50597,14950,
,N,A,CHEMBL630265,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Rattus norvegicus,,,,Intermediate,,,,12254,,10116.0,50597,14950,
,N,A,CHEMBL630266,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Rattus norvegicus,,,,Intermediate,,,,12255,,10116.0,50597,14950,
,N,A,CHEMBL630267,1,1,Kidney,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Rattus norvegicus,,,,Intermediate,,,,12256,2113.0,10116.0,50597,14950,
,N,A,CHEMBL630268,1,1,Kidney,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Rattus norvegicus,,,,Intermediate,,,,12257,2113.0,10116.0,50597,14950,
,N,A,CHEMBL630269,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12258,,10116.0,50597,14950,
,N,A,CHEMBL630270,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Rattus norvegicus,,,,Intermediate,,,,12259,,10116.0,50597,14950,
,N,A,CHEMBL630141,1,1,Lung,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12260,2048.0,10116.0,50597,14950,
,N,A,CHEMBL630142,1,1,Lung,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Rattus norvegicus,,,,Intermediate,,,,12261,2048.0,10116.0,50597,14950,
,N,A,CHEMBL630143,1,1,Muscle tissue,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Rattus norvegicus,,,,Intermediate,,,,12262,2385.0,10116.0,50597,14950,
,N,A,CHEMBL630144,1,1,Muscle tissue,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Rattus norvegicus,,,,Intermediate,,,,12263,2385.0,10116.0,50597,14950,
,N,A,CHEMBL630145,1,1,Prostate gland,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Rattus norvegicus,,,,Intermediate,,,,12264,2367.0,10116.0,50597,14950,
,N,A,CHEMBL630146,1,1,Prostate gland,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Rattus norvegicus,,,,Intermediate,,,,12265,2367.0,10116.0,50597,14950,
,N,A,CHEMBL630147,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Rattus norvegicus,,,,Intermediate,,,,12266,,10116.0,50597,14950,
,N,A,CHEMBL630148,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Rattus norvegicus,,,,Intermediate,,,,12267,,10116.0,50597,14950,
,N,A,CHEMBL630149,1,1,,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Rattus norvegicus,,,,Intermediate,,,,12268,,10116.0,50597,14950,
,N,A,CHEMBL630150,1,1,Spleen,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12269,2106.0,10116.0,50597,14950,
,N,A,CHEMBL630151,1,1,Spleen,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Rattus norvegicus,,,,Intermediate,,,,12270,2106.0,10116.0,50597,14950,
,N,A,CHEMBL632031,1,1,Thyroid gland,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Rattus norvegicus,,,,Intermediate,,,,12271,2046.0,10116.0,50597,14950,
,N,A,CHEMBL632032,1,1,Thyroid gland,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Rattus norvegicus,,,,Intermediate,,,,12272,2046.0,10116.0,50597,14950,
,N,A,CHEMBL632033,1,1,,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12273,,10116.0,50597,14950,
,N,A,CHEMBL632034,1,1,,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12274,,10116.0,50597,14950,
,N,A,CHEMBL632035,1,1,Muscle tissue,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12275,2385.0,10116.0,50597,14950,
,N,A,CHEMBL632036,1,1,,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12276,,10116.0,50597,14950,
,N,A,CHEMBL632037,1,1,Thyroid gland,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Rattus norvegicus,,,,Intermediate,,,,12277,2046.0,10116.0,50597,14950,
,N,A,CHEMBL632038,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,,,,Intermediate,,,,12278,178.0,10116.0,50597,8631,
,N,A,CHEMBL632039,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12279,178.0,10116.0,50597,8631,
,N,A,CHEMBL632040,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12280,178.0,10116.0,50597,8631,
,N,A,CHEMBL632041,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,,,,Intermediate,,,,12281,178.0,10116.0,50597,8631,
,N,A,CHEMBL632042,1,1,Blood,BAO_0000218,"Concentration of compound in blood of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12282,178.0,9615.0,50588,9614,
,N,A,CHEMBL632043,1,1,,BAO_0000218,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12283,,9615.0,50588,9614,
,N,A,CHEMBL632044,1,1,,BAO_0000218,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12284,,9615.0,50588,9614,
,N,A,CHEMBL632045,1,1,Liver,BAO_0000218,"Concentration of compound in liver of dog 1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12285,2107.0,9615.0,50588,9614,
,N,A,CHEMBL632046,1,1,Liver,BAO_0000218,"Concentration of compound in liver of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12286,2107.0,9615.0,50588,9614,
,N,A,CHEMBL632047,1,1,Lung,BAO_0000218,"Concentration of compound in lung of dog 1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12287,2048.0,9615.0,50588,9614,
,N,A,CHEMBL632048,1,1,Lung,BAO_0000218,"Concentration of compound in lung of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12288,2048.0,9615.0,50588,9614,
,N,A,CHEMBL632049,1,1,Muscle tissue,BAO_0000218,"Concentration of compound in muscle of dog 1, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12289,2385.0,9615.0,50588,9614,
,N,A,CHEMBL876418,1,1,Muscle tissue,BAO_0000218,"Concentration of compound in muscle of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12290,2385.0,9615.0,50588,9614,
,N,A,CHEMBL632050,1,1,Spleen,BAO_0000218,"Concentration of compound in spleen of dog 1,after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12291,2106.0,9615.0,50588,9614,
,N,A,CHEMBL632051,1,1,Spleen,BAO_0000218,"Concentration of compound in spleen of dog 2, after administering intravenously",Canis lupus familiaris,,,,Intermediate,,,,12292,2106.0,9615.0,50588,9614,
,U,F,CHEMBL632052,1,0,,BAO_0000218,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,,,Autocuration,,,,12293,,,22224,10353,
,U,F,CHEMBL632053,1,0,,BAO_0000218,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,,,Autocuration,,,,12294,,,22224,10353,
,U,A,CHEMBL632054,1,0,,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,,Autocuration,,,,12295,,,22224,10353,
,U,F,CHEMBL632055,1,0,,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,,Autocuration,,,,12296,,,22224,10353,
,U,F,CHEMBL631181,1,0,,BAO_0000218,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,,,Autocuration,,,,12297,,,22224,10353,
,U,A,CHEMBL631182,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,,,Autocuration,,,,12298,,,22224,9196,
,U,A,CHEMBL631183,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,Autocuration,,,,12299,,,22224,9196,
,U,A,CHEMBL631184,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12300,,,22224,9196,
,U,A,CHEMBL629774,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12301,,,22224,9196,
,U,A,CHEMBL629775,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12302,,,22224,9196,
,U,A,CHEMBL876549,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12303,,,22224,9196,
,U,A,CHEMBL628172,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12304,,,22224,9196,
,U,A,CHEMBL628173,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12305,,,22224,9196,
,U,A,CHEMBL628174,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,,,Autocuration,,,,12306,,,22224,9196,
,U,A,CHEMBL628175,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,,,Autocuration,,,,12307,,,22224,9196,
,U,A,CHEMBL628176,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12308,,,22224,9196,
,U,A,CHEMBL628177,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12309,,,22224,9196,
,U,A,CHEMBL628178,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12310,,,22224,9196,
,U,A,CHEMBL628179,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12311,,,22224,9196,
,U,A,CHEMBL628180,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,,Autocuration,,,,12312,,,22224,9196,
,U,A,CHEMBL628181,1,0,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,,,Autocuration,,,,12313,,,22224,9196,
,U,A,CHEMBL628182,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12314,,,22224,9196,
,U,A,CHEMBL628183,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12315,,,22224,9196,
,U,A,CHEMBL628184,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,,,Autocuration,,,,12316,,,22224,9196,
,U,A,CHEMBL628185,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12317,,,22224,9196,
,U,A,CHEMBL875617,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12318,,,22224,9196,
,U,A,CHEMBL628186,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,,Autocuration,,,,12319,,,22224,9196,
,U,A,CHEMBL628187,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12320,,,22224,9196,
,U,A,CHEMBL628188,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12321,,,22224,9196,
,U,A,CHEMBL628189,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12322,,,22224,9196,
,U,A,CHEMBL628190,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,,,Autocuration,,,,12323,,,22224,9196,
,U,A,CHEMBL628191,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12324,,,22224,9196,
,U,A,CHEMBL626513,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,,,Autocuration,,,,12325,,,22224,9196,
,N,A,CHEMBL626514,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Rattus norvegicus,,,,Intermediate,,,,12326,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626515,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Rattus norvegicus,,,,Intermediate,,,,12327,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626516,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Rattus norvegicus,,,,Intermediate,,,,12328,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626517,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Rattus norvegicus,,,,Intermediate,,,,12329,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626518,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Rattus norvegicus,,,,Intermediate,,,,12330,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626519,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Rattus norvegicus,,,,Intermediate,,,,12331,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626520,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Rattus norvegicus,,,,Intermediate,,,,12332,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626521,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Rattus norvegicus,,,,Intermediate,,,,12333,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626522,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Rattus norvegicus,,,,Intermediate,,,,12334,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626523,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Rattus norvegicus,,,,Intermediate,,,,12335,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626524,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Rattus norvegicus,,,,Intermediate,,,,12336,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626688,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Rattus norvegicus,,,,Intermediate,,,,12337,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626689,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Rattus norvegicus,,,,Intermediate,,,,12338,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626690,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Rattus norvegicus,,,,Intermediate,,,,12339,2046.0,10116.0,50597,8608,
,N,A,CHEMBL626691,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Rattus norvegicus,,,,Intermediate,,,,12340,2046.0,10116.0,50597,8608,
,N,A,CHEMBL627319,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Rattus norvegicus,,,,Intermediate,,,,12341,2046.0,10116.0,50597,8608,
,N,A,CHEMBL624052,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Rattus norvegicus,,,,Intermediate,,,,12342,2046.0,10116.0,50597,8608,
,N,A,CHEMBL624053,1,1,Thyroid gland,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Rattus norvegicus,,,,Intermediate,,,,12343,2046.0,10116.0,50597,8608,
,N,A,CHEMBL624054,1,1,,BAO_0000218,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12344,,10116.0,50597,8085,
,N,A,CHEMBL624055,1,1,,BAO_0000218,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12345,,10116.0,50597,8085,
,N,A,CHEMBL624056,1,1,,BAO_0000218,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12346,,10116.0,50597,8085,
,N,A,CHEMBL624057,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12347,995.0,10116.0,50597,8085,
,N,A,CHEMBL622281,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12348,995.0,10116.0,50597,8085,
,N,A,CHEMBL622282,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12349,995.0,10116.0,50597,8085,
,N,A,CHEMBL622283,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12350,995.0,10116.0,50597,8085,
,N,A,CHEMBL622284,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12351,995.0,10116.0,50597,8085,
,N,A,CHEMBL622285,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12352,995.0,10116.0,50597,8085,
,N,A,CHEMBL622286,1,1,Uterus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,,Intermediate,,,,12353,995.0,10116.0,50597,8085,
,U,P,CHEMBL622287,1,0,,BAO_0000100,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,,,Autocuration,,,,12354,,,22224,7657,
,N,A,CHEMBL622288,1,1,,BAO_0000218,Partition coefficient (logD7.4),Mus musculus,,,,Intermediate,,,,12355,,10090.0,50594,8935,
,N,A,CHEMBL622289,1,1,,BAO_0000218,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,,,,Intermediate,,,,12356,,10090.0,50594,13792,
,N,A,CHEMBL622290,1,1,Brain,BAO_0000218,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,,,,Intermediate,,,,12357,955.0,10090.0,50594,13792,
,N,A,CHEMBL622291,1,1,,BAO_0000218,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,,,,Intermediate,,,,12358,,10090.0,50594,13792,
,N,A,CHEMBL622292,1,1,Brain,BAO_0000218,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Mus musculus,,,,Intermediate,,,,12359,955.0,10090.0,50594,13792,
,N,A,CHEMBL622293,1,1,,BAO_0000218,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,,,,Intermediate,,,,12360,,10090.0,50594,13792,
,N,A,CHEMBL622294,1,1,Brain,BAO_0000218,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,,,,Intermediate,,,,12361,955.0,10090.0,50594,13792,
,N,A,CHEMBL622295,1,1,,BAO_0000218,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,,,,Intermediate,,,,12362,,10090.0,50594,13792,
,N,A,CHEMBL622296,1,1,Brain,BAO_0000218,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Rattus norvegicus,,,,Intermediate,,,,12363,955.0,10116.0,50597,13792,
,N,A,CHEMBL874409,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Rattus norvegicus,,,,Intermediate,,,,12364,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622297,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,,,,Intermediate,,,,12365,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622298,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,,,,Intermediate,,,,12366,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622299,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,,,,Intermediate,,,,12367,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622300,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,,,,Intermediate,,,,12368,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622301,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,,,,Intermediate,,,,12369,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622302,1,1,Plasma,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,,,,Intermediate,,,,12370,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622303,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,,,,Intermediate,,,,12371,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622304,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,,,,Intermediate,,,,12372,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622305,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12373,1969.0,10116.0,50597,14103,
,N,A,CHEMBL622306,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,,,,Intermediate,,,,12374,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626864,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12375,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626865,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,,,,Intermediate,,,,12376,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626866,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12377,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626867,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,,,,Intermediate,,,,12378,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626868,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,,,,Intermediate,,,,12379,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626869,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12380,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626870,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,,,,Intermediate,,,,12381,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626871,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12382,1969.0,10116.0,50597,14103,
,N,A,CHEMBL626872,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,,,,Intermediate,,,,12383,1969.0,10116.0,50597,14103,
,N,A,CHEMBL632185,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,,,,Intermediate,,,,12384,1969.0,10116.0,50597,14103,
,N,A,CHEMBL632186,1,1,Plasma,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Rattus norvegicus,,,,Intermediate,,,,12385,1969.0,10116.0,50597,14103,
,U,A,CHEMBL629310,1,0,,BAO_0000019,Amount of acetic acid produced by the compound,,,,,Autocuration,,,,12386,,,22224,12904,
,U,A,CHEMBL629311,1,0,,BAO_0000019,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,,,Autocuration,,,,12387,,,22224,12904,
,N,A,CHEMBL629312,1,1,,BAO_0000218,Log of (Cbrain/Cblood) in rats,Rattus norvegicus,,,,Intermediate,,,,12388,,10116.0,50597,9663,
,U,A,CHEMBL629313,1,0,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,,Autocuration,,,,12389,,,22224,7652,
,U,A,CHEMBL629314,1,0,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12390,,,22224,7652,
,U,A,CHEMBL629315,1,0,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,,Autocuration,,,,12391,,,22224,7652,
,U,B,CHEMBL629316,1,0,,BAO_0000219,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,,,Autocuration,,,,12392,,,22224,7652,
,U,A,CHEMBL629317,1,0,,BAO_0000221,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12393,,,22224,7652,
,U,A,CHEMBL629318,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,,Autocuration,,,,12394,,,22224,7652,
,U,A,CHEMBL877497,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12395,,,22224,7652,
,U,A,CHEMBL629319,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,,,Autocuration,,,,12396,,,22224,7652,
,U,A,CHEMBL629320,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12397,,,22224,7652,
,U,A,CHEMBL629496,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,,,Autocuration,,,,12398,,,22224,7652,
,U,A,CHEMBL629497,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12399,,,22224,7652,
,U,A,CHEMBL629498,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,,,Autocuration,,,,12400,,,22224,7652,
,U,A,CHEMBL629499,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12401,,,22224,7652,
,U,A,CHEMBL629500,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,,Autocuration,,,,12402,,,22224,7652,
,U,A,CHEMBL629501,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,,,Autocuration,,,,12403,,,22224,7652,
,U,A,CHEMBL629502,1,0,,BAO_0000019,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,,,Autocuration,,,,12404,,,22224,7652,
,U,F,CHEMBL629503,1,0,,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,,,Autocuration,,,In vivo,12405,,,22224,8267,
,N,A,CHEMBL629504,1,1,,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,,12406,,9615.0,50588,8267,
,U,A,CHEMBL629505,1,0,,BAO_0000019,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,,,Autocuration,,,,12407,,,22224,14479,
,U,A,CHEMBL629506,1,0,,BAO_0000019,Compound was evaluated for total body clearance,,,,,Autocuration,,,,12408,,,22224,17515,
,U,A,CHEMBL629507,1,0,,BAO_0000019,Compound was evaluated for volume of distribution at steady state,,,,,Autocuration,,,,12409,,,22224,17515,
,U,A,CHEMBL877498,1,0,,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,,,Autocuration,,,,12410,,,22224,8142,
,U,A,CHEMBL629508,1,0,,BAO_0000019,Percentage of the diamine which is monoprotonated at pH 7.4,,,,,Autocuration,,,,12411,,,22224,14849,
,U,A,CHEMBL629509,1,0,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,,,Autocuration,,,,12412,,,22224,7653,
,N,A,CHEMBL629510,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12413,178.0,10116.0,50597,8631,
,N,A,CHEMBL629511,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,,,Intermediate,,,,12414,178.0,10116.0,50597,8631,
,N,A,CHEMBL629512,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12415,178.0,10116.0,50597,8631,
,N,A,CHEMBL629513,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12416,178.0,10116.0,50597,8631,
,N,A,CHEMBL629514,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,,,,Intermediate,,,,12417,178.0,10116.0,50597,8631,
,N,A,CHEMBL628447,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12418,178.0,10116.0,50597,8631,
,N,A,CHEMBL628448,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,,,,Intermediate,,,,12419,178.0,10116.0,50597,8631,
,N,A,CHEMBL628449,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12420,178.0,10116.0,50597,8631,
,N,A,CHEMBL631119,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12421,178.0,10116.0,50597,8631,
,N,A,CHEMBL631120,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,,,,Intermediate,,,,12422,178.0,10116.0,50597,8631,
,N,A,CHEMBL631121,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12423,178.0,10116.0,50597,8631,
,N,A,CHEMBL874458,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Rattus norvegicus,,,,Intermediate,,,,12424,178.0,10116.0,50597,8631,
,N,A,CHEMBL631122,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12425,178.0,10116.0,50597,8631,
,N,A,CHEMBL631123,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12426,178.0,10116.0,50597,8631,
,N,A,CHEMBL631124,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12427,178.0,10116.0,50597,8631,
,N,A,CHEMBL631125,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,,,Intermediate,,,,12428,178.0,10116.0,50597,8631,
,N,A,CHEMBL631290,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12429,178.0,10116.0,50597,8631,
,N,A,CHEMBL631291,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12430,178.0,10116.0,50597,8631,
,N,A,CHEMBL631292,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12431,178.0,10116.0,50597,8631,
,N,A,CHEMBL631293,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,,,Intermediate,,,,12432,178.0,10116.0,50597,8631,
,N,A,CHEMBL631294,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,,,Intermediate,,,,12433,178.0,10116.0,50597,8631,
,N,A,CHEMBL631295,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,,,Intermediate,,,,12434,178.0,10116.0,50597,8631,
,N,A,CHEMBL631296,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,,,,Intermediate,,,,12435,178.0,10116.0,50597,8631,
,N,A,CHEMBL631297,1,1,Blood,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,,,Intermediate,,,,12436,178.0,10116.0,50597,8631,
,U,A,CHEMBL631298,1,0,,BAO_0000218,Maximum biodistribution (Bmax) was determined.,,,,,Autocuration,,,,12437,,,22224,10263,
,N,A,CHEMBL631299,1,1,,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,,Intermediate,,,,12438,,10090.0,50594,12364,
,N,A,CHEMBL631300,1,1,,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,,Intermediate,,,,12439,,10090.0,50594,12364,
,N,A,CHEMBL631301,1,1,,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,,Intermediate,,,,12440,,10090.0,50594,12364,
,N,A,CHEMBL630291,1,1,,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,,Intermediate,,,,12441,,10090.0,50594,12364,
,U,A,CHEMBL630292,1,0,,BAO_0000218,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,Autocuration,,,,12442,,,22224,14793,
,U,A,CHEMBL630293,1,0,,BAO_0000218,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,,,Autocuration,,,,12443,,,22224,14793,
,U,A,CHEMBL630294,1,0,,BAO_0000218,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,,,Autocuration,,,,12444,,,22224,14793,
,U,A,CHEMBL630295,1,0,,BAO_0000218,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,,,Autocuration,,,,12445,,,22224,14793,
,U,A,CHEMBL630296,1,0,,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,,,Autocuration,,,,12446,,,22224,14793,
,U,A,CHEMBL626782,1,0,,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,,,Autocuration,,,,12447,,,22224,14793,
,U,A,CHEMBL626783,1,0,,BAO_0000218,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,,,Autocuration,,,,12448,,,22224,14793,
,U,A,CHEMBL626784,1,0,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,Autocuration,,,,12449,,,22224,14793,
,U,A,CHEMBL626785,1,0,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,,,Autocuration,,,,12450,,,22224,14793,
,U,A,CHEMBL626786,1,0,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,,,Autocuration,,,,12451,,,22224,14793,
,U,A,CHEMBL626787,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12452,,,22224,9196,
,U,A,CHEMBL626788,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,,Autocuration,,,,12453,,,22224,9196,
,U,A,CHEMBL625927,1,0,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12454,,,22224,9196,
,N,A,CHEMBL625928,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12455,178.0,10116.0,50597,8374,
,N,A,CHEMBL625929,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12456,178.0,10116.0,50597,8374,
,N,A,CHEMBL625930,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,,,,Intermediate,,,,12457,178.0,10116.0,50597,8374,
,N,A,CHEMBL625931,1,1,Blood,BAO_0000218,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Rattus norvegicus,,,,Intermediate,,,,12458,178.0,10116.0,50597,8374,
,N,A,CHEMBL627230,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Rattus norvegicus,,,,Intermediate,,,,12459,178.0,10116.0,50597,8374,
,N,A,CHEMBL627231,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12460,178.0,10116.0,50597,8374,
,N,A,CHEMBL627232,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12461,178.0,10116.0,50597,8374,
,N,A,CHEMBL627233,1,1,Blood,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,,,,Intermediate,,,,12462,178.0,10116.0,50597,8374,
,N,A,CHEMBL875470,1,1,Blood,BAO_0000218,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12463,178.0,10116.0,50597,8374,
,N,A,CHEMBL627234,1,1,Blood,BAO_0000218,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12464,178.0,10116.0,50597,8374,
,N,A,CHEMBL627235,1,1,Blood,BAO_0000218,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12465,178.0,10116.0,50597,8374,
,N,A,CHEMBL627236,1,1,Blood,BAO_0000218,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12466,178.0,10116.0,50597,8374,
,N,A,CHEMBL627237,1,1,Blood,BAO_0000218,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12467,178.0,10116.0,50597,8374,
,N,A,CHEMBL627238,1,1,Blood,BAO_0000218,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12468,178.0,10116.0,50597,8374,
,N,A,CHEMBL627239,1,1,Blood,BAO_0000218,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12469,178.0,10116.0,50597,8374,
,N,A,CHEMBL627240,1,1,Blood,BAO_0000218,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12470,178.0,10116.0,50597,8374,
,N,A,CHEMBL627241,1,1,Blood,BAO_0000218,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12471,178.0,10116.0,50597,8374,
,N,A,CHEMBL627242,1,1,Blood,BAO_0000218,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12472,178.0,10116.0,50597,8374,
,N,A,CHEMBL627243,1,1,Blood,BAO_0000218,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12473,178.0,10116.0,50597,8374,
,N,A,CHEMBL627244,1,1,Blood,BAO_0000218,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12474,178.0,10116.0,50597,8374,
,N,A,CHEMBL627245,1,1,Blood,BAO_0000218,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12475,178.0,10116.0,50597,8374,
,N,A,CHEMBL627246,1,1,Blood,BAO_0000218,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12476,178.0,10116.0,50597,8374,
,N,A,CHEMBL627247,1,1,Blood,BAO_0000218,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12477,178.0,10116.0,50597,8374,
,N,A,CHEMBL627248,1,1,Blood,BAO_0000218,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12478,178.0,10116.0,50597,8374,
,N,A,CHEMBL627249,1,1,Blood,BAO_0000218,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12479,178.0,10116.0,50597,8374,
,N,A,CHEMBL625569,1,1,Blood,BAO_0000218,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12480,178.0,10116.0,50597,8374,
,N,A,CHEMBL625570,1,1,Blood,BAO_0000218,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12481,178.0,10116.0,50597,8374,
,N,A,CHEMBL625571,1,1,Blood,BAO_0000218,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12482,178.0,10116.0,50597,8374,
,N,A,CHEMBL625572,1,1,Blood,BAO_0000218,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12483,178.0,10116.0,50597,8374,
,N,A,CHEMBL625573,1,1,Blood,BAO_0000218,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12484,178.0,10116.0,50597,8374,
,N,A,CHEMBL625574,1,1,Blood,BAO_0000218,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12485,178.0,10116.0,50597,8374,
,N,A,CHEMBL626245,1,1,Blood,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,,,Intermediate,,,,12486,178.0,10116.0,50597,8374,
,N,A,CHEMBL626246,1,1,Blood,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12487,178.0,10116.0,50597,8374,
,U,A,CHEMBL626247,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12488,,,22224,9196,
,U,A,CHEMBL626248,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12489,,,22224,9196,
,U,A,CHEMBL626249,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,,Autocuration,,,,12490,,,22224,9196,
,U,A,CHEMBL626420,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12491,,,22224,9196,
,U,A,CHEMBL626421,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,Autocuration,,,,12492,,,22224,9196,
,U,A,CHEMBL626422,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12493,,,22224,9196,
,U,A,CHEMBL626423,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12494,,,22224,9196,
,U,A,CHEMBL626424,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12495,,,22224,9196,
,N,A,CHEMBL626425,1,1,,BAO_0000218,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Canis lupus familiaris,,,,Intermediate,,,,12496,,9615.0,50588,12023,
,N,A,CHEMBL875476,1,1,,BAO_0000218,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Rattus norvegicus,,,,Intermediate,,,,12497,,10116.0,50597,12023,
,N,A,CHEMBL626426,1,1,,BAO_0000218,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Macaca fascicularis,,,,Intermediate,,,,12498,,9541.0,100710,12023,
,U,P,CHEMBL626427,1,0,,BAO_0000100,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,,Autocuration,,,,12499,,,22224,10580,
,U,P,CHEMBL626428,1,0,,BAO_0000100,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,,Autocuration,,,,12500,,,22224,10580,
,U,A,CHEMBL626429,1,0,,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,,,Autocuration,,,,12501,,,22224,16032,
,U,A,CHEMBL625025,1,0,Urine,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,,,Autocuration,,,,12502,1088.0,,22224,16032,
,N,A,CHEMBL625026,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12503,178.0,10116.0,50597,8594,
,N,A,CHEMBL625027,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12504,178.0,10116.0,50597,8594,
,N,A,CHEMBL874410,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12505,178.0,10116.0,50597,8594,
,N,A,CHEMBL625028,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12506,178.0,10116.0,50597,8594,
,N,A,CHEMBL625029,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12507,178.0,10116.0,50597,8594,
,N,A,CHEMBL625030,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12508,178.0,10116.0,50597,8594,
,N,A,CHEMBL625031,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12509,178.0,10116.0,50597,8594,
,N,A,CHEMBL625032,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12510,178.0,10116.0,50597,8594,
,N,A,CHEMBL625033,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12511,178.0,10116.0,50597,8594,
,N,A,CHEMBL625034,1,1,Blood,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12512,178.0,10116.0,50597,8594,
,N,A,CHEMBL624872,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12513,948.0,10116.0,50597,8594,
,N,A,CHEMBL624873,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12514,948.0,10116.0,50597,8594,
,N,A,CHEMBL624874,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12515,948.0,10116.0,50597,8594,
,N,A,CHEMBL624875,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12516,948.0,10116.0,50597,8594,
,N,A,CHEMBL624876,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12517,948.0,10116.0,50597,8594,
,N,A,CHEMBL624877,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12518,948.0,10116.0,50597,8594,
,N,A,CHEMBL624878,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12519,948.0,10116.0,50597,8594,
,N,A,CHEMBL624879,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12520,948.0,10116.0,50597,8594,
,N,A,CHEMBL624880,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12521,948.0,10116.0,50597,8594,
,N,A,CHEMBL624881,1,1,Heart,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12522,948.0,10116.0,50597,8594,
,N,A,CHEMBL624882,1,1,Heart,BAO_0000218,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Rattus norvegicus,,,,Intermediate,,,,12523,948.0,10116.0,50597,8594,
,N,A,CHEMBL624883,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12524,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624884,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12525,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624885,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12526,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624886,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12527,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624887,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12528,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624888,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12529,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624889,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12530,2113.0,10116.0,50597,8594,
,N,A,CHEMBL624890,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12531,2113.0,10116.0,50597,8594,
,N,A,CHEMBL621964,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12532,2113.0,10116.0,50597,8594,
,N,A,CHEMBL621965,1,1,Kidney,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12533,2113.0,10116.0,50597,8594,
,N,A,CHEMBL621966,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12534,2107.0,10116.0,50597,8594,
,N,A,CHEMBL621967,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12535,2107.0,10116.0,50597,8594,
,N,A,CHEMBL622164,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12536,2107.0,10116.0,50597,8594,
,U,A,CHEMBL623097,1,0,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,,,Autocuration,,,,12537,,,22224,7653,
,U,A,CHEMBL623098,1,0,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,,,Autocuration,,,,12538,,,22224,7653,
,U,A,CHEMBL623099,1,0,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,,,Autocuration,,,,12539,,,22224,7653,
,U,A,CHEMBL623100,1,0,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,,,Autocuration,,,,12540,,,22224,7653,
,N,A,CHEMBL628673,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Rattus norvegicus,,,,Intermediate,,,,12541,,10116.0,50597,9104,
,N,A,CHEMBL628674,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Rattus norvegicus,,,,Intermediate,,,,12542,,10116.0,50597,9104,
,N,A,CHEMBL628675,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Rattus norvegicus,,,,Intermediate,,,,12543,,10116.0,50597,9104,
,N,A,CHEMBL627644,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,,,,Intermediate,,,,12544,,10116.0,50597,9104,
,N,A,CHEMBL627645,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Rattus norvegicus,,,,Intermediate,,,,12545,,10116.0,50597,9104,
,N,A,CHEMBL627646,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Rattus norvegicus,,,,Intermediate,,,,12546,,10116.0,50597,9104,
,N,A,CHEMBL627647,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,,,,Intermediate,,,,12547,,10116.0,50597,9104,
,N,A,CHEMBL627648,1,1,,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Rattus norvegicus,,,,Intermediate,,,,12548,,10116.0,50597,9104,
,N,A,CHEMBL627649,1,1,,BAO_0000218,Free level in rat plasma,Rattus norvegicus,,,,Intermediate,,,,12549,,10116.0,50597,12902,
,U,A,CHEMBL628313,1,0,,BAO_0000019,Level reaching in blood plasma of rat or human was determined,,,,,Autocuration,,,,12550,,,22224,6614,
,N,A,CHEMBL628314,1,1,,BAO_0000218,Log (Cbrain/Cblood) in rats,Rattus norvegicus,,,,Intermediate,,,,12551,,10116.0,50597,9663,
,U,A,CHEMBL628315,1,0,,BAO_0000019,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,,,Autocuration,,,,12552,,,22224,17658,
,U,A,CHEMBL628316,1,0,,BAO_0000019,Mean percentage of compound transport through membrane; expressed as membrane transport,,,,,Autocuration,,,,12553,,,22224,17658,
,U,A,CHEMBL628317,1,0,,BAO_0000218,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,,,Autocuration,,,,12554,,,22224,14314,
,U,A,CHEMBL628473,1,0,,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,,,Autocuration,,,,12555,,,22224,7385,
,U,A,CHEMBL628474,1,0,,BAO_0000019,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,,,Autocuration,,,,12556,,,22224,7385,
,U,A,CHEMBL628475,1,0,,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,,,Autocuration,,,,12557,,,22224,7385,
,U,A,CHEMBL628476,1,0,,BAO_0000019,Net water uptake by a carrier mediated transport (%cm) mechanism,,,,,Autocuration,,,,12558,,,22224,1329,
,U,A,CHEMBL628477,1,0,,BAO_0000218,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,,Autocuration,,,,12559,,314293.0,22224,12187,
,N,A,CHEMBL628478,1,1,,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,,,,Intermediate,,,,12560,,9669.0,50506,12187,
,N,A,CHEMBL628479,1,1,,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,,,,Intermediate,,,,12561,,9669.0,50506,12187,
,U,A,CHEMBL628480,1,0,,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,,Autocuration,,,,12562,,314293.0,22224,12187,
,U,A,CHEMBL628481,1,0,,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Simiiformes,,,,Autocuration,,,,12563,,314293.0,22224,12187,
,N,A,CHEMBL628482,1,1,,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,,12564,,10116.0,50597,12187,
,N,A,CHEMBL628483,1,1,,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,,Intermediate,,,,12565,,10116.0,50597,12187,
,N,A,CHEMBL628484,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,,,,Intermediate,,,,12566,1969.0,10116.0,50597,9278,
,N,A,CHEMBL628485,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,,,Intermediate,,,,12567,1969.0,10116.0,50597,9278,
,N,A,CHEMBL628486,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Macaca fascicularis,,,,Intermediate,,,,12568,1969.0,9541.0,100710,9278,
,N,A,CHEMBL628487,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Homo sapiens,,,,Intermediate,,,,12569,1969.0,9606.0,50587,9278,
,N,A,CHEMBL628488,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,,,,Intermediate,,,,12570,1969.0,10116.0,50597,9278,
,N,A,CHEMBL628489,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,,,Intermediate,,,,12571,1969.0,10116.0,50597,9278,
,N,A,CHEMBL628490,1,1,Plasma,BAO_0000218,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,,,Intermediate,,,,12572,1969.0,10116.0,50597,9278,
,N,A,CHEMBL628491,1,1,,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,,Intermediate,,,,12573,,9541.0,100710,12186,
,N,A,CHEMBL877507,1,1,,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,,Intermediate,,,,12574,,9541.0,100710,12186,
,U,A,CHEMBL628492,1,0,,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,,Autocuration,,,,12575,,,22224,12186,
,U,A,CHEMBL628493,1,0,,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Simiiformes,,,,Autocuration,,,,12576,,314293.0,22224,12041,
,U,A,CHEMBL628494,1,0,,BAO_0000019,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Simiiformes,,,,Autocuration,,,,12577,,314293.0,22224,12041,
,U,A,CHEMBL628495,1,0,,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Simiiformes,,,,Autocuration,,,,12578,,314293.0,22224,12041,
,N,A,CHEMBL628496,1,1,,BAO_0000218,Permeability in Caco-2 assay at 10E-6,Homo sapiens,,,,Intermediate,,,,12579,,9606.0,50587,6737,
,U,A,CHEMBL628497,1,0,Brain,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,,,Autocuration,,,,12580,955.0,,22224,13758,
,U,A,CHEMBL628498,1,0,Brain,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,,,Autocuration,,,,12581,955.0,,22224,13758,
,U,A,CHEMBL628499,1,0,,BAO_0000019,Plasma protein binding was determined,,,,,Autocuration,,,,12582,,,22224,5676,
,U,A,CHEMBL627656,1,0,,BAO_0000218,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,,,Autocuration,,,,12583,,,22224,14793,
,U,A,CHEMBL627657,1,0,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,Autocuration,,,,12584,,,22224,14793,
,U,A,CHEMBL626808,1,0,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,,,Autocuration,,,,12585,,,22224,14793,
,U,A,CHEMBL626809,1,0,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,,,Autocuration,,,,12586,,,22224,14793,
,U,A,CHEMBL626810,1,0,,BAO_0000218,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,,,Autocuration,,,,12587,,,22224,14793,
,U,A,CHEMBL626811,1,0,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,Autocuration,,,,12588,,,22224,14793,
,U,A,CHEMBL874465,1,0,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,,,Autocuration,,,,12589,,,22224,14793,
,U,A,CHEMBL626812,1,0,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,,,Autocuration,,,,12590,,,22224,14793,
,U,A,CHEMBL626813,1,0,,BAO_0000218,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,,,Autocuration,,,,12591,,,22224,14793,
,U,A,CHEMBL626814,1,0,,BAO_0000218,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,,,Autocuration,,,,12592,,,22224,14793,
,U,A,CHEMBL626815,1,0,,BAO_0000019,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,,,Autocuration,,,,12593,,,22224,14000,
,U,A,CHEMBL628566,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,12594,,,22224,5948,
,U,P,CHEMBL628567,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,Autocuration,,,,12595,,,22229,13824,
,U,P,CHEMBL628568,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12596,,,22229,10778,
,N,A,CHEMBL628569,1,1,,BAO_0000218,C max in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,12597,,9615.0,50588,17237,
,N,A,CHEMBL628570,1,1,,BAO_0000218,C max in guinea pig,Cavia porcellus,,,,Intermediate,,,In vivo,12598,,10141.0,50512,17237,
,U,A,CHEMBL628571,1,0,,BAO_0000218,C max value was evaluated,,,,,Autocuration,,,In vivo,12599,,,22224,2809,
,U,A,CHEMBL628572,1,0,,BAO_0000218,Cmax value after oral dose of 0.1 mg//kg,,,,,Autocuration,,,In vivo,12600,,,22224,11954,
,U,A,CHEMBL628573,1,0,,BAO_0000218,Cmax value after oral dose of 0.3 mg/kg,,,,,Autocuration,,,In vivo,12601,,,22224,11954,
,U,A,CHEMBL628574,1,0,,BAO_0000218,Cmax value after oral dose of 1 mg/kg,,,,,Autocuration,,,In vivo,12602,,,22224,11954,
,U,A,CHEMBL628575,1,0,,BAO_0000218,Cmax value after oral dose of 10 mg/kg,,,,,Autocuration,,,In vivo,12603,,,22224,11954,
,U,A,CHEMBL628576,1,0,,BAO_0000218,Cmax value after oral dose of 23.4 mg/kg,,,,,Autocuration,,,In vivo,12604,,,22224,11954,
,U,A,CHEMBL628577,1,0,,BAO_0000218,Cmax value after oral dose of 3 mg/kg,,,,,Autocuration,,,In vivo,12605,,,22224,11954,
,U,A,CHEMBL628578,1,0,,BAO_0000218,Cmax value after oral dose of 3.87 mg/kg,,,,,Autocuration,,,In vivo,12606,,,22224,11954,
,N,A,CHEMBL874466,1,1,,BAO_0000218,Cmax value in female Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,12607,,9615.0,50588,12768,
,N,A,CHEMBL628579,1,1,,BAO_0000218,Cmax value in male rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12608,,10116.0,50597,12768,
,N,A,CHEMBL628580,1,1,Plasma,BAO_0000218,Cmax value in rat plasma when administered 20 mg/kg perorally,Rattus norvegicus,,,,Intermediate,,,In vivo,12609,1969.0,10116.0,50597,12780,
,N,A,CHEMBL628581,1,1,Plasma,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,,,Intermediate,,,In vivo,12610,1969.0,9615.0,50588,15592,
,N,A,CHEMBL628582,1,1,Plasma,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,,,Intermediate,,,In vivo,12611,1969.0,9615.0,50588,15592,
,N,A,CHEMBL628583,1,1,,BAO_0000218,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,,Intermediate,,,,12612,,9615.0,50588,17025,
,U,A,CHEMBL625782,1,0,,BAO_0000218,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,,Autocuration,,,,12613,,314293.0,22224,17025,
,N,A,CHEMBL625783,1,1,,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,,Intermediate,,,,12614,,9986.0,50592,17025,
,N,A,CHEMBL625784,1,1,,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,,Intermediate,,,,12615,,10116.0,50597,17025,
,N,A,CHEMBL625785,1,1,Plasma,BAO_0000218,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,,,,Intermediate,,,,12616,1969.0,9544.0,50797,4236,
,N,A,CHEMBL625786,1,1,,BAO_0000218,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Rattus norvegicus,,,,Intermediate,,,,12617,,10116.0,50597,15791,
,U,A,CHEMBL874467,1,0,,BAO_0000019,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,,,Autocuration,,,,12618,,,22224,11149,
,N,A,CHEMBL625787,1,1,,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,,,,Intermediate,,,,12619,,9615.0,50588,15592,
,N,A,CHEMBL625964,1,1,,BAO_0000218,cytotoxicity against HIV protease enzyme.,Human immunodeficiency virus,,,,Intermediate,,,,12620,,12721.0,50677,15778,
,N,A,CHEMBL625965,1,1,,BAO_0000218,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,,Intermediate,,,,12621,,10090.0,50594,12745,
,N,A,CHEMBL625966,1,1,,BAO_0000218,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Mus musculus,,,,Intermediate,,,,12622,,10090.0,50594,12745,
,N,A,CHEMBL625967,1,1,Plasma,BAO_0000218,The plasma clearance in dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12623,1969.0,9615.0,50588,13941,
,N,A,CHEMBL625968,1,1,Plasma,BAO_0000218,The plasma clearance in rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,12624,1969.0,10116.0,50597,13941,
,N,A,CHEMBL625969,1,1,Plasma,BAO_0000218,Clearance from plasma in male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12625,1969.0,10116.0,50597,16449,
,N,A,CHEMBL625970,1,1,Plasma,BAO_0000218,Clearance from plasma in male cynomolgus monkeys,Macaca fascicularis,,,,Intermediate,,,In vivo,12626,1969.0,9541.0,100710,16449,
,N,A,CHEMBL625971,1,1,Plasma,BAO_0000218,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Canis lupus familiaris,,,,Intermediate,,,In vivo,12627,1969.0,9615.0,50588,14224,
,N,A,CHEMBL625972,1,1,Plasma,BAO_0000218,Clearance of compound in dog plasma,Canis lupus familiaris,,,,Intermediate,,,In vivo,12628,1969.0,9615.0,50588,14224,
,N,A,CHEMBL625973,1,1,Plasma,BAO_0000218,Clearance of compound in human plasma,Homo sapiens,,,,Intermediate,,,In vivo,12629,1969.0,9606.0,50587,14224,
,N,A,CHEMBL625974,1,1,,BAO_0000218,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12630,,9615.0,50588,14317,
,N,A,CHEMBL625975,1,1,,BAO_0000218,Clearance of compound when administered intravenously as an individual dose to a single dog.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12631,,9615.0,50588,14317,
,N,A,CHEMBL625976,1,1,Plasma,BAO_0000218,"Clearance (10 mg/kg, intravenously) in dog plasma",Canis lupus familiaris,,,,Intermediate,,,In vivo,12632,1969.0,9615.0,50588,14224,
,N,A,CHEMBL625977,1,1,,BAO_0000218,Clearance value in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,12633,,9615.0,50588,17237,
,N,A,CHEMBL625978,1,1,,BAO_0000218,Clearance value in guinea pig,Cavia porcellus,,,,Intermediate,,,In vivo,12634,,10141.0,50512,17237,
,N,A,CHEMBL874468,1,1,,BAO_0000218,Clearance values in rats after iv administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,12635,,10116.0,50597,14187,
,U,A,CHEMBL625421,1,0,Plasma,BAO_0000218,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,,,Autocuration,,,In vivo,12636,1969.0,,22224,4806,
,N,A,CHEMBL625422,1,1,,BAO_0000218,In vivo clearance (5 mg/kg) was determined in rabbits,Oryctolagus cuniculus,,,,Intermediate,,,In vivo,12637,,9986.0,50592,15025,
,N,A,CHEMBL625423,1,1,,BAO_0000218,Plasma Clearance rate was determined for the compound in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12638,,10116.0,50597,13197,
,U,A,CHEMBL625424,1,0,,BAO_0000218,Plasma Clearance rate was determined for the compound in squirrel monkeys,Saimiri,,,,Autocuration,,,In vivo,12639,,9520.0,22224,13197,
,N,A,CHEMBL625425,1,1,,BAO_0000218,Plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,12640,,10116.0,50597,13960,
,U,A,CHEMBL625426,1,0,,BAO_0000218,Plasma clearance of the compound,,,,,Autocuration,,,In vivo,12641,,,22224,17820,
,N,A,CHEMBL625427,1,1,,BAO_0000218,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Cavia porcellus,,,,Intermediate,,,In vivo,12642,,10141.0,50512,14706,
,N,A,CHEMBL625428,1,1,,BAO_0000218,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Cavia porcellus,,,,Intermediate,,,In vivo,12643,,10141.0,50512,14706,
,U,A,CHEMBL625429,1,0,,BAO_0000218,Plasma clearance was determined,,,,,Autocuration,,,In vivo,12644,,,22224,6504,
,N,A,CHEMBL625430,1,1,,BAO_0000218,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12645,,9615.0,50588,14925,
,N,A,CHEMBL625431,1,1,,BAO_0000218,Plasma clearance rate was determined for the compound in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12646,,10116.0,50597,13197,
,U,A,CHEMBL627307,1,0,,BAO_0000218,Plasma clearance rate was determined for the compound in squirrel monkeys,Saimiri,,,,Autocuration,,,In vivo,12647,,9520.0,22224,13197,
,U,A,CHEMBL627308,1,0,,BAO_0000218,Slow clearance (CL) was determined,,,,,Autocuration,,,In vivo,12648,,,22224,3437,
,U,A,CHEMBL627309,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12649,,,22224,9196,
,U,A,CHEMBL627310,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,,Autocuration,,,,12650,,,22224,9196,
,U,A,CHEMBL627311,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,,Autocuration,,,,12651,,,22224,9196,
,U,A,CHEMBL627312,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12652,,,22224,9196,
,U,A,CHEMBL627313,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,,Autocuration,,,,12653,,,22224,9196,
,U,A,CHEMBL627314,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12654,,,22224,9196,
,U,A,CHEMBL627315,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12655,,,22224,9196,
,U,A,CHEMBL627316,1,0,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12656,,,22224,9196,
,U,A,CHEMBL627317,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,Autocuration,,,,12657,,,22224,9196,
,U,A,CHEMBL627318,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12658,,,22224,9196,
,U,A,CHEMBL627999,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,,Autocuration,,,,12659,,,22224,9196,
,U,A,CHEMBL628000,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,Autocuration,,,,12660,,,22224,9196,
,U,A,CHEMBL628001,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,Autocuration,,,,12661,,,22224,9196,
,U,A,CHEMBL628002,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12662,,,22224,9196,
,U,A,CHEMBL625610,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12663,,,22224,9196,
,U,A,CHEMBL625611,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12664,,,22224,9196,
,U,A,CHEMBL625612,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,,Autocuration,,,,12665,,,22224,9196,
,U,A,CHEMBL625613,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,,Autocuration,,,,12666,,,22224,9196,
,U,A,CHEMBL875479,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,Autocuration,,,,12667,,,22224,9196,
,U,A,CHEMBL625614,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,Autocuration,,,,12668,,,22224,9196,
,U,A,CHEMBL625615,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,Autocuration,,,,12669,,,22224,9196,
,U,A,CHEMBL626302,1,0,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,,Autocuration,,,,12670,,,22224,9196,
,N,A,CHEMBL626303,1,1,Blood,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12671,178.0,10116.0,50597,8374,
,N,A,CHEMBL627420,1,1,Blood,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,,,Intermediate,,,,12672,178.0,10116.0,50597,8374,
,N,A,CHEMBL627421,1,1,,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,,Intermediate,,,,12673,,10116.0,50597,13477,
,N,A,CHEMBL625695,1,1,,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,,Intermediate,,,,12674,,10116.0,50597,13477,
,N,A,CHEMBL625696,1,1,,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,,Intermediate,,,,12675,,10116.0,50597,13477,
,N,A,CHEMBL875606,1,1,Brain,BAO_0000218,Distribution of compound in mice brain was measured after 1 hr,Mus musculus,,,,Intermediate,,,,12676,955.0,10090.0,50594,10009,
,N,A,CHEMBL625697,1,1,Brain,BAO_0000218,Distribution of compound in mice brain was measured after 24 hr r,Mus musculus,,,,Intermediate,,,,12677,955.0,10090.0,50594,10009,
,N,A,CHEMBL625698,1,1,Brain,BAO_0000218,Distribution of compound in mice brain was measured after 2 hr,Mus musculus,,,,Intermediate,,,,12678,955.0,10090.0,50594,10009,
,N,A,CHEMBL625699,1,1,Brain,BAO_0000218,Distribution of compound in mice brain was measured after 3 hr,Mus musculus,,,,Intermediate,,,,12679,955.0,10090.0,50594,10009,
,N,A,CHEMBL625700,1,1,Brain,BAO_0000218,Distribution of compound in mice brain was measured after 6 hr,Mus musculus,,,,Intermediate,,,,12680,955.0,10090.0,50594,10009,
,N,A,CHEMBL625701,1,1,,BAO_0000218,Distribution of compound in mice liver was measured after 1 hr,Mus musculus,,,,Intermediate,,,,12681,,10090.0,50594,10009,
,N,A,CHEMBL625702,1,1,,BAO_0000218,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Mus musculus,,,,Intermediate,,,,12682,,10090.0,50594,10009,
,N,A,CHEMBL625703,1,1,,BAO_0000218,Distribution of compound in mice liver was measured after 2 hr,Mus musculus,,,,Intermediate,,,,12683,,10090.0,50594,10009,
,N,A,CHEMBL625704,1,1,,BAO_0000218,Distribution of compound in mice liver was measured after 3 hr,Mus musculus,,,,Intermediate,,,,12684,,10090.0,50594,10009,
,N,A,CHEMBL625705,1,1,,BAO_0000218,Distribution of compound in mice liver was measured after 6 hr,Mus musculus,,,,Intermediate,,,,12685,,10090.0,50594,10009,
,N,A,CHEMBL625706,1,1,Adrenal medulla,BAO_0000218,Distribution in dog adrenal medulla 30 min after administration.,Canis lupus familiaris,,,,Intermediate,,,,12686,1236.0,9615.0,50588,8170,
,N,A,CHEMBL625707,1,1,Adrenal medulla,BAO_0000218,Distribution in dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12687,1236.0,9615.0,50588,8170,
,N,A,CHEMBL625708,1,1,,BAO_0000218,Distribution in female dog Ovary 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12688,,9615.0,50588,8170,
,N,A,CHEMBL625709,1,1,,BAO_0000218,Distribution in female dog Ovary 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12689,,9615.0,50588,8170,
,N,A,CHEMBL624180,1,1,,BAO_0000218,Distribution in female dog adipose 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12690,,9615.0,50588,8170,
,N,A,CHEMBL624181,1,1,,BAO_0000218,Distribution in female dog adipose 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12691,,9615.0,50588,8170,
,N,A,CHEMBL624182,1,1,Adrenal cortex,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12692,1235.0,9615.0,50588,8170,
,N,A,CHEMBL624183,1,1,Adrenal cortex,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12693,1235.0,9615.0,50588,8170,
,N,A,CHEMBL624184,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12694,2107.0,10116.0,50597,8594,
,N,A,CHEMBL877489,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12695,2107.0,10116.0,50597,8594,
,N,A,CHEMBL624185,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12696,2107.0,10116.0,50597,8594,
,N,A,CHEMBL624186,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12697,2107.0,10116.0,50597,8594,
,N,A,CHEMBL624187,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12698,2107.0,10116.0,50597,8594,
,N,A,CHEMBL624188,1,1,Liver,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12699,2107.0,10116.0,50597,8594,
,N,A,CHEMBL624189,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12700,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624190,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12701,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624191,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12702,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624192,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12703,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624193,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12704,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624194,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12705,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624891,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12706,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624892,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12707,2048.0,10116.0,50597,8594,
,N,A,CHEMBL624893,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12708,2048.0,10116.0,50597,8594,
,N,A,CHEMBL627632,1,1,Lung,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12709,2048.0,10116.0,50597,8594,
,N,A,CHEMBL627633,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12710,,10116.0,50597,8594,
,N,A,CHEMBL627634,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12711,,10116.0,50597,8594,
,N,A,CHEMBL627635,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12712,,10116.0,50597,8594,
,N,A,CHEMBL627636,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12713,,10116.0,50597,8594,
,N,A,CHEMBL626816,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12714,,10116.0,50597,8594,
,N,A,CHEMBL626817,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12715,,10116.0,50597,8594,
,N,A,CHEMBL626818,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12716,,10116.0,50597,8594,
,N,A,CHEMBL626819,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12717,,10116.0,50597,8594,
,N,A,CHEMBL626820,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12718,,10116.0,50597,8594,
,N,A,CHEMBL626821,1,1,,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12719,,10116.0,50597,8594,
,N,A,CHEMBL626822,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12720,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626823,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12721,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626824,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12722,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626825,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12723,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626826,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12724,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626827,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12725,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626828,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12726,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626829,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12727,2046.0,10116.0,50597,8594,
,N,A,CHEMBL626830,1,1,Thyroid gland,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12728,2046.0,10116.0,50597,8594,
,N,A,CHEMBL627150,1,1,,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12729,,10116.0,50597,8594,
,N,A,CHEMBL627151,1,1,,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12730,,10116.0,50597,8594,
,N,A,CHEMBL627152,1,1,,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,,Intermediate,,,,12731,,10116.0,50597,8594,
,N,A,CHEMBL627153,1,1,,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12732,,10116.0,50597,8594,
,U,A,CHEMBL627154,1,0,,BAO_0000019,Rate of acetate production by the compound was determined,,,,,Autocuration,,,,12733,,,22224,12904,
,U,A,CHEMBL627155,1,0,,BAO_0000019,Rate of acetate production by the compound was determined; Not determined,,,,,Autocuration,,,,12734,,,22224,12904,
,U,A,CHEMBL627156,1,0,,BAO_0000019,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,,,Autocuration,,,,12735,,,22224,3730,
,U,A,CHEMBL627157,1,0,,BAO_0000019,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,,,Autocuration,,,,12736,,,22224,3627,
,N,A,CHEMBL627158,1,1,,BAO_0000218,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,,,,Intermediate,,,,12737,,9986.0,50592,13799,
,N,A,CHEMBL627159,1,1,Plasma,BAO_0000218,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,,,,Intermediate,,,,12738,1969.0,9986.0,50592,13799,
,N,A,CHEMBL627160,1,1,,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Mus musculus,,,,Intermediate,,,,12739,,10090.0,50594,13799,
,N,A,CHEMBL628540,1,1,,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,,,Intermediate,,,,12740,,10116.0,50597,13799,
,N,A,CHEMBL628541,1,1,Plasma,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,,,Intermediate,,,,12741,1969.0,10116.0,50597,13799,
,N,A,CHEMBL628542,1,1,Plasma,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,,,Intermediate,,,,12742,1969.0,10116.0,50597,13799,
,U,P,CHEMBL628543,1,0,,BAO_0000100,Solubility after at a pH 1.2,,,,,Autocuration,,,,12743,,,22229,6629,
,U,P,CHEMBL628544,1,0,,BAO_0000100,Solubility after at pH 1.2,,,,,Autocuration,,,,12744,,,22229,6629,
,U,P,CHEMBL628545,1,0,,BAO_0000100,Solubility after injection of water,,,,,Autocuration,,,,12745,,,22229,6629,
,U,A,CHEMBL628546,1,0,,BAO_0000019,Statistical significance of IC 50 values; Expressed as R value,,,,,Autocuration,,,,12746,,,22224,14000,
,U,A,CHEMBL874455,1,0,,BAO_0000019,Systemic availability with respect to methyldopa was determined,,,,,Autocuration,,,,12747,,,22224,8267,
,N,A,CHEMBL628547,1,1,,BAO_0000218,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,,,,Intermediate,,,,12748,,10116.0,50597,13799,
,N,A,CHEMBL628548,1,1,Plasma,BAO_0000218,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,,,,Intermediate,,,,12749,1969.0,10116.0,50597,13799,
,N,A,CHEMBL628549,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12750,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628550,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12751,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628551,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,,,,Intermediate,,,,12752,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628552,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Oryctolagus cuniculus,,,,Intermediate,,,,12753,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628553,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Oryctolagus cuniculus,,,,Intermediate,,,,12754,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628554,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Oryctolagus cuniculus,,,,Intermediate,,,,12755,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628555,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,12756,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628556,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,12757,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628557,1,1,Kidney,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12758,2113.0,9986.0,50592,7132,
,N,A,CHEMBL628558,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12759,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628559,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Oryctolagus cuniculus,,,,Intermediate,,,,12760,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628560,1,1,Feces,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12761,1988.0,9986.0,50592,7132,
,N,A,CHEMBL874456,1,1,Urine,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,,,,Intermediate,,,,12762,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628561,1,1,Feces,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Oryctolagus cuniculus,,,,Intermediate,,,,12763,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628562,1,1,Feces,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,,,,Intermediate,,,,12764,1988.0,9986.0,50592,7132,
,N,A,CHEMBL628563,1,1,Urine,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Oryctolagus cuniculus,,,,Intermediate,,,,12765,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628564,1,1,Urine,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Oryctolagus cuniculus,,,,Intermediate,,,,12766,1088.0,9986.0,50592,7132,
,N,A,CHEMBL628565,1,1,Urine,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,12767,1088.0,9986.0,50592,7132,
,N,A,CHEMBL631248,1,1,Urine,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,12768,1088.0,9986.0,50592,7132,
,N,A,CHEMBL631249,1,1,Urine,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,,,,Intermediate,,,,12769,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627214,1,1,Kidney,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12770,2113.0,9986.0,50592,7132,
,N,A,CHEMBL874591,1,1,Feces,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12771,1988.0,9986.0,50592,7132,
,N,A,CHEMBL627215,1,1,Feces,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,,,Intermediate,,,,12772,1988.0,9986.0,50592,7132,
,N,A,CHEMBL625471,1,1,Feces,BAO_0000218,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Oryctolagus cuniculus,,,,Intermediate,,,,12773,1988.0,9986.0,50592,7132,
,N,A,CHEMBL625472,1,1,,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Oryctolagus cuniculus,,,,Intermediate,,,,12774,,9986.0,50592,7132,
,N,A,CHEMBL625473,1,1,,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,,,,Intermediate,,,,12775,,9986.0,50592,7132,
,N,A,CHEMBL625474,1,1,,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12776,,9615.0,50588,13317,
,N,A,CHEMBL625475,1,1,,BAO_0000218,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12777,,9615.0,50588,15341,
,N,A,CHEMBL625476,1,1,,BAO_0000218,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,12778,,10116.0,50597,15341,
,N,A,CHEMBL625477,1,1,,BAO_0000218,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,12779,,10116.0,50597,15341,
,N,A,CHEMBL625478,1,1,,BAO_0000218,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,12780,,10116.0,50597,15341,
,N,A,CHEMBL625479,1,1,esophageal tunica muscularis mucosae,BAO_0000218,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,,,,Intermediate,,,In vitro,12781,,10116.0,50597,12801,
,N,A,CHEMBL625480,1,1,esophageal tunica muscularis mucosae,BAO_0000218,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,,,,Intermediate,,,In vitro,12782,,10116.0,50597,12801,
,N,A,CHEMBL625481,1,1,Plasma,BAO_0000218,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Rattus norvegicus,,,,Intermediate,,,In vivo,12783,1969.0,10116.0,50597,14856,
,N,A,CHEMBL625482,1,1,,BAO_0000218,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,12784,,10116.0,50597,14062,
,N,A,CHEMBL625483,1,1,,BAO_0000218,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,12785,,10116.0,50597,14062,
,N,A,CHEMBL625484,1,1,,BAO_0000218,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,12786,,10116.0,50597,14062,
,N,A,CHEMBL625485,1,1,,BAO_0000218,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,12787,,10116.0,50597,14062,
,N,A,CHEMBL625486,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,12788,1969.0,9615.0,50588,14346,
,N,A,CHEMBL625487,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12789,1969.0,10116.0,50597,14346,
,N,A,CHEMBL625488,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12790,1969.0,10116.0,50597,14346,
,N,A,CHEMBL625489,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12791,1969.0,10116.0,50597,14346,
,N,A,CHEMBL625490,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12792,1969.0,10116.0,50597,14346,
,N,A,CHEMBL625491,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,12793,1969.0,9615.0,50588,14346,
,N,A,CHEMBL625492,1,1,Plasma,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12794,1969.0,10116.0,50597,14346,
,N,A,CHEMBL625493,1,1,Plasma,BAO_0000218,plasma clearance in human,Homo sapiens,,,,Intermediate,,,In vivo,12795,1969.0,9606.0,50587,15711,
,N,A,CHEMBL625494,1,1,,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,12796,,10116.0,50597,14886,
,N,A,CHEMBL625495,1,1,,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,12797,,10116.0,50597,14886,
,N,A,CHEMBL625496,1,1,,BAO_0000218,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,12798,,10116.0,50597,14886,
,U,P,CHEMBL625497,1,0,,BAO_0000100,1-Octanol/water partition coefficient measured at 7.4,,,,,Autocuration,,,,12799,,,22229,4115,
,U,P,CHEMBL625498,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12800,,,22229,13733,
,U,A,CHEMBL625499,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,12801,,,22224,12102,
,U,P,CHEMBL625500,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12802,,,22229,12676,
,U,P,CHEMBL625501,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12803,,,22229,13733,
,U,P,CHEMBL625502,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12804,,,22229,13740,
,U,P,CHEMBL625503,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,,,Autocuration,,,,12805,,,22229,12766,
,U,P,CHEMBL625504,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12806,,,22229,2764,
,U,P,CHEMBL625505,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12807,,,22229,12355,
,U,P,CHEMBL625506,1,0,,BAO_0000100,Calculated partition coefficient of the compound,,,,,Autocuration,,,,12808,,,22229,11314,
,U,A,CHEMBL625507,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,12809,,,22224,12706,
,U,P,CHEMBL625508,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12810,,,22229,12645,
,U,P,CHEMBL625509,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12811,,,22229,13668,
,U,P,CHEMBL625510,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12812,,,22229,12819,
,U,P,CHEMBL883125,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12813,,,22229,13668,
,U,P,CHEMBL625511,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12814,,,22229,13017,
,U,A,CHEMBL874650,1,0,,BAO_0000019,Partition coefficient of the compound,,,,,Autocuration,,,,12815,,,22224,2448,
,U,A,CHEMBL625512,1,0,,BAO_0000019,Partition coefficient of the compound,,,,,Autocuration,,,,12816,,,22224,11526,
,U,A,CHEMBL625513,1,0,,BAO_0000019,Partition coefficient of compound was determined,,,,,Autocuration,,,,12817,,,22224,12426,
,U,A,CHEMBL625514,1,0,,BAO_0000019,Partition coefficient was determined,,,,,Autocuration,,,,12818,,,22224,2448,
,U,P,CHEMBL625515,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12819,,,22229,12001,
,U,P,CHEMBL625516,1,0,,BAO_0000100,partition coefficient of compound was determined,,,,,Autocuration,,,,12820,,,22229,12426,
,N,A,CHEMBL625517,1,1,,BAO_0000218,The total body administered intravenously in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,12821,,9615.0,50588,13204,
,N,A,CHEMBL625518,1,1,,BAO_0000218,The total body administered intravenously in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,12822,,10116.0,50597,13204,
,N,A,CHEMBL625519,1,1,,BAO_0000218,Time taken for the administration to female NIH mice weighing 25-30 g.,Mus musculus,,,,Intermediate,,,,12823,,10090.0,50594,13889,
,U,A,CHEMBL625520,1,0,,BAO_0000019,Time taken for the administration,,,,,Autocuration,,,,12824,,,22224,13889,
,N,A,CHEMBL874651,1,1,,BAO_0000218,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,,Intermediate,,,In vivo,12825,,9615.0,50588,17025,
,U,A,CHEMBL625521,1,0,,BAO_0000218,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,,Autocuration,,,In vivo,12826,,314293.0,22224,17025,
,N,A,CHEMBL623171,1,1,,BAO_0000218,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,,Intermediate,,,In vivo,12827,,9986.0,50592,17025,
,N,A,CHEMBL623853,1,1,,BAO_0000218,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,,Intermediate,,,In vivo,12828,,10116.0,50597,17025,
,U,A,CHEMBL623854,1,0,,BAO_0000019,Plasma clearance for the compound was determined.,,,,,Autocuration,,,,12829,,,22224,15067,
,U,P,CHEMBL874405,1,0,,BAO_0000100,CLog P value of the compound,,,,,Autocuration,,,,12830,,,22224,3091,
,U,P,CHEMBL623855,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12831,,,22229,15592,
,U,P,CHEMBL623856,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12832,,,22229,14738,
,U,P,CHEMBL623857,1,0,,BAO_0000100,ClogP value of the compound; nd ='no data',,,,,Autocuration,,,,12833,,,22224,14738,
,U,P,CHEMBL623858,1,0,,BAO_0000100,ClogP value of the compound; nd ='not determined',,,,,Autocuration,,,,12834,,,22224,14738,
,U,P,CHEMBL623859,1,0,,BAO_0000100,CLog P was determined,,,,,Autocuration,,,,12835,,,22224,6076,
,U,P,CHEMBL839829,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12836,,,22229,17840,
,U,A,CHEMBL623860,1,0,,BAO_0000019,CLogP was calculated,,,,,Autocuration,,,,12837,,,22224,13589,
,U,A,CHEMBL623861,1,0,,BAO_0000019,CLogP value was determined,,,,,Autocuration,,,,12838,,,22224,17655,
,U,A,CHEMBL623862,1,0,,BAO_0000019,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,,,Autocuration,,,,12839,,,22224,5867,
,U,P,CHEMBL874406,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12840,,,22229,5867,
,U,P,CHEMBL623863,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12841,,,22229,10783,
,U,P,CHEMBL624021,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12842,,,22229,14849,
,N,A,CHEMBL624022,1,1,Adrenal medulla,BAO_0000218,Distribution in female dog adrenal medulla 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12843,1236.0,9615.0,50588,8170,
,N,A,CHEMBL624023,1,1,Adrenal medulla,BAO_0000218,Distribution in female dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12844,1236.0,9615.0,50588,8170,
,N,A,CHEMBL624024,1,1,,BAO_0000218,Distribution in female dog bile 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12845,,9615.0,50588,8170,
,N,A,CHEMBL624025,1,1,,BAO_0000218,Distribution in female dog bile 72 hr after administration.,Canis lupus familiaris,,,,Intermediate,,,,12846,,9615.0,50588,8170,
,N,A,CHEMBL624026,1,1,,BAO_0000218,Distribution in female dog blood 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12847,,9615.0,50588,8170,
,N,A,CHEMBL624027,1,1,,BAO_0000218,Distribution in female dog blood 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12848,,9615.0,50588,8170,
,N,A,CHEMBL624028,1,1,,BAO_0000218,Distribution in female dog heart 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12849,,9615.0,50588,8170,
,N,A,CHEMBL624029,1,1,,BAO_0000218,Distribution in female dog heart 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12850,,9615.0,50588,8170,
,N,A,CHEMBL624030,1,1,,BAO_0000218,Distribution in female dog kidney 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12851,,9615.0,50588,8170,
,N,A,CHEMBL624031,1,1,,BAO_0000218,Distribution in female dog kidney 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12852,,9615.0,50588,8170,
,N,A,CHEMBL624032,1,1,Intestine,BAO_0000218,Distribution in female dog large intestine 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12853,160.0,9615.0,50588,8170,
,N,A,CHEMBL874407,1,1,Intestine,BAO_0000218,Distribution in female dog large intestine 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12854,160.0,9615.0,50588,8170,
,N,A,CHEMBL624033,1,1,,BAO_0000218,Distribution in female dog liver 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12855,,9615.0,50588,8170,
,N,A,CHEMBL624034,1,1,,BAO_0000218,Distribution in female dog liver 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12856,,9615.0,50588,8170,
,N,A,CHEMBL624035,1,1,,BAO_0000218,Distribution in female dog lung 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12857,,9615.0,50588,8170,
,N,A,CHEMBL624036,1,1,,BAO_0000218,Distribution in female dog lung 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12858,,9615.0,50588,8170,
,N,A,CHEMBL624037,1,1,Muscle tissue,BAO_0000218,Distribution in female dog muscle 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12859,2385.0,9615.0,50588,8170,
,N,A,CHEMBL624038,1,1,Muscle tissue,BAO_0000218,Distribution in female dog muscle 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12860,2385.0,9615.0,50588,8170,
,N,A,CHEMBL624039,1,1,,BAO_0000218,Distribution in female dog pancreas 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12861,,9615.0,50588,8170,
,N,A,CHEMBL624040,1,1,,BAO_0000218,Distribution in female dog pancreas 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12862,,9615.0,50588,8170,
,N,A,CHEMBL624041,1,1,Intestine,BAO_0000218,Distribution in female dog small intestine 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12863,160.0,9615.0,50588,8170,
,N,A,CHEMBL624042,1,1,Intestine,BAO_0000218,Distribution in female dog small intestine 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12864,160.0,9615.0,50588,8170,
,N,A,CHEMBL624043,1,1,Spleen,BAO_0000218,Distribution in female dog spleen 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12865,2106.0,9615.0,50588,8170,
,N,A,CHEMBL624044,1,1,Spleen,BAO_0000218,Distribution in female dog spleen 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12866,2106.0,9615.0,50588,8170,
,N,A,CHEMBL624045,1,1,Stomach,BAO_0000218,Distribution in female dog stomach 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12867,945.0,9615.0,50588,8170,
,N,A,CHEMBL624046,1,1,Stomach,BAO_0000218,Distribution in female dog stomach 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12868,945.0,9615.0,50588,8170,
,N,A,CHEMBL624047,1,1,Thyroid gland,BAO_0000218,Distribution in female dog thyroid 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12869,2046.0,9615.0,50588,8170,
,N,A,CHEMBL624048,1,1,Thyroid gland,BAO_0000218,Distribution in female dog thyroid 72 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12870,2046.0,9615.0,50588,8170,
,N,A,CHEMBL874408,1,1,Urine,BAO_0000218,Distribution in female dog urine 24 hours after administration.,Canis lupus familiaris,,,,Intermediate,,,,12871,1088.0,9615.0,50588,8170,
,N,A,CHEMBL624049,1,1,Urine,BAO_0000218,Distribution in female dog urine 72 hr after administration.,Canis lupus familiaris,,,,Intermediate,,,,12872,1088.0,9615.0,50588,8170,
,U,A,CHEMBL624050,1,0,Plasma,BAO_0000218,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,,,Autocuration,,,,12873,1969.0,,22224,14283,
,U,A,CHEMBL624051,1,0,,BAO_0000019,Plasma concentration at 7 hr after intravenous dosing,,,,,Autocuration,,,,12874,,,22224,5623,
,N,A,CHEMBL623278,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12875,,10116.0,50597,13477,
,N,A,CHEMBL623279,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12876,,10116.0,50597,13477,
,N,A,CHEMBL623280,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12877,,10116.0,50597,13477,
,N,A,CHEMBL623963,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12878,,10116.0,50597,13477,
,N,A,CHEMBL623964,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12879,,10116.0,50597,13477,
,N,A,CHEMBL623965,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12880,,10116.0,50597,13477,
,N,A,CHEMBL623966,1,1,,BAO_0000218,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Rattus norvegicus,,,,Intermediate,,,,12881,,10116.0,50597,13477,
,N,A,CHEMBL874415,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Rattus norvegicus,,,,Intermediate,,,,12882,,10116.0,50597,13477,
,N,A,CHEMBL623967,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Rattus norvegicus,,,,Intermediate,,,,12883,,10116.0,50597,13477,
,N,A,CHEMBL623968,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Rattus norvegicus,,,,Intermediate,,,,12884,,10116.0,50597,13477,
,N,A,CHEMBL623969,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Rattus norvegicus,,,,Intermediate,,,,12885,,10116.0,50597,13477,
,N,A,CHEMBL628409,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Rattus norvegicus,,,,Intermediate,,,,12886,,10116.0,50597,13477,
,N,A,CHEMBL628410,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Rattus norvegicus,,,,Intermediate,,,,12887,,10116.0,50597,13477,
,N,A,CHEMBL628411,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Rattus norvegicus,,,,Intermediate,,,,12888,,10116.0,50597,13477,
,N,A,CHEMBL628412,1,1,,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Rattus norvegicus,,,,Intermediate,,,,12889,,10116.0,50597,13477,
,U,A,CHEMBL628413,1,0,,BAO_0000019,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,,,Autocuration,,,,12890,,,22224,12553,
,U,A,CHEMBL628414,1,0,Plasma,BAO_0000019,The concentration in plasmat; Not determined,,,,,Autocuration,,,,12891,1969.0,,22224,14548,
,N,A,CHEMBL628415,1,1,,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in blood,Rattus norvegicus,,,,Intermediate,,,,12892,,10116.0,50597,14393,
,N,A,CHEMBL628416,1,1,,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Rattus norvegicus,,,,Intermediate,,,,12893,,10116.0,50597,14393,
,N,A,CHEMBL628417,1,1,,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in heart,Rattus norvegicus,,,,Intermediate,,,,12894,,10116.0,50597,14393,
,N,A,CHEMBL874908,1,1,Liver,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in liver,Rattus norvegicus,,,,Intermediate,,,,12895,2107.0,10116.0,50597,14393,
,N,A,CHEMBL628418,1,1,,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in plasma,Rattus norvegicus,,,,Intermediate,,,,12896,,10116.0,50597,14393,
,N,A,CHEMBL628419,1,1,Muscle tissue,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Rattus norvegicus,,,,Intermediate,,,,12897,2385.0,10116.0,50597,14393,
,N,A,CHEMBL628420,1,1,,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Rattus norvegicus,,,,Intermediate,,,,12898,,10116.0,50597,14393,
,U,A,CHEMBL628421,1,0,,BAO_0000019,Water solubility at 37 degree C.,,,,,Autocuration,,,,12899,,,22224,1629,
,U,P,CHEMBL626726,1,0,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,,Autocuration,,,,12900,,,22229,8194,
,U,P,CHEMBL626727,1,0,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,Autocuration,,,,12901,,,22229,8194,
,N,A,CHEMBL626728,1,1,Blood,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12902,178.0,10116.0,50597,8594,
,N,A,CHEMBL626729,1,1,Blood,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12903,178.0,10116.0,50597,8594,
,N,A,CHEMBL626730,1,1,Blood,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12904,178.0,10116.0,50597,8594,
,N,A,CHEMBL626731,1,1,Blood,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12905,178.0,10116.0,50597,8594,
,N,A,CHEMBL626732,1,1,Blood,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12906,178.0,10116.0,50597,8594,
,N,A,CHEMBL626733,1,1,Heart,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12907,948.0,10116.0,50597,8594,
,N,A,CHEMBL626734,1,1,Heart,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12908,948.0,10116.0,50597,8594,
,N,A,CHEMBL626735,1,1,Heart,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12909,948.0,10116.0,50597,8594,
,N,A,CHEMBL874909,1,1,Heart,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12910,948.0,10116.0,50597,8594,
,N,A,CHEMBL626736,1,1,Heart,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12911,948.0,10116.0,50597,8594,
,N,A,CHEMBL626737,1,1,Kidney,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12912,2113.0,10116.0,50597,8594,
,N,A,CHEMBL630999,1,1,Kidney,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12913,2113.0,10116.0,50597,8594,
,N,A,CHEMBL631000,1,1,Kidney,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12914,2113.0,10116.0,50597,8594,
,N,A,CHEMBL631001,1,1,Kidney,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12915,2113.0,10116.0,50597,8594,
,N,A,CHEMBL631002,1,1,Kidney,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12916,2113.0,10116.0,50597,8594,
,N,A,CHEMBL631003,1,1,Liver,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12917,2107.0,10116.0,50597,8594,
,N,A,CHEMBL631004,1,1,Liver,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12918,2107.0,10116.0,50597,8594,
,N,A,CHEMBL631005,1,1,Liver,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12919,2107.0,10116.0,50597,8594,
,N,A,CHEMBL631006,1,1,Liver,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12920,2107.0,10116.0,50597,8594,
,N,A,CHEMBL631007,1,1,Liver,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12921,2107.0,10116.0,50597,8594,
,N,A,CHEMBL631008,1,1,Lung,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12922,2048.0,10116.0,50597,8594,
,N,A,CHEMBL631009,1,1,Lung,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12923,2048.0,10116.0,50597,8594,
,N,A,CHEMBL631010,1,1,Lung,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12924,2048.0,10116.0,50597,8594,
,N,A,CHEMBL631011,1,1,Lung,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12925,2048.0,10116.0,50597,8594,
,N,A,CHEMBL631012,1,1,Lung,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12926,2048.0,10116.0,50597,8594,
,N,A,CHEMBL630271,1,1,Thyroid gland,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12927,2046.0,10116.0,50597,8594,
,N,A,CHEMBL630272,1,1,Thyroid gland,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12928,2046.0,10116.0,50597,8594,
,N,A,CHEMBL630273,1,1,Thyroid gland,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12929,2046.0,10116.0,50597,8594,
,N,A,CHEMBL630274,1,1,Thyroid gland,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12930,2046.0,10116.0,50597,8594,
,N,A,CHEMBL630275,1,1,Thyroid gland,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12931,2046.0,10116.0,50597,8594,
,N,A,CHEMBL875782,1,1,,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12932,,10116.0,50597,8594,
,N,A,CHEMBL630276,1,1,,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12933,,10116.0,50597,8594,
,N,A,CHEMBL630277,1,1,,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12934,,10116.0,50597,8594,
,N,A,CHEMBL630278,1,1,,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12935,,10116.0,50597,8594,
,N,A,CHEMBL630279,1,1,,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,,Intermediate,,,,12936,,10116.0,50597,8594,
,U,A,CHEMBL630280,1,0,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,,,Autocuration,,,,12937,,,22224,8151,
,U,A,CHEMBL630281,1,0,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,Autocuration,,,,12938,,,22224,8151,
,N,A,CHEMBL630282,1,1,,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,,,,Intermediate,,,,12939,,9986.0,50592,7132,
,N,A,CHEMBL630283,1,1,,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Oryctolagus cuniculus,,,,Intermediate,,,,12940,,9986.0,50592,7132,
,U,A,CHEMBL630284,1,0,,BAO_0000019,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,,,Autocuration,,,,12941,,,22224,5797,
,U,A,CHEMBL630285,1,0,,BAO_0000019,Alkylating activity was determined,,,,,Autocuration,,,,12942,,,22224,7849,
,U,A,CHEMBL630286,1,0,,BAO_0000251,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,,,,Autocuration,,,,12943,,,22224,14220,Microsomes
,N,A,CHEMBL630069,1,1,,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Oryctolagus cuniculus,,,,Intermediate,,,,12944,,9986.0,50592,8650,
,N,A,CHEMBL630070,1,1,,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Oryctolagus cuniculus,,,,Intermediate,,,,12945,,9986.0,50592,8650,
,N,A,CHEMBL630071,1,1,,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Oryctolagus cuniculus,,,,Intermediate,,,,12946,,9986.0,50592,8650,
,N,A,CHEMBL630072,1,1,,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Oryctolagus cuniculus,,,,Intermediate,,,,12947,,9986.0,50592,8650,
,N,A,CHEMBL875110,1,1,,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Oryctolagus cuniculus,,,,Intermediate,,,,12948,,9986.0,50592,8650,
,N,A,CHEMBL630073,1,1,,BAO_0000218,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,,,,Intermediate,,,,12949,,10116.0,50597,7116,
,U,A,CHEMBL630074,1,0,,BAO_0000019,Compound was tested for inactivation kinetic values,,,,,Autocuration,,,,12950,,,22224,14131,
,U,A,CHEMBL630075,1,0,,BAO_0000218,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,,,Autocuration,,,In vivo,12951,,,22224,7415,
,U,A,CHEMBL630076,1,0,,BAO_0000019,Dissociation rate calculated from the first-order equation using the t1/2 value,,,,,Autocuration,,,,12952,,,22224,13178,
,U,P,CHEMBL630077,1,0,,BAO_0000100,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,,,Autocuration,,,,12953,,,22229,8815,
,U,P,CHEMBL630078,1,0,,BAO_0000100,Aqueous solubility was measured,,,,,Autocuration,,,,12954,,,22229,1450,
,U,P,CHEMBL630079,1,0,,BAO_0000100,Aqueous solubility was measured at a pH 4,,,,,Autocuration,,,,12955,,,22229,1450,
,U,P,CHEMBL630080,1,0,,BAO_0000100,Aqueous solubility (pH 7),,,,,Autocuration,,,,12956,,,22229,1450,
,U,P,CHEMBL630081,1,0,,BAO_0000100,Aqueous solubility was measured at a pH 9,,,,,Autocuration,,,,12957,,,22229,1450,
,U,A,CHEMBL630082,1,0,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,,,Autocuration,,,,12958,,,22224,12711,
,U,A,CHEMBL630083,1,0,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,,Autocuration,,,,12959,,,22224,12711,
,U,A,CHEMBL630084,1,0,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,,Autocuration,,,,12960,,,22224,12711,
,U,P,CHEMBL629198,1,0,,BAO_0000100,Aqueous solubility of the compound,,,,,Autocuration,,,,12961,,,22229,15032,
,U,P,CHEMBL629199,1,0,,BAO_0000100,Aqueous solubility at 37 degree Celsius at pH 7.38,,,,,Autocuration,,,,12962,,,22229,9964,
,U,P,CHEMBL629200,1,0,,BAO_0000100,Aqueous solubility in pH 7.4 phosphate buffer,,,,,Autocuration,,,,12963,,,22229,14962,
,N,A,CHEMBL629201,1,1,,BAO_0000218,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,,,,Intermediate,,,,12964,,9615.0,50588,12487,
,N,A,CHEMBL629202,1,1,,BAO_0000218,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,,,,Intermediate,,,,12965,,9615.0,50588,12487,
,N,A,CHEMBL875111,1,1,,BAO_0000218,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,,Intermediate,,,,12966,,9606.0,50587,10026,
,N,A,CHEMBL629203,1,1,,BAO_0000218,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,,Intermediate,,,,12967,,9606.0,50587,10026,
,N,A,CHEMBL629204,1,1,,BAO_0000218,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,,Intermediate,,,,12968,,9606.0,50587,10026,
,N,A,CHEMBL629205,1,1,,BAO_0000218,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,,Intermediate,,,,12969,,9606.0,50587,10026,
,N,A,CHEMBL629206,1,1,,BAO_0000218,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,,Intermediate,,,,12970,,9606.0,50587,10026,
,U,A,CHEMBL631185,1,0,,BAO_0000019,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,,,Autocuration,,,,12971,,,22224,10026,
,N,A,CHEMBL631186,1,1,,BAO_0000218,Compound was evaluated for the average bile flow rat in rats,Rattus norvegicus,,,,Intermediate,,,,12972,,10116.0,50597,7415,
,N,A,CHEMBL631187,1,1,,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,,,,Intermediate,,,,12973,,9986.0,50592,17025,
,N,A,CHEMBL631188,1,1,,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,,,,Intermediate,,,,12974,,9986.0,50592,17025,
,U,A,CHEMBL876419,1,0,,BAO_0000019,Average half life period was determined,,,,,Autocuration,,,,12975,,,22224,10184,
,U,A,CHEMBL631189,1,0,,BAO_0000019,Average half life period was determined,,,,,Autocuration,,,,12976,,,22224,10184,
,N,A,CHEMBL631190,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12977,,10298.0,50602,8613,
,N,A,CHEMBL631191,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12978,,10298.0,50602,8613,
,N,A,CHEMBL631192,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12979,,10298.0,50602,8613,
,N,A,CHEMBL632400,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12980,,10298.0,50602,8613,
,N,A,CHEMBL630564,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12981,,10298.0,50602,8613,
,N,A,CHEMBL630565,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12982,,10298.0,50602,8613,
,N,A,CHEMBL630566,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12983,,10298.0,50602,8613,
,N,A,CHEMBL631229,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12984,,10298.0,50602,8613,
,N,A,CHEMBL631230,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,12985,,10298.0,50602,8613,
,U,P,CHEMBL876428,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12986,,,22229,6030,
,U,P,CHEMBL631231,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12987,,,22229,6147,
,U,P,CHEMBL631232,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),,,,,Autocuration,,,,12988,,,22229,14556,
,U,A,CHEMBL631233,1,0,,BAO_0000019,Hydrophilicity was determined,,,,,Autocuration,,,,12989,,,22224,768,
,U,P,CHEMBL631234,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12990,,,22229,14452,
,U,A,CHEMBL883126,1,0,,BAO_0000019,Increased absorption was determined,,,,,Autocuration,,,,12991,,,22224,5237,
,U,P,CHEMBL631235,1,0,,BAO_0000100,Lipophilicity value was evaluated,,,,,Autocuration,,,,12992,,,22224,14378,
,U,P,CHEMBL631236,1,0,,BAO_0000100,Log P value of the compound.,,,,,Autocuration,,,,12993,,,22224,14418,
,U,A,CHEMBL631237,1,0,,BAO_0000019,Partition coefficient of compound was determined,,,,,Autocuration,,,,12994,,,22224,5249,
,U,P,CHEMBL631238,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12995,,,22229,14621,
,U,P,CHEMBL876429,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12996,,,22229,12542,
,U,A,CHEMBL631414,1,0,,BAO_0000019,Partition coefficient was measured by medchem software; Not calculated,,,,,Autocuration,,,,12997,,,22224,12542,
,U,P,CHEMBL631415,1,0,,BAO_0000100,Partition coefficient was measured by octanol-water using standard shake-flask method,,,,,Autocuration,,,,12998,,,22224,12542,
,U,P,CHEMBL631416,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,12999,,,22229,15462,
,U,A,CHEMBL631417,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,13000,,,22224,14884,
,U,P,CHEMBL631418,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13001,,,22229,16526,
,U,P,CHEMBL631419,1,0,,BAO_0000100,The Octanol/Water partition coefficient CLogP,,,,,Autocuration,,,,13002,,,22229,13693,
,U,A,CHEMBL631420,1,0,,BAO_0000019,The pharmacokinetic parameter C Log p was reported,,,,,Autocuration,,,,13003,,,22224,13693,
,U,P,CHEMBL631421,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13004,,,22229,13779,
,U,P,CHEMBL631422,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13005,,,22229,14772,
,U,P,CHEMBL631423,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13006,,,22229,14393,
,N,A,CHEMBL876430,1,1,Plasma,BAO_0000218,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,13007,1969.0,10116.0,50597,14793,
,N,A,CHEMBL631424,1,1,Plasma,BAO_0000218,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,13008,1969.0,10116.0,50597,14793,
,N,A,CHEMBL631425,1,1,Plasma,BAO_0000218,Compound was administered intravenously in dog to evaluate plasma clearance values,Canis lupus familiaris,,,,Intermediate,,,In vivo,13009,1969.0,9615.0,50588,13744,
,U,A,CHEMBL631426,1,0,Plasma,BAO_0000218,Compound was administered intravenously in monkey to evaluate plasma clearance values,Simiiformes,,,,Autocuration,,,In vivo,13010,1969.0,314293.0,22224,13744,
,N,A,CHEMBL631427,1,1,Plasma,BAO_0000218,Compound was administered intravenously in mouse to evaluate plasma clearance values,Mus musculus,,,,Intermediate,,,In vivo,13011,1969.0,10090.0,50594,13744,
,N,A,CHEMBL631428,1,1,Plasma,BAO_0000218,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Canis lupus familiaris,,,,Intermediate,,,In vivo,13012,1969.0,9615.0,50588,13207,
,N,A,CHEMBL631429,1,1,Liver,BAO_0000218,Intrinsic clearance in Rhesus liver microsome,Macaca mulatta,,,,Intermediate,,,In vitro,13013,2107.0,9544.0,50797,5669,Microsomes
,N,A,CHEMBL631430,1,1,Liver,BAO_0000218,Intrinsic clearance in dog liver microsome,Canis lupus familiaris,,,,Intermediate,,,In vitro,13014,2107.0,9615.0,50588,5669,Microsomes
,N,A,CHEMBL631431,1,1,Liver,BAO_0000218,Intrinsic clearance in rat liver microsome,Rattus norvegicus,,,,Intermediate,,,In vitro,13015,2107.0,10116.0,50597,5669,Microsomes
,N,A,CHEMBL631432,1,1,Plasma,BAO_0000218,Low plasma clearance was calculated in rhesus monkey,Macaca mulatta,,,,Intermediate,,,In vivo,13016,1969.0,9544.0,50797,4853,
,N,A,CHEMBL631433,1,1,,BAO_0000218,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Canis lupus familiaris,,,,Intermediate,,,In vivo,13017,,9615.0,50588,16452,
,U,A,CHEMBL631434,1,0,,BAO_0000218,Plasma clearance after intravenous dose of 0.3 mg/kg,,,,,Autocuration,,,In vivo,13018,,,22224,11954,
,U,A,CHEMBL631435,1,0,,BAO_0000218,Plasma clearance after intravenous dose of 1 mg/kg,,,,,Autocuration,,,In vivo,13019,,,22224,11954,
,U,A,CHEMBL631436,1,0,,BAO_0000218,Plasma clearance after intravenous dose of 3 mg/kg,,,,,Autocuration,,,In vivo,13020,,,22224,11954,
,U,A,CHEMBL631437,1,0,,BAO_0000218,Plasma clearance after intravenous dose of 3.87 mg/kg,,,,,Autocuration,,,In vivo,13021,,,22224,11954,
,N,A,CHEMBL631438,1,1,,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13022,,10116.0,50597,5669,
,N,A,CHEMBL876431,1,1,,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,,Intermediate,,,In vivo,13023,,9544.0,50797,5669,
,N,A,CHEMBL631439,1,1,,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13024,,9615.0,50588,5669,
,N,A,CHEMBL631440,1,1,,BAO_0000218,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13025,,10116.0,50597,13662,
,U,A,CHEMBL631441,1,0,,BAO_0000019,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,,,Autocuration,,,,13026,,,22224,8272,
,U,A,CHEMBL631442,1,0,,BAO_0000019,Critical Micellar concentration was determined,,,,,Autocuration,,,,13027,,,22224,13410,
,U,A,CHEMBL626525,1,0,,BAO_0000019,Critical Micellar concentration of the compound. was determined,,,,,Autocuration,,,,13028,,,22224,13410,
,U,A,CHEMBL627168,1,0,,BAO_0000019,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,,,Autocuration,,,,13029,,,22224,12628,
,U,A,CHEMBL875618,1,0,,BAO_0000019,Critical micellar concentration was measured in water by the dye solubilization method,,,,,Autocuration,,,,13030,,,22224,9675,
,U,B,CHEMBL626612,1,0,,BAO_0000019,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,,,Autocuration,,,,13031,,,22224,12628,
,U,A,CHEMBL626613,1,0,,BAO_0000019,CMR value (relative to BAY K 8644),,,,,Autocuration,,,,13032,,,22224,12766,
,U,A,CHEMBL626614,1,0,,BAO_0000019,Carbamoylating activity was determined,,,,,Autocuration,,,,13033,,,22224,7849,
,U,A,CHEMBL626615,1,0,,BAO_0000218,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,,Autocuration,,,,13034,,314293.0,22224,12187,
,U,A,CHEMBL626616,1,0,,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,,,Autocuration,,,,13035,,,22224,2040,
,U,A,CHEMBL626617,1,0,,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,,,Autocuration,,,,13036,,,22224,2040,
,N,A,CHEMBL626618,1,1,Plasma,BAO_0000218,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Canis lupus familiaris,,,,Intermediate,,,In vivo,13037,1969.0,9615.0,50588,14180,
,N,A,CHEMBL626619,1,1,Plasma,BAO_0000218,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Rattus norvegicus,,,,Intermediate,,,In vivo,13038,1969.0,10116.0,50597,14180,
,N,A,CHEMBL626620,1,1,,BAO_0000218,"Clearance rate at 0.46 mg/kg, iv, in dogs",Canis lupus familiaris,,,,Intermediate,,,In vivo,13039,,9615.0,50588,14474,
,N,A,CHEMBL626621,1,1,,BAO_0000218,"Clearance rate at 5.5 mg/kg, iv, in rat",Rattus norvegicus,,,,Intermediate,,,In vivo,13040,,10116.0,50597,14474,
,N,A,CHEMBL626622,1,1,,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,,,,Intermediate,,,In vivo,13041,,9541.0,100710,14548,
,N,A,CHEMBL626623,1,1,,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,,,,Intermediate,,,In vivo,13042,,9541.0,100710,14548,
,N,A,CHEMBL626624,1,1,,BAO_0000218,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,,,,Intermediate,,,In vivo,13043,,9615.0,50588,14548,
,N,A,CHEMBL626625,1,1,,BAO_0000218,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,In vivo,13044,,10116.0,50597,14548,
,N,A,CHEMBL626626,1,1,Liver,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,,,,Intermediate,,,Ex vivo,13045,2107.0,10116.0,50597,6125,
,U,A,CHEMBL626627,1,0,,BAO_0000218,Tested for the total clearance of the compound,,,,,Autocuration,,,In vivo,13046,,,22224,6874,
,N,A,CHEMBL626628,1,1,,BAO_0000218,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,13047,,9615.0,50588,15343,
,U,A,CHEMBL626629,1,0,,BAO_0000218,Total body clearance was determined,,,,,Autocuration,,,In vivo,13048,,,22224,6236,
,N,A,CHEMBL626630,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13049,,10116.0,50597,11510,
,N,A,CHEMBL626631,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13050,,10116.0,50597,11510,
,U,P,CHEMBL626632,1,0,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,,Autocuration,,,,13051,,,22229,8194,
,U,P,CHEMBL626633,1,0,,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,Autocuration,,,,13052,,,22229,8194,
,U,P,CHEMBL626634,1,0,,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,,,Autocuration,,,,13053,,,22229,8194,
,U,P,CHEMBL626635,1,0,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,,Autocuration,,,,13054,,,22229,8194,
,U,P,CHEMBL626636,1,0,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,Autocuration,,,,13055,,,22229,8194,
,U,P,CHEMBL626637,1,0,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,,Autocuration,,,,13056,,,22229,8194,
,N,A,CHEMBL626638,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Pneumocystis carinii,,,,Intermediate,,,,13057,,4754.0,50339,13273,
,N,A,CHEMBL626639,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Pneumocystis carinii,,,,Intermediate,,,,13058,,4754.0,50339,13273,
,N,A,CHEMBL626640,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Pneumocystis carinii,,,,Intermediate,,,,13059,,4754.0,50339,13273,
,N,A,CHEMBL626641,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Pneumocystis carinii,,,,Intermediate,,,,13060,,4754.0,50339,13273,
,N,A,CHEMBL627272,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Pneumocystis carinii,,,,Intermediate,,,,13061,,4754.0,50339,13273,
,N,A,CHEMBL627273,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Pneumocystis carinii,,,,Intermediate,,,,13062,,4754.0,50339,13273,
,N,A,CHEMBL627441,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13063,,4754.0,50339,13273,
,N,A,CHEMBL628355,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13064,,4754.0,50339,13273,
,N,A,CHEMBL628356,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13065,,4754.0,50339,13273,
,N,A,CHEMBL628357,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13066,,4754.0,50339,13273,
,N,A,CHEMBL628358,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13067,,4754.0,50339,13273,
,N,A,CHEMBL622307,1,1,,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Pneumocystis carinii,,,,Intermediate,,,,13068,,4754.0,50339,13273,
,U,A,CHEMBL622527,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,,,Autocuration,,,,13069,,,22224,13118,
,U,A,CHEMBL622528,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,,,Autocuration,,,,13070,,,22224,13118,
,U,A,CHEMBL622529,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,,,Autocuration,,,,13071,,,22224,13118,
,U,A,CHEMBL622992,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,,,Autocuration,,,,13072,,,22224,13118,
,U,A,CHEMBL622993,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,,,Autocuration,,,,13073,,,22224,13118,
,U,A,CHEMBL622994,1,0,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,,,Autocuration,,,,13074,,,22224,13118,
,N,A,CHEMBL622995,1,1,,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Rattus norvegicus,,,,Intermediate,,,,13075,,10116.0,50597,10633,
,N,A,CHEMBL622996,1,1,,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Rattus norvegicus,,,,Intermediate,,,,13076,,10116.0,50597,10633,
,N,A,CHEMBL622997,1,1,,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Rattus norvegicus,,,,Intermediate,,,,13077,,10116.0,50597,10633,
,N,A,CHEMBL622998,1,1,,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Rattus norvegicus,,,,Intermediate,,,,13078,,10116.0,50597,10633,
,U,A,CHEMBL622999,1,0,,BAO_0000218,Cp max following ip administration at 1 mg/kg,,,,,Autocuration,,,,13079,,,22224,5767,
,U,A,CHEMBL623000,1,0,Plasma,BAO_0000218,Maximum concentration in plasma was reported at 0.5 hour,,,,,Autocuration,,,In vivo,13080,1969.0,,22224,3302,
,U,A,CHEMBL623001,1,0,Plasma,BAO_0000218,Maximum concentration in plasma was reported at 2 hour,,,,,Autocuration,,,In vivo,13081,1969.0,,22224,3302,
,N,A,CHEMBL623002,1,1,,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Mus musculus,,,,Intermediate,,,,13082,,10090.0,50594,12467,
,U,P,CHEMBL623003,1,0,,BAO_0000100,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,,,Autocuration,,,,13083,,,22229,11778,
,U,A,CHEMBL623004,1,0,,BAO_0000019,Steady state concentration was evaluated,,,,,Autocuration,,,,13084,,,22224,4321,
,U,A,CHEMBL623005,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,13085,,,22224,14884,
,U,A,CHEMBL623006,1,0,,BAO_0000019,Partition coefficient (logD7.4),,,,,Autocuration,,,,13086,,,22224,15234,
,N,A,CHEMBL623007,1,1,Liver,BAO_0000218,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13087,2107.0,10116.0,50597,14198,
,N,A,CHEMBL623008,1,1,Bone,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13088,10000001.0,10116.0,50597,14198,
,N,A,CHEMBL876654,1,1,Cerebellum,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13089,2037.0,10116.0,50597,14198,
,N,A,CHEMBL623009,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13090,,10116.0,50597,14198,
,N,A,CHEMBL623010,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13091,,10116.0,50597,14198,
,N,A,CHEMBL623011,1,1,Heart,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13092,948.0,10116.0,50597,14198,
,N,A,CHEMBL623012,1,1,Intestine,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13093,160.0,10116.0,50597,14198,
,U,A,CHEMBL623013,1,0,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,,Autocuration,,,,13094,,,22224,8151,
,U,A,CHEMBL623014,1,0,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,Autocuration,,,,13095,,,22224,8151,
,U,A,CHEMBL623015,1,0,Urine,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,,,Autocuration,,,,13096,1088.0,,22224,8151,
,U,A,CHEMBL623016,1,0,Urine,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,,,Autocuration,,,,13097,1088.0,,22224,8151,
,U,A,CHEMBL624858,1,0,Urine,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,,,Autocuration,,,,13098,1088.0,,22224,8151,
,N,A,CHEMBL624859,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Rattus norvegicus,,,,Intermediate,,,,13099,,10116.0,50597,8151,
,N,A,CHEMBL624860,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,13100,,10116.0,50597,8151,
,N,A,CHEMBL624861,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,,Intermediate,,,,13101,,10116.0,50597,8151,
,N,A,CHEMBL624862,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Rattus norvegicus,,,,Intermediate,,,,13102,,10116.0,50597,8151,
,N,A,CHEMBL624863,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Rattus norvegicus,,,,Intermediate,,,,13103,,10116.0,50597,8151,
,N,A,CHEMBL876655,1,1,,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,,Intermediate,,,,13104,,10116.0,50597,8151,
,N,A,CHEMBL624864,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,,,,Intermediate,,,,13105,,9615.0,50588,6996,
,N,A,CHEMBL624865,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,,,,Intermediate,,,,13106,,9615.0,50588,6996,
,N,A,CHEMBL624866,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,,Intermediate,,,,13107,,9615.0,50588,6996,
,N,F,CHEMBL624867,1,1,,BAO_0000218,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Canis lupus familiaris,,,,Expert,,,,13108,,9615.0,50588,6996,
,N,A,CHEMBL624868,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,,,,Intermediate,,,,13109,,9615.0,50588,6996,
,N,A,CHEMBL628450,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Canis lupus familiaris,,,,Intermediate,,,,13110,,9615.0,50588,6996,
,N,A,CHEMBL628451,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,,,,Intermediate,,,,13111,,9615.0,50588,6996,
,N,A,CHEMBL628452,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,,,,Intermediate,,,,13112,,9615.0,50588,6996,
,N,A,CHEMBL628453,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,,Intermediate,,,,13113,,9615.0,50588,6996,
,N,A,CHEMBL628454,1,1,,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Canis lupus familiaris,,,,Intermediate,,,,13114,,9615.0,50588,6996,
,N,A,CHEMBL628455,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,,,,Intermediate,,,,13115,,9615.0,50588,6996,
,N,A,CHEMBL628456,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,,,,Intermediate,,,,13116,,9615.0,50588,6996,
,N,A,CHEMBL628457,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,,Intermediate,,,,13117,,9615.0,50588,6996,
,N,A,CHEMBL877505,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Canis lupus familiaris,,,,Intermediate,,,,13118,,9615.0,50588,6996,
,N,A,CHEMBL628458,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Canis lupus familiaris,,,,Intermediate,,,,13119,,9615.0,50588,6996,
,N,A,CHEMBL628459,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,,,,Intermediate,,,,13120,,9615.0,50588,6996,
,N,A,CHEMBL628460,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,,,,Intermediate,,,,13121,,9615.0,50588,6996,
,N,A,CHEMBL628461,1,1,,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,,,,Intermediate,,,,13122,,9615.0,50588,6996,
,U,B,CHEMBL628462,1,0,,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,,,Autocuration,,,,13123,,,22224,6996,
,N,A,CHEMBL628463,1,1,,BAO_0000218,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Canis lupus familiaris,,,,Intermediate,,,,13124,,9615.0,50588,6996,
,N,F,CHEMBL625666,1,1,,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Rattus norvegicus,,,,Expert,,,,13125,,10116.0,50597,6996,
,U,B,CHEMBL625667,1,0,,BAO_0000218,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,,Autocuration,,,,13126,,,22224,6996,
,N,A,CHEMBL625668,1,1,,BAO_0000218,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,,,,Expert,,,,13127,,10116.0,50597,6996,
,N,A,CHEMBL625669,1,1,,BAO_0000218,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,,,,Intermediate,,,,13128,,10116.0,50597,6996,
,U,A,CHEMBL625670,1,0,,BAO_0000019,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,,,Autocuration,,,,13129,,,22224,7114,
,N,A,CHEMBL625671,1,1,,BAO_0000218,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,,,,Intermediate,,,,13130,,10116.0,50597,7114,
,N,A,CHEMBL625672,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Human herpesvirus 1,,,,Intermediate,,,,13131,,10298.0,50602,8613,
,N,A,CHEMBL625673,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Human herpesvirus 1,,,,Intermediate,,,,13132,,10298.0,50602,8613,
,N,A,CHEMBL625674,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Human herpesvirus 1,,,,Intermediate,,,,13133,,10298.0,50602,8613,
,N,A,CHEMBL625675,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Human herpesvirus 1,,,,Intermediate,,,,13134,,10298.0,50602,8613,
,N,A,CHEMBL627637,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Human herpesvirus 1,,,,Intermediate,,,,13135,,10298.0,50602,8613,
,N,A,CHEMBL627638,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Human herpesvirus 1,,,,Intermediate,,,,13136,,10298.0,50602,8613,
,N,A,CHEMBL627639,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Human herpesvirus 1,,,,Intermediate,,,,13137,,10298.0,50602,8613,
,N,A,CHEMBL627640,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Human herpesvirus 1,,,,Intermediate,,,,13138,,10298.0,50602,8613,
,N,A,CHEMBL627641,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Human herpesvirus 1,,,,Intermediate,,,,13139,,10298.0,50602,8613,
,N,A,CHEMBL627642,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,,,,Intermediate,,,,13140,,10298.0,50602,8613,
,N,A,CHEMBL877506,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,,,,Intermediate,,,,13141,,10298.0,50602,8613,
,N,A,CHEMBL627275,1,1,,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Mus musculus,,,,Intermediate,,,,13142,,10090.0,50594,8613,
,N,A,CHEMBL627643,1,1,,BAO_0000218,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Mustela putorius furo,,,,Intermediate,,,,13143,,9669.0,50506,11219,
,N,A,CHEMBL631246,1,1,,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,,,,Intermediate,,,,13144,,9669.0,50506,11219,
,N,A,CHEMBL631247,1,1,,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,,,,Intermediate,,,,13145,,9669.0,50506,11219,
,N,A,CHEMBL629532,1,1,,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,,,,Intermediate,,,,13146,,9669.0,50506,11219,
,N,A,CHEMBL629533,1,1,,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Mustela putorius furo,,,,Intermediate,,,,13147,,9669.0,50506,11219,
,N,A,CHEMBL629534,1,1,,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,,,,Intermediate,,,,13148,,9669.0,50506,11219,
,N,A,CHEMBL629535,1,1,,BAO_0000218,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Mustela putorius furo,,,,Intermediate,,,,13149,,9669.0,50506,11219,
,U,A,CHEMBL625932,1,0,,BAO_0000019,Pharmacokinetic parameter :drug bound to plasma was reported,,,,,Autocuration,,,,13150,,,22224,14837,
,U,A,CHEMBL625933,1,0,,BAO_0000019,compound was evaluated for drug bound in plasma,,,,,Autocuration,,,,13151,,,22224,14837,
,N,A,CHEMBL625934,1,1,,BAO_0000218,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,,,Intermediate,,,,13152,,10116.0,50597,15343,
,U,A,CHEMBL625935,1,0,,BAO_0000218,Bioavailability,Eutheria,,,,Autocuration,,,,13153,,9347.0,22224,13761,
,N,A,CHEMBL625936,1,1,,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Rattus norvegicus,,,,Intermediate,,,,13154,,10116.0,50597,14810,
,N,A,CHEMBL625937,1,1,,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Rattus norvegicus,,,,Intermediate,,,,13155,,10116.0,50597,14810,
,N,A,CHEMBL625938,1,1,,BAO_0000218,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,,,,Intermediate,,,,13156,,9615.0,50588,13249,
,N,A,CHEMBL625939,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13157,1970.0,10116.0,50597,9267,
,N,A,CHEMBL625940,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13158,1970.0,10116.0,50597,9267,
,N,A,CHEMBL874464,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13159,1970.0,10116.0,50597,9267,
,N,A,CHEMBL625941,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13160,1970.0,10116.0,50597,9267,
,N,A,CHEMBL625942,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13161,1970.0,10116.0,50597,9267,
,N,A,CHEMBL625943,1,1,Bile,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Rattus norvegicus,,,,Intermediate,,,,13162,1970.0,10116.0,50597,9267,
,N,A,CHEMBL625944,1,1,Serum,BAO_0000218,In vitro protein binding in human serum at 5 ug/ml,Homo sapiens,,,,Intermediate,,,,13163,1977.0,9606.0,50587,15549,
,U,A,CHEMBL625945,1,0,,BAO_0000019,Serum protein binding ability was measured,,,,,Autocuration,,,,13164,,,22224,10929,
,U,A,CHEMBL625946,1,0,,BAO_0000019,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,,,Autocuration,,,,13165,,,22224,15444,
,U,A,CHEMBL625947,1,0,,BAO_0000218,Oral bioavailability in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,13166,,9615.0,22224,12860,
,N,A,CHEMBL625948,1,1,,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,,Intermediate,,,In vivo,13167,,10116.0,50597,12170,
,U,A,CHEMBL625949,1,0,,BAO_0000218,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,,,Autocuration,,,In vivo,13168,,,22224,15173,
,U,A,CHEMBL625950,1,0,,BAO_0000218,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,,,Autocuration,,,In vivo,13169,,,22224,15173,
,U,A,CHEMBL625951,1,0,,BAO_0000218,Oral bioavailability (dose 15 mg/kg i.v.),Eutheria,,,,Autocuration,,,In vivo,13170,,9347.0,22224,15173,
,U,A,CHEMBL625952,1,0,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,,,Autocuration,,,In vivo,13171,,,22224,15173,
,U,A,CHEMBL625953,1,0,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,,,Autocuration,,,In vivo,13172,,,22224,15173,
,U,A,CHEMBL625954,1,0,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,,,Autocuration,,,In vivo,13173,,,22224,15173,
,U,A,CHEMBL882959,1,0,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,,,Autocuration,,,In vivo,13174,,,22224,15173,
,N,A,CHEMBL625955,1,1,,BAO_0000218,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Canis lupus familiaris,,,,Intermediate,,,In vivo,13175,,9615.0,50588,11767,
,U,A,CHEMBL625956,1,0,,BAO_0000218,Bioavailability in ferret,Mustela putorius furo,,,,Autocuration,,,In vivo,13176,,9669.0,22224,11219,
,N,A,CHEMBL625957,1,1,,BAO_0000218,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,,Intermediate,,,In vivo,13177,,9541.0,100710,12186,
,N,A,CHEMBL625958,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13178,,10116.0,50597,11510,
,N,A,CHEMBL625959,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13179,,10116.0,50597,11510,
,N,A,CHEMBL626642,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13180,,10116.0,50597,11510,
,N,A,CHEMBL631330,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13181,,10116.0,50597,11510,
,N,A,CHEMBL631331,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13182,,10116.0,50597,11510,
,N,A,CHEMBL631332,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,,Intermediate,,,,13183,,10116.0,50597,11510,
,N,A,CHEMBL631333,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13184,,10116.0,50597,11510,
,N,A,CHEMBL632018,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13185,,10116.0,50597,11510,
,N,A,CHEMBL632019,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13186,,10116.0,50597,11510,
,N,A,CHEMBL632020,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13187,,10116.0,50597,11510,
,N,A,CHEMBL632021,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13188,,10116.0,50597,11510,
,N,A,CHEMBL632022,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13189,,10116.0,50597,11510,
,N,A,CHEMBL632023,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13190,,10116.0,50597,11510,
,N,A,CHEMBL632024,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13191,,10116.0,50597,11510,
,N,A,CHEMBL874472,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13192,,10116.0,50597,11510,
,N,A,CHEMBL632025,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13193,,10116.0,50597,11510,
,N,A,CHEMBL632026,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13194,,10116.0,50597,11510,
,N,A,CHEMBL632027,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13195,,10116.0,50597,11510,
,N,A,CHEMBL632028,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13196,,10116.0,50597,11510,
,N,A,CHEMBL626430,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13197,,10116.0,50597,11510,
,N,A,CHEMBL626431,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13198,,10116.0,50597,11510,
,N,A,CHEMBL626432,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13199,,10116.0,50597,11510,
,N,A,CHEMBL626433,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13200,,10116.0,50597,11510,
,N,A,CHEMBL626434,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13201,,10116.0,50597,11510,
,N,A,CHEMBL627280,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13202,,10116.0,50597,11510,
,N,A,CHEMBL627281,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13203,,10116.0,50597,11510,
,N,A,CHEMBL627282,1,1,,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13204,,10116.0,50597,11510,
,U,A,CHEMBL627283,1,0,,BAO_0000019,Total body clearance was measured at given dose,,,,,Autocuration,,,,13205,,,22224,7199,
,U,A,CHEMBL627284,1,0,,BAO_0000218,Total body clearance was measured at given dose.,,,,,Autocuration,,,,13206,,,22224,7199,
,N,A,CHEMBL627285,1,1,,BAO_0000218,Metabolic clearance from the body in rat,Rattus norvegicus,,,,Intermediate,,,,13207,,10116.0,50597,7095,
,U,A,CHEMBL627286,1,0,,BAO_0000218,Renal clearance from the body,,,,,Autocuration,,,In vivo,13208,,,22224,7095,
,N,A,CHEMBL875477,1,1,,BAO_0000218,Renal clearance from the body in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13209,,10116.0,50597,7095,
,N,A,CHEMBL627287,1,1,,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13210,,10116.0,50597,12528,
,N,A,CHEMBL627288,1,1,,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13211,,9615.0,50588,12528,
,N,A,CHEMBL627289,1,1,,BAO_0000218,Total clearance from the body in rat,Rattus norvegicus,,,,Intermediate,,,,13212,,10116.0,50597,7095,
,N,A,CHEMBL627290,1,1,Plasma,BAO_0000218,Clearance into cortex from rat plasma or PBS,Rattus norvegicus,,,,Intermediate,,,In vivo,13213,1969.0,10116.0,50597,14223,
,U,A,CHEMBL627291,1,0,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,,,Autocuration,,,In vivo,13214,,,22224,13569,
,U,A,CHEMBL627292,1,0,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,,,Autocuration,,,In vivo,13215,,,22224,13569,
,U,A,CHEMBL627293,1,0,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,,,Autocuration,,,In vivo,13216,,,22224,13569,
,U,A,CHEMBL627294,1,0,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,,,Autocuration,,,In vivo,13217,,,22224,13569,
,U,A,CHEMBL875478,1,0,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,,,Autocuration,,,In vivo,13218,,,22224,13569,
,U,A,CHEMBL627295,1,0,,BAO_0000218,Clearance was determined,,,,,Autocuration,,,In vivo,13219,,,22224,13979,
,N,A,CHEMBL627296,1,1,,BAO_0000218,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Mus musculus,,,,Intermediate,,,In vivo,13220,,10090.0,50594,14315,
,N,A,CHEMBL626119,1,1,,BAO_0000218,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Oryctolagus cuniculus,,,,Intermediate,,,In vivo,13221,,9986.0,50592,14315,
,N,A,CHEMBL626120,1,1,,BAO_0000218,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Rattus norvegicus,,,,Intermediate,,,In vivo,13222,,10116.0,50597,14315,
,N,A,CHEMBL626121,1,1,,BAO_0000218,Clearance in rat after iv dose (100 ug/kg),Rattus norvegicus,,,,Intermediate,,,In vivo,13223,,10116.0,50597,12174,
,U,A,CHEMBL626122,1,0,,BAO_0000218,Clearance in guinea pig,Cavia porcellus,,,,Autocuration,,,In vivo,13224,,10141.0,22224,12797,
,N,A,CHEMBL626123,1,1,,BAO_0000218,Compound was evaluated for clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13225,,10116.0,50597,12797,
,N,A,CHEMBL623456,1,1,,BAO_0000218,Compound was evaluated for the clearance in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13226,,9615.0,50588,12797,
,N,A,CHEMBL623457,1,1,,BAO_0000218,Compound was evaluated for the clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13227,,10116.0,50597,12797,
,N,A,CHEMBL623458,1,1,,BAO_0000218,Compound was tested in vivo for clearance after iv administration in the rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13228,,10116.0,50597,11500,
,U,A,CHEMBL623459,1,0,,BAO_0000218,IV clearance determined at an iv dose of 14 mg/kg,,,,,Autocuration,,,In vivo,13229,,,22224,15173,
,U,A,CHEMBL875484,1,0,,BAO_0000218,IV clearance determined at an iv dose of 15.2 mg/kg,,,,,Autocuration,,,In vivo,13230,,,22224,15173,
,U,A,CHEMBL623460,1,0,,BAO_0000218,IV clearance determined at an iv dose of 15 mg/kg,,,,,Autocuration,,,In vivo,13231,,,22224,15173,
,U,A,CHEMBL623461,1,0,,BAO_0000218,IV clearance determined at an peroral dose of 30 mg/kg.,,,,,Autocuration,,,In vivo,13232,,,22224,15173,
,U,A,CHEMBL623462,1,0,,BAO_0000218,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,,,Autocuration,,,In vivo,13233,,,22224,15173,
,U,A,CHEMBL627386,1,0,,BAO_0000218,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,,,Autocuration,,,In vivo,13234,,,22224,15173,
,N,A,CHEMBL627387,1,1,Kidney,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13235,2113.0,10116.0,50597,14198,
,N,A,CHEMBL627388,1,1,Liver,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13236,2107.0,10116.0,50597,14198,
,N,A,CHEMBL627389,1,1,Lung,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13237,2048.0,10116.0,50597,14198,
,N,A,CHEMBL627390,1,1,Muscle tissue,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13238,2385.0,10116.0,50597,14198,
,N,A,CHEMBL627391,1,1,Plasma,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13239,1969.0,10116.0,50597,14198,
,N,A,CHEMBL627392,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13240,,10116.0,50597,14198,
,N,A,CHEMBL627393,1,1,Spleen,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13241,2106.0,10116.0,50597,14198,
,N,A,CHEMBL627394,1,1,Trachea,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13242,3126.0,10116.0,50597,14198,
,N,A,CHEMBL627395,1,1,Bone,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13243,10000001.0,10116.0,50597,14198,
,N,A,CHEMBL875485,1,1,Cerebellum,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13244,2037.0,10116.0,50597,14198,
,N,A,CHEMBL627396,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13245,,10116.0,50597,14198,
,N,A,CHEMBL627397,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13246,,10116.0,50597,14198,
,N,A,CHEMBL627398,1,1,Heart,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13247,948.0,10116.0,50597,14198,
,N,A,CHEMBL627399,1,1,Bone,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13248,10000001.0,10116.0,50597,14198,
,N,A,CHEMBL627400,1,1,Kidney,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13249,2113.0,10116.0,50597,14198,
,N,A,CHEMBL627401,1,1,Liver,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13250,2107.0,10116.0,50597,14198,
,N,A,CHEMBL627402,1,1,Lung,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13251,2048.0,10116.0,50597,14198,
,N,A,CHEMBL627403,1,1,Muscle tissue,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13252,2385.0,10116.0,50597,14198,
,N,A,CHEMBL627404,1,1,Plasma,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13253,1969.0,10116.0,50597,14198,
,N,A,CHEMBL623101,1,1,,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13254,,10116.0,50597,14198,
,N,A,CHEMBL877480,1,1,Spleen,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13255,2106.0,10116.0,50597,14198,
,N,A,CHEMBL623102,1,1,Trachea,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13256,3126.0,10116.0,50597,14198,
,N,A,CHEMBL623103,1,1,Bone,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13257,10000001.0,10116.0,50597,14198,
,N,A,CHEMBL623104,1,1,Cerebellum,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13258,2037.0,10116.0,50597,14198,
,N,A,CHEMBL623105,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13259,,10116.0,50597,14198,
,N,A,CHEMBL623106,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13260,,10116.0,50597,14198,
,N,A,CHEMBL623107,1,1,Heart,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13261,948.0,10116.0,50597,14198,
,N,A,CHEMBL623108,1,1,Intestine,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13262,160.0,10116.0,50597,14198,
,N,A,CHEMBL623109,1,1,Kidney,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13263,2113.0,10116.0,50597,14198,
,N,A,CHEMBL623110,1,1,Liver,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13264,2107.0,10116.0,50597,14198,
,N,A,CHEMBL623111,1,1,Lung,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13265,2048.0,10116.0,50597,14198,
,N,A,CHEMBL625060,1,1,Muscle tissue,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13266,2385.0,10116.0,50597,14198,
,N,A,CHEMBL625061,1,1,Plasma,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13267,1969.0,10116.0,50597,14198,
,N,A,CHEMBL625062,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13268,,10116.0,50597,14198,
,N,A,CHEMBL625063,1,1,Spleen,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13269,2106.0,10116.0,50597,14198,
,N,A,CHEMBL625064,1,1,Trachea,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13270,3126.0,10116.0,50597,14198,
,N,A,CHEMBL625065,1,1,Bone,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13271,10000001.0,10116.0,50597,14198,
,N,A,CHEMBL625066,1,1,Cerebellum,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13272,2037.0,10116.0,50597,14198,
,N,A,CHEMBL625067,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13273,,10116.0,50597,14198,
,N,A,CHEMBL625068,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13274,,10116.0,50597,14198,
,N,A,CHEMBL622159,1,1,Heart,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13275,948.0,10116.0,50597,14198,
,N,A,CHEMBL622160,1,1,Intestine,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13276,160.0,10116.0,50597,14198,
,N,A,CHEMBL622161,1,1,Kidney,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13277,2113.0,10116.0,50597,14198,
,N,A,CHEMBL622162,1,1,Lung,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13278,2048.0,10116.0,50597,14198,
,N,A,CHEMBL622163,1,1,Muscle tissue,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13279,2385.0,10116.0,50597,14198,
,N,A,CHEMBL622313,1,1,Plasma,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13280,1969.0,10116.0,50597,14198,
,N,A,CHEMBL622314,1,1,,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13281,,10116.0,50597,14198,
,N,A,CHEMBL622315,1,1,Spleen,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13282,2106.0,10116.0,50597,14198,
,N,A,CHEMBL622316,1,1,Trachea,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13283,3126.0,10116.0,50597,14198,
,N,A,CHEMBL877486,1,1,,BAO_0000218,Normal diffusion coefficient in water for Escherichia coli,Escherichia coli,,,,Intermediate,,,,13284,,562.0,50212,15599,
,U,A,CHEMBL622317,1,0,,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined,,,,,Autocuration,,,,13285,,,22224,8204,
,U,A,CHEMBL622318,1,0,,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,,,Autocuration,,,,13286,,,22224,8204,
,U,A,CHEMBL622319,1,0,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,,,Autocuration,,,,13287,,,22224,6154,
,U,A,CHEMBL622320,1,0,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,,,Autocuration,,,,13288,,,22224,6154,
,U,A,CHEMBL622321,1,0,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,,,Autocuration,,,,13289,,,22224,6154,
,U,A,CHEMBL622322,1,0,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,,,Autocuration,,,,13290,,,22224,6154,
,U,A,CHEMBL622323,1,0,,BAO_0000019,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,,,Autocuration,,,,13291,,,22224,7114,
,N,A,CHEMBL622324,1,1,,BAO_0000218,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,,,,Intermediate,,,,13292,,10116.0,50597,7114,
,N,A,CHEMBL622325,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13293,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622326,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13294,1088.0,9615.0,50588,8133,
,N,A,CHEMBL877487,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13295,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622327,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13296,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622328,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13297,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622329,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13298,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622330,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13299,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622331,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13300,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622332,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13301,1088.0,9615.0,50588,8133,
,N,A,CHEMBL622333,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13302,1088.0,9615.0,50588,8133,
,U,A,CHEMBL627658,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,,,Autocuration,,,,13303,1088.0,314293.0,22224,8133,
,U,A,CHEMBL630428,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,,,,Autocuration,,,,13304,1088.0,314293.0,22224,8133,
,U,A,CHEMBL630429,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,,,Autocuration,,,,13305,1088.0,314293.0,22224,8133,
,U,A,CHEMBL630430,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Simiiformes,,,,Autocuration,,,,13306,1088.0,314293.0,22224,8133,
,U,A,CHEMBL630431,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Simiiformes,,,,Autocuration,,,,13307,1088.0,314293.0,22224,8133,
,N,A,CHEMBL630432,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13308,1088.0,10116.0,50597,8133,
,N,A,CHEMBL630433,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13309,1088.0,10116.0,50597,8133,
,N,A,CHEMBL630434,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13310,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629372,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13311,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629553,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13312,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629554,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13313,1088.0,10116.0,50597,8133,
,N,A,CHEMBL874447,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13314,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629555,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13315,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629556,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13316,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629557,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13317,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629558,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13318,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629559,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13319,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629560,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13320,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629561,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13321,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629562,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13322,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629563,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13323,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629564,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13324,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629565,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13325,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629566,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13326,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629567,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13327,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629568,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13328,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629569,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13329,1088.0,9615.0,50588,8133,
,N,A,CHEMBL629570,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13330,1088.0,9615.0,50588,8133,
,U,A,CHEMBL629571,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,,,Autocuration,,,,13331,1088.0,314293.0,22224,8133,
,U,A,CHEMBL629572,1,0,,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,,Autocuration,,,In vivo,13332,,10116.0,22224,12170,
,U,A,CHEMBL629573,1,0,,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,,Autocuration,,,In vivo,13333,,10116.0,22224,12170,
,U,A,CHEMBL629574,1,0,,BAO_0000218,Bioavailability (dose 20 mg/kg),Eutheria,,,,Autocuration,,,In vivo,13334,,9347.0,22224,4985,
,U,A,CHEMBL629575,1,0,,BAO_0000218,Bioavailability in dog,Canis lupus familiaris,,,,Autocuration,,,In vivo,13335,,9615.0,22224,15145,
,U,A,CHEMBL874448,1,0,,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,,,,Autocuration,,,In vivo,13336,,10116.0,22224,14080,
,U,A,CHEMBL629576,1,0,,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d.),Primates,,,,Autocuration,,,In vivo,13337,,9443.0,22224,11219,
,U,A,CHEMBL629577,1,0,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,13338,,10116.0,22224,15145,
,U,A,CHEMBL629578,1,0,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,13339,,10116.0,22224,15145,
,U,A,CHEMBL629579,1,0,,BAO_0000218,Bioavailability in dog (dose 3.0 mg/kg p.o.),Canis lupus familiaris,,,,Autocuration,,,In vivo,13340,,9615.0,22224,1202,
,U,A,CHEMBL882958,1,0,,BAO_0000218,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Canis lupus familiaris,,,,Autocuration,,,In vivo,13341,,9615.0,22224,1202,
,N,A,CHEMBL629580,1,1,,BAO_0000218,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Pan troglodytes,,,,Intermediate,,,In vivo,13342,,9598.0,50505,1202,
,U,A,CHEMBL629581,1,0,,BAO_0000218,Bioavailability,Eutheria,,,,Autocuration,,,In vivo,13343,,9347.0,22224,4026,
,U,A,CHEMBL629582,1,0,,BAO_0000218,Bioavailability in squirrel monkey,Saimiri,,,,Autocuration,,,In vivo,13344,,9520.0,22224,1492,
,N,A,CHEMBL628522,1,1,,BAO_0000218,Bioavailability was evaluated in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13345,,9615.0,50588,12793,
,N,A,CHEMBL625432,1,1,,BAO_0000218,Bioavailability was evaluated in hamster,Cricetinae,,,,Intermediate,,,In vivo,13346,,10026.0,100712,12793,
,U,A,CHEMBL625433,1,0,,BAO_0000218,Bioavailability in rat,Rattus norvegicus,,,,Autocuration,,,In vivo,13347,,10116.0,22224,12793,
,N,A,CHEMBL625434,1,1,Plasma,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,13348,1969.0,10116.0,50597,14793,
,N,A,CHEMBL625435,1,1,Plasma,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Rattus norvegicus,,,,Intermediate,,,In vivo,13349,1969.0,10116.0,50597,14793,
,U,A,CHEMBL625436,1,0,,BAO_0000218,Bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,,Autocuration,,,In vivo,13350,,10116.0,22224,14793,
,N,A,CHEMBL874588,1,1,,BAO_0000218,Bioavailability was measured in cynomolgus monkeys.,Macaca fascicularis,,,,Intermediate,,,In vivo,13351,,9541.0,100710,14731,
,N,A,CHEMBL625437,1,1,,BAO_0000218,Bioavailability was measured in nude mice.,Mus musculus,,,,Intermediate,,,In vivo,13352,,10090.0,50594,14731,
,U,A,CHEMBL625438,1,0,,BAO_0000218,Bioavailability in ferret (dose 10 mg/kg i.d.),Mustela putorius furo,,,,Autocuration,,,In vivo,13353,,9669.0,22224,12187,
,U,A,CHEMBL625439,1,0,,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Simiiformes,,,,Autocuration,,,In vivo,13354,,314293.0,22224,12187,
,U,A,CHEMBL625440,1,0,,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Simiiformes,,,,Autocuration,,,In vivo,13355,,314293.0,22224,12187,
,U,A,CHEMBL625441,1,0,,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Simiiformes,,,,Autocuration,,,In vivo,13356,,314293.0,22224,12187,
,U,A,CHEMBL625442,1,0,,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,,,,Autocuration,,,In vivo,13357,,10116.0,22224,12187,
,N,A,CHEMBL625443,1,1,,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,,Intermediate,,,In vivo,13358,,10116.0,50597,12187,
,U,A,CHEMBL625444,1,0,,BAO_0000218,Bioavailability was determined; extremely poor,,,,,Autocuration,,,In vivo,13359,,,22224,17431,
,N,A,CHEMBL625445,1,1,,BAO_0000218,% bioavailability in mice after oral administration of prodrug,Mus musculus,,,,Intermediate,,,In vivo,13360,,10090.0,50594,13318,
,N,A,CHEMBL625446,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Canis lupus familiaris,,,,Intermediate,,,In vivo,13361,,9615.0,50588,9025,
,N,A,CHEMBL882960,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Canis lupus familiaris,,,,Intermediate,,,In vivo,13362,,9615.0,50588,9025,
,N,A,CHEMBL625447,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Canis lupus familiaris,,,,Intermediate,,,In vivo,13363,,9615.0,50588,9025,
,N,A,CHEMBL625448,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Canis lupus familiaris,,,,Intermediate,,,In vivo,13364,,9615.0,50588,9025,
,N,A,CHEMBL625449,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Canis lupus familiaris,,,,Intermediate,,,In vivo,13365,,9615.0,50588,9025,
,N,A,CHEMBL874589,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Canis lupus familiaris,,,,Intermediate,,,In vivo,13366,,9615.0,50588,9025,
,N,A,CHEMBL625450,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Canis lupus familiaris,,,,Intermediate,,,In vivo,13367,,9615.0,50588,9025,
,N,A,CHEMBL625451,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Canis lupus familiaris,,,,Intermediate,,,In vivo,13368,,9615.0,50588,9025,
,N,A,CHEMBL626584,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Canis lupus familiaris,,,,Intermediate,,,In vivo,13369,,9615.0,50588,9025,
,N,A,CHEMBL626585,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Canis lupus familiaris,,,,Intermediate,,,In vivo,13370,,9615.0,50588,9025,
,N,A,CHEMBL626586,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Canis lupus familiaris,,,,Intermediate,,,In vivo,13371,,9615.0,50588,9025,
,N,A,CHEMBL626587,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Canis lupus familiaris,,,,Intermediate,,,In vivo,13372,,9615.0,50588,9025,
,N,A,CHEMBL626588,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Canis lupus familiaris,,,,Intermediate,,,In vivo,13373,,9615.0,50588,9025,
,N,A,CHEMBL626589,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Canis lupus familiaris,,,,Intermediate,,,In vivo,13374,,9615.0,50588,9025,
,N,A,CHEMBL626590,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Canis lupus familiaris,,,,Intermediate,,,In vivo,13375,,9615.0,50588,9025,
,N,A,CHEMBL626591,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Canis lupus familiaris,,,,Intermediate,,,In vivo,13376,,9615.0,50588,9025,
,N,A,CHEMBL627181,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Canis lupus familiaris,,,,Intermediate,,,In vivo,13377,,9615.0,50588,9025,
,N,A,CHEMBL628083,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Canis lupus familiaris,,,,Intermediate,,,In vivo,13378,,9615.0,50588,9025,
,U,A,CHEMBL628084,1,0,,BAO_0000218,IV clearance determined at an peroral dose of 15 mg/kg.,,,,,Autocuration,,,In vivo,13379,,,22224,15173,
,N,F,CHEMBL628085,1,1,,BAO_0000218,Mouse oral clearance was measured against Hymenolepiasis nana.,Hymenolepis nana,,,,Expert,,,In vivo,13380,,102285.0,50064,7732,
,N,F,CHEMBL628086,1,1,,BAO_0000218,Mouse oral clearance was measured against Nematospiroides dubius,Heligmosomoides polygyrus,,,,Expert,,,In vivo,13381,,6339.0,50545,7732,
,U,F,CHEMBL628087,1,0,,BAO_0000218,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,,,Autocuration,,,In vivo,13382,,,22224,7732,
,N,A,CHEMBL628088,1,1,,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,Mus musculus,,,,Intermediate,,,In vivo,13383,,10090.0,50594,7732,
,U,B,CHEMBL628089,1,0,,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,,,Autocuration,,,In vivo,13384,,,22224,7732,
,U,A,CHEMBL628090,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13385,,,22224,8328,
,U,A,CHEMBL628091,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13386,,,22224,8328,
,U,A,CHEMBL628092,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13387,,,22224,8328,
,U,A,CHEMBL628093,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13388,,,22224,8328,
,U,A,CHEMBL875607,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13389,,,22224,8328,
,U,A,CHEMBL625710,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13390,,,22224,8328,
,U,A,CHEMBL625711,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13391,,,22224,8328,
,U,A,CHEMBL625712,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13392,,,22224,8328,
,U,A,CHEMBL625713,1,0,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,,,Autocuration,,,In vivo,13393,,,22224,8328,
,N,A,CHEMBL625714,1,1,,BAO_0000218,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Canis lupus familiaris,,,,Intermediate,,,In vivo,13394,,9615.0,50588,13376,
,N,A,CHEMBL625715,1,1,,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Macaca mulatta,,,,Intermediate,,,In vivo,13395,,9544.0,50797,13477,
,N,A,CHEMBL625716,1,1,,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13396,,10116.0,50597,13477,
,N,A,CHEMBL625717,1,1,,BAO_0000218,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13397,,10116.0,50597,13477,
,N,A,CHEMBL625718,1,1,,BAO_0000218,Plasma clearance was determined for the compound in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13398,,10116.0,50597,13313,
,N,A,CHEMBL625719,1,1,,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,,,,Intermediate,,,In vivo,13399,,10116.0,50597,12504,
,N,A,CHEMBL625720,1,1,,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,,,,Intermediate,,,In vivo,13400,,10116.0,50597,12504,
,N,A,CHEMBL625721,1,1,,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,,,,Intermediate,,,In vivo,13401,,10116.0,50597,12504,
,N,A,CHEMBL625722,1,1,,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,,,,Intermediate,,,In vivo,13402,,10116.0,50597,12504,
,N,A,CHEMBL625723,1,1,,BAO_0000218,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,,,,Intermediate,,,In vivo,13403,,10116.0,50597,13129,
,N,A,CHEMBL625724,1,1,,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Heligmosomoides polygyrus,,,,Intermediate,,,In vivo,13404,,6339.0,50545,7732,
,N,A,CHEMBL625725,1,1,,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Heligmosomoides polygyrus,,,,Intermediate,,,In vivo,13405,,6339.0,50545,7732,
,N,A,CHEMBL625726,1,1,,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Heligmosomoides polygyrus,,,,Intermediate,,,In vivo,13406,,6339.0,50545,7732,
,N,A,CHEMBL875608,1,1,,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Heligmosomoides polygyrus,,,,Intermediate,,,In vivo,13407,,6339.0,50545,7732,
,N,A,CHEMBL625727,1,1,,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Heligmosomoides polygyrus,,,,Intermediate,,,In vivo,13408,,6339.0,50545,7732,
,U,A,CHEMBL625728,1,0,Urine,BAO_0000218,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,,,,Autocuration,,,In vivo,13409,1088.0,10116.0,22224,9278,
,U,A,CHEMBL625729,1,0,,BAO_0000218,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,,,,Autocuration,,,In vivo,13410,,10116.0,22224,9278,
,U,A,CHEMBL625730,1,0,,BAO_0000218,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,,,,Autocuration,,,In vivo,13411,,10116.0,22224,9278,
,U,A,CHEMBL625731,1,0,Urine,BAO_0000218,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,,,,Autocuration,,,In vivo,13412,1088.0,10116.0,22224,9278,
,U,A,CHEMBL626417,1,0,Urine,BAO_0000218,Urinary clearance was determined in rat at 25 mg/kg os dosage,Rattus norvegicus,,,,Autocuration,,,In vivo,13413,1088.0,10116.0,22224,9278,
,N,A,CHEMBL626418,1,1,Urine,BAO_0000218,Urinary clearance was determined at 100 mg/kg oral dosage in human,Homo sapiens,,,,Intermediate,,,In vivo,13414,1088.0,9606.0,50587,9278,
,N,A,CHEMBL626419,1,1,Urine,BAO_0000218,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Canis lupus familiaris,,,,Intermediate,,,In vivo,13415,1088.0,9615.0,50588,9278,
,N,A,CHEMBL626592,1,1,Plasma,BAO_0000218,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Canis lupus familiaris,,,,Intermediate,,,In vivo,13416,1969.0,9615.0,50588,5932,
,N,A,CHEMBL626593,1,1,Plasma,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,,,,Intermediate,,,In vivo,13417,1969.0,10116.0,50597,5932,
,N,A,CHEMBL626594,1,1,,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13418,,10116.0,50597,5182,
,N,A,CHEMBL625035,1,1,,BAO_0000218,Clearance rate in dogs,Canis lupus familiaris,,,,Intermediate,,,In vivo,13419,,9615.0,50588,10499,
,U,A,CHEMBL625036,1,0,,BAO_0000019,Compound was measured for intrinsic clearance,,,,,Autocuration,,,In vitro,13420,,,22224,6051,
,U,P,CHEMBL625037,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13421,,,22229,17508,
,U,P,CHEMBL625038,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13422,,,22229,6228,
,U,P,CHEMBL625039,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13423,,,22229,6231,
,U,P,CHEMBL625040,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13424,,,22229,17740,
,U,P,CHEMBL625041,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13425,,,22229,6495,
,U,P,CHEMBL625042,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13426,,,22229,2171,
,U,A,CHEMBL874411,1,0,,BAO_0000019,Partition coefficient of the compound,,,,,Autocuration,,,,13427,,,22224,3255,
,U,A,CHEMBL625043,1,0,,BAO_0000019,Permeability,,,,,Autocuration,,,,13428,,,22224,6821,
,U,P,CHEMBL625044,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13429,,,22229,2685,
,U,A,CHEMBL625045,1,0,,BAO_0000019,Partition coefficient (logD),,,,,Autocuration,,,,13430,,,22224,17584,
,U,P,CHEMBL625046,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,Autocuration,,,,13431,,,22229,13824,
,U,P,CHEMBL625047,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,Autocuration,,,,13432,,,22229,13824,
,U,P,CHEMBL625048,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13433,,,22229,16479,
,U,P,CHEMBL625049,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13434,,,22229,11997,
,U,P,CHEMBL625050,1,0,,BAO_0000100,Calculated logarithm of partition coefficient (P) was determined,,,,,Autocuration,,,,13435,,,22229,2988,
,U,P,CHEMBL625051,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13436,,,22229,931,
,U,P,CHEMBL874412,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13437,,,22229,4381,
,U,P,CHEMBL625052,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13438,,,22229,4397,
,U,P,CHEMBL625053,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13439,,,22229,5889,
,U,A,CHEMBL623250,1,0,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,,,Autocuration,,,,13440,,,22224,6154,
,U,A,CHEMBL623251,1,0,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,,,Autocuration,,,,13441,,,22224,6154,
,U,A,CHEMBL623252,1,0,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,,,Autocuration,,,,13442,,,22224,6154,
,U,A,CHEMBL623253,1,0,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,,,Autocuration,,,,13443,,,22224,6154,
,U,A,CHEMBL623254,1,0,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,,,Autocuration,,,,13444,,,22224,6154,
,U,A,CHEMBL623255,1,0,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,,,Autocuration,,,,13445,,,22224,6154,
,U,A,CHEMBL626831,1,0,,BAO_0000019,Percent degradation of compound at a pH of 1 over a 18 hr period,,,,,Autocuration,,,,13446,,,22224,6887,
,U,A,CHEMBL877494,1,0,,BAO_0000019,Percent degradation of compound at pH of 1 over an 18 hr period,,,,,Autocuration,,,,13447,,,22224,6887,
,U,A,CHEMBL626832,1,0,,BAO_0000019,Delta Logarithm of Partition Coefficient value was determined.,,,,,Autocuration,,,,13448,,,22224,14116,
,U,A,CHEMBL626833,1,0,,BAO_0000019,Delta logPoct-cyc,,,,,Autocuration,,,,13449,,,22224,11137,
,U,P,CHEMBL626834,1,0,,BAO_0000100,Lipophilicity estimated on reversed phase TLC,,,,,Autocuration,,,,13450,,,22224,7230,
,U,A,CHEMBL626835,1,0,,BAO_0000019,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,,,Autocuration,,,,13451,,,22224,15741,
,U,A,CHEMBL626836,1,0,,BAO_0000019,Delta logPoct-cyc,,,,,Autocuration,,,,13452,,,22224,9663,
,U,P,CHEMBL626837,1,0,,BAO_0000100,Change in logarithm of partition coefficient of the compound,,,,,Autocuration,,,,13453,,,22229,9663,
,U,A,CHEMBL626838,1,0,,BAO_0000019,Delta logD (pH 6.5),,,,,Autocuration,,,,13454,,,22224,13807,
,U,P,CHEMBL626839,1,0,,BAO_0000100,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,,,Autocuration,,,,13455,,,22224,13807,
,U,A,CHEMBL626840,1,0,,BAO_0000019,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,,,Autocuration,,,,13456,,,22224,17425,
,U,A,CHEMBL626841,1,0,,BAO_0000019,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,,,Autocuration,,,,13457,,,22224,12143,
,U,A,CHEMBL626842,1,0,,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,,,Autocuration,,,,13458,,,22224,12608,
,U,A,CHEMBL626843,1,0,,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,,,Autocuration,,,,13459,,,22224,12608,
,N,A,CHEMBL626844,1,1,,BAO_0000218,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Rattus norvegicus,,,,Intermediate,,,,13460,,10116.0,50597,8649,
,N,A,CHEMBL877495,1,1,,BAO_0000218,Amount of deuterium retained was reported after normal workup in rats,Rattus norvegicus,,,,Intermediate,,,,13461,,10116.0,50597,8649,
,N,A,CHEMBL626845,1,1,,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Rattus norvegicus,,,,Intermediate,,,,13462,,10116.0,50597,8649,
,N,A,CHEMBL626846,1,1,,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Rattus norvegicus,,,,Intermediate,,,,13463,,10116.0,50597,8649,
,N,A,CHEMBL626847,1,1,,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,,,,Intermediate,,,,13464,,10116.0,50597,8649,
,N,A,CHEMBL628677,1,1,,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,,,,Intermediate,,,,13465,,10116.0,50597,8649,
,N,A,CHEMBL628678,1,1,,BAO_0000218,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Rattus norvegicus,,,,Intermediate,,,,13466,,10116.0,50597,8649,
,U,A,CHEMBL628679,1,0,,BAO_0000019,Compound was subjected to electrochemical oxidation,,,,,Autocuration,,,,13467,,,22224,9659,
,U,A,CHEMBL628680,1,0,,BAO_0000019,Compound was subjected to photochemical oxidation,,,,,Autocuration,,,,13468,,,22224,9659,
,U,A,CHEMBL628681,1,0,,BAO_0000019,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,,,Autocuration,,,,13469,,,22224,9659,
,U,A,CHEMBL628682,1,0,,BAO_0000019,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,,,Autocuration,,,,13470,,,22224,9659,
,U,A,CHEMBL628683,1,0,,BAO_0000019,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,,,Autocuration,,,,13471,,,22224,9659,
,N,A,CHEMBL628684,1,1,,BAO_0000218,Percent diffusion through fuzzy rat skin after 48 h of incubation,Rattus norvegicus,,,,Intermediate,,,,13472,,10116.0,50597,9607,
,U,P,CHEMBL877501,1,0,,BAO_0000100,Dissociation constant (pKa),,,,,Autocuration,,,,13473,,,22229,7057,
,U,P,CHEMBL628685,1,0,,BAO_0000100,Dissociation constant value of the compound; ND means not determined.,,,,,Autocuration,,,,13474,,,22224,7057,
,N,A,CHEMBL628686,1,1,Blood,BAO_0000218,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13475,178.0,10116.0,50597,7911,
,N,A,CHEMBL628687,1,1,Blood,BAO_0000218,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13476,178.0,10116.0,50597,7911,
,N,A,CHEMBL628688,1,1,,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13477,,10116.0,50597,7911,
,N,A,CHEMBL628689,1,1,,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13478,,10116.0,50597,7911,
,N,A,CHEMBL628690,1,1,Liver,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13479,2107.0,10116.0,50597,7911,
,N,A,CHEMBL629363,1,1,Liver,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13480,2107.0,10116.0,50597,7911,
,N,A,CHEMBL629364,1,1,Spleen,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13481,2106.0,10116.0,50597,7911,
,N,A,CHEMBL629365,1,1,Spleen,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13482,2106.0,10116.0,50597,7911,
,N,A,CHEMBL629366,1,1,,BAO_0000218,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13483,,10116.0,50597,7911,
,N,A,CHEMBL629367,1,1,Urine,BAO_0000218,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13484,1088.0,10116.0,50597,7911,
,N,A,CHEMBL629368,1,1,Feces,BAO_0000218,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13485,1988.0,10116.0,50597,7911,
,N,A,CHEMBL877502,1,1,Urine,BAO_0000218,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,,,,Intermediate,,,,13486,1088.0,10116.0,50597,7911,
,N,A,CHEMBL629369,1,1,Cerebellum,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Mus musculus,,,,Intermediate,,,,13487,2037.0,10090.0,50594,13792,
,N,A,CHEMBL629370,1,1,Brain,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Mus musculus,,,,Intermediate,,,,13488,955.0,10090.0,50594,13792,
,U,A,CHEMBL629371,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Simiiformes,,,,Autocuration,,,,13489,1088.0,314293.0,22224,8133,
,U,A,CHEMBL626276,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,,,Autocuration,,,,13490,1088.0,314293.0,22224,8133,
,U,A,CHEMBL626277,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,,,,Autocuration,,,,13491,1088.0,314293.0,22224,8133,
,U,A,CHEMBL631250,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,,,,Autocuration,,,,13492,1088.0,314293.0,22224,8133,
,N,A,CHEMBL631251,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13493,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631252,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13494,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631253,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13495,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631254,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13496,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631255,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13497,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631256,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13498,1088.0,10116.0,50597,8133,
,N,A,CHEMBL631257,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13499,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628009,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13500,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628010,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13501,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628011,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13502,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628012,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13503,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628013,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13504,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628014,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13505,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628015,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13506,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628016,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13507,1088.0,9615.0,50588,8133,
,N,A,CHEMBL874461,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13508,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628017,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13509,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628018,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13510,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628019,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13511,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628020,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13512,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628021,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13513,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628022,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13514,1088.0,9615.0,50588,8133,
,N,A,CHEMBL628023,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,,,,Intermediate,,,,13515,1088.0,9615.0,50588,8133,
,U,A,CHEMBL628024,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,,,Autocuration,,,,13516,1088.0,314293.0,22224,8133,
,U,A,CHEMBL628025,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,,,,Autocuration,,,,13517,1088.0,314293.0,22224,8133,
,U,A,CHEMBL628026,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,,,Autocuration,,,,13518,1088.0,314293.0,22224,8133,
,U,A,CHEMBL628027,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,,,,Autocuration,,,,13519,1088.0,314293.0,22224,8133,
,U,A,CHEMBL628028,1,0,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,,,,Autocuration,,,,13520,1088.0,314293.0,22224,8133,
,N,A,CHEMBL628029,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13521,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628030,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13522,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628031,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13523,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628032,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13524,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628033,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13525,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628034,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13526,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628035,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13527,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628036,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13528,1088.0,10116.0,50597,8133,
,N,A,CHEMBL874462,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13529,1088.0,10116.0,50597,8133,
,N,A,CHEMBL628037,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Canis lupus familiaris,,,,Intermediate,,,In vivo,13530,,9615.0,50588,9025,
,N,A,CHEMBL628123,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Canis lupus familiaris,,,,Intermediate,,,In vivo,13531,,9615.0,50588,9025,
,N,A,CHEMBL628124,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Canis lupus familiaris,,,,Intermediate,,,In vivo,13532,,9615.0,50588,9025,
,N,A,CHEMBL628125,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Canis lupus familiaris,,,,Intermediate,,,In vivo,13533,,9615.0,50588,9025,
,N,A,CHEMBL628126,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Canis lupus familiaris,,,,Intermediate,,,In vivo,13534,,9615.0,50588,9025,
,N,A,CHEMBL628127,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Canis lupus familiaris,,,,Intermediate,,,In vivo,13535,,9615.0,50588,9025,
,N,A,CHEMBL628128,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Canis lupus familiaris,,,,Intermediate,,,In vivo,13536,,9615.0,50588,9025,
,N,A,CHEMBL628129,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Canis lupus familiaris,,,,Intermediate,,,In vivo,13537,,9615.0,50588,9025,
,N,A,CHEMBL628130,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Canis lupus familiaris,,,,Intermediate,,,In vivo,13538,,9615.0,50588,9025,
,N,A,CHEMBL628131,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Canis lupus familiaris,,,,Intermediate,,,In vivo,13539,,9615.0,50588,9025,
,N,A,CHEMBL628132,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Canis lupus familiaris,,,,Intermediate,,,In vivo,13540,,9615.0,50588,9025,
,N,A,CHEMBL628133,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Canis lupus familiaris,,,,Intermediate,,,In vivo,13541,,9615.0,50588,9025,
,N,A,CHEMBL628134,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Canis lupus familiaris,,,,Intermediate,,,In vivo,13542,,9615.0,50588,9025,
,N,A,CHEMBL628135,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Canis lupus familiaris,,,,Intermediate,,,In vivo,13543,,9615.0,50588,9025,
,N,A,CHEMBL628136,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Canis lupus familiaris,,,,Intermediate,,,In vivo,13544,,9615.0,50588,9025,
,N,A,CHEMBL628137,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Canis lupus familiaris,,,,Intermediate,,,In vivo,13545,,9615.0,50588,9025,
,N,A,CHEMBL628138,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Canis lupus familiaris,,,,Intermediate,,,In vivo,13546,,9615.0,50588,9025,
,N,A,CHEMBL628139,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Canis lupus familiaris,,,,Intermediate,,,In vivo,13547,,9615.0,50588,9025,
,N,A,CHEMBL628140,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Canis lupus familiaris,,,,Intermediate,,,In vivo,13548,,9615.0,50588,9025,
,N,A,CHEMBL628141,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Canis lupus familiaris,,,,Intermediate,,,In vivo,13549,,9615.0,50588,9025,
,N,A,CHEMBL628142,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Canis lupus familiaris,,,,Intermediate,,,In vivo,13550,,9615.0,50588,9025,
,N,A,CHEMBL628143,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Canis lupus familiaris,,,,Intermediate,,,In vivo,13551,,9615.0,50588,9025,
,N,A,CHEMBL628144,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Canis lupus familiaris,,,,Intermediate,,,In vivo,13552,,9615.0,50588,9025,
,N,A,CHEMBL628145,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Canis lupus familiaris,,,,Intermediate,,,In vivo,13553,,9615.0,50588,9025,
,N,A,CHEMBL628146,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Canis lupus familiaris,,,,Intermediate,,,In vivo,13554,,9615.0,50588,9025,
,N,A,CHEMBL625355,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Canis lupus familiaris,,,,Intermediate,,,In vivo,13555,,9615.0,50588,9025,
,N,A,CHEMBL625356,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Canis lupus familiaris,,,,Intermediate,,,In vivo,13556,,9615.0,50588,9025,
,N,A,CHEMBL625357,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Canis lupus familiaris,,,,Intermediate,,,In vivo,13557,,9615.0,50588,9025,
,N,A,CHEMBL625527,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Canis lupus familiaris,,,,Intermediate,,,In vivo,13558,,9615.0,50588,9025,
,N,A,CHEMBL875473,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Canis lupus familiaris,,,,Intermediate,,,In vivo,13559,,9615.0,50588,9025,
,N,A,CHEMBL625528,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Canis lupus familiaris,,,,Intermediate,,,In vivo,13560,,9615.0,50588,9025,
,N,A,CHEMBL626304,1,1,,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Rattus norvegicus,,,,Intermediate,,,In vivo,13561,,10116.0,50597,9025,
,N,A,CHEMBL624138,1,1,Artery,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Canis lupus familiaris,,,,Intermediate,,,In vivo,13562,1637.0,9615.0,50588,9025,
,U,P,CHEMBL624139,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13563,,,22229,6448,
,U,P,CHEMBL624140,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13564,,,22229,17221,
,U,P,CHEMBL624141,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13565,,,22229,6545,
,U,P,CHEMBL624142,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13566,,,22229,577,
,U,P,CHEMBL624143,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13567,,,22229,6285,
,U,P,CHEMBL624144,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13568,,,22229,6500,
,U,P,CHEMBL624145,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13569,,,22229,6716,
,U,P,CHEMBL624146,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13570,,,22229,13658,
,U,P,CHEMBL624147,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13571,,,22229,6549,
,U,P,CHEMBL883123,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),,,,,Autocuration,,,,13572,,,22229,14685,
,U,A,CHEMBL624148,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,13573,,,22224,6893,
,U,A,CHEMBL874416,1,0,,BAO_0000019,Kinetic parameter was determined,,,,,Autocuration,,,,13574,,,22224,3687,
,U,P,CHEMBL624149,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13575,,,22229,4207,
,U,P,CHEMBL624150,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13576,,,22229,4626,
,U,P,CHEMBL624151,1,0,,BAO_0000100,Lipophilicity was determined,,,,,Autocuration,,,,13577,,,22224,1021,
,U,P,CHEMBL624152,1,0,,BAO_0000100,Lipophilicity was determined,,,,,Autocuration,,,,13578,,,22224,3777,
,U,P,CHEMBL622139,1,0,,BAO_0000100,Lipophilicity was determined,,,,,Autocuration,,,,13579,,,22224,17533,
,U,P,CHEMBL622140,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13580,,,22229,6524,
,U,P,CHEMBL622141,1,0,,BAO_0000100,Lipophilicity was determined,,,,,Autocuration,,,,13581,,,22224,17533,
,U,P,CHEMBL622142,1,0,,BAO_0000100,Lipophilicity in octanol-water,,,,,Autocuration,,,,13582,,,22224,6480,
,U,P,CHEMBL622143,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13583,,,22229,17606,
,U,P,CHEMBL622144,1,0,,BAO_0000100,Octanol-water partition coefficient was determined,,,,,Autocuration,,,,13584,,,22229,6863,
,U,A,CHEMBL877473,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,13585,,,22224,1356,
,U,P,CHEMBL622145,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13586,,,22229,3326,
,U,A,CHEMBL622146,1,0,,BAO_0000019,Partition coefficient was determined; ND means not determined,,,,,Autocuration,,,,13587,,,22224,1356,
,U,P,CHEMBL622147,1,0,,BAO_0000100,Calculated partition coefficient (clogP),,,,,Autocuration,,,,13588,,,22229,12984,
,U,A,CHEMBL622148,1,0,,BAO_0000019,Partition coefficient of the compound,,,,,Autocuration,,,,13589,,,22224,17363,
,U,A,CHEMBL883124,1,0,,BAO_0000019,Permeability was determined,,,,,Autocuration,,,,13590,,,22224,6827,
,U,P,CHEMBL622149,1,0,,BAO_0000100,The compound was evaluated for the partition coefficient,,,,,Autocuration,,,,13591,,,22229,261,
,U,A,CHEMBL622150,1,0,,BAO_0000019,Partition coefficient (logP),,,,,Autocuration,,,,13592,,,22224,2685,
,U,P,CHEMBL622151,1,0,,BAO_0000100,The lipophilicity was reported,,,,,Autocuration,,,,13593,,,22224,414,
,U,P,CHEMBL622152,1,0,,BAO_0000100,logarithm of the octanol-water partition coefficient for the compound,,,,,Autocuration,,,,13594,,,22229,15769,
,U,A,CHEMBL622153,1,0,,BAO_0000019,Clogp value was determined,,,,,Autocuration,,,,13595,,,22224,17248,
,U,A,CHEMBL877474,1,0,,BAO_0000218,Clp at a dose of 1.5 mg/kg,,,,,Autocuration,,,In vivo,13596,,,22224,16935,
,U,A,CHEMBL622154,1,0,,BAO_0000218,Clp at a dose of 2.0 mg/kg,,,,,Autocuration,,,In vivo,13597,,,22224,16935,
,U,A,CHEMBL622155,1,0,Plasma,BAO_0000218,"Clp, plasma clearance at a dose of 10 mg/kg",,,,,Autocuration,,,In vivo,13598,1969.0,,22224,14832,
,U,A,CHEMBL622156,1,0,Plasma,BAO_0000218,"Clp, plasma clearance at a dose of 50 mg/kg",,,,,Autocuration,,,In vivo,13599,1969.0,,22224,14832,
,N,A,CHEMBL622157,1,1,Plasma,BAO_0000218,Compound was tested for plasma clearance in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13600,1969.0,10116.0,50597,2399,
,N,A,CHEMBL622158,1,1,Plasma,BAO_0000218,Compound was tested for plasma clearance in rat; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,13601,1969.0,10116.0,50597,2399,
,N,A,CHEMBL622807,1,1,,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,In vivo,13602,,10116.0,50597,6227,
,N,A,CHEMBL622808,1,1,,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Macaca mulatta,,,,Intermediate,,,In vivo,13603,,9544.0,50797,6227,
,U,A,CHEMBL622809,1,0,,BAO_0000218,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,,,Autocuration,,,In vivo,13604,,,22224,5623,
,U,A,CHEMBL622810,1,0,,BAO_0000218,Plasma clearance determined,,,,,Autocuration,,,In vivo,13605,,,22224,4854,
,N,A,CHEMBL876653,1,1,,BAO_0000218,Plasma clearance after iv administration at 3 mg/kg in hamster,Cricetinae,,,,Intermediate,,,In vivo,13606,,10026.0,100712,4493,
,N,A,CHEMBL622811,1,1,,BAO_0000218,Plasma clearance after iv administration at 4 mg/kg in hamster,Cricetinae,,,,Intermediate,,,In vivo,13607,,10026.0,100712,4493,
,N,A,CHEMBL622986,1,1,,BAO_0000218,Rate of clearance in rat was determined,Rattus norvegicus,,,,Intermediate,,,In vivo,13608,,10116.0,50597,14956,
,N,A,CHEMBL622987,1,1,Plasma,BAO_0000218,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13609,1969.0,10116.0,50597,15372,
,N,A,CHEMBL622988,1,1,Plasma,BAO_0000218,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13610,1969.0,10116.0,50597,15372,
,N,A,CHEMBL622989,1,1,Plasma,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13611,1969.0,10116.0,50597,15372,
,N,A,CHEMBL622990,1,1,Plasma,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13612,1969.0,10116.0,50597,15372,
,U,A,CHEMBL622991,1,0,Plasma,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,,,,Autocuration,,,In vivo,13613,1969.0,314293.0,22224,15604,
,N,A,CHEMBL622227,1,1,Plasma,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13614,1969.0,10116.0,50597,15604,
,N,A,CHEMBL622228,1,1,Plasma,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13615,1969.0,9615.0,50588,15604,
,N,A,CHEMBL622229,1,1,,BAO_0000218,Clpl value in rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13616,,10116.0,50597,14964,
,N,A,CHEMBL622230,1,1,,BAO_0000218,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,,Intermediate,,,In vivo,13617,,10141.0,50512,15240,
,N,A,CHEMBL622231,1,1,,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Rattus norvegicus,,,,Intermediate,,,In vivo,13618,,10116.0,50597,16449,
,N,A,CHEMBL622232,1,1,,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Macaca fascicularis,,,,Intermediate,,,In vivo,13619,,9541.0,100710,16449,
,U,A,CHEMBL622233,1,0,,BAO_0000218,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13620,,,22224,12902,
,U,A,CHEMBL622234,1,0,,BAO_0000218,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13621,,,22224,12902,
,U,A,CHEMBL622235,1,0,,BAO_0000218,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13622,,,22224,12902,
,U,A,CHEMBL622236,1,0,,BAO_0000218,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13623,,,22224,12902,
,U,A,CHEMBL622237,1,0,,BAO_0000218,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13624,,,22224,12902,
,U,A,CHEMBL877482,1,0,,BAO_0000218,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13625,,,22224,12902,
,U,A,CHEMBL622238,1,0,,BAO_0000218,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13626,,,22224,12902,
,U,A,CHEMBL622239,1,0,,BAO_0000218,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,,,Autocuration,,,In vivo,13627,,,22224,12902,
,U,A,CHEMBL622240,1,0,Blood,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood,,,,,Autocuration,,,In vivo,13628,178.0,,22224,11149,
,U,A,CHEMBL622241,1,0,Blood,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,,,Autocuration,,,In vivo,13629,178.0,,22224,11149,
,N,A,CHEMBL631013,1,1,,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13630,,10116.0,50597,5669,
,N,A,CHEMBL631014,1,1,,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,,Intermediate,,,In vivo,13631,,9544.0,50797,5669,
,N,A,CHEMBL631015,1,1,,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in dog,Canis lupus familiaris,,,,Intermediate,,,In vivo,13632,,9615.0,50588,5669,
,N,A,CHEMBL631016,1,1,,BAO_0000218,Cmax was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13633,,10116.0,50597,5669,
,N,A,CHEMBL631017,1,1,,BAO_0000218,Cmax was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13634,,10116.0,50597,5669,
,N,A,CHEMBL631018,1,1,,BAO_0000218,Cmax was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,,,,Intermediate,,,In vivo,13635,,10116.0,50597,5669,
,U,A,CHEMBL631019,1,0,,BAO_0000218,Cmax was determined,,,,,Autocuration,,,In vivo,13636,,,22224,4236,
,N,A,CHEMBL875761,1,1,Brain,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Mus musculus,,,,Intermediate,,,,13637,955.0,10090.0,50594,13792,
,N,A,CHEMBL631020,1,1,Brain,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Mus musculus,,,,Intermediate,,,,13638,955.0,10090.0,50594,13792,
,N,A,CHEMBL631669,1,1,Brain,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Mus musculus,,,,Intermediate,,,,13639,955.0,10090.0,50594,13792,
,N,A,CHEMBL631670,1,1,Brain,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Mus musculus,,,,Intermediate,,,,13640,955.0,10090.0,50594,13792,
,N,A,CHEMBL631671,1,1,Striatum,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Mus musculus,,,,Intermediate,,,,13641,2435.0,10090.0,50594,13792,
,N,A,CHEMBL631672,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Rattus norvegicus,,,,Intermediate,,,,13642,178.0,10116.0,50597,8418,
,N,A,CHEMBL631673,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Rattus norvegicus,,,,Intermediate,,,,13643,178.0,10116.0,50597,8418,
,N,A,CHEMBL631856,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Rattus norvegicus,,,,Intermediate,,,,13644,178.0,10116.0,50597,8418,
,N,A,CHEMBL631857,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Rattus norvegicus,,,,Intermediate,,,,13645,178.0,10116.0,50597,8418,
,N,A,CHEMBL631858,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Rattus norvegicus,,,,Intermediate,,,,13646,178.0,10116.0,50597,8418,
,N,A,CHEMBL631859,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Rattus norvegicus,,,,Intermediate,,,,13647,178.0,10116.0,50597,8418,
,N,A,CHEMBL631860,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Rattus norvegicus,,,,Intermediate,,,,13648,178.0,10116.0,50597,8418,
,N,A,CHEMBL631861,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Rattus norvegicus,,,,Intermediate,,,,13649,178.0,10116.0,50597,8418,
,N,A,CHEMBL631862,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Rattus norvegicus,,,,Intermediate,,,,13650,178.0,10116.0,50597,8418,
,N,A,CHEMBL631863,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Rattus norvegicus,,,,Intermediate,,,,13651,178.0,10116.0,50597,8418,
,N,A,CHEMBL631864,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Rattus norvegicus,,,,Intermediate,,,,13652,178.0,10116.0,50597,8418,
,N,A,CHEMBL631865,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Rattus norvegicus,,,,Intermediate,,,,13653,178.0,10116.0,50597,8418,
,N,A,CHEMBL631866,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Rattus norvegicus,,,,Intermediate,,,,13654,178.0,10116.0,50597,8418,
,N,A,CHEMBL629360,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Rattus norvegicus,,,,Intermediate,,,,13655,178.0,10116.0,50597,8418,
,N,A,CHEMBL629361,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,,,,Intermediate,,,,13656,178.0,10116.0,50597,8418,
,N,A,CHEMBL629362,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Rattus norvegicus,,,,Intermediate,,,,13657,178.0,10116.0,50597,8418,
,N,A,CHEMBL630740,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Rattus norvegicus,,,,Intermediate,,,,13658,178.0,10116.0,50597,8418,
,N,A,CHEMBL630741,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Rattus norvegicus,,,,Intermediate,,,,13659,178.0,10116.0,50597,8418,
,N,A,CHEMBL630742,1,1,Blood,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Rattus norvegicus,,,,Intermediate,,,,13660,178.0,10116.0,50597,8418,
,N,A,CHEMBL630743,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Rattus norvegicus,,,,Intermediate,,,,13661,,10116.0,50597,8418,
,N,A,CHEMBL630744,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Rattus norvegicus,,,,Intermediate,,,,13662,,10116.0,50597,8418,
,N,A,CHEMBL630745,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Rattus norvegicus,,,,Intermediate,,,,13663,,10116.0,50597,8418,
,N,A,CHEMBL630746,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,,Intermediate,,,,13664,,10116.0,50597,8418,
,N,A,CHEMBL630747,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Rattus norvegicus,,,,Intermediate,,,,13665,,10116.0,50597,8418,
,N,A,CHEMBL630748,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Rattus norvegicus,,,,Intermediate,,,,13666,,10116.0,50597,8418,
,N,A,CHEMBL632056,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Rattus norvegicus,,,,Intermediate,,,,13667,,10116.0,50597,8418,
,N,A,CHEMBL632057,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,,Intermediate,,,,13668,,10116.0,50597,8418,
,N,A,CHEMBL632058,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Rattus norvegicus,,,,Intermediate,,,,13669,,10116.0,50597,8418,
,N,A,CHEMBL632059,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,,,,Intermediate,,,,13670,,10116.0,50597,8418,
,N,A,CHEMBL632060,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Rattus norvegicus,,,,Intermediate,,,,13671,,10116.0,50597,8418,
,N,A,CHEMBL632061,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,,,,Intermediate,,,,13672,,10116.0,50597,8418,
,N,A,CHEMBL629207,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Rattus norvegicus,,,,Intermediate,,,,13673,,10116.0,50597,8418,
,N,A,CHEMBL629208,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Rattus norvegicus,,,,Intermediate,,,,13674,,10116.0,50597,8418,
,N,A,CHEMBL629209,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Rattus norvegicus,,,,Intermediate,,,,13675,,10116.0,50597,8418,
,N,A,CHEMBL629210,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Rattus norvegicus,,,,Intermediate,,,,13676,,10116.0,50597,8418,
,N,A,CHEMBL629211,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,,,,Intermediate,,,,13677,,10116.0,50597,8418,
,N,A,CHEMBL629212,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,,Intermediate,,,,13678,,10116.0,50597,8418,
,N,A,CHEMBL629213,1,1,,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Rattus norvegicus,,,,Intermediate,,,,13679,,10116.0,50597,8418,
,N,A,CHEMBL629214,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13680,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629215,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13681,1088.0,10116.0,50597,8133,
,N,A,CHEMBL635154,1,1,Urine,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Rattus norvegicus,,,,Intermediate,,,,13682,1088.0,10116.0,50597,8133,
,N,A,CHEMBL629216,1,1,,BAO_0000218,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13683,,10116.0,50597,6996,
,N,A,CHEMBL629217,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,13684,,10116.0,50597,6996,
,N,A,CHEMBL629218,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13685,,10116.0,50597,6996,
,N,A,CHEMBL629219,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13686,,10116.0,50597,6996,
,N,A,CHEMBL629220,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,13687,,10116.0,50597,6996,
,N,A,CHEMBL629221,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,13688,,10116.0,50597,6996,
,N,A,CHEMBL631127,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13689,,10116.0,50597,6996,
,N,A,CHEMBL631128,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,13690,,10116.0,50597,6996,
,N,A,CHEMBL631129,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13691,,10116.0,50597,6996,
,N,A,CHEMBL631130,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13692,,10116.0,50597,6996,
,N,A,CHEMBL631131,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,13693,,10116.0,50597,6996,
,N,A,CHEMBL631132,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,13694,,10116.0,50597,6996,
,N,A,CHEMBL631133,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13695,,10116.0,50597,6996,
,N,A,CHEMBL631134,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,13696,,10116.0,50597,6996,
,N,A,CHEMBL875120,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13697,,10116.0,50597,6996,
,N,A,CHEMBL631135,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13698,,10116.0,50597,6996,
,N,A,CHEMBL631136,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,13699,,10116.0,50597,6996,
,N,A,CHEMBL631137,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,13700,,10116.0,50597,6996,
,N,A,CHEMBL631138,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13701,,10116.0,50597,6996,
,N,A,CHEMBL631139,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,,Intermediate,,,,13702,,10116.0,50597,6996,
,N,A,CHEMBL631140,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13703,,10116.0,50597,6996,
,N,A,CHEMBL631141,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13704,,10116.0,50597,6996,
,N,A,CHEMBL631142,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,,Intermediate,,,,13705,,10116.0,50597,6996,
,N,A,CHEMBL631143,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,,Intermediate,,,,13706,,10116.0,50597,6996,
,N,A,CHEMBL631144,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,,Intermediate,,,,13707,,10116.0,50597,6996,
,N,A,CHEMBL631145,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,13708,,9615.0,50588,6996,
,N,A,CHEMBL631146,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13709,,9615.0,50588,6996,
,N,A,CHEMBL631147,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,13710,,9615.0,50588,6996,
,N,A,CHEMBL631148,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13711,,9615.0,50588,6996,
,N,A,CHEMBL631149,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13712,,9615.0,50588,6996,
,N,A,CHEMBL631150,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13713,,9615.0,50588,6996,
,N,A,CHEMBL631151,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13714,,9615.0,50588,6996,
,N,A,CHEMBL631152,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13715,,9615.0,50588,6996,
,N,A,CHEMBL631443,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13716,,9615.0,50588,6996,
,N,A,CHEMBL631444,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13717,,9615.0,50588,6996,
,N,A,CHEMBL631445,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,13718,,9615.0,50588,6996,
,N,A,CHEMBL631446,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,,Intermediate,,,,13719,,9615.0,50588,6996,
,N,A,CHEMBL631447,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13720,,9615.0,50588,6996,
,N,A,CHEMBL631448,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13721,,9615.0,50588,6996,
,N,A,CHEMBL631449,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,,Intermediate,,,,13722,,9615.0,50588,6996,
,N,A,CHEMBL631450,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,,Intermediate,,,,13723,,9615.0,50588,6996,
,N,A,CHEMBL629724,1,1,,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,,Intermediate,,,,13724,,9615.0,50588,6996,
,N,A,CHEMBL629725,1,1,Zone of skin,BAO_0000218,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13725,14.0,10090.0,50594,9716,
,N,A,CHEMBL629726,1,1,Zone of skin,BAO_0000218,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13726,14.0,10090.0,50594,9716,
,N,A,CHEMBL629727,1,1,Spleen,BAO_0000218,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13727,2106.0,10090.0,50594,9716,
,N,A,CHEMBL630404,1,1,Spleen,BAO_0000218,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13728,2106.0,10090.0,50594,9716,
,N,A,CHEMBL630405,1,1,Spleen,BAO_0000218,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13729,2106.0,10090.0,50594,9716,
,N,A,CHEMBL630406,1,1,Spleen,BAO_0000218,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13730,2106.0,10090.0,50594,9716,
,N,A,CHEMBL630407,1,1,Stomach,BAO_0000218,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13731,945.0,10090.0,50594,9716,
,N,A,CHEMBL630573,1,1,Stomach,BAO_0000218,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13732,945.0,10090.0,50594,9716,
,N,A,CHEMBL630574,1,1,Stomach,BAO_0000218,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13733,945.0,10090.0,50594,9716,
,N,A,CHEMBL630575,1,1,Stomach,BAO_0000218,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13734,945.0,10090.0,50594,9716,
,N,A,CHEMBL630576,1,1,,BAO_0000218,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13735,,10090.0,50594,9716,
,N,A,CHEMBL630577,1,1,,BAO_0000218,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13736,,10090.0,50594,9716,
,N,A,CHEMBL630578,1,1,,BAO_0000218,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13737,,10090.0,50594,9716,
,N,A,CHEMBL630579,1,1,,BAO_0000218,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,,Intermediate,,,In vivo,13738,,10090.0,50594,9716,
,N,A,CHEMBL630580,1,1,Kidney,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13739,2113.0,10090.0,50594,12192,
,N,A,CHEMBL630581,1,1,Kidney,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Mus musculus,,,,Intermediate,,,,13740,2113.0,10090.0,50594,12192,
,N,A,CHEMBL630582,1,1,Kidney,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13741,2113.0,10090.0,50594,12192,
,N,A,CHEMBL630583,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Mus musculus,,,,Intermediate,,,,13742,,10090.0,50594,12192,
,N,A,CHEMBL630584,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13743,,10090.0,50594,12192,
,N,A,CHEMBL630585,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Mus musculus,,,,Intermediate,,,,13744,,10090.0,50594,12192,
,N,A,CHEMBL630586,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13745,,10090.0,50594,12192,
,N,A,CHEMBL630587,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Mus musculus,,,,Intermediate,,,,13746,,10090.0,50594,12192,
,N,A,CHEMBL630588,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13747,,10090.0,50594,12192,
,N,A,CHEMBL630589,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Mus musculus,,,,Intermediate,,,,13748,,10090.0,50594,12192,
,N,A,CHEMBL630590,1,1,,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Mus musculus,,,,Intermediate,,,,13749,,10090.0,50594,12192,
,U,A,CHEMBL630591,1,0,Feces,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 h,,,,,Autocuration,,,,13750,1988.0,,22224,12192,
,U,A,CHEMBL630592,1,0,Feces,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,,,Autocuration,,,,13751,1988.0,,22224,12192,
,U,A,CHEMBL630593,1,0,,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,,,Autocuration,,,,13752,,,22224,12192,
,U,A,CHEMBL630594,1,0,,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,,,Autocuration,,,,13753,,,22224,12192,
,U,A,CHEMBL630595,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,,,Autocuration,,,,13754,1088.0,,22224,12192,
,U,A,CHEMBL630596,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,,,Autocuration,,,,13755,1088.0,,22224,12192,
,U,A,CHEMBL630597,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,,,Autocuration,,,,13756,1088.0,,22224,12192,
,U,A,CHEMBL630598,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,,,Autocuration,,,,13757,1088.0,,22224,12192,
,U,A,CHEMBL630599,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,,,Autocuration,,,,13758,1088.0,,22224,12192,
,U,A,CHEMBL630600,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,,,Autocuration,,,,13759,1088.0,,22224,12192,
,U,A,CHEMBL630601,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,,,Autocuration,,,,13760,1088.0,,22224,12192,
,U,A,CHEMBL630602,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,,,Autocuration,,,,13761,1088.0,,22224,12192,
,U,A,CHEMBL630603,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,,,Autocuration,,,,13762,1088.0,,22224,12192,
,U,A,CHEMBL630604,1,0,Urine,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,,,Autocuration,,,,13763,1088.0,,22224,12192,
,N,A,CHEMBL624869,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13764,178.0,10116.0,50597,12017,
,N,A,CHEMBL624870,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13765,178.0,10116.0,50597,12017,
,N,A,CHEMBL623189,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13766,178.0,10116.0,50597,12017,
,N,A,CHEMBL623190,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13767,178.0,10116.0,50597,12017,
,N,A,CHEMBL623191,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13768,178.0,10116.0,50597,12017,
,N,A,CHEMBL623192,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13769,,10116.0,50597,12017,
,N,A,CHEMBL623193,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13770,,10116.0,50597,12017,
,N,A,CHEMBL623194,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13771,,10116.0,50597,12017,
,N,A,CHEMBL623195,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13772,,10116.0,50597,12017,
,N,A,CHEMBL623196,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13773,,10116.0,50597,12017,
,N,A,CHEMBL623197,1,1,,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,,,,Intermediate,,,,13774,,10116.0,50597,11836,
,N,A,CHEMBL623198,1,1,,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13775,,10116.0,50597,11836,
,N,A,CHEMBL623199,1,1,,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,,,Intermediate,,,,13776,,10116.0,50597,11836,
,N,A,CHEMBL623200,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13777,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623201,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13778,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623202,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13779,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623203,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13780,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623204,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13781,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623205,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,,,Intermediate,,,,13782,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623206,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13783,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623207,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,,,,Intermediate,,,,13784,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623208,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,,,Intermediate,,,,13785,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623209,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13786,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623210,1,1,Muscle tissue,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,,,Intermediate,,,,13787,2385.0,10116.0,50597,11836,
,N,A,CHEMBL623211,1,1,,BAO_0000218,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13788,,10116.0,50597,11836,
,N,A,CHEMBL623212,1,1,Uterus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,,Intermediate,,,,13789,995.0,10116.0,50597,11836,
,U,A,CHEMBL623213,1,0,,BAO_0000019,Tested in vitro for intrinsic activity relative to quinpirole,,,,,Autocuration,,,,13790,,,22224,12640,
,U,A,CHEMBL623214,1,0,,BAO_0000019,"Relative ion enhancement, determined in pulsed ultrafiltration",,,,,Autocuration,,,,13791,,,22224,14218,
,U,A,CHEMBL623215,1,0,,BAO_0000019,% ionization at the pH 7.4 at 37 degree Centigrade,,,,,Autocuration,,,,13792,,,22224,11296,
,U,A,CHEMBL623216,1,0,,BAO_0000019,Percentage ionization was measured,,,,,Autocuration,,,,13793,,,22224,10929,
,N,A,CHEMBL623217,1,1,,BAO_0000218,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Bos taurus,,,,Intermediate,,,,13794,,9913.0,50591,13841,
,U,A,CHEMBL623218,1,0,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,,,Autocuration,,,,13795,,,22224,10431,
,U,A,CHEMBL623913,1,0,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,,,Autocuration,,,,13796,,,22224,10431,
,U,A,CHEMBL623914,1,0,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,,,Autocuration,,,,13797,,,22224,10431,
,U,P,CHEMBL623915,1,0,,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water,,,,,Autocuration,,,,13798,,,22229,8826,
,U,P,CHEMBL624080,1,0,,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,,,Autocuration,,,,13799,,,22229,8826,
,U,A,CHEMBL624081,1,0,,BAO_0000019,Equilibrium constant measured by the pulse radiolysis at pH 7,,,,,Autocuration,,,,13800,,,22224,9884,
,N,A,CHEMBL624082,1,1,,BAO_0000218,In vitro hydrolytic rate constant determined in human blood,Homo sapiens,,,,Intermediate,,,,13801,,9606.0,50587,9827,
,N,A,CHEMBL625054,1,1,,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Homo sapiens,,,,Intermediate,,,,13802,,9606.0,50587,10009,
,U,A,CHEMBL877485,1,0,,BAO_0000019,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,,,Autocuration,,,,13803,,,22224,10009,
,N,A,CHEMBL625055,1,1,,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Mus musculus,,,,Intermediate,,,,13804,,10090.0,50594,10009,
,N,A,CHEMBL625056,1,1,,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Mus musculus,,,,Intermediate,,,,13805,,10090.0,50594,10009,
,N,A,CHEMBL625057,1,1,,BAO_0000218,In vitro oxidation of compound in presence of human plasma,Homo sapiens,,,,Intermediate,,,,13806,,9606.0,50587,10009,
,U,A,CHEMBL625058,1,0,,BAO_0000019,In vitro oxidation of compound in presence of hydrogen peroxide,,,,,Autocuration,,,,13807,,,22224,10009,
,N,A,CHEMBL625059,1,1,,BAO_0000218,In vitro oxidation of compound in presence of mouse brain homogenate,Mus musculus,,,,Intermediate,,,,13808,,10090.0,50594,10009,
,N,A,CHEMBL629536,1,1,,BAO_0000218,In vitro oxidation of compound in presence of mouse liver homogenate,Mus musculus,,,,Intermediate,,,,13809,,10090.0,50594,10009,
,N,A,CHEMBL629537,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13810,,10116.0,50597,11510,
,N,A,CHEMBL629538,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13811,,10116.0,50597,11510,
,N,A,CHEMBL629539,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13812,,10116.0,50597,11510,
,N,A,CHEMBL874445,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13813,,10116.0,50597,11510,
,N,A,CHEMBL629540,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13814,,10116.0,50597,11510,
,N,A,CHEMBL629541,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13815,,10116.0,50597,11510,
,N,A,CHEMBL629542,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13816,,10116.0,50597,11510,
,N,A,CHEMBL630243,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,,Intermediate,,,,13817,,10116.0,50597,11510,
,N,A,CHEMBL630244,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13818,,10116.0,50597,11510,
,N,A,CHEMBL630245,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13819,,10116.0,50597,11510,
,N,A,CHEMBL630246,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13820,,10116.0,50597,11510,
,N,A,CHEMBL630247,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13821,,10116.0,50597,11510,
,N,A,CHEMBL630248,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13822,,10116.0,50597,11510,
,N,A,CHEMBL630249,1,1,Blood,BAO_0000218,Biodistribution in rat blood at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13823,178.0,10116.0,50597,13100,
,N,A,CHEMBL630250,1,1,Blood,BAO_0000218,Biodistribution in rat blood at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13824,178.0,10116.0,50597,13100,
,N,A,CHEMBL630251,1,1,Blood,BAO_0000218,Biodistribution in rat blood at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13825,178.0,10116.0,50597,13100,
,N,A,CHEMBL630252,1,1,Blood,BAO_0000218,Biodistribution in rat blood at 3 hr after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13826,178.0,10116.0,50597,13100,
,N,A,CHEMBL630408,1,1,Blood,BAO_0000218,Biodistribution in rat blood at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13827,178.0,10116.0,50597,13100,
,N,A,CHEMBL630409,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13828,2037.0,10116.0,50597,13100,
,N,A,CHEMBL874446,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13829,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630410,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13830,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630411,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13831,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630412,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13832,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630413,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13833,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630414,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 3 hr after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13834,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630415,1,1,Cerebellum,BAO_0000218,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13835,2037.0,10116.0,50597,13100,
,N,A,CHEMBL630416,1,1,,BAO_0000218,Biodistribution in rat cortex at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13836,,10116.0,50597,13100,
,N,A,CHEMBL630417,1,1,,BAO_0000218,Biodistribution in rat cortex at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13837,,10116.0,50597,13100,
,N,A,CHEMBL630418,1,1,,BAO_0000218,Biodistribution in rat cortex at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13838,,10116.0,50597,13100,
,N,A,CHEMBL630419,1,1,,BAO_0000218,Biodistribution in rat cortex at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13839,,10116.0,50597,13100,
,N,A,CHEMBL630420,1,1,,BAO_0000218,Biodistribution in rat cortex at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13840,,10116.0,50597,13100,
,N,A,CHEMBL630421,1,1,,BAO_0000218,Biodistribution in rat cortex at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13841,,10116.0,50597,13100,
,N,A,CHEMBL630422,1,1,,BAO_0000218,Biodistribution in rat cortex at 3 hr after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13842,,10116.0,50597,13100,
,N,A,CHEMBL630423,1,1,,BAO_0000218,Biodistribution in rat cortex at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13843,,10116.0,50597,13100,
,N,A,CHEMBL630424,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13844,948.0,10116.0,50597,13100,
,N,A,CHEMBL630425,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13845,948.0,10116.0,50597,13100,
,N,A,CHEMBL629462,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13846,948.0,10116.0,50597,13100,
,N,A,CHEMBL630426,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13847,948.0,10116.0,50597,13100,
,N,A,CHEMBL630427,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13848,948.0,10116.0,50597,13100,
,N,A,CHEMBL625877,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 3 hr after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13849,948.0,10116.0,50597,13100,
,N,A,CHEMBL625878,1,1,Heart,BAO_0000218,Biodistribution in rat heart at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13850,948.0,10116.0,50597,13100,
,N,A,CHEMBL625879,1,1,Hippocampus,BAO_0000218,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13851,10000000.0,10116.0,50597,13100,
,N,A,CHEMBL625880,1,1,Hippocampus,BAO_0000218,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13852,10000000.0,10116.0,50597,13100,
,N,A,CHEMBL625881,1,1,Hippocampus,BAO_0000218,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13853,10000000.0,10116.0,50597,13100,
,N,A,CHEMBL625882,1,1,Hippocampus,BAO_0000218,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13854,10000000.0,10116.0,50597,13100,
,N,A,CHEMBL625883,1,1,Hippocampus,BAO_0000218,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13855,10000000.0,10116.0,50597,13100,
,N,A,CHEMBL625884,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13856,2113.0,10116.0,50597,13100,
,N,A,CHEMBL625885,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13857,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628649,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13858,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628650,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13859,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628651,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13860,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628652,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13861,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628653,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13862,2113.0,10116.0,50597,13100,
,N,A,CHEMBL628654,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13863,2107.0,10116.0,50597,13100,
,N,A,CHEMBL628655,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13864,2107.0,10116.0,50597,13100,
,N,A,CHEMBL625238,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13865,2107.0,10116.0,50597,13100,
,N,A,CHEMBL625239,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13866,2107.0,10116.0,50597,13100,
,N,A,CHEMBL625240,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13867,2107.0,10116.0,50597,13100,
,N,A,CHEMBL625241,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13868,2107.0,10116.0,50597,13100,
,N,A,CHEMBL625242,1,1,Liver,BAO_0000218,Biodistribution in rat liver at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13869,2107.0,10116.0,50597,13100,
,N,A,CHEMBL874587,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13870,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625405,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13871,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625406,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13872,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625407,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13873,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625408,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13874,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625409,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,13875,2048.0,10116.0,50597,13100,
,N,A,CHEMBL625410,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Rattus norvegicus,,,,Intermediate,,,,13876,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625411,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Rattus norvegicus,,,,Intermediate,,,,13877,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625412,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Rattus norvegicus,,,,Intermediate,,,,13878,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625413,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Rattus norvegicus,,,,Intermediate,,,,13879,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625414,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Rattus norvegicus,,,,Intermediate,,,,13880,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625415,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,,,,Intermediate,,,,13881,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625416,1,1,Thoracic aorta,BAO_0000218,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,,,,Intermediate,,,,13882,1515.0,10116.0,50597,12361,
,N,A,CHEMBL625417,1,1,Urine,BAO_0000218,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Rattus norvegicus,,,,Intermediate,,,,13883,1088.0,10116.0,50597,12712,
,N,A,CHEMBL625418,1,1,Feces,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Rattus norvegicus,,,,Intermediate,,,,13884,1988.0,10116.0,50597,7415,
,N,A,CHEMBL625419,1,1,Urine,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Rattus norvegicus,,,,Intermediate,,,,13885,1088.0,10116.0,50597,7415,
,N,A,CHEMBL625420,1,1,,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Rattus norvegicus,,,,Intermediate,,,,13886,,10116.0,50597,7415,
,N,A,CHEMBL626996,1,1,,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Rattus norvegicus,,,,Intermediate,,,,13887,,10116.0,50597,7415,
,N,A,CHEMBL626997,1,1,Feces,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Rattus norvegicus,,,,Intermediate,,,,13888,1988.0,10116.0,50597,7415,
,N,A,CHEMBL626998,1,1,Urine,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Rattus norvegicus,,,,Intermediate,,,,13889,1088.0,10116.0,50597,7415,
,N,A,CHEMBL626999,1,1,,BAO_0000218,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Rattus norvegicus,,,,Intermediate,,,,13890,,10116.0,50597,7415,
,N,A,CHEMBL627000,1,1,,BAO_0000218,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Mus musculus,,,,Intermediate,,,,13891,,10090.0,50594,8050,
,N,A,CHEMBL627001,1,1,,BAO_0000218,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Mus musculus,,,,Intermediate,,,,13892,,10090.0,50594,8050,
,N,A,CHEMBL627002,1,1,,BAO_0000218,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Mus musculus,,,,Intermediate,,,,13893,,10090.0,50594,8050,
,N,A,CHEMBL627003,1,1,,BAO_0000218,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Mus musculus,,,,Intermediate,,,,13894,,10090.0,50594,8050,
,N,A,CHEMBL627004,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Mus musculus,,,,Intermediate,,,,13895,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627005,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Mus musculus,,,,Intermediate,,,,13896,1088.0,10090.0,50594,8050,
,N,A,CHEMBL874594,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Mus musculus,,,,Intermediate,,,,13897,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627006,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Mus musculus,,,,Intermediate,,,,13898,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627007,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Mus musculus,,,,Intermediate,,,,13899,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627884,1,1,Urine,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Mus musculus,,,,Intermediate,,,,13900,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627885,1,1,Urine,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Mus musculus,,,,Intermediate,,,,13901,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627886,1,1,Urine,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Mus musculus,,,,Intermediate,,,,13902,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627887,1,1,Urine,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Mus musculus,,,,Intermediate,,,,13903,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627888,1,1,Urine,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Mus musculus,,,,Intermediate,,,,13904,1088.0,10090.0,50594,8050,
,N,A,CHEMBL628057,1,1,Urine,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Mus musculus,,,,Intermediate,,,,13905,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627405,1,1,Urine,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Mus musculus,,,,Intermediate,,,,13906,1088.0,10090.0,50594,8050,
,N,A,CHEMBL627406,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13907,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627407,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13908,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627408,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13909,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627409,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13910,1088.0,9615.0,50588,12582,
,N,A,CHEMBL875486,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13911,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627410,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13912,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627411,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13913,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627412,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13914,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627413,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13915,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627414,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13916,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627415,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13917,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627416,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13918,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627417,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13919,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627418,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13920,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627419,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13921,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627320,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13922,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627321,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,13923,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627322,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13924,2113.0,10116.0,50597,12017,
,N,A,CHEMBL627323,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13925,2113.0,10116.0,50597,12017,
,N,A,CHEMBL627491,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13926,2113.0,10116.0,50597,12017,
,N,A,CHEMBL627492,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13927,2113.0,10116.0,50597,12017,
,N,A,CHEMBL627493,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13928,2113.0,10116.0,50597,12017,
,N,A,CHEMBL627494,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13929,2107.0,10116.0,50597,12017,
,N,A,CHEMBL627495,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13930,2107.0,10116.0,50597,12017,
,N,A,CHEMBL627496,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13931,2107.0,10116.0,50597,12017,
,N,A,CHEMBL627497,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13932,2107.0,10116.0,50597,12017,
,N,A,CHEMBL627498,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13933,2107.0,10116.0,50597,12017,
,N,A,CHEMBL627499,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13934,2048.0,10116.0,50597,12017,
,N,A,CHEMBL627500,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13935,2048.0,10116.0,50597,12017,
,N,A,CHEMBL627501,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13936,2048.0,10116.0,50597,12017,
,N,A,CHEMBL625616,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13937,2048.0,10116.0,50597,12017,
,N,A,CHEMBL625617,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13938,2048.0,10116.0,50597,12017,
,N,A,CHEMBL625618,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13939,2385.0,10116.0,50597,12017,
,N,A,CHEMBL625619,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13940,2385.0,10116.0,50597,12017,
,N,A,CHEMBL625620,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13941,2385.0,10116.0,50597,12017,
,N,A,CHEMBL625621,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13942,2385.0,10116.0,50597,12017,
,N,A,CHEMBL625622,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13943,2385.0,10116.0,50597,12017,
,N,A,CHEMBL625788,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13944,2106.0,10116.0,50597,12017,
,N,A,CHEMBL625789,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13945,2106.0,10116.0,50597,12017,
,N,A,CHEMBL625790,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13946,2106.0,10116.0,50597,12017,
,N,A,CHEMBL625791,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13947,2106.0,10116.0,50597,12017,
,N,A,CHEMBL622334,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13948,2106.0,10116.0,50597,12017,
,N,A,CHEMBL622335,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13949,2046.0,10116.0,50597,12017,
,N,A,CHEMBL622336,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13950,2046.0,10116.0,50597,12017,
,N,A,CHEMBL622337,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13951,2046.0,10116.0,50597,12017,
,N,A,CHEMBL622338,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13952,2046.0,10116.0,50597,12017,
,N,A,CHEMBL622339,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13953,2046.0,10116.0,50597,12017,
,N,A,CHEMBL624153,1,1,,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13954,,10116.0,50597,12017,
,N,A,CHEMBL628430,1,1,,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13955,,10116.0,50597,12017,
,N,A,CHEMBL628431,1,1,,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,13956,,10116.0,50597,12017,
,N,A,CHEMBL628432,1,1,,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13957,,10116.0,50597,12017,
,N,A,CHEMBL628433,1,1,,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,13958,,10116.0,50597,12017,
,N,A,CHEMBL628434,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,13959,2106.0,10116.0,50597,12017,
,N,A,CHEMBL626789,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,13960,2106.0,10116.0,50597,12017,
,N,A,CHEMBL626790,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Rattus norvegicus,,,,Intermediate,,,In vivo,13961,2106.0,10116.0,50597,12017,
,N,A,CHEMBL626791,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,13962,2106.0,10116.0,50597,12017,
,N,A,CHEMBL626792,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,13963,2106.0,10116.0,50597,12017,
,N,A,CHEMBL626793,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,13964,2106.0,10116.0,50597,12017,
,N,A,CHEMBL627436,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13965,,10116.0,50597,11510,
,N,A,CHEMBL627437,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13966,,10116.0,50597,11510,
,N,A,CHEMBL627438,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13967,,10116.0,50597,11510,
,N,A,CHEMBL627439,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13968,,10116.0,50597,11510,
,N,A,CHEMBL627440,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13969,,10116.0,50597,11510,
,N,A,CHEMBL627602,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13970,,10116.0,50597,11510,
,N,A,CHEMBL627603,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13971,,10116.0,50597,11510,
,N,A,CHEMBL627604,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13972,,10116.0,50597,11510,
,N,A,CHEMBL627605,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13973,,10116.0,50597,11510,
,N,A,CHEMBL627606,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13974,,10116.0,50597,11510,
,N,A,CHEMBL627607,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13975,,10116.0,50597,11510,
,N,A,CHEMBL627608,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13976,,10116.0,50597,11510,
,N,A,CHEMBL627609,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13977,,10116.0,50597,11510,
,N,A,CHEMBL627610,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13978,,10116.0,50597,11510,
,N,A,CHEMBL627611,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13979,,10116.0,50597,11510,
,N,A,CHEMBL627612,1,1,,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,,Intermediate,,,,13980,,10116.0,50597,11510,
,U,P,CHEMBL627613,1,0,,BAO_0000100,Octanol:water partition coefficient is evaluated,,,,,Autocuration,,,,13981,,,22229,8362,
,U,P,CHEMBL627614,1,0,,BAO_0000100,Partition coefficient in 1-octanol/water system,,,,,Autocuration,,,,13982,,,22224,8257,
,U,P,CHEMBL627615,1,0,,BAO_0000100,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,,,Autocuration,,,,13983,,,22224,8257,
,U,P,CHEMBL627616,1,0,,BAO_0000100,Partition coefficient in octanol/water system was determined,,,,,Autocuration,,,,13984,,,22224,9468,
,U,P,CHEMBL627617,1,0,,BAO_0000100,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,,,Autocuration,,,,13985,,,22224,9468,
,U,A,CHEMBL627618,1,0,,BAO_0000019,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,,,Autocuration,,,,13986,,,22224,10568,
,U,A,CHEMBL627619,1,0,,BAO_0000019,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,,,Autocuration,,,,13987,,,22224,10568,
,U,A,CHEMBL627620,1,0,,BAO_0000019,Pseudo-first-order rate constant of the compound,,,,,Autocuration,,,,13988,,,22224,15359,
,U,A,CHEMBL627621,1,0,,BAO_0000019,Pseudo-first-order rate constant with 1-min time point,,,,,Autocuration,,,,13989,,,22224,15359,
,U,A,CHEMBL627622,1,0,,BAO_0000019,Pseudo-first-order rate constant without 1-min time point,,,,,Autocuration,,,,13990,,,22224,15359,
,U,A,CHEMBL627623,1,0,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,,,Autocuration,,,,13991,,,22224,10431,
,U,A,CHEMBL627624,1,0,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,,,Autocuration,,,,13992,,,22224,10431,
,U,A,CHEMBL627625,1,0,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,,,Autocuration,,,,13993,,,22224,10431,
,U,A,CHEMBL628523,1,0,,BAO_0000019,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,,,Autocuration,,,,13994,,,22224,15704,
,U,A,CHEMBL628524,1,0,,BAO_0000019,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,,,Autocuration,,,,13995,,,22224,15287,
,U,A,CHEMBL628525,1,0,,BAO_0000019,The efflux rate constant of the compound,,,,,Autocuration,,,,13996,,,22224,7516,
,U,A,CHEMBL625732,1,0,,BAO_0000019,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,Autocuration,,,,13997,,,22224,12973,
,U,A,CHEMBL625733,1,0,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,Autocuration,,,,13998,,,22224,12973,
,U,F,CHEMBL625734,1,0,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,Autocuration,,,,13999,,,22224,12973,
,U,A,CHEMBL625913,1,0,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,,,Autocuration,,,,14000,,,22224,12973,
,U,A,CHEMBL625914,1,0,,BAO_0000019,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,,,Autocuration,,,,14001,,,22224,8696,
,U,A,CHEMBL625915,1,0,,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,,,Autocuration,,,,14002,,,22224,15052,
,U,A,CHEMBL625916,1,0,,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,,,Autocuration,,,,14003,,,22224,15052,
,U,A,CHEMBL625917,1,0,,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,,,Autocuration,,,,14004,,,22224,10503,
,U,A,CHEMBL625918,1,0,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14005,,,22224,8354,
,U,A,CHEMBL625919,1,0,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14006,,,22224,8354,
,U,A,CHEMBL625920,1,0,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14007,,,22224,8354,
,U,A,CHEMBL874453,1,0,,BAO_0000019,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14008,,,22224,8354,
,U,A,CHEMBL625921,1,0,,BAO_0000019,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14009,,,22224,8354,
,U,A,CHEMBL625922,1,0,,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,,,Autocuration,,,,14010,,,22224,10503,
,U,A,CHEMBL625923,1,0,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14011,,,22224,8354,
,U,A,CHEMBL625924,1,0,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14012,,,22224,8354,
,U,A,CHEMBL625925,1,0,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14013,,,22224,8354,
,U,A,CHEMBL625926,1,0,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14014,,,22224,8354,
,N,A,CHEMBL627704,1,1,Lung,BAO_0000218,Biodistribution in rat lung at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14015,2048.0,10116.0,50597,13100,
,N,A,CHEMBL627705,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14016,,10116.0,50597,13100,
,N,A,CHEMBL627706,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14017,,10116.0,50597,13100,
,N,A,CHEMBL627707,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14018,,10116.0,50597,13100,
,N,A,CHEMBL627708,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14019,,10116.0,50597,13100,
,N,A,CHEMBL628361,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14020,,10116.0,50597,13100,
,N,A,CHEMBL628362,1,1,,BAO_0000218,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14021,,10116.0,50597,13100,
,N,A,CHEMBL628363,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14022,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628364,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14023,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628365,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14024,2435.0,10116.0,50597,13100,
,N,A,CHEMBL874454,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14025,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628531,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14026,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628532,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14027,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628533,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 3 hr after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14028,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628534,1,1,Striatum,BAO_0000218,Biodistribution in rat striatum at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14029,2435.0,10116.0,50597,13100,
,N,A,CHEMBL628535,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14030,2046.0,10116.0,50597,13100,
,N,A,CHEMBL628536,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14031,2046.0,10116.0,50597,13100,
,N,A,CHEMBL628537,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14032,2046.0,10116.0,50597,13100,
,N,A,CHEMBL628538,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14033,2046.0,10116.0,50597,13100,
,N,A,CHEMBL628539,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14034,2046.0,10116.0,50597,13100,
,N,A,CHEMBL630297,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14035,2046.0,10116.0,50597,13100,
,N,A,CHEMBL630298,1,1,Thyroid gland,BAO_0000218,Biodistribution in rat thyroid at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14036,2046.0,10116.0,50597,13100,
,N,A,CHEMBL630299,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14037,955.0,10116.0,50597,13100,
,N,A,CHEMBL628094,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14038,955.0,10116.0,50597,13100,
,N,A,CHEMBL628095,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14039,955.0,10116.0,50597,13100,
,N,A,CHEMBL874648,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14040,955.0,10116.0,50597,13100,
,N,A,CHEMBL628096,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14041,955.0,10116.0,50597,13100,
,N,A,CHEMBL628097,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14042,955.0,10116.0,50597,13100,
,N,A,CHEMBL628098,1,1,Brain,BAO_0000218,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Rattus norvegicus,,,,Intermediate,,,In vivo,14043,955.0,10116.0,50597,13100,
,U,A,CHEMBL628099,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,,,Autocuration,,,,14044,,,22224,13331,
,U,A,CHEMBL628100,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,,Autocuration,,,,14045,,,22224,13331,
,U,A,CHEMBL628101,1,0,,BAO_0000019,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,,,Autocuration,,,,14046,,,22224,13331,
,U,A,CHEMBL628102,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,,,Autocuration,,,,14047,,,22224,13331,
,U,A,CHEMBL628103,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,,,Autocuration,,,,14048,,,22224,13331,
,U,A,CHEMBL628104,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,,Autocuration,,,,14049,,,22224,13331,
,U,A,CHEMBL628105,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,,,Autocuration,,,,14050,,,22224,13331,
,U,A,CHEMBL628106,1,0,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,,,Autocuration,,,,14051,,,22224,13331,
,N,A,CHEMBL628107,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14052,1088.0,10116.0,50597,10086,
,U,F,CHEMBL628108,1,0,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,,,Autocuration,,,,14053,1088.0,,22224,10086,
,N,A,CHEMBL628109,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14054,1088.0,10116.0,50597,10086,
,U,F,CHEMBL625299,1,0,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,,,Autocuration,,,,14055,1088.0,,22224,10086,
,N,A,CHEMBL625300,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14056,1088.0,10116.0,50597,10086,
,N,A,CHEMBL625301,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14057,1088.0,10116.0,50597,10086,
,N,A,CHEMBL625302,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14058,1088.0,10116.0,50597,10086,
,N,A,CHEMBL874649,1,1,Urine,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Rattus norvegicus,,,,Intermediate,,,,14059,1088.0,10116.0,50597,10086,
,N,A,CHEMBL625303,1,1,,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Rattus norvegicus,,,,Intermediate,,,,14060,,10116.0,50597,13248,
,N,A,CHEMBL625463,1,1,,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Rattus norvegicus,,,,Intermediate,,,,14061,,10116.0,50597,13248,
,N,A,CHEMBL625464,1,1,Liver,BAO_0000218,In vitro metabolism in human liver microsomes,Homo sapiens,,,,Intermediate,,,,14062,2107.0,9606.0,50587,14527,
,N,A,CHEMBL625465,1,1,,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Homo sapiens,,,,Intermediate,,,,14063,,9606.0,50587,3008,
,N,A,CHEMBL625466,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14064,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625467,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14065,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625468,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14066,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625469,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14067,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625470,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14068,1088.0,10116.0,50597,12582,
,N,A,CHEMBL632418,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14069,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627250,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14070,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627251,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14071,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627252,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14072,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627253,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14073,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627254,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14074,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875471,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14075,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627255,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14076,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627256,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14077,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627257,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14078,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627258,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14079,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627259,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14080,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627260,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14081,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623256,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14082,1088.0,10116.0,50597,12582,
,N,A,CHEMBL874413,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14083,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623257,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14084,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623258,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14085,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623259,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14086,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623260,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14087,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623261,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14088,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623262,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14089,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623263,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14090,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623264,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14091,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623265,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14092,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623266,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14093,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623267,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14094,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623268,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14095,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623269,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14096,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623270,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14097,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623271,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14098,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623272,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14099,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623273,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14100,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623274,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14101,1088.0,10116.0,50597,12582,
,N,A,CHEMBL874414,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14102,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623275,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14103,1088.0,10116.0,50597,12582,
,N,A,CHEMBL629150,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14104,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623276,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14105,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623277,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14106,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623112,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14107,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623113,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14108,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623800,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14109,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623801,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14110,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623802,1,1,Spleen,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,,,Intermediate,,,In vivo,14111,2106.0,10116.0,50597,12017,
,N,A,CHEMBL623803,1,1,Uterus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14112,995.0,10116.0,50597,12017,
,N,A,CHEMBL623970,1,1,Uterus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14113,995.0,10116.0,50597,12017,
,N,A,CHEMBL623971,1,1,Uterus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14114,995.0,10116.0,50597,12017,
,N,A,CHEMBL623972,1,1,Blood,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14115,178.0,10116.0,50597,14045,
,N,A,CHEMBL623973,1,1,Blood,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14116,178.0,10116.0,50597,14045,
,N,A,CHEMBL623974,1,1,Blood,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14117,178.0,10116.0,50597,14045,
,N,A,CHEMBL623975,1,1,Blood,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14118,178.0,10116.0,50597,14045,
,N,A,CHEMBL623976,1,1,Brain,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14119,955.0,10116.0,50597,14045,
,N,A,CHEMBL623977,1,1,Brain,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14120,955.0,10116.0,50597,14045,
,N,A,CHEMBL623978,1,1,Brain,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14121,955.0,10116.0,50597,14045,
,N,A,CHEMBL623979,1,1,Brain,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14122,955.0,10116.0,50597,14045,
,N,A,CHEMBL623980,1,1,,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14123,,10116.0,50597,14045,
,N,A,CHEMBL623981,1,1,,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14124,,10116.0,50597,14045,
,N,A,CHEMBL626278,1,1,,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14125,,10116.0,50597,14045,
,N,A,CHEMBL626279,1,1,,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,,,,Intermediate,,,In vivo,14126,,10116.0,50597,14045,
,N,A,CHEMBL626280,1,1,,BAO_0000218,Biodistribution in mice bladder plus excreted urine was determined,Mus musculus,,,,Intermediate,,,In vivo,14127,,10090.0,50594,14045,
,N,A,CHEMBL626281,1,1,,BAO_0000218,"Percentage biodistribution in mouse blood, 10 minutes post injection",Mus musculus,,,,Intermediate,,,,14128,,10090.0,50594,14045,
,N,A,CHEMBL626282,1,1,,BAO_0000218,"Percentage biodistribution in mouse blood, 30 minutes post injection",Mus musculus,,,,Intermediate,,,,14129,,10090.0,50594,14045,
,N,A,CHEMBL626283,1,1,,BAO_0000218,"Percentage biodistribution in mouse blood, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14130,,10090.0,50594,14045,
,N,A,CHEMBL626284,1,1,,BAO_0000218,"Percentage biodistribution in mouse blood, 60 minutes post injection",Mus musculus,,,,Intermediate,,,,14131,,10090.0,50594,14045,
,N,A,CHEMBL626285,1,1,Brain,BAO_0000218,"Percentage biodistribution in mouse brain, 10 minutes post injection",Mus musculus,,,,Intermediate,,,,14132,955.0,10090.0,50594,14045,
,N,A,CHEMBL626286,1,1,Brain,BAO_0000218,"Percentage biodistribution in mouse brain, 30 minutes post injection",Mus musculus,,,,Intermediate,,,,14133,955.0,10090.0,50594,14045,
,N,A,CHEMBL626287,1,1,Brain,BAO_0000218,"Percentage biodistribution in mouse brain, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14134,955.0,10090.0,50594,14045,
,N,A,CHEMBL626288,1,1,Brain,BAO_0000218,"Percentage biodistribution in mouse brain, 60 minutes post injection",Mus musculus,,,,Intermediate,,,,14135,955.0,10090.0,50594,14045,
,N,A,CHEMBL626289,1,1,,BAO_0000218,"Percentage biodistribution in mouse heart, 10 minutes post injection",Mus musculus,,,,Intermediate,,,,14136,,10090.0,50594,14045,
,N,A,CHEMBL626290,1,1,,BAO_0000218,"Percentage biodistribution in mouse heart, 30 minutes post injection",Mus musculus,,,,Intermediate,,,,14137,,10090.0,50594,14045,
,N,A,CHEMBL626291,1,1,,BAO_0000218,"Percentage biodistribution in mouse heart, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14138,,10090.0,50594,14045,
,N,A,CHEMBL839888,1,1,,BAO_0000218,"Percentage biodistribution in mouse heart, 60 minutes post injection",Mus musculus,,,,Intermediate,,,,14139,,10090.0,50594,14045,
,N,A,CHEMBL626292,1,1,Intestine,BAO_0000218,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Mus musculus,,,,Intermediate,,,,14140,160.0,10090.0,50594,14045,
,N,A,CHEMBL626293,1,1,Intestine,BAO_0000218,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Mus musculus,,,,Intermediate,,,,14141,160.0,10090.0,50594,14045,
,N,A,CHEMBL626294,1,1,Intestine,BAO_0000218,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14142,160.0,10090.0,50594,14045,
,N,A,CHEMBL626295,1,1,Intestine,BAO_0000218,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Mus musculus,,,,Intermediate,,,,14143,160.0,10090.0,50594,14045,
,N,A,CHEMBL627659,1,1,Liver,BAO_0000218,"Percentage biodistribution in mouse liver, 10 minutes post injection",Mus musculus,,,,Intermediate,,,,14144,2107.0,10090.0,50594,14045,
,N,A,CHEMBL627660,1,1,Liver,BAO_0000218,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Mus musculus,,,,Intermediate,,,,14145,2107.0,10090.0,50594,14045,
,N,A,CHEMBL627661,1,1,Liver,BAO_0000218,"Percentage biodistribution in mouse liver, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14146,2107.0,10090.0,50594,14045,
,N,A,CHEMBL627662,1,1,Liver,BAO_0000218,Biodistribution in mice liver at 60 minutes of post injection,Mus musculus,,,,Intermediate,,,In vivo,14147,2107.0,10090.0,50594,14045,
,N,A,CHEMBL627663,1,1,Lung,BAO_0000218,Biodistribution in mice lungs at 10 min of post injection,Mus musculus,,,,Intermediate,,,In vivo,14148,2048.0,10090.0,50594,14045,
,N,A,CHEMBL627664,1,1,,BAO_0000218,"Percentage biodistribution in mouse lung, 30 minutes post injection",Mus musculus,,,,Intermediate,,,,14149,,10090.0,50594,14045,
,N,A,CHEMBL627665,1,1,,BAO_0000218,"Percentage biodistribution in mousee lung, 5 minutes post injection",Mus musculus,,,,Intermediate,,,,14150,,10090.0,50594,14045,
,N,A,CHEMBL627666,1,1,Lung,BAO_0000218,Biodistribution in mice lungs at 60 min of post injection,Mus musculus,,,,Intermediate,,,In vivo,14151,2048.0,10090.0,50594,14045,
,N,A,CHEMBL627667,1,1,Spleen,BAO_0000218,Percentage biodistribution in mouse spleen,Mus musculus,,,,Intermediate,,,,14152,2106.0,10090.0,50594,14045,
,N,A,CHEMBL627668,1,1,Stomach,BAO_0000218,Percentage biodistribution in mouse stomach,Mus musculus,,,,Intermediate,,,,14153,945.0,10090.0,50594,14045,
,N,A,CHEMBL627669,1,1,Urine,BAO_0000218,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Mus musculus,,,,Intermediate,,,,14154,1088.0,10090.0,50594,11745,
,U,A,CHEMBL627670,1,0,Urinary bladder,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,,,Autocuration,,,In vivo,14155,1255.0,,22224,13257,
,U,A,CHEMBL627671,1,0,Blood,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,,,Autocuration,,,In vivo,14156,178.0,,22224,13257,
,U,A,CHEMBL627672,1,0,Bone element,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,,,Autocuration,,,In vivo,14157,1474.0,,22224,13257,
,U,A,CHEMBL627673,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,,,Autocuration,,,In vivo,14158,,,22224,13257,
,U,A,CHEMBL627674,1,0,Kidney,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,,,Autocuration,,,In vivo,14159,2113.0,,22224,13257,
,U,A,CHEMBL627675,1,0,Liver,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,,,Autocuration,,,In vivo,14160,2107.0,,22224,13257,
,U,A,CHEMBL627676,1,0,Lung,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,,,Autocuration,,,In vivo,14161,2048.0,,22224,13257,
,U,A,CHEMBL627677,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,,,Autocuration,,,In vivo,14162,2385.0,,22224,13257,
,U,A,CHEMBL627678,1,0,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14163,,,22224,8354,
,N,A,CHEMBL627679,1,1,Serum,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum,Rattus norvegicus,,,,Intermediate,,,,14164,1977.0,10116.0,50597,7095,
,U,A,CHEMBL627680,1,0,,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,,Autocuration,,,,14165,,,22224,12185,
,U,A,CHEMBL627681,1,0,,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,,Autocuration,,,,14166,,,22224,12185,
,U,A,CHEMBL627682,1,0,,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,,Autocuration,,,,14167,,,22224,12185,
,U,A,CHEMBL627683,1,0,,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,,Autocuration,,,,14168,,,22224,12185,
,U,A,CHEMBL627684,1,0,,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,,,Autocuration,,,,14169,,,22224,12686,
,U,A,CHEMBL874441,1,0,,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,,Autocuration,,,,14170,,,22224,12686,
,U,A,CHEMBL627685,1,0,,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,,,Autocuration,,,,14171,,,22224,12686,
,U,A,CHEMBL627686,1,0,,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,,Autocuration,,,,14172,,,22224,12686,
,U,A,CHEMBL627687,1,0,,BAO_0000019,Apparent rate constant Koff for inactivation of dTMP synthase.,,,,,Autocuration,,,,14173,,,22224,8057,
,U,A,CHEMBL627688,1,0,,BAO_0000019,The irreversible inhibitor activity by second order rate equation.,,,,,Autocuration,,,,14174,,,22224,15778,
,N,A,CHEMBL628038,1,1,,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,14175,,10116.0,50597,12375,
,N,A,CHEMBL628039,1,1,,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Rattus norvegicus,,,,Intermediate,,,,14176,,10116.0,50597,12375,
,N,A,CHEMBL628040,1,1,,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Rattus norvegicus,,,,Intermediate,,,,14177,,10116.0,50597,12375,
,U,A,CHEMBL628041,1,0,,BAO_0000019,Dissociation rate calculated from the first-order equation using t1/2 value,,,,,Autocuration,,,,14178,,,22224,13588,
,U,A,CHEMBL630226,1,0,,BAO_0000019,The compound was tested for Binding constant against DNA,,,,,Autocuration,,,,14179,,,22224,15039,
,U,A,CHEMBL628042,1,0,,BAO_0000019,First order rate constant for cyclization of the compound,,,,,Autocuration,,,,14180,,,22224,9500,
,U,A,CHEMBL625232,1,0,,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,,Autocuration,,,,14181,,,22224,10014,
,U,A,CHEMBL625233,1,0,,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,,Autocuration,,,,14182,,,22224,10014,
,U,A,CHEMBL625979,1,0,,BAO_0000019,Hydrolysis rate constant was determined,,,,,Autocuration,,,,14183,,,22224,568,
,U,A,CHEMBL625980,1,0,,BAO_0000019,Observed first order rate constant,,,,,Autocuration,,,,14184,,,22224,10026,
,U,A,CHEMBL625981,1,0,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,Autocuration,,,,14185,,,22224,10281,
,U,A,CHEMBL625982,1,0,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,Autocuration,,,,14186,,,22224,10281,
,U,A,CHEMBL625983,1,0,,BAO_0000019,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,,,Autocuration,,,,14187,,,22224,9680,
,U,A,CHEMBL625984,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14188,,,22224,13028,
,U,A,CHEMBL625985,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14189,,,22224,13028,
,U,A,CHEMBL625986,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14190,,,22224,13028,
,U,A,CHEMBL625987,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14191,,,22224,13028,
,U,A,CHEMBL625988,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14192,,,22224,13028,
,U,A,CHEMBL625989,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14193,,,22224,13028,
,U,A,CHEMBL625990,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14194,,,22224,13028,
,U,A,CHEMBL625991,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14195,,,22224,13028,
,U,A,CHEMBL625992,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14196,,,22224,13028,
,U,A,CHEMBL625993,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14197,,,22224,13028,
,U,A,CHEMBL631973,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14198,,,22224,13028,
,U,A,CHEMBL632143,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14199,,,22224,13028,
,U,A,CHEMBL632144,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14200,,,22224,13028,
,U,A,CHEMBL632145,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14201,,,22224,13028,
,U,A,CHEMBL632146,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14202,,,22224,13028,
,U,A,CHEMBL632147,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14203,,,22224,13028,
,U,A,CHEMBL632148,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14204,,,22224,13028,
,U,A,CHEMBL632149,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14205,,,22224,13028,
,U,A,CHEMBL632150,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14206,,,22224,13028,
,U,A,CHEMBL632151,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14207,,,22224,13028,
,N,A,CHEMBL632152,1,1,,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Homo sapiens,,,,Intermediate,,,,14208,,9606.0,50587,3008,
,N,A,CHEMBL632153,1,1,,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,,,,Intermediate,,,,14209,,9606.0,50587,4509,
,N,A,CHEMBL632154,1,1,,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,,,,Intermediate,,,,14210,,9606.0,50587,4509,
,N,A,CHEMBL632155,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14211,,10298.0,50602,8613,
,N,A,CHEMBL632156,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,,Intermediate,,,,14212,,10298.0,50602,8613,
,N,A,CHEMBL632157,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14213,,10298.0,50602,8613,
,N,A,CHEMBL632158,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14214,,10298.0,50602,8613,
,N,A,CHEMBL632159,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,,Intermediate,,,,14215,,10298.0,50602,8613,
,N,A,CHEMBL626305,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14216,,10298.0,50602,8613,
,N,A,CHEMBL626306,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,,Intermediate,,,,14217,,10298.0,50602,8613,
,N,A,CHEMBL626307,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14218,,10298.0,50602,8613,
,N,A,CHEMBL626308,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14219,,10298.0,50602,8613,
,N,A,CHEMBL626479,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14220,,10298.0,50602,8613,
,N,A,CHEMBL626480,1,1,,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,,Intermediate,,,,14221,,10298.0,50602,8613,
,U,P,CHEMBL626481,1,0,,BAO_0000100,Calculated partition coefficient (clogP) (MlogP),,,,,Autocuration,,,,14222,,,22229,6021,
,U,A,CHEMBL626482,1,0,,BAO_0000019,Equipotent potent ratio relative to carbachol (nicotinic activity),,,,,Autocuration,,,,14223,,,22224,9348,
,N,A,CHEMBL626483,1,1,,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Canis lupus familiaris,,,,Intermediate,,,,14224,,9615.0,50588,15592,
,N,A,CHEMBL626484,1,1,,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Canis lupus familiaris,,,,Intermediate,,,,14225,,9615.0,50588,15592,
,U,P,CHEMBL626485,1,0,,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,,,Autocuration,,,,14226,,,22229,15592,
,U,P,CHEMBL626486,1,0,,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,,,Autocuration,,,,14227,,,22229,15592,
,U,P,CHEMBL626487,1,0,,BAO_0000100,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,,,Autocuration,,,,14228,,,22229,15592,
,N,A,CHEMBL626488,1,1,Plasma,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,,,Intermediate,,,In vivo,14229,1969.0,9615.0,50588,15592,
,N,A,CHEMBL626489,1,1,Serum,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Rattus norvegicus,,,,Intermediate,,,,14230,1977.0,10116.0,50597,7095,
,U,A,CHEMBL626490,1,0,,BAO_0000019,Area under the MAP curve measured over 5 min; ND means Not determined,,,,,Autocuration,,,,14231,,,22224,16618,
,U,P,CHEMBL626491,1,0,,BAO_0000100,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,,,Autocuration,,,,14232,,,22224,16835,
,U,P,CHEMBL626492,1,0,,BAO_0000100,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,,,Autocuration,,,,14233,,,22229,15284,
,U,A,CHEMBL626493,1,0,,BAO_0000019,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,,,Autocuration,,,,14234,,,22224,15750,
,N,A,CHEMBL626494,1,1,,BAO_0000218,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,,,,Intermediate,,,In vivo,14235,,10116.0,50597,16618,
,U,A,CHEMBL626495,1,0,,BAO_0000218,Half life after oral tested,,,,,Autocuration,,,In vivo,14236,,,22224,16618,
,N,A,CHEMBL626496,1,1,Plasma,BAO_0000218,Half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,,,,Intermediate,,,,14237,1969.0,10116.0,50597,15812,
,N,A,CHEMBL626497,1,1,,BAO_0000218,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,,,,Intermediate,,,In vivo,14238,,10116.0,50597,16618,
,U,A,CHEMBL626498,1,0,,BAO_0000218,Oral bioavailability after oral tested,,,,,Autocuration,,,In vivo,14239,,,22224,16618,
,N,A,CHEMBL626499,1,1,,BAO_0000218,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Rattus norvegicus,,,,Intermediate,,,,14240,,10116.0,50597,13098,
,N,A,CHEMBL626500,1,1,,BAO_0000218,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Rattus norvegicus,,,,Intermediate,,,,14241,,10116.0,50597,13098,
,N,A,CHEMBL626501,1,1,Plasma,BAO_0000218,half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,,,,Intermediate,,,,14242,1969.0,10116.0,50597,15812,
,N,A,CHEMBL626502,1,1,Plasma,BAO_0000218,half life was determined in plasma of rat; NT means not tested,Rattus norvegicus,,,,Intermediate,,,,14243,1969.0,10116.0,50597,15812,
,N,A,CHEMBL626503,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Rattus norvegicus,,,,Intermediate,,,,14244,,10116.0,50597,11510,
,N,A,CHEMBL626504,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Rattus norvegicus,,,,Intermediate,,,,14245,,10116.0,50597,11510,
,N,A,CHEMBL626505,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Rattus norvegicus,,,,Intermediate,,,,14246,,10116.0,50597,11510,
,N,A,CHEMBL626506,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Rattus norvegicus,,,,Intermediate,,,,14247,,10116.0,50597,11510,
,N,A,CHEMBL626507,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Rattus norvegicus,,,,Intermediate,,,,14248,,10116.0,50597,11510,
,N,A,CHEMBL626508,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Rattus norvegicus,,,,Intermediate,,,,14249,,10116.0,50597,11510,
,N,A,CHEMBL626509,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Rattus norvegicus,,,,Intermediate,,,,14250,,10116.0,50597,11510,
,N,A,CHEMBL875480,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Rattus norvegicus,,,,Intermediate,,,,14251,,10116.0,50597,11510,
,N,A,CHEMBL626510,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Rattus norvegicus,,,,Intermediate,,,,14252,,10116.0,50597,11510,
,N,A,CHEMBL626511,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Rattus norvegicus,,,,Intermediate,,,,14253,,10116.0,50597,11510,
,N,A,CHEMBL626512,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Rattus norvegicus,,,,Intermediate,,,,14254,,10116.0,50597,11510,
,N,A,CHEMBL628208,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Rattus norvegicus,,,,Intermediate,,,,14255,,10116.0,50597,11510,
,N,A,CHEMBL628209,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Rattus norvegicus,,,,Intermediate,,,,14256,,10116.0,50597,11510,
,N,A,CHEMBL628210,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Rattus norvegicus,,,,Intermediate,,,,14257,,10116.0,50597,11510,
,N,A,CHEMBL628211,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Rattus norvegicus,,,,Intermediate,,,,14258,,10116.0,50597,11510,
,N,A,CHEMBL628212,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Rattus norvegicus,,,,Intermediate,,,,14259,,10116.0,50597,11510,
,N,A,CHEMBL628213,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Rattus norvegicus,,,,Intermediate,,,,14260,,10116.0,50597,11510,
,N,A,CHEMBL628214,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14261,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628215,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14262,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628216,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14263,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626595,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14264,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626596,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14265,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626597,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14266,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626598,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14267,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622242,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14268,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622243,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14269,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622244,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14270,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622245,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14271,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622246,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14272,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622247,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14273,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622248,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14274,1088.0,10116.0,50597,12582,
,N,A,CHEMBL877483,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14275,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622249,1,1,Urine,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14276,1088.0,10116.0,50597,12582,
,N,A,CHEMBL622250,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14277,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622251,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14278,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622252,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14279,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622253,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14280,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622254,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14281,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622255,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14282,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622256,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14283,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622257,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14284,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622258,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14285,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622259,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14286,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622927,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14287,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622928,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14288,1088.0,9615.0,50588,12582,
,N,A,CHEMBL622929,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14289,1088.0,9615.0,50588,12582,
,N,A,CHEMBL623182,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14290,1088.0,9615.0,50588,12582,
,N,A,CHEMBL623183,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14291,1088.0,9615.0,50588,12582,
,N,A,CHEMBL623184,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14292,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623185,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14293,1088.0,10116.0,50597,12582,
,N,A,CHEMBL877484,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14294,1088.0,10116.0,50597,12582,
,N,A,CHEMBL627274,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14295,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623186,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14296,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623187,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14297,1088.0,10116.0,50597,12582,
,N,A,CHEMBL623188,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14298,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628055,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14299,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628056,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14300,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628200,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14301,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628201,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14302,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628202,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14303,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628203,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14304,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628204,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14305,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628205,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14306,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628206,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14307,1088.0,10116.0,50597,12582,
,U,A,CHEMBL628207,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,,,Autocuration,,,In vivo,14308,2367.0,,22224,13257,
,U,A,CHEMBL627220,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,,,Autocuration,,,In vivo,14309,2367.0,,22224,13257,
,U,A,CHEMBL627221,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,,,Autocuration,,,In vivo,14310,2385.0,,22224,13257,
,U,A,CHEMBL627222,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,,,Autocuration,,,In vivo,14311,2367.0,,22224,13257,
,U,A,CHEMBL627223,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,,,Autocuration,,,In vivo,14312,,,22224,13257,
,U,A,CHEMBL632062,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,,,Autocuration,,,In vivo,14313,2385.0,,22224,13257,
,U,A,CHEMBL632063,1,0,Spleen,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,,,Autocuration,,,In vivo,14314,2106.0,,22224,13257,
,U,A,CHEMBL632064,1,0,Urinary bladder,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,,,Autocuration,,,In vivo,14315,1255.0,,22224,13257,
,U,A,CHEMBL632065,1,0,Blood,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,,,Autocuration,,,In vivo,14316,178.0,,22224,13257,
,U,A,CHEMBL632066,1,0,Bone element,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,,,Autocuration,,,In vivo,14317,1474.0,,22224,13257,
,U,A,CHEMBL632067,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,,,Autocuration,,,In vivo,14318,,,22224,13257,
,U,A,CHEMBL629188,1,0,Kidney,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,,,Autocuration,,,In vivo,14319,2113.0,,22224,13257,
,U,A,CHEMBL629189,1,0,Liver,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,,,Autocuration,,,In vivo,14320,2107.0,,22224,13257,
,U,A,CHEMBL629190,1,0,Lung,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,,,Autocuration,,,In vivo,14321,2048.0,,22224,13257,
,U,A,CHEMBL629191,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,,,Autocuration,,,In vivo,14322,2385.0,,22224,13257,
,U,A,CHEMBL629192,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,,,Autocuration,,,In vivo,14323,2367.0,,22224,13257,
,U,A,CHEMBL629193,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,,,Autocuration,,,In vivo,14324,2385.0,,22224,13257,
,U,A,CHEMBL629194,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,,,Autocuration,,,In vivo,14325,2367.0,,22224,13257,
,U,A,CHEMBL629195,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,,,Autocuration,,,In vivo,14326,,,22224,13257,
,U,A,CHEMBL629373,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,,,Autocuration,,,In vivo,14327,2385.0,,22224,13257,
,U,A,CHEMBL629374,1,0,Spleen,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,,,Autocuration,,,In vivo,14328,2106.0,,22224,13257,
,U,A,CHEMBL629375,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,,,Autocuration,,,In vivo,14329,2367.0,,22224,13257,
,U,A,CHEMBL629376,1,0,Urinary bladder,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,,,Autocuration,,,In vivo,14330,1255.0,,22224,13257,
,U,A,CHEMBL629377,1,0,Blood,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,,,Autocuration,,,In vivo,14331,178.0,,22224,13257,
,U,A,CHEMBL629378,1,0,Bone element,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,,,Autocuration,,,In vivo,14332,1474.0,,22224,13257,
,U,A,CHEMBL629379,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,,,Autocuration,,,In vivo,14333,,,22224,13257,
,U,A,CHEMBL629151,1,0,Kidney,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,,,Autocuration,,,In vivo,14334,2113.0,,22224,13257,
,U,A,CHEMBL629152,1,0,Liver,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,,,Autocuration,,,In vivo,14335,2107.0,,22224,13257,
,U,A,CHEMBL629153,1,0,Lung,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,,,Autocuration,,,In vivo,14336,2048.0,,22224,13257,
,U,A,CHEMBL629154,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,,,Autocuration,,,In vivo,14337,2385.0,,22224,13257,
,U,A,CHEMBL629155,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,,,Autocuration,,,In vivo,14338,2367.0,,22224,13257,
,U,A,CHEMBL629156,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,,,Autocuration,,,In vivo,14339,2367.0,,22224,13257,
,U,A,CHEMBL629157,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,,,Autocuration,,,In vivo,14340,2385.0,,22224,13257,
,U,A,CHEMBL629158,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,,,Autocuration,,,In vivo,14341,2367.0,,22224,13257,
,U,A,CHEMBL629159,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,,,Autocuration,,,In vivo,14342,,,22224,13257,
,U,A,CHEMBL629160,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,,,Autocuration,,,In vivo,14343,2385.0,,22224,13257,
,U,A,CHEMBL629161,1,0,Spleen,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,,,Autocuration,,,In vivo,14344,2106.0,,22224,13257,
,U,A,CHEMBL629162,1,0,Urinary bladder,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,,,Autocuration,,,In vivo,14345,1255.0,,22224,13257,
,U,A,CHEMBL629163,1,0,Blood,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,,,Autocuration,,,In vivo,14346,178.0,,22224,13257,
,U,A,CHEMBL629164,1,0,Bone element,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,,,Autocuration,,,In vivo,14347,1474.0,,22224,13257,
,U,A,CHEMBL629165,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,,,Autocuration,,,In vivo,14348,,,22224,13257,
,U,A,CHEMBL629166,1,0,Liver,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,,,Autocuration,,,In vivo,14349,2107.0,,22224,13257,
,U,A,CHEMBL629167,1,0,Lung,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,,,Autocuration,,,In vivo,14350,2048.0,,22224,13257,
,U,A,CHEMBL629168,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,,,Autocuration,,,In vivo,14351,2385.0,,22224,13257,
,U,A,CHEMBL629169,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,,,Autocuration,,,,14352,,,22224,2193,
,U,A,CHEMBL629170,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,,,Autocuration,,,,14353,,,22224,2193,
,U,A,CHEMBL631153,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,,,Autocuration,,,,14354,,,22224,2193,
,U,A,CHEMBL875121,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,,,Autocuration,,,,14355,,,22224,2193,
,U,A,CHEMBL631154,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,,,Autocuration,,,,14356,,,22224,2193,
,U,A,CHEMBL631155,1,0,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,,,Autocuration,,,,14357,,,22224,2193,
,U,A,CHEMBL631156,1,0,,BAO_0000019,Hydrolysis rate constant was determined,,,,,Autocuration,,,,14358,,,22224,568,
,U,A,CHEMBL631157,1,0,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,,,Autocuration,,,,14359,,,22224,9680,
,U,A,CHEMBL631158,1,0,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,,Autocuration,,,,14360,,,22224,9680,
,U,A,CHEMBL631159,1,0,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,,Autocuration,,,,14361,,,22224,9680,
,U,A,CHEMBL631160,1,0,,BAO_0000019,Observed second order rate constant,,,,,Autocuration,,,,14362,,,22224,10026,
,U,A,CHEMBL631161,1,0,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,Autocuration,,,,14363,,,22224,10281,
,U,A,CHEMBL631162,1,0,,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,,Autocuration,,,,14364,,,22224,10014,
,U,A,CHEMBL630313,1,0,,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,,Autocuration,,,,14365,,,22224,10014,
,U,A,CHEMBL630314,1,0,,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,,Autocuration,,,,14366,,,22224,9680,
,U,A,CHEMBL630315,1,0,,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,,Autocuration,,,,14367,,,22224,9680,
,U,A,CHEMBL630316,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14368,,,22224,13028,
,U,A,CHEMBL630986,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14369,,,22224,13028,
,U,A,CHEMBL630987,1,0,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14370,,,22224,13028,
,U,A,CHEMBL630988,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14371,,,22224,13028,
,U,A,CHEMBL630989,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14372,,,22224,13028,
,U,A,CHEMBL630990,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14373,,,22224,13028,
,U,A,CHEMBL630991,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14374,,,22224,13028,
,U,A,CHEMBL630992,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14375,,,22224,13028,
,U,A,CHEMBL630993,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14376,,,22224,13028,
,U,A,CHEMBL630994,1,0,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,Autocuration,,,,14377,,,22224,13028,
,N,A,CHEMBL630995,1,1,,BAO_0000218,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Rattus norvegicus,,,,Intermediate,,,,14378,,10116.0,50597,10014,
,U,A,CHEMBL629252,1,0,,BAO_0000019,Association constant for compound at 31 degree C was determined,,,,,Autocuration,,,,14379,,,22224,9962,
,U,A,CHEMBL629253,1,0,,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound,,,,,Autocuration,,,,14380,,,22224,12029,
,U,A,CHEMBL629944,1,0,,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,,,Autocuration,,,,14381,,,22224,12029,
,N,A,CHEMBL629945,1,1,Trachea,BAO_0000218,Dissociation constants vs LTE4 on guinea pig trachea,Cavia porcellus,,,,Intermediate,,,,14382,3126.0,10141.0,50512,10583,
,U,A,CHEMBL629946,1,0,,BAO_0000019,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,,,Autocuration,,,,14383,,,22224,568,
,U,A,CHEMBL629947,1,0,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,,,Autocuration,,,,14384,,,22224,568,
,U,A,CHEMBL629948,1,0,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,,,Autocuration,,,,14385,,,22224,568,
,U,A,CHEMBL856024,1,0,,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,,,Autocuration,,,,14386,,,22224,568,
,U,A,CHEMBL629949,1,0,,BAO_0000019,Affinity constant KD value was derived from TMP,,,,,Autocuration,,,,14387,,,22224,7493,
,U,A,CHEMBL629950,1,0,,BAO_0000019,Apparent dissociation (binding) rate constant was evaluated,,,,,Autocuration,,,,14388,,,22224,8371,
,U,P,CHEMBL630127,1,0,,BAO_0000100,Dissociation constant (KD) of the compound,,,,,Autocuration,,,,14389,,,22224,13114,
,U,P,CHEMBL630128,1,0,,BAO_0000100,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,,,Autocuration,,,,14390,,,22224,15515,
,U,P,CHEMBL630129,1,0,,BAO_0000100,Dissociation constant from ESR titration experiments,,,,,Autocuration,,,,14391,,,22224,522,
,U,,CHEMBL630130,1,0,,BAO_0000019,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,,Autocuration,,,,14392,,,22224,13888,
,U,P,CHEMBL875234,1,0,,BAO_0000100,Dissociation constant was evaluated.,,,,,Autocuration,,,,14393,,,22224,2616,
,U,P,CHEMBL630131,1,0,,BAO_0000100,Dissociation constant was reported,,,,,Autocuration,,,,14394,,,22224,3798,
,N,A,CHEMBL630132,1,1,,BAO_0000218,Dissociation constant was determined in rat pituitary cells.,Rattus norvegicus,,,,Intermediate,,,,14395,,10116.0,50597,8731,
,U,A,CHEMBL630133,1,0,,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,,,Autocuration,,,,14396,,,22224,11892,
,U,A,CHEMBL630134,1,0,,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,,,Autocuration,,,,14397,,,22224,11892,
,U,A,CHEMBL630135,1,0,,BAO_0000019,Equilibrium dissociation constant of the compound,,,,,Autocuration,,,,14398,,,22224,2582,
,U,A,CHEMBL630136,1,0,,BAO_0000019,Equilibrium dissociation constant was determined,,,,,Autocuration,,,,14399,,,22224,11892,
,U,A,CHEMBL630137,1,0,,BAO_0000019,Kinetic constant KD was evaluated,,,,,Autocuration,,,,14400,,,22224,13396,
,U,A,CHEMBL630138,1,0,,BAO_0000019,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,,,Autocuration,,,,14401,,,22224,603,
,U,A,CHEMBL630139,1,0,,BAO_0000019,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,,,Autocuration,,,,14402,,,22224,15673,
,U,A,CHEMBL630140,1,0,,BAO_0000019,Rate constant for hydrolysis in aqueous acetone.,,,,,Autocuration,,,,14403,,,22224,10368,
,U,A,CHEMBL875235,1,0,,BAO_0000019,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,,,Autocuration,,,,14404,,,22224,14228,
,N,A,CHEMBL876439,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Rattus norvegicus,,,,Intermediate,,,,14405,,10116.0,50597,11510,
,N,A,CHEMBL630605,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Rattus norvegicus,,,,Intermediate,,,,14406,,10116.0,50597,11510,
,N,A,CHEMBL630606,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Rattus norvegicus,,,,Intermediate,,,,14407,,10116.0,50597,11510,
,N,A,CHEMBL630607,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Rattus norvegicus,,,,Intermediate,,,,14408,,10116.0,50597,11510,
,N,A,CHEMBL630608,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Rattus norvegicus,,,,Intermediate,,,,14409,,10116.0,50597,11510,
,N,A,CHEMBL630609,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Rattus norvegicus,,,,Intermediate,,,,14410,,10116.0,50597,11510,
,N,A,CHEMBL630610,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Rattus norvegicus,,,,Intermediate,,,,14411,,10116.0,50597,11510,
,N,A,CHEMBL630611,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Rattus norvegicus,,,,Intermediate,,,,14412,,10116.0,50597,11510,
,N,A,CHEMBL629552,1,1,,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Rattus norvegicus,,,,Intermediate,,,,14413,,10116.0,50597,11510,
,N,A,CHEMBL629733,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14414,,10116.0,50597,11510,
,N,A,CHEMBL629734,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14415,,10116.0,50597,11510,
,N,A,CHEMBL629735,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14416,,10116.0,50597,11510,
,N,A,CHEMBL629736,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14417,,10116.0,50597,11510,
,N,A,CHEMBL629737,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14418,,10116.0,50597,11510,
,N,A,CHEMBL629738,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14419,,10116.0,50597,11510,
,N,A,CHEMBL629739,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14420,,10116.0,50597,11510,
,N,A,CHEMBL629740,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,,Intermediate,,,,14421,,10116.0,50597,11510,
,N,A,CHEMBL629741,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14422,,10116.0,50597,11510,
,N,A,CHEMBL629742,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14423,,10116.0,50597,11510,
,N,A,CHEMBL629743,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14424,,10116.0,50597,11510,
,N,A,CHEMBL629744,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14425,,10116.0,50597,11510,
,N,A,CHEMBL629745,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14426,,10116.0,50597,11510,
,N,A,CHEMBL629746,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14427,,10116.0,50597,11510,
,N,A,CHEMBL629747,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14428,,10116.0,50597,11510,
,N,A,CHEMBL629748,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14429,,10116.0,50597,11510,
,N,A,CHEMBL629749,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14430,,10116.0,50597,11510,
,N,A,CHEMBL629750,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14431,,10116.0,50597,11510,
,N,A,CHEMBL629751,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14432,,10116.0,50597,11510,
,N,A,CHEMBL629752,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14433,,10116.0,50597,11510,
,N,A,CHEMBL629753,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14434,,10116.0,50597,11510,
,N,A,CHEMBL629754,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14435,,10116.0,50597,11510,
,N,A,CHEMBL629755,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14436,,10116.0,50597,11510,
,N,A,CHEMBL629756,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14437,,10116.0,50597,11510,
,N,A,CHEMBL629757,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14438,,10116.0,50597,11510,
,N,A,CHEMBL629758,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14439,,10116.0,50597,11510,
,N,A,CHEMBL629759,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14440,,10116.0,50597,11510,
,N,A,CHEMBL629760,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14441,,10116.0,50597,11510,
,N,A,CHEMBL876443,1,1,,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,,Intermediate,,,,14442,,10116.0,50597,11510,
,N,A,CHEMBL629761,1,1,,BAO_0000218,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,,Intermediate,,,,14443,,9615.0,50588,8310,
,N,A,CHEMBL629762,1,1,,BAO_0000218,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,,Intermediate,,,,14444,,9615.0,50588,8310,
,N,A,CHEMBL629763,1,1,,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14445,,10090.0,50594,8310,
,N,A,CHEMBL629764,1,1,,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14446,,10090.0,50594,8310,
,N,A,CHEMBL629765,1,1,,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14447,,10090.0,50594,8310,
,N,A,CHEMBL629766,1,1,,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14448,,10090.0,50594,8310,
,N,A,CHEMBL629767,1,1,,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14449,,10090.0,50594,8310,
,N,A,CHEMBL629768,1,1,,BAO_0000218,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,,Intermediate,,,,14450,,9615.0,50588,8310,
,N,A,CHEMBL629769,1,1,,BAO_0000218,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14451,,10090.0,50594,8310,
,N,A,CHEMBL629770,1,1,,BAO_0000218,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,,Intermediate,,,,14452,,9615.0,50588,8310,
,N,A,CHEMBL629771,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Canis lupus familiaris,,,,Intermediate,,,,14453,,9615.0,50588,8310,
,N,A,CHEMBL629772,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14454,,10090.0,50594,8310,
,N,A,CHEMBL629773,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14455,,10090.0,50594,8310,
,N,A,CHEMBL625455,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14456,,10090.0,50594,8310,
,N,A,CHEMBL625456,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14457,,10090.0,50594,8310,
,N,A,CHEMBL625457,1,1,,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Mus musculus,,,,Intermediate,,,,14458,,10090.0,50594,8310,
,N,A,CHEMBL625458,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14459,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625459,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14460,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875483,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14461,1088.0,10116.0,50597,12582,
,N,A,CHEMBL634779,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14462,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625460,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14463,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626117,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14464,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626118,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14465,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628342,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14466,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628343,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14467,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628344,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14468,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628345,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14469,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628346,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14470,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628347,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14471,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628348,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14472,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628349,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14473,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875611,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14474,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628350,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14475,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628351,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14476,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628352,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14477,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628353,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14478,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628354,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14479,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626667,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14480,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626668,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14481,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626669,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14482,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626670,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14483,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626671,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14484,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626672,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14485,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626673,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14486,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626674,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14487,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626675,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14488,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626676,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14489,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626677,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14490,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626678,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14491,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626679,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14492,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875612,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14493,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626680,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14494,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626681,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14495,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626682,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14496,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626683,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14497,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626684,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14498,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626685,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14499,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626686,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14500,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626687,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14501,1088.0,10116.0,50597,12582,
,N,A,CHEMBL624978,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14502,1088.0,10116.0,50597,12582,
,N,A,CHEMBL624979,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14503,1088.0,10116.0,50597,12582,
,N,A,CHEMBL624980,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14504,1088.0,10116.0,50597,12582,
,N,A,CHEMBL624981,1,1,Urine,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14505,1088.0,10116.0,50597,12582,
,N,A,CHEMBL624982,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14506,1088.0,9615.0,50588,12582,
,U,A,CHEMBL627564,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,,,Autocuration,,,In vivo,14507,2367.0,,22224,13257,
,U,A,CHEMBL627565,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,,,Autocuration,,,In vivo,14508,2367.0,,22224,13257,
,U,A,CHEMBL627566,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,,,Autocuration,,,In vivo,14509,,,22224,13257,
,U,A,CHEMBL627567,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,,,Autocuration,,,In vivo,14510,2385.0,,22224,13257,
,U,A,CHEMBL627568,1,0,Spleen,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,,,Autocuration,,,In vivo,14511,2106.0,,22224,13257,
,U,A,CHEMBL627569,1,0,Kidney,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,,,Autocuration,,,In vivo,14512,2113.0,,22224,13257,
,U,A,CHEMBL627570,1,0,Urinary bladder,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,,,Autocuration,,,In vivo,14513,1255.0,,22224,13257,
,U,A,CHEMBL627571,1,0,Blood,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,,,Autocuration,,,In vivo,14514,178.0,,22224,13257,
,U,A,CHEMBL627572,1,0,Bone element,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,,,Autocuration,,,In vivo,14515,1474.0,,22224,13257,
,U,A,CHEMBL627573,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,,,Autocuration,,,In vivo,14516,,,22224,13257,
,U,A,CHEMBL627574,1,0,Kidney,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,,,Autocuration,,,In vivo,14517,2113.0,,22224,13257,
,U,A,CHEMBL627575,1,0,Liver,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,,,Autocuration,,,In vivo,14518,2107.0,,22224,13257,
,U,A,CHEMBL627576,1,0,Lung,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,,,Autocuration,,,In vivo,14519,2048.0,,22224,13257,
,U,A,CHEMBL627577,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,,,Autocuration,,,In vivo,14520,2385.0,,22224,13257,
,U,A,CHEMBL627578,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,,,Autocuration,,,In vivo,14521,2367.0,,22224,13257,
,U,A,CHEMBL627579,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,,,Autocuration,,,In vivo,14522,2367.0,,22224,13257,
,U,A,CHEMBL627580,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,,,Autocuration,,,In vivo,14523,2385.0,,22224,13257,
,U,A,CHEMBL627581,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,,,Autocuration,,,In vivo,14524,2367.0,,22224,13257,
,U,A,CHEMBL627582,1,0,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,,,Autocuration,,,In vivo,14525,,,22224,13257,
,U,A,CHEMBL627583,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,,,Autocuration,,,In vivo,14526,2385.0,,22224,13257,
,U,A,CHEMBL627584,1,0,Spleen,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,,,Autocuration,,,In vivo,14527,2106.0,,22224,13257,
,U,A,CHEMBL627585,1,0,Prostate gland,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,,,Autocuration,,,In vivo,14528,2367.0,,22224,13257,
,U,A,CHEMBL627586,1,0,Muscle tissue,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,,,Autocuration,,,In vivo,14529,2385.0,,22224,13257,
,N,A,CHEMBL627587,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14530,,10116.0,50597,15413,
,N,A,CHEMBL627588,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14531,,10116.0,50597,15413,
,N,A,CHEMBL628250,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14532,,10116.0,50597,15413,
,N,A,CHEMBL628251,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14533,,10116.0,50597,15413,
,N,A,CHEMBL628252,1,1,Hippocampus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14534,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL628253,1,1,Hippocampus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14535,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL628254,1,1,Hypothalamus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14536,1898.0,10116.0,50597,15413,
,N,A,CHEMBL877493,1,1,Hypothalamus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14537,1898.0,10116.0,50597,15413,
,N,A,CHEMBL628255,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14538,,10116.0,50597,15413,
,N,A,CHEMBL628256,1,1,,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14539,,10116.0,50597,15413,
,N,A,CHEMBL628257,1,1,Hippocampus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14540,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL628258,1,1,Hypothalamus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14541,1898.0,10116.0,50597,15413,
,N,A,CHEMBL628259,1,1,,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14542,,10116.0,50597,15413,
,N,A,CHEMBL628429,1,1,,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14543,,10116.0,50597,15413,
,N,A,CHEMBL626862,1,1,Hippocampus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,,Intermediate,,,In vivo,14544,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL626863,1,1,Hypothalamus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,14545,1898.0,10116.0,50597,15413,
,N,A,CHEMBL625886,1,1,Cerebellum,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Rattus norvegicus,,,,Intermediate,,,In vivo,14546,2037.0,10116.0,50597,15413,
,N,A,CHEMBL625887,1,1,Cerebellum,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,,,Intermediate,,,In vivo,14547,2037.0,10116.0,50597,15413,
,N,A,CHEMBL625888,1,1,,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Rattus norvegicus,,,,Intermediate,,,In vivo,14548,,10116.0,50597,15413,
,N,A,CHEMBL625889,1,1,,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,,,Intermediate,,,In vivo,14549,,10116.0,50597,15413,
,N,A,CHEMBL625890,1,1,Hippocampus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Rattus norvegicus,,,,Intermediate,,,In vivo,14550,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL625891,1,1,Hippocampus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,,,Intermediate,,,In vivo,14551,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL625892,1,1,Hypothalamus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,,,,Intermediate,,,In vivo,14552,1898.0,10116.0,50597,15413,
,N,A,CHEMBL625893,1,1,Hypothalamus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,,,Intermediate,,,In vivo,14553,1898.0,10116.0,50597,15413,
,N,A,CHEMBL625894,1,1,Cerebellum,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Rattus norvegicus,,,,Intermediate,,,In vivo,14554,2037.0,10116.0,50597,15413,
,N,A,CHEMBL625895,1,1,,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Rattus norvegicus,,,,Intermediate,,,In vivo,14555,,10116.0,50597,15413,
,U,A,CHEMBL625896,1,0,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,Autocuration,,,,14556,,,22224,12404,
,U,A,CHEMBL625897,1,0,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,,,Autocuration,,,,14557,,,22224,568,
,U,A,CHEMBL625898,1,0,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,,Autocuration,,,,14558,,,22224,568,
,U,A,CHEMBL625899,1,0,,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,,Autocuration,,,,14559,,,22224,568,
,U,A,CHEMBL626124,1,0,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,Autocuration,,,,14560,,,22224,12404,
,N,A,CHEMBL628500,1,1,,BAO_0000218,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Escherichia coli,,,,Intermediate,,,,14561,,562.0,50212,7624,
,N,A,CHEMBL857856,1,1,,BAO_0000218,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Rattus norvegicus,,,,Intermediate,,,,14562,,10116.0,50597,7624,
,N,A,CHEMBL628501,1,1,,BAO_0000218,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Rattus norvegicus,,,,Intermediate,,,,14563,,10116.0,50597,7624,
,U,A,CHEMBL628502,1,0,,BAO_0000019,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,,,Autocuration,,,,14564,,,22224,4643,
,U,A,CHEMBL628503,1,0,,BAO_0000019,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,,,Autocuration,,,,14565,,,22224,11532,
,U,A,CHEMBL628504,1,0,,BAO_0000019,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,,,Autocuration,,,,14566,,,22224,11018,
,U,A,CHEMBL628505,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,,Autocuration,,,,14567,,,22224,2276,
,U,A,CHEMBL874452,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,,,Autocuration,,,,14568,,,22224,2276,
,U,A,CHEMBL628506,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,,,Autocuration,,,,14569,,,22224,2276,
,U,A,CHEMBL628507,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,,Autocuration,,,,14570,,,22224,2276,
,U,A,CHEMBL628508,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,,,Autocuration,,,,14571,,,22224,2276,
,U,A,CHEMBL628509,1,0,,BAO_0000019,Michaelis constant (KM) was evaluated,,,,,Autocuration,,,,14572,,,22224,8949,
,U,A,CHEMBL628510,1,0,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,Autocuration,,,,14573,,,22224,12404,
,U,B,CHEMBL628511,1,0,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,,,Autocuration,,,,14574,,,22224,7625,
,U,B,CHEMBL628512,1,0,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,,,Autocuration,,,,14575,,,22224,7625,
,U,B,CHEMBL628513,1,0,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,,,Autocuration,,,,14576,,,22224,7625,
,U,B,CHEMBL628514,1,0,,BAO_0000019,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,,,Autocuration,,,,14577,,,22224,7625,
,U,A,CHEMBL628515,1,0,,BAO_0000019,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,,,Autocuration,,,,14578,,,22224,12908,
,U,A,CHEMBL628516,1,0,,BAO_0000019,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,,,Autocuration,,,,14579,,,22224,10368,
,U,A,CHEMBL628517,1,0,,BAO_0000019,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,,Autocuration,,,,14580,,,22224,13108,
,U,A,CHEMBL628518,1,0,,BAO_0000019,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,,Autocuration,,,,14581,,,22224,13108,
,U,A,CHEMBL628519,1,0,,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,,,Autocuration,,,,14582,,,22224,15217,
,U,A,CHEMBL628520,1,0,,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,,,Autocuration,,,,14583,,,22224,15217,
,U,A,CHEMBL628521,1,0,,BAO_0000019,Binding constant was determined,,,,,Autocuration,,,,14584,,,22224,10933,
,U,A,CHEMBL630443,1,0,,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,,,Autocuration,,,,14585,,,22224,2363,
,U,A,CHEMBL630444,1,0,,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,,,Autocuration,,,,14586,,,22224,2363,
,U,A,CHEMBL857732,1,0,,BAO_0000019,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,,,Autocuration,,,,14587,,,22224,2276,
,U,P,CHEMBL630445,1,0,,BAO_0000100,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,,,Autocuration,,,,14588,,,22224,14915,
,U,A,CHEMBL630446,1,0,,BAO_0000019,Catalytic rate constant of the compound,,,,,Autocuration,,,,14589,,,22224,8847,
,U,B,CHEMBL630447,1,0,,BAO_0000019,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,,,Autocuration,,,,14590,,,22224,15357,
,U,A,CHEMBL630448,1,0,,BAO_0000019,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,,,Autocuration,,,,14591,,,22224,2869,
,U,A,CHEMBL630449,1,0,,BAO_0000019,Catalytic rate constant against phospholipase A2 was determined,,,,,Autocuration,,,,14592,,,22224,3484,
,U,A,CHEMBL630450,1,0,,BAO_0000019,"Compound was evaluated for catalytic constant, Kcat",,,,,Autocuration,,,,14593,,,22224,1373,
,U,A,CHEMBL630451,1,0,,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,,,Autocuration,,,,14594,,,22224,8142,
,U,A,CHEMBL630452,1,0,,BAO_0000019,Kcat calculated from 0.693/T1/2,,,,,Autocuration,,,,14595,,,22224,14131,
,U,A,CHEMBL630453,1,0,,BAO_0000019,Kcat was determined,,,,,Autocuration,,,,14596,,,22224,17269,
,U,A,CHEMBL630454,1,0,,BAO_0000019,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,,,Autocuration,,,,14597,,,22224,3485,
,U,A,CHEMBL630455,1,0,,BAO_0000019,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,,,Autocuration,,,,14598,,,22224,3485,
,U,A,CHEMBL631487,1,0,,BAO_0000019,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,,,Autocuration,,,,14599,,,22224,3485,
,U,A,CHEMBL631488,1,0,,BAO_0000019,Kcat value was determined,,,,,Autocuration,,,,14600,,,22224,5962,
,U,A,CHEMBL876440,1,0,,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,,,Autocuration,,,,14601,,,22224,3133,
,U,A,CHEMBL631489,1,0,,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,,,Autocuration,,,,14602,,,22224,3133,
,U,A,CHEMBL857742,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,,Autocuration,,,,14603,,,22224,2276,
,U,A,CHEMBL631490,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,,Autocuration,,,,14604,,,22224,2276,
,U,A,CHEMBL631491,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,,,Autocuration,,,,14605,,,22224,2276,
,U,A,CHEMBL631492,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,,Autocuration,,,,14606,,,22224,2276,
,U,A,CHEMBL631493,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,,Autocuration,,,,14607,,,22224,2276,
,U,A,CHEMBL631494,1,0,,BAO_0000019,Kinetic parameter for rate of conversion to PABA was determined,,,,,Autocuration,,,,14608,,,22224,4892,
,U,A,CHEMBL631495,1,0,,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,,Autocuration,,,,14609,,,22224,3133,
,N,A,CHEMBL631496,1,1,Feces,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,,,,Intermediate,,,,14610,1988.0,10116.0,50597,11488,
,N,A,CHEMBL631497,1,1,Urine,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,,,Intermediate,,,,14611,1088.0,10116.0,50597,11488,
,N,A,CHEMBL631498,1,1,Urine,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,,,Intermediate,,,,14612,1088.0,10116.0,50597,11488,
,N,A,CHEMBL629776,1,1,Urine,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,,,Intermediate,,,,14613,1088.0,10116.0,50597,11488,
,N,A,CHEMBL629777,1,1,Urine,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,,,Intermediate,,,,14614,1088.0,10116.0,50597,11488,
,N,A,CHEMBL629778,1,1,Urine,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,,,,Intermediate,,,,14615,1088.0,10116.0,50597,11488,
,N,A,CHEMBL630456,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14616,,10116.0,50597,11488,
,N,A,CHEMBL630457,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14617,,10116.0,50597,11488,
,N,A,CHEMBL630458,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14618,,10116.0,50597,11488,
,N,A,CHEMBL630459,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14619,,10116.0,50597,11488,
,N,A,CHEMBL630460,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14620,,10116.0,50597,11488,
,N,A,CHEMBL876550,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14621,,10116.0,50597,11488,
,N,A,CHEMBL630461,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14622,,10116.0,50597,11488,
,N,A,CHEMBL630462,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14623,,10116.0,50597,11488,
,N,A,CHEMBL630463,1,1,,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14624,,10116.0,50597,11488,
,N,A,CHEMBL630464,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14625,,10116.0,50597,11488,
,N,A,CHEMBL630465,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14626,,10116.0,50597,11488,
,N,A,CHEMBL630466,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14627,,10116.0,50597,11488,
,N,A,CHEMBL630467,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14628,,10116.0,50597,11488,
,N,A,CHEMBL630633,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14629,,10116.0,50597,11488,
,N,A,CHEMBL630634,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14630,,10116.0,50597,11488,
,N,A,CHEMBL630635,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14631,,10116.0,50597,11488,
,N,A,CHEMBL630636,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14632,,10116.0,50597,11488,
,N,A,CHEMBL630637,1,1,,BAO_0000218,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Rattus norvegicus,,,,Intermediate,,,,14633,,10116.0,50597,11488,
,N,A,CHEMBL630638,1,1,Feces,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,,,,Intermediate,,,,14634,1988.0,9986.0,50592,7132,
,N,A,CHEMBL630639,1,1,Feces,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,,,,Intermediate,,,,14635,1988.0,9986.0,50592,7132,
,N,A,CHEMBL630640,1,1,Feces,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,14636,1988.0,9986.0,50592,7132,
,N,A,CHEMBL876551,1,1,Feces,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,14637,1988.0,9986.0,50592,7132,
,N,A,CHEMBL630641,1,1,Urine,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,,,,Intermediate,,,,14638,1088.0,9986.0,50592,7132,
,N,A,CHEMBL630642,1,1,Urine,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,,,,Intermediate,,,,14639,1088.0,9986.0,50592,7132,
,N,A,CHEMBL630643,1,1,Urine,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,14640,1088.0,9986.0,50592,7132,
,N,A,CHEMBL630644,1,1,Urine,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,14641,1088.0,9986.0,50592,7132,
,N,A,CHEMBL630645,1,1,Urine,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,,,,Intermediate,,,,14642,1088.0,9986.0,50592,7132,
,N,A,CHEMBL625599,1,1,Feces,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,,,,Intermediate,,,,14643,1988.0,9986.0,50592,7132,
,N,A,CHEMBL625600,1,1,Feces,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,,,,Intermediate,,,,14644,1988.0,9986.0,50592,7132,
,N,A,CHEMBL625601,1,1,Feces,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,14645,1988.0,9986.0,50592,7132,
,N,A,CHEMBL625602,1,1,Feces,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,14646,1988.0,9986.0,50592,7132,
,N,A,CHEMBL627470,1,1,Urine,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,,,,Intermediate,,,,14647,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627471,1,1,Urine,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,,,,Intermediate,,,,14648,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627472,1,1,Urine,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,,,Intermediate,,,,14649,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627473,1,1,Urine,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,,,Intermediate,,,,14650,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627474,1,1,Urine,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,,,,Intermediate,,,,14651,1088.0,9986.0,50592,7132,
,N,A,CHEMBL627475,1,1,Blood,BAO_0000218,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14652,178.0,10116.0,50597,13925,
,N,A,CHEMBL627476,1,1,Blood,BAO_0000218,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14653,178.0,10116.0,50597,13925,
,N,A,CHEMBL627477,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14654,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627478,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14655,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627479,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14656,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627480,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14657,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627481,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14658,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627482,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14659,1088.0,9615.0,50588,12582,
,N,A,CHEMBL627483,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14660,1088.0,9615.0,50588,12582,
,N,A,CHEMBL875636,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14661,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625764,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14662,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625765,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14663,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625766,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14664,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625767,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14665,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625768,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14666,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625769,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14667,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625770,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14668,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625771,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14669,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625772,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14670,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625773,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,,,Intermediate,,,,14671,1088.0,9615.0,50588,12582,
,N,A,CHEMBL625774,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14672,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625775,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14673,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625776,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14674,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625777,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14675,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625778,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14676,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625779,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14677,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625780,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14678,1088.0,10116.0,50597,12582,
,N,A,CHEMBL625781,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14679,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875637,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14680,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626473,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14681,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626474,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14682,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626475,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14683,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626476,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14684,1088.0,10116.0,50597,12582,
,N,A,CHEMBL634397,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14685,1088.0,10116.0,50597,12582,
,N,A,CHEMBL626477,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14686,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631069,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14687,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631070,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14688,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631071,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14689,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631072,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14690,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631073,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14691,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631074,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14692,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631075,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14693,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631725,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14694,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631726,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14695,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631727,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14696,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631728,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14697,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631729,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14698,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631730,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14699,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631731,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14700,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631910,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14701,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631911,1,1,Hippocampus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Rattus norvegicus,,,,Intermediate,,,In vivo,14702,10000000.0,10116.0,50597,15413,
,N,A,CHEMBL631912,1,1,Hypothalamus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,,,,Intermediate,,,In vivo,14703,1898.0,10116.0,50597,15413,
,N,A,CHEMBL631913,1,1,Hypothalamus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Rattus norvegicus,,,,Intermediate,,,In vivo,14704,1898.0,10116.0,50597,15413,
,N,A,CHEMBL631914,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14705,178.0,10116.0,50597,12017,
,N,A,CHEMBL631915,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14706,178.0,10116.0,50597,12017,
,N,A,CHEMBL875778,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14707,178.0,10116.0,50597,12017,
,N,A,CHEMBL631916,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14708,178.0,10116.0,50597,12017,
,N,A,CHEMBL631917,1,1,Blood,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14709,178.0,10116.0,50597,12017,
,N,A,CHEMBL631918,1,1,Blood,BAO_0000218,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14710,178.0,10116.0,50597,12017,
,N,A,CHEMBL631919,1,1,Blood,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14711,178.0,10116.0,50597,12017,
,N,A,CHEMBL631920,1,1,Blood,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14712,178.0,10116.0,50597,12017,
,N,A,CHEMBL631921,1,1,Blood,BAO_0000218,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14713,178.0,10116.0,50597,12017,
,N,A,CHEMBL631922,1,1,Blood,BAO_0000218,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14714,178.0,10116.0,50597,12017,
,N,A,CHEMBL631923,1,1,Blood,BAO_0000218,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14715,178.0,10116.0,50597,12017,
,N,A,CHEMBL631924,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14716,,10116.0,50597,12017,
,N,A,CHEMBL630234,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14717,,10116.0,50597,12017,
,N,A,CHEMBL630235,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14718,,10116.0,50597,12017,
,N,A,CHEMBL630236,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14719,,10116.0,50597,12017,
,N,A,CHEMBL630237,1,1,,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14720,,10116.0,50597,12017,
,N,A,CHEMBL630238,1,1,,BAO_0000218,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14721,,10116.0,50597,12017,
,N,A,CHEMBL630239,1,1,,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14722,,10116.0,50597,12017,
,N,A,CHEMBL630303,1,1,,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14723,,10116.0,50597,12017,
,N,A,CHEMBL630304,1,1,,BAO_0000218,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14724,,10116.0,50597,12017,
,N,A,CHEMBL630305,1,1,,BAO_0000218,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14725,,10116.0,50597,12017,
,N,A,CHEMBL630306,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14726,2113.0,10116.0,50597,12017,
,N,A,CHEMBL630307,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14727,2113.0,10116.0,50597,12017,
,N,A,CHEMBL630308,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14728,2113.0,10116.0,50597,12017,
,N,A,CHEMBL630309,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14729,2113.0,10116.0,50597,12017,
,N,A,CHEMBL629309,1,1,Kidney,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14730,2113.0,10116.0,50597,12017,
,N,A,CHEMBL629993,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14731,2113.0,10116.0,50597,12017,
,N,A,CHEMBL629994,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14732,2113.0,10116.0,50597,12017,
,N,A,CHEMBL629995,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14733,2113.0,10116.0,50597,12017,
,N,A,CHEMBL631993,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14734,2113.0,10116.0,50597,12017,
,N,A,CHEMBL631994,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14735,2113.0,10116.0,50597,12017,
,N,A,CHEMBL631995,1,1,Kidney,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14736,2113.0,10116.0,50597,12017,
,N,A,CHEMBL631996,1,1,Liver,BAO_0000218,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14737,2107.0,10116.0,50597,12017,
,N,A,CHEMBL631997,1,1,Liver,BAO_0000218,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14738,2107.0,10116.0,50597,12017,
,N,A,CHEMBL631998,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14739,2107.0,10116.0,50597,12017,
,N,A,CHEMBL631999,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14740,2107.0,10116.0,50597,12017,
,N,A,CHEMBL632000,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14741,2107.0,10116.0,50597,12017,
,N,A,CHEMBL632001,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14742,2107.0,10116.0,50597,12017,
,N,A,CHEMBL874424,1,1,Liver,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14743,2107.0,10116.0,50597,12017,
,N,A,CHEMBL632002,1,1,Liver,BAO_0000218,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14744,2107.0,10116.0,50597,12017,
,N,A,CHEMBL632003,1,1,Liver,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14745,2107.0,10116.0,50597,12017,
,U,A,CHEMBL632004,1,0,,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,,Autocuration,,,,14746,,,22224,3133,
,U,A,CHEMBL632005,1,0,,BAO_0000019,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,,,Autocuration,,,,14747,,,22224,2742,
,U,A,CHEMBL632006,1,0,,BAO_0000019,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,,,Autocuration,,,,14748,,,22224,2742,
,U,A,CHEMBL632007,1,0,,BAO_0000019,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,,,Autocuration,,,,14749,,,22224,2742,
,U,A,CHEMBL632008,1,0,,BAO_0000019,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,,,Autocuration,,,,14750,,,22224,2742,
,U,A,CHEMBL632009,1,0,,BAO_0000019,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,,,Autocuration,,,,14751,,,22224,2742,
,U,A,CHEMBL632010,1,0,,BAO_0000019,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,,,Autocuration,,,,14752,,,22224,2742,
,U,A,CHEMBL857750,1,0,,BAO_0000019,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,,,Autocuration,,,,14753,,,22224,2742,
,U,A,CHEMBL632011,1,0,,BAO_0000019,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,,,Autocuration,,,,14754,,,22224,2742,
,U,A,CHEMBL632012,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,Autocuration,,,,14755,,,22224,2276,
,U,A,CHEMBL632013,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,Autocuration,,,,14756,,,22224,2276,
,U,A,CHEMBL632014,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,,,Autocuration,,,,14757,,,22224,2276,
,U,A,CHEMBL629622,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,Autocuration,,,,14758,,,22224,2276,
,U,A,CHEMBL629623,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,Autocuration,,,,14759,,,22224,2276,
,U,A,CHEMBL629624,1,0,,BAO_0000019,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,,,Autocuration,,,,14760,,,22224,2276,
,U,A,CHEMBL629625,1,0,,BAO_0000019,Ratio of Kcat to that of Km was determined,,,,,Autocuration,,,,14761,,,22224,17269,
,U,A,CHEMBL629626,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,,Autocuration,,,,14762,,,22224,2276,
,U,A,CHEMBL629627,1,0,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,,Autocuration,,,,14763,,,22224,2276,
,U,A,CHEMBL629628,1,0,,BAO_0000019,"Compound was evaluated for constant, Kd",,,,,Autocuration,,,,14764,,,22224,15917,
,U,A,CHEMBL629629,1,0,,BAO_0000019,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,,,Autocuration,,,,14765,,,22224,10933,
,U,A,CHEMBL629630,1,0,,BAO_0000019,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,,,Autocuration,,,,14766,,,22224,10933,
,U,A,CHEMBL856030,1,0,,BAO_0000019,Dissociation Constant of compound determined,,,,,Autocuration,,,,14767,,,22224,14293,
,U,B,CHEMBL629631,1,0,,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,,,Autocuration,,,,14768,,,22224,6698,
,U,B,CHEMBL629632,1,0,,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,,,Autocuration,,,,14769,,,22224,6698,
,U,P,CHEMBL629633,1,0,,BAO_0000100,Dissociation constant of compound with Fructose was determined,,,,,Autocuration,,,,14770,,,22224,4318,
,U,P,CHEMBL629634,1,0,,BAO_0000100,Dissociation constant of compound with Fructose was determined; Not determined,,,,,Autocuration,,,,14771,,,22224,4318,
,U,P,CHEMBL629635,1,0,,BAO_0000100,Dissociation constant of compound with Lactulose was determined,,,,,Autocuration,,,,14772,,,22224,4318,
,U,P,CHEMBL629636,1,0,,BAO_0000100,Dissociation constant of compound with Lactulose was determined; Not determined,,,,,Autocuration,,,,14773,,,22224,4318,
,U,P,CHEMBL629637,1,0,,BAO_0000100,Dissociation constant of the Compound,,,,,Autocuration,,,,14774,,,22224,14959,
,U,P,CHEMBL629638,1,0,,BAO_0000100,Dissociation constant by non-linear regression analysis,,,,,Autocuration,,,,14775,,,22224,5913,
,U,P,CHEMBL629639,1,0,,BAO_0000100,Dissociation constant was determined,,,,,Autocuration,,,,14776,,,22224,14218,
,U,P,CHEMBL629640,1,0,,BAO_0000100,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,,,Autocuration,,,,14777,,,22224,10689,
,U,P,CHEMBL629641,1,0,,BAO_0000100,Dissociation constant was determined,,,,,Autocuration,,,,14778,,,22224,13925,
,U,P,CHEMBL631344,1,0,,BAO_0000100,Dissociation constant was determined,,,,,Autocuration,,,,14779,,,22224,16359,
,N,A,CHEMBL631345,1,1,Muscle tissue,BAO_0000218,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Rattus norvegicus,,,,Intermediate,,,,14780,2385.0,10116.0,50597,10944,
,U,A,CHEMBL631346,1,0,,BAO_0000019,The dissociation constant determined by fluorescence displacement assay,,,,,Autocuration,,,,14781,,,22224,11080,
,U,A,CHEMBL631524,1,0,,BAO_0000019,kd value surface plasmon resonance (SPR) method,,,,,Autocuration,,,,14782,,,22224,17805,
,N,A,CHEMBL631525,1,1,Muscle tissue,BAO_0000218,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Rattus norvegicus,,,,Intermediate,,,,14783,2385.0,10116.0,50597,10944,
,U,F,CHEMBL631526,1,0,,BAO_0000019,First dissociation constant of the binding of compound to V30M TTR,,,,,Autocuration,,,,14784,,,22224,16645,
,U,F,CHEMBL631527,1,0,,BAO_0000019,Second dissociation constant of the binding of compound to V30M TTR,,,,,Autocuration,,,,14785,,,22224,16645,
,U,A,CHEMBL631528,1,0,,BAO_0000019,"Compound was evaluated for equilibrium constant, Ke",,,,,Autocuration,,,,14786,,,22224,7793,
,U,A,CHEMBL631529,1,0,Hypothalamus,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,,,Autocuration,,,,14787,1898.0,,22224,12199,
,U,A,CHEMBL631530,1,0,Hypothalamus,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,,,Autocuration,,,,14788,1898.0,,22224,12199,
,U,A,CHEMBL631531,1,0,,BAO_0000019,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,,,Autocuration,,,,14789,,,22224,9680,
,U,A,CHEMBL631532,1,0,,BAO_0000019,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,,,Autocuration,,,,14790,,,22224,9680,
,U,A,CHEMBL631533,1,0,,BAO_0000019,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,,,Autocuration,,,,14791,,,22224,9680,
,N,A,CHEMBL876552,1,1,,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,,Intermediate,,,,14792,,10090.0,50594,13758,
,N,A,CHEMBL631534,1,1,,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,,,,Intermediate,,,,14793,,10090.0,50594,13758,
,N,A,CHEMBL631535,1,1,,BAO_0000218,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,,Intermediate,,,,14794,,10090.0,50594,13758,
,N,A,CHEMBL631536,1,1,,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,,Intermediate,,,,14795,,10090.0,50594,13758,
,N,A,CHEMBL631537,1,1,,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Mus musculus,,,,Intermediate,,,,14796,,10090.0,50594,13758,
,N,A,CHEMBL631538,1,1,,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,,,,Intermediate,,,,14797,,10090.0,50594,13758,
,N,A,CHEMBL631539,1,1,,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Mus musculus,,,,Intermediate,,,,14798,,10090.0,50594,13758,
,N,A,CHEMBL631540,1,1,,BAO_0000218,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,,Intermediate,,,,14799,,10090.0,50594,13758,
,N,A,CHEMBL625637,1,1,,BAO_0000218,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,,14800,,10116.0,50597,14393,
,N,A,CHEMBL625638,1,1,,BAO_0000218,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,,Intermediate,,,,14801,,10116.0,50597,14393,
,N,A,CHEMBL625639,1,1,,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,,Intermediate,,,,14802,,10116.0,50597,15078,
,N,A,CHEMBL625640,1,1,Brain,BAO_0000218,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14803,955.0,10116.0,50597,13925,
,N,A,CHEMBL625641,1,1,Brain,BAO_0000218,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14804,955.0,10116.0,50597,13925,
,N,A,CHEMBL625642,1,1,Heart,BAO_0000218,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14805,948.0,10116.0,50597,13925,
,N,A,CHEMBL625643,1,1,Heart,BAO_0000218,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14806,948.0,10116.0,50597,13925,
,N,A,CHEMBL625644,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14807,2113.0,10116.0,50597,13925,
,N,A,CHEMBL625645,1,1,Kidney,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14808,2113.0,10116.0,50597,13925,
,N,A,CHEMBL625646,1,1,Liver,BAO_0000218,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14809,2107.0,10116.0,50597,13925,
,N,A,CHEMBL625647,1,1,Liver,BAO_0000218,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14810,2107.0,10116.0,50597,13925,
,N,A,CHEMBL625648,1,1,Lung,BAO_0000218,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14811,2048.0,10116.0,50597,13925,
,N,A,CHEMBL625649,1,1,Lung,BAO_0000218,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14812,2048.0,10116.0,50597,13925,
,N,A,CHEMBL625650,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14813,2385.0,10116.0,50597,13925,
,N,A,CHEMBL625651,1,1,Muscle tissue,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14814,2385.0,10116.0,50597,13925,
,N,A,CHEMBL625652,1,1,Zone of skin,BAO_0000218,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14815,14.0,10116.0,50597,13925,
,N,A,CHEMBL625653,1,1,Zone of skin,BAO_0000218,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14816,14.0,10116.0,50597,13925,
,N,A,CHEMBL625654,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14817,2106.0,10116.0,50597,13925,
,N,A,CHEMBL625655,1,1,Spleen,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,,,Intermediate,,,In vivo,14818,2106.0,10116.0,50597,13925,
,N,A,CHEMBL625656,1,1,Blood,BAO_0000218,Biodistribution of Compound in rat blood after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14819,178.0,10116.0,50597,9712,
,N,A,CHEMBL625657,1,1,Blood,BAO_0000218,Biodistribution of Compound in rat blood after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14820,178.0,10116.0,50597,9712,
,N,A,CHEMBL625658,1,1,Brain,BAO_0000218,Biodistribution of Compound in rat brain after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14821,955.0,10116.0,50597,9712,
,N,A,CHEMBL625659,1,1,Brain,BAO_0000218,Biodistribution of Compound in rat brain after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14822,955.0,10116.0,50597,9712,
,N,A,CHEMBL625660,1,1,Heart,BAO_0000218,Biodistribution of Compound in rat heart after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14823,948.0,10116.0,50597,9712,
,N,A,CHEMBL625661,1,1,Heart,BAO_0000218,Biodistribution of Compound in rat heart after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14824,948.0,10116.0,50597,9712,
,N,A,CHEMBL625662,1,1,Liver,BAO_0000218,Biodistribution of Compound in rat liver after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14825,2107.0,10116.0,50597,9712,
,N,A,CHEMBL625663,1,1,Liver,BAO_0000218,Biodistribution of Compound in rat liver after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14826,2107.0,10116.0,50597,9712,
,N,A,CHEMBL875621,1,1,Lung,BAO_0000218,Biodistribution of Compound in rat lung after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14827,2048.0,10116.0,50597,9712,
,N,A,CHEMBL628382,1,1,Lung,BAO_0000218,Biodistribution of Compound in rat lung after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14828,2048.0,10116.0,50597,9712,
,N,A,CHEMBL628383,1,1,Muscle tissue,BAO_0000218,Biodistribution of Compound in rat muscle after 15 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14829,2385.0,10116.0,50597,9712,
,N,A,CHEMBL628384,1,1,Muscle tissue,BAO_0000218,Biodistribution of Compound in rat muscle after 2 minutes of administration,Rattus norvegicus,,,,Intermediate,,,In vivo,14830,2385.0,10116.0,50597,9712,
,N,A,CHEMBL628385,1,1,,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Rattus norvegicus,,,,Intermediate,,,,14831,,10116.0,50597,13925,
,N,A,CHEMBL875753,1,1,,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Rattus norvegicus,,,,Intermediate,,,,14832,,10116.0,50597,13925,
,N,A,CHEMBL628386,1,1,,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Rattus norvegicus,,,,Intermediate,,,,14833,,10116.0,50597,13925,
,N,A,CHEMBL628387,1,1,,BAO_0000218,Organ distribution in rat blood 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14834,,10116.0,50597,6941,
,N,A,CHEMBL628388,1,1,,BAO_0000218,Organ distribution in rat blood 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14835,,10116.0,50597,6941,
,N,A,CHEMBL628389,1,1,,BAO_0000218,Organ distribution in rat blood 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14836,,10116.0,50597,6941,
,N,A,CHEMBL632756,1,1,,BAO_0000218,Organ distribution in rat blood 30 min after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14837,,10116.0,50597,6941,
,N,A,CHEMBL628390,1,1,,BAO_0000218,Organ distribution in rat brain 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14838,,10116.0,50597,6941,
,N,A,CHEMBL631811,1,1,,BAO_0000218,Organ distribution in rat brain 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14839,,10116.0,50597,6941,
,N,A,CHEMBL631812,1,1,,BAO_0000218,Organ distribution in rat brain 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14840,,10116.0,50597,6941,
,N,A,CHEMBL631813,1,1,,BAO_0000218,Organ distribution in rat heart 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14841,,10116.0,50597,6941,
,N,A,CHEMBL631814,1,1,,BAO_0000218,Organ distribution in rat heart 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14842,,10116.0,50597,6941,
,N,A,CHEMBL631815,1,1,,BAO_0000218,Organ distribution in rat heart 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14843,,10116.0,50597,6941,
,N,A,CHEMBL631816,1,1,,BAO_0000218,Organ distribution in rat kidney 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14844,,10116.0,50597,6941,
,N,A,CHEMBL875758,1,1,,BAO_0000218,Organ distribution in rat kidney 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14845,,10116.0,50597,6941,
,N,A,CHEMBL631817,1,1,,BAO_0000218,Organ distribution in rat kidney 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14846,,10116.0,50597,6941,
,N,A,CHEMBL631818,1,1,Liver,BAO_0000218,Organ distribution in rat liver 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14847,2107.0,10116.0,50597,6941,
,N,A,CHEMBL631819,1,1,Liver,BAO_0000218,Organ distribution in rat liver 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14848,2107.0,10116.0,50597,6941,
,N,A,CHEMBL631820,1,1,Liver,BAO_0000218,Organ distribution in rat liver 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14849,2107.0,10116.0,50597,6941,
,N,A,CHEMBL631821,1,1,,BAO_0000218,Organ distribution in rat lung 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14850,,10116.0,50597,6941,
,N,A,CHEMBL631822,1,1,,BAO_0000218,Organ distribution in rat lung 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14851,,10116.0,50597,6941,
,N,A,CHEMBL631823,1,1,,BAO_0000218,Organ distribution in rat lung 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14852,,10116.0,50597,6941,
,N,A,CHEMBL631824,1,1,Muscle tissue,BAO_0000218,Organ distribution in rat muscle 2 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14853,2385.0,10116.0,50597,6941,
,N,A,CHEMBL631825,1,1,Muscle tissue,BAO_0000218,Organ distribution in rat muscle 2 hr after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14854,2385.0,10116.0,50597,6941,
,N,A,CHEMBL631826,1,1,Muscle tissue,BAO_0000218,Organ distribution in rat muscle 30 minutes after intravenous injection,Rattus norvegicus,,,,Intermediate,,,,14855,2385.0,10116.0,50597,6941,
,N,A,CHEMBL631827,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,,Intermediate,,,In vivo,14856,,10090.0,50594,14439,
,N,A,CHEMBL631828,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,,Intermediate,,,In vivo,14857,,10090.0,50594,14439,
,N,A,CHEMBL631829,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,,Intermediate,,,In vivo,14858,,10090.0,50594,14439,
,N,A,CHEMBL875759,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14859,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631830,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14860,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631831,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14861,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631832,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14862,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631833,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14863,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631834,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14864,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631835,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14865,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631836,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14866,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631837,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14867,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631838,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14868,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631839,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14869,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631840,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14870,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631841,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14871,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631842,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14872,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631843,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14873,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631844,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14874,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631845,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14875,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631846,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14876,1088.0,10116.0,50597,12582,
,N,A,CHEMBL875760,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14877,1088.0,10116.0,50597,12582,
,N,A,CHEMBL632199,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14878,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631847,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14879,1088.0,10116.0,50597,12582,
,N,A,CHEMBL631848,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14880,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628707,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14881,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628708,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14882,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628709,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14883,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628710,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14884,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628711,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14885,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628712,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14886,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628713,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14887,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628714,1,1,Urine,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,,,Intermediate,,,,14888,1088.0,10116.0,50597,12582,
,N,A,CHEMBL628715,1,1,,BAO_0000218,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Rattus norvegicus,,,,Intermediate,,,,14889,,10116.0,50597,7415,
,U,A,CHEMBL629179,1,0,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,,,Autocuration,,,,14890,,,22224,7313,
,U,A,CHEMBL629180,1,0,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,,,Autocuration,,,,14891,,,22224,7313,
,U,A,CHEMBL875108,1,0,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,,,Autocuration,,,,14892,,,22224,7313,
,U,A,CHEMBL629181,1,0,Adrenal cortex,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14893,1235.0,,22224,7570,
,U,A,CHEMBL629182,1,0,Adrenal cortex,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14894,1235.0,,22224,7570,
,U,A,CHEMBL629183,1,0,,BAO_0000019,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,,,Autocuration,,,,14895,,,22224,7570,
,U,A,CHEMBL629184,1,0,,BAO_0000019,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14896,,,22224,7570,
,U,A,CHEMBL629185,1,0,Adrenal cortex,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,,,Autocuration,,,,14897,1235.0,,22224,7570,
,U,A,CHEMBL629186,1,0,Adrenal cortex,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14898,1235.0,,22224,7570,
,U,A,CHEMBL629187,1,0,,BAO_0000019,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,,,Autocuration,,,,14899,,,22224,7570,
,U,A,CHEMBL629887,1,0,,BAO_0000019,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,,Autocuration,,,,14900,,,22224,7570,
,U,A,CHEMBL629888,1,0,,BAO_0000019,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,,,Autocuration,,,,14901,,,22224,7570,
,U,A,CHEMBL629889,1,0,,BAO_0000019,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14902,,,22224,7570,
,U,A,CHEMBL629890,1,0,Adrenal cortex,BAO_0000019,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,,,Autocuration,,,,14903,1235.0,,22224,7570,
,U,A,CHEMBL629891,1,0,,BAO_0000019,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14904,,,22224,7570,
,U,A,CHEMBL629892,1,0,,BAO_0000019,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,,,Autocuration,,,,14905,,,22224,7570,
,U,A,CHEMBL629893,1,0,Adrenal cortex,BAO_0000019,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,,,Autocuration,,,,14906,1235.0,,22224,7570,
,U,A,CHEMBL629894,1,0,,BAO_0000019,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,,,Autocuration,,,,14907,,,22224,7570,
,U,A,CHEMBL629895,1,0,,BAO_0000019,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,,Autocuration,,,,14908,,,22224,7570,
,U,A,CHEMBL875109,1,0,,BAO_0000218,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,,Autocuration,,,In vivo,14909,,9615.0,22224,14122,
,U,A,CHEMBL629896,1,0,,BAO_0000218,Absolute bioavailability in male cynomolgus monkeys,Macaca fascicularis,,,,Autocuration,,,In vivo,14910,,9541.0,22224,16449,
,U,A,CHEMBL629897,1,0,,BAO_0000218,Absolute bioavailability in maleSprague-Dawley rats,Rattus norvegicus,,,,Autocuration,,,In vivo,14911,,10116.0,22224,16449,
,N,A,CHEMBL629898,1,1,Liver,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14912,2107.0,10116.0,50597,12017,
,N,A,CHEMBL630057,1,1,Liver,BAO_0000218,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14913,2107.0,10116.0,50597,12017,
,N,A,CHEMBL630058,1,1,Liver,BAO_0000218,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14914,2107.0,10116.0,50597,12017,
,N,A,CHEMBL630059,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14915,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630060,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14916,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630061,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14917,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630062,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14918,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630063,1,1,Lung,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14919,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630064,1,1,Lung,BAO_0000218,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14920,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630065,1,1,Lung,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14921,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630066,1,1,Lung,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14922,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630067,1,1,Lung,BAO_0000218,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14923,2048.0,10116.0,50597,12017,
,N,A,CHEMBL630068,1,1,Lung,BAO_0000218,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14924,2048.0,10116.0,50597,12017,
,N,A,CHEMBL631113,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14925,2385.0,10116.0,50597,12017,
,N,A,CHEMBL631114,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14926,2385.0,10116.0,50597,12017,
,N,A,CHEMBL631115,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14927,2385.0,10116.0,50597,12017,
,N,A,CHEMBL631116,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14928,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630528,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14929,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630529,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14930,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630530,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14931,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630531,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14932,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630532,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14933,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630533,1,1,Muscle tissue,BAO_0000218,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14934,2385.0,10116.0,50597,12017,
,N,A,CHEMBL630534,1,1,Blood,BAO_0000218,Biodistribution in normal mice blood after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14935,178.0,10090.0,50594,15045,
,N,A,CHEMBL630535,1,1,Blood,BAO_0000218,Biodistribution in normal mice blood after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14936,178.0,10090.0,50594,15045,
,N,A,CHEMBL630536,1,1,Blood,BAO_0000218,Biodistribution in normal mice blood after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14937,178.0,10090.0,50594,15045,
,N,A,CHEMBL630537,1,1,Bone,BAO_0000218,Biodistribution in normal mice bone after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14938,10000001.0,10090.0,50594,15045,
,N,A,CHEMBL630538,1,1,Bone,BAO_0000218,Biodistribution in normal mice bone after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14939,10000001.0,10090.0,50594,15045,
,N,A,CHEMBL630539,1,1,Bone,BAO_0000218,Biodistribution in normal mice bone after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14940,10000001.0,10090.0,50594,15045,
,N,A,CHEMBL630540,1,1,Heart,BAO_0000218,Biodistribution in normal mice heart after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14941,948.0,10090.0,50594,15045,
,N,A,CHEMBL630541,1,1,Heart,BAO_0000218,Biodistribution in normal mice heart after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14942,948.0,10090.0,50594,15045,
,N,A,CHEMBL630542,1,1,Heart,BAO_0000218,Biodistribution in normal mice heart after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14943,948.0,10090.0,50594,15045,
,N,A,CHEMBL630543,1,1,Kidney,BAO_0000218,Biodistribution in normal mice kidney after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14944,2113.0,10090.0,50594,15045,
,N,A,CHEMBL630544,1,1,Kidney,BAO_0000218,Biodistribution in normal mice kidney after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14945,2113.0,10090.0,50594,15045,
,N,A,CHEMBL630545,1,1,Kidney,BAO_0000218,Biodistribution in normal mice kidney after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14946,2113.0,10090.0,50594,15045,
,N,A,CHEMBL630546,1,1,Liver,BAO_0000218,Biodistribution in normal mice liver after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14947,2107.0,10090.0,50594,15045,
,N,A,CHEMBL630547,1,1,Liver,BAO_0000218,Biodistribution in normal mice liver after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14948,2107.0,10090.0,50594,15045,
,N,A,CHEMBL630548,1,1,Liver,BAO_0000218,Biodistribution in normal mice liver after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14949,2107.0,10090.0,50594,15045,
,N,A,CHEMBL630549,1,1,Spleen,BAO_0000218,Biodistribution in normal mice spleen after 120 hr,Mus musculus,,,,Intermediate,,,In vivo,14950,2106.0,10090.0,50594,15045,
,N,A,CHEMBL630550,1,1,Spleen,BAO_0000218,Biodistribution in normal mice spleen after 24 hr,Mus musculus,,,,Intermediate,,,In vivo,14951,2106.0,10090.0,50594,15045,
,N,A,CHEMBL876426,1,1,Spleen,BAO_0000218,Biodistribution in normal mice spleen after 4 hr,Mus musculus,,,,Intermediate,,,In vivo,14952,2106.0,10090.0,50594,15045,
,N,A,CHEMBL630551,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14953,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630552,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14954,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630553,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14955,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630554,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14956,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630555,1,1,Spleen,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14957,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630556,1,1,Spleen,BAO_0000218,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14958,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630557,1,1,Spleen,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14959,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630558,1,1,Spleen,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,,Intermediate,,,In vivo,14960,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630559,1,1,Spleen,BAO_0000218,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14961,2106.0,10116.0,50597,12017,
,N,A,CHEMBL630560,1,1,Spleen,BAO_0000218,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14962,2106.0,10116.0,50597,12017,
,N,A,CHEMBL876427,1,1,Thyroid gland,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,,Intermediate,,,In vivo,14963,2046.0,10116.0,50597,12017,
,N,A,CHEMBL630561,1,1,,BAO_0000218,The Kel values in female wistar rats.,Rattus norvegicus,,,,Intermediate,,,,14964,,10116.0,50597,14941,
,U,A,CHEMBL630562,1,0,,BAO_0000019,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,,,Autocuration,,,,14965,,,22224,4646,
,U,A,CHEMBL630563,1,0,,BAO_0000019,Hydrolysis rate constant of the compound,,,,,Autocuration,,,,14966,,,22224,8847,
,U,P,CHEMBL629673,1,0,,BAO_0000100,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,,,Autocuration,,,,14967,,,22229,11778,
,U,A,CHEMBL629674,1,0,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,,,Autocuration,,,,14968,,,22224,2363,
,U,A,CHEMBL629675,1,0,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,,,Autocuration,,,,14969,,,22224,2363,
,U,A,CHEMBL629676,1,0,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,,,Autocuration,,,,14970,,,22224,2363,
,U,A,CHEMBL629677,1,0,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,,,Autocuration,,,,14971,,,22224,2363,
,U,A,CHEMBL629678,1,0,,BAO_0000019,Apparent inactivation rate constant was evaluated,,,,,Autocuration,,,,14972,,,22224,8371,
,U,A,CHEMBL629679,1,0,,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,,,Autocuration,,,,14973,,,22224,14883,
,U,A,CHEMBL629680,1,0,,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,,,Autocuration,,,,14974,,,22224,14883,
,U,A,CHEMBL629681,1,0,,BAO_0000019,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,,,Autocuration,,,,14975,,,22224,4643,
,U,A,CHEMBL629682,1,0,,BAO_0000019,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,,,Autocuration,,,,14976,,,22224,3519,
,U,A,CHEMBL629683,1,0,,BAO_0000019,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,,,Autocuration,,,,14977,,,22224,10600,
,U,F,CHEMBL629684,1,0,,BAO_0000019,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,,,Autocuration,,,,14978,,,22224,8501,
,U,P,CHEMBL629685,1,0,,BAO_0000100,Dissociation constant was determined,,,,,Autocuration,,,,14979,,,22224,8505,
,U,P,CHEMBL629686,1,0,,BAO_0000100,Dissociation constant was determined,,,,,Autocuration,,,,14980,,,22224,9778,
,U,P,CHEMBL872932,1,0,,BAO_0000100,Dissociation constant at pH 7.4,,,,,Autocuration,,,,14981,,,22224,9778,
,U,P,CHEMBL629687,1,0,,BAO_0000100,Dissociation constant in presence of 1 mM dithiothreitol,,,,,Autocuration,,,,14982,,,22224,9778,
,U,A,CHEMBL872931,1,0,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,,Autocuration,,,,14983,,,22224,13007,
,U,A,CHEMBL628151,1,0,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,,Autocuration,,,,14984,,,22224,13007,
,U,A,CHEMBL628152,1,0,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,,Autocuration,,,,14985,,,22224,13007,
,U,A,CHEMBL628153,1,0,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,,Autocuration,,,,14986,,,22224,13007,
,U,A,CHEMBL628154,1,0,,BAO_0000019,Kinetic constant for aromatization of androstenedione,,,,,Autocuration,,,,14987,,,22224,11482,
,U,A,CHEMBL628155,1,0,,BAO_0000019,Kinetic constant for aromatization of testosterone,,,,,Autocuration,,,,14988,,,22224,11482,
,U,A,CHEMBL628156,1,0,,BAO_0000019,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,,,Autocuration,,,,14989,,,22224,2303,
,U,A,CHEMBL628157,1,0,,BAO_0000019,Local inhibition constant was determined,,,,,Autocuration,,,,14990,,,22224,11964,
,N,A,CHEMBL857533,1,1,,BAO_0000218,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Saccharomyces cerevisiae,,,,Intermediate,,,,14991,,4932.0,50347,3140,
,U,P,CHEMBL628158,1,0,,BAO_0000100,Dissociation constant value of the compound,,,,,Autocuration,,,,14992,,,22224,10650,
,U,A,CHEMBL628159,1,0,Cornea,BAO_0000019,In vitro permeability through cornea without epithelium,,,,,Autocuration,,,,14993,964.0,,22224,4667,
,U,A,CHEMBL875616,1,0,Cornea,BAO_0000019,In vitro permeability through intact cornea,,,,,Autocuration,,,,14994,964.0,,22224,4667,
,N,A,CHEMBL628160,1,1,Cornea,BAO_0000218,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Oryctolagus cuniculus,,,,Intermediate,,,,14995,964.0,9986.0,50592,9199,
,U,A,CHEMBL628161,1,0,,BAO_0000019,Rate of enzyme inactivation for the compound was determined,,,,,Autocuration,,,,14996,,,22224,11966,
,U,A,CHEMBL628162,1,0,Cornea,BAO_0000019,In vitro permeability through cornea without epithelium,,,,,Autocuration,,,,14997,964.0,,22224,4667,
,U,A,CHEMBL628163,1,0,Cornea,BAO_0000019,In vitro permeability through intact cornea,,,,,Autocuration,,,,14998,964.0,,22224,4667,
,U,A,CHEMBL628164,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,14999,,,22224,8354,
,U,A,CHEMBL628165,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15000,,,22224,8354,
,U,A,CHEMBL628166,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15001,,,22224,8354,
,U,A,CHEMBL628167,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15002,,,22224,8354,
,U,A,CHEMBL628168,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15003,,,22224,8354,
,U,A,CHEMBL628169,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15004,,,22224,8354,
,U,A,CHEMBL628170,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15005,,,22224,8354,
,U,A,CHEMBL628171,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15006,,,22224,8354,
,U,A,CHEMBL627434,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15007,,,22224,8354,
,U,A,CHEMBL627435,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15008,,,22224,8354,
,U,A,CHEMBL628110,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15009,,,22224,8354,
,U,A,CHEMBL628111,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15010,,,22224,8354,
,U,A,CHEMBL628112,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15011,,,22224,8354,
,U,A,CHEMBL628260,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15012,,,22224,8354,
,U,A,CHEMBL628261,1,0,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,Autocuration,,,,15013,,,22224,8354,
,N,A,CHEMBL628262,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,,Intermediate,,,In vivo,15014,,10090.0,50594,14439,
,N,A,CHEMBL628263,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Homo sapiens,,,,Intermediate,,,In vivo,15015,,9606.0,50587,14439,
,N,A,CHEMBL628264,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,,Intermediate,,,In vivo,15016,,10090.0,50594,14439,
,N,A,CHEMBL628265,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,,Intermediate,,,In vivo,15017,,10090.0,50594,14439,
,N,A,CHEMBL628266,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,,Intermediate,,,In vivo,15018,,10090.0,50594,14439,
,N,A,CHEMBL628267,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,,Intermediate,,,In vivo,15019,,10090.0,50594,14439,
,N,A,CHEMBL628268,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Mus musculus,,,,Intermediate,,,In vivo,15020,,10090.0,50594,14439,
,N,A,CHEMBL628269,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,,Intermediate,,,In vivo,15021,,10090.0,50594,14439,
,N,A,CHEMBL628270,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,,Intermediate,,,In vivo,15022,,10090.0,50594,14439,
,N,A,CHEMBL628271,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,,Intermediate,,,In vivo,15023,,10090.0,50594,14439,
,N,A,CHEMBL628272,1,1,,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,,Intermediate,,,In vivo,15024,,10090.0,50594,14439,
